Non	NNP	compound	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	nsubj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	pobj	O
tumours	NNS	ROOT	O
:	:	punct	O
results	NNS	dep	O
of	IN	case	O
a	DT	det	O
comparative	JJ	amod	O
study	NN	nmod	O
between	IN	case	O
SPET	NN	nmod	O
with	IN	case	O
123I	CD	compound	O
-	HYPH	punct	O
alpha	NN	compound	O
-	HYPH	punct	O
methyl	NN	compound	O
tyrosine	NN	nmod	O
and	CC	cc	O
PET	NN	conj	O
with	IN	case	O
18F	NN	compound	O
-	HYPH	punct	O
deoxyglucose	NN	nmod	O
.	.	punct	O
Positron	NN	compound	O
emission	NN	compound	O
tomography	NN	ROOT	O
in	IN	case	O
a	DT	det	O
case	NN	nmod	O
of	IN	prep	O
intracranial	JJ	amod	B-Cancer
hemangiopericytoma	NN	pobj	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
AND	CC	cc	O
PURPOSE	NN	conj	O
:	:	punct	O
Cerebral	JJ	amod	O
cavernous	JJ	amod	O
malformations	NNS	nsubj	O
(	-LRB-	punct	O
CCMs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
prevalent	JJ	amod	O
cerebral	JJ	amod	O
vascular	JJ	amod	O
lesions	NNS	dep	O
involving	VBG	acl	O
aberrant	JJ	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O
Due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
low	JJ	amod	O
prevalence	NN	nmod	O
of	IN	case	O
hemangiopericytomas	NNS	nmod	B-Cancer
(	-LRB-	punct	O
HPCs	NNS	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
data	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
biophysiological	JJ	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
this	DT	det	O
tumor	NN	nmod	B-Cancer
are	VBP	cop	O
rare	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
dynamic	JJ	amod	O
uptake	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	O
analogue	NN	nmod	O
[	-LRB-	punct	O
18F	NN	dep	O
]	-RRB-	punct	O
FDG	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
diseased	JJ	amod	O
nodes	NNS	nmod	O
and	CC	cc	O
upper	JJ	amod	O
arm	NN	compound	O
skeletal	JJ	amod	O
muscle	NN	conj	O
in	IN	case	O
both	DT	det	O
metabolic	JJ	amod	O
states	NNS	nmod	O
.	.	punct	O
Positron	NN	compound	O
emission	NN	compound	O
tomography	NN	nsubj	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
a	DT	det	O
sixfold	RB	advmod	O
increased	VBN	amod	O
uptake	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	B-Simple_chemical
11C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
methionine	NN	nmod	I-Simple_chemical
and	CC	cc	O
hyperperfusion	NN	conj	O
in	IN	case	O
the	DT	det	O
HPC	NN	nmod	B-Cancer
,	,	punct	O
whereas	IN	dep	O
glucose	NN	compound	B-Simple_chemical
utilization	NN	nsubjpass	O
was	VBD	auxpass	O
decreased	VBN	parataxis	O
in	IN	case	O
this	DT	det	O
area	NN	nmod	O
.	.	punct	O

Tumors	NNS	nsubj	O
display	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
and	CC	cc	O
glycolysis	NN	conj	O
.	.	punct	O
This	DT	det	O
low	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
utilization	NN	nsubj	O
is	VBZ	cop	O
in	IN	case	O
contrast	NN	ROOT	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
[	-LRB-	punct	B-Simple_chemical
11C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
methionine	NN	compound	I-Simple_chemical
uptake	NN	nmod	O
and	CC	cc	O
the	DT	det	O
malignancy	NN	conj	O
of	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
no	DT	neg	O
major	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
PET	NN	compound	O
investigation	NN	nmod	O
of	IN	case	O
glucose	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
the	DT	det	O
less	RBR	amod	O
expensive	JJ	amod	O
SPET	NN	compound	O
measurement	NN	conj	O
of	IN	case	O
amino	NN	compound	O
acid	NN	compound	O
uptake	NN	nmod	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
their	PRP$	poss	O
accuracy	NN	nmod	O
in	IN	mark	O
evaluating	VBG	acl	O
the	DT	det	O
malignancy	NN	compound	O
grade	NN	dobj	O
of	IN	prep	O
primary	JJ	amod	O
brain	NN	compound	O
tumours	NNS	pobj	O
.	.	punct	O
The	DT	det	O
characteristics	NNS	nsubj	O
of	IN	case	O
HPCs	NNS	nmod	B-Cancer
in	IN	case	O
PET	NN	nmod	O
described	VBN	acl	O
herein	RB	advmod	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
offer	NN	ROOT	O
additional	JJ	amod	O
diagnostic	JJ	amod	O
criteria	NNS	dobj	O
and	CC	cc	O
may	MD	aux	O
help	VB	conj	O
especially	RB	advmod	O
to	TO	mark	O
differentiate	VB	xcomp	O
these	DT	det	O
tumors	NNS	dobj	B-Cancer
from	IN	case	O
meningiomas	NNS	nmod	B-Cancer
.	.	punct	O

Prophylactic	JJ	amod	O
thyroidectomy	NN	nsubj	O
in	IN	case	O
MEN	NN	compound	O
IIA	NN	nmod	O
:	:	punct	O
does	VBZ	aux	O
the	DT	det	O
calcitonin	NN	compound	O
level	NN	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
tumor	NN	nmod	O
spread	NN	acl	O
?	.	punct	O
Thyrotropin	NN	compound	B-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
role	NN	dep	O
for	IN	case	O
thyroid	NN	compound	B-Organ
tumourigenesis	NN	nmod	O
?	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
Human	JJ	amod	B-Organism
thyroid	NN	nsubj	B-Cancer
tumours	NNS	nsubj	I-Cancer
represent	VBP	ROOT	O
an	DT	det	O
example	NN	dobj	O
of	IN	case	O
the	DT	det	O
interplay	NN	nmod	O
of	IN	case	O
genetic	JJ	intj	O
and	CC	cc	O
non	JJ	conj	O
genetic	JJ	amod	O
carcinogenesis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
abnormalities	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
elements	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Thyrotropin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TSH	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
dependent	JJ	amod	O
cAMP	NN	compound	B-Simple_chemical
regulatory	JJ	amod	O
cascade	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
both	CC	cc:preconj	O
in	IN	case	O
benign	JJ	amod	B-Pathological_formation
and	CC	cc	O
malignant	JJ	conj	B-Cancer
thyroid	NN	compound	I-Cancer
tumours	NNS	nmod	I-Cancer
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
activating	VBG	amod	O
mutations	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
TSH	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
Gs	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
gene	NN	conj	O
in	IN	case	O
thyroid	NN	compound	B-Cancer
toxic	JJ	amod	I-Cancer
adenoma	NN	nmod	I-Cancer
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cAMP	NN	compound	B-Simple_chemical
pathway	NN	nmod	O
and	CC	cc	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
hypothesised	VBN	conj	O
that	IN	mark	O
these	DT	det	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
causative	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
have	VBP	aux	O
led	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
the	DT	det	O
supplemental	JJ	amod	O
intake	NN	nsubj	O
of	IN	prep	O
these	DT	det	O
vitamins	NNS	pobj	O
may	MD	aux	O
reduce	VB	ccomp	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
recent	JJ	amod	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
more	JJR	amod	O
caution	NN	dobj	O
in	IN	mark	O
accepting	VBG	advcl	O
such	PDT	amod	O
a	DT	det	O
hypothesis	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
activating	VBG	amod	O
TSH	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
mutations	NNS	nmod	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
differentiated	VBN	amod	O
thyroid	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
At	IN	case	O
present	JJ	nmod	O
,	,	punct	O
the	DT	det	O
percentage	NN	nsubj	O
of	IN	prep	O
such	PDT	predet	O
a	DT	det	O
modification	NN	pobj	O
is	VBZ	ROOT	O
low	JJ	acomp	O
,	,	punct	O
unless	IN	mark	O
referred	VBN	advcl	O
to	IN	prep	O
selected	VBN	amod	O
series	NN	pobj	O
of	IN	prep	O
tumours	NNS	pobj	B-Cancer
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
Activating	VBG	amod	O
mutations	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
TSH	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
group	NN	nmod	O
of	IN	case	O
differentiated	VBN	amod	O
carcinomas	NNS	nmod	B-Cancer
with	IN	case	O
high	JJ	amod	O
basal	JJ	amod	O
adenylyl	JJ	amod	B-Gene_or_gene_product
cyclase	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
few	JJ	amod	O
cases	NNS	conj	O
of	IN	case	O
hyperfunctioning	VBG	amod	O
thyroid	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TSH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	O
cAMP	NN	compound	B-Simple_chemical
pathway	NN	compound	O
alterations	NNS	nmod	O
in	IN	case	O
thyroid	NN	compound	B-Organ
transformation	NN	nmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

This	DT	nsubj	O
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
therapeutic	JJ	amod	O
concept	NN	nmod	O
of	IN	case	O
prophylactic	JJ	amod	O
thyroidectomy	NN	nmod	O
in	IN	case	O
affected	VBN	amod	O
family	NN	compound	O
members	NNS	nmod	O
with	IN	case	O
the	DT	det	O
goal	NN	nmod	O
of	IN	prep	O
removing	VBG	pcomp	O
the	DT	det	O
thyroid	NN	dobj	O
before	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
carcinoma	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
TSH	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
alterations	NNS	nmod	O
in	IN	case	O
benign	JJ	amod	B-Pathological_formation
and	CC	cc	O
malignant	JJ	conj	B-Cancer
thyroid	NN	compound	I-Cancer
neoplasia	NN	nmod	I-Cancer
is	VBZ	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	O
/	:	punct	O
Erk	NN	conj	O
and	CC	cc	O
PI3K	NN	conj	O
/	:	punct	O
Akt	NN	compound	O
signaling	NN	conj	O
.	.	punct	O
Cooccurrence	NN	nsubj	O
of	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
predictor	NN	ROOT	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O
BACKGROUND	NN	nsubj	O
AND	CC	cc	O
OBJECTIVES	NNS	conj	O
:	:	punct	O
Even	RB	advmod	O
though	IN	mark	O
the	DT	det	O
pathological	JJ	amod	O
background	NN	nsubj	O
contributes	VBZ	dep	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
the	DT	det	O
biological	JJ	amod	O
characteristics	NNS	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
have	VBP	aux	O
also	RB	advmod	O
gained	VBN	ROOT	O
wide	JJ	amod	O
attention	NN	dobj	O
.	.	punct	O

Few	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cadherin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
catenin	NN	compound	B-Gene_or_gene_product
complex	NN	nmod	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
alpha	NN	compound	O
-	:	punct	O
SMA	NN	nsubjpass	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
were	VBD	auxpass	O
identified	VBN	ccomp	O
as	IN	case	O
independent	JJ	amod	O
predictive	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Their	PRP$	nmod:poss	O
correlation	NN	nsubjpass	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
predictability	NN	conj	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
,	,	punct	O
by	IN	mark	O
combining	VBG	acl	O
these	DT	det	O
factors	NNS	dobj	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
discussed	VBN	ROOT	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
and	CC	cc	O
explore	VBP	conj	O
their	PRP$	nmod:poss	O
roles	NNS	dobj	O
in	IN	case	O
progression	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
One	CD	nummod	O
hundred	CD	nsubjpass	O
and	CC	cc	O
one	CD	nummod	O
specimens	NNS	conj	B-Multi-tissue_structure
obtained	VBN	acl	O
from	IN	case	O
surgery	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
using	VBG	acl	O
monoclonal	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
anti	JJ	compound	O
-	HYPH	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
p53	NN	conj	B-Gene_or_gene_product
antibodies	NNS	dobj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
quantified	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
MCT	NN	compound	O
isoforms	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
glioblastoma	NN	compound	O
multiforme	NN	nmod	O
and	CC	cc	O
glioma	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
cells	NNS	compound	O
lines	NNS	conj	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	appos	O
in	IN	case	O
50	CD	nmod	O
.	.	punct	O
5	CD	ROOT	O
and	CC	cc	O
64	CD	conj	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
positive	JJ	amod	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	dobj	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
immunostaining	NN	conj	O
in	IN	case	O
44	CD	nmod	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
28	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
58	CD	conj	O
.	.	punct	O
9	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
studied	VBN	amod	O
primary	JJ	amod	O
tumors	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
63	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
45	CD	appos	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
72	CD	conj	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastases	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
staining	NN	nsubj	O
was	VBD	cop	O
positive	JJ	ROOT	O
in	IN	case	O
29	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	conj	O
between	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
or	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

By	IN	mark	O
modulating	VBG	advcl	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	O
model	NN	nmod	O
of	IN	case	O
melanoma	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	acl:relcl	O
on	IN	case	O
melanocyte	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
Pten	NNP	compound	O
loss	NN	nmod	O
and	CC	cc	O
Braf	NN	compound	O
(	-LRB-	punct	O
V600E	NN	appos	O
)	-RRB-	punct	O
mutation	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
central	JJ	amod	O
mediator	NN	ccomp	O
of	IN	case	O
melanoma	NN	compound	O
metastasis	NN	nmod	O
to	TO	case	O
the	DT	det	O
lymph	NN	compound	O
nodes	NNS	nmod	O
and	CC	cc	O
lungs	NNS	conj	O
.	.	punct	O
A	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
overexpression	NN	conj	O
correlated	VBD	ROOT	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
alpha	NN	compound	O
-	:	punct	O
SMA	NN	nsubjpass	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
were	VBD	auxpass	O
identified	VBN	ccomp	O
as	IN	case	O
independent	JJ	amod	O
predictive	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Multivariate	JJ	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
cooccurrence	NN	nsubj	O
of	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
was	VBD	cop	O
an	DT	det	O
independent	JJ	amod	O
factor	NN	ccomp	O
indicating	VBG	acl	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
D10S541	NN	nmod	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
was	VBD	auxpass	O
found	VBN	dep	O
in	IN	case	O
37	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
21	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
A	DT	det	O
study	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
may	MD	aux	O
be	VB	cop	O
helpful	JJ	appos	O
to	TO	mark	O
predict	VB	xcomp	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	dobj	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

WT1	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Wilms	NN	amod	O
tumor	NN	nmod	O
.	.	punct	O
Proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
promoter	NN	nsubjpass	O
is	VBZ	auxpass	O
down	RB	advmod	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
Wilms	NN	nmod:poss	B-Cancer
'	POS	punct	I-Cancer
tumor	NN	compound	I-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
WT1	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
Wilms	NN	amod	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
WT1	NN	nsubj	O
induces	VBZ	ROOT	O
G1	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
myeloblastic	JJ	amod	O
leukemia	NN	compound	O
M1	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
Wilms	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	I-Gene_or_gene_product
tumor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
WT1	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	ROOT	O
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
zinc	NN	compound	B-Simple_chemical
-	HYPH	punct	O
finger	NN	compound	O
transcription	NN	compound	O
factor	NN	dobj	O
.	.	punct	O

The	DT	det	O
Wilms	NN	amod	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
WT1	NN	nsubj	O
induces	VBZ	ROOT	O
G1	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
myeloblastic	JJ	amod	O
leukemia	NN	compound	O
M1	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
WT1	NN	nsubj	B-Gene_or_gene_product
represses	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
growth	NN	compound	O
factor	NN	compound	O
receptors	NNS	conj	O
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	O
and	CC	cc	O
MYC	NN	conj	O
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O
The	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nsubj	O
encodes	VBZ	ROOT	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	dobj	O
which	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
cell	NN	dobj	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

WT1	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Wilms	NN	amod	O
tumor	NN	nmod	O
.	.	punct	O
N	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
coexpressed	VBN	ROOT	O
with	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
developing	VBG	amod	O
kidney	NN	nmod	B-Organ
and	CC	cc	O
is	VBZ	auxpass	O
overexpressed	VBN	conj	O
in	IN	prep	O
many	JJ	amod	O
Wilms	NN	poss	B-Cancer
'	POS	case	I-Cancer
tumors	NNS	pobj	I-Cancer
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
elucidate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
WT1	NN	nmod	O
in	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
overexpressed	VBD	ROOT	O
exogenous	JJ	amod	O
WT1	NN	dobj	O
in	IN	case	O
murine	JJ	amod	O
M1	NN	compound	O
myeloblastic	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
isopropyl	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
-	HYPH	punct	O
D	NN	compound	O
-	HYPH	punct	O
thiogalactoside	NN	nmod:npmod	O
(	-LRB-	punct	O
IPTG	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
controlled	VBN	amod	O
expression	NN	compound	O
system	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
promoter	NN	nsubjpass	O
was	VBD	auxpass	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
by	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
elucidate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
WT1	NN	nmod	O
in	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
overexpressed	VBD	ROOT	O
exogenous	JJ	amod	O
WT1	NN	dobj	O
in	IN	case	O
murine	JJ	amod	O
M1	NN	compound	O
myeloblastic	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
isopropyl	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
-	HYPH	punct	O
D	NN	compound	O
-	HYPH	punct	O
thiogalactoside	NN	nmod:npmod	O
(	-LRB-	punct	O
IPTG	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
controlled	VBN	amod	O
expression	NN	compound	O
system	NN	dobj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
mutant	JJ	amod	O
WT1	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
R394W	NN	appos	B-Amino_acid
)	-RRB-	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
mutation	NN	dobj	O
in	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
domain	NN	nmod	O
could	MD	aux	O
not	RB	neg	O
repress	VB	ROOT	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
promoter	NN	dobj	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
elucidate	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
WT1	NN	nmod	O
in	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
overexpressed	VBD	ROOT	O
exogenous	JJ	amod	O
WT1	NN	dobj	O
in	IN	case	O
murine	JJ	amod	O
M1	NN	compound	O
myeloblastic	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
isopropyl	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
-	HYPH	punct	O
D	NN	compound	O
-	HYPH	punct	O
thiogalactoside	NN	nmod:npmod	O
(	-LRB-	punct	O
IPTG	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
controlled	VBN	amod	O
expression	NN	compound	O
system	NN	dobj	O
.	.	punct	O
Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
oligonucleotides	NNS	nsubj	O
containing	VBG	acl	O
the	DT	det	O
WT1	NN	compound	B-Gene_or_gene_product
motifs	NNS	dobj	O
could	MD	aux	O
bind	VB	ccomp	O
recombinant	JJ	amod	O
WT1	NN	compound	B-Gene_or_gene_product
proteins	NNS	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	compound	O
suppression	NN	nsubj	O
of	IN	case	O
WT1	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
WT1	NN	compound	O
anti	NN	amod	O
-	HYPH	punct	O
sense	NN	amod	O
oligonucleotide	NN	nmod	O
inhibits	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
leukemia	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
WT1	NN	nsubj	O
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
their	PRP$	nmod:poss	O
proliferation	NN	nmod	O
.	.	punct	O
This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
repression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
promoter	NN	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
through	IN	case	O
the	DT	det	O
WT1	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

WT1	NN	nsubjpass	O
was	VBD	auxpass	O
isolated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Wilms	NN	amod	O
tumor	NN	nmod	O
.	.	punct	O
This	DT	det	O
finding	NN	nsubj	O
may	MD	aux	O
help	VB	ROOT	O
to	TO	mark	O
elucidate	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
of	IN	case	O
WT1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	conj	I-Gene_or_gene_product
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
renal	JJ	amod	B-Organ
development	NN	conj	O
.	.	punct	O

Hypermethylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
HRK	NN	compound	O
promoter	NN	nmod	O
alone	RB	advmod	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
overall	JJ	amod	O
outcome	NN	nmod	O
,	,	punct	O
but	CC	cc	O
relapse	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
shorter	JJR	conj	O
.	.	punct	O
Tumour	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
distribution	NN	nsubj	O
of	IN	case	O
BRCA1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	compound	O
methylation	NN	nmod	O
supports	VBZ	ROOT	O
a	DT	det	O
pathogenetic	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cancer
and	CC	cc	O
ovarian	JJ	conj	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
The	DT	det	O
role	NN	nsubj	O
of	IN	case	O
BRCA1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
sporadic	JJ	amod	O
breast	NN	nmod	B-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
remains	VBZ	ROOT	O
elusive	JJ	xcomp	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
Direct	JJ	amod	O
involvement	NN	nsubjpass	O
of	IN	case	O
BRCA1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
finding	NN	nmod	O
that	IN	mark	O
the	DT	det	O
BRCA1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	nsubjpass	O
CpG	NN	compound	O
island	NN	dep	O
is	VBZ	auxpass	O
methylated	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
proportion	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
and	CC	cc	O
ovarian	JJ	conj	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
the	DT	det	O
incidence	NN	dobj	O
of	IN	case	O
BRCA1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
in	IN	case	O
which	WDT	nmod	O
loss	NN	nsubjpass	O
of	IN	case	O
BRCA1	NN	nmod	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
pathogenesis	NN	nmod	O
(	-LRB-	punct	O
breast	NN	intj	B-Cancer
and	CC	cc	O
ovarian	JJ	conj	B-Cancer
carcinomas	NNS	appos	I-Cancer
)	-RRB-	punct	O
with	IN	case	O
the	DT	det	O
incidence	NN	nmod	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
in	IN	case	O
which	WDT	nmod	O
BRCA1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
unlikely	JJ	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
pathogenesis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
revealed	VBD	ROOT	O
PTEN	NN	compound	O
promoter	NN	compound	O
methylation	NN	dobj	O
in	IN	case	O
15	CD	nmod	O
.	.	punct	O
9	CD	nummod	O
%	NN	amod	O
CCMs	NNS	ROOT	O
.	.	punct	O
Promoter	NN	compound	O
region	NN	compound	O
hypermethylation	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
more	RBR	advmod	O
common	JJ	ROOT	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
008	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
breast	NN	nmod	B-Cancer
and	CC	cc	O
ovarian	JJ	conj	B-Cancer
cancer	NN	conj	I-Cancer
(	-LRB-	punct	O
6	CD	dep	O
/	SYM	punct	O
38	CD	nummod	O
tumours	NNS	conj	B-Cancer
methylated	VBD	acl	O
)	-RRB-	punct	O
than	IN	case	O
in	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	advcl	I-Cancer
(	-LRB-	punct	O
0	CD	compound	O
/	SYM	punct	O
35	CD	nummod	O
tumours	NNS	dep	B-Cancer
methylated	VBD	acl	O
)	-RRB-	punct	O
or	CC	cc	O
in	IN	case	O
leukaemias	NNS	conj	B-Cancer
(	-LRB-	punct	O
0	CD	compound	O
/	SYM	punct	O
19	CD	nummod	O
samples	NNS	dep	B-Cancer
methylated	VBD	acl	O
)	-RRB-	punct	O
.	.	punct	O

Hypermethylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
HRK	NN	compound	O
promoter	NN	nmod	O
alone	RB	advmod	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
overall	JJ	amod	O
outcome	NN	nmod	O
,	,	punct	O
but	CC	cc	O
relapse	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
shorter	JJR	conj	O
.	.	punct	O
The	DT	det	O
restriction	NN	nsubj	O
of	IN	case	O
BRCA1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	compound	O
hypermethylation	NN	nmod	O
to	TO	case	O
breast	NN	compound	B-Cancer
and	CC	cc	O
ovarian	JJ	conj	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
pathogenetic	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
BRCA1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
methylation	NN	nmod	O
in	IN	case	O
these	DT	det	O
tumours	NNS	nmod	B-Cancer
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	ccomp	O
the	DT	det	O
rarity	NN	intj	O
of	IN	case	O
observed	VBN	amod	O
BRCA1	NN	compound	B-Gene_or_gene_product
mutations	NNS	nmod	O
in	IN	case	O
sporadic	JJ	amod	O
breast	NN	nmod	B-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
is	VBZ	cop	O
due	JJ	case	O
to	TO	case	O
the	DT	det	O
greater	JJR	amod	O
likelihood	NN	nmod	O
of	IN	case	O
BRCA1	NN	compound	B-Gene_or_gene_product
inactivation	NN	nmod	O
by	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
mutational	JJ	amod	O
mechanisms	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
methylation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
Regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
resident	JJ	amod	O
chromosomal	JJ	amod	B-Cellular_component
copy	NN	nmod	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myb	NN	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
leukemogenesis	NN	nmod	O
.	.	punct	O

Bicistronic	JJ	amod	O
retroviral	JJ	amod	O
vector	NN	nsubj	O
reveals	VBZ	ROOT	O
capacity	NN	dobj	O
of	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
erbA	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
erythroleukemia	NN	dobj	O
and	CC	cc	O
to	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
operate	VB	conj	O
with	IN	prep	O
v	CD	compound	O
-	HYPH	punct	O
myb	VBN	pobj	O
.	.	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
frequent	JJ	amod	O
target	NN	attr	O
of	IN	case	O
retroviral	JJ	amod	B-Organism
insertional	JJ	amod	O
mutagenesis	NN	nmod	O
in	IN	case	O
murine	JJ	amod	B-Organism
leukemia	NN	compound	I-Organism
virus	NN	nmod:npmod	I-Organism
-	:	punct	O
induced	VBN	amod	O
myeloid	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
retrovirus	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
potentially	RB	advmod	O
contributing	VBG	acl	O
to	TO	case	O
leukemogenesis	NN	nmod	O
.	.	punct	O
Induction	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
leukemogenic	JJ	amod	O
phenotype	NN	nmod	O
is	VBZ	auxpass	O
generally	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
inappropriate	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
transcriptional	JJ	amod	O
regulator	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
Despite	IN	case	O
intensive	JJ	amod	O
investigations	NNS	nmod	O
,	,	punct	O
the	DT	det	O
target	NN	compound	O
genes	NNS	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nmod	I-Gene_or_gene_product
that	WDT	nsubjpass	O
are	VBP	auxpass	O
specifically	RB	advmod	O
involved	VBN	acl:relcl	O
in	IN	case	O
development	NN	nmod	O
of	IN	case	O
these	DT	det	O
myeloid	JJ	amod	B-Cell
lineage	NN	compound	O
neoplasms	NNS	nmod	B-Cancer
are	VBP	cop	O
still	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

c	LS	compound	O
-	HYPH	punct	O
MYC	NNP	nsubj	O
functions	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
switch	NN	nmod	O
to	TO	mark	O
alter	VB	advcl	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
mammary	JJ	amod	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
to	TO	case	O
oncostatin	NN	compound	O
M	NN	nmod	O
.	.	punct	O
In	FW	amod	O
vitro	FW	dep	O
assays	NNS	nsubj	O
have	VBP	aux	O
indicated	VBN	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	compound	O
gene	NN	ccomp	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myb	NN	nmod	I-Gene_or_gene_product
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
resident	JJ	amod	O
chromosomal	JJ	amod	B-Cellular_component
gene	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
yet	RB	advmod	O
been	VBN	auxpass	O
demonstrated	VBN	acl:relcl	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
MnSO4	NN	compound	O
co	NN	compound	O
-	:	punct	O
operates	VBZ	ccomp	O
with	IN	case	O
overexpressed	VBN	amod	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	nmod	O
in	IN	prep	O
inducing	VBG	pcomp	O
transformation	NN	dobj	O
,	,	punct	O
while	IN	mark	O
5	CD	compound	O
-	HYPH	punct	O
azacytidine	NN	compound	O
transformation	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	advcl	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
overexpression	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
involve	VB	conj	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O
To	TO	mark	O
address	VB	advcl	O
this	DT	det	O
question	NN	dobj	O
further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
myeloblastic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
M1	NN	appos	B-Cell
,	,	punct	O
expressing	VBG	acl	O
a	DT	det	O
conditionally	RB	advmod	O
active	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myb	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
estrogen	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
fusion	NN	compound	O
protein	NN	dobj	O
(	-LRB-	punct	O
MybER	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	O
-	HYPH	punct	O
MYC	NN	compound	O
overexpression	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
rescue	VB	xcomp	O
proliferation	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
release	VB	conj	O
the	DT	det	O
differentiation	NN	compound	O
block	NN	dobj	O
imposed	VBN	acl	O
by	IN	case	O
Runx2	NN	nmod	O
.	.	punct	O
Activation	NN	nsubj	O
of	IN	case	O
MybER	NN	nmod	B-Gene_or_gene_product
both	CC	nmod	O
prevented	VBD	ROOT	O
the	DT	det	O
growth	NN	compound	O
arrest	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
rapidly	RB	advmod	O
restored	VBD	conj	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
nearly	RB	advmod	O
terminal	JJ	amod	O
differentiated	VBN	amod	O
cells	NNS	nmod	B-Cell
that	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
exposed	VBN	acl:relcl	O
to	TO	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
for	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

Transformants	NNS	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	O
-	HYPH	punct	O
azacytidine	NN	pobj	O
lost	VBD	ROOT	O
c	NN	nmod:npmod	O
-	HYPH	punct	O
myc	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Restoration	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
after	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
block	NN	conj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ccomp	O
a	DT	det	O
direct	JJ	amod	O
,	,	punct	O
transcriptionally	RB	advmod	O
regulated	VBN	amod	O
target	NN	attr	O
of	IN	prep	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myb	NN	pobj	I-Gene_or_gene_product
.	.	punct	O

Transformants	NNS	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	O
-	HYPH	punct	O
azacytidine	NN	pobj	O
lost	VBD	ROOT	O
c	NN	nmod:npmod	O
-	HYPH	punct	O
myc	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubj	I-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
target	NN	attr	O
that	WDT	nsubj	O
transduces	VBZ	relcl	O
Myb	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
proliferative	JJ	amod	O
signal	NN	dobj	O
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
a	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
estrogen	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
fusion	NN	compound	O
protein	NN	nmod	O
alone	RB	advmod	O
to	TO	mark	O
also	RB	advmod	O
reverse	VB	acl	O
growth	NN	compound	O
arrest	NN	dobj	O
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
.	.	punct	O

Bicistronic	JJ	amod	O
retroviral	JJ	amod	O
vector	NN	nsubj	O
reveals	VBZ	ROOT	O
capacity	NN	dobj	O
of	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
erbA	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
erythroleukemia	NN	dobj	O
and	CC	cc	O
to	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
operate	VB	conj	O
with	IN	prep	O
v	CD	compound	O
-	HYPH	punct	O
myb	VBN	pobj	O
.	.	punct	O
To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
this	DT	det	O
regulatory	JJ	amod	O
connection	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
Myb	NN	compound	B-Gene_or_gene_product
'	POS	punct	O
s	NNS	compound	O
oncogenicity	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
Myb	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
myeloid	JJ	amod	B-Cell
leukemic	JJ	amod	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
RI	NN	nmod	I-Cell
-	:	punct	I-Cell
4	CD	nummod	I-Cell
-	SYM	punct	I-Cell
11	CD	nummod	I-Cell
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
Hoxa9	NN	nmod	O
/	:	punct	O
Meis1	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	conj	O
,	,	punct	O
retroviral	JJ	amod	O
insertional	JJ	amod	O
mutagenesis	NN	nsubjpass	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
using	VBG	xcomp	O
retrovirus	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	dobj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
cell	NN	compound	B-Cell
line	NN	nmod	I-Cell
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
insertional	JJ	amod	O
mutagenesis	NN	nmod	O
and	CC	cc	O
cannot	NN	advmod	O
be	VB	auxpass	O
effectively	RB	advmod	O
down	RB	advmod	O
regulated	VBN	conj	O
by	IN	case	O
cytokine	NN	nmod	O
.	.	punct	O

Bicistronic	JJ	amod	O
retroviral	JJ	amod	O
vector	NN	nsubj	O
reveals	VBZ	ROOT	O
capacity	NN	dobj	O
of	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
erbA	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
erythroleukemia	NN	dobj	O
and	CC	cc	O
to	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
operate	VB	conj	O
with	IN	prep	O
v	CD	compound	O
-	HYPH	punct	O
myb	VBN	pobj	O
.	.	punct	O
Myb	NN	nmod:poss	B-Gene_or_gene_product
'	POS	punct	O
s	NNS	compound	O
ability	NN	nsubjpass	O
to	TO	mark	O
regulate	VB	acl	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod:poss	I-Gene_or_gene_product
'	''	case	I-Gene_or_gene_product
s	NNS	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
demonstrated	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
showing	VBG	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
through	IN	case	O
which	WDT	nmod	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myb	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
exert	VB	acl:relcl	O
its	PRP$	nmod:poss	O
oncogenic	JJ	amod	O
potential	NN	dobj	O
in	IN	case	O
myeloid	JJ	amod	B-Cell
lineage	NN	compound	I-Cell
hematopoietic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
experiments	NNS	nmod	O
,	,	punct	O
the	DT	det	O
metastasis	NN	nsubjpass	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
tumor	NN	nmod:npmod	O
-	HYPH	punct	O
engrafted	VBN	amod	O
mice	NNS	nmod	O
were	VBD	auxpass	O
monitored	VBN	ROOT	O
.	.	punct	O
Adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
in	FW	amod	O
vivo	FW	dep	O
results	NNS	ROOT	O
in	IN	case	O
high	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
transgene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastases	NNS	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
Inhibition	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
strategy	NN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	O
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	O
shark	NN	pobj	O
(	-LRB-	punct	O
Prionace	NN	compound	O
glauca	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
its	PRP$	poss	O
widespread	JJ	amod	O
application	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
hampered	VBN	ROOT	O
by	IN	agent	O
difficulties	NNS	pobj	O
in	IN	case	O
the	DT	det	O
large	JJ	amod	O
-	HYPH	punct	O
scale	NN	amod	O
production	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nmod	O
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
cell	NN	compound	O
growth	NN	conj	O
.	.	punct	O
This	DT	det	O
limitation	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
resolved	VBN	ROOT	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
delivery	NN	nmod	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

VEGF165	NN	nsubj	O
expressed	VBN	acl	O
by	IN	case	O
a	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
recombinant	JJ	amod	O
adenovirus	NN	compound	O
vector	NN	nmod	O
induces	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
constructed	VBN	ROOT	O
a	DT	det	O
recombinant	JJ	amod	O
adenovirus	NN	dobj	B-Organism
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
murine	JJ	amod	B-Organism
endostatin	NN	dobj	B-Gene_or_gene_product
that	WDT	nsubj	O
is	VBZ	cop	O
biologically	RB	advmod	O
active	JJ	acl:relcl	O
both	CC	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
by	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
165	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Green	JJ	compound	O
fluorescence	NN	compound	O
protein	NN	compound	O
transfected	VBN	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
fat	NN	compound	O
pad	NN	nmod	O
of	IN	case	O
young	JJ	amod	O
female	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Persistent	JJ	amod	O
high	JJ	amod	O
serum	NN	compound	B-Organism_substance
levels	NNS	nsubjpass	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
605	CD	compound	O
-	SYM	punct	O
1740	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	dep	O
;	:	punct	O
mean	NN	dep	O
,	,	punct	O
936	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
achieved	VBN	ROOT	O
after	IN	case	O
systemic	JJ	amod	O
administration	NN	nmod	O
of	IN	case	O
the	DT	det	O
vector	NN	nmod	O
to	TO	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
which	WDT	nsubj	O
resulted	VBD	acl:relcl	O
in	IN	case	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
the	DT	det	O
growth	NN	compound	O
rates	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
volumes	NNS	conj	O
of	IN	case	O
JC	NN	compound	B-Cancer
breast	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
Lewis	NN	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
and	CC	cc	O
P	NN	conj	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mice	NNS	nsubj	O
bearing	VBG	acl	O
subcutaneous	JJ	amod	O
tumor	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	:	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NNP	compound	O
pretreated	VBD	amod	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
showed	VBD	appos	O
>	NN	amod	O
50	CD	compound	O
%	NN	compound	O
reduction	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
spontaneous	JJ	amod	O
pulmonary	JJ	amod	O
metastases	NNS	dobj	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
endostatin	NN	compound	B-Gene_or_gene_product
vector	NN	compound	O
treatment	NN	nsubj	O
completely	RB	advmod	O
prevented	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Cancer
micrometastases	NNS	nmod	I-Cancer
in	IN	case	O
Lewis	NN	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
0001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	O
from	IN	case	O
linomide	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
revealed	VBD	ROOT	O
marked	JJ	amod	O
avascularity	NN	dobj	O
.	.	punct	O
Immunohistochemical	JJ	amod	O
staining	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
demonstrated	VBD	ROOT	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
treatment	NN	compound	O
group	NN	nmod	O
versus	CC	cc	O
the	DT	det	O
controls	NNS	conj	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
show	VBP	appos	O
the	DT	det	O
effectiveness	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	SYM	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NNP	nmod	O
as	IN	case	O
an	DT	det	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
in	IN	mark	O
suppressing	VBG	acl	O
tumor	NN	compound	O
growth	NN	dobj	O
during	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	O
progression	NN	nmod	O
,	,	punct	O
validating	VBG	advcl	O
the	DT	det	O
application	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	SYM	punct	O
5	CD	compound	O
-	HYPH	punct	O
VAS	NN	compound	O
gene	NN	compound	O
therapy	NN	nmod	O
in	IN	case	O
treatment	NN	nmod	O
against	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
clearly	RB	advmod	O
demonstrates	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
of	IN	case	O
vector	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
antiangiogenic	JJ	amod	O
gene	NN	compound	O
therapy	NN	nmod	O
as	IN	case	O
a	DT	det	O
component	NN	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

PTEN	NN	compound	O
promoter	NN	compound	O
hypermethylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
mechanism	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
High	JJ	amod	O
frequency	NN	nsubj	O
of	IN	case	O
hypermethylation	NN	nmod	O
at	IN	case	O
the	DT	det	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
locus	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
gene	NN	compound	O
silencing	NN	nmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Simian	JJ	amod	O
virus	NN	compound	O
40	CD	nummod	O
large	JJ	amod	O
T	NN	compound	O
antigen	NN	nsubj	O
and	CC	cc	O
two	CD	nummod	O
independent	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
antigen	NN	compound	O
segments	NNS	nsubj	O
sensitize	VBP	ROOT	O
cells	NNS	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
genotoxic	JJ	amod	O
damage	NN	nmod	O
.	.	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
14	CD	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
final	JJ	amod	I-Gene_or_gene_product
sigma	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
causes	VBZ	conj	O
cells	NNS	dobj	B-Cell
to	TO	mark	O
arrest	VB	xcomp	O
in	IN	case	O
G	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

AQP5	NN	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
mainly	RB	advmod	O
in	IN	case	O
cell	NN	compound	O
membranes	NNS	nmod	O
in	IN	case	O
carcinoma	NN	compound	O
tissues	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
almost	RB	advmod	O
absent	JJ	conj	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O
By	IN	case	O
SAGE	NN	nmod	O
(	-LRB-	punct	O
serial	JJ	amod	O
analysis	NN	dep	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
)	-RRB-	punct	O
analysis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	dobj	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
gene	NN	nmod	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
is	VBZ	cop	O
7	CD	nummod	O
-	HYPH	punct	O
fold	VB	advmod	O
lower	JJR	acl:relcl	O
in	IN	case	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
than	IN	case	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
epithelium	NN	nmod	I-Tissue
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
a	DT	det	O
transcript	NN	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
U3	NN	compound	O
region	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
its	PRP$	nmod:poss	O
presence	NN	nsubj	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
trans	JJ	amod	O
-	HYPH	punct	O
activating	VBG	amod	O
activity	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
verified	VBD	ROOT	O
this	DT	det	O
finding	NN	dobj	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

AQP5	NN	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
mainly	RB	advmod	O
in	IN	case	O
cell	NN	compound	O
membranes	NNS	nmod	O
in	IN	case	O
carcinoma	NN	compound	O
tissues	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	cop	O
almost	RB	advmod	O
absent	JJ	conj	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O
Remarkably	RB	advmod	O
,	,	punct	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
mRNA	NN	nsubj	O
was	VBD	cop	O
undetectable	JJ	ROOT	O
in	IN	case	O
45	CD	nmod	O
of	IN	case	O
48	CD	nummod	O
primary	JJ	amod	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
D10S541	NN	nmod	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
was	VBD	auxpass	O
found	VBN	dep	O
in	IN	case	O
37	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
21	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Genetic	JJ	amod	O
alterations	NNS	nsubj	O
at	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	nmod	I-Gene_or_gene_product
such	JJ	case	O
as	IN	mwe	O
loss	NN	nmod	O
of	IN	case	O
heterozygosity	NN	nmod	O
were	VBD	cop	O
rare	JJ	ROOT	O
(	-LRB-	punct	O
1	CD	nummod	O
/	SYM	punct	O
20	CD	nummod	O
informative	JJ	amod	O
cases	NNS	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
mutations	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	conj	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
34	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
positive	JJ	amod	O
c	NN	compound	O
-	HYPH	punct	O
kit	NN	compound	O
protein	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
c	NN	compound	O
-	HYPH	punct	O
kit	NN	compound	O
gene	NN	compound	O
mutation	NN	compound	O
rates	NNS	conj	O
were	VBD	cop	O
97	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
80	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
41	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
34	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
hypermethylation	NN	nsubjpass	O
of	IN	case	O
CpG	NN	compound	O
islands	NNS	nmod	O
in	IN	case	O
the	DT	det	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
91	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
75	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
lack	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

After	IN	case	O
48	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
DR	NN	compound	O
antigen	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
substantially	RB	advmod	O
increased	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
significant	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	conj	O
in	IN	case	O
methylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DR	NN	compound	O
alpha	NN	compound	O
locus	NN	nmod	O
or	CC	cc	O
in	IN	case	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
DR	NN	compound	O
mRNA	NN	nmod	O
which	WDT	nsubj	O
was	VBD	cop	O
present	JJ	acl:relcl	O
.	.	punct	O
Hypermethylation	NN	nsubj	O
of	IN	prep	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	pobj	I-Gene_or_gene_product
is	VBZ	cop	O
functionally	RB	advmod	O
important	JJ	ROOT	O
,	,	punct	O
because	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
non	NNP	dep	O
-	HYPH	punct	O
expressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
the	DT	det	O
drug	NN	nmod	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aza	NNP	compound	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxycytidine	NN	dep	I-Simple_chemical
resulted	VBD	advcl	O
in	IN	case	O
demethylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
upregulation	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
occurs	VBZ	conj	O
only	RB	advmod	O
in	IN	case	O
highly	RB	advmod	O
malignant	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
lacking	VBG	acl	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
showed	VBD	ROOT	O
increased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
breaks	NNS	nmod	O
and	CC	cc	O
gaps	NNS	conj	O
when	WRB	advmod	O
exposed	VBN	advcl	O
to	TO	case	O
gamma	NN	compound	O
-	HYPH	punct	O
irradiation	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
loss	NN	nsubj	O
or	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
BRK1	NN	nmod	O
is	VBZ	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
protective	JJ	xcomp	O
against	IN	case	O
tumor	NN	compound	O
development	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
proliferation	NN	nmod	O
and	CC	cc	O
motility	NN	compound	O
defects	NNS	conj	O
in	IN	case	O
affected	VBN	amod	O
cells	NNS	nmod	O
.	.	punct	O
Therefore	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
contributes	VBZ	ccomp	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
by	IN	mark	O
impairing	VBG	advcl	O
the	DT	det	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
checkpoint	NN	compound	O
function	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
allowing	VBG	advcl	O
an	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
genetic	JJ	amod	O
defects	NNS	nmod	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
tumors	NNS	nmod	O
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O
Hypermethylation	NN	nsubj	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
final	JJ	amod	B-Gene_or_gene_product
sigma	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
are	VBP	cop	O
the	DT	det	O
most	RBS	advmod	O
consistent	JJ	amod	O
molecular	JJ	amod	O
alterations	NNS	nsubj	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
identified	VBN	ROOT	O
so	RB	advmod	O
far	RB	advmod	O
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	O
-	:	punct	O
ABL	NN	nmod	O
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	O
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	O
-	HYPH	punct	O
ABL	NN	conj	O
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O
Reduced	VBN	amod	O
oncogenicity	NN	ROOT	O
of	IN	case	O
p190	NN	compound	B-Gene_or_gene_product
Bcr	NN	compound	I-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
Abl	NNP	compound	I-Gene_or_gene_product
F	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
domain	NN	compound	O
mutants	NNS	nmod	O
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	O
-	:	punct	O
ABL	NN	nmod	O
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	O
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	O
-	HYPH	punct	O
ABL	NN	conj	O
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O
The	DT	det	O
deregulated	VBN	amod	O
Bcr	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
Abl	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nsubj	O
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
Philadelphia	NNP	compound	O
(	-LRB-	punct	O
Ph	NNP	appos	O
)	-RRB-	punct	O
-	:	punct	O
positive	JJ	amod	O
leukemia	NN	nmod	B-Cancer
in	IN	case	O
humans	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	O
-	:	punct	O
ABL	NN	nmod	O
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	O
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	O
-	HYPH	punct	O
ABL	NN	conj	O
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O
To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
the	DT	det	O
C	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
Abl	NN	compound	B-Gene_or_gene_product
actin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
domain	NN	nmod	O
within	IN	case	O
Bcr	NN	compound	B-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
Abl	NN	compound	I-Gene_or_gene_product
p190	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
leukemia	NN	compound	B-Cancer
/	:	punct	O
lymphoma	NN	nmod	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
mutant	JJ	amod	O
p190	NN	compound	B-Gene_or_gene_product
DNA	NN	compound	B-Cellular_component
constructs	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
generate	VB	xcomp	O
transgenic	JJ	amod	B-Organism
mice	NNS	dobj	I-Organism
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
in	IN	case	O
Hoxa9	NN	nmod	O
/	:	punct	O
Meis1	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	conj	O
,	,	punct	O
retroviral	JJ	amod	O
insertional	JJ	amod	O
mutagenesis	NN	nsubjpass	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
using	VBG	xcomp	O
retrovirus	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
transfer	NN	dobj	O
.	.	punct	O
Eight	CD	nummod	O
founder	NN	nsubjpass	O
and	CC	cc	O
progeny	NN	compound	O
mice	NNS	conj	B-Organism
of	IN	case	O
5	CD	nummod	O
different	JJ	amod	O
lines	NNS	nmod	O
were	VBD	auxpass	O
monitored	VBN	ROOT	O
for	IN	case	O
leukemogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
average	JJ	amod	O
latency	NN	nsubj	O
of	IN	case	O
leukemia	NN	compound	O
induction	NN	nmod	O
was	VBD	cop	O
shorter	JJR	ROOT	O
for	IN	case	O
the	DT	det	O
erbA	NN	compound	O
/	:	punct	O
myb	VBD	compound	O
IRES	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
3	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
than	IN	case	O
for	IN	case	O
the	DT	det	O
erbA	NN	compound	O
IRES	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O
Latency	NN	nsubjpass	O
was	VBD	auxpass	O
markedly	RB	advmod	O
increased	VBN	ROOT	O
and	CC	cc	O
occurrence	NN	conj	O
decreased	VBD	conj	O
in	IN	case	O
the	DT	det	O
p190	NN	compound	B-Gene_or_gene_product
del	NN	compound	O
C	NN	compound	O
lines	NNS	nmod	B-Organism
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
nonmutated	JJ	amod	O
p190	NN	compound	B-Gene_or_gene_product
BCR	NN	nmod	I-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
ABL	NN	compound	I-Gene_or_gene_product
transgenics	NNS	conj	B-Organism
.	.	punct	O

To	TO	mark	O
assess	VB	ROOT	O
the	DT	det	O
lymphoid	JJ	amod	O
tumorigenic	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
bcl	NN	nmod	O
-	SYM	punct	O
2	CD	nummod	O
,	,	punct	O
mice	NNS	dobj	O
of	IN	case	O
five	CD	nummod	O
independent	JJ	amod	O
strains	NNS	nmod	O
expressing	VBG	acl	O
a	DT	det	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	dobj	O
in	IN	case	O
B	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
T	NN	compound	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
monitored	VBN	conj	O
for	IN	case	O
disease	NN	nmod	O
up	IN	case	O
to	TO	case	O
12	CD	nummod	O
months	NNS	nmod	O
of	IN	case	O
age	NN	nmod	O
.	.	punct	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
involved	VBN	amod	O
hematologic	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
of	IN	case	O
the	DT	det	O
p190	NN	compound	B-Gene_or_gene_product
del	NN	compound	O
C	NN	compound	O
transgenics	NNS	nmod	B-Organism
with	IN	case	O
end	NN	compound	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
showed	VBD	ROOT	O
high	JJ	amod	O
-	HYPH	punct	O
level	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
transgene	NN	nmod	O
and	CC	cc	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	conj	O
of	IN	case	O
Cbl	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Hef1	NN	conj	B-Gene_or_gene_product
/	:	punct	O
Cas	NN	conj	B-Gene_or_gene_product
,	,	punct	O
proteins	NNS	conj	O
previously	RB	advmod	O
shown	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
affected	VBN	xcomp	O
by	IN	case	O
Bcr	NN	compound	B-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
Abl	NNP	nmod	I-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
actin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
domain	NN	nsubj	O
of	IN	case	O
Abl	NN	nmod	B-Gene_or_gene_product
enhances	VBZ	ccomp	O
leukemia	NN	compound	B-Cancer
development	NN	dobj	O
but	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	conj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
absolute	JJ	amod	O
requirement	NN	xcomp	O
for	IN	case	O
leukemogenesis	NN	nmod	O
.	.	punct	O

Due	JJ	case	O
to	TO	aux	O
space	NN	advcl	O
limitations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
review	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
CNS	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
refer	VBP	conj	O
the	DT	det	O
reader	NN	dobj	O
to	IN	prep	O
other	JJ	amod	O
chapters	NNS	pobj	O
in	IN	prep	O
this	DT	det	O
book	NN	pobj	O
and	CC	cc	O
to	TO	conj	O
recent	JJ	amod	O
publications	NNS	pobj	O
on	IN	prep	O
the	DT	det	O
assembly	NN	pobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O
Building	VBG	advcl	O
the	DT	det	O
vertebrate	JJ	compound	O
vasculature	NN	dobj	B-Anatomical_system
:	:	punct	O
research	NN	nsubj	O
is	VBZ	aux	O
going	VBG	ROOT	O
swimmingly	RB	advmod	O
.	.	punct	O

Due	JJ	case	O
to	TO	aux	O
space	NN	advcl	O
limitations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
review	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
CNS	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
refer	VBP	conj	O
the	DT	det	O
reader	NN	dobj	O
to	IN	prep	O
other	JJ	amod	O
chapters	NNS	pobj	O
in	IN	prep	O
this	DT	det	O
book	NN	pobj	O
and	CC	cc	O
to	TO	conj	O
recent	JJ	amod	O
publications	NNS	pobj	O
on	IN	prep	O
the	DT	det	O
assembly	NN	pobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
vertebrate	JJ	compound	O
vasculature	NN	nsubj	B-Anatomical_system
develops	VBZ	ROOT	O
in	IN	prep	O
remarkably	RB	advmod	O
similar	JJ	amod	O
fashion	NN	pobj	O
in	IN	prep	O
all	DT	det	O
vertebrates	NNS	pobj	O
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	O
CNS	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
A	DT	det	O
cohort	NN	nsubj	O
of	IN	case	O
unspecified	JJ	amod	O
mesodermal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
differentiates	VBZ	ROOT	O
into	IN	case	O
primitive	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
migrate	VBP	acl:relcl	O
to	IN	dep	O
and	CC	cc	O
occupy	VB	amod	O
positions	NNS	dobj	O
within	IN	case	O
the	DT	det	O
stereotypical	JJ	amod	O
blueprint	NN	nmod	O
of	IN	prep	O
the	DT	det	O
primitive	JJ	amod	O
vasculature	NN	pobj	B-Anatomical_system
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	O
subsequently	RB	advmod	O
proliferate	VBP	ROOT	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	mark	O
form	VB	xcomp	O
endothelial	JJ	amod	O
tubes	NNS	dobj	O
and	CC	cc	O
capillary	JJ	conj	O
-	HYPH	punct	O
like	JJ	conj	O
structures	NNS	pobj	O
.	.	punct	O
Once	RB	mark	O
in	IN	case	O
position	NN	nmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	B-Cell
coalesce	NNS	ROOT	O
and	CC	cc	O
form	NN	compound	O
cords	NNS	conj	B-Tissue
,	,	punct	O
which	WDT	nsubj	O
lumenize	VBP	acl:relcl	O
and	CC	cc	O
become	VB	auxpass	O
ensheathed	VBN	conj	O
by	IN	prep	O
supporting	VBG	amod	O
pericytes	NNS	pobj	B-Cell
and	CC	cc	O
smooth	VB	amod	B-Cell
muscle	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
ones	NNS	pobj	O
requires	VBZ	ROOT	O
highly	RB	advmod	O
coordinated	VBN	amod	O
restructuring	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
surrounding	JJ	amod	O
extracellular	JJ	amod	O
matrix	NN	conj	O
.	.	punct	O
This	DT	det	O
primitive	JJ	amod	O
vascular	JJ	amod	B-Anatomical_system
network	NN	nsubjpass	I-Anatomical_system
is	VBZ	auxpass	O
extensively	RB	advmod	O
remodeled	VBN	ROOT	O
in	IN	prep	O
some	DT	det	O
places	NNS	pobj	O
,	,	punct	O
and	CC	cc	O
expanded	VBN	conj	O
by	IN	prep	O
sprouting	VBG	pcomp	O
in	IN	prep	O
others	NNS	pobj	O
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	O
CNS	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
Various	JJ	amod	O
studies	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
mouse	NN	preconj	B-Organism
,	,	punct	O
quail	NN	conj	B-Organism
/	SYM	punct	O
chick	NN	conj	B-Organism
,	,	punct	O
and	CC	cc	O
frog	NN	dobj	B-Organism
have	VBP	aux	O
uncovered	VBN	ROOT	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
signals	NNS	nmod	O
that	WDT	nsubj	O
guide	VBP	acl:relcl	O
these	DT	det	O
complex	NN	compound	O
processes	NNS	dobj	O
but	CC	cc	O
many	JJ	amod	O
gaps	NNS	conj	O
still	RB	advmod	O
exist	VBP	acl	O
in	IN	case	O
our	PRP$	nmod:poss	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
embryonic	JJ	amod	B-Anatomical_system
vasculature	NN	nsubjpass	I-Anatomical_system
is	VBZ	auxpass	O
built	VBN	acl:relcl	O
.	.	punct	O

This	DT	det	O
chapter	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
morphology	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
formation	NN	nmod	O
in	IN	prep	O
and	CC	cc	O
around	IN	case	O
the	DT	det	O
early	JJ	amod	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	conj	O
(	-LRB-	punct	O
CNS	NN	appos	O
,	,	punct	O
i	LS	appos	O
.	.	punct	O
e	LS	ccomp	O
.	.	punct	O
,	,	punct	O
brain	NN	ROOT	O
and	CC	cc	O
spinal	JJ	amod	O
cord	NN	conj	O
)	-RRB-	punct	O
of	IN	prep	O
avian	JJ	amod	O
embryos	NNS	pobj	O
.	.	punct	O
Because	IN	mark	O
many	JJ	amod	O
questions	NNS	nsubj	O
will	MD	aux	O
require	VB	advcl	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
properly	RB	advmod	O
addressed	VBN	ccomp	O
,	,	punct	O
the	DT	det	O
zebrafish	NN	appos	B-Organism
,	,	punct	O
with	IN	case	O
its	PRP$	nmod:poss	O
unique	JJ	amod	O
accessibility	NN	nmod	O
to	TO	case	O
analysis	NN	nmod	O
by	IN	case	O
combined	JJ	amod	O
embryological	JJ	amod	B-Developing_anatomical_structure
,	,	punct	O
molecular	JJ	conj	O
,	,	punct	O
and	CC	cc	O
genetic	JJ	conj	O
methods	NNS	nmod	O
,	,	punct	O
should	MD	aux	O
prove	VB	ROOT	O
invaluable	JJ	xcomp	O
in	IN	mark	O
identifying	VBG	advcl	O
new	JJ	amod	O
molecules	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	nmod	O
and	CC	cc	O
integrating	NN	compound	O
pathways	NNS	conj	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
embryonic	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Tumor	NN	compound	O
metastasis	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
fibrinolytic	JJ	amod	O
system	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O
[	-LRB-	punct	O
Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	ROOT	I-Gene_or_gene_product
and	CC	cc	O
new	JJ	amod	O
drugs	NNS	conj	O
.	.	punct	O
Protective	JJ	amod	O
effect	NN	ROOT	O
against	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
infections	NNS	conj	O
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
peptide	NN	nmod	O
,	,	punct	O
LL	NN	compound	O
-	:	punct	O
37	CD	appos	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
pro	NN	compound	O
-	HYPH	punct	O
form	NN	conj	O
,	,	punct	O
human	JJ	amod	O
cationic	JJ	amod	O
antimicrobial	JJ	amod	O
protein	NN	appos	O
18	CD	nummod	O
(	-LRB-	punct	O
hCAP	NN	compound	O
-	:	punct	O
18	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
cancer	NN	compound	O
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
,	,	punct	O
originally	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
interferon	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
gamma	NN	compound	I-Gene_or_gene_product
inducing	VBG	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
IGIF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
family	NN	nmod	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
structure	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
its	PRP$	nmod:poss	O
processing	NN	conj	O
,	,	punct	O
receptor	NN	conj	O
,	,	punct	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	conj	O
and	CC	cc	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
properties	NNS	conj	O
.	.	punct	O

IL	NN	compound	O
-	HYPH	punct	O
17	CD	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gut	NN	compound	O
homeostasis	NN	nmod	O
.	.	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
also	RB	advmod	O
functionally	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
as	IN	mark	O
it	PRP	nsubj	O
induces	VBZ	advcl	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
Th1	NN	compound	B-Gene_or_gene_product
cytokines	NNS	nmod	O
and	CC	cc	O
participates	VBZ	conj	O
in	IN	case	O
cell	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
immune	JJ	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

IL	NN	compound	O
-	HYPH	punct	O
17	CD	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gut	NN	compound	O
homeostasis	NN	nmod	O
.	.	punct	O
A	DT	det	O
summary	NN	nsubjpass	O
is	VBZ	auxpass	O
made	VBN	ROOT	O
of	IN	prep	O
recent	JJ	amod	O
advances	NNS	pobj	O
in	IN	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
structure	NN	nmod	O
,	,	punct	O
processing	NN	conj	O
,	,	punct	O
receptor	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
immunoregulatory	JJ	amod	O
functions	NNS	conj	O
.	.	punct	O

IL	NN	compound	O
-	HYPH	punct	O
17	CD	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gut	NN	compound	O
homeostasis	NN	nmod	O
.	.	punct	O
It	PRP	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
modulation	NN	nmod	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
,	,	punct	O
infections	NNS	conj	O
and	CC	cc	O
autoimmune	JJ	amod	O
and	CC	cc	O
inflammatory	JJ	conj	O
diseases	NNS	conj	O
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
Flt	NN	compound	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
KDR	NN	conj	O
.	.	punct	O
A	DT	det	O
small	JJ	amod	O
peptide	NN	ROOT	O
derived	VBN	acl	O
from	IN	case	O
Flt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
functions	VBZ	nmod	O
as	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
inhibitor	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
Flt	NN	compound	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
KDR	NN	conj	O
.	.	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulator	NN	ROOT	O
which	WDT	nsubj	O
functions	VBZ	acl:relcl	O
through	IN	case	O
two	CD	nummod	O
endothelial	JJ	amod	B-Cell
specific	JJ	amod	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
,	,	punct	O
Flt	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
and	CC	cc	O
Flk	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
Flt	NN	compound	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
KDR	NN	conj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
work	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
11	CD	nummod	O
-	HYPH	punct	O
amino	NN	compound	O
acid	NN	compound	O
peptide	NN	nsubj	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
second	JJ	amod	O
immunoglobulin	NN	intj	O
-	HYPH	punct	O
like	JJ	case	O
domain	NN	nmod	O
of	IN	case	O
Flt	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
functions	VBZ	nmod	O
as	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
inhibitor	NN	nmod	O
in	IN	case	O
chick	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
inhibited	VBD	ccomp	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
in	IN	case	O
Miles	NNP	nmod:poss	O
'	POS	case	O
assay	NN	nmod	O
without	IN	case	O
binding	VBG	advcl	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
directly	RB	advmod	O
.	.	punct	O

U	NNP	compound	O
-	HYPH	punct	O
995	CD	nsubjpass	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
two	CD	nummod	O
single	JJ	amod	O
peptides	NNS	nmod	O
with	IN	case	O
molecular	JJ	amod	O
mass	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
kDa	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O
Circular	JJ	amod	O
dichroism	NN	nsubj	O
and	CC	cc	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analyses	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
peptide	NN	nsubj	O
forms	VBZ	ccomp	O
a	DT	det	O
stable	JJ	amod	O
extended	VBD	amod	O
structure	NN	dobj	O
in	IN	case	O
solution	NN	nmod	O
,	,	punct	O
presumably	RB	advmod	O
beta	NN	nmod:npmod	O
-	HYPH	punct	O
sheet	NN	amod	O
structure	NN	appos	O
and	CC	cc	O
is	VBZ	cop	O
most	RBS	advmod	O
likely	RB	advmod	O
existing	VBG	conj	O
as	IN	prep	O
a	DT	det	O
dimer	NN	pobj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
integrin	NN	compound	O
alpha5beta1	NN	compound	O
antagonistic	JJ	amod	O
peptide	NN	ROOT	O
,	,	punct	O
A5	NN	compound	O
-	:	punct	O
1	CD	appos	O
,	,	punct	O
screened	VBN	acl	O
by	IN	case	O
Protein	NN	compound	O
Chip	NN	compound	O
system	NN	nmod	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
small	JJ	amod	O
peptide	NN	compound	O
functions	VBZ	ccomp	O
as	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
inhibitor	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
VEGF	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
through	IN	case	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O

Prognostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
p53	NN	compound	O
protein	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
expression	NN	conj	O
in	IN	case	O
resected	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
Coexpression	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
in	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	B-Organ
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
OBJECTIVE	NN	nsubj	O
:	:	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	dep	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Few	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
clarify	VB	xcomp	O
how	WRB	advmod	O
expression	NN	nsubj	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
participates	VBZ	ccomp	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
whether	IN	mark	O
the	DT	det	O
coexpression	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
has	VBZ	conj	O
a	DT	det	O
significance	NN	dobj	O
for	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinicopathological	JJ	amod	O
features	NNS	conj	O
in	IN	case	O
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
SCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
study	NN	nsubj	O
provides	VBZ	appos	O
new	JJ	amod	O
candidate	NN	compound	O
genes	NNS	dobj	O
for	IN	case	O
the	DT	det	O
esophageal	JJ	amod	O
cancer	NN	compound	O
microenvironment	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Tissues	NNS	compound	B-Tissue
samples	NNS	nsubjpass	I-Tissue
were	VBD	auxpass	O
taken	VBN	dep	O
from	IN	case	O
60	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
esophageal	JJ	amod	B-Cancer
SCC	NN	nmod	I-Cancer
after	IN	case	O
surgery	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
in	IN	case	O
these	DT	det	O
SCC	NN	nmod	B-Cancer
was	VBD	auxpass	O
examined	VBN	ROOT	O
immunohistochemically	RB	advmod	O
.	.	punct	O

Tumor	NN	compound	O
sections	NNS	nsubjpass	O
were	VBD	auxpass	O
stained	VBN	ROOT	O
for	IN	case	O
:	:	punct	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
CD31	NN	nmod	O
and	CC	cc	O
PAS	NN	conj	O
or	CC	cc	O
hypoxia	NN	conj	O
inducible	JJ	amod	O
factor	NN	compound	O
1alpha	NN	conj	O
(	-LRB-	punct	O
HIF	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Microvessel	NN	compound	B-Tissue
density	NN	nsubjpass	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	mark	O
counting	VBG	advcl	O
microvessels	NNS	dobj	B-Tissue
in	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
sections	NNS	nmod	I-Multi-tissue_structure
stained	VBN	acl	O
for	IN	case	O
Factor	NN	compound	B-Gene_or_gene_product
VIII	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Cell	NN	compound	O
proliferation	NN	nsubjpass	O
in	IN	case	O
each	DT	det	O
sample	NN	nmod	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
Ki	NN	compound	O
-	HYPH	punct	O
67	CD	nummod	O
proliferation	NN	compound	O
marker	NN	dobj	O
.	.	punct	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
labeling	VBG	compound	O
index	NN	nsubjpass	O
(	-LRB-	punct	O
LI	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
calculated	VBN	ROOT	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
antigen	NN	compound	O
immunostaining	NN	advcl	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
proliferative	JJ	amod	O
marker	NN	nmod	O
.	.	punct	O

TUNEL	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O
Apoptotic	JJ	amod	O
index	NN	nsubjpass	O
(	-LRB-	punct	O
AI	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
calculated	VBN	ROOT	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
terminal	JJ	amod	B-Gene_or_gene_product
deoxynucleotidyl	NN	compound	I-Gene_or_gene_product
transferase	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
deoxyuridine	NN	nsubj	B-Simple_chemical
triphosphate	NN	conj	I-Simple_chemical
biotin	NN	compound	I-Simple_chemical
nick	NN	compound	O
end	NN	compound	O
labeling	NN	dobj	O
,	,	punct	O
to	TO	mark	O
evaluate	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
paraffin	NN	amod	O
sections	NNS	nsubjpass	O
from	IN	case	O
49	CD	nummod	O
subjects	NNS	nmod	O
with	IN	case	O
OSCC	NN	nmod	O
were	VBD	auxpass	O
subjected	VBN	dep	O
to	TO	case	O
immunohistochemical	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
highest	JJS	amod	O
MVD	NN	dobj	O
(	-LRB-	punct	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
immunoreactivity	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
58	CD	nmod	O
.	.	punct	O
3	CD	nummod	O
%	NN	nsubjpass	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
61	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
60	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

No	DT	neg	O
clinicopathologic	JJ	amod	O
factors	NNS	nsubjpass	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	nmod	O
or	CC	cc	O
VEGF	NN	conj	O
expression	NN	dep	O
.	.	punct	O
VEGF	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
were	VBD	auxpass	O
significantly	RB	advmod	O
coexpressed	VBN	ROOT	O
in	IN	case	O
26	CD	nummod	O
(	-LRB-	punct	O
43	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
clinicopathologic	JJ	amod	O
factors	NNS	nsubjpass	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	nmod	O
or	CC	cc	O
VEGF	NN	conj	O
expression	NN	dep	O
.	.	punct	O
Histological	JJ	amod	O
venous	JJ	amod	B-Multi-tissue_structure
invasion	NN	nsubjpass	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
distant	JJ	amod	O
metastasis	NN	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
The	DT	det	O
two	CD	nummod	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
more	RBR	advmod	O
frequently	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
with	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
p53	NN	compound	B-Gene_or_gene_product
coexpression	NN	dobj	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
without	IN	case	O
the	DT	det	O
coexpression	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
The	DT	det	O
MVD	NN	nsubj	O
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
LI	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	dep	O
and	CC	cc	O
p	NN	conj	O
less	JJR	amod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
AI	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
with	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
without	IN	case	O
it	PRP	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
The	DT	det	O
MVD	NN	nsubj	O
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
LI	NN	conj	O
were	VBD	cop	O
higher	JJR	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
AI	NN	nsubj	O
was	VBD	cop	O
lower	JJR	conj	O
in	IN	case	O
the	DT	det	O
SCC	NN	nmod	B-Cancer
with	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
/	:	punct	O
p53	NN	compound	B-Gene_or_gene_product
coexpression	NN	nmod	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
without	IN	case	O
the	DT	det	O
coexpression	NN	nmod	O
.	.	punct	O

More	JJR	amod	O
than	IN	quantmod	O
50	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
coexpressed	VBD	ROOT	O
vimentin	NN	dobj	O
and	CC	cc	O
keratin	NN	conj	O
.	.	punct	O
The	DT	det	O
5	CD	nummod	O
-	HYPH	punct	O
yr	NN	compound	O
survival	NN	compound	O
rate	NN	nsubj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
the	DT	det	O
coexpression	NN	nmod	O
was	VBD	cop	O
poorer	VBN	ROOT	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
mutant	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
distant	JJ	amod	O
metastasis	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	B-Cancer
SCC	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
coexpression	NN	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
have	VBP	conj	O
important	JJ	amod	O
clinical	JJ	amod	O
significance	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
of	IN	case	O
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
hepatocellular	JJ	amod	O
carcinoma	NN	nmod	O
]	-RRB-	punct	O
.	.	punct	O
[	-LRB-	punct	O
mRNA	NN	compound	O
expression	NN	ROOT	O
of	IN	case	O
metastasis	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
gene	NN	compound	O
nm23	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
carcinoma	NN	nmod	B-Cancer
of	IN	case	O
buccal	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
.	.	punct	O
II	CD	ROOT	O
.	.	punct	O
Quantitative	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
PCR	NN	compound	O
amplification	NN	ROOT	O
]	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
be	VB	ROOT	O
that	IN	mark	O
metastasis	NN	compound	O
suppression	NN	nsubj	O
by	IN	case	O
the	DT	det	O
nm23	NN	compound	O
gene	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
tissue	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
phenomenon	NN	ccomp	O
.	.	punct	O
The	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
conspicuous	JJ	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
gene	NN	ROOT	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
colon	NN	compound	O
cancers	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
authors	NNS	nsubj	O
detected	VBD	ROOT	O
both	CC	cc:preconj	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	conj	I-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
47	CD	nummod	O
tissues	NNS	compound	B-Tissue
samples	NNS	nmod	I-Tissue
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
carcinoma	NN	nmod	B-Cancer
of	IN	case	I-Cancer
buccal	JJ	amod	I-Cancer
mucosa	NN	nmod	I-Cancer
(	-LRB-	punct	O
CBM	NN	appos	B-Cancer
)	-RRB-	punct	O
by	IN	case	O
quantitative	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
PCR	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	compound	O
and	CC	cc	O
nm23	NN	compound	O
-	HYPH	punct	O
H2	NN	conj	O
mRNA	NN	dobj	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
expression	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
mRNA	NN	conj	O
varied	VBD	ccomp	O
in	IN	case	O
normal	JJ	amod	O
buccal	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
leukoplakia	NN	conj	B-Pathological_formation
,	,	punct	O
adjacent	JJ	amod	O
nontumorous	JJ	amod	B-Multi-tissue_structure
mucosa	NN	conj	I-Multi-tissue_structure
,	,	punct	O
submandibular	JJ	amod	B-Organ
gland	NN	conj	I-Organ
,	,	punct	O
CBM	NN	conj	B-Cancer
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
nodes	NNS	conj	I-Multi-tissue_structure
with	IN	nmod	O
or	CC	cc	O
without	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	compound	O
and	CC	cc	O
nm23	NN	compound	O
-	HYPH	punct	O
H2	NN	conj	O
mRNA	NN	dobj	O
.	.	punct	O
The	DT	det	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	compound	O
levels	NNS	nsubj	O
in	IN	case	O
CBM	NN	nmod	B-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
were	VBD	cop	O
lower	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
CBM	NN	nmod	B-Cancer
without	IN	case	O
metastases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
no	DT	neg	O
significance	NN	nsubjpass	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	compound	O
levels	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	advcl	O
between	IN	case	O
CBM	NN	nmod	B-Cancer
with	IN	cc	O
and	CC	cc	O
CBM	NN	conj	B-Cancer
without	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
RNAs	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
(	-LRB-	punct	O
RNA	NN	appos	O
)	-RRB-	punct	O
hybridization	NN	nmod	O
in	IN	case	O
productively	RB	advmod	O
infected	JJ	amod	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
48	CD	nummod	O
h	NN	compound	O
postinfection	NN	dep	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
were	VBD	cop	O
apparent	JJ	amod	O
140	CD	nummod	O
h	NN	compound	O
postinfection	NN	dep	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
were	VBD	cop	O
comparative	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
Northern	NN	compound	O
blotting	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

More	RBR	advmod	O
recent	JJ	amod	O
data	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
human	JJ	amod	O
nm23	NN	compound	O
gene	NN	compound	O
homologues	NNS	nmod	O
,	,	punct	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	appos	O
and	CC	cc	O
nm23	NN	compound	O
-	HYPH	punct	O
H2	NN	conj	O
,	,	punct	O
and	CC	cc	O
have	VBP	aux	O
shown	VBN	conj	O
that	IN	mark	O
deletion	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
alleles	NNS	nmod	O
occurs	VBZ	ccomp	O
in	IN	case	O
some	DT	det	O
colon	NN	compound	O
carcinomas	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
authors	NNS	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
,	,	punct	O
as	IN	mark	O
also	RB	advmod	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
Northern	NN	compound	O
blotting	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H1	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
significantly	RB	advmod	O
correlated	VBD	ccomp	O
inversely	RB	advmod	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
CBM	NN	nmod	B-Cancer
,	,	punct	O
while	IN	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
H2	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
not	RB	cc	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	compound	O
and	CC	cc	O
nm23	NN	compound	O
-	HYPH	punct	O
H2	NN	conj	O
mRNA	NN	dobj	O
.	.	punct	O
Q	NNP	compound	O
-	HYPH	punct	O
RT	NNP	compound	O
-	HYPH	punct	O
PCR	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
useful	JJ	amod	O
method	NN	ROOT	O
to	TO	mark	O
detect	VB	acl	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
nm23	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
buccal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	O
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	O
ester	NN	compound	O
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	O
.	.	punct	O
Neoplastic	JJ	amod	O
transformation	NN	ROOT	O
and	CC	cc	O
tumorigenesis	NN	conj	O
associated	VBN	acl	O
with	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
phospholipase	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
isozymes	NNS	nmod	O
in	IN	case	O
cultured	VBN	amod	O
murine	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Diacylglycerol	NN	nsubj	O
(	-LRB-	punct	O
DG	NNS	appos	O
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
phospholipid	JJ	amod	O
metabolism	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
an	DT	det	O
endogenous	JJ	amod	O
activator	NN	conj	O
of	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	nmod	O
.	.	punct	O
Phospholipase	NN	compound	B-Gene_or_gene_product
D	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
PLD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
.	.	punct	O

Further	JJ	amod	O
analysis	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
although	IN	mark	O
LMP1	NN	nsubj	O
(	-LRB-	punct	O
TRADD	NN	appos	O
)	-RRB-	punct	O
promotes	VBZ	advcl	O
cell	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
prevent	VB	ccomp	O
the	DT	det	O
eventual	JJ	amod	O
onset	NN	dobj	O
of	IN	case	O
senescence	NN	nmod	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
suppressor	NN	compound	O
p16	NN	nmod	O
(	-LRB-	punct	O
Ink4a	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
PLD	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
significantly	RB	advmod	O
elevated	JJ	xcomp	O
in	IN	case	O
many	JJ	amod	O
tumours	NNS	nmod	B-Cancer
and	CC	cc	O
transformed	VBN	amod	O
cells	NNS	conj	B-Cell
,	,	punct	O
suggesting	VBG	xcomp	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
PLD	NN	nsubjpass	B-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
stable	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	dobj	I-Cell
overexpressing	VBG	acl	O
PLD1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
PLD2	NN	conj	B-Gene_or_gene_product
from	IN	case	O
fibroblast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
hybrid	NN	compound	O
cells	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
exhibited	VBD	ROOT	O
normal	JJ	amod	O
morphology	NN	dobj	O
,	,	punct	O
anchorage	JJ	amod	O
requirement	NN	conj	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
largely	RB	advmod	O
extended	VBD	conj	O
latency	NN	compound	O
periods	NNS	dobj	O
of	IN	case	O
tumorigenicity	NN	nmod	O
in	IN	case	O
newborn	JJ	amod	O
rats	NNS	nmod	O
.	.	punct	O
These	DT	det	O
cells	NNS	nsubj	B-Cell
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
control	JJ	amod	O
cells	NNS	conj	B-Cell
,	,	punct	O
showed	VBD	ROOT	O
altered	JJ	amod	O
growth	NN	compound	O
properties	NNS	dobj	O
and	CC	cc	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
rk	RB	compound	O
-	SYM	punct	O
2	CD	nsubj	O
diminished	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
-	:	punct	O
2	CD	dep	O
and	CC	cc	O
-	SYM	punct	O
9	CD	nmod	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	O
lung	NN	nmod	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
tumor	NN	compound	O
metastasis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O
Both	CC	cc:preconj	O
PLD1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PLD2	NN	conj	B-Gene_or_gene_product
also	RB	advmod	O
induced	VBD	ROOT	O
an	DT	det	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloprotease	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
as	IN	mark	O
detected	VBN	advcl	O
by	IN	case	O
zymograms	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
introduced	VBN	advcl	O
into	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
selected	VBN	amod	O
clones	NNS	nsubj	O
generated	VBN	acl	O
from	IN	case	O
either	CC	det	O
gene	NN	nmod	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
tumors	NNS	dobj	O
,	,	punct	O
although	IN	mark	O
those	DT	nsubj	O
carrying	VBG	acl	O
the	DT	det	O
mutated	VBN	amod	O
version	NN	dobj	O
were	VBD	cop	O
more	RBR	advmod	O
efficient	JJ	advcl	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
both	CC	cc:preconj	O
PLD1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PLD2	NN	conj	B-Gene_or_gene_product
transformants	NNS	dep	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
vector	NN	compound	B-Cell
-	HYPH	punct	I-Cell
transfectants	NNS	conj	I-Cell
,	,	punct	O
induced	VBD	ROOT	O
undifferentiated	JJ	amod	O
sarcoma	NN	dobj	B-Cancer
when	WRB	advmod	O
transplanted	VBN	advcl	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nsubjpass	O
and	CC	cc	O
sub	NN	compound	O
-	HYPH	punct	O
G1	NN	compound	O
population	NN	nsubjpass	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
.	.	punct	O
Both	DT	cc:preconj	O
PLD1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
and	CC	cc	O
PLD2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
distributions	NNS	nsubj	O
in	IN	case	O
stable	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
revealed	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
fraction	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
S	NN	compound	O
phase	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
cyclin	NN	compound	O
B	NN	nmod	O
,	,	punct	O
cyclin	NN	compound	O
E	NN	conj	O
,	,	punct	O
and	CC	cc	O
dephosphorylation	NN	conj	O
of	IN	case	O
cdk2	NN	nmod	O
in	IN	case	O
ciprofloxacin	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
bladder	NN	compound	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D3	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
known	VBN	acl	O
as	IN	case	O
an	DT	det	O
activator	NN	nmod	O
of	IN	case	O
G	NN	nmod	O
(	-LRB-	punct	O
1	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
S	NN	compound	O
phase	NN	compound	O
transition	NN	nmod	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
aberrantly	RB	advmod	O
high	JJ	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
overexpressing	VBG	acl	O
PLD1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
PLD2	NN	conj	B-Gene_or_gene_product
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TNFalpha	NN	compound	O
treatment	NN	nsubj	O
alone	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
suppressed	VBN	acl:relcl	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
PLD	NN	compound	B-Gene_or_gene_product
isozymes	NNS	nmod	O
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
Troponin	NN	intj	B-Gene_or_gene_product
I	PRP	nsubj	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
by	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
'	''	punct	O
s	VBZ	compound	O
bFGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	O
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	O
shark	NN	pobj	O
(	-LRB-	punct	O
Prionace	NN	compound	O
glauca	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Troponin	NN	compound	B-Gene_or_gene_product
I	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
TnI	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
cartilage	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	ROOT	O
,	,	punct	O
first	RB	advmod	O
demonstrated	VBN	acl	O
by	IN	case	O
Moses	NNP	nmod	O
et	FW	dep	O
al	FW	conj	O
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
two	CD	nummod	O
candidate	NN	compound	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
RNA	NN	compound	O
-	HYPH	punct	O
damaging	NN	compound	O
agents	NNS	nsubjpass	O
,	,	punct	O
onconase	NN	conj	O
and	CC	cc	O
(	-LRB-	punct	O
-	SYM	punct	O
4	LS	conj	O
)	-RRB-	punct	O
rhEDN	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
screened	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	nmod	O
using	VBG	xcomp	O
three	CD	nummod	O
distinct	JJ	amod	O
types	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
in	IN	case	O
culture	NN	nmod	O
:	:	punct	O
HPV	NN	compound	O
-	:	punct	O
16	CD	nummod	O
E6	NN	compound	O
/	:	punct	O
E7	NN	nmod:npmod	O
-	:	punct	O
immortalized	VBN	amod	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cells	NNS	dep	O
(	-LRB-	punct	O
HUVECs	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
Kras	NNP	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
HPV	NNP	compound	O
-	:	punct	O
16	CD	nummod	O
E6	NN	compound	O
/	:	punct	O
E7	NN	compound	O
HUVEC	NN	appos	O
(	-LRB-	punct	O
Rhim	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
Carcinogenesis	NN	appos	O
4	CD	nummod	O
,	,	punct	O
673	CD	nummod	O
-	SYM	punct	O
681	CD	nummod	O
,	,	punct	O
1998	CD	amod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
primary	JJ	amod	O
HUVECs	NNS	conj	O
.	.	punct	O
(	-LRB-	punct	O
1999	CD	ROOT	O
,	,	punct	O
Proc	NNP	appos	O
.	.	punct	O
Natl	NN	ROOT	O
.	.	punct	O
Acad	NNP	ROOT	O
.	.	punct	O
Sci	NNP	ROOT	O
.	.	punct	O
USA	NNP	ROOT	O
2645	CD	nummod	O
-	SYM	punct	O
2650	CD	nummod	O
)	-RRB-	punct	O
to	TO	mark	O
inhibit	VB	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
,	,	punct	O
both	CC	cc:preconj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
inhibit	VB	conj	O
metastasis	NN	dobj	O
of	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
Despite	IN	prep	O
convincing	VBG	amod	O
evidence	NN	pobj	O
of	IN	prep	O
its	PRP$	poss	O
efficacy	NN	pobj	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
TnI	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
proliferative	JJ	amod	O
and	CC	cc	O
anti	JJ	conj	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agent	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
In	IN	prep	O
the	DT	det	O
current	JJ	amod	O
article	NN	pobj	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
TnI	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ccomp	O
both	CC	cc:preconj	O
bFGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
and	CC	cc	O
basal	JJ	conj	O
levels	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
hypothesize	VBP	conj	O
that	IN	mark	O
this	DT	det	O
inhibition	NN	nsubj	O
is	VBZ	aux	O
occurring	VBG	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
via	IN	case	O
an	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
TnI	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
surface	NN	compound	I-Cellular_component
bFGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
on	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
further	RB	advmod	O
support	VBP	ROOT	O
this	DT	det	O
hypothesis	NN	dobj	O
by	IN	mark	O
providing	VBG	advcl	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
TnI	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
act	VB	ccomp	O
on	IN	case	O
nonendothelial	JJ	nmod	B-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
and	CC	cc	O
by	IN	mark	O
demonstrating	VBG	conj	O
that	IN	mark	O
this	DT	det	O
inhibitory	JJ	amod	O
action	NN	nsubj	O
is	VBZ	cop	O
specific	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
bFGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
Preliminary	JJ	amod	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TnI	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	aux	O
competing	VBG	ccomp	O
with	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
for	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
bFGF	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
on	IN	case	O
responsive	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

HTPB	NN	nsubj	O
disrupted	VBD	ROOT	O
F	NN	compound	O
-	HYPH	punct	O
actin	NN	compound	O
dynamics	NNS	dobj	O
via	IN	mark	O
downregulating	VBG	advcl	O
RhoA	NN	compound	O
activity	NN	dobj	O
.	.	punct	O
RhoA	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
promotes	VBZ	ROOT	O
transformation	NN	dobj	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
thyroid	NN	compound	B-Cell
cell	NN	compound	I-Cell
differentiation	NN	nmod	O
interfering	VBG	acl	O
with	IN	case	O
thyroid	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

With	IN	case	O
regard	NN	dep	O
to	TO	case	O
differentiation	NN	nmod	O
,	,	punct	O
hypoxic	JJ	amod	O
cells	NNS	nsubj	O
lost	VBD	ROOT	O
their	PRP$	nmod:poss	O
neuronal	JJ	amod	O
/	SYM	punct	O
neuroendocrine	JJ	dep	O
features	NNS	dobj	O
and	CC	cc	O
gained	VBD	conj	O
marker	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
,	,	punct	O
neural	JJ	dep	O
crest	NN	dep	O
-	HYPH	punct	O
like	IN	dep	O
phenotype	NN	nmod	O
.	.	punct	O
Highly	RB	advmod	O
specialized	VBN	amod	O
cells	NNS	nsubj	B-Cell
,	,	punct	O
the	DT	det	O
thyrocytes	NNS	appos	B-Cell
,	,	punct	O
express	VBP	ROOT	O
a	DT	det	O
thyroid	NN	nmod:npmod	B-Organ
-	HYPH	punct	O
specific	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
for	IN	case	O
thyroglobulin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Tg	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
thyroperoxidase	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
the	DT	det	O
transcription	NN	compound	O
factors	NNS	conj	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
TTF	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Pax	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
implication	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
small	JJ	amod	O
GTPase	NN	compound	O
RhoA	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
TSH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
proliferation	NN	nmod	O
of	IN	case	O
FRTL	NN	compound	B-Cell
-	HYPH	punct	I-Cell
5	CD	nummod	I-Cell
rat	NN	compound	I-Cell
thyroid	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
demonstrated	VBN	ROOT	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
further	RB	advmod	O
analyze	VB	advcl	O
RhoA	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
in	IN	case	O
thyroid	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
differentiation	NN	compound	O
patterns	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
combined	VBD	ROOT	O
transient	JJ	amod	O
and	CC	cc	O
stable	JJ	conj	O
transfection	NN	compound	O
assays	NNS	dobj	O
to	TO	mark	O
express	VB	xcomp	O
different	JJ	amod	O
mutant	JJ	amod	O
RhoA	NN	compound	B-Gene_or_gene_product
forms	NNS	dobj	O
in	IN	case	O
FRTL	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
5	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Constitutively	RB	advmod	O
active	JJ	amod	O
RhoA	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
FRTL	NN	compound	O
-	HYPH	punct	O
5	CD	nummod	O
-	HYPH	punct	O
RhoA	NN	compound	B-Gene_or_gene_product
QL	NN	compound	O
cells	NNS	appos	O
)	-RRB-	punct	O
exhibited	VBD	ROOT	O
a	DT	det	O
fibroblast	NN	compound	B-Cell
-	HYPH	punct	O
like	IN	case	O
phenotype	NN	dobj	O
with	IN	case	O
organized	VBN	amod	O
actin	NN	compound	B-Gene_or_gene_product
fibers	NNS	nmod	B-Cellular_component
,	,	punct	O
whereas	IN	dep	O
cells	NNS	nsubj	B-Cell
expressing	VBG	acl	O
the	DT	det	O
RhoA	NN	compound	B-Gene_or_gene_product
negative	JJ	amod	O
dominant	JJ	amod	O
phenotype	NN	dobj	O
(	-LRB-	punct	O
FRTL	NN	compound	B-Cell
-	HYPH	punct	I-Cell
5	CD	nummod	I-Cell
-	HYPH	punct	I-Cell
RhoA	NN	compound	I-Cell
N19	NN	compound	I-Cell
cells	NNS	appos	I-Cell
)	-RRB-	punct	O
present	VBP	parataxis	O
a	DT	det	O
rounded	VBN	amod	O
morphology	NN	dobj	O
and	CC	cc	O
lose	VBP	conj	O
normal	JJ	amod	O
cytoskeletal	JJ	amod	B-Cellular_component
architecture	NN	dobj	O
.	.	punct	O

Over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
either	CC	det	O
rho	NN	compound	O
gene	NN	nmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
anchorage	NN	amod	O
-	HYPH	punct	O
and	CC	cc	O
serum	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
RhoA	NN	nmod	B-Gene_or_gene_product
results	VBZ	ROOT	O
in	IN	case	O
TSH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
independent	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
and	CC	cc	O
induces	VBZ	conj	O
tumors	NNS	dobj	B-Cancer
when	WRB	advmod	O
inoculated	VBN	advcl	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
expressions	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
in	IN	case	O
Galpha	NNP	compound	O
(	-LRB-	punct	O
12	CD	nummod	O
)	-RRB-	punct	O
QL	NN	compound	O
cells	NNS	nmod	O
were	VBD	auxpass	O
validated	VBN	ROOT	O
by	IN	case	O
immunoblot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
FRTL	NNP	compound	O
-	HYPH	punct	O
5	CD	compound	O
-	HYPH	punct	O
RhoA	NN	compound	B-Gene_or_gene_product
QL	NN	compound	O
cells	NNS	nsubj	O
express	VBP	ROOT	O
less	JJR	amod	O
Tg	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
TTF	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
than	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
FRTL	NNP	compound	B-Cell
-	:	punct	I-Cell
5	CD	nummod	I-Cell
(	-LRB-	punct	O
FRTL	NN	compound	B-Cell
-	HYPH	punct	I-Cell
5	CD	nummod	I-Cell
-	HYPH	punct	O
vector	NN	conj	O
)	-RRB-	punct	O
or	CC	cc	O
FRTL	NN	compound	O
-	HYPH	punct	O
5	CD	compound	O
-	HYPH	punct	O
RhoA	NN	compound	B-Gene_or_gene_product
N19	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
loss	NN	dobj	O
at	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
stage	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
This	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
since	IN	mark	O
transient	JJ	amod	O
or	CC	cc	O
stable	JJ	conj	O
expression	NN	nsubj	O
of	IN	case	O
RhoA	NN	compound	B-Gene_or_gene_product
QL	NN	nmod	O
results	VBZ	advcl	O
in	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
Tg	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
an	DT	det	O
artificial	JJ	amod	O
promoter	NN	conj	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
depends	VBZ	conj	O
exclusively	RB	advmod	O
on	IN	case	O
TTF	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
putative	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
rho	NN	compound	O
proteins	NNS	nmod	O
from	IN	case	O
Aplysia	NN	compound	O
californica	NN	nmod	O
as	IN	case	O
transforming	VBG	amod	O
GTPases	NNS	nmod	O
utilizing	VBG	acl	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
and	CC	cc	O
a	DT	det	O
Val	NN	compound	O
-	HYPH	punct	O
14	CD	nummod	O
mutant	JJ	conj	O
,	,	punct	O
equivalent	JJ	advcl	O
to	IN	case	O
the	DT	det	O
oncogenic	JJ	amod	O
Val	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
mutation	NN	nmod	O
of	IN	case	O
ras	NN	compound	O
genes	NNS	nmod	O
found	VBN	acl	O
in	IN	case	O
animal	NN	nmod	O
and	CC	cc	O
human	JJ	conj	O
tumors	NNS	dep	O
.	.	punct	O
The	DT	det	O
similarity	NN	nsubj	O
between	IN	case	O
RhoA	NN	compound	B-Gene_or_gene_product
effects	NNS	nmod	O
and	CC	cc	O
thyroid	NN	compound	B-Cell
transformation	NN	conj	O
by	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
suggests	VBZ	ROOT	O
that	IN	mark	O
RhoA	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
act	VB	ccomp	O
as	IN	case	O
a	DT	det	O
downstream	JJ	amod	O
effector	NN	nmod	O
of	IN	case	O
Ras	NN	nmod	B-Gene_or_gene_product
;	:	punct	O
in	IN	case	O
fact	NN	nmod	O
,	,	punct	O
the	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
RhoA	NN	compound	B-Gene_or_gene_product
N19	NN	nsubj	O
abolished	VBD	parataxis	O
the	DT	det	O
down	JJ	advmod	O
-	HYPH	punct	O
regulatory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
Ras	NN	compound	B-Gene_or_gene_product
V12	NN	nmod	O
over	IN	case	O
the	DT	det	O
Tg	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
appropriate	JJ	amod	O
conditions	NNS	nmod	O
rho	NN	ccomp	O
genes	NNS	compound	O
function	VBP	dobj	O
as	IN	case	O
oncogenes	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
in	IN	case	O
fibroblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
active	JJ	amod	O
RhoA	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
able	JJ	acl:relcl	O
to	TO	mark	O
transform	VB	xcomp	O
FRTL	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
5	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
coupled	VBN	conj	O
to	TO	case	O
a	DT	det	O
loss	NN	nmod	O
of	IN	case	O
thyroid	NN	compound	B-Cell
differentiation	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
impaired	JJ	amod	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Risk	NN	ROOT	O
of	IN	case	O
myelodysplastic	JJ	amod	O
syndrome	NN	nmod	O
and	CC	cc	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	conj	O
in	IN	case	O
congenital	JJ	amod	O
neutropenias	NNS	nmod	O
.	.	punct	O
Clinical	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
plasma	NN	compound	B-Organism_substance
endostatin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
/	:	punct	O
myelodysplastic	JJ	amod	O
syndrome	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
Endostatin	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
C	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
fragment	NN	appos	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
XVIII	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
endogenous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	appos	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	O
-	:	punct	O
kappaB	NN	nsubjpass	O
and	CC	cc	O
associated	VBN	amod	O
regulatory	JJ	amod	O
factors	NNS	conj	O
(	-LRB-	punct	O
including	VBG	case	O
IkappaB	NN	compound	O
kinase	NN	compound	O
subunits	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
IkappaB	NN	compound	O
family	NN	compound	O
member	NN	conj	O
Bcl	NN	compound	O
-	HYPH	punct	O
3	CD	dep	O
)	-RRB-	punct	O
are	VBP	auxpass	O
strongly	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
hematologic	JJ	amod	O
and	CC	cc	O
solid	JJ	conj	O
tumor	NN	compound	O
malignancies	NNS	nmod	O
.	.	punct	O
While	IN	mark	O
endostatin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	aux	O
being	VBG	auxpass	O
investigated	VBN	advcl	O
for	IN	prep	O
its	PRP$	poss	O
usefulness	NN	pobj	O
in	IN	prep	O
treating	VBG	pcomp	O
solid	JJ	amod	B-Cancer
tumors	NNS	dobj	I-Cancer
,	,	punct	O
its	PRP$	nmod:poss	O
significance	NN	nsubj	O
in	IN	case	O
hematologic	JJ	amod	B-Cancer
malignancies	NNS	nmod	I-Cancer
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	O
who	WP	nsubj	O
transform	VBP	acl:relcl	O
to	TO	mark	O
overt	VB	xcomp	O
MDS	NN	dobj	O
or	CC	cc	O
AML	NN	conj	O
,	,	punct	O
hematopoietic	JJ	amod	O
stem	NN	compound	O
cell	NN	compound	O
transplantation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
chance	NN	ROOT	O
for	IN	prep	O
cure	NN	pobj	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
authors	NNS	nsubj	O
evaluated	VBD	dep	O
plasma	NN	compound	B-Organism_substance
endostatin	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
PE	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	dobj	O
using	VBG	acl	O
an	DT	det	O
enzyme	NN	compound	O
linked	VBN	amod	O
immunoassay	NN	dobj	O
in	IN	case	O
71	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
acute	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
AML	NN	appos	B-Cancer
)	-RRB-	punct	O
and	CC	cc	O
43	CD	nummod	O
patients	NNS	conj	B-Organism
with	IN	case	O
myelodysplastic	JJ	amod	O
syndrome	NN	nmod	O
(	-LRB-	punct	O
MDS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
correlated	VBD	conj	O
PE	NN	dobj	B-Gene_or_gene_product
with	IN	case	O
various	JJ	amod	O
clinical	JJ	amod	O
parameters	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationships	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
age	NN	nmod	O
at	IN	case	O
onset	NN	nmod	O
of	IN	case	O
MDS	NN	nmod	O
or	CC	cc	O
AML	NN	conj	O
and	CC	cc	O
patient	NN	conj	O
gender	NN	conj	O
,	,	punct	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
dose	NN	conj	O
,	,	punct	O
or	CC	cc	O
duration	NN	conj	O
of	IN	case	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
median	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
level	NN	nmod	O
between	IN	case	O
AML	NN	compound	B-Cancer
/	:	punct	O
MDS	NN	compound	O
patients	NNS	nmod	B-Organism
and	CC	cc	O
the	DT	det	O
normal	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

Pretreatment	NN	amod	O
IL	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
outcome	NN	nmod	O
.	.	punct	O
Nevertheless	RB	advmod	O
,	,	punct	O
patients	NNS	nsubj	B-Organism
who	WP	nsubj	O
achieved	VBD	acl:relcl	O
complete	JJ	amod	O
remission	NN	dobj	O
(	-LRB-	punct	O
CR	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
lower	JJR	amod	O
median	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
level	NN	dobj	O
compared	VBN	case	O
to	TO	case	O
those	DT	nmod	O
who	WP	nsubj	O
did	VBD	acl:relcl	O
not	RB	neg	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
profile	NN	nsubj	O
was	VBD	cop	O
independently	RB	advmod	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
,	,	punct	O
PE	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
significant	JJ	xcomp	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
03	CD	nummod	O
)	-RRB-	punct	O
predictor	NN	dobj	O
of	IN	case	O
overall	JJ	amod	O
survival	NN	nmod	O
(	-LRB-	punct	O
OS	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
adjustment	NN	nmod	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
baseline	NN	compound	O
covariates	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
patient	NN	compound	B-Organism
age	NN	nmod	O
,	,	punct	O
history	NN	appos	O
of	IN	case	O
antecedent	JJ	amod	O
hematologic	JJ	amod	O
disorders	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
use	NN	conj	O
of	IN	prep	O
protective	JJ	amod	O
environments	NNS	pobj	O
.	.	punct	O

No	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationships	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
age	NN	nmod	O
at	IN	case	O
onset	NN	nmod	O
of	IN	case	O
MDS	NN	nmod	O
or	CC	cc	O
AML	NN	conj	O
and	CC	cc	O
patient	NN	conj	O
gender	NN	conj	O
,	,	punct	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
dose	NN	conj	O
,	,	punct	O
or	CC	cc	O
duration	NN	conj	O
of	IN	case	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O
The	DT	det	O
prognostic	JJ	amod	O
value	NN	nsubjpass	O
of	IN	case	O
PE	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
evaluated	VBN	ROOT	O
by	IN	mark	O
dividing	VBG	advcl	O
MDS	NN	compound	O
/	:	punct	O
AML	NN	compound	B-Cancer
patients	NNS	dobj	B-Organism
into	IN	case	O
high	JJ	amod	O
and	CC	cc	O
low	JJ	conj	O
PE	NN	compound	B-Gene_or_gene_product
groups	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
median	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
level	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
controls	NNS	nmod	O
as	IN	case	O
the	DT	det	O
cut	NN	compound	O
-	HYPH	punct	O
off	RP	advmod	O
.	.	punct	O

The	DT	det	O
coagulative	JJ	amod	O
parameters	NNS	nsubj	O
including	VBG	case	O
the	DT	det	O
prothrombin	NN	compound	O
time	NN	nmod	O
,	,	punct	O
activated	VBN	ROOT	O
partial	JJ	amod	O
thromboplastin	NN	compound	O
time	NN	dobj	O
,	,	punct	O
and	CC	cc	O
fibrinogen	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
collected	VBN	conj	O
and	CC	cc	O
studied	VBN	conj	O
retrospectively	RB	advmod	O
.	.	punct	O
The	DT	det	O
authors	NNS	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
patients	NNS	nsubj	B-Organism
in	IN	case	O
the	DT	det	O
high	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
group	NN	nmod	O
survived	VBD	ccomp	O
for	IN	case	O
a	DT	det	O
significantly	RB	advmod	O
shorter	JJR	amod	O
time	NN	nmod	O
than	IN	case	O
those	DT	det	O
patients	NNS	nmod	B-Organism
in	IN	case	O
the	DT	det	O
low	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
group	NN	nmod	O
.	.	punct	O

No	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationships	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
age	NN	nmod	O
at	IN	case	O
onset	NN	nmod	O
of	IN	case	O
MDS	NN	nmod	O
or	CC	cc	O
AML	NN	conj	O
and	CC	cc	O
patient	NN	conj	O
gender	NN	conj	O
,	,	punct	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
dose	NN	conj	O
,	,	punct	O
or	CC	cc	O
duration	NN	conj	O
of	IN	case	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
PE	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
useful	JJ	amod	O
prognostic	JJ	amod	O
predictor	NN	dep	O
of	IN	case	O
CR	NN	nmod	O
and	CC	cc	O
OS	NN	conj	O
for	IN	case	O
AML	NN	compound	B-Cancer
/	:	punct	O
MDS	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
high	JJ	amod	O
TP	NN	nsubjpass	O
is	VBZ	auxpass	O
most	RBS	advmod	O
likely	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
mechanism	NN	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
high	JJ	amod	O
PE	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
poor	JJ	amod	O
clinical	JJ	amod	O
outcome	NN	conj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
,	,	punct	O
although	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
related	JJ	advcl	O
to	TO	case	O
the	DT	det	O
possible	JJ	amod	O
PE	NN	compound	B-Gene_or_gene_product
reflection	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
burden	NN	nmod	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	O
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O
Modulation	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
progelatinase	VB	conj	B-Gene_or_gene_product
a	DT	dep	I-Gene_or_gene_product
by	IN	case	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
mimetics	NNS	nmod	O
and	CC	cc	O
antagonists	NNS	conj	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	O
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
angiogenic	JJ	amod	O
action	NN	nsubjpass	O
of	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	O
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
SFLLR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
agonist	NN	appos	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
peptide	NN	conj	O
and	CC	cc	O
non	JJ	amod	O
peptide	NN	compound	O
antagonists	NNS	conj	O
on	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
chick	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	compound	I-Multi-tissue_structure
(	-LRB-	punct	O
CAM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
system	NN	nmod	O
.	.	punct	O

Integrin	JJ	compound	O
alpha5beta1	NN	nsubjpass	O
immobilized	VBD	acl	O
on	IN	case	O
a	DT	det	O
ProteoChip	NNP	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
screen	VB	xcomp	O
new	JJ	amod	O
antagonistic	JJ	amod	O
peptides	NNS	dobj	O
from	IN	case	O
multiple	JJ	amod	O
hexapeptide	NN	amod	O
sub	NN	compound	O
-	HYPH	punct	O
libraries	NNS	nmod	O
of	IN	case	O
the	DT	det	O
positional	JJ	amod	O
scanning	NN	compound	O
synthetic	JJ	amod	O
peptide	NN	compound	O
combinatorial	JJ	amod	O
library	NN	nmod	O
(	-LRB-	punct	O
PS	NN	compound	O
-	:	punct	O
SPCL	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O
As	IN	mark	O
antagonists	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
the	DT	det	O
tripeptide	NN	compound	B-Gene_or_gene_product
FPR	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
peptide	NN	conj	O
1	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	npadvmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
disubstituted	VBN	amod	I-Simple_chemical
piperazine	NN	compound	I-Simple_chemical
derivatives	NNS	conj	I-Simple_chemical
.	.	punct	O

Adipose	NN	compound	O
tissue	NN	ROOT	O
layered	VBD	acl	O
on	IN	case	O
CAM	NN	compound	O
stimulated	JJ	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O
The	DT	det	O
pentapeptide	NN	compound	B-Gene_or_gene_product
SFLLR	NN	nsubj	I-Gene_or_gene_product
,	,	punct	O
like	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
caused	VBD	ROOT	O
a	DT	det	O
marked	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
CAM	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	O
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O
FPR	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
piperazine	NN	compound	B-Simple_chemical
derivatives	NNS	conj	I-Simple_chemical
caused	VBD	ROOT	O
suppression	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
thrombin	NN	nmod	B-Gene_or_gene_product
antagonized	VBD	ccomp	O
its	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

Thrombin	NN	nsubj	O
greatly	RB	advmod	O
potentiates	VBZ	ROOT	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod:npmod	O
-	:	punct	O
(	-LRB-	punct	O
VEGF	NN	appos	O
-	:	punct	O
)	-RRB-	punct	O
induced	VBD	amod	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
.	.	punct	O
Thrombin	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
SFLLR	NN	conj	B-Gene_or_gene_product
activated	VBD	ROOT	O
progelatinase	NN	compound	B-Gene_or_gene_product
A	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
culture	NN	compound	O
medium	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
cord	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
rk	RB	compound	O
-	SYM	punct	O
2	CD	nsubj	O
diminished	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
-	:	punct	O
2	CD	dep	O
and	CC	cc	O
-	SYM	punct	O
9	CD	nmod	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	O
lung	NN	nmod	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
tumor	NN	compound	O
metastasis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
early	JJ	amod	O
steps	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
local	JJ	amod	O
dissolution	NN	nmod	O
of	IN	case	O
basement	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
collagen	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

1	LS	nummod	O
-	HYPH	punct	O
Tetradecylpyrrolidine	NN	compound	O
N	NN	compound	O
-	HYPH	punct	O
oxide	NN	nsubj	O
(	-LRB-	punct	O
TPNO	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
immediately	RB	advmod	O
after	IN	case	O
addition	NN	appos	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
over	IN	case	O
the	DT	det	O
whole	JJ	amod	O
concentration	NN	compound	O
range	NN	nmod	O
.	.	punct	O
FPR	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
piperazine	NN	compound	B-Simple_chemical
derivatives	NNS	conj	I-Simple_chemical
inhibited	VBD	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
this	DT	det	O
enzyme	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
thrombin	NN	nsubj	O
increases	VBZ	ROOT	O
the	DT	det	O
secretion	NN	dobj	O
of	IN	case	O
VEGF	NN	nmod	O
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
synthesis	NN	conj	O
of	IN	case	O
matrix	NN	compound	O
metalloprotease	NN	compound	O
-	:	punct	O
9	CD	dep	O
and	CC	cc	O
alpha	NN	compound	O
(	-LRB-	punct	O
v	LS	appos	O
)	-RRB-	punct	O
beta	NN	compound	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
integrin	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
prostate	NN	compound	O
cancer	NN	compound	O
PC	NN	compound	O
-	:	punct	O
3	CD	nummod	O
cells	NNS	nmod	O
.	.	punct	O
They	PRP	nsubj	O
also	RB	advmod	O
antagonised	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
thrombin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
SFLLR	NN	conj	B-Gene_or_gene_product
on	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
could	MD	aux	O
explain	VB	ROOT	O
the	DT	dep	O
angiogenic	JJ	dobj	O
and	CC	cc	O
tumor	NN	conj	O
-	HYPH	punct	O
promoting	VBG	dep	O
effect	NN	dep	O
of	IN	case	O
thrombin	NN	nmod	O
and	CC	cc	O
provide	VBP	conj	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
thrombin	NN	compound	O
receptor	NN	compound	O
mimetics	NNS	nmod	O
or	CC	cc	O
antagonists	NNS	conj	O
for	IN	case	O
therapeutic	JJ	amod	O
application	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
non	JJ	amod	O
-	HYPH	punct	O
thrombogenic	JJ	amod	O
agonists	NNS	nsubjpass	O
or	CC	cc	O
antagonists	NNS	conj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
thrombin	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
can	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
as	IN	case	O
modulators	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
PTEN	NN	compound	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
was	VBD	auxpass	O
negatively	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O
Abnormal	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
molecular	JJ	amod	O
marker	NN	ROOT	O
of	IN	case	O
submucosal	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
colon	NN	compound	O
cancers	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
BACKGROUND	NN	dep	O
:	:	punct	O
Impaired	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Serum	NN	compound	O
soluble	JJ	amod	O
vascular	JJ	amod	O
adhesion	NN	compound	O
protein	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	cop	O
a	DT	det	O
valuable	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	ROOT	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
immunohistochemical	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
adhesion	NN	compound	O
molecules	NNS	nmod	O
,	,	punct	O
focusing	VBG	advcl	O
on	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
investigate	VB	conj	O
differences	NNS	dobj	O
between	IN	case	O
differentiated	VBN	amod	O
and	CC	cc	O
undifferentiated	JJ	conj	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
at	IN	case	O
the	DT	det	O
early	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
and	CC	cc	O
explore	VBP	conj	O
their	PRP$	nmod:poss	O
roles	NNS	dobj	O
in	IN	case	O
progression	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
staining	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
performed	VBN	dep	O
using	VBG	xcomp	O
specimens	NNS	dobj	B-Multi-tissue_structure
from	IN	case	O
143	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	O
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Abnormal	NNP	amod	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
staining	NN	conj	O
correlated	VBN	dep	O
with	IN	case	O
depth	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Cancer
invasion	NN	nmod	O
in	IN	case	O
differentiated	VBN	amod	O
-	HYPH	punct	O
type	NN	compound	O
tumours	NNS	nmod	B-Cancer
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
intense	JJ	amod	O
staining	NN	nsubj	O
for	IN	case	O
HER2	NN	nmod	O
on	IN	case	O
the	DT	det	O
basolateral	JJ	amod	O
membrane	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
of	IN	case	O
intestinal	JJ	amod	O
metaplasia	NN	nmod	O
(	-LRB-	punct	O
22	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
91	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	O
in	FW	compound	O
situ	FW	advmod	O
(	-LRB-	punct	O
9	CD	nummod	O
/	SYM	punct	O
10	CD	dep	O
;	:	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
lesions	NNS	attr	O
that	WDT	nsubj	O
displayed	VBD	acl:relcl	O
a	DT	det	O
significantly	RB	advmod	O
high	JJ	amod	O
proliferation	NN	compound	O
index	NN	dobj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
abnormal	JJ	amod	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
frequently	RB	advmod	O
found	VBN	ROOT	O
even	RB	advmod	O
in	IN	case	O
intramucosal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
of	IN	case	O
undifferentiated	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
tumours	NNS	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
apparent	JJ	amod	O
difference	NN	dobj	O
in	IN	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
catenin	NN	compound	B-Gene_or_gene_product
complex	NN	compound	O
abnormality	NN	nmod	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
cancer	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
tumors	NNS	nsubj	O
with	IN	case	O
beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	compound	O
stabilization	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
melanomas	NNS	nmod	O
.	.	punct	O
Absent	JJ	amod	O
staining	NN	nsubjpass	O
of	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
PTEN	NN	compound	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
microsatellites	NNS	nmod	O
in	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O
Multivariate	JJ	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
abnormal	JJ	amod	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
as	IN	case	O
an	DT	det	O
independent	JJ	amod	O
factor	NN	nmod	O
that	WDT	nsubj	O
correlated	VBD	acl:relcl	O
with	IN	case	O
submucosal	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
D10S541	NN	nmod	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
was	VBD	auxpass	O
found	VBN	dep	O
in	IN	case	O
37	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
21	CD	nummod	O
/	SYM	punct	O
56	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
CONCLUSION	NN	nsubjpass	O
:	:	punct	O
Abnormal	NNP	amod	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
possible	JJ	amod	O
marker	NN	appos	O
of	IN	case	O
submucosal	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
in	IN	case	O
differentiated	VBN	amod	O
-	HYPH	punct	O
type	NN	compound	O
early	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
absent	JJ	amod	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
staining	NN	conj	O
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
predictor	NN	nmod	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
both	DT	det	O
types	NNS	nmod	O
.	.	punct	O

Erbb2	NN	nsubj	O
suppresses	VBZ	ROOT	O
DNA	NN	compound	O
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	O
skin	NN	compound	O
tumorigenesis	NN	dobj	O
.	.	punct	O
Dominant	JJ	amod	O
negative	JJ	amod	O
interference	NN	nsubj	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
AP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
causes	VBZ	ROOT	O
inhibition	NN	dobj	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
suppresses	VBZ	conj	O
malignant	JJ	amod	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
melanoma	NN	compound	O
skin	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
HER3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
family	NN	nmod	O
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
melanoma	NN	compound	O
skin	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Increasing	VBG	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
ErbB	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
malignancy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
Erbb2	NN	compound	O
activation	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
skin	NN	compound	O
tumorigenesis	NN	nmod	O
by	IN	mark	O
suppressing	VBG	advcl	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
occur	VB	ccomp	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	nmod	I-Cell
and	CC	cc	O
fibroblasts	NNS	conj	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dep	I-Cell
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
AP	NN	compound	O
-	:	punct	O
1	CD	nmod	O
in	IN	case	O
skin	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
following	VBG	case	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NN	compound	O
or	CC	cc	O
TPA	NN	compound	O
exposure	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
association	NN	nsubj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2beta	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
between	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	conj	I-Gene_or_gene_product
double	JJ	amod	O
positivity	NN	dep	O
and	CC	cc	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

Erbb2	NN	nsubj	O
suppresses	VBZ	ROOT	O
DNA	NN	compound	O
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	O
skin	NN	compound	O
tumorigenesis	NN	dobj	O
.	.	punct	O
In	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
transfection	NN	compound	O
experiments	NNS	nmod	O
,	,	punct	O
exogenous	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	nmod	I-Gene_or_gene_product
robustly	RB	advmod	O
activated	VBD	ROOT	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	nmod	O
/	:	punct	O
Akt	NNP	nsubj	O
suppressed	VBD	ROOT	O
the	DT	det	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
BMP	NNP	compound	O
-	HYPH	punct	O
2	CD	nummod	O
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2delta	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
deleted	VBN	amod	O
residues	NNS	dep	O
31	CD	nummod	O
-	SYM	punct	O
117	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
not	RB	neg	O
only	RB	cc:preconj	O
repressed	VBD	ROOT	O
the	DT	det	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
but	CC	cc	O
also	RB	advmod	O
suppressed	VBD	conj	O
endogenous	JJ	amod	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
transcription	NN	dobj	O
in	IN	case	O
the	DT	det	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
overexpressing	VBG	amod	O
cell	NN	compound	B-Cell
line	NN	compound	I-Cell
MRC	NN	compound	I-Cell
-	:	punct	I-Cell
5VA	JJ	dep	I-Cell
.	.	punct	O

Ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
SEMA3B	NN	nmod	O
or	CC	cc	O
SEMA3F	NN	conj	O
reduced	VBD	ROOT	O
soft	JJ	amod	O
-	HYPH	punct	O
agar	NN	amod	O
colony	NN	compound	O
formation	NN	dobj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	O
invasion	NN	conj	O
of	IN	case	O
ovarian	JJ	amod	O
cancer	NN	compound	O
cell	NN	compound	O
cultures	NNS	nmod	O
.	.	punct	O
Overexpression	NN	nsubj	O
of	IN	case	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2A	NN	nmod	I-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
decreased	VBN	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
and	CC	cc	O
inhibitin	NN	conj	O
of	IN	case	O
colony	NN	compound	B-Cell
formation	NN	nmod	O
.	.	punct	O

By	IN	case	O
use	NN	nmod	O
of	IN	case	O
electric	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	compound	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	:	punct	O
14	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
)	-RRB-	punct	O
activates	VBZ	ccomp	O
AP	NN	compound	O
-	:	punct	O
1	CD	dobj	O
in	IN	case	O
human	JJ	amod	O
dermal	JJ	amod	O
fibroblasts	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
interleukin	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
beta	NN	nmod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	appos	O
)	-RRB-	punct	O
results	VBZ	parataxis	O
in	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
activation	NN	nmod	O
.	.	punct	O
Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
strongly	RB	advmod	O
support	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
gene	NN	compound	O
family	NN	nmod	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
AP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2gamma	NN	dep	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
ErbB	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TNFalpha	NN	compound	O
treatment	NN	nsubj	O
alone	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
suppressed	VBN	acl:relcl	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O
Interference	NN	nsubj	O
with	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
AP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
might	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
potential	JJ	amod	O
strategy	NN	dobj	O
for	IN	case	O
modulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
malignant	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

RASMC	NN	compound	O
proliferation	NN	nsubj	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	O
.	.	punct	O
VEGF165	NN	nsubj	B-Gene_or_gene_product
mediates	VBZ	ROOT	O
formation	NN	dobj	O
of	IN	case	O
complexes	NNS	nmod	O
containing	VBG	acl	O
VEGFR	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
neuropilin	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
that	WDT	nsubj	O
enhance	VBP	acl:relcl	O
VEGF165	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
receptor	NN	compound	O
binding	NN	dobj	O
.	.	punct	O

VEGF165	NN	nsubj	O
expressed	VBN	acl	O
by	IN	case	O
a	DT	det	O
replication	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
recombinant	JJ	amod	O
adenovirus	NN	compound	O
vector	NN	nmod	O
induces	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Co	NN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
KDR	NN	conj	B-Gene_or_gene_product
on	IN	case	O
the	DT	det	O
surface	NN	nmod	B-Cellular_component
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EC	NN	appos	B-Cell
)	-RRB-	punct	O
enhances	VBZ	ROOT	O
VEGF165	NN	compound	B-Gene_or_gene_product
binding	NN	dobj	O
to	TO	case	O
KDR	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
EC	NN	conj	B-Cell
chemotaxis	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
VEGF165	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Modulating	VBG	ROOT	O
metastasis	NN	dobj	O
by	IN	case	O
a	DT	det	O
lymphangiogenic	JJ	amod	O
switch	NN	nmod	O
in	IN	case	O
prostate	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Overexpression	NN	nsubj	O
of	IN	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
prostate	NN	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	FW	amod	O
vivo	FW	dep	O
results	NNS	ROOT	O
in	IN	case	O
increased	VBN	amod	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
and	CC	cc	O
growth	NN	conj	O
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
receptor	NN	nsubj	O
,	,	punct	O
VEGFR	NN	compound	O
-	:	punct	O
2	CD	nummod	O
/	:	punct	O
KDR	NN	appos	O
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
VEGF	NNP	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
NRP1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
angiogenesis	NN	dobj	O
by	IN	mark	O
analyzing	VBG	advcl	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
.	.	punct	O

RASMC	NN	compound	O
proliferation	NN	nsubj	O
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	ROOT	O
.	.	punct	O
An	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
complex	NN	nsubjpass	O
containing	VBG	acl	O
NRP1	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
immunoprecipitated	VBN	ROOT	O
from	IN	case	O
EC	NN	nmod	B-Cell
by	IN	case	O
anti	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
NRP1	NN	compound	I-Gene_or_gene_product
antibodies	NNS	nmod	I-Gene_or_gene_product
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
VEGF165	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
phVEGF121	NN	nmod	O
,	,	punct	O
phVEGF165	NN	conj	O
,	,	punct	O
and	CC	cc	O
phVEGF189	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
these	DT	det	O
isoforms	NNS	nsubj	O
are	VBP	cop	O
biologically	RB	advmod	O
equivalent	JJ	ccomp	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
VEGF121	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
bind	VB	acl:relcl	O
to	TO	case	O
NRP1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
support	VB	ROOT	O
complex	NN	compound	O
formation	NN	dobj	O
.	.	punct	O

VEGF	NNP	compound	O
-	HYPH	punct	O
A	NNP	nsubjpass	O
(	-LRB-	punct	O
165	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
B	NN	conj	O
,	,	punct	O
C	NN	conj	O
,	,	punct	O
Flt	NNP	compound	O
-	HYPH	punct	O
1	CD	conj	O
,	,	punct	O
and	CC	cc	O
KDR	NN	conj	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O
Complexes	NNS	nsubjpass	O
containing	VBG	acl	O
VEGF165	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
NRP1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
were	VBD	auxpass	O
also	RB	advmod	O
formed	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
intercellular	JJ	amod	B-Immaterial_anatomical_entity
fashion	NN	nmod	O
by	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	nmod	O
of	IN	case	O
EC	NN	nmod	B-Cell
expressing	VBG	acl	O
KDR	NN	dobj	B-Gene_or_gene_product
only	RB	advmod	O
,	,	punct	O
with	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
NRP1	NN	dobj	B-Gene_or_gene_product
only	RB	advmod	O
,	,	punct	O
for	IN	case	O
example	NN	nmod	O
,	,	punct	O
breast	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
phVEGF121	NN	nmod	O
,	,	punct	O
phVEGF165	NN	conj	O
,	,	punct	O
and	CC	cc	O
phVEGF189	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
these	DT	det	O
isoforms	NNS	nsubj	O
are	VBP	cop	O
biologically	RB	advmod	O
equivalent	JJ	ccomp	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
.	.	punct	O
VEGF165	NN	nsubj	B-Gene_or_gene_product
also	RB	advmod	O
mediated	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
NRP1	NN	compound	B-Gene_or_gene_product
dimer	NN	nmod	O
to	TO	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
KDR	NN	dobj	B-Gene_or_gene_product
only	RB	advmod	O
,	,	punct	O
confirming	VBG	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
such	JJ	amod	O
complexes	NNS	nmod	O
.	.	punct	O

This	DT	det	O
potentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
kinase	NN	compound	O
insert	NN	compound	O
domain	NN	compound	O
-	:	punct	O
containing	VBG	amod	O
receptor	NN	dep	O
[	-LRB-	punct	O
KDR	NN	appos	O
]	-RRB-	punct	O
and	CC	cc	O
fms	NN	conj	O
-	HYPH	punct	O
like	IN	prep	O
tyrosine	NN	compound	O
kinase	NN	pobj	O
[	-LRB-	punct	O
Flt	NN	compound	O
-	:	punct	O
1	CD	nummod	O
]	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
complexes	NNS	nmod	O
containing	VBG	acl	O
KDR	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
NRP1	NN	conj	B-Gene_or_gene_product
markedly	RB	advmod	O
increased	VBD	ROOT	O
125I	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF165	NN	compound	I-Gene_or_gene_product
binding	VBG	dobj	O
to	TO	case	O
KDR	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
potentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
kinase	NN	compound	O
insert	NN	compound	O
domain	NN	compound	O
-	:	punct	O
containing	VBG	amod	O
receptor	NN	dep	O
[	-LRB-	punct	O
KDR	NN	appos	O
]	-RRB-	punct	O
and	CC	cc	O
fms	NN	conj	O
-	HYPH	punct	O
like	IN	prep	O
tyrosine	NN	compound	O
kinase	NN	pobj	O
[	-LRB-	punct	O
Flt	NN	compound	O
-	:	punct	O
1	CD	nummod	O
]	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
formation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
ternary	JJ	amod	O
complex	NN	nmod	O
of	IN	case	O
VEGF165	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
KDR	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
NRP1	NN	conj	B-Gene_or_gene_product
potentiates	VBZ	ccomp	O
VEGF165	NN	compound	B-Gene_or_gene_product
binding	VBG	dobj	O
to	TO	case	O
KDR	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
require	VB	ROOT	O
direct	JJ	amod	O
cell	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
contact	NN	dobj	O
,	,	punct	O
yet	RB	advmod	O
result	VBP	advcl	O
from	IN	case	O
continuous	JJ	amod	O
interaction	NN	nmod	O
between	IN	case	O
activated	VBN	amod	O
lymphoid	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
EC	NN	conj	O
.	.	punct	O
These	DT	det	O
complexes	NNS	nsubjpass	O
are	VBP	auxpass	O
formed	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	B-Cellular_component
of	IN	case	O
EC	NN	nmod	B-Cell
and	CC	cc	O
in	IN	case	O
a	DT	det	O
juxtacrine	NN	compound	O
manner	NN	conj	O
via	IN	case	O
association	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
NRP1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
EC	NN	compound	B-Cell
KDR	NNP	conj	B-Gene_or_gene_product
.	.	punct	O

[	-LRB-	punct	O
Tumor	NN	compound	O
metastasis	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
fibrinolytic	JJ	amod	O
system	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O
[	-LRB-	punct	O
Radiologic	NNP	nmod:npmod	O
-	HYPH	punct	O
pathologic	JJ	amod	O
correlations	NNS	ROOT	O
in	IN	case	O
breast	NN	compound	B-Organism_subdivision
diseases	NNS	nmod	O
]	-RRB-	punct	O

In	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
objective	NN	nsubj	O
of	IN	prep	O
this	DT	det	O
article	NN	pobj	O
is	VBZ	ROOT	O
to	TO	mark	O
explain	VB	xcomp	O
radiologic	JJ	amod	O
patterns	NNS	dobj	O
of	IN	case	O
benign	JJ	amod	B-Pathological_formation
and	CC	cc	O
malignant	JJ	conj	B-Pathological_formation
breast	NN	compound	I-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
(	-LRB-	punct	O
masses	NNS	dep	B-Pathological_formation
,	,	punct	O
microcalcifications	NNS	appos	B-Pathological_formation
)	-RRB-	punct	O
based	VBN	case	O
on	IN	case	O
histological	JJ	amod	O
correlations	NNS	nmod	O
.	.	punct	O

Cancer	NN	compound	O
neoangiogenesis	NN	nsubjpass	O
is	VBZ	cop	O
often	RB	advmod	O
disordered	VBN	ROOT	O
and	CC	cc	O
abnormal	JJ	conj	O
,	,	punct	O
with	IN	case	O
evidence	NN	nmod	O
of	IN	mark	O
coexisting	VBG	acl	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
dysfunction	NN	dobj	O
.	.	punct	O
The	DT	det	O
stromal	JJ	amod	B-Tissue
fibrous	JJ	amod	I-Tissue
reaction	NN	nsubj	O
associated	VBN	acl	O
to	IN	case	O
infiltrating	VBG	amod	O
carcinomas	NNS	nmod	B-Cancer
is	VBZ	cop	O
responsible	JJ	ROOT	O
of	IN	case	O
focal	JJ	amod	O
increased	VBN	amod	O
density	NN	nmod	O
,	,	punct	O
and	CC	cc	O
architectural	JJ	amod	O
distorsion	NN	conj	O
,	,	punct	O
ultrasound	VBP	conj	O
acoustic	JJ	amod	O
shadowing	NN	dobj	O
;	:	punct	O
abnormal	JJ	amod	O
neoangiogenesis	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
detected	VBN	parataxis	O
by	IN	case	O
Doppler	NNP	nmod	O
,	,	punct	O
CT	NN	conj	O
or	CC	cc	O
MR	NN	conj	O
imaging	NN	acl	O
.	.	punct	O

p63	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
,	,	punct	O
hormone	NN	compound	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
negative	JJ	amod	O
neoplasms	NNS	ROOT	O
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
.	.	punct	O
Invasive	JJ	amod	O
carcinomas	NNS	nsubj	B-Cancer
without	IN	case	O
spiculated	JJ	amod	B-Multi-tissue_structure
margins	NNS	nmod	I-Multi-tissue_structure
are	VBP	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
tumors	NNS	ROOT	B-Cancer
.	.	punct	O

The	DT	det	O
breast	NN	compound	O
epithelium	NN	compound	O
comprises	VBZ	compound	O
cells	NNS	ROOT	O
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
stem	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
progenitor	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
more	RBR	advmod	O
differentiated	VBN	amod	O
epithelial	JJ	amod	O
and	CC	cc	O
myoepithelial	JJ	conj	O
cells	NNS	conj	O
.	.	punct	O
Mammographic	JJ	amod	O
patterns	NNS	nsubj	O
of	IN	prep	O
microcalcifications	NNS	pobj	B-Pathological_formation
depend	VBP	ROOT	O
on	IN	case	O
their	PRP$	nmod:poss	O
physiopathological	JJ	amod	O
process	NN	nmod	O
(	-LRB-	punct	O
necrosis	NN	dep	O
,	,	punct	O
secretion	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
shape	NN	nsubj	O
of	IN	case	O
clusters	NNS	nmod	B-Pathological_formation
(	-LRB-	punct	O
round	RB	dep	O
,	,	punct	O
triangular	JJ	appos	O
)	-RRB-	punct	O
typifies	VBZ	conj	O
their	PRP$	nmod:poss	O
anatomical	JJ	amod	O
site	NN	dobj	O
of	IN	case	O
origin	NN	nmod	O
(	-LRB-	punct	O
lobular	JJ	dep	B-Multi-tissue_structure
,	,	punct	O
ductal	JJ	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
MTSS1	NN	nmod	O
will	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O
Less	RBR	amod	O
frequent	JJ	amod	O
lesions	NNS	nsubjpass	B-Pathological_formation
(	-LRB-	punct	O
invasive	JJ	amod	O
lobular	JJ	amod	B-Cancer
,	,	punct	O
mucinous	JJ	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
medullary	JJ	conj	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
radial	JJ	amod	B-Pathological_formation
scar	NN	appos	I-Pathological_formation
)	-RRB-	punct	O
will	MD	aux	O
be	VB	auxpass	O
also	RB	advmod	O
explained	VBN	ROOT	O
based	VBN	xcomp	O
on	IN	prep	O
radiopathological	JJ	amod	O
correlations	NNS	pobj	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O
Knowledge	NN	nsubj	O
of	IN	case	O
radiopathological	JJ	amod	O
correlations	NNS	nmod	O
in	IN	case	O
breast	NN	compound	B-Organism_subdivision
diseases	NNS	nmod	O
helps	VBZ	ROOT	O
the	DT	det	O
radiologists	NNS	dobj	O
to	TO	mark	O
analyze	VB	acl	O
and	CC	cc	O
characterize	VB	conj	O
breast	NN	compound	B-Pathological_formation
lesions	NNS	dobj	I-Pathological_formation
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
had	VBD	aux	O
played	VBN	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
dependent	JJ	amod	O
on	IN	case	O
its	PRP$	nmod:poss	O
phosphatase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
Pten	NN	amod	B-Gene_or_gene_product
signaling	NN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
PTEN	NN	nsubj	O
(	-LRB-	punct	O
phosphatase	NN	compound	O
and	CC	cc	O
tensin	NN	compound	O
homologue	NN	nmod	O
deleted	VBN	acl	O
on	IN	case	O
chromosome	NN	nmod	O
10	CD	nummod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	dep	O
identified	VBN	acl	O
on	IN	case	O
human	JJ	amod	O
chromosome	NN	compound	O
10q23	NN	nmod	O
.	.	punct	O
In	IN	case	O
1997	CD	nmod	O
,	,	punct	O
the	DT	det	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
(	-LRB-	punct	O
phosphatase	NN	dep	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tensin	NN	compound	I-Gene_or_gene_product
homolog	NN	conj	I-Gene_or_gene_product
deleted	VBN	acl	I-Gene_or_gene_product
on	IN	case	I-Gene_or_gene_product
chromosome	NN	nmod	I-Gene_or_gene_product
10	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
on	IN	case	O
the	DT	det	O
long	JJ	amod	O
arm	NN	compound	O
of	IN	case	O
chromosome	NN	nmod	B-Cellular_component
10	CD	nummod	I-Cellular_component
.	.	punct	O

Phosphatase	NN	nsubj	O
and	CC	cc	O
tension	NN	conj	O
homolog	NN	dep	O
deleted	VBN	acl	O
on	IN	case	O
chromosome	NN	nmod	O
10	CD	nummod	O
(	-LRB-	punct	O
PTEN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
frequently	RB	advmod	O
deficient	JJ	ROOT	O
in	IN	case	O
various	JJ	amod	O
pathologies	NNS	nmod	O
due	JJ	case	O
to	TO	mwe	O
mutation	NN	nmod	O
or	CC	cc	O
epigenetic	JJ	amod	O
alterations	NNS	conj	O
.	.	punct	O
Since	IN	mark	O
then	RB	advmod	O
,	,	punct	O
important	JJ	amod	O
progress	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
made	VBN	ROOT	O
with	IN	prep	O
respect	NN	pobj	O
to	TO	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
Pten	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
pathogenesis	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

PTEN	NN	compound	O
promoter	NN	compound	O
hypermethylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
mechanism	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
This	DT	det	O
review	NN	nsubj	O
summarizes	VBZ	ROOT	O
the	DT	det	O
current	JJ	amod	O
state	NN	dobj	O
of	IN	prep	O
the	DT	det	O
art	NN	pobj	O
concerning	VBG	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
aberrant	JJ	amod	O
Pten	NNP	compound	B-Gene_or_gene_product
function	NN	nmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
biologic	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
loss	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cycle	NN	compound	O
control	NN	nmod	O
and	CC	cc	O
uncontrolled	JJ	amod	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
,	,	punct	O
escape	VBP	xcomp	O
from	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
brain	NN	compound	B-Organ
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
aberrant	JJ	amod	O
neoangiogenesis	NN	conj	O
.	.	punct	O

Substantial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
can	MD	aux	O
inhibit	VB	ccomp	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
many	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Most	JJS	nsubj	O
of	IN	prep	O
the	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
suppressive	JJ	amod	O
properties	NNS	pobj	O
of	IN	prep	O
Pten	NNP	pobj	B-Gene_or_gene_product
are	VBP	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
its	PRP$	nmod:poss	O
lipid	NN	compound	B-Simple_chemical
phosphatase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
the	DT	det	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
'	''	punct	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PI3K	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
/	:	punct	O
Akt	DT	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
through	IN	case	O
dephosphorylation	NN	nmod	O
of	IN	case	O
phosphatidylinositol	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
triphosphate	NN	advcl	I-Simple_chemical
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
had	VBD	aux	O
played	VBN	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
dependent	JJ	amod	O
on	IN	case	O
its	PRP$	nmod:poss	O
phosphatase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
The	DT	det	O
additional	JJ	amod	O
function	NN	nsubj	O
of	IN	prep	O
Pten	NNP	pobj	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
dual	JJ	amod	O
-	HYPH	punct	O
specificity	NN	compound	O
protein	NN	compound	O
phosphatase	NN	nmod	O
may	MD	aux	O
also	RB	advmod	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
glioma	NN	compound	B-Cancer
pathogenesis	NN	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
PTEN	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
proliferating	VBG	amod	O
cell	NN	compound	O
nuclear	JJ	amod	O
antigen	NN	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
Erk1	NN	nmod	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
Akt	NNP	conj	O
.	.	punct	O
Besides	IN	prep	O
the	DT	det	O
wealth	NN	pobj	O
of	IN	case	O
data	NNS	nmod	O
elucidating	VBG	acl	O
the	DT	det	O
functional	JJ	amod	O
roles	NNS	dobj	O
of	IN	case	O
Pten	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
recent	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
diagnostic	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
alterations	NNS	nmod	O
as	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
marker	NN	nmod	O
for	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
anaplastic	JJ	amod	B-Cancer
astrocytomas	NNS	nmod	I-Cancer
and	CC	cc	O
anaplastic	JJ	amod	B-Cancer
oligodendrogliomas	NNS	conj	I-Cancer
.	.	punct	O

Reduced	VBN	amod	O
PTEN	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
proliferating	VBG	amod	O
cell	NN	compound	O
nuclear	JJ	amod	O
antigen	NN	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
Erk1	NN	nmod	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
Akt	NNP	conj	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
possibility	NN	nsubj	O
of	IN	case	O
selective	JJ	amod	O
targeting	NN	nmod	O
of	IN	case	O
PTEN	NN	compound	B-Gene_or_gene_product
mutant	JJ	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
by	IN	case	O
specific	JJ	amod	O
pharmacologic	JJ	amod	O
inhibitors	NNS	nmod	O
of	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Pten	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
PI3K	NN	appos	B-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
opens	VBZ	ROOT	O
up	RP	prt	O
new	JJ	amod	O
perspectives	NNS	dobj	O
for	IN	case	O
a	DT	det	O
targeted	VBN	amod	O
molecular	JJ	amod	O
therapy	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
.	.	punct	O

[	-LRB-	punct	O
Altered	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
PTEN	NN	compound	O
gene	NN	nmod	O
and	CC	cc	O
LOH	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
]	-RRB-	punct	O
.	.	punct	O
[	-LRB-	punct	O
A	DT	det	O
case	NN	compound	O
report	NN	ROOT	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
responding	VBG	acl	O
to	TO	case	O
TS	NN	nmod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
oral	JJ	amod	B-Organism_subdivision
fluorouracil	NN	compound	B-Simple_chemical
derivative	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
for	IN	case	O
its	PRP$	nmod:poss	O
anticancer	NN	compound	O
effect	NN	nmod	O
on	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
anticancer	NN	compound	O
effect	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O
TS	NN	nsubj	B-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
,	,	punct	O
oral	JJ	amod	B-Organism_subdivision
anticancer	NN	compound	B-Cancer
agent	NN	nsubjpass	O
composed	VBN	acl	O
of	IN	case	O
two	CD	nummod	O
modulators	NNS	nmod	O
,	,	punct	O
gimeracil	NN	appos	B-Simple_chemical
(	-LRB-	punct	O
CDHP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
oteracil	NN	compound	B-Simple_chemical
potassium	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
Oxo	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
are	VBP	auxpass	O
mixed	VBN	ROOT	O
with	IN	case	O
tegafur	NN	nmod	B-Simple_chemical
in	IN	case	O
a	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
:	:	punct	O
0	CD	nummod	O
.	.	punct	O
4	CD	nummod	O
:	:	punct	O
1	CD	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
for	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
report	VBP	ROOT	O
one	CD	nummod	O
case	NN	dobj	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
with	IN	case	O
lung	NN	nmod	B-Organ
and	CC	cc	O
lymph	NN	conj	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	dep	O
that	WDT	nsubj	O
completely	RB	advmod	O
responded	VBD	acl:relcl	O
to	TO	case	O
TS	NN	nmod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
.	.	punct	O

Gangliocytic	JJ	amod	O
paraganglioma	NN	nsubjpass	O
(	-LRB-	punct	O
GPG	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
local	JJ	amod	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pancreas	NN	nmod	O
of	IN	case	O
a	DT	det	O
74	CD	nummod	O
-	HYPH	punct	O
yr	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
female	NN	nmod	O
who	WP	nsubj	O
presented	VBD	acl:relcl	O
with	IN	prep	O
diarrhea	NNS	pobj	O
,	,	punct	O
steatorrhea	NNS	conj	O
,	,	punct	O
vomiting	NN	conj	O
,	,	punct	O
nausea	NN	conj	O
,	,	punct	O
and	CC	cc	O
abdominal	JJ	amod	O
pain	NN	conj	O
.	.	punct	O
A	DT	det	O
71	CD	nummod	O
-	HYPH	punct	O
year	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
woman	NN	nsubjpass	B-Organism
was	VBD	auxpass	O
admitted	VBN	ROOT	O
to	IN	prep	O
our	PRP$	poss	O
hospital	NN	pobj	O
because	IN	prep	O
of	IN	pcomp	O
breathlessness	NN	pobj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
LOH	NN	nsubjpass	O
of	IN	case	O
epigenetic	JJ	amod	O
microsatellites	NNS	nmod	O
of	IN	case	O
PTEN	NN	nmod	O
(	-LRB-	punct	O
D10S541	NN	appos	O
,	,	punct	O
D10S583	NN	conj	O
and	CC	cc	O
D10S1687	NN	conj	O
)	-RRB-	punct	O
in	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	O
cancer	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	dep	O
by	IN	case	O
PCR	NN	compound	O
-	HYPH	punct	O
SSCP	NNP	nmod	O
.	.	punct	O
A	DT	det	O
diagnosis	NN	nsubjpass	O
of	IN	case	O
advanced	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
with	IN	case	O
extensive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
and	CC	cc	O
multiple	JJ	amod	O
pulmonary	JJ	amod	B-Organ
metastases	NNS	conj	O
was	VBD	auxpass	O
made	VBN	ROOT	O
.	.	punct	O

Tumor	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
mice	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O
One	CD	compound	O
hundred	CD	nummod	O
mg	NN	compound	O
/	,	punct	O
body	NN	nsubjpass	O
/	:	punct	O
day	NN	appos	O
of	IN	prep	O
TS	NN	pobj	B-Simple_chemical
-	CD	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
was	VBD	auxpass	O
orally	RB	advmod	O
administrated	VBN	ROOT	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
decreased	VBD	ROOT	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
pulmonary	JJ	amod	O
metastasis	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
increased	VBD	parataxis	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lung	NN	nmod	O
.	.	punct	O
A	DT	det	O
partial	JJ	amod	O
response	NN	nsubjpass	O
(	-LRB-	punct	O
PR	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
obtained	VBN	ROOT	O
after	IN	case	O
the	DT	det	O
first	JJ	amod	O
course	NN	nmod	O
with	IN	case	O
regression	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
pulmonary	JJ	amod	B-Organ
metastases	NNS	nmod	O
.	.	punct	O

All	DT	det	O
courses	NNS	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
safety	NN	nmod	O
and	CC	cc	O
31	CD	conj	O
for	IN	case	O
efficacy	NN	nmod	O
.	.	punct	O
After	IN	prep	O
1	CD	nummod	O
drug	NN	npadvmod	O
-	HYPH	punct	O
free	JJ	amod	O
week	NN	pobj	O
,	,	punct	O
the	DT	det	O
second	JJ	amod	O
course	NN	nsubjpass	O
was	VBD	auxpass	O
administered	VBN	ROOT	O
with	IN	prep	O
120	CD	compound	O
mg	NN	compound	O
/	,	punct	O
body	NN	pobj	O
/	:	punct	O
day	NN	appos	O
of	IN	case	O
TS	NN	nmod	B-Simple_chemical
-	:	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
for	IN	case	O
4	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

Electronmicroscopically	RB	advmod	O
,	,	punct	O
thrombus	NN	compound	O
formation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nmod	O
prevented	VBD	ROOT	O
tumor	NN	compound	O
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	compound	O
formation	NN	conj	O
.	.	punct	O
After	IN	case	O
two	CD	nummod	O
courses	NNS	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nsubjpass	B-Cancer
was	VBD	auxpass	O
reduced	VBN	ROOT	O
to	TO	case	O
an	DT	det	O
ulcer	NN	compound	B-Pathological_formation
scar	NN	nmod	I-Pathological_formation
with	IN	case	O
pathological	JJ	amod	O
confirmation	NN	nmod	O
of	IN	case	O
a	DT	det	O
complete	JJ	amod	O
disappearance	NN	nmod	O
of	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

This	DT	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
RPE	NN	compound	O
tumor	NN	compound	O
cells	NNS	nsubj	O
metastasize	VBP	ccomp	O
to	TO	case	O
lymph	NN	compound	O
node	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
computed	JJ	amod	O
tomography	NN	nsubj	O
(	-LRB-	punct	O
CT	NN	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
a	DT	det	O
complete	JJ	amod	O
regression	NN	dobj	O
of	IN	case	O
the	DT	det	O
extensive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
diffuse	JJ	amod	O
lung	NN	compound	B-Organ
metastases	NNS	conj	O
,	,	punct	O
for	IN	case	O
a	DT	det	O
complete	JJ	amod	O
response	NN	nmod	O
(	-LRB-	punct	O
CR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Tumor	NN	compound	O
size	NN	nsubjpass	O
,	,	punct	O
serosal	JJ	amod	O
invasion	NN	appos	O
,	,	punct	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	appos	O
,	,	punct	O
peritoneal	JJ	amod	O
dissemination	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNM	NN	compound	O
classification	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
level	NN	nmod	O
.	.	punct	O
The	DT	det	O
serum	NN	compound	B-Organism_substance
level	NN	nsubjpass	O
of	IN	case	O
CEA	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
reduced	VBN	ROOT	O
from	IN	case	O
172	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	ROOT	O
to	TO	case	O
8	CD	nummod	O
.	.	punct	O
1	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	ROOT	O
after	IN	case	O
TS	NN	compound	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

No	DT	neg	O
ocular	JJ	amod	O
or	CC	cc	O
systemic	JJ	conj	O
bevacizumab	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
side	JJ	compound	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O
As	IN	prep	O
for	IN	prep	O
adverse	JJ	amod	O
events	NNS	pobj	O
,	,	punct	O
only	RB	advmod	O
pigmentation	NN	nsubjpass	B-Pathological_formation
of	IN	case	O
the	DT	det	O
skin	NN	pobj	B-Organ
and	CC	cc	O
Grade	NNP	conj	O
2	CD	nummod	O
oral	JJ	amod	B-Pathological_formation
aphta	NNS	nmod	I-Pathological_formation
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
Systemic	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
:	:	punct	O
a	DT	det	O
cascade	NN	dep	O
of	IN	case	O
biochemical	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
This	DT	det	O
study	NN	nsubj	O
investigates	VBZ	ROOT	O
the	DT	det	O
systemic	JJ	amod	O
biochemical	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
fracture	NN	compound	B-Pathological_formation
healing	VBG	nmod	O
in	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
rigid	JJ	amod	O
osteotomy	NN	advcl	O
in	IN	case	O
a	DT	det	O
prospective	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
study	NN	nmod	O
in	IN	case	O
humans	NNS	nmod	B-Organism
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
further	RB	advmod	O
clarify	VB	advcl	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
mechanical	JJ	amod	O
strain	NN	nmod	O
on	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Organ
formation	NN	nmod	O
,	,	punct	O
bone	NN	compound	B-Organ
growth	NN	compound	O
factors	NNS	conj	O
(	-LRB-	punct	O
insulin	NN	nsubjpass	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
IGF	NNP	appos	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
I	PRP	dep	I-Gene_or_gene_product
,	,	punct	O
IGF	NN	compound	B-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
IGFBP	NN	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
,	,	punct	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
beta1	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
FGF	NN	conj	I-Gene_or_gene_product
[	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
)	-RRB-	punct	O
,	,	punct	O
bone	NN	compound	B-Cellular_component
matrix	NN	compound	I-Cellular_component
degrading	VBG	compound	O
enzymes	NNS	conj	O
(	-LRB-	punct	O
matrix	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
metalloproteinases	NNS	dep	I-Gene_or_gene_product
[	-LRB-	punct	I-Gene_or_gene_product
MMPs	NNS	dep	I-Gene_or_gene_product
]	-RRB-	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
,	,	punct	O
2	CD	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
3	LS	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
human	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
hormone	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
hGH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
bone	NN	compound	B-Organ
formation	NN	compound	O
markers	NNS	conj	O
(	-LRB-	punct	O
ALP	NN	dep	B-Gene_or_gene_product
,	,	punct	O
bone	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
specific	JJ	amod	I-Gene_or_gene_product
ALP	NNP	compound	I-Gene_or_gene_product
[	-LRB-	punct	O
BAP	NN	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
osteocalcin	NN	conj	B-Gene_or_gene_product
[	-LRB-	punct	O
OC	NNP	appos	B-Gene_or_gene_product
]	-RRB-	punct	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
samples	NNS	nmod	I-Organism_substance
from	IN	case	O
10	CD	nummod	O
patients	NNS	nmod	B-Organism
in	IN	case	O
each	DT	det	O
group	NN	compound	O
pre	JJ	dep	O
-	HYPH	punct	O
and	CC	cc	O
postoperatively	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
distraction	NN	compound	O
rate	NN	nmod	O
on	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
growth	NN	nmod	O
in	IN	case	O
intramembraneous	JJ	amod	O
ossification	NN	nmod	O
after	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
distraction	NN	compound	O
group	NN	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
postoperative	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
bFGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
ALP	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
BAP	NN	nsubjpass	B-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
observed	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
lengthening	NN	nmod	O
and	CC	cc	O
the	DT	det	O
consolidation	NN	compound	O
period	NN	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
baseline	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
activity	NN	nsubj	O
,	,	punct	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
quenched	JJ	amod	O
fluorescence	NN	compound	O
substrate	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
increased	VBD	xcomp	O
during	IN	case	O
early	JJ	amod	O
healing	NN	nmod	O
(	-LRB-	punct	O
3	CD	compound	O
-	SYM	punct	O
8	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
then	RB	advmod	O
decreased	VBD	conj	O
between	IN	case	O
24	CD	nummod	O
and	CC	cc	O
36	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	nummod	O
until	IN	case	O
24	CD	nummod	O
weeks	NNS	dep	O
,	,	punct	O
Mann	NNP	compound	O
-	HYPH	punct	O
Whitney	NNP	compound	O
U	NNP	compound	O
-	HYPH	punct	O
test	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Osteotomy	JJ	amod	O
fracture	NN	compound	O
healing	VBG	nsubj	O
without	IN	case	O
the	DT	det	O
traction	NN	compound	O
stimulus	NN	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
corresponding	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
blood	NN	compound	O
vessel	NN	compound	O
density	NN	nsubj	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
1	CD	nummod	O
mm	NN	nmod	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
disruption	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
of	IN	case	O
the	DT	det	O
gap	NN	nmod	O
or	CC	cc	O
to	TO	case	O
a	DT	det	O
less	RBR	advmod	O
optimal	JJ	amod	O
mechanical	JJ	amod	O
stimulation	NN	conj	O
of	IN	case	O
cells	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
comparison	NN	nsubj	O
of	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
higher	JJR	amod	O
increase	NN	dobj	O
in	IN	prep	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta1	NN	intj	I-Gene_or_gene_product
,	,	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
IGFBP	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
hGH	NN	conj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
lengthening	JJ	amod	O
group	NN	nmod	O
during	IN	case	O
the	DT	det	O
distraction	NN	compound	O
period	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
key	JJ	amod	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
mechanotransduction	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
distraction	NN	compound	O
rate	NN	nmod	O
on	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
growth	NN	nmod	O
in	IN	case	O
intramembraneous	JJ	amod	O
ossification	NN	nmod	O
after	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
.	.	punct	O
The	DT	det	O
time	NN	compound	O
courses	NNS	nsubj	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
bone	NN	compound	B-Organ
growth	NN	compound	O
factors	NNS	conj	O
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta1	NN	dep	I-Gene_or_gene_product
and	CC	cc	O
bFGF	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
hGH	NN	conj	B-Gene_or_gene_product
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
correlated	VBD	ROOT	O
significantly	RB	advmod	O
during	IN	case	O
the	DT	det	O
lengthening	NN	amod	O
phase	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
common	JJ	amod	O
regulatory	JJ	amod	O
pathways	NNS	dobj	O
for	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
in	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O

Correlation	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
between	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
parameters	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
formed	VBN	acl	O
during	IN	case	O
distraction	NN	nmod	O
.	.	punct	O
Significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
osteoblastic	JJ	amod	O
marker	NN	compound	O
BAP	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta1	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
bFGF	NN	conj	B-Gene_or_gene_product
suggests	VBZ	ROOT	O
strain	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
osteoblastic	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
as	IN	case	O
a	DT	det	O
major	JJ	amod	O
source	NN	nmod	O
of	IN	case	O
systemically	RB	advmod	O
increased	VBN	amod	O
bone	NN	compound	B-Organ
growth	NN	compound	O
factors	NNS	nmod	O
during	IN	case	O
callus	NN	compound	O
distraction	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
blood	NN	compound	O
vessel	NN	compound	O
density	NN	nsubj	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
1	CD	nummod	O
mm	NN	nmod	O
/	,	punct	O
day	NN	compound	O
distraction	NN	compound	O
rate	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
disruption	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
of	IN	case	O
the	DT	det	O
gap	NN	nmod	O
or	CC	cc	O
to	TO	case	O
a	DT	det	O
less	RBR	advmod	O
optimal	JJ	amod	O
mechanical	JJ	amod	O
stimulation	NN	conj	O
of	IN	case	O
cells	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
The	DT	det	O
systemic	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
might	MD	aux	O
reflect	VB	ROOT	O
an	DT	det	O
increased	VBN	amod	O
local	JJ	amod	O
stimulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
during	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	O
type	NN	compound	O
5	CD	nummod	O
55	CD	nummod	O
-	HYPH	punct	O
kDa	NN	compound	O
E1B	NN	compound	O
protein	NN	nsubj	O
(	-LRB-	punct	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	NN	appos	O
)	-RRB-	punct	O
cooperates	VBZ	ROOT	O
with	IN	case	O
E1A	NN	compound	O
gene	NN	compound	O
products	NNS	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	O
transformation	NN	dobj	O
.	.	punct	O
Human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
oncoprotein	NN	compound	O
E6	NN	nsubj	B-Gene_or_gene_product
inactivates	VBZ	ROOT	O
the	DT	det	O
transcriptional	JJ	amod	O
coactivator	NN	compound	O
human	JJ	amod	B-Organism
ADA3	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

CONTEXT	NN	ROOT	O
:	:	punct	O
Nasopharyngeal	JJ	compound	O
carcinoma	NN	nsubj	O
(	-LRB-	punct	O
NPC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
common	JJ	amod	O
in	IN	prep	O
southern	JJ	amod	O
China	NNP	pobj	O
and	CC	cc	O
North	NNP	compound	O
Africa	NNP	conj	O
,	,	punct	O
has	VBZ	dep	O
a	DT	det	O
complex	JJ	amod	O
etiology	NN	dobj	O
involving	VBG	acl	O
interplay	NN	dobj	O
between	IN	case	O
viral	JJ	amod	O
,	,	punct	O
environmental	JJ	conj	O
,	,	punct	O
and	CC	cc	O
hereditary	JJ	conj	O
factors	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
almost	RB	advmod	O
constantly	RB	advmod	O
associated	VBN	conj	O
with	IN	prep	O
the	DT	det	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	pobj	O
.	.	punct	O
High	NNP	amod	O
-	HYPH	punct	O
risk	NN	compound	O
human	JJ	amod	B-Organism
papillomaviruses	NNS	nsubjpass	I-Organism
(	-LRB-	punct	O
HPVs	NNS	appos	B-Organism
)	-RRB-	punct	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
carcinomas	NNS	nmod	B-Cancer
of	IN	case	O
the	DT	det	O
cervix	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
other	JJ	amod	O
genital	JJ	amod	B-Cancer
tumors	NNS	conj	I-Cancer
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	O
type	NN	compound	O
5	CD	nummod	O
55	CD	nummod	O
-	HYPH	punct	O
kDa	NN	compound	O
E1B	NN	compound	O
protein	NN	nsubj	O
(	-LRB-	punct	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	NN	appos	O
)	-RRB-	punct	O
cooperates	VBZ	ROOT	O
with	IN	case	O
E1A	NN	compound	O
gene	NN	compound	O
products	NNS	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	O
transformation	NN	dobj	O
.	.	punct	O
The	DT	det	O
HPV	NN	compound	B-Organism
oncoprotein	NN	compound	O
E6	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	O
type	NN	compound	O
5	CD	nummod	O
55	CD	nummod	O
-	HYPH	punct	O
kDa	NN	compound	O
E1B	NN	compound	O
protein	NN	nsubj	O
(	-LRB-	punct	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	NN	appos	O
)	-RRB-	punct	O
cooperates	VBZ	ROOT	O
with	IN	case	O
E1A	NN	compound	O
gene	NN	compound	O
products	NNS	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	O
transformation	NN	dobj	O
.	.	punct	O
We	PRP	nsubj	O
identify	VBP	ROOT	O
here	RB	advmod	O
hADA3	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
human	JJ	amod	B-Organism
homologue	NN	conj	O
of	IN	case	O
the	DT	det	O
yeast	NN	compound	B-Organism
transcriptional	JJ	amod	O
coactivator	NN	nmod	O
yADA3	NN	dep	B-Gene_or_gene_product
,	,	punct	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
E6	NN	compound	B-Gene_or_gene_product
-	:	punct	O
interacting	VBG	amod	O
protein	NN	nmod	O
and	CC	cc	O
a	DT	det	O
target	NN	conj	O
of	IN	case	O
E6	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
degradation	NN	nmod	O
.	.	punct	O

The	DT	det	O
adenovirus	NN	compound	O
type	NN	compound	O
5	CD	nummod	O
55	CD	nummod	O
-	HYPH	punct	O
kDa	NN	compound	O
E1B	NN	compound	O
protein	NN	nsubj	O
(	-LRB-	punct	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	NN	appos	O
)	-RRB-	punct	O
cooperates	VBZ	ROOT	O
with	IN	case	O
E1A	NN	compound	O
gene	NN	compound	O
products	NNS	nmod	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	O
transformation	NN	dobj	O
.	.	punct	O
hADA3	NN	nsubj	B-Gene_or_gene_product
binds	VBZ	ROOT	O
selectively	RB	advmod	O
to	IN	case	O
the	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
risk	NN	amod	O
HPV	NN	compound	B-Organism
E6	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
and	CC	cc	O
only	RB	advmod	O
to	TO	case	O
immortalization	NN	compound	O
-	HYPH	punct	O
competent	JJ	amod	O
E6	NN	compound	B-Gene_or_gene_product
mutants	NNS	conj	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	O
expression	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
hallmark	NN	ccomp	O
of	IN	case	O
cancer	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
hADA3	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
coactivator	NN	nmod	O
for	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	nmod	O
by	IN	case	O
stabilizing	VBG	amod	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
previously	RB	advmod	O
that	IN	mark	O
the	DT	det	O
55	CD	compound	O
-	HYPH	punct	O
kDa	NN	amod	O
polypeptide	NN	nsubj	O
abrogates	VBZ	ccomp	O
p53	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
mutants	NNS	nsubj	O
defective	JJ	amod	O
in	IN	case	O
p53	NN	compound	O
binding	NN	nmod	O
are	VBP	cop	O
unable	JJ	conj	O
to	TO	mark	O
cooperate	VB	xcomp	O
with	IN	case	O
E1A	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
.	.	punct	O
Notably	RB	advmod	O
,	,	punct	O
three	CD	nummod	O
immortalizing	VBG	amod	O
E6	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
that	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
induce	VB	acl:relcl	O
direct	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
degradation	NN	dobj	O
but	CC	cc	O
do	VBP	aux	O
interact	VB	conj	O
with	IN	case	O
hADA3	NN	nmod	B-Gene_or_gene_product
induced	VBD	ROOT	O
the	DT	det	O
abrogation	NN	dobj	O
of	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transactivation	NN	nmod	O
and	CC	cc	O
G	NN	compound	O
(	-LRB-	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
after	IN	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
,	,	punct	O
comparable	JJ	advcl	O
to	TO	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
E6	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
strategy	NN	dobj	O
of	IN	case	O
HPV	NN	compound	B-Organism
E6	NN	nmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
loss	NN	dobj	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
function	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
direct	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
degradation	NN	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	O
expression	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
hallmark	NN	ccomp	O
of	IN	case	O
cancer	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
Given	VBN	case	O
the	DT	det	O
likely	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
hADA3	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
multiple	JJ	amod	O
coactivator	NN	compound	O
complexes	NNS	nmod	O
,	,	punct	O
inactivation	NN	nsubj	O
of	IN	case	O
its	PRP$	nmod:poss	O
function	NN	nmod	O
may	MD	aux	O
allow	VB	ROOT	O
E6	NN	nsubj	B-Gene_or_gene_product
to	TO	mark	O
perturb	JJ	ccomp	O
numerous	JJ	amod	O
cellular	JJ	amod	B-Cell
pathways	NNS	dobj	O
during	IN	case	O
HPV	NN	compound	B-Organism
oncogenesis	NN	nmod	O
.	.	punct	O

Prophylactic	JJ	amod	O
thyroidectomy	NN	nsubj	O
in	IN	case	O
MEN	NN	compound	O
IIA	NN	nmod	O
:	:	punct	O
does	VBZ	aux	O
the	DT	det	O
calcitonin	NN	compound	O
level	NN	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
tumor	NN	nmod	O
spread	NN	acl	O
?	.	punct	O
Immunohistochemical	JJ	amod	O
staining	NN	ROOT	O
for	IN	case	O
thyroid	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
helpful	JJ	amod	O
aid	NN	conj	O
in	IN	mark	O
discerning	VBG	acl	O
primary	JJ	amod	O
site	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
origin	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
brain	NN	compound	B-Organ
metastases	NNS	nmod	O
.	.	punct	O

Metastatic	JJ	amod	O
disease	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
causes	NNS	nmod	O
of	IN	case	O
death	NN	nmod	O
from	IN	case	O
cancer	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
beings	NNS	nmod	O
.	.	punct	O
Metastatic	JJ	amod	O
carcinoma	NN	nsubj	B-Cancer
of	IN	case	O
unknown	JJ	amod	O
primary	JJ	amod	O
origin	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
perplexing	NN	amod	O
but	CC	cc	O
common	JJ	conj	O
problem	NN	ROOT	O
,	,	punct	O
accounting	VBG	acl	O
for	IN	prep	O
up	RB	quantmod	O
to	TO	quantmod	O
10	CD	nummod	O
%	NN	pobj	O
to	TO	quantmod	O
15	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
all	DT	det	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
at	IN	case	O
presentation	NN	nmod	O
.	.	punct	O

The	DT	det	O
tumor	NN	nsubj	O
may	MD	aux	O
present	VB	ROOT	O
with	IN	case	O
widespread	JJ	amod	O
metastases	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
unresponsive	JJ	acl:relcl	O
to	TO	case	O
aggressive	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O
Many	JJ	nsubj	O
of	IN	case	O
these	DT	det	O
metastases	NNS	nmod	O
presumably	RB	advmod	O
arise	VBP	ROOT	O
from	IN	case	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
the	DT	det	O
morphologic	JJ	amod	O
features	NNS	nsubj	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
profile	NN	conj	O
of	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
often	RB	advmod	O
too	RB	advmod	O
nonspecific	JJ	conj	O
to	TO	mark	O
permit	VB	xcomp	O
unequivocal	JJ	amod	O
confirmation	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
Thyroid	NN	compound	B-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
lung	NN	compound	B-Cancer
adenocarcinomas	NNS	nmod	I-Cancer
and	CC	cc	O
thyroid	NN	compound	B-Cancer
carcinomas	NNS	conj	I-Cancer
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
adenocarcinomas	NNS	conj	B-Cancer
arising	VBG	acl	O
from	IN	case	O
other	JJ	amod	O
sites	NNS	nmod	B-Multi-tissue_structure
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O
For	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
,	,	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
staining	NN	dep	O
is	VBZ	auxpass	O
now	RB	advmod	O
routinely	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
distinguish	VB	xcomp	O
a	DT	det	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
from	IN	case	O
a	DT	det	O
lung	NN	compound	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
Along	IN	case	O
these	DT	det	O
same	JJ	amod	O
lines	NNS	nmod	O
,	,	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubj	O
might	MD	aux	O
prove	VB	ROOT	O
useful	JJ	xcomp	O
in	IN	mark	O
localizing	VBG	advcl	O
the	DT	det	O
tumor	NN	compound	B-Cancer
origin	NN	dobj	O
of	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
encountered	VBD	acl	O
outside	IN	advmod	O
of	IN	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
.	.	punct	O

The	DT	det	O
study	NN	compound	O
population	NN	nsubj	O
comprised	VBD	ROOT	O
23	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
histopathologically	RB	advmod	O
proven	JJ	amod	O
primary	JJ	amod	O
brain	NN	compound	O
tumours	NNS	nmod	O
;	:	punct	O
14	CD	nsubj	O
had	VBD	parataxis	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
gliomas	NN	dobj	O
,	,	punct	O
and	CC	cc	O
nine	CD	nummod	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
brain	NN	compound	O
neoplasms	NNS	conj	O
.	.	punct	O
The	DT	det	O
archival	NN	compound	O
surgical	JJ	amod	O
pathology	NN	compound	O
files	NNS	nsubjpass	O
of	IN	prep	O
The	DT	det	O
Johns	NNP	compound	O
Hopkins	NNP	compound	O
Hospital	NNP	pobj	O
were	VBD	auxpass	O
searched	VBN	ROOT	O
for	IN	case	O
cases	NNS	nmod	O
of	IN	case	O
brain	NN	compound	B-Organ
metastases	NNS	nmod	O
biopsied	VBD	acl	O
between	IN	prep	O
1990	CD	pobj	O
and	CC	cc	O
2000	CD	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	O
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Tissue	NN	compound	B-Tissue
blocks	NNS	nsubjpass	I-Tissue
were	VBD	auxpass	O
obtained	VBN	ROOT	O
and	CC	cc	O
immunoperoxidase	NN	conj	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	conj	O
using	VBG	xcomp	O
the	DT	det	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
antibody	NN	dobj	O
.	.	punct	O

PATIENTS	NNS	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
erbB2	NNP	dep	O
,	,	punct	O
evaluated	VBN	acl	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
in	IN	case	O
145	CD	compound	O
of	IN	advmod	O
173	CD	nummod	O
patients	NNS	nmod	O
randomly	RB	advmod	O
assigned	VBN	ROOT	O
to	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
year	NN	nmod	O
adjuvant	JJ	amod	O
tamoxifen	NN	dobj	O
or	CC	cc	O
no	DT	neg	O
further	JJ	amod	O
therapy	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
considered	VBN	conj	O
overexpressed	VBN	xcomp	O
if	IN	mark	O
greater	JJR	amod	O
than	IN	quantmod	O
10	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
showed	VBD	advcl	O
specific	JJ	amod	O
membrane	NN	compound	O
staining	NN	dobj	O
.	.	punct	O
The	DT	det	O
medical	JJ	amod	O
records	NNS	nsubjpass	O
were	VBD	auxpass	O
reviewed	VBN	ROOT	O
independent	JJ	oprd	O
of	IN	case	O
the	DT	det	O
staining	NN	nmod	O
results	VBZ	conj	O
to	TO	mark	O
determine	VB	xcomp	O
site	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
origin	NN	nmod	O
.	.	punct	O

The	DT	det	O
study	NN	compound	O
population	NN	nsubj	O
comprised	VBD	ROOT	O
23	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
histopathologically	RB	advmod	O
proven	JJ	amod	O
primary	JJ	amod	O
brain	NN	compound	O
tumours	NNS	nmod	O
;	:	punct	O
14	CD	nsubj	O
had	VBD	parataxis	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
gliomas	NN	dobj	O
,	,	punct	O
and	CC	cc	O
nine	CD	nummod	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
brain	NN	compound	O
neoplasms	NNS	conj	O
.	.	punct	O
Seventy	CD	compound	O
-	HYPH	punct	O
five	CD	nummod	O
patients	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
biopsies	NNS	dobj	O
of	IN	case	O
carcinomas	NNS	nmod	B-Cancer
metastatic	JJ	amod	O
to	TO	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
.	.	punct	O

The	DT	det	O
study	NN	compound	O
population	NN	nsubj	O
comprised	VBD	ROOT	O
23	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
histopathologically	RB	advmod	O
proven	JJ	amod	O
primary	JJ	amod	O
brain	NN	compound	O
tumours	NNS	nmod	O
;	:	punct	O
14	CD	nsubj	O
had	VBD	parataxis	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
gliomas	NN	dobj	O
,	,	punct	O
and	CC	cc	O
nine	CD	nummod	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
brain	NN	compound	O
neoplasms	NNS	conj	O
.	.	punct	O
At	IN	prep	O
the	DT	det	O
time	NN	pobj	O
of	IN	prep	O
brain	NN	compound	B-Organ
biopsy	NN	pobj	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nsubjpass	B-Multi-tissue_structure
of	IN	case	O
tumor	NN	compound	B-Cancer
origin	NN	nmod	O
was	VBD	auxpass	O
known	VBN	ROOT	O
in	IN	case	O
45	CD	nummod	O
cases	NNS	nmod	O
and	CC	cc	O
unknown	JJ	conj	O
in	IN	case	O
30	CD	nummod	O
cases	NNS	nmod	O
.	.	punct	O

Electronmicroscopically	RB	advmod	O
,	,	punct	O
thrombus	NN	compound	O
formation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nmod	O
prevented	VBD	ROOT	O
tumor	NN	compound	O
invasion	NN	dobj	O
and	CC	cc	O
metastasis	NN	compound	O
formation	NN	conj	O
.	.	punct	O
Ultimately	RB	advmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
site	NN	nsubjpass	B-Multi-tissue_structure
was	VBD	auxpass	O
established	VBN	ROOT	O
on	IN	case	O
clinical	JJ	amod	O
and	CC	cc	O
radiographic	JJ	conj	O
grounds	NNS	nmod	O
in	IN	case	O
71	CD	nummod	O
cases	NNS	nmod	O
(	-LRB-	punct	O
95	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
surgically	RB	advmod	O
resected	VBN	amod	O
46	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
lung	NN	compound	O
cancers	NNS	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	conj	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
These	DT	nsubj	O
included	VBD	ROOT	O
40	CD	nummod	O
(	-LRB-	punct	O
56	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastases	NNS	dobj	O
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
31	CD	nummod	O
(	-LRB-	punct	O
44	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastases	NNS	conj	O
from	IN	case	O
some	DT	det	O
nonpulmonary	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
surgically	RB	advmod	O
resected	VBN	amod	O
46	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
lung	NN	compound	O
cancers	NNS	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	conj	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubj	O
was	VBD	cop	O
present	JJ	ROOT	O
in	IN	case	O
31	CD	nmod	O
of	IN	case	O
the	DT	det	O
40	CD	nummod	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastatic	JJ	amod	O
lung	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
in	IN	case	O
only	RB	advmod	O
1	CD	conj	O
of	IN	case	O
the	DT	det	O
31	CD	nummod	O
(	-LRB-	punct	O
3	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
metastatic	JJ	amod	O
nonpulmonary	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
a	DT	det	O
small	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	dep	I-Cancer
of	IN	case	O
the	DT	det	O
sinonasal	JJ	amod	B-Organism_subdivision
tract	NN	nmod	I-Organism_subdivision
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
gene	NN	compound	O
product	NN	nmod	O
in	IN	case	O
surgically	RB	advmod	O
resected	VBN	amod	O
46	CD	nummod	O
pairs	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
lung	NN	compound	O
cancers	NNS	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	conj	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
When	WRB	advmod	O
the	DT	det	O
metastatic	JJ	amod	O
lung	NN	compound	B-Cancer
carcinomas	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
subtyped	VBN	advcl	O
,	,	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
11	CD	compound	O
of	IN	advmod	O
11	CD	nummod	O
(	-LRB-	punct	O
100	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
adenocarcinomas	NNS	nmod	B-Cancer
,	,	punct	O
in	IN	case	O
6	CD	nmod	O
of	IN	advmod	O
7	CD	nummod	O
(	-LRB-	punct	O
86	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
small	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
in	IN	case	O
15	CD	compound	O
of	IN	advmod	O
19	CD	nummod	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	intj	O
)	-RRB-	punct	O
large	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
in	IN	case	O
none	NN	conj	O
of	IN	case	O
3	CD	nummod	O
(	-LRB-	punct	O
0	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Determining	VBG	csubj	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
levels	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
valuable	JJ	ROOT	O
for	IN	mark	O
predicting	VBG	advcl	O
prognosis	NN	dobj	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
.	.	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
staining	NN	nsubj	O
is	VBZ	cop	O
very	RB	advmod	O
reliable	JJ	ROOT	O
in	IN	mark	O
discerning	VBG	advcl	O
whether	IN	mark	O
a	DT	det	O
brain	NN	compound	B-Organ
metastasis	NN	nsubj	O
has	VBZ	aux	O
arisen	VBN	ccomp	O
from	IN	case	O
a	DT	det	O
pulmonary	JJ	amod	B-Multi-tissue_structure
or	CC	cc	O
nonpulmonary	JJ	conj	B-Multi-tissue_structure
site	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
particularly	RB	advmod	O
when	WRB	advmod	O
dealing	VBG	advcl	O
with	IN	case	O
adenocarcinomas	NNS	nmod	B-Cancer
and	CC	cc	O
large	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	conj	I-Cancer
.	.	punct	O

Metastatic	JJ	amod	O
lesions	NNS	nsubjpass	O
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
TTF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
immunohistochemistry	NN	nsubj	O
could	MD	aux	O
focus	VB	ROOT	O
the	DT	det	O
search	NN	dobj	O
for	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
for	IN	case	O
patients	NNS	nmod	B-Organism
presenting	VBG	acl	O
with	IN	case	O
brain	NN	compound	B-Organ
metastasis	NN	nmod	O
as	IN	case	O
the	DT	det	O
initial	JJ	amod	O
manifestation	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Expression	NN	ROOT	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
small	JJ	amod	O
cell	NN	compound	O
lung	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinical	JJ	amod	O
significance	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O
Protein	NN	compound	O
expression	NN	compound	O
profile	NN	ROOT	O
of	IN	case	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
indicative	JJ	amod	O
of	IN	case	O
the	DT	det	O
incidence	NN	nmod	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	cop	O
the	DT	det	O
assessment	NN	ROOT	O
of	IN	case	O
correlations	NNS	nmod	O
among	IN	case	O
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
apoptosis	NN	compound	O
-	HYPH	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	nmod	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	conj	O
-	:	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
relationships	NNS	conj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
with	IN	case	O
selected	VBN	amod	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
firstly	RB	advmod	O
whether	IN	mark	O
different	JJ	amod	O
protein	NN	compound	O
expression	NN	compound	O
patterns	NNS	nsubj	O
exist	VBP	ccomp	O
in	IN	case	O
primary	JJ	amod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
and	CC	cc	O
secondly	RB	conj	O
,	,	punct	O
whether	IN	mark	O
or	CC	cc	O
not	RB	neg	O
different	JJ	amod	O
patterns	NNS	nsubj	O
exist	VBP	ccomp	O
in	IN	case	O
tumours	NNS	nmod	B-Cancer
with	IN	case	O
positive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
small	JJ	amod	O
cell	NN	compound	O
lung	NN	compound	O
cancer	NN	nmod	O
(	-LRB-	punct	O
NSCLC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
For	IN	prep	O
this	DT	det	O
reason	NN	pobj	O
,	,	punct	O
formalin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
fixed	VBN	amod	O
,	,	punct	O
paraffin	NN	amod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
specimens	NNS	nsubjpass	B-Tissue
from	IN	case	O
130	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	cop	O
the	DT	det	O
assessment	NN	ROOT	O
of	IN	case	O
correlations	NNS	nmod	O
among	IN	case	O
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
apoptosis	NN	compound	O
-	HYPH	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	nmod	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	conj	O
-	:	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
relationships	NNS	conj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
with	IN	case	O
selected	VBN	amod	O
clinicopathological	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O
In	IN	case	O
a	DT	det	O
first	JJ	amod	O
step	NN	nmod	O
,	,	punct	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
which	WDT	nsubj	O
showed	VBD	ccomp	O
a	DT	det	O
relationship	NN	dobj	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
HSP27	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
stage	NN	conj	O
,	,	punct	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
and	CC	cc	O
histological	JJ	amod	O
grade	NN	conj	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
JUN	NN	compound	B-Gene_or_gene_product
,	,	punct	O
ERBB2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
MYC	NN	conj	B-Gene_or_gene_product
,	,	punct	O
cyclin	NN	compound	B-Gene_or_gene_product
D	NN	conj	I-Gene_or_gene_product
,	,	punct	O
PCNA	NN	conj	B-Gene_or_gene_product
,	,	punct	O
bFGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
VEGF	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
Hsp70	NN	conj	B-Gene_or_gene_product
proteins	NNS	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	dobj	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	dep	O
between	IN	case	O
tumor	NN	compound	O
prognosis	NN	nmod	O
and	CC	cc	O
EGFR	NN	conj	O
,	,	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	conj	O
or	CC	cc	O
Fas	NN	conj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
,	,	punct	O
Fas	NN	compound	B-Gene_or_gene_product
ligand	NN	conj	I-Gene_or_gene_product
,	,	punct	O
Fas	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CD95	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
PAI	NN	nsubj	B-Gene_or_gene_product
showed	VBD	ROOT	O
an	DT	det	O
inverse	JJ	amod	O
correlation	NN	dobj	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubjpass	O
:	:	punct	O
The	DT	det	O
parameters	NNS	nsubj	O
associated	VBN	acl	O
with	IN	prep	O
locating	VBG	pobj	O
and	CC	cc	O
then	RB	advmod	O
photocoagulating	VBG	dep	O
CNV	NN	compound	O
feeder	NN	compound	O
vessels	NNS	dobj	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
optimized	VBN	conj	O
using	VBG	xcomp	O
published	VBN	amod	O
data	NNS	dobj	O
and	CC	cc	O
data	NNS	conj	O
derived	VBN	acl	O
from	IN	mark	O
modeling	VBG	advcl	O
the	DT	det	O
choroidal	JJ	amod	O
vasculature	NN	dobj	O
.	.	punct	O
In	IN	case	O
a	DT	det	O
second	JJ	amod	O
step	NN	nmod	O
,	,	punct	O
these	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
further	RB	advmod	O
analyzed	VBN	ROOT	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analyses	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
defined	VBN	acl	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
score	NN	nmod	O
identifies	VBZ	appos	O
a	DT	det	O
distinct	JJ	amod	O
group	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	O
cancers	NNS	nmod	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
(	-LRB-	punct	O
log	NN	compound	O
-	HYPH	punct	O
rank	NN	compound	O
test	NN	dep	O
,	,	punct	O
12	CD	appos	O
.	.	punct	O
22	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0005	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
resulting	VBG	amod	O
clusters	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
to	TO	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
or	CC	cc	O
without	IN	conj	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
LDH5	NN	compound	O
protein	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
well	RB	advmod	O
characterized	VBN	amod	O
large	JJ	amod	O
cohort	NN	nmod	O
of	IN	case	O
primary	JJ	amod	O
lung	NN	compound	O
cancers	NNS	nmod	O
in	IN	case	O
correlation	NN	nmod	O
to	TO	case	O
clinico	VB	nmod:npmod	O
-	HYPH	punct	O
pathological	JJ	amod	O
data	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
possible	JJ	amod	O
impact	NN	conj	O
on	IN	case	O
patient	NN	compound	O
survival	NN	nmod	O
.	.	punct	O
The	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
different	JJ	amod	O
protein	NN	compound	O
expression	NN	compound	O
patterns	NNS	nsubj	O
exist	VBP	ccomp	O
between	IN	case	O
primary	JJ	amod	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
and	CC	cc	O
within	IN	case	O
carcinomas	NNS	conj	B-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
involvement	NN	nmod	O
.	.	punct	O

Using	VBG	ROOT	O
univariate	JJ	amod	O
analysis	NN	dobj	O
,	,	punct	O
the	DT	det	O
S	NNP	compound	O
-	HYPH	punct	O
100beta	CD	compound	O
level	NN	nsubjpass	O
and	CC	cc	O
metastatic	JJ	amod	O
profile	NN	conj	O
were	VBD	auxpass	O
found	VBN	parataxis	O
to	TO	mark	O
be	VB	cop	O
statistically	RB	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	xcomp	O
for	IN	case	O
survival	NN	nmod	O
.	.	punct	O
The	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
various	JJ	amod	O
metastasis	NN	compound	O
profiles	NNS	nsubj	O
exist	VBP	ccomp	O
.	.	punct	O

An	DT	det	O
antibody	NN	nsubj	O
directed	VBN	acl	O
against	IN	case	O
PDGF	NN	compound	O
receptor	NN	compound	O
beta	NN	nmod	O
enhances	VBZ	ROOT	O
the	DT	det	O
antitumor	NN	dobj	O
and	CC	cc	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
activities	NNS	conj	O
of	IN	case	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
receptor	NN	compound	O
2	CD	nummod	O
antibody	NN	nmod	O
.	.	punct	O
Antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	JJ	conj	B-Cancer
effects	NNS	nsubj	O
of	IN	case	O
a	DT	det	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
Cbeta	NN	compound	I-Gene_or_gene_product
inhibitor	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
xenografts	NNS	ROOT	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nmod	O
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
cell	NN	compound	O
growth	NN	conj	O
.	.	punct	O
In	IN	case	O
cell	NN	compound	B-Cell
culture	NN	nmod	O
,	,	punct	O
the	DT	det	O
compound	NN	nsubj	O
317615	CD	nummod	B-Simple_chemical
2HCl	CD	dep	I-Simple_chemical
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HUVEC	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
not	RB	neg	O
very	RB	advmod	O
effective	JJ	ROOT	O
against	IN	case	O
MX	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
1	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
8	CD	dobj	O
.	.	punct	O
1	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
or	CC	cc	O
SKOV	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
ovarian	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
IC50	NN	nsubj	O
=	JJ	acl:relcl	O
9	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
microM	NN	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
cervical	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
paclitaxel	NN	nsubj	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
through	IN	case	O
an	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
with	IN	case	O
prior	JJ	amod	O
G2	NN	dep	O
/	:	punct	O
M	NN	dep	O
arrest	NN	nmod	O
.	.	punct	O
Exposure	NN	nsubj	O
to	TO	prep	O
combinations	NNS	pobj	O
of	IN	prep	O
paclitaxel	NN	pobj	B-Simple_chemical
or	CC	cc	O
carboplatin	NN	conj	B-Simple_chemical
and	CC	cc	O
317615	CD	conj	B-Simple_chemical
x	CC	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
with	IN	case	O
MX	NN	compound	B-Cell
-	HYPH	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
culture	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
survival	NN	nmod	O
that	WDT	nsubj	O
reflected	VBD	acl:relcl	O
primarily	RB	advmod	O
additivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
agents	NNS	nmod	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
pathway	NN	dobj	O
of	IN	case	O
the	DT	det	O
cytotoxic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
paclitaxel	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
cervical	JJ	amod	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
Exposure	NN	nsubj	O
of	IN	case	O
SKOV	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
paclitaxel	NN	nmod	B-Simple_chemical
or	CC	cc	O
carboplatin	NN	conj	B-Simple_chemical
along	IN	prep	O
with	IN	case	O
317615	CD	nummod	B-Simple_chemical
2HCl	CD	nmod	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
cell	NN	compound	B-Cell
survivals	NNS	nmod	O
that	WDT	nsubj	O
reflected	VBD	acl:relcl	O
additivity	NN	dobj	O
of	IN	prep	O
317615	CD	pobj	B-Simple_chemical
x	CC	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
with	IN	prep	O
paclitaxel	NN	pobj	B-Simple_chemical
and	CC	cc	O
greater	JJR	amod	O
-	HYPH	punct	O
than	IN	advmod	O
-	HYPH	punct	O
additive	JJ	amod	O
cytotoxicity	NN	conj	O
with	IN	prep	O
carboplatin	NN	pobj	B-Simple_chemical
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
approximately	RB	advmod	O
60	CD	nummod	O
%	NN	amod	O
reduction	NN	nmod	O
in	IN	case	O
tumor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
by	IN	case	O
quantitative	JJ	amod	O
morphometry	NN	nmod	O
of	IN	case	O
CD31	NN	nmod	O
-	HYPH	punct	O
stained	JJ	amod	O
tumor	NN	compound	O
areas	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
appearance	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
apoptosis	NN	nmod	O
by	IN	case	O
internucleosomal	JJ	amod	O
DNA	NN	compound	O
fragmentation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Administration	NN	nsubj	O
of	IN	case	O
317615	CD	pobj	B-Simple_chemical
x	NN	cc	I-Simple_chemical
2HCI	CD	conj	I-Simple_chemical
orally	RB	advmod	O
twice	RB	advmod	O
daily	RB	nmod	O
to	TO	mark	O
nude	VB	acl	B-Organism
mice	NNS	dobj	I-Organism
bearing	VBG	acl	O
subcutaneous	JJ	amod	O
MX	NN	compound	B-Cancer
-	:	punct	I-Cancer
1	CD	nummod	I-Cancer
tumors	NNS	dobj	I-Cancer
or	CC	cc	O
SKOV	NN	compound	B-Cancer
-	:	punct	I-Cancer
3	CD	nummod	I-Cancer
tumors	NNS	nsubj	I-Cancer
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
intratumoral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
CD105	NN	conj	B-Gene_or_gene_product
staining	NN	nmod	O
with	IN	case	O
decreases	NNS	nmod	O
of	IN	case	O
35	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
43	CD	nummod	O
%	NN	conj	O
in	IN	case	O
MX	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
1	CD	nummod	I-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
60	CD	nummod	O
%	NN	conj	O
and	CC	cc	O
75	CD	nummod	O
%	NN	conj	O
in	IN	case	O
SKOV	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
3	CD	nummod	I-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

In	IN	case	O
cervical	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
paclitaxel	NN	nsubj	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
through	IN	case	O
an	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
with	IN	case	O
prior	JJ	amod	O
G2	NN	dep	O
/	:	punct	O
M	NN	dep	O
arrest	NN	nmod	O
.	.	punct	O
317615	CD	nsubj	B-Simple_chemical
x	CC	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
was	VBD	cop	O
an	DT	det	O
active	JJ	amod	O
antitumor	NN	compound	B-Cancer
agent	NN	ROOT	O
against	IN	case	O
the	DT	det	O
MX	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
1	CD	nummod	I-Cancer
xenograft	NN	nmod	I-Cancer
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
delay	NN	dobj	O
produced	VBN	acl	O
by	IN	case	O
paclitaxel	NN	nmod	B-Simple_chemical
by	IN	prep	O
1	CD	pobj	O
.	.	punct	O
7	CD	nummod	O
-	HYPH	punct	O
fold	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
delay	NN	conj	O
produced	VBN	acl	O
by	IN	case	O
carboplatin	NN	nmod	B-Simple_chemical
by	IN	case	O
3	CD	nmod	O
.	.	punct	O
8	CD	nummod	O
-	HYPH	punct	O
fold	NN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
200	CD	nummod	O
micrograms	NNS	compound	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nsubjpass	O
was	VBD	auxpass	O
injected	VBN	ROOT	O
i	LS	dobj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
into	IN	case	O
mice	NNS	nmod	O
it	PRP	nsubj	O
suppressed	VBD	ROOT	O
sarcoma	NN	compound	O
-	:	punct	O
180	CD	nummod	O
cell	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
B16	NN	compound	O
-	:	punct	O
F10	NN	compound	O
mouse	NN	compound	O
melanoma	NN	compound	O
cell	NN	compound	O
metastasis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Administration	NN	nsubj	O
of	IN	prep	O
317615	CD	pobj	B-Simple_chemical
x	NN	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
also	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
delay	NN	dobj	O
produced	VBN	acl	O
by	IN	case	O
fractionated	VBN	amod	O
radiation	NN	compound	O
therapy	NN	nmod	O
in	IN	case	O
the	DT	det	O
MX	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
1	CD	nummod	I-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

Two	CD	ROOT	O
of	IN	case	O
12	CD	nummod	O
cell	NN	compound	O
lines	NNS	nmod	O
formed	VBD	acl	O
xenografts	NNS	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
with	IN	prep	O
317615	CD	pobj	B-Simple_chemical
x	CC	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
alone	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
lifespan	NN	dobj	O
of	IN	case	O
animals	NNS	nmod	O
bearing	VBG	acl	O
intraperitoneal	JJ	amod	B-Cancer
SKOV	NN	compound	I-Cancer
-	:	punct	I-Cancer
3	CD	nummod	I-Cancer
xenografts	NNS	dobj	I-Cancer
by	IN	prep	O
1	CD	pobj	O
.	.	punct	O
9	CD	nummod	O
fold	NN	ROOT	O
compared	VBN	acl	O
with	IN	prep	O
untreated	JJ	amod	O
control	NN	compound	O
animals	NNS	pobj	O
.	.	punct	O

Both	DT	det	O
agents	NNS	nsubj	O
inhibited	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
induced	VBD	amod	O
apoptosis	NN	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
tumors	NNS	nmod	O
from	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O
The	DT	det	O
combination	NN	nsubj	O
of	IN	prep	O
paclitaxel	NN	pobj	B-Simple_chemical
and	CC	cc	O
317615	CD	conj	B-Simple_chemical
x	NN	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
resulted	VBD	ROOT	O
in	IN	prep	O
100	CD	nummod	O
%	NN	pobj	O
120	CD	nummod	O
-	HYPH	punct	O
day	NN	compound	O
survival	NN	nmod	O
of	IN	prep	O
SKOV	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
3	CD	nummod	I-Cancer
bearing	VBG	compound	O
animals	NNS	pobj	O
.	.	punct	O

Treated	VBN	amod	O
animals	NNS	nsubj	O
also	RB	advmod	O
displayed	VBD	ROOT	O
a	DT	det	O
2	CD	nummod	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
reduction	NN	dobj	O
of	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
mRNA	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O
Administration	NN	nsubj	O
of	IN	prep	O
317615	CD	pobj	B-Simple_chemical
x	CC	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
along	IN	prep	O
with	IN	prep	O
carboplatin	NN	pobj	B-Simple_chemical
to	TO	prep	O
animals	NNS	pobj	O
bearing	VBG	acl	O
the	DT	det	O
SKOV	NNP	compound	B-Cancer
-	:	punct	I-Cancer
3	CD	nummod	I-Cancer
tumor	NN	dobj	I-Cancer
produced	VBD	ROOT	O
a	DT	det	O
1	CD	nummod	O
.	.	punct	O
8	CD	nummod	O
-	HYPH	punct	O
fold	JJ	dep	O
increase	NN	dobj	O
in	IN	case	O
lifespan	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
carboplatin	NN	advcl	B-Simple_chemical
alone	RB	advmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
head	NN	amod	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
using	VBG	acl	O
UM	NN	compound	O
-	HYPH	punct	O
SCC	NN	compound	O
-	:	punct	O
11A	NN	compound	O
cells	NNS	dobj	O
,	,	punct	O
2ME2	NN	nsubj	O
exhibited	VBD	ROOT	O
antitumor	NN	dobj	O
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	O
immunostaining	NN	nmod	O
.	.	punct	O
317615	CD	nsubj	B-Simple_chemical
x	NN	cc	I-Simple_chemical
2HCl	CD	conj	I-Simple_chemical
is	VBZ	ROOT	O
a	DT	det	O
promising	JJ	amod	O
new	JJ	amod	O
antiangiogenic	JJ	amod	O
agent	NN	attr	O
that	WDT	nsubj	O
is	VBZ	cop	O
in	IN	case	O
early	JJ	amod	O
phase	NN	compound	O
clinical	JJ	amod	O
testing	NN	relcl	O
.	.	punct	O

Increased	VBN	amod	O
serum	NN	compound	O
levels	NNS	ROOT	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O
Expression	NN	ROOT	O
of	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
on	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
and	CC	cc	O
effect	NN	conj	O
on	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
motility	NN	conj	O
and	CC	cc	O
platelet	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
activating	VBG	dep	I-Simple_chemical
factor	NN	compound	I-Simple_chemical
synthesis	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	O
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	O
.	.	punct	O
CD40	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
by	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
may	MD	aux	O
trigger	VB	ROOT	O
diverse	JJ	amod	O
cellular	JJ	amod	B-Cell
responses	NNS	dobj	O
,	,	punct	O
ranging	VBG	advcl	O
from	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
to	TO	case	O
growth	NN	compound	O
suppression	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
death	NN	conj	O
,	,	punct	O
in	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
malignant	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
.	.	punct	O

CD40	NN	compound	O
expression	NN	nsubj	O
on	IN	case	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
pathophysiologic	JJ	amod	O
role	NN	nsubj	O
of	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
expressed	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
remains	VBZ	ROOT	O
unclear	JJ	xcomp	O
.	.	punct	O

Patients	NNS	nsubj	O
whose	WP$	nmod:poss	O
tumors	NNS	nsubj	O
were	VBD	cop	O
CD40	NN	compound	O
-	HYPH	punct	O
negative	NN	dep	O
showed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
better	JJR	amod	O
N	NN	compound	O
stage	NN	dobj	O
,	,	punct	O
overall	JJ	amod	O
stage	NN	appos	O
at	IN	case	O
presentation	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
than	IN	case	O
those	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
CD40	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
CD40	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
CD154	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
in	IN	case	O
24	CD	nummod	O
primary	JJ	amod	O
cultures	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
its	PRP$	nmod:poss	O
correlation	NN	dobj	O
with	IN	case	O
tumor	NN	compound	B-Cancer
stage	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
potential	JJ	amod	O
functional	JJ	amod	O
significance	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	O
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
coexpression	NN	dobj	O
of	IN	case	O
CD40	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CD154	NN	conj	B-Gene_or_gene_product
in	IN	case	O
most	JJS	nmod	O
of	IN	case	O
the	DT	det	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	O
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	O
.	.	punct	O
CD154	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
CD40	NN	compound	B-Gene_or_gene_product
expression	NN	dep	O
,	,	punct	O
significantly	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cancer
stage	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	O
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
also	RB	advmod	O
released	VBD	ROOT	O
the	DT	det	O
soluble	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
into	IN	case	O
the	DT	det	O
supernatant	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
14	CD	compound	O
of	IN	case	O
18	CD	nummod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
(	-LRB-	punct	O
78	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
expressed	VBD	ROOT	O
CD40	NN	dobj	O
on	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	nmod	O
.	.	punct	O
CD40	NN	compound	B-Gene_or_gene_product
engagement	NN	nsubj	O
by	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
apoptosis	NN	dobj	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
CD154	NN	nsubj	B-Gene_or_gene_product
stimulated	VBD	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
motility	NN	conj	O
and	CC	cc	O
production	NN	conj	O
of	IN	case	O
PAF	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
phospholipid	JJ	amod	O
mediator	NN	appos	O
of	IN	case	O
inflammation	NN	nmod	O
with	IN	case	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PA	NN	nsubj	O
through	IN	case	O
protease	NN	compound	O
cascade	NN	nmod	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
PAF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	dobj	I-Gene_or_gene_product
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
cells	NNS	nsubj	O
were	VBD	cop	O
more	RBR	advmod	O
rigid	JJ	ROOT	O
and	CC	cc	O
show	VBP	conj	O
reduced	VBN	amod	O
motility	NN	dobj	O
.	.	punct	O
Blockade	NN	nsubj	O
of	IN	case	O
PAF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
WEB	NN	nmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2170	CD	nummod	I-Simple_chemical
,	,	punct	O
a	DT	det	O
PAF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
antagonist	NN	appos	O
,	,	punct	O
abolished	VBD	ROOT	O
the	DT	det	O
CD154	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
motility	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
PAF	NN	nmod	B-Simple_chemical
synthesized	VBN	acl	O
after	IN	case	O
CD154	NN	compound	B-Gene_or_gene_product
stimulation	NN	nmod	O
in	IN	case	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
motility	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
surface	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
CD40	NN	nmod	O
and	CC	cc	O
the	DT	det	O
metastatic	JJ	amod	O
spread	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
identifies	VBZ	ROOT	O
new	JJ	amod	O
functional	JJ	amod	O
properties	NNS	dobj	O
for	IN	case	O
CD154	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
potentially	RB	advmod	O
relevant	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
dissemination	NN	conj	O
of	IN	case	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Survivin	NN	nsubj	O
functions	VBZ	nsubj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
upstream	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
molecular	JJ	amod	O
targeting	NN	conj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
results	VBZ	appos	O
in	IN	case	O
anticancer	NN	compound	O
activity	NN	nmod	O
via	IN	case	O
a	DT	det	O
dual	JJ	amod	O
mechanism	NN	nmod	O
of	IN	case	O
induction	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
DNA	NN	compound	B-Cellular_component
damage	NN	nsubj	O
induces	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
cycle	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
acute	JJ	amod	B-Cell
lymphoblastic	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Molecular	JJ	amod	O
antagonists	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
apoptosis	NN	compound	O
protein	NN	compound	O
survivin	NN	nmod	O
have	VBP	aux	O
shown	VBN	dep	O
promise	NN	dobj	O
as	IN	case	O
novel	JJ	amod	O
anticancer	NN	compound	O
strategies	NNS	nmod	O
for	IN	mark	O
triggering	VBG	acl	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	dobj	O
,	,	punct	O
dysregulating	VBG	advcl	O
mitotic	JJ	amod	O
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
inhibiting	VBG	conj	O
tumor	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
preclinical	JJ	amod	O
models	NNS	nmod	O
.	.	punct	O
Survivin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
member	NN	attr	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	B-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
apoptosis	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
(	-LRB-	punct	O
IAP	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
family	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
survivin	NN	amod	O
couples	NNS	nsubj	O
to	TO	prep	O
the	DT	det	O
cell	NN	compound	O
death	NN	compound	O
machinery	NN	pobj	O
has	VBZ	aux	O
remained	VBN	ROOT	O
elusive	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
relevant	JJ	amod	O
cellular	JJ	amod	O
targets	NNS	nsubjpass	O
of	IN	case	O
survivin	NN	compound	O
antagonists	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
completely	RB	advmod	O
elucidated	VBN	conj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
chemotherapeutic	JJ	amod	O
drug	NN	compound	O
doxorubicin	NN	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	NN	amod	O
agent	NN	appos	O
,	,	punct	O
activates	VBZ	ccomp	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
survivin	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
inducing	VBG	acl	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
childhood	NN	compound	O
acute	JJ	amod	B-Cancer
lymphoblastic	JJ	amod	I-Cancer
leukemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
ALL	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	O
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	O
at	IN	case	O
serine	NN	nmod	O
392	CD	nummod	O
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	O
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
(	-LRB-	punct	O
wt	NN	appos	O
)	-RRB-	punct	O
p53	NN	compound	B-Gene_or_gene_product
ALL	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
EU	NN	compound	B-Cell
-	SYM	punct	I-Cell
3	CD	nummod	I-Cell
cell	NN	compound	I-Cell
line	NN	appos	I-Cell
)	-RRB-	punct	O
with	IN	case	O
doxorubicin	NN	nmod	B-Simple_chemical
caused	VBD	ROOT	O
accumulation	NN	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
dramatic	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
depletion	NN	appos	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
(	-LRB-	punct	O
increased	VBN	amod	O
sub	NN	compound	O
-	HYPH	punct	O
G	NN	compound	O
(	-LRB-	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
compartment	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	O
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	O
at	IN	case	O
serine	NN	nmod	O
392	CD	nummod	O
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	O
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	ROOT	O
,	,	punct	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	intj	O
of	IN	case	O
mutant	JJ	amod	O
(	-LRB-	punct	O
mut	NN	compound	O
)	-RRB-	punct	O
p53	NN	compound	B-Gene_or_gene_product
cells	NNS	nmod	O
(	-LRB-	punct	O
EU	NN	compound	B-Cell
-	SYM	punct	I-Cell
6	CD	nummod	I-Cell
/	:	punct	I-Cell
ALL	NN	compound	I-Cell
line	NN	appos	I-Cell
)	-RRB-	punct	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
survivin	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
induced	VBN	amod	O
G	NN	conj	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	compound	O
arrest	NN	conj	O
without	IN	mark	O
inducing	VBG	acl	O
apoptosis	NN	dobj	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
FOXO3a	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
doxorubicin	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	amod	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
cells	NNS	nmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
promote	VB	xcomp	O
Akt	JJ	compound	O
phosphorylation	NN	dobj	O
and	CC	cc	O
arrest	NN	compound	O
cell	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
treating	VBG	csubj	O
EU	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
6	CD	dobj	I-Cell
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
survivin	NN	compound	B-Gene_or_gene_product
antisense	JJ	nsubj	O
resensitized	VBD	ROOT	O
these	DT	det	O
cells	NNS	dobj	B-Cell
to	TO	case	O
doxorubicin	NN	nmod	B-Simple_chemical
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	O
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	O
at	IN	case	O
serine	NN	nmod	O
392	CD	nummod	O
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	O
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	O
.	.	punct	O
With	IN	case	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
null	NN	amod	O
cell	NN	compound	O
line	NN	nmod	O
(	-LRB-	punct	O
EU	NN	dep	B-Cell
-	SYM	punct	I-Cell
4	CD	nummod	I-Cell
)	-RRB-	punct	I-Cell
,	,	punct	O
although	IN	mark	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
arrested	VBD	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
G	NN	nmod	O
(	-LRB-	punct	O
2	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	conj	O
,	,	punct	O
survivin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
unchanged	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
cells	NNS	nsubj	B-Cell
underwent	VBD	conj	O
only	RB	advmod	O
limited	JJ	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	compound	O
)	-RRB-	punct	O
doxorubicin	NN	compound	O
incubation	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
p53	NN	nmod	O
at	IN	case	O
serine	NN	nmod	O
392	CD	nummod	O
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
p21	NN	nmod	O
,	,	punct	O
G2	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
increase	NN	conj	O
of	IN	case	O
proapoptotic	JJ	amod	O
protein	NN	compound	O
Bax	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
of	IN	case	O
wt	RB	compound	O
-	HYPH	punct	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
EU	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
4	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
could	MD	aux	O
restore	VB	ROOT	O
the	DT	det	O
doxorubicin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
p53	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
survivin	NN	compound	B-Gene_or_gene_product
pathway	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
significantly	RB	advmod	O
decreased	VBN	amod	O
survivin	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
apoptosis	NN	conj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
after	IN	case	O
doxorubicin	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
survivin	NN	amod	O
couples	NNS	nsubj	O
to	TO	prep	O
the	DT	det	O
cell	NN	compound	O
death	NN	compound	O
machinery	NN	pobj	O
has	VBZ	aux	O
remained	VBN	ROOT	O
elusive	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
relevant	JJ	amod	O
cellular	JJ	amod	O
targets	NNS	nsubjpass	O
of	IN	case	O
survivin	NN	compound	O
antagonists	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
completely	RB	advmod	O
elucidated	VBN	conj	O
.	.	punct	O
Following	VBG	case	O
cotransfection	NN	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
null	NN	amod	O
EU	NNP	compound	O
-	HYPH	punct	O
4	CD	nummod	O
cells	NNS	nmod	O
with	IN	case	O
survivin	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
-	HYPH	punct	O
luciferase	NN	compound	B-Gene_or_gene_product
constructs	NNS	nmod	O
and	CC	cc	O
either	CC	cc:preconj	O
wt	RB	advmod	O
-	HYPH	punct	O
p53	NN	dep	B-Gene_or_gene_product
or	CC	cc	O
different	JJ	amod	O
mut	NN	compound	O
-	HYPH	punct	O
p53	NN	compound	B-Gene_or_gene_product
expression	NN	compound	O
vectors	NNS	conj	O
,	,	punct	O
wt	RB	compound	O
-	HYPH	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
inhibited	VBD	ROOT	O
survivin	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
activity	NN	dobj	O
;	:	punct	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
inhibition	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
abrogated	VBN	parataxis	O
by	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
murine	JJ	amod	B-Gene_or_gene_product
double	JJ	amod	I-Gene_or_gene_product
minute2	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MDM2	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
protein	NN	nmod	O
.	.	punct	O

p53	NN	compound	O
up	RB	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
and	CC	cc	O
p53	NN	compound	O
-	:	punct	O
mediated	VBN	amod	O
proliferation	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
were	VBD	auxpass	O
substantiated	VBN	ROOT	O
using	VBG	xcomp	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
intrinsic	JJ	nmod	O
and	CC	cc	O
the	DT	det	O
extrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O
Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
studies	NNS	nsubj	O
define	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
-	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
activated	VBN	acl	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
down	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
loss	NN	nsubj	O
of	IN	case	O
wt	RB	nummod	O
-	HYPH	punct	O
p53	NN	compound	B-Gene_or_gene_product
function	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
up	RB	advmod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
resistance	NN	conj	O
to	TO	prep	O
DNA	NN	compound	B-Cellular_component
-	HYPH	punct	O
damaging	JJ	amod	O
agents	NNS	pobj	O
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
ATP	NNP	npadvmod	O
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	O
ascites	VBZ	nmod	O
and	CC	cc	O
L1210	NN	compound	O
murine	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	conj	O
.	.	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alkylmorpholine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
oxides	NNS	nmod	I-Simple_chemical
on	IN	case	O
ATP	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	B-Cell
ascites	VBZ	nmod	I-Cell
and	CC	cc	O
L1210	NN	compound	B-Cell
leukaemia	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
ATP	NNP	npadvmod	O
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	O
ascites	VBZ	nmod	O
and	CC	cc	O
L1210	NN	compound	O
murine	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	conj	O
.	.	punct	O
The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
alkylmorpholine	NN	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
oxides	NNS	nmod	I-Simple_chemical
on	IN	case	O
ATP	NNP	npadvmod	B-Simple_chemical
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	B-Cell
ascites	VBZ	nmod	I-Cell
and	CC	cc	O
L1210	NN	compound	B-Cell
murine	JJ	amod	I-Cell
leukaemia	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	O
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	O
acid	NN	compound	O
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
respiration	NN	conj	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
and	CC	cc	O
exogenous	JJ	conj	O
respiration	NN	nmod	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
in	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

1	LS	nummod	O
-	HYPH	punct	O
Tetradecylpyrrolidine	NN	compound	O
N	NN	compound	O
-	HYPH	punct	O
oxide	NN	nsubj	O
(	-LRB-	punct	O
TPNO	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
immediately	RB	advmod	O
after	IN	case	O
addition	NN	appos	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	nmod	O
over	IN	case	O
the	DT	det	O
whole	JJ	amod	O
concentration	NN	compound	O
range	NN	nmod	O
.	.	punct	O
4	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Dodecylmorpholine	NNP	compound	I-Simple_chemical
N	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
DMNO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
active	JJ	amod	O
compounds	NNS	nmod	O
,	,	punct	O
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
ATP	NN	nmod	B-Simple_chemical
immediately	RB	advmod	O
after	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
suspension	NN	nmod	O
of	IN	case	O
Ehrlich	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
an	DT	det	O
ice	NN	compound	O
bath	NN	nmod	O
.	.	punct	O

After	IN	case	O
2	CD	nummod	O
h	NN	compound	O
incubation	NN	nsubj	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
the	DT	det	O
drop	NN	dep	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	O
level	NN	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
.	.	punct	O
After	IN	case	O
2	CD	nummod	O
h	NN	compound	O
incubation	NN	nsubj	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
the	DT	det	O
drop	NN	npadvmod	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	B-Simple_chemical
level	NN	nmod	O
was	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
ATP	NN	compound	O
level	NN	nmod	O
might	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
the	DT	det	O
amine	NN	compound	O
oxide	NN	nmod	O
with	IN	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	compound	O
integrity	NN	nmod	O
.	.	punct	O
A	DT	det	O
possible	JJ	amod	O
explanation	NN	nsubj	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	B-Simple_chemical
level	NN	nmod	O
might	MD	aux	O
be	VB	cop	O
interaction	NN	ROOT	O
of	IN	case	O
the	DT	det	O
amine	NN	compound	B-Simple_chemical
oxide	NN	nmod	I-Simple_chemical
with	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
promotes	VBZ	ROOT	O
microvessel	NN	compound	B-Tissue
formation	NN	dobj	O
from	IN	case	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Multi-tissue_structure
aorta	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
through	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
in	IN	case	O
vascular	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O
To	TO	mark	O
delineate	VB	advcl	O
the	DT	det	O
roles	NNS	dobj	O
that	IN	mark	O
oxygen	NN	nsubj	B-Simple_chemical
and	CC	cc	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
FGFs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
play	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
from	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Multi-tissue_structure
aorta	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
we	PRP	nsubj	O
cultured	VBD	ROOT	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Multi-tissue_structure
aorta	NN	compound	I-Multi-tissue_structure
explants	NNS	dobj	I-Multi-tissue_structure
(	-LRB-	punct	O
thoracic	NN	compound	B-Multi-tissue_structure
level	NN	dep	O
to	TO	case	O
lateral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
supplying	VBG	acl	O
the	DT	det	O
mesonephros	NN	dobj	B-Organ
and	CC	cc	O
metanephros	NN	conj	B-Organ
)	-RRB-	punct	O
in	IN	case	O
a	DT	det	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
type	NN	compound	B-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
collagen	NN	compound	I-Gene_or_gene_product
gel	NN	compound	O
matrix	NN	nmod	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	O
humor	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
During	IN	case	O
8	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
culture	NN	nmod	O
under	IN	case	O
5	CD	compound	O
%	NN	compound	O
O	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
room	NN	compound	O
air	NN	conj	O
,	,	punct	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
FGF2	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
explants	NNS	nmod	O
stimulated	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
Gs	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IB	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
positive	JJ	dep	O
,	,	punct	O
CD31	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	conj	O
,	,	punct	O
and	CC	cc	O
Flk	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
microvessels	NNS	dobj	O
in	IN	case	O
a	DT	det	O
concentration	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Newly	RB	amod	O
forming	VBG	compound	O
vessels	NNS	nsubj	O
have	VBP	ROOT	O
thin	JJ	amod	O
caliber	NN	dobj	O
,	,	punct	O
a	DT	det	O
markedly	RB	advmod	O
reduced	VBN	amod	O
vessel	NN	compound	O
lumen	NN	appos	O
,	,	punct	O
markedly	RB	advmod	O
reduced	VBD	amod	O
pericyte	NN	compound	O
recruitment	NN	dobj	O
,	,	punct	O
and	CC	cc	O
deficient	JJ	amod	O
vascular	JJ	amod	O
perfusion	NN	conj	O
.	.	punct	O
FGF2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
microvessel	NN	compound	B-Tissue
formation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
sequestration	NN	nmod	O
of	IN	case	O
FGF2	NN	nmod	B-Gene_or_gene_product
via	IN	case	O
addition	NN	nmod	O
of	IN	case	O
soluble	JJ	amod	O
FGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
FGFR	NN	intj	B-Gene_or_gene_product
)	-RRB-	punct	O
chimera	NN	compound	O
protein	NN	nmod	O
or	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
FGF2	NN	compound	B-Gene_or_gene_product
antibodies	NNS	conj	O
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
FGFR2	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
change	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
six	CD	nummod	O
tested	VBN	amod	O
TFs	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
paired	JJ	amod	O
normal	JJ	amod	O
fibroblasts	NNS	advcl	O
.	.	punct	O
FGFR1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
FGFR2	NN	conj	B-Gene_or_gene_product
were	VBD	cop	O
present	JJ	ROOT	O
on	IN	case	O
explants	NNS	nmod	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	O
receptor	NN	nmod	O
2	CD	nummod	O
.	.	punct	O
Levels	NNS	nsubjpass	O
of	IN	case	O
FGFR1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
FGFR2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
aorta	NN	nmod	I-Multi-tissue_structure
cultured	VBN	acl	O
under	IN	case	O
5	CD	compound	O
%	NN	compound	O
O	NN	nmod	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
relative	JJ	amod	O
to	TO	aux	O
room	NN	xcomp	O
air	NN	dobj	O
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
FGFR2	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
change	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
six	CD	nummod	O
tested	VBN	amod	O
TFs	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
paired	JJ	amod	O
normal	JJ	amod	O
fibroblasts	NNS	advcl	O
.	.	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
low	JJ	amod	O
oxygen	NN	nsubj	B-Simple_chemical
upregulates	VBZ	ccomp	O
FGFR1	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
aorta	NN	nmod	I-Multi-tissue_structure
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
renders	VBZ	conj	O
it	PRP	nsubj	O
more	RBR	advmod	O
responsive	JJ	ccomp	O
to	TO	case	O
FGF2	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
the	DT	det	O
integrin	NN	compound	O
alpha2beta1	NN	nmod	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O
Insulin	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	ROOT	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
receptor	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
vasculogenesis	NN	pobj	O
/	:	punct	O
angiogenesis	NN	dep	O
in	IN	case	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Organ
development	NN	nmod	O
.	.	punct	O

Morphogenesis	NN	ROOT	O
of	IN	case	O
embryonic	JJ	amod	O
CNS	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
The	DT	det	O
structural	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
development	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pulmonary	JJ	amod	B-Anatomical_system
system	NN	nmod	I-Anatomical_system
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
appropriate	JJ	amod	O
early	JJ	amod	O
vascularization	NN	nmod	O
of	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Organ
lung	NN	nmod	I-Organ
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
several	JJ	amod	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
angiogenic	JJ	amod	O
cytokine	NN	compound	O
vascular	JJ	amod	O
permeability	NN	compound	O
factor	NN	nsubj	O
/	:	punct	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	conj	O
(	-LRB-	punct	O
VPF	NN	dep	O
/	:	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
likely	RB	advmod	O
regulates	VBZ	acl:relcl	O
endothelial	JJ	amod	O
cells	NNS	compound	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
migration	NN	dobj	O
.	.	punct	O
Our	PRP$	nmod:poss	O
previous	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
agent	NN	ccomp	O
for	IN	case	O
fetal	JJ	amod	B-Cell
lung	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

This	DT	det	O
growth	NN	compound	O
factor	NN	compound	O
system	NN	nsubj	O
exerts	VBZ	ROOT	O
multiple	JJ	amod	O
physiologic	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
vasculature	NN	nmod	O
through	IN	case	O
both	CC	cc:preconj	O
endocrine	JJ	amod	O
and	CC	cc	O
autocrine	JJ	conj	O
/	:	punct	O
paracrine	JJ	dep	O
mechanisms	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
assess	VB	advcl	O
its	PRP$	nmod:poss	O
role	NN	dobj	O
on	IN	case	O
human	JJ	amod	B-Organism
vascular	JJ	amod	B-Multi-tissue_structure
lung	NN	compound	B-Organ
development	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
first	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	intj	I-Gene_or_gene_product
/	SYM	punct	O
II	CD	conj	B-Gene_or_gene_product
and	CC	cc	O
IGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
type	NN	conj	I-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
IR	NNP	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-Organism
embryonic	JJ	amod	B-Tissue
and	CC	cc	O
fetal	JJ	conj	B-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
at	IN	case	O
4	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
wk	NN	nmod	O
of	IN	prep	O
gestation	NN	pobj	O
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
ligands	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
,	,	punct	O
the	DT	det	O
receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
only	RB	advmod	O
.	.	punct	O
Immunohistochemical	JJ	amod	O
and	CC	cc	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	compound	I-Gene_or_gene_product
/	SYM	punct	O
II	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	compound	I-Gene_or_gene_product
ligands	NNS	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
transcripts	NNS	conj	O
in	IN	case	O
embryonic	JJ	amod	B-Organ
lungs	NNS	nmod	I-Organ
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
4	CD	compound	O
wk	NN	compound	O
gestation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
IGF	NN	compound	O
system	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
growth	NN	compound	O
factors	NNS	conj	O
and	CC	cc	O
integrin	NN	compound	O
receptors	NNS	conj	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
.	.	punct	O
Immunotargeting	VBG	csubj	O
using	VBG	xcomp	O
an	DT	det	O
anti	NN	amod	O
-	HYPH	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	compound	I-Gene_or_gene_product
neutralizing	VBG	compound	O
antibody	NN	dobj	O
on	IN	case	O
human	JJ	amod	B-Organism
fetal	JJ	amod	B-Organ
lung	NN	compound	I-Organ
explants	NNS	nmod	I-Organ
demonstrated	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
blockade	NN	dobj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
.	.	punct	O

VEGF	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
parallel	NN	nmod	O
to	TO	case	O
enhanced	VBN	amod	O
IGF	NNP	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nmod	O
.	.	punct	O
Inactivation	NN	nsubj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	nmod	I-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
loss	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
accompanied	VBN	acl	O
by	IN	case	O
dramatic	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
fetal	JJ	amod	B-Organ
lung	NN	compound	I-Organ
explant	NN	amod	O
morphology	NN	nmod	O
.	.	punct	O

Mice	NNS	nsubj	O
that	WDT	nsubj	O
received	VBD	acl:relcl	O
either	CC	cc:preconj	O
IR	NN	dobj	O
or	CC	cc	O
TEMF	NN	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
fewer	JJR	amod	O
lung	NN	compound	O
metastatic	JJ	amod	O
sites	NNS	dobj	O
and	CC	cc	O
slower	JJR	conj	O
tumor	NN	compound	O
growth	NN	dobj	O
than	IN	mark	O
did	VBD	advcl	O
untreated	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O
Terminal	JJ	amod	O
transferase	NN	compound	O
dUTP	NN	compound	O
end	NN	compound	O
-	HYPH	punct	O
labeling	NN	compound	O
assay	NN	nsubj	O
and	CC	cc	O
TEM	NN	compound	O
studies	NNS	conj	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
IGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
lungs	NNS	nmod	B-Organ
demonstrated	VBD	ROOT	O
numerous	JJ	amod	O
apoptotic	JJ	amod	O
mesenchymal	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
discuss	VB	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
IGF	NNP	compound	O
-	SYM	punct	O
1	CD	nummod	O
,	,	punct	O
IGF	NNP	compound	O
-	HYPH	punct	O
1R	NN	nmod	O
,	,	punct	O
and	CC	cc	O
IGF	NN	compound	O
binding	NN	compound	O
proteins	NNS	conj	O
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	O
and	CC	cc	O
summarize	VB	conj	O
evidence	NN	dep	O
implicating	VBG	acl	O
involvement	NN	dobj	O
of	IN	case	O
this	DT	det	O
system	NN	nmod	O
in	IN	case	O
vascular	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O
Rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Organ
lung	NN	compound	I-Organ
explant	NN	amod	O
studies	NNS	nsubj	O
further	RB	advmod	O
validated	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	compound	I-Gene_or_gene_product
system	NN	nmod	O
for	IN	case	O
lung	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
.	.	punct	O

VEGF	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
parallel	NN	nmod	O
to	TO	case	O
enhanced	VBN	amod	O
IGF	NNP	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nmod	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
demonstration	NN	dobj	O
of	IN	case	O
IGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	NNP	compound	I-Gene_or_gene_product
/	SYM	punct	O
II	CD	nummod	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
lung	NN	nmod	B-Organ
in	IN	case	O
early	JJ	amod	O
gestation	NN	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
that	IN	mark	O
the	DT	det	O
IGF	NN	compound	B-Gene_or_gene_product
family	NN	nsubjpass	O
of	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
acting	VBG	acl	O
through	IN	case	O
the	DT	det	O
IGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IR	NNP	nmod	I-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
as	IN	case	O
a	DT	det	O
survival	NN	compound	O
factor	NN	nmod	O
during	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
lung	NN	compound	B-Organ
vascularization	NN	nmod	O
.	.	punct	O

Stimulation	NN	ROOT	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
by	IN	case	O
vascular	JJ	amod	O
permeability	NN	compound	O
factor	NN	compound	O
/	:	punct	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
through	IN	case	O
cooperative	JJ	amod	O
mechanisms	NNS	nmod	O
involving	VBG	acl	O
the	DT	det	O
alphavbeta3	NN	compound	O
integrin	NN	dobj	O
,	,	punct	O
osteopontin	NN	conj	O
,	,	punct	O
and	CC	cc	O
thrombin	NN	conj	O
.	.	punct	O
Enhanced	VBN	amod	O
expression	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
periodontal	JJ	amod	B-Organism_subdivision
pathogens	NNS	nmod	O
in	IN	case	O
gingival	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

Among	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	nsubj	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	cop	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	ROOT	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
recently	RB	advmod	O
attracted	VBN	ROOT	O
attention	NN	dobj	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
inducer	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ischemia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
.	.	punct	O
Aberrant	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
often	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lesion	NN	compound	B-Pathological_formation
formation	NN	nmod	O
in	IN	case	O
chronic	JJ	amod	O
periodontitis	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	O
(	-LRB-	punct	O
Ang	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
-	SYM	punct	O
2	CD	nummod	O
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
properties	NNS	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
gingival	JJ	amod	B-Cell
fibroblasts	NNS	compound	I-Cell
(	-LRB-	punct	O
HGF	NN	appos	B-Cell
)	-RRB-	punct	O
culture	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
whereby	WRB	advmod	O
hematopoietic	JJ	amod	O
growth	NN	compound	O
factors	NNS	nsubj	O
(	-LRB-	punct	O
HGFs	NNS	appos	O
)	-RRB-	punct	O
modulate	VBP	acl:relcl	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
myeloid	JJ	amod	O
leukemic	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
protein	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
synthesis	NN	conj	O
for	IN	mark	O
altering	VBG	acl	O
apoptosis	NN	dobj	O
in	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
-	:	punct	O
stimulated	VBN	nmod	O
vs	CC	cc	O
.	.	punct	O
quiescent	JJ	amod	O
leukemic	JJ	amod	O
TF1	NN	compound	O
cells	NNS	ROOT	O
.	.	punct	O
HGF	NN	nsubjpass	B-Cell
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
lipopolysaccharide	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
LPS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
vesicle	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
Ve	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
outer	JJ	amod	B-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
protein	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
OMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
from	IN	case	O
Actinobacillus	NN	compound	B-Organism
actinomycetemcomitans	NNS	nmod	I-Organism
and	CC	cc	O
Porphyromonas	NN	compound	B-Organism
gingivalis	NN	conj	I-Organism
.	.	punct	O

Levels	NNS	nsubjpass	O
of	IN	case	O
pro	NN	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
angiogenic	JJ	amod	O
inhibitor	NN	compound	O
pigment	NN	compound	O
epithelium	NN	compound	O
-	HYPH	punct	O
derived	VBN	amod	O
factor	NN	conj	O
(	-LRB-	punct	O
PEDF	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O
HGF	NN	nsubj	B-Cell
constitutively	RB	advmod	O
produced	VBD	ROOT	O
VEGF	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
levels	NNS	conj	O
were	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
by	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
Ve	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
OMP	NN	conj	B-Gene_or_gene_product
from	IN	case	O
A	NN	nmod	B-Organism
.	.	punct	I-Organism
actinomycetemcomitans	NNS	ROOT	I-Organism
and	CC	cc	O
P	NN	conj	B-Organism
.	.	punct	I-Organism
gingivalis	NN	ROOT	I-Organism
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	nummod	O
microg	NN	compound	O
/	:	punct	O
ml	NN	nmod	O
or	CC	cc	O
higher	JJR	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
ERK	NN	nmod	O
or	CC	cc	O
Sp1	NN	conj	O
suppressed	VBD	ROOT	O
M	NN	nmod:npmod	O
-	HYPH	punct	O
CSF	NNP	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	dobj	O
at	IN	case	O
the	DT	dep	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	compound	O
level	NN	conj	O
.	.	punct	O
On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
increased	VBN	ROOT	O
by	IN	case	O
LPS	NN	compound	B-Simple_chemical
stimulation	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
insulin	NN	nsubj	O
increased	VBD	ROOT	O
VEGF	NN	compound	O
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
human	JJ	amod	O
RPE	NN	compound	O
cells	NNS	nmod	O
and	CC	cc	O
enhanced	VBN	conj	O
VEGF	NN	compound	O
promoter	NN	compound	O
activity	NN	dobj	O
without	IN	mark	O
affecting	VBG	advcl	O
transcript	NN	compound	O
stability	NN	dobj	O
.	.	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
Ve	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
OMP	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HGF	NN	conj	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
enhanced	VBD	ROOT	O
vascular	JJ	amod	O
permeability	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
A	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	compound	O
enhancement	NN	compound	O
(	-LRB-	punct	O
VPE	NN	appos	O
)	-RRB-	punct	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
using	VBG	xcomp	O
guinea	NN	compound	B-Organism
pigs	NNS	dobj	I-Organism
to	TO	mark	O
ascertain	VB	xcomp	O
whether	IN	mark	O
supernatant	JJ	nsubj	B-Organism_substance
from	IN	case	O
cultures	NNS	nmod	O
of	IN	case	O
Ve	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
OMP	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HGF	NN	conj	B-Cell
enhance	VBP	ccomp	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

OPN	NNP	nsubj	O
promoted	VBD	ROOT	O
EC	NN	compound	O
migration	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
;	:	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	compound	O
induction	NN	nsubjpass	O
of	IN	case	O
alphavbeta3	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
increased	VBN	amod	O
EC	NN	compound	O
migration	NN	nmod	O
toward	IN	case	O
OPN	NNP	nmod	O
.	.	punct	O
Supernatant	JJ	nsubj	O
from	IN	case	O
cultures	NNS	nmod	O
of	IN	case	O
Ve	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
OMP	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
stimulated	VBN	amod	O
HGF	NN	conj	B-Cell
strongly	RB	advmod	O
induced	VBD	ROOT	O
VPE	NN	dobj	O
.	.	punct	O

Human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cells	NNS	ROOT	O
(	-LRB-	punct	O
HUVECs	NNS	appos	O
)	-RRB-	punct	O
and	CC	cc	O
rat	NN	compound	O
aorta	NN	dep	O
smooth	VBP	amod	O
muscle	NN	compound	O
cells	NNS	conj	O
(	-LRB-	punct	O
RASMCs	NNS	appos	O
)	-RRB-	punct	O
infected	VBN	acl	O
with	IN	case	O
AdCMV	NN	nmod	O
.	.	punct	O
VEGF165	NN	nsubj	O
(	-LRB-	punct	O
5	CD	dep	O
and	CC	cc	O
20	CD	conj	O
plaque	NN	conj	O
-	HYPH	punct	O
forming	VBG	amod	O
units	NNS	dep	O
[	-LRB-	punct	O
pfu	NN	appos	O
]	-RRB-	punct	O
per	IN	case	O
cell	NN	nmod	O
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
VEGF	NN	compound	O
mRNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
protein	NN	compound	O
secretion	NN	conj	O
into	IN	case	O
the	DT	det	O
supernatant	NN	nmod	O
.	.	punct	O
This	DT	nsubjpass	O
was	VBD	auxpass	O
markedly	RB	advmod	O
suppressed	VBN	ROOT	O
upon	IN	case	O
simultaneous	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product
polyclonal	JJ	amod	O
antibodies	NNS	nmod	O
with	IN	case	O
the	DT	det	O
supernatant	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Insulin	NN	nsubj	O
increases	VBZ	appos	O
VEGF	NN	compound	O
mRNA	NN	dobj	O
and	CC	cc	O
secreted	VBN	amod	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
RPE	NN	compound	O
cells	NNS	nmod	O
through	IN	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Heating	VBG	amod	O
and	CC	cc	O
protease	NN	conj	O
treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
stimulants	NNS	nmod	O
reduced	VBD	ROOT	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product
enhancing	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
Ve	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
OMP	NN	conj	B-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

After	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
before	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
capillary	JJ	amod	O
length	NN	compound	O
density	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	O
mRNA	NN	nsubj	O
increased	VBD	ROOT	O
greater	JJR	advmod	O
than	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
fold	NN	nmod	O
and	CC	cc	O
then	RB	advmod	O
declined	VBD	conj	O
to	TO	mark	O
control	VB	xcomp	O
levels	NNS	dobj	O
after	IN	case	O
3	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Ve	NNP	nsubj	B-Gene_or_gene_product
and	CC	cc	O
OMP	NN	conj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
crucial	JJ	amod	O
heat	NN	compound	O
-	HYPH	punct	O
labile	JJ	amod	O
and	CC	cc	O
protease	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	conj	O
components	NNS	ccomp	O
of	IN	case	O
periodontal	JJ	amod	B-Organism_subdivision
pathogens	NNS	nmod	O
that	WDT	nsubj	O
enhance	VBP	acl:relcl	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

VEGF	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	mark	O
it	PRP	nsubj	O
promotes	VBZ	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
new	JJ	amod	O
blood	NN	compound	O
vessel	NN	compound	O
formation	NN	conj	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
VEGF	NN	nsubjpass	B-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
etiology	NN	nmod	O
of	IN	case	O
periodontitis	NN	nmod	O
in	IN	case	O
its	PRP$	nmod:poss	O
early	JJ	amod	O
stages	NNS	nmod	O
according	VBG	case	O
to	IN	case	O
neovascularization	NN	nmod	O
stimulated	VBN	acl	O
by	IN	case	O
periodontal	JJ	amod	B-Organism_subdivision
pathogens	NNS	nmod	O
causing	VBG	acl	O
swelling	NN	dobj	O
and	CC	cc	O
edema	NN	conj	B-Pathological_formation
.	.	punct	O

NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	ROOT	O
and	CC	cc	O
IKK	NN	conj	O
as	IN	case	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
in	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Rel	NN	compound	B-Gene_or_gene_product
transcriptional	JJ	amod	O
pathway	NN	ROOT	O
:	:	punct	O
implications	NNS	dep	O
in	IN	case	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
coagulation	NN	compound	O
function	NN	nsubj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pancreatic	JJ	amod	O
carcinoma	NN	nmod	O
is	VBZ	cop	O
abnormal	JJ	appos	O
and	CC	cc	O
the	DT	det	O
reason	NN	nsubj	O
is	VBZ	punct	O
not	RB	neg	O
very	RB	advmod	O
clear	JJ	acomp	O
.	.	punct	O
Despite	IN	prep	O
considerable	JJ	amod	O
efforts	NNS	pobj	O
in	IN	mark	O
understanding	VBG	acl	O
the	DT	det	O
cellular	JJ	amod	B-Cell
mechanisms	NNS	dobj	O
contributing	VBG	acl	O
to	TO	case	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
prognosis	NN	nsubj	O
of	IN	case	O
this	DT	det	O
malignant	JJ	amod	O
disease	NN	nmod	O
is	VBZ	cop	O
still	RB	advmod	O
extremely	RB	advmod	O
poor	JJ	ROOT	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
coagulation	NN	compound	O
function	NN	nsubj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pancreatic	JJ	amod	O
carcinoma	NN	nmod	O
is	VBZ	cop	O
abnormal	JJ	appos	O
and	CC	cc	O
the	DT	det	O
reason	NN	nsubj	O
is	VBZ	punct	O
not	RB	neg	O
very	RB	advmod	O
clear	JJ	acomp	O
.	.	punct	O
Although	IN	mark	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	nsubj	I-Cancer
is	VBZ	cop	O
the	DT	det	O
fifth	JJ	amod	O
common	JJ	amod	O
cause	NN	advcl	O
of	IN	prep	O
cancer	NN	compound	B-Cancer
death	NN	pobj	O
in	IN	prep	O
Western	JJ	compound	O
countries	NNS	pobj	O
,	,	punct	O
current	JJ	amod	O
options	NNS	nsubj	O
in	IN	case	O
treatment	NN	nmod	O
enable	VBP	ROOT	O
a	DT	det	O
5	CD	nummod	O
-	HYPH	punct	O
yr	NN	compound	O
survival	NN	compound	O
rate	NN	dobj	O
for	IN	case	O
all	DT	det	O
stages	NNS	nmod	O
of	IN	prep	O
less	JJR	advmod	O
than	IN	quantmod	O
5	CD	nummod	O
%	NN	pobj	O
.	.	punct	O

Metastatic	JJ	amod	O
disease	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
causes	NNS	nmod	O
of	IN	case	O
death	NN	nmod	O
from	IN	case	O
cancer	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
beings	NNS	nmod	O
.	.	punct	O
In	IN	prep	O
the	DT	det	O
face	NN	pobj	O
fo	IN	prep	O
the	DT	det	O
fatal	JJ	amod	B-Developing_anatomical_structure
outcome	NN	pobj	O
,	,	punct	O
new	JJ	amod	O
approaches	NNS	nsubjpass	O
to	TO	case	O
the	DT	det	O
therapy	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
established	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	O
-	:	punct	O
kappaB	NN	nsubjpass	O
and	CC	cc	O
associated	VBN	amod	O
regulatory	JJ	amod	O
factors	NNS	conj	O
(	-LRB-	punct	O
including	VBG	case	O
IkappaB	NN	compound	O
kinase	NN	compound	O
subunits	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
IkappaB	NN	compound	O
family	NN	compound	O
member	NN	conj	O
Bcl	NN	compound	O
-	HYPH	punct	O
3	CD	dep	O
)	-RRB-	punct	O
are	VBP	auxpass	O
strongly	RB	advmod	O
implicated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
hematologic	JJ	amod	O
and	CC	cc	O
solid	JJ	conj	O
tumor	NN	compound	O
malignancies	NNS	nmod	O
.	.	punct	O
Based	VBN	case	O
on	IN	case	O
its	PRP$	nmod:poss	O
role	NN	nmod	O
in	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
proliferation	NN	conj	O
,	,	punct	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Rel	NN	nsubj	B-Gene_or_gene_product
has	VBZ	aux	O
gained	VBN	ROOT	O
the	DT	det	O
attention	NN	dobj	O
of	IN	prep	O
many	JJ	amod	O
laboratories	NNS	pobj	O
.	.	punct	O

A	DT	det	O
role	NN	nsubj	O
for	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
control	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
promotion	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
/	:	punct	O
metastasis	NN	conj	O
.	.	punct	O
This	DT	det	O
review	NN	nsubj	O
provides	VBZ	ROOT	O
basic	JJ	amod	O
information	NN	dobj	O
for	IN	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
aims	VBZ	conj	O
at	IN	case	O
presenting	VBG	amod	O
experimental	JJ	amod	O
data	NNS	nmod	O
illustrating	VBG	acl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Rel	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

[	-LRB-	punct	O
Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
in	IN	case	O
severe	JJ	amod	O
chronic	JJ	amod	O
central	JJ	amod	O
serous	JJ	amod	O
chorioretinopaty	NN	nmod	O
]	-RRB-	punct	O
Combined	JJ	amod	O
topical	JJ	amod	O
fluconazole	NN	ROOT	B-Simple_chemical
and	CC	cc	O
corticosteroid	NN	compound	B-Simple_chemical
treatment	NN	conj	O
for	IN	prep	O
experimental	JJ	amod	O
Candida	NN	compound	B-Organism
albicans	NNS	compound	I-Organism
keratomycosis	NN	pobj	O
.	.	punct	O

DESIGN	NN	ROOT	O
:	:	punct	O
Experimental	JJ	amod	O
study	NN	appos	O
and	CC	cc	O
interventional	JJ	amod	O
case	NN	compound	O
series	NN	conj	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
most	RBS	advmod	O
efficient	JJ	amod	O
time	NN	compound	O
point	NN	dobj	O
and	CC	cc	O
concentration	NN	conj	O
of	IN	prep	O
topical	JJ	amod	O
corticosteroids	NNS	pobj	B-Simple_chemical
in	IN	case	O
Candida	NN	compound	B-Organism
albicans	NNS	compound	I-Organism
keratitis	NN	nmod	O
treated	VBN	acl	O
with	IN	prep	O
fluconazole	NN	pobj	B-Simple_chemical
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
Photodynamic	NNP	compound	O
Therapy	NNP	nmod	O
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
chronic	JJ	amod	O
Central	JJ	compound	O
Serous	NNP	amod	O
Chorioretinopathy	NNP	nmod	O
(	-LRB-	punct	O
CSC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Corneas	NNS	nsubjpass	B-Multi-tissue_structure
of	IN	case	O
105	CD	nummod	O
rabbits	NNS	nmod	B-Organism
were	VBD	auxpass	O
infected	VBN	dep	O
with	IN	case	O
viable	JJ	amod	O
yeast	NN	compound	B-Organism
cells	NNS	nmod	B-Cell
of	IN	case	O
C	NN	nmod	B-Organism
.	.	punct	I-Organism
albicans	NNS	ROOT	I-Organism
(	-LRB-	punct	O
2	CD	dep	O
.	.	punct	O
5	CD	dep	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O

After	IN	prep	O
15	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
clots	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
histology	NN	nmod	O
and	CC	cc	O
electron	NN	conj	O
microscopy	NN	conj	O
.	.	punct	O
After	IN	prep	O
a	DT	det	O
48	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
incubation	NN	compound	O
period	NN	pobj	O
,	,	punct	O
seven	CD	nummod	O
groups	NNS	nsubjpass	O
of	IN	case	O
animals	NNS	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
for	IN	prep	O
21	CD	nummod	O
days	NNS	pobj	O
with	IN	prep	O
fluconazole	NN	pobj	B-Simple_chemical
,	,	punct	O
with	IN	prep	O
group	NN	pobj	O
I	CD	nsubj	O
acting	VBG	acl	O
as	IN	prep	O
a	DT	det	O
control	NN	pobj	O
,	,	punct	O
and	CC	cc	O
groups	NNS	conj	O
II	CD	nummod	O
to	TO	case	O
VII	NN	nmod	O
receiving	VBG	acl	O
adjunct	JJ	compound	O
therapy	NN	dobj	O
with	IN	case	O
the	DT	det	O
corticosteroid	NN	compound	B-Simple_chemical
prednisolone	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	O
or	CC	cc	O
10	CD	conj	O
times	NNS	dep	O
daily	RB	advmod	O
;	:	punct	O
3	CD	nummod	O
,	,	punct	O
9	CD	conj	O
,	,	punct	O
or	CC	cc	O
15	CD	conj	O
days	NNS	dep	O
after	IN	case	O
infection	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Main	JJ	amod	O
outcome	NN	compound	O
measures	NNS	nsubj	O
included	VBD	ROOT	O
best	RBS	advmod	O
corrected	VBN	amod	O
visual	JJ	amod	O
acuity	NN	dobj	O
,	,	punct	O
ophthalmic	JJ	amod	O
examination	NN	conj	O
,	,	punct	O
retinal	JJ	amod	O
photography	NN	conj	O
,	,	punct	O
and	CC	cc	O
angiography	NN	conj	O
.	.	punct	O
The	DT	det	O
degree	NN	nsubjpass	O
of	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
infiltration	NN	nmod	O
,	,	punct	O
ulceration	NN	conj	O
,	,	punct	O
corneal	NN	compound	B-Multi-tissue_structure
clouding	NN	conj	O
,	,	punct	O
hypopyon	NN	dep	O
,	,	punct	O
conjunctivitis	NN	conj	O
,	,	punct	O
neovascularization	NN	conj	O
,	,	punct	O
and	CC	cc	O
corneal	NN	compound	B-Multi-tissue_structure
perforation	NN	conj	O
was	VBD	auxpass	O
monitored	VBN	ROOT	O
over	IN	prep	O
a	DT	det	O
24	CD	nummod	O
-	HYPH	punct	O
day	NN	compound	O
period	NN	pobj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
recultivation	NN	conj	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
fluconazole	NN	nmod	B-Simple_chemical
of	IN	case	O
the	DT	det	O
C	NN	nmod	B-Organism
.	.	punct	I-Organism
albicans	VBZ	ROOT	I-Organism
pathogen	NN	dobj	O
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
MATERIALS	NNS	conj	O
:	:	punct	O
The	DT	det	O
prospective	JJ	amod	O
trial	NN	nsubj	O
included	VBD	ROOT	O
287	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
subfoveal	JJ	amod	O
neovascularization	NN	nmod	O
due	JJ	case	O
to	TO	case	O
AMD	NN	nmod	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
verified	VBN	acl:relcl	O
by	IN	case	O
fluorescein	NN	compound	O
angiography	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
control	JJ	compound	O
group	NN	nsubj	O
showed	VBD	dep	O
the	DT	det	O
highest	JJS	amod	O
level	NN	dobj	O
of	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
clouding	NN	nmod	O
and	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
cases	NNS	compound	O
treatment	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
vascular	JJ	amod	O
leakage	NN	nmod	O
,	,	punct	O
stabilization	NN	conj	O
,	,	punct	O
or	CC	cc	O
improved	JJ	amod	O
vision	NN	conj	O
.	.	punct	O
In	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
by	IN	case	O
day	NN	nmod	O
24	CD	nummod	O
,	,	punct	O
the	DT	det	O
majority	NN	nsubj	O
of	IN	case	O
groups	NNS	nmod	O
also	RB	advmod	O
treated	VBN	ROOT	O
with	IN	case	O
prednisolone	NN	nmod	B-Simple_chemical
displayed	VBD	conj	O
significantly	RB	advmod	O
less	JJR	advmod	O
corneal	NN	compound	B-Multi-tissue_structure
clouding	NN	dobj	O
and	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O

This	DT	det	O
decrease	NN	nsubj	O
persisted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
2	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
An	DT	det	O
immediate	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
clouding	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
groups	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
additional	JJ	amod	O
low	JJ	amod	O
-	:	punct	O
or	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	conj	O
prednisolone	VBN	nmod	B-Simple_chemical
from	IN	case	O
day	NN	nmod	O
9	CD	nummod	O
after	IN	case	O
inoculation	NN	nmod	O
.	.	punct	O

This	DT	det	O
decrease	NN	nsubj	O
persisted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
2	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
After	IN	case	O
additional	JJ	amod	O
prednisolone	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
from	IN	case	O
day	NN	nmod	O
9	CD	nummod	O
or	CC	cc	O
15	CD	conj	O
after	IN	case	O
inoculation	NN	nmod	O
,	,	punct	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
recultivation	NN	compound	O
rate	NN	nmod	O
of	IN	case	O
C	NN	nmod	B-Organism
.	.	punct	I-Organism
albicans	NNS	ROOT	I-Organism
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	nmod	O
.	.	punct	O

This	DT	det	O
decrease	NN	nsubj	O
persisted	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
2	CD	nummod	O
weeks	NNS	nmod	O
of	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
Early	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
prednisolone	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
day	NN	dep	O
3	CD	nummod	O
,	,	punct	O
low	JJ	conj	O
and	CC	cc	O
high	JJ	conj	O
dose	NN	dep	O
)	-RRB-	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
recultivation	NN	nmod	O
of	IN	case	O
significantly	RB	advmod	O
more	JJR	amod	O
C	NN	nmod	B-Organism
.	.	punct	I-Organism
albicans	NNS	ROOT	I-Organism
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
All	DT	det	O
patients	NNS	nsubj	O
completed	VBD	dep	O
therapy	NN	dobj	O
and	CC	cc	O
tolerability	NN	conj	O
was	VBD	ROOT	O
good	JJ	acomp	O
.	.	punct	O
CONCLUSIONS	NNS	dep	O
:	:	punct	O
Fluconazole	NN	amod	B-Simple_chemical
plus	CC	cc	O
adjunct	JJ	conj	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
prednisolone	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
was	VBD	cop	O
most	RBS	advmod	O
effective	JJ	ROOT	O
when	WRB	advmod	O
administered	VBN	advcl	O
9	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
infection	NN	nmod	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
cases	NNS	compound	O
treatment	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
vascular	JJ	amod	O
leakage	NN	nmod	O
,	,	punct	O
stabilization	NN	conj	O
,	,	punct	O
or	CC	cc	O
improved	JJ	amod	O
vision	NN	conj	O
.	.	punct	O
The	DT	det	O
delayed	VBN	amod	O
application	NN	nsubjpass	O
of	IN	case	O
corticosteroids	NNS	nmod	B-Simple_chemical
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
antimycotic	JJ	amod	B-Simple_chemical
drugs	NNS	nmod	I-Simple_chemical
in	IN	case	O
cases	NNS	nmod	O
of	IN	case	O
fungal	JJ	amod	O
keratitis	NN	nmod	O
is	VBZ	auxpass	O
therefore	RB	advmod	O
not	RB	neg	O
contraindicated	VBN	ROOT	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
beneficial	JJ	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Targeting	VBG	ROOT	O
TNF	NN	dobj	O
for	IN	prep	O
Treatment	NN	pobj	O
of	IN	prep	O
Cancer	NNP	pobj	O
and	CC	cc	O
Autoimmunity	NN	conj	O
.	.	punct	O
Solid	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
therapy	NN	ROOT	O
:	:	punct	O
manipulation	NN	dep	O
of	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Multi-tissue_structure
with	IN	case	O
TNF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
effective	JJ	amod	O
HDAC	NN	compound	O
inhibitors	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
remain	VBP	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
developed	VBN	xcomp	O
.	.	punct	O
Drug	NN	compound	O
delivery	NN	nsubj	O
to	TO	prep	O
solid	JJ	amod	B-Cancer
tumors	NNS	pobj	I-Cancer
is	VBZ	ROOT	O
one	CD	attr	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
challenging	JJ	amod	O
aspects	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Several	JJ	amod	O
such	JJ	amod	O
agents	NNS	nsubj	O
are	VBP	cop	O
currently	RB	advmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	ROOT	O
,	,	punct	O
and	CC	cc	O
many	JJ	amod	O
others	NNS	nsubj	O
are	VBP	conj	O
under	IN	prep	O
development	NN	pobj	O
.	.	punct	O
Whereas	IN	mark	O
agents	NNS	nsubj	O
seem	VBP	advcl	O
promising	NN	xcomp	O
in	IN	case	O
the	DT	det	O
test	NN	compound	O
tube	NN	nmod	O
,	,	punct	O
clinical	JJ	amod	O
trials	NNS	nsubj	O
often	RB	advmod	O
fail	VBP	ROOT	O
due	JJ	advmod	O
to	TO	mwe	O
unfavorable	JJ	amod	O
pharmacokinetics	NNS	pobj	O
,	,	punct	O
poor	JJ	amod	O
delivery	NN	conj	O
,	,	punct	O
low	JJ	amod	O
local	JJ	amod	O
concentrations	NNS	conj	O
,	,	punct	O
and	CC	cc	O
limited	JJ	amod	O
accumulation	NN	conj	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
cell	NN	nmod	B-Cell
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
A	DT	det	O
major	JJ	amod	O
step	NN	compound	O
forwards	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
the	DT	det	O
recognition	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	O
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	O
progression	NN	dobj	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
has	VBZ	ROOT	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

VDAs	NNS	nsubj	O
specifically	RB	advmod	O
target	NN	ROOT	O
and	CC	cc	O
destroy	VB	conj	O
well	RB	advmod	O
-	HYPH	punct	O
established	JJ	amod	O
tumor	NN	compound	O
vessels	NNS	conj	O
with	IN	case	O
ischemia	NN	nmod	O
and	CC	cc	O
destruction	NN	conj	O
of	IN	case	O
large	JJ	amod	O
masses	NNS	nmod	O
with	IN	case	O
central	JJ	amod	O
hemorrhagic	JJ	amod	O
necrosis	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
a	DT	det	O
thin	JJ	amod	O
peripheral	JJ	amod	O
tumor	NN	compound	O
layer	NN	nmod	O
.	.	punct	O
Destruction	NN	nsubj	O
of	IN	prep	O
an	DT	det	O
existing	VBG	amod	O
vasculature	NN	pobj	B-Multi-tissue_structure
also	RB	advmod	O
directly	RB	advmod	O
inflicts	VBZ	ROOT	O
serious	JJ	amod	O
damage	NN	dobj	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cell	NN	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
process	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
blood	NN	compound	O
vessel	NN	compound	O
formation	NN	nmod	O
is	VBZ	cop	O
complex	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
each	DT	det	O
tumor	NN	nsubj	O
exhibits	VBZ	conj	O
unique	JJ	amod	O
features	NNS	dobj	O
in	IN	case	O
its	PRP$	nmod:poss	O
vasculature	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
bed	NN	nsubjpass	I-Multi-tissue_structure
can	MD	aux	O
be	VB	auxpass	O
manipulated	VBN	ROOT	O
facilitating	VBG	xcomp	O
enhanced	VBN	amod	O
permissiveness	NN	dobj	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	B-Cancer
for	IN	case	O
administered	VBN	amod	O
chemotherapeutics	NNS	nmod	O
.	.	punct	O

Tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
-	:	punct	O
alpha	NN	nsubjpass	O
(	-LRB-	punct	O
TNF	NN	compound	O
-	:	punct	O
alpha	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
isolated	VBN	ROOT	O
two	CD	nummod	O
decades	NNS	nmod:npmod	O
ago	RB	advmod	O
as	IN	case	O
a	DT	det	O
macrophageproduced	JJ	amod	O
protein	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
effectively	RB	advmod	O
kill	VB	acl:relcl	O
tumor	NN	compound	O
cells	NNS	dobj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
focus	VBP	ROOT	O
on	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TNF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
local	JJ	amod	O
and	CC	cc	O
systemic	JJ	conj	O
therapy	NN	nmod	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
chemotherapy	NN	nmod	O
.	.	punct	O

Different	JJ	amod	O
antiangiogenic	JJ	amod	O
therapeutics	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
improve	VB	xcomp	O
tumor	NN	compound	O
control	NN	dobj	O
through	IN	case	O
vascular	JJ	amod	O
-	HYPH	punct	O
targeting	VBG	dep	O
agents	NNS	nmod	O
(	-LRB-	punct	O
VTA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
these	DT	det	O
settings	NNS	nmod	O
TNF	NN	nsubj	B-Gene_or_gene_product
demonstrates	VBZ	ROOT	O
potent	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
activity	NN	dobj	O
on	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
bed	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
which	WDT	nsubj	O
strongly	RB	advmod	O
improves	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
response	NN	dobj	O
.	.	punct	O

The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
perfluorocarbon	NN	npadvmod	O
-	HYPH	punct	O
based	VBN	amod	O
artificial	JJ	amod	O
oxygen	NN	compound	O
carriers	NNS	nmod	O
on	IN	case	O
tissue	NN	npadvmod	O
-	HYPH	punct	O
engineered	VBN	amod	O
trachea	NNS	nmod	O
.	.	punct	O
Comparison	NN	ROOT	O
of	IN	case	O
tissue	NN	compound	B-Tissue
integration	NN	nmod	O
between	IN	case	O
polyester	NN	nmod	B-Simple_chemical
and	CC	cc	O
polypropylene	NN	conj	B-Simple_chemical
prostheses	NNS	dep	O
in	IN	prep	O
the	DT	det	O
preperitoneal	JJ	amod	B-Immaterial_anatomical_entity
space	NN	pobj	I-Immaterial_anatomical_entity
.	.	punct	O

Bone	NN	compound	O
marrow	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
mesenchymal	JJ	amod	O
stem	NN	compound	O
cells	NNS	nsubjpass	O
(	-LRB-	punct	O
BM	NN	compound	O
-	:	punct	O
MSC	NN	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
attractive	JJ	amod	O
therapeutic	JJ	amod	O
cell	NN	compound	O
source	NN	xcomp	O
for	IN	case	O
tissue	NN	compound	O
regeneration	NN	nmod	O
and	CC	cc	O
repair	NN	conj	O
.	.	punct	O
Tissue	NN	compound	B-Tissue
integration	NN	nsubjpass	O
and	CC	cc	O
implant	JJ	amod	O
characteristics	NNS	conj	O
of	IN	case	O
various	JJ	amod	O
biomaterials	NNS	nmod	O
commonly	RB	advmod	O
used	VBN	acl	O
for	IN	prep	O
inguinal	JJ	amod	B-Pathological_formation
hernia	NN	compound	I-Pathological_formation
repair	NN	pobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
extensively	RB	advmod	O
.	.	punct	O

Smooth	NNP	amod	O
muscle	NN	nmod:npmod	O
-	HYPH	punct	O
rich	JJ	amod	O
tissues	NNS	nsubj	O
respond	VBP	ROOT	O
to	TO	case	O
mechanical	JJ	amod	O
overload	NN	nmod	O
by	IN	case	O
an	DT	det	O
adaptive	JJ	amod	O
hypertrophic	JJ	amod	O
growth	NN	nmod	O
combined	VBN	acl	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
potentiates	VBZ	acl:relcl	O
their	PRP$	nmod:poss	O
mechanical	JJ	amod	O
overload	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
capabilities	NNS	dobj	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
behavior	NN	amod	O
and	CC	cc	O
tissue	NN	conj	B-Tissue
response	NN	dobj	O
between	IN	case	O
two	CD	nummod	O
new	JJ	amod	O
polyester	NN	compound	B-Simple_chemical
prostheses	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
commonly	RB	advmod	O
used	VBN	amod	O
polypropylene	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
PP	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
mesh	NN	conj	O
.	.	punct	O

Six	CD	nummod	O
edentulous	JJ	amod	O
patients	NNS	ROOT	O
(	-LRB-	punct	O
aged	JJ	dep	O
60	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
severely	RB	advmod	O
atrophic	JJ	amod	O
mandible	NN	amod	O
underwent	VBD	amod	O
bone	NN	compound	O
augmentation	NN	conj	O
with	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O
The	DT	det	O
polyester	NN	compound	B-Simple_chemical
prostheses	NNS	nsubj	O
utilized	VBN	acl	O
were	VBD	ccomp	O
polyester	RB	amod	B-Simple_chemical
flat	NN	attr	O
(	-LRB-	punct	O
PF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
polyester	NN	conj	B-Simple_chemical
soft	JJ	amod	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	dobj	O
(	-LRB-	punct	O
PS	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
the	DT	det	O
PP	NN	compound	O
mesh	NN	amod	O
utilized	VBN	nsubj	O
was	VBD	ROOT	O
Marlex	NNP	attr	O
.	.	punct	O

RESEARCH	NNP	compound	O
DESIGN	NN	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Adipose	NN	compound	O
tissue	NN	compound	O
samples	NNS	dep	O
from	IN	case	O
visceral	JJ	nmod	O
(	-LRB-	punct	O
VAT	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
subcutaneous	JJ	conj	O
(	-LRB-	punct	O
SAT	NN	dep	O
)	-RRB-	punct	O
sites	NNS	dep	O
,	,	punct	O
obtained	VBN	acl	O
from	IN	case	O
36	CD	nummod	O
obese	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
mean	JJ	amod	O
BMI	NN	appos	O
46	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
kg	NN	compound	O
/	:	punct	O
m	NN	nsubjpass	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
during	IN	case	O
bariatric	JJ	amod	O
surgery	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
layered	VBN	ROOT	O
on	IN	case	O
chick	NN	compound	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
(	-LRB-	punct	O
CAM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Eight	CD	nummod	O
randomly	RB	nsubj	O
assigned	VBN	ROOT	O
4	CD	nummod	O
x	CC	cc	O
4	CD	nummod	O
-	HYPH	punct	O
cm2	JJ	compound	O
pieces	NNS	nsubjpass	O
of	IN	prep	O
two	CD	nummod	O
different	JJ	amod	O
meshes	NNS	pobj	O
were	VBD	auxpass	O
fixed	VBN	ccomp	O
in	IN	prep	O
the	DT	det	O
preperitoneal	JJ	amod	B-Immaterial_anatomical_entity
space	NN	pobj	I-Immaterial_anatomical_entity
with	IN	prep	O
a	DT	det	O
centrally	RB	advmod	O
placed	VBN	amod	O
single	JJ	amod	O
suture	NN	pobj	O
.	.	punct	O

Histological	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
throughout	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
in	IN	case	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	nmod	O
.	.	punct	O
Gross	JJ	amod	O
evaluation	NN	nsubj	O
included	VBD	ROOT	O
shrinkage	NN	dobj	O
and	CC	cc	O
stiffness	NN	conj	O
.	.	punct	O

The	DT	det	O
foreign	JJ	amod	O
body	NN	compound	O
reaction	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
.	.	punct	O
Histological	JJ	amod	O
evaluation	NN	nsubj	O
included	VBD	ROOT	O
amount	NN	dobj	O
of	IN	case	O
fibrous	JJ	amod	B-Tissue
and	CC	cc	O
fat	JJ	conj	B-Tissue
encapsulation	NN	nmod	O
,	,	punct	O
connective	JJ	amod	B-Tissue
tissue	NN	conj	I-Tissue
,	,	punct	O
foreign	JJ	amod	O
-	HYPH	punct	O
body	NN	compound	O
reaction	NN	conj	O
,	,	punct	O
neovascularization	NN	conj	O
,	,	punct	O
hemorrhage	NN	conj	O
,	,	punct	O
necrosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
exudate	VB	conj	B-Organism_substance
.	.	punct	O

Main	JJ	amod	O
outcome	NN	compound	O
measures	NNS	nsubj	O
included	VBD	ROOT	O
best	RBS	advmod	O
corrected	VBN	amod	O
visual	JJ	amod	O
acuity	NN	dobj	O
,	,	punct	O
ophthalmic	JJ	amod	O
examination	NN	conj	O
,	,	punct	O
retinal	JJ	amod	O
photography	NN	conj	O
,	,	punct	O
and	CC	cc	O
angiography	NN	conj	O
.	.	punct	O
Evaluations	NNS	nsubjpass	O
were	VBD	auxpass	O
graded	VBN	ROOT	O
on	IN	prep	O
a	DT	det	O
zero	CD	quantmod	O
to	TO	quantmod	O
four	CD	nummod	O
scale	NN	pobj	O
.	.	punct	O

Vascular	JJ	compound	O
histomorphometry	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
in	IN	prep	O
two	CD	nummod	O
different	JJ	amod	O
areas	NNS	pobj	O
in	IN	prep	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	pobj	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
first	JJ	nmod	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
1	CD	compound	O
mm	NN	amod	O
area	NN	nmod	O
from	IN	prep	O
the	DT	det	O
osteotomy	NN	amod	O
line	NN	pobj	O
,	,	punct	O
representing	VBG	acl	O
the	DT	det	O
oldest	JJS	dobj	O
and	CC	cc	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	O
area	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O
The	DT	det	O
area	NN	nsubjpass	O
and	CC	cc	O
the	DT	det	O
area	NN	compound	O
ratio	NN	conj	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
calibrated	JJ	amod	O
micrometer	NN	dobj	O
.	.	punct	O

Histological	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
throughout	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
in	IN	case	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	nmod	O
.	.	punct	O
PP	NN	compound	B-Simple_chemical
mesh	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
more	RBR	advmod	O
fibrous	JJ	amod	B-Tissue
encapsulation	NN	nmod	O
and	CC	cc	O
stiffness	RB	conj	O
than	IN	case	O
PF	NN	compound	O
and	CC	cc	O
PS	NN	conj	O
prostheses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
foreign	JJ	amod	O
body	NN	compound	O
reaction	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
.	.	punct	O
PP	NNS	nsubj	B-Simple_chemical
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
less	RBR	advmod	O
connective	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	nmod	O
and	CC	cc	O
foreign	JJ	amod	O
-	HYPH	punct	O
body	NN	compound	O
reaction	NN	conj	O
than	IN	case	O
PF	NN	compound	O
and	CC	cc	O
PS	NN	conj	O
prostheses	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Blood	NN	compound	O
vessels	NNS	nsubj	O
initiated	VBD	appos	O
growth	NN	dobj	O
and	CC	cc	O
elongated	VBN	conj	O
from	IN	case	O
the	DT	det	O
fat	NN	compound	O
tissue	NN	compound	O
fragments	NNS	nmod	O
over	IN	case	O
15	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
in	IN	case	O
fat	NN	compound	B-Tissue
encapsulation	NN	nmod	O
,	,	punct	O
necrosis	NN	conj	O
,	,	punct	O
hemorrhage	NN	conj	O
,	,	punct	O
or	CC	cc	O
exudate	VB	conj	B-Organism_substance
between	IN	prep	O
prostheses	NNS	pobj	O
.	.	punct	O

Histological	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
throughout	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
in	IN	case	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	nmod	O
.	.	punct	O
Both	DT	det	O
polyester	NN	compound	B-Simple_chemical
prostheses	NNS	nsubj	O
(	-LRB-	punct	O
PF	NN	dep	O
and	CC	cc	O
PS	NN	conj	O
)	-RRB-	punct	O
have	VBP	ROOT	O
better	JJR	amod	O
tissue	NN	compound	B-Tissue
integration	NN	dobj	O
than	IN	case	O
the	DT	det	O
PP	NN	compound	B-Simple_chemical
mesh	NN	advcl	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
the	DT	det	O
higher	JJR	amod	O
amount	NN	nmod	O
of	IN	case	O
connective	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
lower	JJR	amod	O
extent	NN	conj	O
of	IN	case	O
fibrous	JJ	amod	B-Tissue
encapsulation	NN	nmod	O
.	.	punct	O

Convergence	NN	ROOT	O
of	IN	case	O
p53	NN	compound	O
and	CC	cc	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	conj	O
signaling	NN	compound	O
networks	NNS	nmod	O
.	.	punct	O
Integration	NN	ROOT	O
of	IN	case	O
interferon	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	nmod	B-Gene_or_gene_product
signalling	NN	acl	O
to	TO	case	O
p53	NN	compound	B-Gene_or_gene_product
responses	NNS	nmod	O
in	IN	case	O
tumour	NN	compound	B-Cancer
suppression	NN	nmod	O
and	CC	cc	O
antiviral	JJ	amod	B-Organism
defence	NN	conj	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
OSM	NN	nsubj	O
can	MD	aux	O
also	RB	advmod	O
suppress	VB	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
tumor	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
cell	NN	compound	O
lines	NNS	conj	O
.	.	punct	O
Swift	NN	amod	O
elimination	NN	nsubj	O
of	IN	case	O
undesirable	JJ	amod	O
cells	NNS	nmod	B-Cell
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
feature	NN	ROOT	O
in	IN	case	O
tumour	NN	compound	B-Cancer
suppression	NN	nmod	O
and	CC	cc	O
immunity	NN	conj	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
The	DT	det	O
tumour	NN	compound	B-Cancer
suppressor	NN	nsubj	O
p53	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
interferon	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
-	:	punct	B-Gene_or_gene_product
beta	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
cancerous	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
in	IN	case	O
antiviral	JJ	amod	B-Organism
immune	JJ	amod	O
responses	NNS	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
but	CC	cc	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
about	IN	case	O
their	PRP$	nmod:poss	O
interrelationship	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
transcription	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
is	VBZ	auxpass	O
induced	VBN	ccomp	O
by	IN	case	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
accompanied	VBN	acl	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
level	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	nsubj	B-Gene_or_gene_product
signalling	NN	acl	O
itself	PRP	dobj	O
does	VBZ	aux	O
not	RB	neg	O
activate	VB	ROOT	O
p53	NN	dobj	B-Gene_or_gene_product
;	:	punct	O
rather	RB	cc	O
,	,	punct	O
it	PRP	nsubj	O
contributes	VBZ	conj	O
to	TO	mark	O
boosting	VBG	xcomp	O
p53	NN	compound	B-Gene_or_gene_product
responses	NNS	dobj	O
to	TO	case	O
stress	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
examples	NNS	dobj	O
in	IN	case	O
which	WDT	nmod	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
induction	NN	nsubj	O
by	IN	case	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	nmod	B-Gene_or_gene_product
contributes	VBZ	acl:relcl	O
to	TO	case	O
tumour	NN	compound	B-Cancer
suppression	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
p53	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
virally	RB	advmod	B-Organism
infected	JJ	amod	O
cells	NNS	nmod	B-Cell
to	TO	mark	O
evoke	VB	xcomp	O
an	DT	det	O
apoptotic	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
critical	JJ	conj	O
for	IN	case	O
antiviral	JJ	amod	B-Organism
defence	NN	nmod	O
of	IN	case	O
the	DT	det	O
host	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
the	DT	det	O
tumor	NN	compound	O
suppressive	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	O
become	VBP	advcl	O
concerted	VBN	xcomp	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
cues	NNS	nmod	O
arriving	VBG	acl	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
during	IN	case	O
tissue	NN	compound	O
homeostasis	NN	nmod	O
,	,	punct	O
remains	VBZ	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O
Our	PRP$	nmod:poss	O
study	NN	nsubj	O
reveals	VBZ	ROOT	O
a	DT	det	O
hitherto	RB	advmod	O
unrecognized	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
beta	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
tumour	NN	compound	B-Cancer
suppression	NN	nmod	O
and	CC	cc	O
antiviral	JJ	amod	B-Organism
immunity	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
have	VB	acl:relcl	O
therapeutic	JJ	amod	O
implications	NNS	dobj	O
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
T140	NN	compound	B-Simple_chemical
analogs	NNS	nsubj	I-Simple_chemical
as	IN	case	O
CXCR4	NN	compound	B-Gene_or_gene_product
antagonists	NNS	nmod	O
identified	VBN	ROOT	O
as	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
agents	NNS	nmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
A	DT	det	O
chemokine	NN	compound	O
receptor	NN	nsubjpass	O
,	,	punct	O
CXCR4	NN	appos	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
endogenous	JJ	amod	O
ligand	NN	conj	O
,	,	punct	O
stromal	JJ	amod	B-Gene_or_gene_product
cell	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
SDF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
metastasis	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Little	JJ	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O
T140	NN	compound	B-Simple_chemical
analogs	NNS	nsubj	I-Simple_chemical
are	VBP	cop	O
peptidic	JJ	amod	O
CXCR4	NN	compound	B-Gene_or_gene_product
antagonists	NNS	ROOT	O
composed	VBN	acl	O
of	IN	case	O
14	CD	nummod	O
amino	NN	compound	O
acid	NN	compound	O
residues	NNS	nmod	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
previously	RB	advmod	O
developed	VBN	acl:relcl	O
as	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
HIV	NN	compound	B-Organism
agents	NNS	nmod	O
having	VBG	acl	O
inhibitory	JJ	amod	O
activity	NN	dobj	O
against	IN	case	O
HIV	NN	compound	B-Organism
-	HYPH	punct	O
entry	NN	nmod	O
through	IN	case	O
its	PRP$	nmod:poss	O
co	NN	compound	O
-	HYPH	punct	O
receptor	NN	nmod	O
,	,	punct	O
CXCR4	NN	appos	B-Gene_or_gene_product
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Herein	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
these	DT	det	O
compounds	NNS	nsubj	O
effectively	RB	advmod	O
inhibited	VBD	ccomp	O
SDF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
migration	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	dep	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
)	-RRB-	punct	O
,	,	punct	O
human	JJ	amod	B-Organism
leukemia	NN	compound	B-Cell
T	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
Sup	NN	compound	B-Cell
-	HYPH	punct	I-Cell
T1	NN	appos	I-Cell
)	-RRB-	punct	O
and	CC	cc	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	compound	O
-	SYM	punct	O
100	CD	nummod	O
nM	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

HTPB	NN	nsubj	O
delayed	VBD	ROOT	O
lung	NN	compound	O
metastasis	NN	dobj	O
of	IN	case	O
4T1	NN	compound	O
mouse	NN	compound	O
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
slow	JJ	amod	O
release	NN	compound	O
administration	NN	nsubj	O
by	IN	case	O
subcutaneous	JJ	amod	O
injection	NN	nmod	O
using	VBG	acl	O
an	DT	det	O
Alzet	NNP	compound	O
osmotic	JJ	amod	O
pump	NN	dobj	O
of	IN	case	O
a	DT	det	O
potent	JJ	amod	O
and	CC	cc	O
bio	NN	nmod:npmod	O
-	HYPH	punct	O
stable	JJ	conj	O
T140	NN	compound	B-Simple_chemical
analog	NN	nmod	I-Simple_chemical
,	,	punct	O
4F	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
benzoyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
TN14003	NN	appos	I-Simple_chemical
,	,	punct	O
gave	VBD	ROOT	O
a	DT	det	O
partial	JJ	dobj	O
,	,	punct	O
but	CC	cc	O
statistically	RB	advmod	O
significant	JJ	conj	O
(	-LRB-	punct	O
P	NN	compound	O
<	ADD	nsubj	O
/	:	punct	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
05	CD	nummod	O
(	-LRB-	punct	O
t	NN	compound	O
-	:	punct	O
test	NN	compound	O
)	-RRB-	punct	O
)	-RRB-	punct	O
reduction	NN	ROOT	O
in	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	nmod	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
in	IN	case	O
SCID	NN	compound	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
even	RB	advmod	O
though	IN	mark	O
no	DT	det	O
attempt	NN	nsubjpass	O
was	VBD	auxpass	O
made	VBN	advcl	O
to	TO	aux	O
inhibit	VB	xcomp	O
other	JJ	amod	O
important	JJ	amod	O
targets	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
CCR7	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
PTHrP	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
neutralizing	VBG	amod	O
antibodies	NNS	nsubj	O
slowed	VBD	ROOT	O
the	DT	det	O
progression	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
xenografts	NNS	advmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
T140	NN	compound	B-Simple_chemical
analogs	NNS	nsubj	I-Simple_chemical
have	VBP	ccomp	O
potential	JJ	amod	O
use	NN	dobj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
small	JJ	amod	O
molecular	JJ	amod	O
CXCR4	NN	compound	B-Gene_or_gene_product
antagonists	NNS	nsubj	O
could	MD	aux	O
potentially	RB	advmod	O
replace	VB	conj	O
neutralizing	VBG	amod	O
antibodies	NNS	dobj	O
as	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	dep	O
agents	NNS	nmod	O
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
IL	NN	nsubj	O
-	:	punct	O
12	CD	nummod	O
activates	VBZ	ccomp	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
program	NN	dobj	O
in	IN	case	O
Con	NN	compound	O
A	NNP	compound	O
-	HYPH	punct	O
activated	VBN	amod	O
mouse	NN	compound	O
spleen	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
activated	VBN	dep	O
spc	NN	dep	O
)	-RRB-	punct	O
or	CC	cc	O
human	JJ	amod	O
PBMC	NN	conj	O
(	-LRB-	punct	O
activated	VBN	amod	O
PBMC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
CCL16	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ROOT	O
an	DT	det	O
angiogenic	JJ	amod	O
program	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Besides	IN	mark	O
regulating	VBG	advcl	O
leukocyte	NN	compound	B-Cell
trafficking	VBG	dobj	O
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
injured	JJ	conj	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
several	JJ	amod	O
chemokines	NNS	nsubj	O
may	MD	aux	O
positively	RB	advmod	O
or	CC	advmod	O
negatively	RB	advmod	O
regulate	VB	ROOT	O
angiogenesis	NN	dobj	O
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
CCL16	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ccomp	O
an	DT	det	O
angiogenic	JJ	amod	O
program	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
activating	VBG	advcl	O
CCR1	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
CCL16	NN	nsubj	B-Gene_or_gene_product
induces	VBZ	ROOT	O
dose	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
random	JJ	amod	O
and	CC	cc	O
directional	JJ	conj	O
migration	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
isolated	VBN	acl	O
from	IN	case	O
large	JJ	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
liver	NN	compound	B-Tissue
capillaries	NNS	conj	I-Tissue
without	IN	mark	O
inducing	VBG	advcl	O
their	PRP$	nmod:poss	O
proliferation	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
It	PRP	nsubj	O
also	RB	advmod	O
promotes	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
differentiation	NN	dobj	O
into	IN	case	O
capillary	JJ	npadvmod	B-Tissue
-	HYPH	punct	I-Tissue
like	JJ	amod	I-Tissue
structures	NNS	nmod	I-Tissue
in	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
assay	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
angiogenic	JJ	conj	O
in	IN	case	O
the	DT	det	O
chick	NN	compound	B-Organism
chorionallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
These	DT	det	O
angiogenic	JJ	amod	O
activities	NNS	nsubjpass	O
are	VBP	auxpass	O
neutralized	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
antibody	NN	nmod	O
against	IN	case	O
CCL16	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
The	DT	det	O
direct	JJ	amod	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
CCL16	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
further	RB	advmod	O
amplified	VBN	ROOT	O
by	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
prime	JJ	acl	O
endothelium	NN	dobj	B-Tissue
to	TO	case	O
a	DT	det	O
mitogen	NN	compound	O
signal	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
A	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
to	TO	mark	O
raise	VB	conj	O
their	PRP$	nmod:poss	O
basal	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
CXCL8	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CCL2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
2	CD	nummod	O
other	JJ	amod	O
angiogenic	JJ	amod	O
chemokines	NNS	appos	O
.	.	punct	O

PMN	NNP	npadvmod	O
-	HYPH	punct	O
triggered	VBN	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
local	JJ	amod	O
injection	NN	nmod	O
and	CC	cc	O
daily	RB	advmod	O
i	NN	conj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
administration	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Hyp	NN	compound	O
salt	NN	nmod	O
in	IN	case	O
an	DT	det	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
-	HYPH	punct	O
induced	VBN	amod	O
murine	JJ	amod	O
model	NN	nmod	O
.	.	punct	O
BX471	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
R	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
chloro	NNS	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorophenyl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
methyl	NN	nsubj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	SYM	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
piperazinyl	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
oxoethoxy	NN	appos	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
phenyl	NN	nsubj	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
urea	NN	compound	I-Simple_chemical
hydrochloric	JJ	amod	I-Simple_chemical
acid	NN	compound	I-Simple_chemical
salt	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
CCR1	NN	compound	B-Gene_or_gene_product
antagonist	NN	appos	O
,	,	punct	O
inhibits	VBZ	ROOT	O
angiogenic	JJ	amod	O
properties	NNS	dobj	O
of	IN	case	O
CCL16	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
whereas	IN	dep	O
blocking	NN	nsubj	O
of	IN	case	O
CCR8	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
desensitizing	VBG	conj	O
CCR2	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
both	DT	neg	O
well	RB	advmod	O
known	JJ	amod	O
receptors	NNS	advcl	O
for	IN	case	O
CCL16	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
abolish	VB	conj	O
endothelial	JJ	amod	B-Cell
activation	NN	dobj	O
.	.	punct	O

IL	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
inhibition	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
functions	NNS	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
depends	VBZ	ROOT	O
on	IN	case	O
lymphocyte	NN	compound	O
-	HYPH	punct	O
endothelial	JJ	amod	O
cell	NN	compound	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nmod	O
.	.	punct	O
CCL16	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
specifically	RB	advmod	O
cross	JJ	ROOT	O
-	HYPH	punct	O
linked	VBN	acl	O
to	TO	case	O
CCR1	NN	nmod	B-Gene_or_gene_product
expressed	VBN	acl	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Whereas	IN	mark	O
homogeneous	JJ	amod	O
and	CC	cc	O
intense	JJ	conj	O
immunoreactivity	NN	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
large	JJ	amod	O
and	CC	cc	O
intermediate	JJ	conj	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
heterogeneity	NN	nsubjpass	O
of	IN	case	O
expression	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
capillaries	NNS	nmod	O
.	.	punct	O
The	DT	det	O
largely	RB	advmod	O
restricted	JJ	amod	O
CCL16	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
chemokine	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
hepatic	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
formation	NN	nmod	O
during	IN	case	O
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
angiogenesis	NN	conj	O
associated	VBN	acl	O
to	TO	case	O
hepatic	JJ	amod	B-Organ
diseases	NNS	nmod	O
.	.	punct	O

Caspase	NN	nsubjpass	O
8	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
mitochondrial	JJ	amod	O
extrinsic	JJ	amod	O
pathway	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
caspase	NN	conj	O
9	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	case	O
mitochondrial	JJ	amod	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
to	IN	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
.	.	punct	O
Simvastatin	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
CLL	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
caspase	NN	nmod	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Genomic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
one	CD	nummod	O
mechanism	NN	ROOT	O
proposed	VBN	acl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
disease	NN	compound	O
progression	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
AND	CC	cc	O
OBJECTIVES	NNS	conj	O
:	:	punct	O
Chronic	JJ	amod	B-Cancer
lymphocytic	JJ	amod	I-Cancer
leukemia	NN	nsubj	I-Cancer
(	-LRB-	punct	O
CLL	NN	appos	B-Cancer
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
leukemia	NN	dep	B-Cancer
in	IN	case	O
the	DT	det	O
western	JJ	amod	O
world	NN	nmod	O
.	.	punct	O

The	DT	det	O
tumor	NN	nsubj	O
may	MD	aux	O
present	VB	ROOT	O
with	IN	case	O
widespread	JJ	amod	O
metastases	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
unresponsive	JJ	acl:relcl	O
to	TO	case	O
aggressive	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O
Despite	IN	case	O
several	JJ	amod	O
advances	NNS	nmod	O
in	IN	case	O
therapeutic	JJ	amod	O
options	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disease	NN	nsubj	O
remains	VBZ	ROOT	O
incurable	JJ	xcomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
regard	NN	nmod	O
,	,	punct	O
inhibitors	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	amod	O
antitumoral	JJ	amod	O
agents	NNS	xcomp	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
repeatedly	RB	advmod	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
statins	NNS	nsubj	B-Simple_chemical
,	,	punct	O
competitive	JJ	amod	O
inhibitors	NNS	appos	O
of	IN	case	O
3	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
hydroxy	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
methyl	NN	compound	I-Gene_or_gene_product
glutaryl	NN	compound	I-Gene_or_gene_product
coenzyme	NN	compound	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HMG	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
CoA	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
reductase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
have	VBP	ccomp	O
antineoplastic	JJ	amod	B-Cancer
effects	NNS	dobj	O
.	.	punct	O

B	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
lines	NNS	nsubj	O
established	VBN	acl	O
from	IN	case	O
two	CD	nummod	O
individuals	NNS	nmod	O
with	IN	case	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
acute	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
T	NN	compound	O
-	:	punct	O
ALL	NN	appos	O
)	-RRB-	punct	O
express	VBP	ROOT	O
HLA	NN	compound	O
-	HYPH	punct	O
DR	NN	compound	O
antigens	NNS	dobj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
isogenic	JJ	amod	O
T	NN	compound	O
-	:	punct	O
cells	NNS	nsubj	O
do	VBP	parataxis	O
not	RB	neg	O
.	.	punct	O
Therefore	RB	advmod	O
we	PRP	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
simvastatin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Sim	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
on	IN	case	O
malignant	JJ	amod	B-Cell
B	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
derived	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CLL	NN	nmod	B-Cancer
and	CC	cc	O
mechanisms	NNS	conj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
the	DT	det	O
drug	NN	nmod	O
.	.	punct	O

METHODOLOGY	NN	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
M	NN	nmod:npmod	O
-	HYPH	punct	O
CSF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	compound	O
production	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
Purified	VBN	amod	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
CLL	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
from	IN	case	O
15	CD	nummod	O
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
cultured	VBN	dep	O
either	CC	cc:preconj	O
alone	RB	advmod	O
or	CC	cc	O
with	IN	case	O
Sim	NN	conj	B-Simple_chemical
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
10	CD	nummod	O
,	,	punct	O
50	CD	nummod	O
,	,	punct	O
and	CC	cc	O
100	CD	nummod	O
microM	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
bolus	NN	compound	O
(	-LRB-	punct	O
3h	NN	appos	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
doxorubicin	NN	nmod	O
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
viable	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
concomitant	JJ	amod	O
increase	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O
Viability	NN	nsubjpass	O
,	,	punct	O
measured	VBN	acl	O
by	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
dehydrogenases	NNS	nmod	O
,	,	punct	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
treated	VBN	acl	O
with	IN	case	O
Sim	NN	nmod	B-Simple_chemical
at	IN	case	O
50	CD	nummod	O
and	CC	cc	O
100	CD	conj	O
microM	NN	nmod	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
005	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
cell	NN	compound	O
apoptosis	NN	nmod	O
increased	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
enhancing	NN	nmod	O
of	IN	case	O
concentration	NN	nmod	O
.	.	punct	O
The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	acl	O
by	IN	case	O
annexin	NN	compound	B-Gene_or_gene_product
binding	NN	nmod	O
to	TO	case	O
exposed	VBN	amod	O
phosphatidylserine	NN	compound	B-Amino_acid
moieties	NNS	nmod	O
,	,	punct	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
in	IN	case	O
the	DT	det	O
treated	VBN	amod	O
cells	NNS	nmod	B-Cell
at	IN	case	O
concentrations	NNS	nmod	O
higher	JJR	amod	O
than	IN	case	O
50	CD	nummod	O
microM	NN	nmod	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
measured	VBN	ROOT	O
by	IN	case	O
DNA	NN	compound	O
fragmentation	NN	nmod	O
and	CC	cc	O
microscope	NN	compound	O
examination	NN	conj	O
.	.	punct	O
The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
necrosis	NN	nmod	O
,	,	punct	O
as	IN	mark	O
measured	VBN	acl	O
by	IN	case	O
propidium	NN	compound	B-Simple_chemical
iodide	NN	compound	I-Simple_chemical
internalization	NN	nmod	O
,	,	punct	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
24	CD	nummod	O
hours	NNS	compound	O
exposure	NN	nmod	O
to	TO	case	O
Sim	NN	nmod	B-Simple_chemical
at	IN	case	O
50	CD	nummod	O
microM	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
measured	VBN	ROOT	O
by	IN	case	O
DNA	NN	compound	O
fragmentation	NN	nmod	O
and	CC	cc	O
microscope	NN	compound	O
examination	NN	conj	O
.	.	punct	O
The	DT	det	O
apoptotic	JJ	amod	O
cascade	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
immunoblot	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
caspases	NNS	nmod	B-Gene_or_gene_product
following	VBG	case	O
Sim	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

Caspase	NN	nsubjpass	O
8	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
mitochondrial	JJ	amod	O
extrinsic	JJ	amod	O
pathway	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
caspase	NN	conj	O
9	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	case	O
mitochondrial	JJ	amod	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
to	IN	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
.	.	punct	O
These	DT	nsubj	O
showed	VBD	ROOT	O
cleavage	NN	dobj	O
of	IN	case	O
caspases	NNS	nmod	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
8	CD	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
3	CD	conj	B-Gene_or_gene_product
.	.	punct	O

Caspase	NN	nsubjpass	O
8	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
mitochondrial	JJ	amod	O
extrinsic	JJ	amod	O
pathway	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
caspase	NN	conj	O
9	CD	nummod	O
(	-LRB-	punct	O
involved	VBN	acl	O
in	IN	case	O
mitochondrial	JJ	amod	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
to	IN	case	O
a	DT	det	O
much	RB	advmod	O
lesser	JJR	amod	O
extent	NN	conj	O
.	.	punct	O
Addition	NN	ROOT	O
of	IN	case	O
the	DT	det	O
caspase	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
Z	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
VAD	NNP	nmod	I-Simple_chemical
.	.	punct	I-Simple_chemical
fmk	NN	advmod	I-Simple_chemical
inhibited	VBD	ROOT	O
caspase	NN	dobj	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
3	CD	conj	B-Gene_or_gene_product
significantly	RB	advmod	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
caspase	NN	dobj	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Cell	NN	compound	O
clones	NNS	nsubj	O
expressing	VBG	acl	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p75	NN	nmod	O
showed	VBD	dep	O
a	DT	det	O
high	JJ	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
even	RB	advmod	O
in	IN	case	O
10	CD	compound	O
%	NN	amod	O
serum	NN	nmod:npmod	O
-	HYPH	punct	O
supplemented	VBN	amod	O
medium	NN	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
Exposure	NN	nsubj	O
of	IN	case	O
clonal	JJ	amod	B-Cell
B	NN	compound	I-Cell
lymphocytes	NNS	nmod	I-Cell
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CLL	NN	nmod	B-Cancer
to	TO	case	O
simvastatin	NN	nmod	B-Simple_chemical
decreases	VBZ	appos	O
viability	NN	dobj	O
significantly	RB	advmod	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
sequential	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
caspase	NN	compound	O
-	:	punct	O
9	CD	compound	O
and	CC	cc	O
caspase	NN	compound	O
-	:	punct	O
3	CD	conj	O
/	SYM	punct	O
-	SYM	punct	O
7	CD	nmod	O
and	CC	cc	O
the	DT	det	O
cleavage	NN	conj	O
of	IN	case	O
poly	NN	amod	O
(	-LRB-	punct	O
ADP	NN	compound	O
-	HYPH	punct	O
ribose	NN	amod	O
)	-RRB-	punct	O
polymerase	NN	nmod	O
(	-LRB-	punct	O
PARP	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
behind	IN	case	O
those	DT	det	O
mitochondrial	JJ	amod	O
events	NNS	nmod	O
.	.	punct	O
The	DT	det	O
apoptosis	NN	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
Sim	NN	nmod	B-Simple_chemical
is	VBZ	auxpass	O
probably	RB	advmod	O
initiated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
caspase	NN	nmod	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
indirectly	RB	advmod	O
leads	VBZ	acl:relcl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
8	CD	conj	B-Gene_or_gene_product
.	.	punct	O

[	-LRB-	punct	O
Activation	NN	ROOT	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
involvement	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
]	-RRB-	punct	O
Autocrine	NN	compound	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	compound	O
regulation	NN	nsubj	O
of	IN	case	O
bovine	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	conj	I-Gene_or_gene_product
involves	VBZ	ROOT	O
modulation	NN	dobj	O
of	IN	case	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
pp60c	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
expression	NN	dep	O
.	.	punct	O

The	DT	det	O
rapid	JJ	amod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
Tie1	NN	nmod	O
by	IN	case	O
shear	NN	compound	O
stress	NN	compound	O
changes	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
rapid	JJ	amod	O
binding	NN	conj	O
to	TO	case	O
Tie2	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
destabilization	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
initiate	VB	advcl	O
the	DT	det	O
process	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	O
restructuring	NN	nmod	O
.	.	punct	O
Rapid	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubj	O
and	CC	cc	O
inhibition	NN	nsubj	O
of	IN	case	O
thrombosis	NN	nmod	O
are	VBP	cop	O
critical	JJ	conj	O
for	IN	case	O
the	DT	det	O
resolution	NN	nmod	O
of	IN	case	O
denudation	NN	nmod	O
injuries	NNS	ROOT	O
to	TO	prep	O
the	DT	det	O
vessel	NN	compound	B-Multi-tissue_structure
wall	NN	pobj	I-Multi-tissue_structure
.	.	punct	O

Endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nsubj	O
and	CC	cc	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
expression	NN	conj	O
are	VBP	cop	O
the	DT	det	O
result	NN	ROOT	O
of	IN	case	O
loss	NN	nmod	O
of	IN	case	O
breast	NN	compound	O
tissue	NN	compound	O
polarity	NN	nmod	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
autocrine	NN	compound	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
,	,	punct	O
with	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
angiotensin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
converting	NN	compound	I-Gene_or_gene_product
enzyme	NN	compound	I-Gene_or_gene_product
inhibitor	NN	compound	O
lisinopril	NN	nmod	B-Simple_chemical
or	CC	cc	O
the	DT	det	O
angiotensin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
antagonist	NN	compound	O
sar1	NN	conj	B-Gene_or_gene_product
,	,	punct	O
ile8	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
angiotensin	NN	appos	I-Simple_chemical
II	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
leads	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
urokinase	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
u	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	conj	O
(	-LRB-	punct	O
Bell	NNP	dep	O
,	,	punct	O
L	NNP	appos	O
.	.	punct	O
,	,	punct	O
and	CC	cc	O
J	NN	conj	O
.	.	punct	O
A	DT	ROOT	O
.	.	punct	O
Madri	NNP	ROOT	O
.	.	punct	O
1990	CD	nummod	O
.	.	punct	O
Am	VBP	ROOT	O
.	.	punct	O
J	NNP	ROOT	O
.	.	punct	O
Pathol	NNP	ROOT	O
.	.	punct	O
137	CD	ROOT	O
:	:	punct	O
7	CD	nummod	O
-	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
EGF	NN	compound	O
receptor	NN	compound	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
amplified	VBN	ROOT	O
and	CC	cc	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	conj	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
increased	VBN	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
constitutive	JJ	amod	O
activity	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
oncogene	NN	compound	O
erb	NN	compound	O
B	NN	nmod	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
autocrine	JJ	amod	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
with	IN	case	O
the	DT	det	O
converting	NN	compound	O
-	HYPH	punct	O
enzyme	NN	compound	O
inhibitor	NN	nmod	O
or	CC	cc	O
the	DT	det	O
receptor	NN	compound	O
antagonist	NN	conj	O
also	RB	advmod	O
leads	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	nmod	I-Gene_or_gene_product
:	:	punct	O
pp60c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
increased	VBD	conj	O
7	CD	nummod	O
-	SYM	punct	O
11	CD	nummod	O
-	HYPH	punct	O
fold	NN	dep	O
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
3	CD	nummod	O
-	HYPH	punct	O
fold	NN	conj	O
,	,	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	conj	O
2	CD	nummod	O
-	SYM	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	NN	dobj	O
.	.	punct	O

Assays	NNS	nsubj	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
,	,	punct	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
antigenicity	NN	conj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	O
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
STAT	NN	compound	O
family	NN	compound	O
member	NN	conj	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	O
oncoprotein	NN	nmod	O
.	.	punct	O
Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
expression	NN	nsubjpass	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	nmod	I-Gene_or_gene_product
was	VBD	cop	O
constitutively	RB	advmod	O
elevated	JJ	ROOT	O
after	IN	case	O
stable	JJ	amod	O
infection	NN	nmod	O
with	IN	case	O
a	DT	det	O
retroviral	JJ	amod	O
vector	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
coding	VBG	compound	O
sequence	NN	dobj	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	O
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O
Constitutively	RB	advmod	O
increased	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	O
activity	NN	nsubj	O
reconstituted	VBD	ROOT	O
the	DT	det	O
increases	NNS	dobj	O
in	IN	case	O
migration	NN	nmod	O
and	CC	cc	O
u	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PA	NN	conj	I-Gene_or_gene_product
observed	VBN	acl	O
with	IN	case	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	compound	O
interruption	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	O
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O
Antisera	NN	nsubj	O
to	TO	case	O
bovine	JJ	amod	B-Organism
u	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
PA	NN	nmod	I-Gene_or_gene_product
blocked	VBD	ROOT	O
the	DT	det	O
increase	NN	dobj	O
in	IN	case	O
migration	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
increased	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	O
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
increases	NNS	nsubj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	conj	I-Gene_or_gene_product
after	IN	case	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	compound	O
inhibition	NN	nmod	O
are	VBP	cop	O
at	IN	advmod	O
least	JJS	advmod	O
partially	RB	advmod	O
pp60c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	ccomp	I-Gene_or_gene_product
mediated	VBN	acl	O
.	.	punct	O

Angiopoietin	NN	nsubj	O
-	HYPH	punct	O
1	CD	nummod	O
prevents	VBZ	ROOT	O
VEGF	NNP	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	O
permeability	NN	dobj	O
by	IN	prep	O
sequestering	VBG	pcomp	O
Src	NNP	dobj	O
through	IN	prep	O
mDia	NNS	pobj	O
.	.	punct	O
Elevated	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
with	IN	case	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	compound	O
inhibition	NN	nmod	O
may	MD	aux	O
act	VB	ROOT	O
to	TO	mark	O
enhance	VB	xcomp	O
intimal	JJ	amod	B-Pathological_formation
wound	NN	compound	I-Pathological_formation
closure	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
reduce	VB	conj	O
luminal	JJ	amod	B-Immaterial_anatomical_entity
thrombogenicity	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
metabolic	JJ	amod	O
changes	NNS	nmod	O
underlying	VBG	acl	O
growth	NN	compound	O
factor	NN	compound	O
angiogenic	JJ	amod	O
activation	NN	dobj	O
:	:	punct	O
identification	NN	dep	O
of	IN	case	O
new	JJ	amod	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
.	.	punct	O
Cell	NN	nmod:npmod	B-Cell
type	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
nonischemic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
by	IN	case	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ischemia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
.	.	punct	O
Understanding	VBG	csubj	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
regulating	VBG	acl	O
angiogenesis	NN	dobj	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
ischemic	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
oxygen	NN	compound	O
tension	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
VEGF	NN	compound	O
production	NN	dobj	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
hypoxia	NN	compound	O
inducible	JJ	amod	O
factor	NN	compound	O
1	CD	nummod	O
alpha	NN	compound	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1alpha	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O
Hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
activates	VBZ	ROOT	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
hypoxic	JJ	amod	B-Tissue
/	SYM	punct	O
ischemic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

Reduced	VBN	amod	O
oxygen	NN	compound	O
tension	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
VEGF	NN	compound	O
production	NN	dobj	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
hypoxia	NN	compound	O
inducible	JJ	amod	O
factor	NN	compound	O
1	CD	nummod	O
alpha	NN	compound	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1alpha	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	O
cultures	NNS	nmod	O
of	IN	case	O
cardiac	JJ	nmod	B-Cell
and	CC	cc	O
vascular	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
to	TO	case	O
hypoxia	NN	nmod	O
or	CC	cc	O
AdCA5	NN	conj	B-Organism
,	,	punct	O
an	DT	det	O
adenovirus	NN	appos	O
encoding	VBG	acl	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
modulates	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
angiopoietin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
ANGPT1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
ANGPT2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
placental	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
platelet	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
JNK1	NN	nmod	O
or	CC	cc	O
p38	NN	conj	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
expression	NN	dobj	O
.	.	punct	O
Loss	NNP	compound	O
-	HYPH	punct	O
of	IN	amod	O
-	HYPH	punct	O
function	NN	dep	O
effects	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
HIF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	O
null	NN	amod	O
embryonic	JJ	amod	O
stem	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

With	IN	case	O
regard	NN	dep	O
to	TO	case	O
differentiation	NN	nmod	O
,	,	punct	O
hypoxic	JJ	amod	O
cells	NNS	nsubj	O
lost	VBD	ROOT	O
their	PRP$	nmod:poss	O
neuronal	JJ	amod	O
/	SYM	punct	O
neuroendocrine	JJ	dep	O
features	NNS	dobj	O
and	CC	cc	O
gained	VBD	conj	O
marker	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
,	,	punct	O
neural	JJ	dep	O
crest	NN	dep	O
-	HYPH	punct	O
like	IN	dep	O
phenotype	NN	nmod	O
.	.	punct	O
Depending	VBG	case	O
on	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
type	NN	nmod	O
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
ANGPT1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ANGPT2	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
either	CC	cc:preconj	O
activated	VBN	ROOT	O
or	CC	cc	O
repressed	VBN	conj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
hypoxia	NN	nmod	O
or	CC	cc	O
AdCA5	NN	conj	B-Organism
.	.	punct	O

Low	JJ	amod	O
glucose	NN	nsubj	O
potentiated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O
In	IN	prep	O
all	DT	det	O
cases	NNS	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
complete	JJ	amod	O
concordance	NN	nsubj	O
between	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
of	IN	case	O
hypoxia	NN	nmod	O
and	CC	cc	O
AdCA5	NN	conj	B-Organism
.	.	punct	O

Two	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	prep	O
injection	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
histological	JJ	amod	O
evidence	NN	nsubj	O
of	IN	case	O
neovascularization	NN	nmod	O
in	IN	case	O
the	DT	det	O
tissues	NNS	nmod	O
surrounding	VBG	acl	O
the	DT	det	O
Matrigel	NNP	dobj	O
containing	VBG	acl	O
AdCMV	NN	dobj	O
.	.	punct	O
VEGF165	NN	nsubjpass	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
significant	JJ	amod	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
AdCMV	NN	nmod	O
.	.	punct	O
beta	NN	compound	O
gal	NN	ROOT	O
.	.	punct	O
Injection	NN	nsubj	O
of	IN	case	O
AdCA5	NN	nmod	B-Organism
into	IN	case	O
mouse	NN	compound	B-Organism
eyes	NNS	nmod	B-Organ
induced	VBD	ROOT	O
neovascularization	NN	dobj	O
in	IN	case	O
multiple	JJ	amod	O
capillary	JJ	amod	B-Multi-tissue_structure
beds	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
not	RB	neg	O
responsive	JJ	amod	O
to	TO	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
VEGF	NN	compound	O
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	O
retinal	JJ	amod	O
VEGF	NN	compound	O
transcripts	NNS	nmod	O
.	.	punct	O
Analysis	NN	nsubj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
revealed	VBD	ROOT	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
ANGPT1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
ANGPT2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
platelet	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B	NN	conj	I-Gene_or_gene_product
,	,	punct	O
placental	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	conj	O
in	IN	case	O
AdCA5	NN	compound	B-Organism
-	HYPH	punct	O
injected	VBN	amod	O
eyes	NNS	nmod	B-Organ
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
JNK1	NN	nmod	O
or	CC	cc	O
p38	NN	conj	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
expression	NN	dobj	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
HIF	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
master	NN	amod	O
regulator	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	mark	O
controlling	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
adenovirus	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
is	VBZ	cop	O
sufficient	JJ	conj	O
to	TO	mark	O
induce	VB	xcomp	O
angiogenesis	NN	dobj	O
in	IN	case	O
nonischemic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
of	IN	case	O
an	DT	det	O
adult	JJ	amod	O
animal	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
phVEGF121	NN	nmod	O
,	,	punct	O
phVEGF165	NN	conj	O
,	,	punct	O
and	CC	cc	O
phVEGF189	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
these	DT	det	O
isoforms	NNS	nsubj	O
are	VBP	cop	O
biologically	RB	advmod	O
equivalent	JJ	ccomp	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
.	.	punct	O
Differential	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
by	IN	case	O
angiotensin	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
mitogen	NN	ROOT	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
exclusively	RB	advmod	O
on	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Angiotensin	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ANG	NN	appos	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
blood	NN	compound	B-Organism_substance
pressure	NN	nmod	O
and	CC	cc	O
body	NN	compound	B-Organism_substance
fluid	NN	compound	I-Organism_substance
homeostasis	NN	conj	O
,	,	punct	O
exerts	VBZ	ROOT	O
mitogenic	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
,	,	punct	O
Ang	NN	compound	O
-	,	punct	O
2	CD	nummod	O
also	RB	advmod	O
promotes	VBZ	ROOT	O
rapid	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
capillary	JJ	amod	O
diameter	NN	nmod	O
,	,	punct	O
remodeling	NN	advcl	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	O
lamina	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
stimulates	VBZ	conj	O
sprouting	NN	dobj	O
of	IN	prep	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	pobj	O
.	.	punct	O
We	PRP	nsubj	O
therefore	RB	advmod	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
ANG	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
mediator	NN	ccomp	O
between	IN	case	O
homeostatic	JJ	amod	O
changes	NNS	nmod	O
within	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
perfusion	NN	nmod	I-Multi-tissue_structure
bed	NN	dep	I-Multi-tissue_structure
and	CC	cc	O
growth	NN	compound	O
factor	NN	conj	O
-	:	punct	O
driven	VBN	amod	O
angiogenesis	NN	conj	O
.	.	punct	O

Anagen	NNP	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nsubj	O
offers	VBZ	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
the	DT	det	O
physiologic	JJ	amod	O
controls	NNS	dobj	O
of	IN	case	O
cutaneous	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
interesting	JJ	amod	O
system	NN	conj	O
for	IN	mark	O
screening	VBG	acl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
potential	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
applied	VBD	ROOT	O
the	DT	det	O
alginate	JJ	compound	B-Simple_chemical
implant	JJ	amod	O
angiogenesis	NN	compound	O
model	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
with	IN	case	O
normal	JJ	amod	O
ANG	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
,	,	punct	O
elevated	JJ	amod	O
ANG	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
levels	NNS	conj	O
by	IN	case	O
transgenic	JJ	amod	O
overexpression	NN	nmod	O
of	IN	case	O
angiotensinogen	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
AOGEN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
in	IN	case	O
AT2	NN	nmod:npmod	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	conj	B-Organism
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
Angiopoietin	NN	conj	O
1	CD	nummod	O
(	-LRB-	punct	O
Ang1	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
both	CC	cc:preconj	O
potent	JJ	amod	O
proangiogenic	JJ	amod	O
factors	NNS	ROOT	O
,	,	punct	O
but	CC	cc	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	nsubj	O
causes	VBZ	acl:relcl	O
vascular	JJ	amod	O
permeability	NN	dobj	O
,	,	punct	O
Ang1	NN	nsubj	O
stabilizes	VBZ	acl:relcl	O
blood	NN	compound	O
vessels	NNS	dobj	O
and	CC	cc	O
protects	VBZ	conj	O
them	PRP	dobj	O
from	IN	case	O
VEGF	NNP	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
plasma	NN	compound	O
leakage	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
circulating	VBG	amod	O
ANG	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
the	DT	det	O
angiotensin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
converting	NN	compound	I-Gene_or_gene_product
enzyme	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
ACE	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitor	NN	compound	O
enalapril	NN	nmod	B-Simple_chemical
or	CC	cc	O
the	DT	det	O
AT1	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
antagonist	NN	compound	O
losartan	NN	conj	B-Simple_chemical
induced	VBD	ccomp	O
a	DT	det	O
stimulation	NN	dobj	O
of	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
implying	VBG	acl	O
an	DT	det	O
inhibitory	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
ANG	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
through	IN	case	O
the	DT	det	O
AT1	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Anagen	NNP	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	nsubj	O
offers	VBZ	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
model	NN	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
the	DT	det	O
physiologic	JJ	amod	O
controls	NNS	dobj	O
of	IN	case	O
cutaneous	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
interesting	JJ	amod	O
system	NN	conj	O
for	IN	mark	O
screening	VBG	acl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
potential	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
strong	JJ	amod	O
increase	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
AOGEN	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
compared	VBN	case	O
with	IN	case	O
mice	NNS	nmod	B-Organism
with	IN	case	O
normal	JJ	amod	O
ANG	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
suggests	VBZ	ROOT	O
additional	JJ	amod	O
stimulatory	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
,	,	punct	O
Ang	NN	compound	O
-	,	punct	O
2	CD	nummod	O
also	RB	advmod	O
promotes	VBZ	ROOT	O
rapid	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
capillary	JJ	amod	O
diameter	NN	nmod	O
,	,	punct	O
remodeling	NN	advcl	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	O
lamina	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
stimulates	VBZ	conj	O
sprouting	NN	dobj	O
of	IN	prep	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	pobj	O
.	.	punct	O
We	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
ANG	NN	nmod:npmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
stimulation	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
the	DT	det	O
AT2	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
impaired	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
was	VBD	auxpass	O
obtained	VBN	ccomp	O
in	IN	case	O
AT2	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
knockout	JJ	compound	O
mice	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
,	,	punct	O
Ang	NN	compound	O
-	,	punct	O
2	CD	nummod	O
also	RB	advmod	O
promotes	VBZ	ROOT	O
rapid	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
capillary	JJ	amod	O
diameter	NN	nmod	O
,	,	punct	O
remodeling	NN	advcl	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	O
lamina	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
stimulates	VBZ	conj	O
sprouting	NN	dobj	O
of	IN	prep	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	pobj	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
provide	VBP	ROOT	O
the	DT	det	O
first	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
AT2	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
mediates	VBZ	ccomp	O
a	DT	det	O
stimulation	NN	dobj	O
of	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
and	CC	cc	O
indicate	VBP	conj	O
that	IN	mark	O
ANG	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
humoral	JJ	amod	O
regulator	NN	ccomp	O
of	IN	case	O
peripheral	JJ	amod	O
angiogenesis	NN	nmod	O
involving	VBG	acl	O
two	CD	nummod	O
receptor	NN	compound	O
subtypes	NNS	dobj	O
with	IN	case	O
opposing	JJ	amod	O
actions	NNS	nmod	O
.	.	punct	O

Activated	VBN	amod	O
platelets	NNS	nsubj	O
enhance	VBP	ROOT	O
ovarian	JJ	amod	O
cancer	NN	compound	O
cell	NN	compound	O
invasion	NN	dobj	O
in	IN	case	O
a	DT	det	O
cellular	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Insulin	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	prep	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
invasion	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
resistance	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
Bcl	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
lactoferrin	NN	nsubj	O
enhances	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
family	NN	nmod	O
,	,	punct	O
Fas	NN	appos	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	O
mucosa	NN	nmod	O
during	IN	case	O
both	CC	cc:preconj	O
early	JJ	amod	O
and	CC	cc	O
late	JJ	conj	O
stages	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O
Colon	NN	compound	B-Cancer
cancer	NN	nsubj	I-Cancer
overexpresses	VBZ	ROOT	O
insulin	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
insulin	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	nmod	O
or	CC	cc	O
adenomatous	JJ	conj	B-Multi-tissue_structure
mucosa	NN	dep	I-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
postulated	VBN	conj	O
that	IN	mark	O
colorectal	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
depend	VBP	ccomp	O
on	IN	case	O
the	DT	det	O
IGF1	NN	compound	B-Gene_or_gene_product
/	:	punct	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
pathway	NN	nmod	O
for	IN	case	O
their	PRP$	nmod:poss	O
growth	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IGF	NNP	nmod	O
-	SYM	punct	O
1	CD	nummod	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
principally	RB	advmod	O
through	IN	case	O
the	DT	det	O
IGF	NNP	compound	O
-	HYPH	punct	O
1R	NN	nmod	O
but	CC	cc	O
are	VBP	auxpass	O
modulated	VBN	conj	O
by	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
multiple	JJ	amod	O
IGF	NN	compound	O
binding	NN	compound	O
proteins	NNS	nmod	O
that	WDT	mark	O
themselves	PRP	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
,	,	punct	O
proteolysis	NN	conj	O
,	,	punct	O
polymerization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	O
or	CC	cc	O
matrix	NN	conj	O
association	NN	conj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
HCT116	NN	dobj	I-Cell
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
established	JJ	amod	O
HCT116	NN	compound	O
/	:	punct	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
transfectants	NNS	nsubj	O
exhibit	VBP	ccomp	O
a	DT	det	O
more	RBR	advmod	O
aggressive	JJ	amod	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
their	PRP$	nmod:poss	O
higher	JJR	amod	O
proliferation	NN	compound	O
rate	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
IGF1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
higher	JJR	amod	O
degree	NN	conj	O
of	IN	case	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	nmod	O
,	,	punct	O
resistance	NN	dobj	O
to	TO	case	O
serum	NN	compound	B-Organism_substance
deprivation	NN	npadvmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
higher	JJR	amod	O
migratory	JJ	amod	O
capability	NN	conj	O
in	IN	case	O
a	DT	det	O
monolayer	JJ	nmod	B-Cell
"	``	punct	O
wounding	JJ	amod	O
assay	NN	dep	O
.	.	punct	O
"	''	ROOT	O
When	WRB	advmod	O
injected	VBN	advcl	O
into	IN	prep	O
nude	JJ	amod	B-Organism
mice	NNS	pobj	I-Organism
,	,	punct	O
HCT116	NN	compound	O
/	:	punct	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	compound	I-Gene_or_gene_product
transfectants	NNS	nsubj	O
were	VBD	cop	O
highly	RB	advmod	O
invasive	JJ	ROOT	O
and	CC	cc	O
produced	VBN	conj	O
distant	JJ	amod	O
metastases	NNS	dobj	B-Cancer
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
parental	JJ	amod	B-Cell
cell	NN	nsubj	I-Cell
did	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

Changes	NNS	nsubjpass	O
in	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	compound	O
(	-LRB-	punct	O
L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cFLIPs	NN	conj	O
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
some	DT	intj	O
but	CC	cc	O
not	RB	cc	O
all	PDT	det:predet	O
the	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
studied	VBN	acl	O
following	VBG	case	O
glucose	NN	compound	O
deprivation	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
overexpression	NN	nsubjpass	O
of	IN	case	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
IGF1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
Akt	NNP	compound	B-Gene_or_gene_product
and	CC	cc	O
up	RB	conj	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	O
protein	NN	compound	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	O
in	IN	case	O
allograft	NN	compound	O
tumors	NNS	nmod	O
specifically	RB	advmod	O
AKT2	NN	dobj	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
Akt	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubj	O
mediates	VBZ	ccomp	O
IGF1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBD	amod	O
Bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
expression	NN	dobj	O
at	IN	case	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	O
in	IN	case	O
allograft	NN	compound	O
tumors	NNS	nmod	O
specifically	RB	advmod	O
AKT2	NN	dobj	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
,	,	punct	O
that	IN	mark	O
IGF1	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NNP	compound	I-Gene_or_gene_product
/	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
Bcl	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nummod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
pathway	NN	nsubj	O
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
a	DT	det	O
more	RBR	advmod	O
aggressive	JJ	amod	O
malignant	JJ	amod	O
phenotype	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
Expression	NN	ROOT	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
correlation	NN	dep	O
with	IN	case	O
cancer	NN	compound	B-Cancer
metastasis	NN	nmod	O
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
overexpression	NN	nsubjpass	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
Eph	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
biomarkers	VBZ	nsubjpass	O
that	WDT	nsubj	O
specifically	RB	advmod	O
correlate	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
phenotypes	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O
Reduced	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
intercellular	JJ	amod	B-Immaterial_anatomical_entity
adhesion	NN	compound	O
molecule	NN	appos	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
aggressive	JJ	amod	O
clinicopathological	JJ	amod	O
phenotypes	NNS	nmod	O
in	IN	case	O
various	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
In	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
EphA2	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
co	NN	compound	O
-	HYPH	punct	O
localize	VB	ROOT	O
to	TO	case	O
sites	NNS	nmod	O
of	IN	case	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
cell	NN	compound	I-Cellular_component
contact	NN	nmod	I-Cellular_component
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	conj	O
that	IN	mark	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nsubj	I-Gene_or_gene_product
regulates	VBZ	ccomp	O
EphA2	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
This	DT	det	O
study	NN	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
clarify	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	dep	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
proteins	NNS	dep	O
and	CC	cc	O
clinicopathological	JJ	amod	O
characteristics	NNS	conj	O
,	,	punct	O
with	IN	case	O
reference	NN	nmod	O
to	TO	case	O
the	DT	det	O
expression	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
performed	VBD	ROOT	O
immunohistochemical	JJ	amod	O
staining	NN	dobj	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
with	IN	case	O
EphA2	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
monoclonal	JJ	amod	O
antibodies	NNS	nmod	O
in	IN	case	O
samples	NNS	nmod	O
from	IN	case	O
194	CD	nummod	O
primary	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
expression	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
had	VBD	ROOT	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
relationship	NN	dobj	O
with	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
,	,	punct	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
and	CC	cc	O
clinical	JJ	amod	O
stage	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0477	CD	dobj	O
,	,	punct	O
0	CD	dobj	O
.	.	punct	O
0316	CD	dobj	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
0467	CD	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
positivity	NN	compound	O
rate	NN	nsubj	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
primary	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
without	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
0014	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
had	VBD	ROOT	O
an	DT	det	O
inverse	JJ	amod	O
relationship	NN	dobj	O
with	IN	case	O
both	CC	det	O
differentiation	NN	compound	O
level	NN	nmod	O
of	IN	case	O
the	DT	dep	O
tumor	NN	nmod	B-Cancer
and	CC	cc	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
invasion	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0430	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
0320	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
relationship	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
EphA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Some	DT	det	O
human	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
overexpress	VB	xcomp	O
eph	NN	amod	O
mRNAs	NNS	dobj	O
without	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
study	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
EphA2	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Tissue
carcinoma	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
correlates	VBZ	ccomp	O
closely	RB	advmod	O
with	IN	case	O
cancer	NN	compound	B-Cancer
progression	NN	nmod	O
and	CC	cc	O
hematogenous	JJ	amod	O
and	CC	cc	O
lymphogenous	JJ	conj	O
metastasis	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
both	CC	cc:preconj	O
EphA2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	conj	I-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
metastasis	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
sensitization	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
occur	VB	ROOT	O
when	WRB	advmod	O
T251	NN	compound	O
-	:	punct	O
708	CD	nsubjpass	O
was	VBD	auxpass	O
targeted	VBN	advcl	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
by	IN	case	O
inclusion	NN	nmod	O
of	IN	case	O
the	DT	det	O
SV40	NN	compound	O
nuclear	JJ	amod	O
localization	NN	compound	O
signal	NN	nmod	O
.	.	punct	O
Nuclear	JJ	amod	B-Cellular_component
translocation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
clusterin	NN	compound	B-Gene_or_gene_product
isoform	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
anoikis	NN	nmod	O
in	IN	case	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
immortalized	VBN	amod	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
opticin	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
this	DT	det	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	prep	O
and	CC	cc	O
could	MD	aux	O
contribute	VB	conj	O
towards	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Clusterin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
potently	RB	advmod	O
induced	VBN	ROOT	O
in	IN	case	O
experimental	JJ	amod	O
models	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
apoptosis	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
rat	NN	compound	B-Organism
prostate	NN	compound	B-Organ
involution	NN	nmod	O
following	VBG	case	O
castration	NN	nmod	O
.	.	punct	O

Brn	RB	compound	O
-	HYPH	punct	O
3a	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
POU	NN	compound	O
gene	NN	compound	O
family	NN	nmod	O
(	-LRB-	punct	O
so	RB	advmod	O
-	HYPH	punct	O
called	VBN	dep	O
because	IN	prep	O
of	IN	pcomp	O
the	DT	det	O
similarity	NN	pobj	O
with	IN	case	O
the	DT	det	O
group	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
Pit	VBP	dep	O
,	,	punct	O
Oct	NN	conj	O
,	,	punct	O
and	CC	cc	O
Unc	NNP	conj	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
neuronal	JJ	amod	O
cells	NNS	nmod	O
engaged	VBN	acl	O
in	IN	case	O
the	DT	det	O
transcription	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
p1	NN	compound	O
and	CC	cc	O
p2	NN	conj	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
powerful	JJ	amod	O
antiapoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
Bcl	NN	npadvmod	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
Nevertheless	RB	advmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
precise	JJ	amod	O
physiological	JJ	amod	O
role	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
yet	RB	advmod	O
been	VBN	auxpass	O
established	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
both	DT	cc:preconj	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
and	CC	cc	O
pro	NN	conj	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
functions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	conj	O
for	IN	case	O
this	DT	det	O
gene	NN	nmod	O
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
opticin	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
this	DT	det	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	prep	O
and	CC	cc	O
could	MD	aux	O
contribute	VB	conj	O
towards	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Clusterin	NN	compound	B-Gene_or_gene_product
expression	NN	compound	O
level	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	compound	O
state	NN	nmod	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
recently	RB	advmod	O
showed	VBD	conj	O
that	IN	mark	O
its	PRP$	nmod:poss	O
over	RP	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
inhibited	VBD	ccomp	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	dobj	O
of	IN	case	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
immortalized	VBN	amod	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
PNT2	NN	dep	I-Cell
and	CC	cc	O
PNT1a	NN	conj	B-Cell
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
opticin	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
this	DT	det	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	prep	O
and	CC	cc	O
could	MD	aux	O
contribute	VB	conj	O
towards	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
clusterin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
PNT1a	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
subjected	VBN	acl	O
to	TO	case	O
serum	NN	compound	B-Organism_substance
-	HYPH	punct	O
starvation	NN	nmod	O
with	IN	case	O
the	DT	det	O
aim	NN	nmod	O
of	IN	mark	O
defining	VBG	acl	O
clusterin	NN	compound	B-Gene_or_gene_product
early	JJ	amod	O
molecular	JJ	amod	O
changes	NNS	dobj	O
following	VBG	case	O
apoptosis	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

With	IN	case	O
U937	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
tunicamycin	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O
Under	IN	case	O
serum	NN	compound	B-Organism_substance
-	HYPH	punct	O
starvation	NN	compound	O
conditions	NNS	nsubjpass	O
,	,	punct	O
decreased	VBD	amod	O
growth	NN	compound	O
rate	NN	conj	O
,	,	punct	O
slow	JJ	amod	O
rounding	VBG	amod	O
-	HYPH	punct	O
up	NN	appos	O
of	IN	case	O
cells	NNS	nmod	B-Cell
,	,	punct	O
cell	NN	compound	B-Cell
detachment	NN	conj	O
,	,	punct	O
and	CC	cc	O
formation	NN	conj	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
indicative	JJ	amod	O
of	IN	case	O
anoikis	NN	compound	O
(	-LRB-	punct	O
detachment	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
)	-RRB-	punct	O
were	VBD	auxpass	O
preceded	VBN	ROOT	O
by	IN	case	O
significant	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
70	CD	nummod	O
kDa	NN	compound	O
clusterin	NN	compound	B-Gene_or_gene_product
precursor	NN	nmod	O
and	CC	cc	O
upregulation	NN	conj	O
of	IN	case	O
45	CD	compound	O
-	SYM	punct	O
40	CD	nummod	O
kDa	NN	compound	O
isoforms	NNS	nmod	O
.	.	punct	O

With	IN	case	O
U937	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
tunicamycin	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O
On	IN	prep	O
the	DT	det	O
8th	JJ	amod	O
day	NN	pobj	O
of	IN	prep	O
serum	NN	npadvmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
culturing	NN	pobj	O
,	,	punct	O
only	RB	advmod	O
the	DT	det	O
higher	JJR	amod	O
molecular	JJ	amod	O
weight	NN	compound	O
protein	NN	compound	O
-	HYPH	punct	O
band	NN	nsubjpass	O
of	IN	case	O
about	RB	advmod	O
45	CD	nummod	O
kDa	NN	nmod	O
was	VBD	auxpass	O
clearly	RB	advmod	O
induced	VBN	ROOT	O
and	CC	cc	O
accumulated	VBN	conj	O
in	IN	case	O
detached	VBN	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	conj	I-Cellular_component
in	IN	case	O
which	WDT	nmod	O
PARP	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
activated	VBN	acl:relcl	O
.	.	punct	O

With	IN	case	O
U937	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
tunicamycin	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O
Anoikis	NNP	nsubjpass	O
was	VBD	auxpass	O
preceded	VBN	ROOT	O
by	IN	case	O
induction	NN	nmod	O
and	CC	cc	O
transloction	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
clusterin	NN	compound	B-Gene_or_gene_product
isoform	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
.	.	punct	O

With	IN	case	O
U937	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
tunicamycin	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
nuclear	JJ	amod	B-Cellular_component
targeting	NN	nsubj	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	O
45	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
isoform	NN	nmod	O
of	IN	case	O
clusterin	NN	nmod	B-Gene_or_gene_product
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
early	JJ	amod	O
and	CC	cc	O
specific	JJ	conj	O
molecular	JJ	amod	O
signal	NN	compound	O
triggering	VBG	compound	O
anoikis	IN	compound	O
-	HYPH	punct	O
death	NN	xcomp	O
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
opticin	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
this	DT	det	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	prep	O
and	CC	cc	O
could	MD	aux	O
contribute	VB	conj	O
towards	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Considering	VBG	advcl	O
also	RB	advmod	O
that	IN	mark	O
clusterin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
downregulated	VBN	advcl	O
during	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
onset	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
its	PRP$	nmod:poss	O
upregulation	NN	nsubj	O
has	VBZ	aux	O
inhibited	VBN	conj	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	conj	O
of	IN	case	O
immortalized	VBN	amod	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
clusterin	NN	nsubj	B-Gene_or_gene_product
might	MD	aux	O
be	VB	cop	O
a	DT	det	O
new	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
oncogene	NN	ccomp	O
in	IN	case	O
the	DT	det	O
prostate	NN	nmod	B-Organ
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	O
/	:	punct	O
CYR61	NN	compound	O
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	O
-	:	punct	O
A	NN	compound	O
and	CC	cc	O
CREB	NN	compound	O
-	:	punct	O
binding	NN	conj	O
protein	NN	compound	O
histone	NN	compound	O
acetyltransferase	NN	nmod	O
.	.	punct	O
Levels	NNS	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
CYR61	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
are	VBP	cop	O
prognostic	JJ	ROOT	O
for	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
individuals	NNS	nmod	B-Organism
with	IN	case	O
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	O
/	:	punct	O
CYR61	NN	compound	O
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	O
-	:	punct	O
A	NN	compound	O
and	CC	cc	O
CREB	NN	compound	O
-	:	punct	O
binding	NN	conj	O
protein	NN	compound	O
histone	NN	compound	O
acetyltransferase	NN	nmod	O
.	.	punct	O
The	DT	det	O
biological	JJ	amod	O
properties	NNS	nsubj	O
of	IN	case	O
CCN	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
include	VBP	ROOT	O
stimulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
adhesion	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
angiogenesis	NN	conj	O
and	CC	cc	O
tumorigenesis	NN	conj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
quantified	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
MCT	NN	compound	O
isoforms	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
glioblastoma	NN	compound	O
multiforme	NN	nmod	O
and	CC	cc	O
glioma	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
cells	NNS	compound	O
lines	NNS	conj	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
quantified	VBD	ROOT	O
CYR61	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
CTGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
WISP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
NOV	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
expression	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
samples	NNS	nmod	B-Cancer
from	IN	case	O
sixty	CD	compound	O
-	HYPH	punct	O
six	CD	nummod	O
primary	JJ	amod	O
gliomas	NNS	nmod	B-Cancer
and	CC	cc	O
five	CD	nummod	O
normal	JJ	amod	O
brain	NN	compound	B-Multi-tissue_structure
samples	NNS	conj	I-Multi-tissue_structure
using	VBG	xcomp	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
hypermethylation	NN	compound	O
status	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
and	CC	cc	O
12q13	NN	conj	O
.	.	punct	O
1	CD	nummod	O
loss	NN	ROOT	O
of	IN	case	O
heterozygosity	NN	nmod	O
in	IN	case	O
31	CD	nummod	O
PCNSLs	NNS	nmod	O
.	.	punct	O
Statistical	JJ	amod	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
links	NNS	dobj	O
between	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
CCN	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
parameters	NNS	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MCT	NN	nsubj	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
were	VBD	cop	O
the	DT	det	O
primary	JJ	amod	O
isoforms	NNS	dep	O
expressed	VBN	acl	O
in	IN	case	O
human	JJ	amod	O
glioblastoma	NN	compound	O
multiforme	NN	amod	O
and	CC	cc	O
glioma	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
Overexpression	NN	nsubj	O
of	IN	case	O
CYR61	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
CTGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
WISP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
NOV	NN	conj	B-Gene_or_gene_product
occurred	VBD	ROOT	O
in	IN	case	O
48	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
32	CD	dep	O
of	IN	advmod	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
58	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
38	CD	appos	O
of	IN	case	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
36	CD	nummod	O
%	NN	appos	O
(	-LRB-	punct	O
24	CD	appos	O
of	IN	advmod	O
66	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
15	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
10	CD	compound	O
of	IN	case	O
66	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
primary	JJ	amod	O
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	O
/	:	punct	O
CYR61	NN	compound	O
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	O
-	:	punct	O
A	NN	compound	O
and	CC	cc	O
CREB	NN	compound	O
-	:	punct	O
binding	NN	conj	O
protein	NN	compound	O
histone	NN	compound	O
acetyltransferase	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
significant	JJ	amod	O
associations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
CYR61	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
versus	CC	cc	O
tumor	NN	compound	B-Cancer
grade	NN	conj	O
,	,	punct	O
pathology	NN	conj	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
and	CC	cc	O
age	NN	conj	O
at	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

Increases	NNS	nsubj	O
in	IN	case	O
these	DT	det	O
mRNA	NN	compound	O
levels	NNS	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
low	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
Also	RB	advmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
existed	VBD	ROOT	O
between	IN	case	O
CTGF	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
versus	CC	cc	O
tumor	NN	compound	B-Cancer
grade	NN	conj	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
and	CC	cc	O
pathology	NN	conj	O
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
CYR61	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
no	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
expression	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
WISP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
or	CC	cc	O
NOV	NN	conj	B-Gene_or_gene_product
versus	CC	cc	O
any	DT	conj	O
of	IN	case	O
the	DT	det	O
pathological	JJ	amod	O
features	NNS	nmod	O
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	O
/	:	punct	O
CYR61	NN	compound	O
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	O
-	:	punct	O
A	NN	compound	O
and	CC	cc	O
CREB	NN	compound	O
-	:	punct	O
binding	NN	conj	O
protein	NN	compound	O
histone	NN	compound	O
acetyltransferase	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
Cox	NN	compound	O
regression	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
CYR61	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
expression	NN	nsubj	O
had	VBD	ccomp	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
patient	NN	compound	B-Organism
survival	NN	nmod	O
.	.	punct	O

Mechanical	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factor	NN	compound	O
CCN1	NN	nmod	O
/	:	punct	O
CYR61	NN	compound	O
gene	NN	conj	O
requires	VBZ	ROOT	O
the	DT	det	O
combined	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
MRTF	NN	compound	O
-	:	punct	O
A	NN	compound	O
and	CC	cc	O
CREB	NN	compound	O
-	:	punct	O
binding	NN	conj	O
protein	NN	compound	O
histone	NN	compound	O
acetyltransferase	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CYR61	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
CTGF	NN	conj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
gliomas	NNS	nmod	B-Cancer
;	:	punct	O
their	PRP$	nmod:poss	O
levels	NNS	nsubj	O
at	IN	case	O
diagnosis	NN	nmod	O
may	MD	aux	O
have	VB	parataxis	O
prognostic	JJ	amod	O
significance	NN	dobj	O
;	:	punct	O
and	CC	cc	O
these	DT	det	O
proteins	NNS	nsubj	O
might	MD	aux	O
serve	VB	conj	O
as	IN	case	O
valuable	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
therapeutic	JJ	amod	O
intervention	NN	nmod	O
.	.	punct	O

SWAP	NNP	compound	O
-	:	punct	O
70	CD	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
by	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
Src	NN	nmod	O
in	IN	case	O
mouse	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
.	.	punct	O
Targeting	VBG	ROOT	O
wide	JJ	amod	O
-	HYPH	punct	O
range	NN	amod	O
oncogenic	JJ	amod	O
transformation	NN	dobj	O
via	IN	case	O
PU24FCl	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
tumor	NN	compound	B-Cancer
Hsp90	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

HSP27	NN	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
protein	NN	compound	O
-	HYPH	punct	O
protein	NN	compound	O
interactions	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
folding	VBG	nmod	O
,	,	punct	O
translocation	NN	conj	O
,	,	punct	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
inappropriate	JJ	amod	O
protein	NN	compound	O
aggregation	NN	nmod	O
.	.	punct	O
Agents	NNS	nsubj	O
that	WDT	nsubj	O
inhibit	VBP	acl:relcl	O
Hsp90	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
hold	VBP	ROOT	O
significant	JJ	amod	O
promise	NN	dobj	O
in	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

HSP27	NN	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
protein	NN	compound	O
-	HYPH	punct	O
protein	NN	compound	O
interactions	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
folding	VBG	nmod	O
,	,	punct	O
translocation	NN	conj	O
,	,	punct	O
and	CC	cc	O
prevention	NN	conj	O
of	IN	case	O
inappropriate	JJ	amod	O
protein	NN	compound	O
aggregation	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
present	VBP	ROOT	O
PU24FCl	NN	dobj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
representative	NN	appos	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
class	NN	nmod	O
of	IN	case	O
designed	VBN	amod	O
Hsp90	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
intraperitoneal	JJ	amod	O
injection	NN	nsubj	O
or	CC	cc	O
oral	JJ	amod	O
administration	NN	conj	O
of	IN	case	O
HTPB	NN	nmod	O
efficiently	RB	advmod	O
inhibited	VBD	ROOT	O
A549	NN	compound	O
xenograft	NN	compound	O
tumor	NN	compound	O
growth	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
without	IN	case	O
side	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O
By	IN	mark	O
specifically	RB	advmod	O
and	CC	advmod	O
potently	RB	advmod	O
inhibiting	VBG	advcl	O
tumor	NN	compound	B-Cancer
Hsp90	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
PU24FCl	NN	nsubj	B-Simple_chemical
exhibits	VBZ	ROOT	O
wide	JJ	amod	O
-	HYPH	punct	O
ranging	VBG	xcomp	O
anti	JJ	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
activities	NNS	dobj	O
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
at	IN	case	O
similar	JJ	amod	O
doses	NNS	nmod	O
in	IN	case	O
all	DT	det	O
tested	VBN	amod	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
OSM	NN	nsubj	O
can	MD	aux	O
also	RB	advmod	O
suppress	VB	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
tumor	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
cell	NN	compound	O
lines	NNS	conj	O
.	.	punct	O
Normal	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
10	CD	nummod	O
-	HYPH	punct	O
to	IN	prep	O
50	CD	nummod	O
-	HYPH	punct	O
fold	VB	nsubj	O
more	RBR	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
these	DT	det	O
effects	NNS	nmod	O
.	.	punct	O

Heat	NN	compound	O
shock	NN	compound	O
protein	NN	nsubj	O
27	CD	nummod	O
(	-LRB-	punct	O
HSP27	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
small	JJ	amod	O
heat	NN	compound	O
shock	NN	compound	O
proteins	NNS	nmod	O
.	.	punct	O
Its	PRP$	nmod:poss	O
Hsp90	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
anti	NN	amod	O
-	HYPH	punct	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	dep	O
effects	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
degradation	NN	nmod	O
of	IN	case	O
Hsp90	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
client	NN	compound	O
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	compound	B-Cell
growth	NN	nmod	O
,	,	punct	O
survival	NN	conj	O
,	,	punct	O
and	CC	cc	O
specific	JJ	amod	O
transformation	NN	conj	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
growth	NN	nmod	O
,	,	punct	O
delay	NN	dep	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	nmod	O
,	,	punct	O
induction	NN	conj	O
of	IN	case	O
morphological	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
changes	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

RAF265	NN	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
FDG	NN	compound	O
accumulation	NN	dobj	O
in	IN	case	O
tumor	NN	nmod	O
xenografts	NNS	advmod	O
after	IN	case	O
1	CD	nummod	O
day	NN	nmod	O
of	IN	case	O
drug	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O
In	IN	case	O
concordance	NN	nmod	O
with	IN	case	O
its	PRP$	nmod:poss	O
higher	JJR	amod	O
affinity	NN	nmod	O
for	IN	case	O
tumor	NN	compound	B-Cancer
Hsp90	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
in	FW	amod	O
vivo	FW	dep	O
PU24FCl	NN	nsubj	B-Simple_chemical
accumulates	VBZ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
while	IN	mark	O
being	VBG	auxpass	O
rapidly	RB	advmod	O
cleared	VBN	advcl	O
from	IN	case	O
normal	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

This	DT	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
based	VBN	ROOT	O
on	IN	case	O
limited	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nmod	O
on	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
transitional	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
of	IN	case	O
the	DT	det	O
bladder	NN	nmod	O
that	WDT	nsubj	O
revealed	VBD	acl:relcl	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
inhibition	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
growth	NN	nmod	O
by	IN	case	O
ciprofloxacin	NN	nmod	O
at	IN	case	O
concentrations	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
easily	RB	advmod	O
attainable	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
urine	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
.	.	punct	O
Concentrations	NNS	nsubj	O
achieved	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
lead	VBP	acl	O
to	TO	case	O
single	JJ	amod	O
-	HYPH	punct	O
agent	NN	compound	O
anti	RB	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activity	NN	nmod	O
at	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
toxic	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
comparative	JJ	amod	O
proteomic	JJ	amod	O
and	CC	cc	O
pathway	NN	conj	O
analysis	NN	dobj	O
of	IN	case	O
four	CD	nummod	O
human	JJ	amod	O
metastatic	JJ	amod	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
to	TO	mark	O
identify	VB	advcl	O
metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	dobj	O
.	.	punct	O
Differential	JJ	amod	O
proteomic	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
metastasis	NN	compound	O
-	:	punct	O
associated	VBN	amod	O
proteins	NNS	nmod	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
comparative	JJ	amod	O
study	NN	appos	O
of	IN	case	O
differentially	JJ	advmod	O
expression	NN	nmod	O
of	IN	case	O
protein	NN	compound	O
profiles	NNS	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
with	IN	case	O
various	JJ	amod	O
metastasic	JJ	amod	O
potential	NN	amod	O
and	CC	cc	O
screening	VBG	conj	O
key	JJ	amod	O
molecules	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
metastasis	NN	nmod	O
and	CC	cc	O
recurrence	NN	conj	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Using	VBG	dep	O
two	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
electrophoresis	NN	dobj	O
and	CC	cc	O
liquid	JJ	amod	O
chromatography	NN	conj	O
-	HYPH	punct	O
electrospray	NN	amod	O
ionization	NN	compound	O
-	HYPH	punct	O
tandem	JJ	amod	O
mass	NN	compound	O
spectrometry	NN	dobj	O
(	-LRB-	punct	O
LC	NN	compound	O
-	HYPH	punct	O
ESI	NNP	compound	O
-	HYPH	punct	O
MS	NNP	dep	O
/	:	punct	O
MS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	parataxis	O
differentially	RB	advmod	O
displayed	VBD	amod	O
proteomics	NNS	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
Hep3B	NN	dep	I-Cell
,	,	punct	O
MHCC97L	NN	conj	B-Cell
,	,	punct	O
MHCC97H	JJ	dobj	B-Cell
with	IN	case	O
different	JJ	amod	O
metastasic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

DESIGN	NN	dep	O
:	:	punct	O
Differentially	RB	advmod	O
expressed	VBN	amod	O
proteins	NNS	nsubjpass	O
discovered	VBN	acl	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	O
lines	NNS	nmod	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
mass	NN	compound	O
spectrometry	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Approximate	NN	compound	O
1	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
protein	NN	compound	O
spots	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	appos	O
on	IN	prep	O
silver	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
stained	JJ	amod	O
gel	NN	pobj	O
by	IN	prep	O
ImageMaster	NNP	pobj	O
(	-LRB-	punct	O
977	CD	intj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
113	CD	nummod	O
spots	NNS	nmod	O
in	IN	case	O
Hep3B	NN	nmod	B-Cell
,	,	punct	O
1092	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
40	CD	dep	O
in	IN	case	O
MHCC97L	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
889	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
14	CD	dep	O
in	IN	case	O
MHCC97H	NN	nmod	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Two	CD	nsubjpass	O
of	IN	case	O
these	DT	det	O
spots	NNS	nmod	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
MALDI	NN	compound	O
-	:	punct	O
MS	NN	compound	O
analysis	NN	nmod	O
as	IN	case	O
proliferating	VBG	amod	O
cell	NN	compound	O
nuclear	JJ	amod	O
antigen	NN	nmod	O
(	-LRB-	punct	O
PCNA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
myeloid	JJ	amod	O
-	HYPH	punct	O
leukemia	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
SET	NN	compound	O
protein	NN	conj	O
.	.	punct	O
Fifty	CD	nummod	O
distinct	JJ	amod	O
different	JJ	amod	O
protein	NN	compound	O
spots	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
online	JJ	compound	O
LC	NN	compound	O
-	HYPH	punct	O
ESI	NNP	compound	O
-	HYPH	punct	O
MS	NNP	compound	O
/	:	punct	O
MS	NNP	nmod	O
.	.	punct	O

This	DT	det	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
total	NN	dobj	O
of	IN	case	O
22	CD	nummod	O
protein	NN	compound	O
-	:	punct	O
spots	NNS	nmod	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
altered	VBN	acl:relcl	O
by	IN	case	O
more	JJR	advmod	O
than	IN	mwe	O
3	CD	nummod	O
-	HYPH	punct	O
folds	NNS	nmod	O
.	.	punct	O
Only	RB	advmod	O
26	CD	nummod	O
protein	NN	compound	O
spots	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
positive	JJ	amod	O
result	NN	dobj	O
,	,	punct	O
including	VBG	case	O
annexin1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
S100A4	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
so	RB	advmod	O
on	RB	advmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
dimensional	JJ	amod	O
electrophoresis	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
-	HYPH	punct	O
DE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
MALDI	NN	compound	O
-	HYPH	punct	O
TOF	NN	compound	O
mass	NN	compound	O
spectrometry	NN	conj	O
,	,	punct	O
a	DT	det	O
total	NN	appos	O
of	IN	case	O
125	CD	nummod	O
proteins	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
post	JJ	nmod:npmod	O
-	HYPH	punct	O
translational	JJ	amod	O
modification	NN	compound	O
forms	NNS	conj	O
or	CC	cc	O
isoforms	NNS	conj	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
differentially	RB	advmod	O
expressed	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
In	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
nonmetastasis	NN	compound	O
Hep3B	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
16	CD	nummod	O
proteins	NNS	nsubj	O
overexpressed	VBN	acl	O
in	IN	case	O
MHCC97H	JJ	nmod	B-Cell
and	CC	cc	O
MHCC97L	NNS	conj	B-Cell
,	,	punct	O
10	CD	nummod	O
proteins	NNS	appos	O
underexpressed	VBN	acl	O
in	IN	case	O
MHCC97H	JJ	nmod	B-Cell
and	CC	cc	O
MHCC97L	NNS	conj	B-Cell
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
annexin	NN	compound	O
II	CD	nummod	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
was	VBD	auxpass	O
positively	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
in	IN	case	O
NPC	NN	nmod	O
.	.	punct	O
Applying	VBG	advcl	O
cell	NN	compound	B-Cell
immunohistochemistry	NN	dobj	O
and	CC	cc	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NNP	conj	O
,	,	punct	O
we	PRP	nsubj	O
further	RB	advmod	O
validated	VBD	ROOT	O
two	CD	nummod	O
interesting	JJ	dobj	O
and	CC	cc	O
different	JJ	conj	O
proteins	NNS	dep	O
,	,	punct	O
annexin1	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
S100A4	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Meanwhile	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	prep	O
HDGF	NN	pobj	O
,	,	punct	O
an	DT	det	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
protein	NN	nsubj	O
and	CC	cc	O
a	DT	det	O
target	NN	conj	O
of	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod	O
,	,	punct	O
induced	VBD	ROOT	O
cell	NN	compound	O
apoptosis	NN	dobj	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
HCC	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
protein	NN	compound	O
profile	NN	nsubj	O
of	IN	case	O
metastatic	JJ	amod	O
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
displayed	VBD	dep	O
obvious	JJ	amod	O
differences	NNS	dobj	O
compared	VBN	case	O
with	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
liver	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
comparative	JJ	amod	O
proteomic	JJ	amod	O
and	CC	cc	O
pathway	NN	conj	O
analysis	NN	dobj	O
of	IN	case	O
four	CD	nummod	O
human	JJ	amod	O
metastatic	JJ	amod	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
to	TO	mark	O
identify	VB	advcl	O
metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	dobj	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
imply	VBP	ROOT	O
that	IN	mark	O
various	JJ	amod	O
different	JJ	amod	O
proteins	NNS	nsubj	O
may	MD	aux	O
lead	VB	ccomp	O
to	TO	case	O
HCC	NN	compound	B-Cancer
metastasis	NN	nmod	O
together	RB	advmod	O
.	.	punct	O

Possible	JJ	amod	O
role	NN	ROOT	O
of	IN	case	O
cyclooxygenase	NN	nmod	O
II	CD	nummod	O
in	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
ovarian	JJ	amod	O
luteal	JJ	amod	O
function	NN	nmod	O
in	IN	case	O
rodents	NNS	nmod	O
.	.	punct	O
Clinical	JJ	amod	O
implication	NN	ROOT	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
peroxisome	NN	compound	B-Gene_or_gene_product
proliferator	NN	compound	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gamma	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
epithelial	JJ	amod	B-Cancer
ovarian	JJ	amod	I-Cancer
tumours	NNS	nmod	I-Cancer
.	.	punct	O

Cyclooxygenase	NN	compound	O
-	HYPH	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
COX	NN	compound	O
-	:	punct	O
2	CD	appos	O
)	-RRB-	punct	O
inhibitors	NNS	nsubj	O
are	VBP	cop	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
agents	NNS	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
have	VBP	acl:relcl	O
potent	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
,	,	punct	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
and	CC	cc	O
analgesic	JJ	conj	O
properties	NNS	dobj	O
yet	RB	advmod	O
do	VBP	aux	O
not	RB	neg	O
affect	VB	ROOT	O
platelet	NN	compound	O
function	NN	dobj	O
in	IN	case	O
the	DT	det	O
manner	NN	nmod	O
of	IN	case	O
traditional	JJ	amod	O
non	JJ	amod	O
-	HYPH	punct	O
steroidal	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
drugs	NNS	nmod	O
.	.	punct	O
Expression	NN	nsubj	O
of	IN	case	O
cyclooxygenase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
COX	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
and	CC	cc	O
peroxisome	NN	compound	B-Gene_or_gene_product
proliferator	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
gamma	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PPARgamma	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
some	DT	det	O
tissues	NNS	nmod	B-Tissue
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
further	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
the	DT	det	O
existing	JJ	amod	O
relationship	NN	nmod	O
between	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
molecules	NNS	nmod	O
and	CC	cc	O
ovarian	JJ	amod	O
cancer	NN	compound	O
progression	NN	conj	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
whether	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
ovarian	JJ	amod	B-Organ
carcinogenesis	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
tumours	NNS	nmod	I-Cancer
and	CC	cc	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
whether	IN	mark	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
controlled	VBN	conj	O
through	IN	case	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
PPARgamma	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
ovarian	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
prostaglandin	NN	compound	O
synthases	NNS	compound	O
cyclooxygenase	NN	nmod	O
(	-LRB-	punct	O
COX	NN	appos	O
)	-RRB-	punct	O
I	CD	dep	O
and	CC	cc	O
COX	NN	compound	O
-	:	punct	O
II	CD	conj	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
progesterone	NN	compound	O
production	NN	conj	O
in	IN	case	O
the	DT	det	O
newly	RB	advmod	O
formed	VBN	amod	O
CL	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
inhibitors	NNS	dobj	O
of	IN	case	O
the	DT	det	O
COX	NN	compound	O
enzymes	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
gonadotropin	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
pseudopregnant	JJ	amod	O
rat	NN	conj	O
as	IN	case	O
a	DT	det	O
model	NN	nmod	O
.	.	punct	O
For	IN	case	O
this	DT	det	O
purpose	NN	nmod	O
,	,	punct	O
the	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
was	VBD	auxpass	O
immunohistochemically	RB	advmod	O
examined	VBN	ROOT	O
in	IN	case	O
71	CD	nummod	O
epithelial	JJ	amod	B-Cancer
ovarian	JJ	amod	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
18	CD	nummod	O
borderline	NN	compound	O
tumours	NNS	appos	B-Cancer
and	CC	cc	O
23	CD	nummod	O
benign	JJ	amod	O
tumours	NNS	conj	B-Cancer
and	CC	cc	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
proteins	NNS	nmod	O
were	VBD	auxpass	O
determined	VBN	conj	O
by	IN	case	O
enzyme	NN	compound	O
immunoassay	NN	nmod	O
in	IN	case	O
four	CD	nummod	O
benign	JJ	amod	O
tumours	NNS	nmod	B-Cancer
,	,	punct	O
three	CD	nummod	O
borderline	NN	compound	O
tumours	NNS	dobj	B-Cancer
and	CC	cc	O
12	CD	nummod	O
carcinomas	NNS	conj	B-Cancer
.	.	punct	O

Increases	NNS	nsubj	O
in	IN	case	O
these	DT	det	O
mRNA	NN	compound	O
levels	NNS	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
low	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
The	DT	det	O
frequency	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
detection	NN	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
and	CC	cc	O
decreased	VBD	conj	O
as	IN	case	O
lesions	NNS	nmod	B-Pathological_formation
progressed	VBN	acl	O
to	TO	case	O
carcinoma	NN	nmod	B-Cancer
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
ligands	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
,	,	punct	O
the	DT	det	O
receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
only	RB	advmod	O
.	.	punct	O
The	DT	det	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
three	CD	nummod	O
borderline	NN	compound	O
tumours	NNS	nmod	B-Cancer
,	,	punct	O
whereas	IN	dep	O
PPARgamma	NN	compound	B-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
them	PRP	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
eight	CD	nmod	O
of	IN	case	O
the	DT	det	O
12	CD	nummod	O
carcinomas	NNS	nmod	B-Cancer
,	,	punct	O
whereas	IN	dep	O
PPARgamma	NN	compound	B-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
only	RB	advmod	O
two	CD	nummod	O
cases	NNS	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
PPARgamma	NN	compound	B-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
eight	CD	nummod	O
carcinomas	NNS	nmod	B-Cancer
in	IN	case	O
which	WDT	nmod	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	acl:relcl	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
PPARgamma	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
COX	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
in	IN	case	O
a	DT	det	O
reciprocal	JJ	amod	O
relationship	NN	ccomp	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
cultured	VBN	amod	O
ovarian	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
Western	NN	compound	O
blot	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
PPARgamma	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
was	VBD	auxpass	O
regulated	VBN	ccomp	O
conversely	RB	advmod	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
stimulation	NN	nmod	O
by	IN	case	O
15	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Delta	NNP	nmod	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
12	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
14	CD	dep	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
PGJ	NN	dep	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
15	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
PGJ	NN	appos	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
PPARgamma	NN	compound	B-Gene_or_gene_product
activator	NN	appos	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
15d	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
PGJ	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
suppressed	VBD	ROOT	O
tumour	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
-	HYPH	punct	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
confirming	VBG	advcl	O
the	DT	det	O
reciprocal	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PPARgamma	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
From	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
PPARgamma	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
might	MD	aux	O
suppress	VB	ccomp	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
via	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
ovarian	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
that	IN	mark	O
low	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
PPARgamma	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
high	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	conj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
tumours	NNS	nmod	I-Cancer
.	.	punct	O

[	-LRB-	punct	O
Effect	NN	ROOT	O
of	IN	case	O
osteopontin	NN	compound	O
silencing	NN	nmod	O
by	IN	case	O
lentivirus	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
delivery	NN	nmod	O
of	IN	case	O
siRNA	NN	nmod	O
on	IN	case	O
glioma	NN	compound	O
cell	NN	compound	O
invasion	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O
Role	NN	ROOT	O
of	IN	case	O
osteopontin	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
adhesion	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
survival	NN	conj	O
and	CC	cc	O
bone	NN	compound	B-Organ
remodeling	NN	conj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
osteopontin	NN	compound	O
silencing	NN	nmod	O
on	IN	case	O
the	DT	det	O
invasion	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
U251	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Osteopontin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
OPN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
secreted	VBN	amod	O
adhesive	JJ	amod	O
glycophosphoprotein	NN	ROOT	O
expressed	VBN	acl	O
by	IN	case	O
several	JJ	amod	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
.	.	punct	O

Parathyroid	JJ	amod	O
hormone	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
protein	NN	nsubj	O
(	-LRB-	punct	O
PTHrP	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
secreted	VBN	amod	O
factor	NN	ROOT	O
expressed	VBN	acl	O
in	IN	case	O
almost	RB	advmod	O
all	DT	amod	O
normal	JJ	amod	O
fetal	JJ	amod	O
and	CC	cc	O
adult	JJ	conj	O
tissues	NNS	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
normally	RB	advmod	O
produced	VBN	ROOT	O
in	IN	case	O
bone	NN	nmod	B-Tissue
,	,	punct	O
teeth	NNS	conj	B-Organ
,	,	punct	O
kidney	NN	conj	B-Organ
and	CC	cc	O
epithelial	JJ	amod	B-Tissue
lining	JJ	compound	I-Tissue
tissues	NNS	conj	I-Tissue
and	CC	cc	O
is	VBZ	auxpass	O
found	VBN	conj	O
in	IN	case	O
plasma	NN	nmod	B-Organism_substance
and	CC	cc	O
breast	NN	compound	B-Organism_substance
milk	NN	conj	I-Organism_substance
.	.	punct	O

Angiogenesis	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
physiologic	JJ	amod	O
and	CC	cc	O
pathologic	JJ	conj	O
events	NNS	nmod	O
including	VBG	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
inflammation	NN	conj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
osteoprotegerin	NN	nsubj	O
(	-LRB-	punct	O
OPG	NN	appos	O
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
osteoclast	JJ	compound	O
development	NN	dobj	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
review	NN	nmod	O
focus	NN	dep	O
will	MD	aux	O
be	VB	cop	O
on	IN	case	O
OPN	NNP	ROOT	B-Gene_or_gene_product
in	IN	case	O
bone	NN	nmod	B-Tissue
and	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	conj	O
in	IN	case	O
adhesion	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
cell	NN	compound	B-Cell
survival	NN	conj	O
.	.	punct	O

OPN	NNP	nsubj	O
promoted	VBD	ROOT	O
EC	NN	compound	O
migration	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
;	:	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	compound	O
induction	NN	nsubjpass	O
of	IN	case	O
alphavbeta3	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
increased	VBN	amod	O
EC	NN	compound	O
migration	NN	nmod	O
toward	IN	case	O
OPN	NNP	nmod	O
.	.	punct	O
These	DT	det	O
aspects	NNS	nsubj	O
of	IN	case	O
OPN	NN	compound	B-Gene_or_gene_product
biology	NN	nmod	O
are	VBP	cop	O
important	JJ	ROOT	O
in	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

L	NNP	compound	O
-	HYPH	punct	O
Carnitine	NNP	compound	O
ameliorates	VBZ	compound	O
methotrexate	NN	advmod	O
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
organ	NN	compound	O
injury	NN	ROOT	O
and	CC	cc	O
inhibits	VBZ	conj	O
leukocyte	NN	compound	O
death	NN	dobj	O
.	.	punct	O
Oxidation	NN	ROOT	O
in	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
Oxygent	JJ	nsubj	O
increases	VBZ	ccomp	O
TET	NN	compound	O
epithelial	JJ	amod	O
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
improves	VBZ	ccomp	O
epithelial	JJ	amod	O
metabolism	NN	dobj	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
impair	VB	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
tends	VBZ	conj	O
to	TO	case	O
slow	VB	amod	O
cartilage	NN	compound	O
tissue	NN	compound	O
formation	NN	nmod	O
.	.	punct	O
Oxygen	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
has	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

Normal	JJ	amod	O
cells	NNS	nsubj	O
mostly	RB	advmod	O
rely	VBP	ROOT	O
on	IN	case	O
mitochondrial	JJ	amod	O
oxidative	JJ	amod	O
phosphorylation	NN	nmod	O
to	TO	mark	O
produce	VB	acl	O
energy	NN	dobj	O
.	.	punct	O
Reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nsubj	I-Simple_chemical
(	-LRB-	punct	O
ROS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
produced	VBN	acl	O
in	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
oxidative	JJ	amod	O
phosphorylation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
by	IN	case	O
activated	VBN	amod	O
phagocytic	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
during	IN	case	O
oxidative	JJ	amod	O
bursts	NNS	nmod	O
,	,	punct	O
exceed	VBP	ROOT	O
the	DT	det	O
physiological	JJ	amod	O
buffering	NN	compound	O
capacity	NN	dobj	O
and	CC	cc	O
result	VB	conj	O
in	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
TNFalpha	NN	nsubj	O
can	MD	aux	O
cause	VB	ccomp	O
DNA	NN	compound	O
damages	NNS	dobj	O
through	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
(	-LRB-	punct	O
ROS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
excessive	JJ	amod	O
production	NN	nsubj	O
of	IN	case	O
ROS	NN	nmod	B-Simple_chemical
can	MD	aux	O
damage	NN	ROOT	O
protein	NN	dobj	O
,	,	punct	O
lipids	NNS	conj	B-Simple_chemical
,	,	punct	O
nucleic	JJ	amod	B-Simple_chemical
acids	NNS	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
matrix	NN	compound	B-Cellular_component
components	NNS	conj	I-Cellular_component
.	.	punct	O

These	DT	det	O
two	CD	nummod	O
transcription	NN	compound	O
factors	NNS	nsubj	O
also	RB	advmod	O
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
fibroblasts	NNS	nmod	O
,	,	punct	O
in	IN	case	O
extracellular	JJ	amod	O
matrix	NN	compound	O
composition	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
cytokine	NN	compound	O
expression	NN	conj	O
.	.	punct	O
They	PRP	nsubj	O
also	RB	advmod	O
serve	VBP	ROOT	O
as	IN	case	O
important	JJ	amod	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signaling	VBG	compound	O
molecules	NNS	nmod	O
that	WDT	nsubj	O
amplify	VBP	acl:relcl	O
the	DT	det	O
synovial	JJ	amod	B-Multi-tissue_structure
inflammatory	JJ	amod	O
-	HYPH	punct	O
proliferative	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Reduced	VBN	amod	O
oxygen	NN	compound	O
tension	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
increase	VB	xcomp	O
VEGF	NN	compound	O
production	NN	dobj	O
by	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
hypoxia	NN	compound	O
inducible	JJ	amod	O
factor	NN	compound	O
1	CD	nummod	O
alpha	NN	compound	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1alpha	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O
Repetitive	JJ	amod	O
cycles	NNS	nsubjpass	O
of	IN	case	O
hypoxia	NN	nmod	O
and	CC	cc	O
reoxygenation	NN	conj	O
associated	VBN	acl	O
with	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
synovial	JJ	amod	B-Multi-tissue_structure
perfusion	NN	nmod	O
are	VBP	auxpass	O
postulated	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
nuclear	JJ	amod	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
kappaB	NN	conj	I-Gene_or_gene_product
,	,	punct	O
two	CD	nummod	O
key	JJ	amod	O
transcription	NN	compound	O
factors	NNS	appos	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
oxygenation	NN	nmod	O
and	CC	cc	O
cytokine	NN	compound	O
stimulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
in	IN	case	O
turn	NN	nmod	O
orchestrate	VBP	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
spectrum	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
critical	JJ	amod	O
to	TO	case	O
the	DT	det	O
persistence	NN	nmod	O
of	IN	case	O
synovitis	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	advcl	O
that	IN	mark	O
such	JJ	amod	O
inhibition	NN	nsubj	O
stems	VBZ	ccomp	O
from	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
of	IN	case	O
immune	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
production	NN	conj	O
of	IN	case	O
IFN	NN	compound	O
-	:	punct	O
gamma	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
downstream	JJ	amod	O
angiostatic	JJ	amod	O
chemokines	NNS	conj	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
involved	VBN	acl	O
are	VBP	auxpass	O
still	RB	advmod	O
poorly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O
An	DT	det	O
understanding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
complex	JJ	amod	O
interactions	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
might	MD	aux	O
allow	VB	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
strategies	NNS	nmod	O
for	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

In	IN	case	O
cervical	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
paclitaxel	NN	nsubj	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
through	IN	case	O
an	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
with	IN	case	O
prior	JJ	amod	O
G2	NN	dep	O
/	:	punct	O
M	NN	dep	O
arrest	NN	nmod	O
.	.	punct	O
Glucocorticoid	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MPK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nsubj	O
inhibits	VBZ	ROOT	O
paclitaxel	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
associated	VBN	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
and	CC	cc	O
contributes	VBZ	conj	O
to	TO	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
survival	NN	nmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
tricyclic	JJ	amod	O
antidepressant	JJ	amod	O
desipramine	NN	nmod	O
(	-LRB-	punct	O
DMI	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
growth	NN	compound	O
inhibition	NN	nmod	O
and	CC	cc	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
in	IN	case	O
cancerous	JJ	amod	O
and	CC	cc	O
noncancerous	JJ	conj	O
cell	NN	compound	O
lines	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
effect	NN	conj	O
of	IN	case	O
DMI	NN	nmod	O
on	IN	case	O
GR	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	nmod	O
.	.	punct	O
Glucocorticoid	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
GR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activation	NN	nsubjpass	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
apoptosis	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Infection	NN	nsubj	O
of	IN	case	O
human	JJ	amod	O
or	CC	cc	O
murine	JJ	conj	O
cells	NNS	nmod	O
with	IN	case	O
murine	JJ	amod	O
leukemia	NN	compound	O
viruses	NNS	nmod	O
rapidly	RB	advmod	O
increases	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubj	O
belong	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
immunoglobulin	NN	compound	O
superfamily	NN	nmod	O
and	CC	cc	O
are	VBP	auxpass	O
involved	VBN	conj	O
in	IN	case	O
T	NN	compound	O
-	HYPH	punct	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
class	NN	compound	O
I	CD	nummod	O
major	JJ	amod	O
histocompatibility	NN	compound	O
complex	NN	compound	O
antigens	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
described	VBN	ROOT	O
a	DT	det	O
group	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	acl:relcl	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
following	VBG	case	O
dexamethasone	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
Dex	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
tricyclic	JJ	amod	O
antidepressant	JJ	amod	O
desipramine	NN	nmod	O
(	-LRB-	punct	O
DMI	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
growth	NN	compound	O
inhibition	NN	nmod	O
and	CC	cc	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
in	IN	case	O
cancerous	JJ	amod	O
and	CC	cc	O
noncancerous	JJ	conj	O
cell	NN	compound	O
lines	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
effect	NN	conj	O
of	IN	case	O
DMI	NN	nmod	O
on	IN	case	O
GR	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	nmod	O
.	.	punct	O
In	IN	case	O
an	DT	det	O
effort	NN	nmod	O
to	TO	mark	O
dissect	VB	acl	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
survival	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
examine	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
events	NNS	dobj	O
downstream	RB	amod	O
of	IN	case	O
GR	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

FA	NN	nsubj	O
induced	VBD	ROOT	O
GR	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
in	IN	case	O
Ca3	NN	compound	O
/	SYM	punct	O
7	CD	nummod	O
cells	NNS	nmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
luciferase	NN	compound	O
reporter	NN	compound	O
gene	NN	nmod	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
response	NN	compound	O
element	NN	nmod	O
(	-LRB-	punct	O
GRE	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
DMI	NN	nsubj	O
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
GR	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
GR	NN	compound	B-Gene_or_gene_product
activation	NN	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
both	CC	cc:preconj	O
the	DT	det	O
rapid	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
MAPK	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MKP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
mRNA	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
sustained	JJ	amod	O
expression	NN	conj	O
.	.	punct	O

Human	JJ	amod	O
LRP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
reversed	VBD	ROOT	O
the	DT	det	O
changes	NNS	dobj	O
in	IN	case	O
protein	NN	compound	O
expression	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
LRP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
deficiency	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
endocytic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
LRP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
was	VBD	auxpass	O
not	RB	neg	O
involved	VBN	parataxis	O
.	.	punct	O
Induction	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MKP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
the	DT	det	O
MCF10A	NN	compound	B-Cell
-	HYPH	punct	I-Cell
Myc	NNP	compound	I-Cell
and	CC	cc	O
MDA	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
paclitaxel	NN	nsubj	O
downregulated	VBD	ccomp	O
the	DT	det	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NNP	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
HeLa	NN	compound	O
and	CC	cc	O
CaSki	NN	conj	O
cells	NNS	nmod	O
.	.	punct	O
Paclitaxel	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
both	DT	det	O
processes	NNS	nsubjpass	O
were	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
Dex	NN	compound	B-Simple_chemical
pretreatment	NN	nmod	O
.	.	punct	O

This	DT	det	O
activation	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
induction	NN	nmod	O
of	IN	case	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	conj	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
p38	NN	compound	O
inhibitor	NN	compound	O
SB203580	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
induction	NN	nsubj	O
of	IN	case	O
MKP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ERK1	NN	dep	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Jun	NNP	compound	I-Gene_or_gene_product
N	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
terminal	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
JNK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
p38	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
was	VBD	auxpass	O
minimally	RB	advmod	O
affected	VBN	parataxis	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
Jun	NN	compound	O
amino	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
kinase	NN	nmod	O
(	-LRB-	punct	O
JNK	NN	appos	O
)	-RRB-	punct	O
blocked	VBD	ROOT	O
type	NN	compound	O
III	CD	nummod	O
collagen	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
LRP	NN	compound	O
-	:	punct	O
1	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
MEFs	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
regulation	NN	dobj	O
of	IN	case	O
JNK	NN	compound	O
activity	NN	nmod	O
as	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
LRP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
controls	VBZ	acl:relcl	O
mRNA	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Blocking	VBG	advcl	O
Dex	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
MKP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
induction	NN	nsubj	O
using	VBG	acl	O
small	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	dobj	O
increased	VBD	ROOT	O
ERK1	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
JNK	NN	conj	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
and	CC	cc	O
decreased	VBN	amod	O
cell	NN	compound	B-Cell
survival	NN	conj	O
.	.	punct	O

Although	IN	mark	O
extracellular	JJ	amod	O
signal	NN	compound	O
-	HYPH	punct	O
regulated	VBN	amod	O
protein	NN	compound	O
kinase	NN	nsubjpass	O
1	CD	nummod	O
/	SYM	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
ERK1	NN	dep	O
/	:	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
c	NN	compound	O
-	HYPH	punct	O
Jun	NN	compound	O
N	NN	compound	O
-	HYPH	punct	O
terminal	JJ	amod	O
kinase	NN	appos	O
1	CD	nummod	O
(	-LRB-	punct	O
JNK1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
p38	NN	conj	O
were	VBD	auxpass	O
activated	VBN	advcl	O
after	IN	case	O
denudation	NN	nmod	O
,	,	punct	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
ERK1	NN	nmod	O
and	CC	cc	O
p38	NN	conj	O
was	VBD	cop	O
more	RBR	advmod	O
rapid	JJ	ROOT	O
and	CC	cc	O
prominent	JJ	conj	O
.	.	punct	O
ERK1	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
JNK	NN	conj	B-Gene_or_gene_product
inactivation	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Ets	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
transcription	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ELK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
dephosphorylation	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
cyclin	NN	compound	O
B	NN	nmod	O
,	,	punct	O
cyclin	NN	compound	O
E	NN	conj	O
,	,	punct	O
and	CC	cc	O
dephosphorylation	NN	conj	O
of	IN	case	O
cdk2	NN	nmod	O
in	IN	case	O
ciprofloxacin	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
bladder	NN	compound	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
explore	VB	advcl	O
the	DT	det	O
gene	NN	compound	O
expression	NN	compound	O
changes	NNS	dobj	O
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
downstream	RB	advmod	O
of	IN	case	O
ELK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
dephosphorylation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
temporal	JJ	amod	O
gene	NN	compound	O
expression	NN	compound	O
data	NNS	nmod	O
and	CC	cc	O
promoter	NN	compound	O
element	NN	compound	O
analyses	NNS	conj	O
.	.	punct	O

cDNA	NN	compound	O
microarray	NN	compound	O
expression	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mouse	NN	compound	O
homologue	NN	nsubjpass	O
of	IN	case	O
Dss1	NN	nmod	O
is	VBZ	auxpass	O
induced	VBN	ccomp	O
by	IN	case	O
TPA	NN	nmod	O
.	.	punct	O
This	DT	det	O
approach	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	O
transcriptional	JJ	amod	O
target	NN	dobj	O
of	IN	case	O
ELK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
human	JJ	amod	B-Organism
tissue	NN	compound	B-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
tPA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

cDNA	NN	compound	O
microarray	NN	compound	O
expression	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mouse	NN	compound	O
homologue	NN	nsubjpass	O
of	IN	case	O
Dss1	NN	nmod	O
is	VBZ	auxpass	O
induced	VBN	ccomp	O
by	IN	case	O
TPA	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
verified	VBD	ROOT	O
the	DT	det	O
predicted	VBN	amod	O
ELK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
-	:	punct	O
>	NN	amod	O
tPA	NN	amod	B-Gene_or_gene_product
transcriptional	JJ	amod	O
regulatory	JJ	amod	O
relationship	NN	dobj	O
using	VBG	acl	O
a	DT	det	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
DMI	NN	nsubj	O
inhibited	VBD	ROOT	O
FA	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
,	,	punct	O
GR	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	dep	O
transcription	NN	dobj	O
when	WRB	advmod	O
both	DT	det	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	advcl	O
together	RB	advmod	O
.	.	punct	O
We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
GR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
MAPK	NN	compound	B-Gene_or_gene_product
inactivation	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
cell	NN	compound	B-Cell
survival	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
potential	JJ	amod	O
transcriptional	JJ	amod	O
targets	NNS	nsubjpass	O
of	IN	case	O
this	DT	det	O
inhibition	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
identified	VBN	conj	O
from	IN	case	O
large	JJ	amod	O
scale	NN	compound	O
gene	NN	compound	O
array	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

a	DT	det	O
pilot	NN	compound	O
study	NN	ROOT	O
.	.	punct	O
Investigating	VBG	ROOT	O
the	DT	det	O
causes	NNS	dobj	O
of	IN	prep	O
low	JJ	amod	O
birth	NN	compound	O
weight	NN	pobj	O
in	IN	prep	O
contrasting	VBG	pcomp	O
ovine	JJ	compound	O
paradigms	NNS	dobj	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
the	DT	det	O
corpus	NN	amod	O
luteum	NN	nmod	O
(	-LRB-	punct	O
CL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
involves	VBZ	acl:relcl	O
angiogenesis	NN	dobj	O
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
establishment	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
pregnancy	NN	nmod	O
.	.	punct	O
Intrauterine	JJ	compound	O
growth	NN	compound	O
restriction	NN	nsubj	O
(	-LRB-	punct	O
IUGR	NN	appos	O
)	-RRB-	punct	O
still	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	case	O
a	DT	det	O
large	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
infant	JJ	amod	B-Organism
mortality	NN	nmod	O
and	CC	cc	O
morbidity	NN	compound	O
worldwide	NN	conj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
identical	JJ	ROOT	O
to	TO	case	O
placental	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Many	JJ	nsubj	O
of	IN	prep	O
the	DT	det	O
circulatory	JJ	amod	O
and	CC	cc	O
transport	NN	conj	O
properties	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
sheep	NN	compound	B-Organism
placenta	NN	pobj	B-Organ
are	VBP	cop	O
similar	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
placenta	NN	nmod	B-Organ
and	CC	cc	O
as	IN	conj	O
such	JJ	amod	O
,	,	punct	O
the	DT	det	O
pregnant	JJ	amod	O
sheep	NN	nsubj	B-Organism
offers	VBZ	conj	O
an	DT	det	O
excellent	JJ	amod	O
model	NN	dobj	O
in	IN	mark	O
which	WDT	pobj	O
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
IUGR	NN	nmod	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
the	DT	det	O
corpus	NN	amod	O
luteum	NN	nmod	O
(	-LRB-	punct	O
CL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
involves	VBZ	acl:relcl	O
angiogenesis	NN	dobj	O
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
establishment	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
pregnancy	NN	nmod	O
.	.	punct	O
Two	CD	nummod	O
natural	JJ	amod	O
models	NNS	nsubj	O
of	IN	case	O
ovine	JJ	compound	O
IUGR	NN	nmod	O
are	VBP	cop	O
those	DT	ROOT	O
of	IN	case	O
hyperthermic	JJ	amod	O
exposure	NN	nmod	O
during	IN	case	O
pregnancy	NN	nmod	O
,	,	punct	O
and	CC	cc	O
adolescent	JJ	amod	O
overfeeding	NN	conj	O
,	,	punct	O
also	RB	advmod	O
during	IN	case	O
pregnancy	NN	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
taxol	NN	nmod	O
,	,	punct	O
cobalt	NN	compound	O
chloride	NN	conj	O
and	CC	cc	O
a	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	compound	O
combination	NN	conj	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	O
tissue	NN	compound	O
assay	NN	nmod	O
and	CC	cc	O
compared	VBN	conj	O
to	TO	case	O
the	DT	det	O
validated	VBN	amod	O
human	JJ	amod	O
placental	JJ	amod	O
vein	NN	compound	O
angiogenesis	NN	compound	O
model	NN	nmod	O
(	-LRB-	punct	O
HPVAM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Both	DT	det	O
models	NNS	nsubj	O
yield	VBP	ROOT	O
significantly	RB	advmod	O
reduced	VBD	amod	O
placental	JJ	amod	B-Organ
weights	NNS	dobj	O
and	CC	cc	O
an	DT	det	O
asymmetrically	JJ	advmod	O
growth	NN	npadvmod	O
-	HYPH	punct	O
restricted	JJ	amod	O
fetus	NN	conj	B-Developing_anatomical_structure
,	,	punct	O
and	CC	cc	O
display	VBP	conj	O
altered	JJ	amod	O
maternal	JJ	amod	O
hormone	NN	compound	O
concentrations	NNS	dobj	O
,	,	punct	O
indicative	JJ	advcl	O
of	IN	case	O
an	DT	det	O
impaired	JJ	amod	O
trophoblast	NN	compound	B-Cell
capacity	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
identical	JJ	ROOT	O
to	TO	case	O
placental	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Additionally	RB	advmod	O
,	,	punct	O
impaired	JJ	amod	O
placental	JJ	amod	B-Organ
angiogenesis	NN	nsubj	O
and	CC	cc	O
uteroplacental	JJ	amod	B-Organism_substance
blood	NN	compound	I-Organism_substance
flow	NN	conj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
early	JJ	amod	O
defect	NN	xcomp	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
hyperthermic	JJ	amod	O
and	CC	cc	O
adolescent	JJ	conj	O
paradigms	NNS	nmod	O
.	.	punct	O

All	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
parameters	NNS	nmod	O
were	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
COX	NN	compound	O
-	HYPH	punct	O
II	CD	nummod	O
inhibitors	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	O
are	VBP	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
serum	NN	compound	O
progesterone	NN	nmod	O
.	.	punct	O
The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
alterations	NNS	nmod	O
in	IN	case	O
placental	JJ	amod	B-Organ
functional	JJ	amod	O
development	NN	nmod	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
irreversible	JJ	xcomp	O
.	.	punct	O

Low	JJ	amod	O
glucose	NN	nsubj	O
potentiated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O
IUGR	NNP	compound	O
fetuses	NNS	nsubj	B-Developing_anatomical_structure
are	VBP	ROOT	O
both	CC	cc:preconj	O
hypoxic	JJ	acomp	O
and	CC	cc	O
hypoglycaemic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
have	VBP	aux	O
reduced	VBN	conj	O
insulin	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
insulin	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	prep	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
elevated	JJ	amod	O
concentrations	NNS	conj	O
of	IN	case	O
lactate	NN	nmod	B-Simple_chemical
.	.	punct	O

Glucose	NNP	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	O
utilization	NN	nmod	O
by	IN	case	O
34	CD	nummod	O
%	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
fetal	JJ	amod	B-Developing_anatomical_structure
utilization	NN	nsubj	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
and	CC	cc	O
glucose	NN	conj	B-Simple_chemical
,	,	punct	O
on	IN	case	O
a	DT	det	O
weight	NN	compound	O
basis	NN	nmod	O
,	,	punct	O
remain	VBP	ROOT	O
constant	JJ	xcomp	O
compared	VBN	prep	O
with	IN	prep	O
control	JJ	compound	O
pregnancies	NNS	pobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
pyruvate	NN	nmod	O
in	IN	case	O
metabolic	JJ	amod	O
signaling	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
high	JJ	amod	O
rates	NNS	nsubj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
can	MD	aux	O
promote	VB	acl:relcl	O
the	DT	det	O
malignant	JJ	amod	O
transformation	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Maintained	VBN	amod	O
utilization	NN	nsubj	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
substrate	NN	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
environment	NN	nmod	O
,	,	punct	O
suggests	VBZ	ROOT	O
increased	VBN	amod	O
sensitivities	NNS	dobj	O
to	TO	case	O
metabolic	JJ	amod	O
signals	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
diseases	NNS	nmod	O
in	IN	case	O
later	JJ	amod	O
adult	JJ	amod	O
life	NN	nmod	O
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
p53	NN	compound	B-Gene_or_gene_product
mutation	NN	compound	O
heterogeneity	NN	ROOT	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
inactivated	VBN	ROOT	O
in	IN	case	O
about	RB	advmod	O
50	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
and	CC	cc	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
component	NN	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cell
response	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
genotoxic	JJ	amod	O
stresses	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
those	DT	nmod	O
generated	VBN	acl	O
by	IN	case	O
radiotherapy	NN	nmod	O
or	CC	cc	O
chemotherapy	NN	conj	O
.	.	punct	O

While	IN	mark	O
many	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	advcl	O
in	IN	case	O
melanoma	NN	nmod	O
,	,	punct	O
the	DT	det	O
relevant	JJ	amod	O
molecular	JJ	amod	O
events	NNS	nsubjpass	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O
It	PRP	nsubj	O
is	VBZ	ROOT	O
therefore	RB	advmod	O
highly	RB	advmod	O
likely	JJ	acomp	O
that	IN	mark	O
these	DT	det	O
alterations	NNS	nsubj	O
are	VBP	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ccomp	O
in	IN	case	O
tumor	NN	compound	B-Cancer
resistance	NN	nmod	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
The	DT	det	O
particular	JJ	amod	O
characteristics	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
alterations	NNS	nmod	O
,	,	punct	O
80	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
missense	NN	compound	O
mutations	NNS	appos	O
leading	VBG	acl	O
to	TO	case	O
functionally	RB	advmod	O
heterogeneous	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
make	VBP	ROOT	O
p53	NN	dobj	B-Gene_or_gene_product
a	DT	det	O
unique	JJ	amod	O
gene	NN	dobj	O
in	IN	case	O
the	DT	det	O
class	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
genes	NNS	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	O
.	.	punct	O
A	DT	det	O
considerable	JJ	amod	O
number	NN	nsubj	O
of	IN	case	O
mutant	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
probably	RB	advmod	O
have	VBP	ROOT	O
an	DT	det	O
oncogenic	JJ	amod	O
activity	NN	dobj	O
per	FW	compound	O
se	FW	nmod	O
and	CC	cc	O
therefore	RB	advmod	O
actively	RB	advmod	O
participate	VBP	conj	O
in	IN	case	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
The	DT	det	O
fact	NN	nsubj	O
that	IN	mark	O
the	DT	det	O
apoptotic	JJ	amod	O
and	CC	cc	O
antiproliferative	JJ	conj	O
functions	NNS	nsubjpass	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
can	MD	aux	O
be	VB	auxpass	O
dissociated	VBN	ccomp	O
in	IN	case	O
certain	JJ	amod	O
mutants	NNS	nmod	O
also	RB	advmod	O
suggests	VBZ	ROOT	O
another	DT	det	O
level	NN	dobj	O
of	IN	case	O
complexity	NN	nmod	O
in	IN	case	O
the	DT	det	O
relationships	NNS	nmod	O
between	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
inactivation	NN	nmod	O
and	CC	cc	O
neoplasia	NN	conj	B-Cancer
.	.	punct	O

DESIGN	NN	ROOT	O
:	:	punct	O
Experimental	JJ	amod	O
study	NN	appos	O
and	CC	cc	O
interventional	JJ	amod	O
case	NN	compound	O
series	NN	conj	O
.	.	punct	O
Randomized	VBN	amod	O
,	,	punct	O
open	JJ	amod	O
label	NN	ROOT	O
,	,	punct	O
prospective	JJ	amod	O
study	NN	appos	O
on	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
zoledronic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
on	IN	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
recurrent	JJ	amod	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
that	WDT	nsubj	O
did	VBD	aux	O
not	RB	neg	O
present	JJ	acl:relcl	O
with	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
at	IN	case	O
baseline	NN	nmod	O
.	.	punct	O

PTHrP	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
skeletal	JJ	amod	O
metastases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
dysregulated	VBN	amod	O
expression	NN	nsubj	O
in	IN	case	O
advanced	JJ	amod	O
cancers	NNS	nmod	O
causes	VBZ	conj	O
malignancy	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
hypercalcemia	NN	dobj	O
.	.	punct	O
OBJECTIVES	NNS	nsubjpass	O
:	:	punct	O
Bisphosphonates	NNS	nsubjpass	B-Simple_chemical
have	VBP	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
successfully	RB	advmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
hypercalcemia	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
reduce	VB	conj	O
skeletal	JJ	amod	B-Anatomical_system
-	HYPH	punct	O
related	JJ	amod	O
complications	NNS	dobj	O
of	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
.	.	punct	O

In	IN	prep	O
addition	NN	pobj	O
to	TO	mark	O
having	VBG	pcomp	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
vitamins	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
alpha	NN	compound	O
-	HYPH	punct	O
tocopheryl	NN	dep	O
succinate	JJ	nmod	O
and	CC	cc	O
beta	NN	compound	O
-	HYPH	punct	O
carotene	NN	conj	O
enhance	VBP	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
agents	NNS	nmod	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
differentiation	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Recent	JJ	amod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
evidence	NN	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
may	MD	aux	O
also	RB	advmod	O
have	VB	ccomp	O
direct	JJ	amod	O
antitumor	JJ	compound	B-Cancer
effects	NNS	dobj	O
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
inhibition	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
reduction	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
indirectly	RB	advmod	O
via	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
accessory	NN	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Bone	NN	compound	O
destruction	NN	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
osteoclastic	JJ	amod	O
bone	NN	compound	O
resorption	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cancer	NN	compound	O
cells	NNS	nsubj	O
stimulate	VBP	conj	O
the	DT	det	O
formation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	O
next	RB	case	O
to	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
.	.	punct	O
This	DT	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
randomized	VBN	amod	O
,	,	punct	O
open	JJ	amod	O
label	NN	attr	O
,	,	punct	O
prospective	JJ	amod	O
study	NN	attr	O
that	WDT	nsubj	O
examined	VBD	acl:relcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
preventive	JJ	amod	O
zoledronic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
treatment	NN	nmod	O
on	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
recurrent	JJ	amod	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
without	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
at	IN	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
randomization	NN	nmod	O
.	.	punct	O

PTHrP	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
skeletal	JJ	amod	O
metastases	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
dysregulated	VBN	amod	O
expression	NN	nsubj	O
in	IN	case	O
advanced	JJ	amod	O
cancers	NNS	nmod	O
causes	VBZ	conj	O
malignancy	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
hypercalcemia	NN	dobj	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Forty	CD	nummod	O
patients	NNS	nsubjpass	B-Organism
with	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
metastatic	JJ	conj	O
advanced	JJ	amod	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
without	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
,	,	punct	O
were	VBD	auxpass	O
randomized	VBN	appos	O
into	IN	prep	O
the	DT	det	O
trial	NN	pobj	O
to	TO	case	O
either	CC	cc:preconj	O
receive	VB	amod	O
zoledronic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
or	CC	cc	O
no	DT	neg	O
treatment	NN	conj	O
.	.	punct	O

Metastatic	JJ	amod	O
lesions	NNS	nsubjpass	O
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
Patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
followed	VBN	ROOT	O
up	RP	advmod	O
until	IN	mark	O
bone	NN	compound	B-Cancer
metastases	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
established	VBN	advcl	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
study	NN	nsubj	O
included	VBD	appos	O
60	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
a	DT	det	O
known	JJ	amod	O
prognosis	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
being	VBG	cop	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
free	JJ	amod	O
at	IN	prep	O
12	CD	nummod	O
mo	NN	pobj	O
was	VBD	appos	O
60	CD	nummod	O
%	NN	attr	O
in	IN	case	O
the	DT	det	O
zoledronic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
and	CC	cc	O
10	CD	nummod	O
%	NN	conj	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	appos	O
.	.	punct	O
0005	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
percentages	NNS	nsubj	O
at	IN	prep	O
18	CD	nummod	O
mo	NN	pobj	O
were	VBD	advcl	O
20	CD	nummod	O
%	NN	attr	O
and	CC	cc	O
5	CD	nummod	O
%	NN	conj	O
respectively	RB	advmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	acomp	O
0	CD	dobj	O
.	.	punct	O
0002	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Estimated	VBN	amod	O
and	CC	cc	O
true	JJ	conj	O
5	CD	compound	O
-	SYM	punct	O
10	CD	nummod	O
year	NN	npadvmod	O
overall	JJ	advmod	O
survival	NN	compound	O
rates	NNS	nsubj	O
from	IN	case	O
first	JJ	amod	O
line	NN	compound	O
antiestrogen	NN	nmod	O
and	CC	cc	O
distant	JJ	amod	O
metastases	NNS	conj	O
were	VBD	cop	O
higher	JJR	ROOT	O
than	IN	mark	O
previously	RB	advmod	O
reported	VBN	advcl	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
population	NN	nmod	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
results	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	appos	O
that	IN	mark	O
bisphosphonates	NNS	nsubj	B-Simple_chemical
as	IN	case	O
adjuvant	JJ	amod	O
treatment	NN	nmod	O
might	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	parataxis	O
need	NN	attr	O
for	IN	prep	O
blinded	JJ	amod	O
randomized	VBN	amod	O
data	NNS	pobj	O
before	IN	mark	O
such	PDT	predet	O
an	DT	det	O
approach	NN	nsubjpass	O
would	MD	aux	O
be	VB	auxpass	O
confirmed	VBN	advcl	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
liver	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
bone	NN	compound	O
metastases	NNS	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
median	JJ	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
S	NNP	compound	O
-	HYPH	punct	O
100beta	CD	intj	O
,	,	punct	O
IL	NN	compound	O
-	:	punct	O
6	CD	dep	O
and	CC	cc	O
IL	NN	conj	O
-	:	punct	O
10	CD	nmod	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
only	JJ	advmod	O
skin	NN	nmod	O
,	,	punct	O
nodal	NN	conj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
lung	NN	compound	O
involvement	NN	conj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
meantime	NN	amod	O
preventive	JJ	amod	O
use	NN	nsubjpass	O
of	IN	case	O
bisphosphonates	NNS	nmod	B-Simple_chemical
in	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
any	DT	det	O
bone	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
should	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
used	VBN	ROOT	O
outside	IN	case	O
the	DT	det	O
scope	NN	nmod	O
of	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
trial	NN	nmod	O
.	.	punct	O

Gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
naked	VBN	amod	O
DNA	NN	nmod	O
encoding	VBG	acl	O
for	IN	case	O
three	CD	nummod	O
isoforms	NNS	nmod	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
stimulates	VBZ	ROOT	O
collateral	JJ	amod	O
development	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Impaired	JJ	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Clinical	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
intensive	JJ	amod	O
insulin	NN	compound	O
therapy	NN	nsubj	O
causes	VBZ	ccomp	O
a	DT	det	O
transient	JJ	amod	O
worsening	NN	dobj	O
of	IN	prep	O
retinopathy	NN	pobj	O
.	.	punct	O
BACKGROUND	NN	dep	O
:	:	punct	O
Diabetic	JJ	amod	O
patients	NNS	nsubjpass	B-Organism
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	aux	O
have	VB	xcomp	O
impaired	JJ	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	dobj	O
,	,	punct	O
although	IN	mark	O
they	PRP	nsubj	O
have	VBP	advcl	O
excessive	JJ	amod	O
neovascularization	NN	dobj	O
in	IN	case	O
the	DT	det	O
retina	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Clinical	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
intensive	JJ	amod	O
insulin	NN	compound	O
therapy	NN	nsubj	O
causes	VBZ	ccomp	O
a	DT	det	O
transient	JJ	amod	O
worsening	NN	dobj	O
of	IN	prep	O
retinopathy	NN	pobj	O
.	.	punct	O
HYPOTHESIS	NN	dep	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
circulation	NN	dobj	O
(	-LRB-	punct	O
CCC	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
proliferative	JJ	amod	O
diabetic	JJ	amod	O
retinopathy	NN	nmod	O
(	-LRB-	punct	O
PDR	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
that	DT	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
DR	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
failure	NN	nsubj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
apoptosis	NN	nmod	O
might	MD	aux	O
lead	VB	advcl	O
to	TO	case	O
intimal	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
lack	NN	conj	O
of	IN	case	O
reversibility	NN	nmod	O
of	IN	case	O
PHT	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
this	DT	dobj	O
and	CC	cc	O
other	JJ	amod	O
key	JJ	amod	O
markers	NNS	conj	O
of	IN	case	O
vasoactivity	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
PHT	NN	nmod	O
and	CC	cc	O
CHD	NN	conj	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Ninety	CD	compound	O
diabetic	JJ	amod	O
patients	NNS	nsubjpass	B-Organism
with	IN	case	O
chronic	JJ	amod	O
total	JJ	amod	O
occlusion	NN	nmod	O
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
major	JJ	amod	O
epicardial	JJ	amod	B-Multi-tissue_structure
coronary	JJ	amod	I-Multi-tissue_structure
artery	NN	nmod	I-Multi-tissue_structure
were	VBD	auxpass	O
enrolled	VBN	appos	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

PATIENTS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	appos	O
with	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
(	-LRB-	punct	O
edema	NN	dep	O
,	,	punct	O
hemorrhages	NNS	conj	O
,	,	punct	O
capillary	JJ	amod	O
dropout	NN	conj	O
,	,	punct	O
and	CC	cc	O
neovascularization	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
subjective	JJ	amod	O
or	CC	cc	O
objective	JJ	conj	O
loss	NN	nsubjpass	O
of	IN	case	O
vision	NN	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
.	.	punct	O
Groups	NNS	ROOT	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
consisted	VBD	dep	O
of	IN	case	O
48	CD	nummod	O
patients	NNS	nmod	B-Organism
without	IN	case	O
DR	NN	nmod	O
and	CC	cc	O
42	CD	nummod	O
patients	NNS	conj	B-Organism
with	IN	case	O
PDR	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
questionable	JJ	acomp	O
,	,	punct	O
whether	IN	mark	O
collateral	JJ	amod	O
arteries	NNS	nsubj	O
also	RB	advmod	O
form	VBP	advcl	O
de	FW	amod	O
novo	FW	dobj	O
in	IN	case	O
ischemic	JJ	amod	O
vascular	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O
Coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
circulation	NN	nsubjpass	O
(	-LRB-	punct	O
CCC	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
according	VBG	case	O
to	IN	case	O
the	DT	det	O
Rentrop	NNP	compound	O
system	NN	nmod	O
.	.	punct	O

Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	nsubj	O
underwent	VBD	ROOT	O
resection	NN	dobj	O
of	IN	case	O
the	DT	det	O
remnant	JJ	amod	O
stomach	NN	nmod	O
for	IN	case	O
RSC	NN	nmod	O
and	CC	cc	O
were	VBD	auxpass	O
divided	VBN	conj	O
into	IN	case	O
two	CD	nummod	O
groups	NNS	nmod	O
:	:	punct	O
the	DT	det	O
RSCB	NN	compound	O
group	NN	nsubj	O
consisted	VBD	parataxis	O
of	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	O
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
distal	JJ	amod	O
gastrectomy	NN	dobj	O
for	IN	case	O
benign	JJ	amod	O
disease	NN	nmod	O
and	CC	cc	O
the	DT	det	O
RSCM	NN	compound	O
group	NN	conj	O
consisted	VBD	acl	O
of	IN	case	O
10	CD	nummod	O
patients	NNS	nmod	O
who	WP	nsubj	O
underwent	VBD	acl:relcl	O
gastrectomy	NN	dobj	O
for	IN	case	O
primary	JJ	amod	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Each	DT	det	O
group	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
divided	VBN	ROOT	O
into	IN	prep	O
two	CD	nummod	O
subgroups	NNS	pobj	O
according	VBG	prep	O
to	IN	prep	O
poor	JJ	pobj	O
and	CC	cc	O
good	JJ	amod	O
CCC	NN	conj	O
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NN	nsubjpass	O
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	compound	O
samples	NNS	nmod	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
RCC	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
40	CD	nummod	O
patients	NNS	conj	O
without	IN	case	O
cancer	NN	nmod	O
(	-LRB-	punct	O
controls	NNS	appos	O
)	-RRB-	punct	O
using	VBG	xcomp	O
a	DT	det	O
sandwich	JJ	amod	O
enzyme	NN	npadvmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunoassay	NN	dobj	O
.	.	punct	O
Serum	NN	compound	B-Organism_substance
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
enzyme	NN	nmod:npmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunosorbent	JJ	amod	O
assay	NN	compound	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
kit	NN	dobj	O
.	.	punct	O

PATIENTS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	appos	O
with	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
(	-LRB-	punct	O
edema	NN	dep	O
,	,	punct	O
hemorrhages	NNS	conj	O
,	,	punct	O
capillary	JJ	amod	O
dropout	NN	conj	O
,	,	punct	O
and	CC	cc	O
neovascularization	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
subjective	JJ	amod	O
or	CC	cc	O
objective	JJ	conj	O
loss	NN	nsubjpass	O
of	IN	case	O
vision	NN	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	NN	amod	O
Rentrop	NNP	compound	O
collateral	JJ	amod	O
score	NN	nsubj	O
was	VBD	cop	O
higher	JJR	appos	O
in	IN	case	O
Group	NN	nmod	O
1	CD	nummod	O
than	IN	prep	O
in	IN	prep	O
Group	NN	pobj	O
2	CD	nummod	O
(	-LRB-	punct	O
2	CD	nummod	O
.	.	punct	O
39	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	dep	O
.	.	punct	O
07	CD	nmod	O
vs	CC	cc	O
.	.	punct	O
1	LS	nummod	O
.	.	punct	O
76	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
76	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	nummod	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
tumor	NN	compound	O
size	NN	nmod	O
,	,	punct	O
gender	NN	conj	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
histology	NN	conj	O
,	,	punct	O
differentiation	NN	conj	O
or	CC	cc	O
preoperative	JJ	amod	O
therapy	NN	conj	O
.	.	punct	O
When	WRB	advmod	O
the	DT	det	O
two	CD	nummod	O
groups	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	advcl	O
with	IN	prep	O
respect	NN	pobj	O
to	TO	prep	O
poor	JJ	pobj	O
and	CC	cc	O
good	JJ	amod	O
CCC	NN	pobj	O
,	,	punct	O
poor	JJ	amod	O
CCC	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PDR	NN	nmod	O
(	-LRB-	punct	O
64	CD	dep	O
vs	CC	cc	O
.	.	punct	O
36	CD	nummod	O
%	NN	nsubj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Immunoblotting	NN	amod	O
and	CC	cc	O
immunostaining	JJ	conj	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
mostly	RB	advmod	O
along	IN	case	O
the	DT	det	O
endothelium	NN	compound	O
lining	JJ	compound	O
peritoneal	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O
Serum	NN	compound	B-Organism_substance
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	nsubj	O
were	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PDR	NN	nmod	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
without	IN	case	O
DR	NN	nmod	O
(	-LRB-	punct	O
219	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
99	CD	nummod	O
vs	CC	cc	O
.	.	punct	O
139	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
98	CD	nummod	O
pg	NN	compound	O
/	SYM	punct	O
ml	NN	nsubj	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
poor	JJ	nmod	O
and	CC	cc	O
good	JJ	amod	O
CCC	NN	conj	O
had	VBD	ROOT	O
similar	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
questionable	JJ	acomp	O
,	,	punct	O
whether	IN	mark	O
collateral	JJ	amod	O
arteries	NNS	nsubj	O
also	RB	advmod	O
form	VBP	advcl	O
de	FW	amod	O
novo	FW	dobj	O
in	IN	case	O
ischemic	JJ	amod	O
vascular	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	dep	O
that	IN	mark	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
PDR	NN	nmod	O
have	VBP	ccomp	O
a	DT	det	O
lower	JJR	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
score	NN	dobj	O
than	IN	case	O
patients	NNS	nmod	B-Organism
without	IN	case	O
DR	NN	nmod	O
.	.	punct	O

Immunoblotting	NN	amod	O
and	CC	cc	O
immunostaining	JJ	conj	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
mostly	RB	advmod	O
along	IN	case	O
the	DT	det	O
endothelium	NN	compound	O
lining	JJ	compound	O
peritoneal	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
in	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
PD	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O
Also	RB	advmod	O
,	,	punct	O
serum	NN	compound	B-Organism_substance
VEGF	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PDR	NN	nmod	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
without	IN	case	O
DR	NN	nmod	O
.	.	punct	O

In	IN	case	O
seven	CD	nummod	O
diabetic	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
proliferative	JJ	amod	O
retinopathy	NN	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
profound	JJ	amod	O
finding	NN	nsubj	O
was	VBD	cop	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	ROOT	O
of	IN	case	O
the	DT	det	O
PEDF	NN	compound	O
level	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	dep	O
:	:	punct	O
237	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NN	compound	O
levels	NNS	nsubj	O
were	VBD	cop	O
comparable	JJ	parataxis	O
to	TO	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
mean	NN	amod	O
value	NN	nmod	O
:	:	punct	O
3153	CD	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
diabetes	VBZ	compound	O
mellitus	NN	nsubj	O
may	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
different	JJ	amod	O
action	NN	dobj	O
on	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
coronary	JJ	conj	B-Multi-tissue_structure
circulation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VEGFR	NN	compound	O
-	:	punct	O
1	CD	nmod	O
facilitates	VBZ	ROOT	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
VEGFR1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
haematopoietic	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
progenitors	NNS	nsubj	O
initiate	VBP	ROOT	O
the	DT	det	O
pre	JJ	nmod:npmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
niche	NN	dobj	O
.	.	punct	O

A	DT	det	O
characteristic	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	O
cells	NNS	nmod	O
is	VBZ	cop	O
their	PRP$	nmod:poss	O
capacity	NN	ROOT	O
to	TO	mark	O
invade	VB	acl	O
their	PRP$	nmod:poss	O
surrounding	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
metastasize	VB	conj	O
to	TO	prep	O
distant	JJ	amod	O
organs	NNS	pobj	O
.	.	punct	O
The	DT	det	O
cellular	JJ	amod	B-Cell
and	CC	cc	O
molecular	JJ	conj	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
a	DT	det	O
tumour	NN	compound	B-Cell
cell	NN	nsubj	I-Cell
undergoes	VBZ	acl:relcl	O
metastasis	NN	dobj	O
to	TO	case	O
a	DT	det	O
predetermined	JJ	amod	O
location	NN	nmod	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
did	VBD	ROOT	O
a	DT	det	O
blind	JJ	amod	O
prospective	JJ	amod	O
study	NN	dobj	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
isolated	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
ITC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nsubjpass	O
-	:	punct	O
1	CD	dep	O
(	-LRB-	punct	O
VEGFR	NN	compound	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nmod	O
at	IN	case	O
tumor	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
,	,	punct	O
premetastatic	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
bone	NN	compound	B-Cell
marrow	NN	nmod:npmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
haematopoietic	JJ	amod	I-Cell
progenitor	NN	compound	I-Cell
cells	NNS	ccomp	I-Cell
that	WDT	nsubj	O
express	VBP	acl:relcl	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFR1	NN	appos	B-Gene_or_gene_product
;	:	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
Flt1	NN	nmod	B-Gene_or_gene_product
)	-RRB-	punct	O
home	RB	advmod	O
to	IN	case	O
tumour	NN	compound	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
pre	JJ	nmod:npmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
sites	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
form	VB	conj	O
cellular	JJ	amod	B-Cell
clusters	NNS	dobj	I-Cell
before	IN	case	O
the	DT	det	O
arrival	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
did	VBD	ROOT	O
a	DT	det	O
blind	JJ	amod	O
prospective	JJ	amod	O
study	NN	dobj	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
significance	NN	dobj	O
of	IN	case	O
isolated	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
ITC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nsubjpass	O
-	:	punct	O
1	CD	dep	O
(	-LRB-	punct	O
VEGFR	NN	compound	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
within	IN	case	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nmod	O
at	IN	case	O
tumor	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
,	,	punct	O
premetastatic	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O
Preventing	VBG	csubj	O
VEGFR1	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
using	VBG	acl	O
antibodies	NNS	dobj	O
or	CC	cc	O
by	IN	case	O
the	DT	det	O
removal	NN	conj	O
of	IN	case	O
VEGFR1	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
cells	NNS	dobj	O
from	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mice	NNS	nmod	B-Organism
abrogates	VBZ	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
these	DT	det	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
clusters	NNS	nmod	B-Cell
and	CC	cc	O
prevents	VBZ	conj	O
tumour	NN	compound	B-Cancer
metastasis	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
reconstitution	NN	nsubj	O
with	IN	case	O
selected	VBN	amod	O
Id3	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
inhibitor	NN	dep	B-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
differentiation	NN	nmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
competent	JJ	amod	O
VEGFR1	NN	dep	B-Gene_or_gene_product
+	CC	cc	O
cells	NNS	conj	O
establishes	VBZ	parataxis	O
cluster	NN	compound	B-Cell
formation	NN	dobj	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
metastasis	NN	conj	O
in	IN	case	O
Id3	NN	compound	B-Gene_or_gene_product
knockout	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Ablation	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	O
-	HYPH	punct	O
9	CD	nummod	O
in	IN	case	O
fibroblasts	NNS	nmod	O
almost	RB	advmod	O
completely	RB	advmod	O
abolished	VBD	ROOT	O
these	DT	det	O
cellular	JJ	amod	O
interactions	NNS	dobj	O
and	CC	cc	O
melanoma	NN	compound	O
cell	NN	compound	O
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
VEGFR1	NN	nsubj	B-Gene_or_gene_product
+	CC	cc	O
cells	NNS	conj	O
express	VBP	ccomp	O
VLA	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
alpha4beta1	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
tumour	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
growth	NN	compound	O
factors	NNS	nsubj	O
upregulate	VBP	conj	O
fibronectin	NN	dobj	B-Gene_or_gene_product
-	:	punct	O
-	:	punct	O
a	DT	det	O
VLA	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
ligand	NN	nmod	O
-	HYPH	punct	O
-	:	punct	O
in	IN	case	O
resident	JJ	amod	O
fibroblasts	NNS	dobj	B-Cell
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
permissive	JJ	amod	O
niche	NN	dobj	O
for	IN	mark	O
incoming	VBG	acl	O
tumour	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
expression	NN	compound	O
levels	NNS	nsubjpass	O
of	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod:npmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
metastasis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
molecules	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
fibronectin	NN	nmod	O
,	,	punct	O
beta1	NN	compound	O
integrin	NN	conj	O
,	,	punct	O
MMP	NN	compound	O
-	:	punct	O
1	CD	conj	O
,	,	punct	O
-	SYM	punct	O
2	CD	conj	O
,	,	punct	O
-	:	punct	O
9	CD	conj	O
,	,	punct	O
and	CC	cc	O
-	SYM	punct	O
14	CD	conj	O
,	,	punct	O
and	CC	cc	O
VEGF	NNP	compound	O
-	HYPH	punct	O
C	NNP	conj	O
,	,	punct	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
highly	RB	advmod	O
metastatic	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Conditioned	JJ	amod	O
media	NNS	nsubj	O
obtained	VBN	acl	O
from	IN	case	O
distinct	JJ	amod	O
tumour	NN	compound	B-Cancer
types	NNS	nmod	O
with	IN	case	O
unique	JJ	amod	O
patterns	NNS	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
redirected	VBD	ROOT	O
fibronectin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
cluster	NN	compound	B-Cell
formation	NN	conj	O
,	,	punct	O
thereby	RB	advmod	O
transforming	VBG	advcl	O
the	DT	det	O
metastatic	JJ	amod	O
profile	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VEGFR	NN	compound	O
-	:	punct	O
1	CD	nmod	O
facilitates	VBZ	ROOT	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
VEGFR1	NN	nmod	B-Gene_or_gene_product
+	CC	cc	O
haematopoietic	JJ	conj	O
progenitors	NNS	dep	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
expression	NN	compound	O
patterns	NNS	nsubj	O
of	IN	case	O
fibronectin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGFR1	NN	conj	B-Gene_or_gene_product
+	CC	cc	O
VLA	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
+	CC	cc	O
clusters	NNS	conj	O
dictate	VBP	ccomp	O
organ	NN	nmod:npmod	B-Organ
-	HYPH	punct	O
specific	JJ	amod	O
tumour	NN	compound	B-Cancer
spread	NN	dobj	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
putative	JJ	amod	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptor	NN	ROOT	O
with	IN	case	O
oncogenic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
The	DT	det	O
Kaposi	NN	poss	B-Organism
'	POS	case	I-Organism
s	NNS	compound	I-Organism
sarcoma	NN	npadvmod	I-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
herpesvirus	NN	compound	I-Organism
G	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
coupled	VBN	amod	I-Gene_or_gene_product
receptor	NN	ROOT	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
therapeutic	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
Kaposi	NN	poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
latent	JJ	amod	O
membrane	NN	compound	O
protein	NN	nsubj	O
LMP1	NN	dep	O
of	IN	case	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
often	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
EBV	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
malignancies	NNS	nmod	O
including	VBG	case	O
nasopharyngeal	JJ	amod	O
carcinoma	NN	nmod	O
and	CC	cc	O
Hodgkin	NN	nmod:poss	O
'	POS	case	O
s	NNS	compound	O
lymphoma	NN	conj	O
.	.	punct	O
The	DT	det	O
Kaposi	NN	poss	B-Organism
'	POS	case	I-Organism
s	NNS	compound	I-Organism
sarcoma	NN	npadvmod	I-Organism
-	HYPH	punct	I-Organism
associated	VBN	amod	I-Organism
herpesvirus	NN	nsubj	I-Organism
(	-LRB-	punct	O
KSHV	NN	appos	B-Organism
)	-RRB-	punct	O
encodes	VBZ	ROOT	O
a	DT	det	O
G	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
coupled	VBN	amod	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
vGPCR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
Kaposi	NN	poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	nmod	I-Cancer
,	,	punct	O
identifying	VBG	advcl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	nmod	O
for	IN	mark	O
preventing	VBG	acl	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	dobj	I-Cancer
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
using	VBG	acl	O
avian	JJ	amod	O
retrovirus	NN	compound	O
-	HYPH	punct	O
mediated	VBN	amod	O
introduction	NN	dobj	O
of	IN	case	O
oncogenes	NNS	nmod	O
into	IN	case	O
a	DT	det	O
small	JJ	amod	O
subset	NN	nmod	O
of	IN	case	O
somatic	JJ	amod	O
mammary	JJ	amod	O
cells	NNS	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
polyoma	NN	compound	O
middle	JJ	amod	O
T	NN	compound	O
antigen	NN	nsubj	O
(	-LRB-	punct	O
PyMT	NN	appos	O
)	-RRB-	punct	O
may	MD	aux	O
also	RB	advmod	O
preferentially	RB	advmod	O
transform	VB	ccomp	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	dobj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
as	IN	case	O
only	RB	advmod	O
a	DT	det	O
fraction	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
advanced	JJ	amod	B-Cancer
Kaposi	NN	nmod:poss	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
lesions	NNS	nmod	I-Cancer
express	VBP	advcl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
this	DT	det	O
unique	JJ	amod	O
viral	JJ	amod	O
oncogene	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
malignant	JJ	amod	O
fibrous	JJ	amod	O
histiocytomas	NNS	nmod	O
,	,	punct	O
leiomyosarcomas	NNS	conj	O
,	,	punct	O
and	CC	cc	O
liposarcomas	NNS	conj	O
.	.	punct	O
We	PRP	nsubj	O
therefore	RB	advmod	O
set	VBD	ROOT	O
out	RP	prt	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
few	JJ	amod	O
cells	NNS	nsubj	B-Cell
that	WDT	nsubj	O
express	VBP	acl:relcl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
represent	VBP	ccomp	O
an	DT	det	O
appropriate	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	mark	O
preexisting	VBG	acl	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	dobj	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
expressed	VBN	ROOT	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
mutant	JJ	amod	O
forms	NNS	dobj	O
of	IN	case	O
VASP	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
to	TO	mark	O
determine	VB	xcomp	O
in	IN	mark	O
what	WDT	det	O
aspects	NNS	nsubj	O
of	IN	prep	O
cytoskeletal	JJ	amod	O
behavior	NN	pobj	O
this	DT	det	O
protein	NN	nsubj	O
participates	VBZ	advcl	O
.	.	punct	O
To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
stably	RB	advmod	O
expressing	VBG	acl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
key	JJ	amod	O
KSHV	NN	conj	B-Organism
latently	RB	advmod	O
expressed	VBD	amod	O
proteins	NNS	dobj	O
(	-LRB-	punct	O
vCyclin	NN	dep	B-Gene_or_gene_product
,	,	punct	O
vFlip	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
LANA1	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	O
subsequently	RB	advmod	O
proliferate	VBP	ROOT	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	mark	O
form	VB	xcomp	O
endothelial	JJ	amod	O
tubes	NNS	dobj	O
and	CC	cc	O
capillary	JJ	conj	O
-	HYPH	punct	O
like	JJ	conj	O
structures	NNS	pobj	O
.	.	punct	O
The	DT	det	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
line	NN	nsubjpass	I-Cell
expressing	VBG	acl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
was	VBD	auxpass	O
rendered	VBN	ROOT	O
sensitive	JJ	xcomp	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
nucleoside	NN	compound	B-Simple_chemical
analogue	NN	nmod	O
ganciclovir	NN	advcl	B-Simple_chemical
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
bicistronic	JJ	amod	O
construct	NN	dobj	O
coexpressing	VBG	acl	O
the	DT	det	O
herpes	NN	compound	B-Organism
simplex	NN	compound	I-Organism
virus	NN	compound	I-Organism
1	CD	nummod	I-Organism
thymidine	NN	compound	B-Gene_or_gene_product
kinase	NN	dobj	I-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
morphological	JJ	amod	O
appearance	NN	nsubjpass	O
was	VBD	auxpass	O
exactly	RB	advmod	O
reproduced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
formed	VBN	acl:relcl	O
when	WRB	advmod	O
the	DT	det	O
mixture	NN	nsubj	O
of	IN	case	O
A431	NN	nmod	O
and	CC	cc	O
F	NN	compound	O
-	HYPH	punct	O
2	CD	nummod	O
cells	NNS	conj	O
at	IN	case	O
the	DT	det	O
ratio	NN	nmod	O
of	IN	case	O
10	CD	nmod	O
:	SYM	punct	O
1	CD	dep	O
were	VBD	cop	O
cotransplanted	VBN	amod	O
s	NNS	nmod	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
into	IN	case	O
the	DT	det	O
back	NN	ROOT	O
of	IN	prep	O
nude	JJ	amod	O
rats	NNS	pobj	O
.	.	punct	O
S	NN	ROOT	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
injection	NN	nsubj	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
with	IN	case	O
mixed	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
populations	NNS	nmod	I-Cell
formed	VBD	ROOT	O
tumors	NNS	dobj	B-Cancer
that	WDT	nsubj	O
approximate	VBP	acl:relcl	O
the	DT	det	O
ratio	NN	dobj	O
of	IN	case	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	nmod	O
and	CC	cc	O
KSHV	NN	conj	B-Organism
latent	JJ	amod	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	dep	B-Cell
.	.	punct	O

Green	JJ	compound	O
fluorescence	NN	compound	O
protein	NN	compound	O
transfected	VBN	amod	O
cancer	NN	compound	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
fat	NN	compound	O
pad	NN	nmod	O
of	IN	case	O
young	JJ	amod	O
female	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
These	DT	det	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
then	RB	advmod	O
treated	VBN	ROOT	O
with	IN	mark	O
ganciclovir	NN	advcl	B-Simple_chemical
to	TO	mark	O
specifically	RB	advmod	O
target	VB	xcomp	O
only	RB	advmod	O
the	DT	det	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	dobj	B-Cell
.	.	punct	O

Growth	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
modified	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
restricted	JJ	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O
Surprisingly	RB	advmod	O
,	,	punct	O
despite	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
KSHV	NN	compound	B-Organism
latent	JJ	amod	O
genes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
vast	JJ	amod	O
majority	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
specifically	RB	advmod	O
targeting	VBG	ROOT	O
only	RB	advmod	O
the	DT	det	O
few	JJ	amod	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	dobj	B-Cell
in	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
resulted	VBD	conj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
regression	NN	nmod	O
.	.	punct	O

The	DT	det	O
introduction	NN	nsubj	O
of	IN	case	O
mutations	NNS	nmod	O
into	IN	case	O
the	DT	det	O
T	NN	compound	O
-	HYPH	punct	O
antigen	NN	compound	O
J	NN	compound	O
domain	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
mutation	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
and	CC	cc	O
variable	JJ	conj	O
inhibition	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
apoptosis	NN	nmod	O
of	IN	case	O
latent	JJ	amod	O
gene	NN	compound	O
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
after	IN	case	O
the	DT	det	O
pharmacologic	JJ	amod	O
deletion	NN	nmod	O
of	IN	case	O
the	DT	det	O
vGPCR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Mechanistically	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
reduced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
molecular	JJ	amod	O
markers	NNS	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
Ki67	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
(	-LRB-	punct	O
factor	NN	compound	O
VIII	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
antiapoptotic	JJ	amod	O
factor	NN	compound	O
Bcl	NN	conj	O
-	SYM	punct	O
2	CD	nummod	O
,	,	punct	O
cell	NN	compound	O
-	HYPH	punct	O
cycle	NN	compound	O
progression	NN	nsubj	O
regulator	NN	parataxis	O
cyclin	NN	compound	O
D1	NN	dobj	O
,	,	punct	O
and	CC	cc	O
survival	NN	compound	O
factor	NN	compound	O
AKT1	NN	conj	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
vGPCR	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
progression	NN	nmod	O
and	CC	cc	O
provide	VB	conj	O
experimental	JJ	amod	O
justification	NN	dobj	O
for	IN	mark	O
developing	VBG	acl	O
molecular	JJ	amod	O
-	HYPH	punct	O
based	VBN	amod	O
therapies	NNS	dobj	O
specifically	RB	advmod	O
targeting	VBG	acl	O
vGPCR	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
effectors	NNS	conj	O
for	IN	prep	O
the	DT	det	O
treatment	NN	pobj	O
of	IN	prep	O
Kaposi	NN	nmod:poss	B-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
sarcoma	NN	compound	I-Cancer
patients	NNS	pobj	B-Organism
.	.	punct	O

Pericytes	NNS	nsubj	O
limit	VBP	ROOT	O
tumor	NN	compound	O
cell	NN	compound	O
metastasis	NN	dobj	O
.	.	punct	O
Mechanisms	NNS	ROOT	O
of	IN	case	O
pericyte	NN	compound	B-Cell
recruitment	NN	nmod	O
in	IN	case	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
:	:	punct	O
a	DT	det	O
new	JJ	amod	O
role	NN	dep	O
for	IN	case	O
metalloproteinases	NNS	nmod	B-Gene_or_gene_product
.	.	punct	O

Pericytes	NNS	nsubj	O
limit	VBP	ROOT	O
tumor	NN	compound	O
cell	NN	compound	O
metastasis	NN	dobj	O
.	.	punct	O
Pericytes	NNS	nsubj	B-Cell
occur	VBP	ROOT	O
in	IN	case	O
tumour	NN	compound	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
are	VBP	cop	O
critical	JJ	conj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
a	DT	det	O
functional	JJ	amod	O
vascular	JJ	amod	B-Anatomical_system
network	NN	nmod	I-Anatomical_system
.	.	punct	O

Pericytes	NNS	nsubj	O
limit	VBP	ROOT	O
tumor	NN	compound	O
cell	NN	compound	O
metastasis	NN	dobj	O
.	.	punct	O
Targeting	VBG	csubj	O
tumour	NN	compound	B-Cell
pericytes	NNS	dobj	I-Cell
is	VBZ	ROOT	O
a	DT	det	O
promising	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
therapy	NN	attr	O
but	CC	cc	O
requires	VBZ	conj	O
identifying	VBG	xcomp	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
recruitment	NN	nmod	O
in	IN	case	O
tumour	NN	nmod	B-Cancer
and	CC	cc	O
addressing	VBG	conj	O
whether	IN	mark	O
these	DT	det	O
mechanisms	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
selectively	RB	advmod	O
harnessed	VBN	ccomp	O
.	.	punct	O

Vascular	JJ	amod	O
development	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
various	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
modifiers	NNS	conj	O
critical	JJ	amod	O
for	IN	prep	O
providing	VBG	pcomp	O
arterial	JJ	amod	O
or	CC	cc	O
venous	JJ	conj	O
identity	NN	dobj	O
,	,	punct	O
interaction	NN	dep	O
with	IN	case	O
the	DT	det	O
surrounding	VBG	amod	O
stroma	NN	nmod	O
and	CC	cc	O
tissues	NNS	conj	O
,	,	punct	O
hierarchic	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	prep	O
pericytes	NNS	pobj	O
.	.	punct	O
Among	IN	case	O
the	DT	det	O
pathways	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
pericyte	NN	compound	B-Cell
recruitment	NN	nmod	O
during	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
,	,	punct	O
the	DT	det	O
contribution	NN	nsubjpass	O
of	IN	case	O
platelet	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
B	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
sphingosine	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
phosphate	NN	conj	I-Gene_or_gene_product
is	VBZ	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Angiopoietin	NN	nsubj	O
-	HYPH	punct	O
1	CD	nummod	O
prevents	VBZ	ROOT	O
VEGF	NNP	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	O
permeability	NN	dobj	O
by	IN	prep	O
sequestering	VBG	pcomp	O
Src	NNP	dobj	O
through	IN	prep	O
mDia	NNS	pobj	O
.	.	punct	O
The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
angiopoietin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
depends	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
tumour	NN	compound	B-Cancer
model	NN	nmod	O
.	.	punct	O

Transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	compound	O
beta	NN	nsubj	O
1	CD	nummod	O
promotes	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	O
liver	NN	compound	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta1	NN	nsubj	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
tumour	NN	compound	B-Cancer
vascularization	NN	dobj	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
maturation	NN	conj	O
.	.	punct	O

Vascular	JJ	amod	O
development	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
various	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
modifiers	NNS	conj	O
critical	JJ	amod	O
for	IN	prep	O
providing	VBG	pcomp	O
arterial	JJ	amod	O
or	CC	cc	O
venous	JJ	conj	O
identity	NN	dobj	O
,	,	punct	O
interaction	NN	dep	O
with	IN	case	O
the	DT	det	O
surrounding	VBG	amod	O
stroma	NN	nmod	O
and	CC	cc	O
tissues	NNS	conj	O
,	,	punct	O
hierarchic	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	prep	O
pericytes	NNS	pobj	O
.	.	punct	O
Recent	JJ	amod	O
reports	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
participation	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
tumour	NN	compound	B-Cell
pericyte	NN	compound	I-Cell
recruitment	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
consistent	JJ	acl:relcl	O
with	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
certain	JJ	amod	O
MMPs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
microvasculature	NN	nmod	B-Tissue
in	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	conj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodelling	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	O
development	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
various	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
certain	JJ	amod	O
modifiers	NNS	conj	O
critical	JJ	amod	O
for	IN	prep	O
providing	VBG	pcomp	O
arterial	JJ	amod	O
or	CC	cc	O
venous	JJ	conj	O
identity	NN	dobj	O
,	,	punct	O
interaction	NN	dep	O
with	IN	case	O
the	DT	det	O
surrounding	VBG	amod	O
stroma	NN	nmod	O
and	CC	cc	O
tissues	NNS	conj	O
,	,	punct	O
hierarchic	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
recruitment	NN	conj	O
of	IN	prep	O
pericytes	NNS	pobj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
for	IN	case	O
MMPs	NNS	nmod	B-Gene_or_gene_product
to	TO	mark	O
contribute	VB	acl	O
to	TO	case	O
pericyte	NN	compound	B-Cell
recruitment	NN	nmod	O
at	IN	case	O
six	CD	nummod	O
levels	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
direct	JJ	amod	O
promotion	NN	dep	O
of	IN	case	O
pericyte	NN	compound	B-Cell
invasion	NN	nmod	O
by	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
degradation	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
stimulation	NN	dep	O
of	IN	case	O
pericyte	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
protection	NN	conj	O
against	IN	case	O
apoptosis	NN	nmod	O
by	IN	case	O
modification	NN	nmod	O
of	IN	case	O
the	DT	det	O
ECM	NNS	nmod	B-Cellular_component
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
activation	NN	dep	O
of	IN	case	O
pericytes	NNS	nmod	B-Cell
through	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
factor	NN	nmod	O
bound	VBD	acl	O
to	TO	case	O
the	DT	det	O
ECM	NN	nmod	B-Cellular_component
;	:	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
transactivation	NN	dep	O
of	IN	case	O
angiogenic	JJ	amod	O
cell	NN	compound	B-Cellular_component
surface	NN	compound	I-Cellular_component
receptor	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
5	LS	dep	O
)	-RRB-	punct	O
propagation	NN	dep	O
of	IN	case	O
angiogenic	JJ	nmod	O
signalling	NN	dep	O
as	IN	case	O
cofactor	NN	nmod	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
6	LS	dep	O
)	-RRB-	punct	O
recruitment	NN	conj	O
of	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Downregulation	NN	ROOT	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	intj	O
sensitizes	VBZ	amod	O
DU145	NN	compound	O
prostate	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
Fas	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
Sensitization	NN	ROOT	O
to	IN	case	O
gimatecan	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
by	IN	case	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
apoptosis	NN	nmod	I-Gene_or_gene_product
inducing	VBG	acl	I-Gene_or_gene_product
ligand	NN	dobj	I-Gene_or_gene_product
in	IN	case	O
prostate	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Since	IN	mark	O
the	DT	det	O
intrinsic	JJ	amod	O
resistance	NN	nsubj	O
of	IN	case	O
prostate	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
likely	RB	advmod	O
reflects	VBZ	advcl	O
a	DT	det	O
low	JJ	amod	O
susceptibility	NN	dobj	O
to	TO	case	O
drug	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
explored	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	mark	O
sensitizing	VBG	acl	O
prostate	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
apoptosis	NN	nmod	O
by	IN	case	O
combination	NN	nmod	O
of	IN	case	O
TRAIL	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
camptothecins	NNS	nmod	B-Simple_chemical
.	.	punct	O

In	IN	case	O
this	DT	det	O
regard	NN	nmod	O
,	,	punct	O
inhibitors	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	amod	O
antitumoral	JJ	amod	O
agents	NNS	xcomp	O
.	.	punct	O
Indeed	RB	advmod	O
,	,	punct	O
these	DT	det	O
agents	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
different	JJ	amod	O
pathways	NNS	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Topotecan	NNP	nsubj	B-Simple_chemical
-	HYPH	punct	O
and	CC	cc	O
gimatecan	NN	conj	B-Simple_chemical
induced	VBN	ROOT	O
moderate	JJ	amod	O
up	RP	prt	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
TRAIL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R1	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
-	:	punct	B-Gene_or_gene_product
R2	NN	conj	I-Gene_or_gene_product
which	WDT	nsubj	O
resulted	VBD	acl:relcl	O
in	IN	case	O
a	DT	det	O
different	JJ	amod	O
cell	NN	compound	B-Cell
response	NN	nmod	O
to	TO	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
androgen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
cells	NNS	nmod	B-Cell
(	-LRB-	punct	O
DU	NN	compound	B-Cell
-	:	punct	I-Cell
145	CD	nummod	I-Cell
and	CC	cc	O
PC	NN	conj	B-Cell
-	:	punct	I-Cell
3	CD	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	ROOT	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	amod	O
anti	RB	amod	O
-	HYPH	punct	O
sense	NN	compound	O
oligonucleotides	NNS	dobj	O
to	IN	mark	O
down	RB	advmod	O
-	HYPH	punct	O
regulate	VB	advcl	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	dep	O
we	PRP	nsubj	O
sensitized	VBD	parataxis	O
DU145	NN	compound	O
cells	NNS	dobj	O
to	TO	case	O
CH	NN	nmod:npmod	O
-	HYPH	punct	O
11	CD	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
In	IN	case	O
DU	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
145	CD	nummod	I-Cell
cells	NNS	compound	I-Cell
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
lower	JJR	amod	O
TRAIL	NN	compound	B-Gene_or_gene_product
concentrations	NNS	nmod	O
and	CC	cc	O
was	VBD	cop	O
earlier	JJR	conj	O
than	IN	case	O
in	IN	case	O
PC	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
using	VBG	xcomp	O
Annexin	NNP	compound	B-Gene_or_gene_product
V	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	O
binding	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

Sunitinib	NNP	nsubj	O
markedly	RB	advmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
PC12	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O
The	DT	det	O
relative	JJ	amod	O
resistance	NN	nsubjpass	O
of	IN	case	O
PC	NN	compound	B-Cell
-	:	punct	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
drug	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
constitutive	JJ	amod	O
Akt	JJ	compound	B-Gene_or_gene_product
activation	NN	nmod	O
,	,	punct	O
higher	JJR	amod	O
levels	NNS	conj	O
of	IN	case	O
cFLIP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
L	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
lower	JJR	amod	O
levels	NNS	conj	O
of	IN	case	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Downregulation	NN	ROOT	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	intj	O
sensitizes	VBZ	amod	O
DU145	NN	compound	O
prostate	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
Fas	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
different	JJ	amod	O
expression	NN	nsubj	O
/	:	punct	O
activation	NN	nsubj	O
of	IN	case	O
apoptosis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
factors	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
the	DT	det	O
sensitization	NN	dobj	O
of	IN	case	O
prostate	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
TRAIL	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Interestingly	RB	ROOT	O
,	,	punct	O
the	DT	det	O
human	JJ	amod	O
B	NN	compound	O
-	HYPH	punct	O
lymphoblastoid	JJ	amod	O
cell	NN	compound	O
line	NN	compound	O
SKW6	NN	intj	O
.	.	punct	O
4	LS	nsubjpass	O
,	,	punct	O
a	DT	det	O
prototype	NN	appos	O
for	IN	case	O
mitochondria	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
death	NN	compound	O
receptor	NN	nmod:npmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
sensitized	VBN	ROOT	O
to	TO	case	O
anti	VB	compound	O
-	HYPH	punct	O
CD95	NN	nmod:npmod	O
and	CC	cc	O
TRAIL	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
under	IN	case	O
glucose	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O
Potentiation	NN	nsubj	O
of	IN	case	O
camptothecin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
by	IN	case	O
TRAIL	NN	nmod	B-Gene_or_gene_product
appears	VBZ	ROOT	O
dependent	JJ	xcomp	O
on	IN	case	O
cooperation	NN	nmod	O
between	IN	case	O
extrinsic	JJ	amod	O
and	CC	cc	O
intrinsic	JJ	conj	O
pathways	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
documented	VBN	advcl	O
by	IN	case	O
loss	NN	nmod	O
of	IN	case	O
the	DT	det	O
sensitization	NN	nmod	O
to	TO	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
reduction	NN	nmod	O
of	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
after	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	compound	O
transfection	NN	nmod	O
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
should	MD	aux	O
diminish	VB	ROOT	O
apoptosis	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
efficacy	NN	nsubj	O
of	IN	case	O
the	DT	det	O
approach	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
critically	RB	advmod	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
intrinsic	JJ	amod	O
susceptibility	NN	nmod	O
to	TO	case	O
apoptosis	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
observations	NNS	nsubj	O
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
multiple	JJ	amod	O
signals	NNS	nmod	O
could	MD	aux	O
enhance	VB	ccomp	O
apoptotic	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
the	DT	det	O
therapeutic	JJ	amod	O
interest	NN	dobj	O
of	IN	case	O
the	DT	det	O
TRAIL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
camptothecin	NN	compound	B-Simple_chemical
combination	NN	nmod	O
.	.	punct	O

Met	JJ	compound	O
amplification	NN	ROOT	O
and	CC	cc	O
tumor	NN	compound	O
progression	NN	conj	O
in	IN	case	O
Cdkn2a	JJ	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
melanocytes	NNS	nmod	O
.	.	punct	O
c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
Mitf	NNP	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
melanocyte	NN	compound	B-Cell
lineage	NN	nmod	I-Cell
.	.	punct	O

MET	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
melanoma	NN	nmod	O
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O
Hepatocyte	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
/	:	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
pathway	NN	xcomp	O
in	IN	case	O
both	CC	cc:preconj	O
melanocyte	NN	compound	B-Cell
development	NN	nmod	O
and	CC	cc	O
melanoma	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

MET	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
melanoma	NN	nmod	O
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
HGF	NN	compound	B-Gene_or_gene_product
stimulation	NN	nsubjpass	O
of	IN	case	O
melanocytes	NNS	nmod	B-Cell
was	VBD	auxpass	O
seen	VBN	ROOT	O
to	IN	case	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
disparate	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
enhancing	VBG	nmod	O
or	CC	cc	O
inhibiting	VBG	conj	O
apoptosis	NN	conj	O
exist	VBP	ccomp	O
in	IN	case	O
myeloid	JJ	amod	O
leukemic	JJ	amod	O
cells	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
environmental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
HGF	NN	nmod:npmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
cellular	JJ	amod	O
synthesis	NN	nmod	O
of	IN	case	O
distinct	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
mRNA	NN	conj	O
.	.	punct	O
In	IN	case	O
an	DT	det	O
effort	NN	nmod	O
to	TO	mark	O
decipher	VB	acl	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
HGF	NN	nsubj	B-Gene_or_gene_product
up	RB	prep	O
-	:	punct	O
regulates	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
receptor	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NNP	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
direct	JJ	amod	O
transcriptional	JJ	amod	O
target	NN	ccomp	O
of	IN	case	O
Mitf	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

Met	JJ	compound	O
amplification	NN	ROOT	O
and	CC	cc	O
tumor	NN	compound	O
progression	NN	conj	O
in	IN	case	O
Cdkn2a	JJ	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
melanocytes	NNS	nmod	O
.	.	punct	O
This	DT	nsubjpass	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
with	IN	case	O
chromatin	NN	compound	B-Cellular_component
immunoprecipitation	NN	compound	O
experiments	NNS	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
promoter	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
adenovirally	RB	advmod	B-Organism
expressed	VBN	amod	O
Mitf	NNP	nmod	B-Gene_or_gene_product
to	TO	mark	O
modulate	VB	acl	O
endogenous	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
melanocytes	NNS	nmod	B-Cell
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	O
receptor	NN	nmod	O
2	CD	nummod	O
.	.	punct	O
Disruption	NN	nsubj	O
of	IN	prep	O
Mitf	NNP	pobj	B-Gene_or_gene_product
blocked	VBD	ROOT	O
HGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
endogenous	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Met	NN	compound	I-Gene_or_gene_product
message	NN	nmod	O
and	CC	cc	O
protein	NN	compound	O
levels	NNS	conj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
HGF	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ccomp	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
receptor	NN	compound	O
levels	NNS	dobj	O
via	IN	case	O
Mitf	NNP	nmod	B-Gene_or_gene_product
.	.	punct	O

Ablation	NN	nsubj	O
of	IN	case	O
ADAM	NNP	nmod	O
-	HYPH	punct	O
9	CD	nummod	O
in	IN	case	O
fibroblasts	NNS	nmod	O
almost	RB	advmod	O
completely	RB	advmod	O
abolished	VBD	ROOT	O
these	DT	det	O
cellular	JJ	amod	O
interactions	NNS	dobj	O
and	CC	cc	O
melanoma	NN	compound	O
cell	NN	compound	O
invasion	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
Mitf	NNP	nmod	B-Gene_or_gene_product
resulted	VBD	ROOT	O
in	IN	case	O
profound	JJ	amod	O
resistance	NN	nmod	O
of	IN	case	O
melanocytes	NNS	nmod	B-Cell
and	CC	cc	O
melanoma	NN	compound	B-Cell
cells	NNS	conj	I-Cell
to	TO	case	O
HGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
matrix	NN	compound	B-Cellular_component
invasion	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
physiologic	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
in	IN	case	O
melanocytic	JJ	amod	B-Cell
development	NN	nmod	O
and	CC	cc	O
melanoma	NN	conj	B-Cancer
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Targeting	VBG	csubj	O
PIM	NNP	compound	O
kinases	NNS	dobj	O
impairs	VBZ	ROOT	O
survival	NN	dobj	O
of	IN	case	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
kinase	NN	compound	O
inhibitor	NN	dep	O
-	HYPH	punct	O
sensitive	JJ	amod	O
and	CC	cc	O
kinase	NN	nmod:npmod	O
inhibitor	NN	nmod:npmod	O
-	HYPH	punct	O
resistant	JJ	conj	O
forms	NNS	nmod	O
of	IN	case	O
Fms	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
BCR	NN	conj	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Cytokines	NNS	nsubj	O
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
induce	VBP	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transducers	NNS	nmod	O
and	CC	cc	O
activators	NNS	compound	O
of	IN	amod	O
transcription	NN	conj	O
(	-LRB-	punct	O
STATs	NNS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
signal	NN	compound	B-Gene_or_gene_product
transducer	NN	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
5	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
STAT5	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
plays	VBZ	ccomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
leukemogenesis	NN	nmod	O
mediated	VBN	acl	O
through	IN	case	O
constitutive	JJ	amod	O
activated	VBN	amod	O
protein	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinases	NNS	nmod	O
(	-LRB-	punct	O
PTK	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Because	IN	mark	O
PIM	NNP	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
STAT5	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
gene	NN	advcl	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
family	NN	nmod	O
of	IN	case	O
PIM	NN	compound	O
serine	NN	compound	B-Amino_acid
/	:	punct	O
threonine	NN	compound	B-Amino_acid
kinases	NNS	nmod	O
(	-LRB-	punct	O
PIM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
to	TO	case	O
PIM	NNP	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
PTK	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
transformation	NN	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
TEL	NN	nmod	O
in	IN	case	O
Ras	NN	nmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
NIH	NN	compound	O
3T3	NN	compound	O
cells	NNS	nsubj	O
inhibits	VBZ	ccomp	O
cell	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
in	IN	case	O
normal	JJ	amod	O
cultures	NNS	conj	O
.	.	punct	O
Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
transformed	VBN	acl	O
to	TO	case	O
growth	NN	compound	O
factor	NN	compound	O
independence	NN	nmod	O
by	IN	case	O
various	JJ	amod	O
oncogenic	JJ	amod	O
PTKs	NN	nmod	O
(	-LRB-	punct	O
TEL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
JAK2	NN	dep	B-Gene_or_gene_product
,	,	punct	O
TEL	NN	appos	B-Gene_or_gene_product
/	:	punct	O
TRKC	NN	conj	B-Gene_or_gene_product
,	,	punct	O
TEL	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	conj	B-Gene_or_gene_product
,	,	punct	O
BCR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	conj	B-Gene_or_gene_product
,	,	punct	O
FLT3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
ITD	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
H4	NN	conj	B-Gene_or_gene_product
/	:	punct	O
PDGFbetaR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
show	VBP	ROOT	O
abundant	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
PIM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Suppression	NN	nsubj	O
of	IN	case	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
negligible	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
transformation	NN	nmod	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
kinase	NN	compound	O
-	HYPH	punct	O
dead	JJ	amod	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
mutant	NN	nmod	O
(	-LRB-	punct	O
PIM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2KD	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
rapid	JJ	amod	O
decline	NN	nmod	O
of	IN	case	O
survival	NN	nmod	O
in	IN	case	O
Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
FLT3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
ITD	NNP	nmod	I-Gene_or_gene_product
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
other	JJ	amod	O
oncogenic	JJ	amod	O
PTKs	NN	conj	B-Gene_or_gene_product
tested	VBN	acl	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Coexpression	NN	ROOT	O
of	IN	prep	O
PIM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1KD	NN	intj	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2KD	NN	conj	I-Gene_or_gene_product
abrogated	VBD	amod	O
growth	NN	compound	O
factor	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
several	JJ	amod	O
PTKs	NN	nmod	O
,	,	punct	O
including	VBG	case	O
BCR	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	appos	B-Gene_or_gene_product
.	.	punct	O

Protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
levels	NNS	nsubj	O
in	IN	case	O
several	JJ	amod	O
transformed	VBN	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
were	VBD	cop	O
subject	JJ	ROOT	O
to	TO	mark	O
down	JJ	advcl	O
modulation	NN	dobj	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
growth	NN	compound	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O
Targeted	VBN	amod	O
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
PIM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
RNA	NN	compound	O
interference	NN	nmod	O
(	-LRB-	punct	O
RNAi	NNS	appos	O
)	-RRB-	punct	O
selectively	RB	advmod	O
abrogated	VBD	ROOT	O
survival	NN	dobj	O
of	IN	case	O
Ba	NN	compound	B-Cell
/	:	punct	I-Cell
F3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
various	JJ	amod	O
Fms	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod:npmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FLT3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
activating	VBG	amod	O
mutants	NNS	dobj	O
[	-LRB-	punct	O
internal	JJ	amod	O
tandem	JJ	amod	O
duplication	NN	dep	O
(	-LRB-	punct	O
ITD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
kinase	NN	compound	O
domain	NN	conj	O
]	-RRB-	punct	O
and	CC	cc	O
attenuated	VBN	amod	O
growth	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
containing	VBG	acl	O
FLT3	NN	compound	B-Gene_or_gene_product
mutations	NNS	dobj	O
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
cells	NNS	nsubj	B-Cell
transformed	VBN	acl	O
by	IN	case	O
FLT3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
BCR	NN	conj	B-Gene_or_gene_product
/	:	punct	O
ABL	NN	compound	B-Gene_or_gene_product
mutations	NNS	dep	O
that	WDT	nsubj	O
confer	VBP	acl:relcl	O
resistance	NN	dobj	O
to	TO	case	O
small	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
molecule	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
inhibitors	NNS	nmod	O
were	VBD	cop	O
still	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
knockdown	NN	nmod	O
of	IN	case	O
PIM	NNP	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
RNAi	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
observations	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
combined	JJ	amod	O
inactivation	NN	nsubj	O
of	IN	case	O
PIM	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
PIM	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
interferes	VBZ	ccomp	O
with	IN	case	O
oncogenic	JJ	amod	O
PTKs	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
PIMs	NNS	nsubj	O
are	VBP	cop	O
alternative	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	ccomp	O
in	IN	case	O
PTK	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
leukemia	NN	nmod	B-Cancer
.	.	punct	O

This	DT	det	O
result	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
alleged	VBN	amod	O
contribution	NN	dobj	O
of	IN	case	O
overexpressed	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
to	TO	case	O
cell	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Targeting	VBG	csubj	O
the	DT	det	O
PIM	NN	compound	O
kinase	NN	compound	O
family	NN	dobj	O
could	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
new	JJ	amod	O
avenue	NN	dobj	O
to	TO	aux	O
overcome	VB	acl	O
resistance	NN	dobj	O
against	IN	case	O
small	JJ	amod	O
-	HYPH	punct	O
molecule	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	compound	O
inhibitors	NNS	nmod	O
.	.	punct	O

Targeting	VBG	ROOT	O
angiogenesis	NN	dobj	O
:	:	punct	O
progress	NN	dep	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
large	JJ	amod	O
molecules	NNS	nmod	O
.	.	punct	O
Ectopic	JJ	amod	O
localization	NN	ROOT	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
ATP	NN	compound	B-Gene_or_gene_product
synthase	NN	nmod	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
target	NN	dep	O
for	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenesis	NN	compound	O
intervention	NN	nmod	O
?	.	punct	O

This	DT	nsubj	O
ultimately	RB	advmod	O
deprives	VBZ	ROOT	O
VEGF	NN	compound	O
receptors	NNS	dobj	O
of	IN	case	O
an	DT	det	O
essential	JJ	amod	O
molecule	NN	nmod	O
required	VBN	acl	O
for	IN	mark	O
promoting	VBG	advcl	O
the	DT	det	O
disruption	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
contacts	NNS	nmod	O
and	CC	cc	O
paracellular	JJ	amod	O
permeability	NN	conj	O
.	.	punct	O
A	DT	det	O
receptor	NN	nsubjpass	O
for	IN	case	O
angiostatin	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
identified	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
as	IN	case	O
F	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
F	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
0	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
ATP	NN	compound	I-Gene_or_gene_product
synthase	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
Moser	NNP	dep	O
et	FW	dep	O
al	FW	dep	O
.	NNP	punct	O
,	,	punct	O
1999	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
GTPase	NN	compound	O
Arf6	NN	nsubj	O
primarily	RB	advmod	O
regulates	VBZ	ROOT	O
recycling	NN	dobj	O
of	IN	case	O
plasma	NN	compound	O
membrane	NN	compound	O
components	NNS	nmod	O
.	.	punct	O
Proc	NNP	ROOT	O
.	.	punct	O

Research	NN	ROOT	O
and	CC	cc	O
discovery	NN	conj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
human	JJ	amod	O
cancer	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
HTLV	NN	compound	O
-	:	punct	O
1	CD	nummod	O
.	.	punct	O
Natl	NN	ROOT	O
.	.	punct	O

Research	NN	ROOT	O
and	CC	cc	O
discovery	NN	conj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
human	JJ	amod	O
cancer	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
HTLV	NN	compound	O
-	:	punct	O
1	CD	nummod	O
.	.	punct	O
Acad	NNP	ROOT	O
.	.	punct	O

Research	NN	ROOT	O
and	CC	cc	O
discovery	NN	conj	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
human	JJ	amod	O
cancer	NN	compound	O
virus	NN	nmod	O
,	,	punct	O
HTLV	NN	compound	O
-	:	punct	O
1	CD	nummod	O
.	.	punct	O
Sci	NNP	ROOT	O
.	.	punct	O

The	DT	det	O
genetics	NNS	ROOT	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
SV	NNP	nmod	O
40	CD	nummod	O
.	.	punct	O
U	NNP	ROOT	O
.	.	punct	O
S	NNP	ROOT	O
.	.	punct	O
A	DT	ROOT	O
.	.	punct	O

[	-LRB-	punct	O
Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
ARF	NN	nmod	O
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O
96	CD	nummod	O
,	,	punct	O
2811	CD	nummod	O
-	SYM	punct	O
2816	CD	ROOT	O
.	.	punct	O

From	IN	prep	O
35	CD	quantmod	O
to	TO	quantmod	O
100	CD	nummod	O
%	NN	nsubjpass	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
amount	NN	pobj	O
of	IN	prep	O
ATP	NN	pobj	O
resynthesized	VBD	acl	O
via	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	auxpass	O
utilized	VBN	ROOT	O
for	IN	case	O
transport	NN	compound	O
purposes	NNS	nmod	O
.	.	punct	O
This	DT	det	O
ectopic	JJ	amod	O
ATP	NN	compound	B-Gene_or_gene_product
synthase	NN	nsubj	I-Gene_or_gene_product
catalyzes	VBZ	ROOT	O
ATP	NN	compound	B-Simple_chemical
synthesis	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
angiostatin	NN	nmod	B-Gene_or_gene_product
over	IN	case	O
a	DT	det	O
wide	JJ	amod	O
pH	NN	compound	O
range	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Angiostatin	NN	nsubj	O
inhibited	VBD	ROOT	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
by	IN	case	O
50	CD	compound	O
-	HYPH	punct	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O
Endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
at	IN	case	O
normal	JJ	amod	O
pH	NN	nmod	O
suffer	VBP	ROOT	O
no	DT	neg	O
ill	NN	amod	O
effects	NNS	dobj	O
from	IN	case	O
this	DT	det	O
angiostatin	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
inhibition	NN	nmod	O
of	IN	case	O
ATP	NN	compound	B-Gene_or_gene_product
synthase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
whereas	IN	dep	O
endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
grown	VBN	acl	O
at	IN	case	O
low	JJ	mwe	O
,	,	punct	O
tumor	NN	nmod	B-Cancer
-	:	punct	O
like	IN	case	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
pH	NN	nmod	O
cannot	NN	advmod	O
maintain	VBP	parataxis	O
a	DT	det	O
normal	JJ	amod	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
pH	NN	dobj	O
and	CC	cc	O
die	VB	conj	O
.	.	punct	O

In	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
there	EX	expl	O
are	VBP	ROOT	O
conflicting	VBG	amod	O
studies	NNS	nsubj	O
questioning	VBG	acl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenin	NN	nmod	O
.	.	punct	O
Angiostatin	NN	nsubj	B-Gene_or_gene_product
inhibits	VBZ	ROOT	O
both	CC	cc:preconj	O
ATP	NN	compound	B-Simple_chemical
synthesis	NN	dobj	O
and	CC	cc	O
ATP	NN	compound	B-Simple_chemical
hydrolysis	NN	conj	O
(	-LRB-	punct	O
Moser	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
2001	CD	amod	O
)	-RRB-	punct	O
and	CC	cc	O
interferes	VBZ	conj	O
with	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
pH	NN	compound	O
regulation	NN	nmod	O
(	-LRB-	punct	O
Wahl	NNP	dep	O
and	CC	cc	O
Grant	NNP	conj	O
,	,	punct	O
2002	CD	nummod	O
;	:	punct	O
Wahl	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
2002	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Angiostatin	NN	nsubj	O
and	CC	cc	O
thalidomide	NN	conj	O
both	CC	conj	O
inhibited	VBD	ROOT	O
tumor	NN	compound	O
growth	NN	dobj	O
by	IN	prep	O
about	RB	advmod	O
55	CD	nummod	O
%	NN	pobj	O
.	.	punct	O
Although	IN	mark	O
angiostatin	NN	nsubj	B-Gene_or_gene_product
administered	VBN	advcl	O
intravenously	RB	advmod	B-Immaterial_anatomical_entity
is	VBZ	auxpass	O
cleared	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
circulation	NN	nmod	O
in	IN	case	O
a	DT	det	O
matter	NN	nmod	O
of	IN	case	O
minutes	NNS	nmod	O
,	,	punct	O
angiostatin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
mimetics	NNS	nsubj	I-Simple_chemical
that	WDT	nsubj	O
are	VBP	cop	O
more	RBR	advmod	O
stable	JJ	advcl	O
have	VBP	conj	O
potential	NN	dobj	O
for	IN	case	O
clinical	JJ	amod	O
application	NN	nmod	O
.	.	punct	O

Angiostatin	NN	nsubj	O
and	CC	cc	O
thalidomide	NN	conj	O
both	CC	conj	O
inhibited	VBD	ROOT	O
tumor	NN	compound	O
growth	NN	dobj	O
by	IN	prep	O
about	RB	advmod	O
55	CD	nummod	O
%	NN	pobj	O
.	.	punct	O
An	DT	det	O
angiostatin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
mimetic	JJ	amod	I-Simple_chemical
activity	NN	nsubjpass	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
polyclonal	JJ	amod	O
antibody	NN	dobj	O
against	IN	case	O
the	DT	det	O
beta	NN	compound	O
catalytic	JJ	amod	O
subunit	NN	nmod	O
of	IN	case	O
ATP	NN	compound	B-Gene_or_gene_product
synthase	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Angiostatin	NN	nsubj	O
and	CC	cc	O
thalidomide	NN	conj	O
inhibit	VBP	appos	O
tumor	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
explore	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
angiostatin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
mimetics	NNS	conj	O
,	,	punct	O
further	JJ	amod	O
work	NN	nsubj	O
needs	VBZ	ROOT	O
to	TO	aux	O
be	VB	auxpass	O
done	VBN	xcomp	O
to	TO	mark	O
evaluate	VB	xcomp	O
clinical	JJ	amod	O
applicability	NN	dobj	O
,	,	punct	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
contraindications	NNS	conj	O
for	IN	case	O
this	DT	det	O
class	NN	nmod	O
of	IN	case	O
therapeutics	NNS	nmod	O
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
Hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	compound	I-Organism
integration	NN	compound	O
event	NN	nsubj	O
in	IN	case	O
human	JJ	amod	B-Organism
chromosome	NN	compound	B-Cellular_component
17p	NN	nmod	I-Cellular_component
near	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
identifies	VBZ	ROOT	O
the	DT	det	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
chromosome	NN	nmod	B-Cellular_component
commonly	RB	advmod	O
deleted	VBN	acl	O
in	IN	case	O
virus	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
positive	JJ	amod	I-Cancer
hepatocellular	JJ	amod	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
The	DT	det	O
development	NN	nsubj	O
of	IN	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
HCC	NN	appos	B-Cancer
)	-RRB-	punct	O
presumably	RB	advmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
steps	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
influenced	VBN	conj	O
by	IN	case	O
numerous	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
Hepatitis	NN	compound	B-Organism
B	NN	compound	I-Organism
virus	NN	nsubjpass	I-Organism
(	-LRB-	punct	O
HBV	NN	appos	B-Organism
)	-RRB-	punct	O
is	VBZ	auxpass	O
strongly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
HCC	NN	nmod	B-Cancer
in	IN	case	O
people	NNS	nmod	B-Organism
chronically	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
the	DT	det	O
virus	NN	nmod	B-Organism
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
viral	JJ	amod	B-Organism
involvement	NN	nmod	O
remains	VBZ	conj	O
unclear	JJ	xcomp	O
.	.	punct	O

These	DT	det	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
genetic	JJ	amod	O
background	NN	dobj	O
but	CC	cc	O
with	IN	case	O
an	DT	det	O
increasing	VBG	amod	O
potential	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
possibility	NN	nsubj	O
is	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
gross	JJ	amod	O
chromosomal	JJ	amod	B-Cellular_component
alterations	NNS	nsubj	O
frequently	RB	advmod	O
observed	VBN	acl	O
in	IN	case	O
HCC	NN	compound	B-Cancer
DNA	NN	nmod	B-Cellular_component
at	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
HBV	NN	compound	B-Organism
integration	NN	nmod	O
may	MD	aux	O
alter	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
important	JJ	amod	O
nearby	JJ	amod	O
cellular	JJ	amod	B-Cell
genes	NNS	nmod	O
.	.	punct	O

These	DT	det	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
genetic	JJ	amod	O
background	NN	dobj	O
but	CC	cc	O
with	IN	case	O
an	DT	det	O
increasing	VBG	amod	O
potential	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
the	DT	dep	O
cloning	NN	dobj	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
a	DT	det	O
HBV	NN	compound	B-Organism
insert	NN	nmod	O
from	IN	case	O
a	DT	det	O
Chinese	JJ	amod	B-Organism
HCC	NN	nmod	B-Cancer
.	.	punct	O

A	DT	det	O
transcript	NN	ROOT	O
from	IN	case	O
the	DT	det	O
long	JJ	amod	O
terminal	JJ	amod	O
repeats	NNS	nmod	O
of	IN	case	O
a	DT	det	O
murine	JJ	amod	O
retrovirus	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
trans	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O
The	DT	det	O
viral	JJ	amod	B-Organism
insert	NN	ROOT	O
mapped	VBN	acl	O
to	TO	case	O
chromosome	NN	compound	B-Cellular_component
17p11	NN	nmod	I-Cellular_component
.	.	punct	I-Cellular_component
2	CD	compound	I-Cellular_component
-	SYM	punct	I-Cellular_component
12	CD	nsubjpass	I-Cellular_component
,	,	punct	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
sequences	NNS	nsubjpass	O
were	VBD	auxpass	O
duplicated	JJ	ROOT	O
at	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
viral	JJ	amod	B-Organism
integration	NN	nmod	O
.	.	punct	O

A	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
Km	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	O
type	NN	appos	O
II	CD	nummod	O
-	HYPH	punct	O
like	IN	case	O
tumor	NN	compound	O
HK	NN	appos	O
is	VBZ	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
form	NN	nmod	O
in	IN	case	O
hepatomas	NNS	nmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
a	DT	det	O
DNA	NN	compound	B-Cellular_component
probe	NN	nsubjpass	O
derived	VBN	acl	O
from	IN	case	O
cellular	JJ	amod	B-Cell
DNA	NN	compound	B-Cellular_component
sequences	NNS	nmod	O
adjacent	JJ	amod	O
to	TO	case	O
the	DT	det	O
previously	RB	advmod	O
characterized	VBN	amod	O
HBV	NN	compound	B-Organism
insert	NN	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
analyze	VB	xcomp	O
a	DT	det	O
set	NN	dobj	O
of	IN	case	O
19	CD	nummod	O
matched	VBN	amod	O
normal	JJ	amod	O
liver	NN	nmod	B-Organ
and	CC	cc	O
HBV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
positive	JJ	amod	O
hepatoma	NN	compound	B-Tissue
samples	NNS	conj	I-Tissue
obtained	VBN	acl	O
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
region	NN	nmod	O
of	IN	prep	O
China	NNP	pobj	O
,	,	punct	O
near	IN	prep	O
Shanghai	NNP	pobj	O
.	.	punct	O

These	DT	det	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nsubj	O
had	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
genetic	JJ	amod	O
background	NN	dobj	O
but	CC	cc	O
with	IN	case	O
an	DT	det	O
increasing	VBG	amod	O
potential	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
DNA	NN	compound	B-Cellular_component
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
two	CD	nummod	O
additional	JJ	amod	O
HCCs	NNS	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
small	JJ	amod	O
region	NN	nsubjpass	O
of	IN	case	O
chromosome	NN	compound	B-Cellular_component
17p	NN	nmod	I-Cellular_component
defined	VBN	acl	O
by	IN	case	O
the	DT	det	O
flanking	JJ	amod	O
cell	NN	compound	B-Cell
DNA	NN	compound	B-Cellular_component
probe	NN	nmod	O
is	VBZ	auxpass	O
commonly	RB	advmod	O
altered	VBN	ccomp	O
in	IN	case	O
hepatomas	NNS	nmod	B-Cancer
.	.	punct	O

3H	NN	compound	O
-	HYPH	punct	O
Cytosine	NN	compound	O
arabinoside	NN	amod	O
incorporation	NN	nsubjpass	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
1	CD	dobj	O
.	.	punct	O
33	CD	compound	O
-	HYPH	punct	O
to	TO	quantmod	O
18	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	ROOT	O
over	RP	prep	O
respective	JJ	amod	O
controls	NNS	pobj	O
in	IN	case	O
14	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O
Restriction	NN	compound	O
fragment	NN	compound	O
length	NN	compound	O
polymorphism	NN	compound	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
one	CD	nummod	O
copy	NN	nmod	O
of	IN	case	O
portions	NNS	nmod	O
of	IN	case	O
chromosome	NN	nmod	B-Cellular_component
17	CD	nummod	I-Cellular_component
occurred	VBD	ccomp	O
in	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
53	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
19	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
The	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
one	CD	nummod	O
allele	NN	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
(	-LRB-	punct	O
located	JJ	dep	O
on	IN	case	O
chromosome	NN	compound	B-Cellular_component
17p13	NN	nmod	I-Cellular_component
)	-RRB-	punct	O
occurred	VBD	ROOT	O
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
6	CD	nummod	O
(	-LRB-	punct	O
60	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
10	CD	nummod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
were	VBD	cop	O
heterozygous	JJ	acl:relcl	O
at	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
locus	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
As	IN	mark	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
possess	VB	xcomp	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
loss	NN	nsubj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
significant	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
HCCs	NNS	nmod	B-Cancer
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
High	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
allele	NN	compound	O
loss	NN	nmod	O
also	RB	advmod	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
for	IN	case	O
chromosomes	NNS	nmod	B-Cellular_component
8q	NN	dep	I-Cellular_component
(	-LRB-	punct	O
4	CD	dep	O
of	IN	case	O
9	CD	nmod	O
;	:	punct	O
44	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
16p	NN	conj	B-Cellular_component
(	-LRB-	punct	O
5	CD	dep	O
of	IN	case	O
6	CD	nmod	O
;	:	punct	O
83	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
may	MD	aux	O
indicate	VB	conj	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
additional	JJ	amod	O
cellular	JJ	amod	B-Cell
genes	NNS	nmod	O
whose	WP$	nmod:poss	O
functional	JJ	amod	O
loss	NN	nsubj	O
is	VBZ	cop	O
important	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
HCCs	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
alpha2beta1	NN	compound	O
integrin	NN	compound	O
receptor	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
Prostate	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
specific	JJ	amod	I-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
regulates	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
modulating	VBG	advcl	O
integrin	NN	compound	B-Gene_or_gene_product
signal	NN	compound	O
transduction	NN	dobj	O
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
transmembrane	JJ	compound	B-Cellular_component
peptidase	NN	compound	O
prostate	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
specific	JJ	amod	I-Gene_or_gene_product
membrane	NN	compound	I-Gene_or_gene_product
antigen	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
PSMA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
universally	RB	advmod	O
upregulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Multi-tissue_structure
of	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
functional	JJ	amod	O
role	NN	nsubjpass	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
investigated	VBN	conj	O
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
angiogenesis	NN	nsubj	O
is	VBZ	aux	O
severely	RB	advmod	O
impaired	JJ	ccomp	O
in	IN	case	O
PSMA	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
null	JJ	amod	O
animals	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
angiogenic	JJ	amod	O
defect	NN	nsubj	O
occurs	VBZ	conj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
invasion	NN	nmod	O
through	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
barrier	NN	nmod	I-Cellular_component
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Because	IN	mark	O
proteolytic	JJ	amod	O
degradation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
component	NN	advcl	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
invasion	NN	nmod	O
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
logical	JJ	ROOT	O
to	TO	aux	O
assume	VB	xcomp	O
that	IN	mark	O
PSMA	NN	nsubj	B-Gene_or_gene_product
participates	VBZ	ccomp	O
in	IN	case	O
matrix	NN	compound	B-Cellular_component
degradation	NN	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
strong	JJ	amod	O
biochemical	JJ	amod	O
and	CC	cc	O
genetic	JJ	conj	O
evidence	NN	dobj	O
of	IN	case	O
a	DT	det	O
central	JJ	amod	O
role	NN	nmod	O
for	IN	case	O
alpha2beta1	NN	compound	O
integrin	NN	nmod	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
more	RBR	conj	O
complex	JJ	dep	O
role	NN	dobj	O
for	IN	case	O
PSMA	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
where	WRB	advmod	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
principal	JJ	amod	O
component	NN	acl:relcl	O
of	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
loop	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	aux	O
tightly	RB	advmod	O
modulating	VBG	acl:relcl	O
laminin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
integrin	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
and	CC	cc	O
GTPase	NN	compound	O
-	HYPH	punct	O
dependent	JJ	conj	O
,	,	punct	O
p21	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PAK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	dobj	O
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
PSMA	NN	compound	B-Gene_or_gene_product
inhibition	NN	nsubj	O
,	,	punct	O
knockdown	NN	conj	O
,	,	punct	O
or	CC	cc	O
deficiency	NN	conj	O
decreases	VBZ	ccomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
invasion	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
via	IN	case	O
integrin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
PAK	NN	conj	B-Gene_or_gene_product
,	,	punct	O
thus	RB	advmod	O
abrogating	VBG	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O

Pak1	NN	nsubj	O
associates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
complex	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	O
and	CC	cc	O
BimL	NN	conj	O
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
BH3	NN	compound	O
-	:	punct	O
only	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
and	CC	cc	O
phosphorylates	VBZ	conj	O
both	DT	det	O
proteins	NNS	dobj	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
neutralization	NN	nsubj	O
of	IN	case	O
beta	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
or	CC	cc	O
the	DT	det	O
inactivation	NN	conj	O
of	IN	case	O
PAK	NN	nmod	B-Gene_or_gene_product
increases	VBZ	ROOT	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
they	PRP	nsubj	O
negatively	RB	advmod	O
regulate	VBP	ccomp	O
PSMA	NNP	dobj	B-Gene_or_gene_product
.	.	punct	O

Pak1	NN	nsubj	O
associates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
complex	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	O
and	CC	cc	O
BimL	NN	conj	O
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
BH3	NN	compound	O
-	:	punct	O
only	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
and	CC	cc	O
phosphorylates	VBZ	conj	O
both	DT	det	O
proteins	NNS	dobj	O
.	.	punct	O
This	DT	det	O
negative	JJ	amod	O
regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
cytoskeleton	NN	nmod	B-Cellular_component
as	IN	case	O
the	DT	det	O
disruption	NN	nsubj	O
of	IN	case	O
interactions	NNS	nmod	O
between	IN	case	O
the	DT	det	O
PSMA	NNP	compound	B-Gene_or_gene_product
cytoplasmic	JJ	amod	B-Organism_substance
tail	NN	nmod	O
and	CC	cc	O
the	DT	det	O
anchor	NN	compound	O
protein	NN	compound	O
filamin	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
decreases	VBZ	conj	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
,	,	punct	O
integrin	NN	compound	B-Gene_or_gene_product
function	NN	conj	O
,	,	punct	O
and	CC	cc	O
PAK	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Pak1	NN	nsubj	O
associates	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
complex	NN	nmod	O
of	IN	case	O
DLC1	NN	nmod	O
and	CC	cc	O
BimL	NN	conj	O
,	,	punct	O
a	DT	det	O
proapoptotic	JJ	amod	O
BH3	NN	compound	O
-	:	punct	O
only	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
and	CC	cc	O
phosphorylates	VBZ	conj	O
both	DT	det	O
proteins	NNS	dobj	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
PAK	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
enhances	VBZ	ROOT	O
the	DT	det	O
PSMA	NNP	dobj	B-Gene_or_gene_product
/	:	punct	O
filamin	NN	compound	B-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
interaction	NN	conj	O
and	CC	cc	O
,	,	punct	O
thus	RB	advmod	O
,	,	punct	O
boosts	VBZ	parataxis	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
a	DT	det	O
similar	JJ	amod	O
vascular	JJ	amod	O
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
morpholino	NN	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
knockdown	NN	nmod	O
of	IN	case	O
the	DT	det	O
integrin	NN	compound	O
alpha2	NN	compound	O
subunit	NN	nmod	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
imply	VBP	ROOT	O
that	IN	mark	O
PSMA	NN	nsubj	B-Gene_or_gene_product
participates	VBZ	ccomp	O
in	IN	case	O
an	DT	det	O
autoregulatory	JJ	amod	O
loop	NN	nmod	O
,	,	punct	O
wherein	JJ	conj	O
active	JJ	amod	O
PSMA	NN	nsubj	B-Gene_or_gene_product
facilitates	VBZ	conj	O
integrin	NN	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
and	CC	cc	O
PAK	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
both	CC	cc:preconj	O
productive	JJ	amod	O
invasion	NN	nmod	O
and	CC	cc	O
downregulation	NN	conj	O
of	IN	case	O
integrin	NN	compound	B-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
signaling	NN	nmod	O
via	IN	case	O
reduced	VBN	amod	O
PSMA	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Physiological	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
signaling	NN	nmod	O
through	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
receptors	NNS	nmod	O
.	.	punct	O
Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
PSMA	NN	nmod	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
true	JJ	amod	O
molecular	JJ	amod	O
interface	NN	nmod	O
,	,	punct	O
integrating	VBG	advcl	O
both	CC	cc:preconj	O
extracellular	JJ	dobj	B-Immaterial_anatomical_entity
and	CC	cc	O
intracellular	JJ	conj	B-Immaterial_anatomical_entity
signals	NNS	dep	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
Heparin	NN	nmod:npmod	B-Simple_chemical
immobilized	VBD	amod	O
porous	JJ	amod	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	ROOT	O
for	IN	case	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
delivery	NN	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
bFGF	NN	nmod	O
in	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
compartment	NN	nmod	O
of	IN	case	O
a	DT	det	O
diverse	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
organs	NNS	nmod	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
Heparin	NN	nmod:npmod	B-Simple_chemical
immobilized	VBD	amod	O
porous	JJ	amod	O
poly	NN	dobj	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
D	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
lactic	JJ	dep	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
co	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glycolic	JJ	amod	I-Simple_chemical
acid	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
(	-LRB-	punct	O
PLGA	NN	dep	B-Simple_chemical
)	-RRB-	punct	O
microspheres	NNS	nsubjpass	O
were	VBD	auxpass	O
prepared	VBN	appos	O
for	IN	case	O
sustained	JJ	amod	O
release	NN	nmod	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
induce	VB	xcomp	O
angiogenesis	NN	dobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
goal	NN	nsubj	O
of	IN	prep	O
this	DT	det	O
research	NN	pobj	O
was	VBD	appos	O
to	TO	mark	O
evaluate	VB	xcomp	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
agent	NN	dobj	O
for	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
based	VBN	case	O
on	IN	case	O
galectin	NN	nmod	O
-	,	punct	O
3	CD	nummod	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
tumorigenicity	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Porous	JJ	amod	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	nsubjpass	O
having	VBG	acl	O
primary	JJ	amod	O
amine	NN	compound	O
groups	NNS	dobj	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
were	VBD	auxpass	O
prepared	VBN	dep	O
using	VBG	xcomp	O
an	DT	det	O
oil	NN	compound	O
-	HYPH	punct	O
in	IN	dep	O
-	HYPH	punct	O
water	NN	pobj	O
(	-LRB-	punct	O
O	NNP	compound	O
/	:	punct	O
W	NN	appos	O
)	-RRB-	punct	O
single	JJ	amod	O
emulsion	NN	compound	O
method	NN	dobj	O
using	VBG	acl	O
Pluronic	NNP	compound	O
F	NNP	compound	O
-	HYPH	punct	O
127	CD	dobj	O
as	IN	case	O
an	DT	det	O
extractable	JJ	amod	O
porogen	NN	nmod	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
Heparin	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
surface	NN	npadvmod	O
immobilized	VBN	ROOT	O
via	IN	prep	O
covalent	JJ	amod	O
conjugation	NN	pobj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Human	JJ	amod	O
umbilical	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
angiostatin	NN	nmod	O
or	CC	cc	O
thalidomide	NN	conj	O
and	CC	cc	O
bFGF	NN	conj	O
-	:	punct	O
induced	VBN	amod	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
MTT	NN	compound	O
assay	NN	nmod	O
.	.	punct	O
bFGF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
loaded	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
heparin	NN	compound	B-Simple_chemical
functionalized	NN	compound	O
(	-LRB-	punct	O
PLGA	NN	compound	B-Simple_chemical
-	:	punct	O
heparin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
microspheres	VBZ	nmod	O
by	IN	case	O
a	DT	det	O
simple	JJ	amod	O
dipping	NN	compound	O
method	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
The	DT	det	O
bFGF	NN	nsubj	B-Gene_or_gene_product
loaded	VBD	ROOT	O
PLGA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
heparin	NN	compound	B-Simple_chemical
microspheres	NNS	nsubjpass	O
were	VBD	auxpass	O
tested	VBN	advcl	O
for	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
release	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
angiogenic	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Bovine	JJ	amod	O
aortic	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nsubjpass	O
(	-LRB-	punct	O
ECs	NNS	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	nsubjpass	O
with	IN	case	O
an	DT	det	O
open	JJ	amod	O
-	HYPH	punct	O
porous	JJ	amod	O
structure	NN	nmod	O
were	VBD	auxpass	O
formed	VBN	appos	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
The	DT	det	O
amount	NN	nsubj	O
of	IN	prep	O
conjugated	VBN	amod	O
amine	NN	compound	O
group	NN	pobj	O
onto	IN	prep	O
the	DT	det	O
microspheres	NNS	pobj	O
was	VBD	ROOT	O
1	CD	attr	O
.	.	punct	O
93	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
01	CD	nummod	O
nmol	NN	compound	O
/	:	punct	O
mg	NN	compound	O
-	HYPH	punct	O
microspheres	NNS	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
was	VBD	cop	O
95	CD	dep	O
.	.	punct	O
8	CD	nummod	O
pmol	NN	compound	O
/	:	punct	O
mg	NN	compound	O
-	HYPH	punct	O
microspheres	NNS	ROOT	O
.	.	punct	O

Immunodetection	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
bFGF	NN	compound	O
mouse	NN	compound	O
monoclonal	JJ	amod	O
antibody	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
react	VB	xcomp	O
with	IN	case	O
recombinant	JJ	amod	O
human	JJ	amod	O
bFGF	NN	nmod	O
in	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
specifically	RB	advmod	O
neutralize	VB	conj	O
the	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	O
on	IN	case	O
bovine	JJ	amod	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
PLGA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
heparin	NN	compound	B-Simple_chemical
microspheres	NNS	nsubj	O
released	VBN	ROOT	O
out	RP	advmod	O
bFGF	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
more	RBR	advmod	O
sustained	JJ	amod	O
manner	NN	nmod	O
with	IN	case	O
a	DT	det	O
smaller	JJR	amod	O
extent	NN	nmod	O
of	IN	case	O
initial	JJ	amod	O
burst	NN	nmod	O
than	IN	case	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
surface	NN	compound	O
immobilized	VBD	amod	O
heparin	NN	nsubj	B-Simple_chemical
controlled	VBD	ccomp	O
the	DT	det	O
release	NN	compound	O
rate	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
Subcutaneous	JJ	amod	O
implantation	NN	nsubj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
loaded	JJ	ROOT	O
PLGA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
heparin	NN	compound	B-Simple_chemical
microspheres	NNS	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
significantly	RB	advmod	O
induced	VBD	advcl	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
vascular	JJ	amod	B-Tissue
microvessels	NNS	nmod	I-Tissue
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
SAT	NN	nsubj	O
and	CC	cc	O
VAT	NN	conj	O
expressed	VBD	dep	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
without	IN	case	O
significant	JJ	amod	O
difference	NN	nmod	O
for	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
PLGA	NN	compound	B-Simple_chemical
microspheres	VBZ	nsubj	O
with	IN	case	O
an	DT	det	O
open	JJ	amod	O
porous	JJ	amod	O
structure	NN	nmod	O
allowed	VBD	appos	O
significant	JJ	amod	O
amount	NN	dobj	O
of	IN	case	O
heparin	NN	compound	B-Simple_chemical
immobilization	NN	nmod	O
and	CC	cc	O
bFGF	NN	compound	B-Gene_or_gene_product
loading	NN	conj	O
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
bFGF	NN	nsubj	B-Gene_or_gene_product
loaded	VBD	ROOT	O
PLGA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
HP	NN	compound	B-Simple_chemical
microspheres	NNS	nsubj	O
showed	VBD	ccomp	O
sustained	JJ	amod	O
release	NN	compound	O
profiles	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
demonstrating	VBG	advcl	O
reversible	JJ	amod	O
and	CC	cc	O
specific	JJ	conj	O
binding	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
immobilized	VBN	amod	O
heparin	NN	nmod	B-Simple_chemical
.	.	punct	O

Both	DT	det	O
cis	NN	nsubj	O
-	HYPH	punct	O
9	CD	dep	O
,	,	punct	O
trans	JJ	compound	O
-	:	punct	O
11	CD	conj	O
and	CC	cc	O
trans	JJ	compound	O
-	HYPH	punct	O
10	CD	conj	O
,	,	punct	O
cis	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
CLA	NNP	compound	O
isomers	NNS	nsubj	O
were	VBD	cop	O
effective	JJ	ROOT	O
in	IN	mark	O
inhibiting	VBG	advcl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O
They	PRP	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
local	JJ	amod	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
an	DT	det	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
syndecans	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
disease	NN	nmod	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

Semaphorins	NNS	nsubj	O
comprise	VBP	ROOT	O
a	DT	det	O
family	NN	dobj	O
of	IN	case	O
molecules	NNS	nmod	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
neuronal	JJ	amod	O
growth	NN	dobj	O
and	CC	cc	O
guidance	NN	conj	O
.	.	punct	O
Syndecans	NNS	nsubj	B-Gene_or_gene_product
are	VBP	ROOT	O
a	DT	det	O
family	NN	attr	O
of	IN	case	O
transmembrane	JJ	amod	B-Cellular_component
heparan	NN	compound	B-Simple_chemical
sulfate	NN	compound	I-Simple_chemical
proteoglycans	NNS	nmod	O
widely	RB	advmod	O
expressed	VBN	acl	O
in	IN	case	O
both	CC	cc:preconj	O
developing	VBG	amod	B-Tissue
and	CC	cc	O
adult	JJ	conj	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
AQPs	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
carcinogenesis	NN	nmod	O
has	VBZ	aux	O
become	VBN	ROOT	O
an	DT	det	O
area	NN	attr	O
of	IN	prep	O
great	JJ	amod	O
interest	NN	pobj	O
.	.	punct	O
Until	IN	mark	O
recently	RB	advmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
role	NN	nsubjpass	O
in	IN	case	O
pathogenesis	NN	nmod	O
was	VBD	auxpass	O
largely	RB	advmod	O
unexplored	VBN	ROOT	O
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
their	PRP$	poss	O
functions	NNS	pobj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
play	VBP	ccomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cancers	NNS	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
the	DT	det	O
reported	VBN	amod	O
involvement	NN	dobj	O
of	IN	case	O
syndecans	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
,	,	punct	O
infectious	JJ	amod	O
diseases	NNS	conj	O
,	,	punct	O
obesity	NN	conj	O
,	,	punct	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
their	PRP$	poss	O
functions	NNS	pobj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
play	VBP	ccomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cancers	NNS	nmod	O
.	.	punct	O
In	IN	case	O
some	DT	det	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
syndecan	JJ	amod	B-Gene_or_gene_product
expression	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
function	NN	dobj	O
(	-LRB-	punct	O
e	NN	compound	O
.	.	punct	O
g	NN	dobj	O
.	.	punct	O
proliferation	NN	ROOT	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
and	CC	cc	O
motility	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
serve	VB	conj	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
marker	NN	nmod	O
for	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
and	CC	cc	O
patient	NN	compound	B-Organism
survival	NN	conj	O
.	.	punct	O

The	DT	det	O
disintegrin	NN	compound	O
-	HYPH	punct	O
like	NN	amod	O
and	CC	cc	O
cysteine	NN	compound	O
-	HYPH	punct	O
rich	JJ	amod	O
domains	NNS	nsubj	O
of	IN	case	O
ADAM	NNP	compound	O
-	HYPH	punct	O
9	CD	nmod	O
mediate	NN	ROOT	O
interactions	NNS	dobj	O
between	IN	case	O
melanoma	NN	compound	O
cells	NNS	nmod	O
and	CC	cc	O
fibroblasts	NNS	conj	O
.	.	punct	O
The	DT	det	O
ectodomains	NNS	nsubj	O
and	CC	cc	O
heparan	VB	compound	B-Simple_chemical
sulfate	JJ	compound	I-Simple_chemical
glycosaminoglycan	JJ	amod	I-Simple_chemical
chains	NNS	conj	O
of	IN	case	O
syndecans	NNS	nmod	B-Gene_or_gene_product
can	MD	aux	O
also	RB	advmod	O
act	VB	ROOT	O
as	IN	case	O
receptors	NNS	nmod	O
/	:	punct	O
co	NN	compound	O
-	HYPH	punct	O
receptors	NNS	conj	O
for	IN	case	O
some	DT	dep	O
bacterial	JJ	nmod	O
and	CC	cc	O
viral	JJ	conj	O
pathogens	NNS	dep	O
,	,	punct	O
mediating	VBG	acl	O
infection	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	O
/	:	punct	O
Erk	NN	conj	O
and	CC	cc	O
PI3K	NN	conj	O
/	:	punct	O
Akt	NN	compound	O
signaling	NN	conj	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
syndecans	NNS	nsubj	B-Gene_or_gene_product
bind	VBP	ROOT	O
to	TO	case	O
obesity	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
factors	NNS	nmod	O
and	CC	cc	O
regulate	VBP	conj	O
their	PRP$	nmod:poss	O
signaling	NN	dobj	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
modulating	NN	advcl	O
food	NN	compound	O
consumption	NN	dobj	O
and	CC	cc	O
weight	NN	compound	O
balance	NN	conj	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
wound	NN	advcl	O
migration	NN	nsubjpass	O
and	CC	cc	O
single	JJ	amod	O
-	HYPH	punct	O
cell	NN	compound	O
motility	NN	conj	O
by	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
compromised	VBN	ROOT	O
.	.	punct	O
In	FW	amod	O
vivo	FW	dep	O
animal	NN	compound	O
models	NNS	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
injury	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
data	NNS	conj	O
also	RB	advmod	O
implicate	VBP	ROOT	O
syndecans	NNS	dobj	B-Gene_or_gene_product
in	IN	case	O
processes	NNS	nmod	O
necessary	JJ	amod	O
for	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
,	,	punct	O
including	VBG	case	O
fibroblast	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
proliferation	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
motility	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
organization	NN	conj	O
.	.	punct	O

The	DT	det	O
later	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	nmod	O
-	:	punct	O
2	CD	dep	O
and	CC	cc	O
-	SYM	punct	O
9	CD	nummod	O
in	IN	case	O
fibroblasts	NNS	nmod	O
suggests	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
extracellular	JJ	amod	O
matrix	NN	compound	O
remodeling	NN	nmod	O
.	.	punct	O
These	DT	det	O
new	JJ	amod	O
insights	NNS	nsubj	O
into	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
syndecans	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
disease	NN	compound	O
and	CC	cc	O
tissue	NN	conj	B-Tissue
repair	NN	nmod	O
coupled	VBN	acl	O
with	IN	case	O
the	DT	det	O
emergence	NN	nmod	O
of	IN	case	O
syndecan	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
molecular	JJ	amod	O
tools	NNS	nmod	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
diseases	NNS	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	ROOT	O
in	IN	case	O
gastric	JJ	amod	B-Organ
carcinogenesis	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Notch	NN	compound	O
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
tumorigenesis	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
human	JJ	nmod	O
and	CC	cc	O
other	JJ	amod	O
mammalian	JJ	amod	O
cancers	NNS	conj	O
.	.	punct	O
The	DT	det	O
CCAAT	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
enhancer	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
several	JJ	amod	O
cancer	NN	compound	B-Cancer
models	NNS	nmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
biological	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
of	IN	case	O
the	DT	det	O
remnant	JJ	amod	O
stomach	NN	nmod	O
(	-LRB-	punct	O
RSC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
analysed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
90	CD	nummod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
(	-LRB-	punct	O
GCs	NNS	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
assessed	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nmod	I-Gene_or_gene_product
on	IN	case	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

PTEN	NN	compound	O
mRNA	NN	nsubjpass	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	auxpass	O
less	RBR	advmod	O
frequently	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
gastric	JJ	amod	O
carcinomas	NNS	nmod	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
gastric	JJ	amod	O
mucosa	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
normal	JJ	amod	O
gastric	JJ	amod	B-Multi-tissue_structure
mucosa	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
zone	NN	nmod	B-Immaterial_anatomical_entity
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
intense	JJ	amod	O
staining	NN	nsubj	O
for	IN	case	O
HER2	NN	nmod	O
on	IN	case	O
the	DT	det	O
basolateral	JJ	amod	O
membrane	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
of	IN	case	O
intestinal	JJ	amod	O
metaplasia	NN	nmod	O
(	-LRB-	punct	O
22	CD	nummod	O
/	SYM	punct	O
24	CD	nummod	O
;	:	punct	O
91	CD	dep	O
.	.	punct	O
7	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
carcinoma	NN	conj	O
in	FW	compound	O
situ	FW	advmod	O
(	-LRB-	punct	O
9	CD	nummod	O
/	SYM	punct	O
10	CD	dep	O
;	:	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
lesions	NNS	attr	O
that	WDT	nsubj	O
displayed	VBD	acl:relcl	O
a	DT	det	O
significantly	RB	advmod	O
high	JJ	amod	O
proliferation	NN	compound	O
index	NN	dobj	O
.	.	punct	O
In	IN	prep	O
intestinal	JJ	amod	B-Pathological_formation
metaplasia	NN	pobj	I-Pathological_formation
,	,	punct	O
dysplasia	NN	conj	B-Pathological_formation
,	,	punct	O
and	CC	cc	O
GC	NN	conj	B-Cancer
of	IN	case	O
the	DT	det	O
intestinal	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
atypical	JJ	conj	O
subtypes	NNS	nmod	O
,	,	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	appos	I-Gene_or_gene_product
was	VBD	ROOT	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	amod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	attr	O
0	CD	nummod	O
.	.	punct	O
0001	CD	ROOT	O
,	,	punct	O
for	IN	case	O
the	DT	det	O
association	NN	nmod	O
with	IN	case	O
histological	JJ	amod	O
type	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MCT	NN	nsubj	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
were	VBD	cop	O
the	DT	det	O
primary	JJ	amod	O
isoforms	NNS	dep	O
expressed	VBN	acl	O
in	IN	case	O
human	JJ	amod	O
glioblastoma	NN	compound	O
multiforme	NN	amod	O
and	CC	cc	O
glioma	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
Ki67	NN	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
marker	NN	appos	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
co	NN	advmod	O
-	HYPH	punct	O
expressed	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
GC	NN	nmod	B-Cancer
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
observed	VBD	ROOT	O
an	DT	det	O
overlap	NN	dobj	O
between	IN	case	O
C	NN	nmod	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	dep	I-Gene_or_gene_product
and	CC	cc	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
GC	NN	nmod	B-Cancer
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
Using	VBG	ROOT	O
GC	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
we	PRP	nsubj	O
show	VBP	parataxis	O
that	IN	mark	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nsubj	I-Gene_or_gene_product
can	MD	aux	O
regulate	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	O
COX	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
transactivate	VB	conj	O
the	DT	det	O
promoter	NN	dobj	O
of	IN	case	O
the	DT	det	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
its	PRP$	nmod:poss	O
methylation	NN	compound	O
status	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
C	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
EBPbeta	NN	nsubj	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
marker	NN	ccomp	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
play	VBP	conj	O
an	DT	det	O
active	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
gastric	JJ	amod	B-Organ
tumourigenesis	NN	nmod	O
by	IN	mark	O
regulating	VBG	advcl	O
COX	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

Both	DT	det	O
cell	NN	compound	O
lines	NNS	nsubj	O
showed	VBD	ROOT	O
reduced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
tissue	NN	compound	O
inhibitor	NN	nmod	O
of	IN	case	O
metalloproteases	NNS	nmod	O
(	-LRB-	punct	O
TIMP	NNS	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
,	,	punct	O
while	IN	mark	O
TIMP	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
and	CC	cc	O
plasminogen	NN	compound	O
activator	NN	compound	O
inhibitor	NN	conj	O
(	-LRB-	punct	O
PAI	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
I	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
was	VBN	auxpass	O
also	RB	advmod	O
reduced	VBN	advcl	O
in	IN	case	O
RSVT2	NN	compound	O
/	:	punct	O
C	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
thus	RB	advmod	O
contributing	VBG	advcl	O
to	IN	case	O
their	PRP$	poss	O
hyperinvasiveness	NN	nmod	O
.	.	punct	O
Lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
downregulates	VBZ	ROOT	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	dobj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
negatively	RB	advmod	O
involved	VBN	acl:relcl	O
in	IN	case	O
lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	nmod:npmod	I-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
invasion	NN	nmod	O
.	.	punct	O

Metastatic	JJ	amod	O
disease	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
causes	NNS	nmod	O
of	IN	case	O
death	NN	nmod	O
from	IN	case	O
cancer	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
beings	NNS	nmod	O
.	.	punct	O
Ovarian	JJ	amod	B-Cancer
cancer	NN	nsubj	I-Cancer
is	VBZ	cop	O
a	DT	det	O
highly	RB	advmod	O
metastatic	JJ	amod	O
disease	NN	ROOT	O
.	.	punct	O

Increased	VBN	amod	O
platelet	NN	compound	O
counts	NNS	nsubjpass	O
and	CC	cc	O
systemic	JJ	amod	O
coagulation	NN	compound	O
activation	NN	conj	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
ovarian	JJ	amod	O
cancer	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
Lysophosphatidic	NN	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
LPA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
levels	NNS	nsubj	O
are	VBP	aux	O
elevated	JJ	ROOT	O
in	IN	case	O
ascites	NNS	nmod	B-Organism_substance
from	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
potential	JJ	amod	O
role	NN	nsubj	O
in	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
metastasis	NN	nmod	O
has	VBZ	aux	O
just	RB	advmod	O
begun	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
revealed	VBN	xcomp	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	O
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
work	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
LPA	NN	nsubj	B-Simple_chemical
stimulates	VBZ	ccomp	O
invasion	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
ovarian	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
or	CC	cc	O
borderline	NN	conj	B-Cell
ovarian	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
although	IN	mark	O
these	DT	det	O
benign	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
indeed	RB	advmod	O
respond	VBP	advcl	O
to	TO	case	O
LPA	NN	nmod	B-Simple_chemical
in	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
.	.	punct	O

These	DT	det	O
enzymes	NNS	nsubj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
physiologic	JJ	amod	O
inhibitors	NNS	conj	O
,	,	punct	O
the	DT	det	O
tissue	NN	compound	O
inhibitors	NNS	appos	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinases	NNS	nmod	O
(	-LRB-	punct	O
TIMPs	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
act	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
coordinated	VBN	amod	O
manner	NN	nmod	O
to	TO	mark	O
form	VB	xcomp	O
an	DT	det	O
integrated	JJ	amod	O
system	NN	dobj	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
LPA	NN	nsubj	B-Simple_chemical
downregulates	VBZ	ccomp	O
tissue	NN	compound	B-Gene_or_gene_product
inhibitor	NN	dobj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
metalloproteinases	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
TIMPs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Both	DT	det	O
cell	NN	compound	O
lines	NNS	nsubj	O
showed	VBD	ROOT	O
reduced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
tissue	NN	compound	O
inhibitor	NN	nmod	O
of	IN	case	O
metalloproteases	NNS	nmod	O
(	-LRB-	punct	O
TIMP	NNS	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
,	,	punct	O
while	IN	mark	O
TIMP	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
and	CC	cc	O
plasminogen	NN	compound	O
activator	NN	compound	O
inhibitor	NN	conj	O
(	-LRB-	punct	O
PAI	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
I	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
was	VBN	auxpass	O
also	RB	advmod	O
reduced	VBN	advcl	O
in	IN	case	O
RSVT2	NN	compound	O
/	:	punct	O
C	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
thus	RB	advmod	O
contributing	VBG	advcl	O
to	IN	case	O
their	PRP$	poss	O
hyperinvasiveness	NN	nmod	O
.	.	punct	O
TIMP2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
TIMP3	NN	conj	B-Gene_or_gene_product
play	VBP	ROOT	O
functional	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
LPA	NN	compound	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
invasion	NN	nmod	O
as	IN	case	O
negative	JJ	amod	O
regulators	NNS	nmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
platelet	NN	compound	O
activation	NN	nmod	O
with	IN	case	O
prostaglandin	NN	compound	O
E1	NN	nmod	O
(	-LRB-	punct	O
PGE	NN	appos	O
(	-LRB-	punct	O
1	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
attenuated	VBD	ROOT	O
the	DT	det	O
invasive	JJ	amod	O
capacity	NN	dobj	O
of	IN	case	O
SKOV3	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
G	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
i	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
protein	NN	nsubjpass	O
,	,	punct	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
kinase	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
PI3K	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
p38	NN	compound	B-Gene_or_gene_product
mitogen	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
cytosolic	JJ	amod	B-Organism_substance
phospholipase	NN	compound	B-Gene_or_gene_product
A	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
urokinase	NN	compound	B-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
uPA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
LPA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cells	NNS	compound	B-Cell
invasion	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
retroviral	JJ	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
delivery	NN	dobj	O
to	TO	mark	O
effect	VB	advcl	O
sustained	JJ	amod	O
autocrine	JJ	compound	O
expression	NN	dobj	O
of	IN	case	O
TIMP	NN	compound	O
-	HYPH	punct	O
3	CD	nmod	O
in	IN	case	O
murine	JJ	amod	O
neuroblastoma	NN	nmod	O
and	CC	cc	O
melanoma	NN	compound	O
tumor	NN	compound	O
cells	NNS	conj	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
further	RB	advmod	O
examine	VB	advcl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
TIMPs	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
TIMP3	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
affect	VB	ROOT	O
two	CD	nummod	O
independent	JJ	amod	O
downstream	JJ	amod	O
targets	NNS	dobj	O
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Activated	VBN	amod	O
platelets	NNS	nsubj	O
enhance	VBP	ROOT	O
ovarian	JJ	amod	O
cancer	NN	compound	O
cell	NN	compound	O
invasion	NN	dobj	O
in	IN	case	O
a	DT	det	O
cellular	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
LPA	NN	nsubj	B-Simple_chemical
stimulates	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
in	IN	case	O
an	DT	det	O
orthotopic	JJ	amod	O
ovarian	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
inhibited	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product
inhibitor	NN	nmod	O
,	,	punct	O
LY294002	NN	appos	B-Simple_chemical
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
gonadotropin	NN	nsubj	O
-	HYPH	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
estrogen	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
maintenance	NN	nsubj	O
of	IN	case	O
SEMA3	NN	compound	O
expression	NN	nmod	O
could	MD	aux	O
control	VB	ROOT	O
ovarian	JJ	amod	O
cancer	NN	compound	O
angiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
LPA	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
likely	RB	advmod	O
a	DT	det	O
key	JJ	amod	O
component	NN	ROOT	O
for	IN	mark	O
promoting	VBG	acl	O
ovarian	JJ	amod	B-Organ
metastasis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
migration	NN	nmod	O
by	IN	case	O
HKa	NN	nmod	O
is	VBZ	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	compound	O
receptor	NN	nmod	O
.	.	punct	O
LPA	NN	nsubj	B-Simple_chemical
downregulates	VBZ	ROOT	O
TIMP3	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
have	VB	aux	O
targets	NNS	acl:relcl	O
other	JJ	xcomp	O
than	IN	prep	O
metalloproteinases	NNS	pobj	O
.	.	punct	O

Mice	NNS	nsubjpass	O
with	IN	case	O
tumor	NN	compound	O
xenograft	NN	nmod	O
and	CC	cc	O
experimental	JJ	amod	O
metastasis	NN	compound	O
model	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
Our	PRP$	nmod:poss	O
in	FW	amod	O
vivo	FW	dep	O
metastasis	NN	compound	O
mouse	NN	compound	B-Organism
model	NN	nsubj	O
is	VBZ	cop	O
useful	JJ	ROOT	O
for	IN	mark	O
studying	VBG	advcl	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
therapeutic	JJ	amod	O
regimes	NNS	nmod	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
a	DT	det	O
model	NN	dobj	O
to	TO	mark	O
study	VB	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
human	JJ	amod	O
adipose	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O
Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
fibrinolytic	JJ	nmod	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
systems	NNS	nmod	O
in	IN	case	O
development	NN	nmod	O
of	IN	case	O
adipose	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
reverses	VBZ	appos	O
rodent	JJ	amod	O
obesity	NN	dobj	O
.	.	punct	O
Obesity	NN	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
common	JJ	amod	O
disorder	NN	attr	O
and	CC	cc	O
related	JJ	amod	O
diseases	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
diabetes	NNS	nmod	O
,	,	punct	O
atherosclerosis	NN	conj	O
,	,	punct	O
hypertension	NN	conj	O
,	,	punct	O
cardiovascular	JJ	amod	B-Anatomical_system
disease	NN	conj	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
are	VBP	cop	O
a	DT	det	O
major	JJ	amod	O
cause	NN	conj	O
of	IN	prep	O
mortality	NN	pobj	O
and	CC	cc	O
morbidity	NN	conj	O
in	IN	prep	O
Western	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
societies	NNS	pobj	O
.	.	punct	O

A	DT	det	O
validated	JJ	amod	O
assay	NN	nsubjpass	O
in	IN	case	O
human	JJ	amod	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
obesity	NN	nmod	O
.	.	punct	O
Development	NN	nsubjpass	O
of	IN	case	O
obesity	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
extensive	JJ	amod	O
modifications	NNS	nmod	O
in	IN	case	O
adipose	NN	amod	B-Tissue
tissue	NN	nmod	I-Tissue
involving	VBG	acl	O
adipogenesis	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
proteolysis	NN	conj	O
.	.	punct	O

Several	JJ	amod	O
enzyme	NN	compound	O
systems	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
metalloproteinases	NNS	nsubj	O
(	-LRB-	punct	O
MPs	NNS	appos	O
)	-RRB-	punct	O
appear	VBP	conj	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
major	JJ	amod	O
group	NN	xcomp	O
involved	VBN	acl	O
in	IN	case	O
most	JJS	amod	O
instances	NNS	nmod	O
of	IN	case	O
neoplastic	JJ	amod	O
invasion	NN	nmod	O
.	.	punct	O
The	DT	det	O
fibrinolytic	JJ	amod	O
(	-LRB-	punct	O
plasminogen	NN	compound	B-Gene_or_gene_product
/	:	punct	O
plasmin	NN	nsubj	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
systems	NNS	nsubj	O
cooperate	VBP	ROOT	O
in	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
.	.	punct	O

A	DT	det	O
validated	JJ	amod	O
assay	NN	nsubjpass	O
in	IN	case	O
human	JJ	amod	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
obesity	NN	nmod	O
.	.	punct	O
A	DT	det	O
nutritionally	RB	advmod	O
induced	VBN	amod	O
obesity	NN	compound	O
model	NN	nsubjpass	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
extensively	RB	advmod	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
fibrinolytic	JJ	amod	O
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
systems	NNS	nmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
obesity	NN	nmod	O
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	O
and	CC	cc	O
MYC	NN	conj	O
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O
These	DT	det	O
studies	NNS	nsubj	O
support	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
of	IN	case	O
both	DT	det	O
systems	NNS	nmod	O
in	IN	case	O
adipogenesis	NN	nmod	O
and	CC	cc	O
obesity	NN	conj	O
;	:	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
specific	JJ	amod	O
members	NNS	nmod	O
of	IN	case	O
these	DT	det	O
families	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
remains	VBZ	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

Collagen	NNP	nmod:npmod	O
-	HYPH	punct	O
poly	JJ	amod	O
glycolic	JJ	amod	O
acid	NN	compound	O
hybrid	NN	compound	O
matrix	NN	nsubj	O
with	IN	case	O
basic	JJ	amod	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	nmod	O
accelerated	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	O
tissue	NN	compound	O
formation	NN	conj	O
in	IN	case	O
diabetic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Extracellular	JJ	amod	B-Cellular_component
matrix	NN	ROOT	I-Cellular_component
as	IN	case	O
a	DT	det	O
bioactive	JJ	amod	O
material	NN	nmod	O
for	IN	case	O
soft	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
reconstruction	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
The	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nsubj	I-Cellular_component
(	-LRB-	punct	O
ECM	NN	appos	B-Cellular_component
)	-RRB-	punct	O
directs	VBZ	ROOT	O
all	DT	det	O
phases	NNS	dobj	O
of	IN	case	O
healing	VBG	nmod	O
following	VBG	case	O
trauma	NN	nmod	O
or	CC	cc	O
disease	NN	conj	O
and	CC	cc	O
is	VBZ	cop	O
therefore	RB	advmod	O
a	DT	det	O
natural	JJ	amod	O
source	NN	conj	O
of	IN	case	O
prosthetic	JJ	amod	O
mesh	NN	amod	O
material	NN	nmod	O
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
used	VBN	acl:relcl	O
strategically	RB	advmod	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
repair	NN	dobj	O
and	CC	cc	O
restoration	NN	conj	O
of	IN	case	O
soft	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
following	VBG	case	O
surgery	NN	nmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Biomaterials	NNS	nsubj	O
such	JJ	amod	O
as	IN	prep	O
Surgisis	NNP	pobj	O
(	-LRB-	punct	O
Cook	NNP	compound	O
Biotech	NNP	compound	O
Incorporated	NNP	appos	O
,	,	punct	O
West	NNP	compound	O
Lafayette	NNP	conj	O
,	,	punct	O
IN	RB	conj	O
,	,	punct	O
USA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
derived	VBN	acl:relcl	O
from	IN	case	O
natural	JJ	amod	O
ECM	NNS	nmod	B-Cellular_component
,	,	punct	O
provide	VBP	ROOT	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
components	NNS	dobj	I-Cellular_component
necessary	JJ	amod	O
to	TO	mark	O
direct	VB	xcomp	O
the	DT	det	O
healing	NN	compound	O
response	NN	dobj	O
,	,	punct	O
allow	VBP	advcl	O
for	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
,	,	punct	O
healthy	JJ	dep	O
tissue	NN	nmod	B-Tissue
and	CC	cc	O
restore	VB	conj	O
tissue	NN	compound	B-Tissue
integrity	NN	dobj	O
to	TO	case	O
the	DT	det	O
damaged	VBN	amod	O
site	NN	nmod	O
.	.	punct	O

Ultrastructural	JJ	amod	O
evidence	NN	nsubj	O
reveals	VBZ	ROOT	O
that	IN	mark	O
at	IN	case	O
8	CD	nummod	O
weeks	NNS	nmod	O
the	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
composed	VBN	ccomp	O
primarily	RB	advmod	O
of	IN	case	O
collagen	NN	nmod	O
and	CC	cc	O
fibroblasts	NNS	conj	O
with	IN	case	O
rough	JJ	amod	O
endoplasmic	JJ	amod	O
reticulum	NN	nmod	O
and	CC	cc	O
vesicles	NNS	conj	O
.	.	punct	O
The	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
D	NN	compound	O
organization	NN	nsubj	O
of	IN	case	O
these	DT	det	O
extracellular	JJ	amod	B-Cellular_component
components	NNS	nmod	I-Cellular_component
distinguishes	VBZ	ROOT	O
the	DT	det	O
Surgisis	NNP	dobj	O
mesh	NN	amod	O
from	IN	prep	O
synthetic	JJ	amod	O
materials	NNS	pobj	O
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
constructive	JJ	amod	O
tissue	NN	nmod	B-Tissue
remodelling	VBG	acl	O
instead	RB	advmod	O
of	IN	case	O
scar	JJ	compound	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
ones	NNS	pobj	O
requires	VBZ	ROOT	O
highly	RB	advmod	O
coordinated	VBN	amod	O
restructuring	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
surrounding	JJ	amod	O
extracellular	JJ	amod	O
matrix	NN	conj	O
.	.	punct	O
Common	JJ	amod	O
features	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
ECM	NNP	npadvmod	B-Cellular_component
-	HYPH	punct	O
assisted	VBN	amod	O
tissue	NN	compound	B-Tissue
remodelling	VBG	nmod	O
include	VBP	ROOT	O
angiogenesis	NN	dobj	O
,	,	punct	O
recruitment	NN	appos	O
of	IN	case	O
circulating	VBG	amod	O
progenitor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
constructive	JJ	amod	O
remodelling	NN	conj	O
of	IN	case	O
damaged	VBN	amod	O
tissue	NN	compound	B-Tissue
structures	NNS	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
-	:	punct	O
2	CD	nummod	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
exclusively	RB	advmod	O
in	IN	case	O
fibroblasts	NNS	nmod	O
,	,	punct	O
reaching	VBG	advcl	O
maximum	NN	amod	O
levels	NNS	dobj	O
8	CD	compound	O
-	SYM	punct	O
12	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	dep	O
,	,	punct	O
decreasing	VBG	advcl	O
by	IN	prep	O
1	CD	pobj	O
.	.	punct	O
5	CD	nummod	O
years	NNS	nsubj	O
but	CC	cc	O
remaining	VBG	conj	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
tissue	NN	compound	B-Tissue
response	NN	nsubjpass	O
to	TO	case	O
this	DT	det	O
biologic	JJ	amod	O
mesh	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
in	IN	prep	O
the	DT	det	O
context	NN	pobj	O
of	IN	case	O
recent	JJ	amod	O
reports	NNS	nmod	O
on	IN	prep	O
clinical	JJ	amod	O
hernia	NN	compound	B-Pathological_formation
repair	NN	pobj	O
.	.	punct	O

[	-LRB-	punct	O
Tumor	NN	compound	O
metastasis	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
fibrinolytic	JJ	amod	O
system	NN	conj	O
]	-RRB-	punct	O
.	.	punct	O
[	-LRB-	punct	O
Study	NN	ROOT	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
spontaneous	JJ	amod	O
apoptosis	NN	conj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
relevance	NN	conj	O
in	IN	case	O
laryngeal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
]	-RRB-	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Head	NNP	nsubjpass	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinomas	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	dep	O
to	TO	mark	O
overexpress	VB	xcomp	O
hypoxia	NN	compound	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	dep	O
(	-LRB-	punct	O
HIF	NN	compound	O
)	-RRB-	punct	O
-	:	punct	O
1alpha	NN	dobj	O
,	,	punct	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	appos	O
that	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
angiogenesis	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
programmed	VBN	intj	O
and	CC	cc	O
therapy	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O
OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
relationship	NN	dobj	O
among	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
spontaneous	JJ	amod	O
apoptosis	NN	conj	O
and	CC	cc	O
clinicopathological	JJ	amod	O
parameters	NNS	conj	O
in	IN	case	O
laryngeal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
LSCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
roles	NNS	nsubj	O
of	IN	case	O
miscrovascularity	NN	compound	O
density	NN	nmod	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
VEGF	NN	compound	O
expression	NN	conj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
(	-LRB-	punct	O
OSCC	NN	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	cop	O
controversial	JJ	ROOT	O
.	.	punct	O
METHOD	NN	ROOT	O
:	:	punct	O
The	DT	det	O
intratumor	NN	compound	B-Tissue
microvessel	NN	compound	I-Tissue
density	NN	nsubjpass	O
(	-LRB-	punct	O
IMVD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
apoptotic	JJ	amod	O
index	NN	compound	O
(	-LRB-	punct	O
AI	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	conj	O
were	VBD	auxpass	O
detected	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	compound	O
SABC	NN	nmod	O
and	CC	cc	O
terminal	JJ	amod	O
uridine	NN	compound	O
deoxynucleotidyl	NN	compound	O
transferase	NN	compound	O
mediated	JJ	amod	O
nick	NNS	compound	O
end	NN	compound	O
labeling	NN	compound	O
(	-LRB-	punct	O
TUNEL	NN	appos	O
)	-RRB-	punct	O
methods	NNS	conj	O
in34	NN	compound	O
LSCC	NN	compound	B-Cancer
patients	NNS	conj	B-Organism
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
average	JJ	amod	O
fibrinogen	NN	compound	O
levels	NNS	nsubj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pancreatic	JJ	amod	O
carcinoma	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
476	CD	appos	O
.	.	punct	O
21	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
142	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
mg	NN	dep	O
/	:	punct	O
dl	NN	dep	O
,	,	punct	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	appos	O
than	IN	case	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
cholangiolithiasis	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
403	CD	dep	O
.	.	punct	O
28	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
126	CD	dep	O
.	.	punct	O
41	LS	meta	O
)	-RRB-	punct	O
mg	NN	dep	O
/	:	punct	O
dl	NN	dep	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
RESULT	NN	nsubj	O
:	:	punct	O
The	DT	det	O
average	JJ	amod	O
IMVD	NN	nsubj	O
was	VBD	dep	O
(	-LRB-	punct	O
21	CD	nummod	O
.	.	punct	O
50	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
8	CD	attr	O
.	.	punct	O
87	CD	attr	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
median	NN	conj	O
of	IN	case	O
AI	NN	nmod	O
was	VBD	ROOT	O
1	CD	attr	O
.	.	punct	O
15	CD	nummod	O
%	NN	ROOT	O
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
average	JJ	amod	O
IMVD	NN	nsubj	O
in	IN	case	O
positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
cervical	JJ	amod	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
metastasis	NN	nmod	O
was	VBD	ROOT	O
(	-LRB-	punct	O
26	CD	nummod	O
.	.	punct	O
33	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	attr	O
.	.	punct	O
70	CD	attr	O
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	O
17	CD	nummod	O
.	.	punct	O
68	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
6	CD	nummod	O
.	.	punct	O
06	CD	conj	O
)	-RRB-	punct	O
respectively	RB	advmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
IMVD	NN	nsubj	O
with	IN	case	O
positive	JJ	amod	O
lymphatic	JJ	amod	B-Cancer
metastasis	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
was	VBD	cop	O
statistical	JJ	conj	O
significantly	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
negative	JJ	amod	O
cervical	JJ	amod	B-Cancer
lymphatic	JJ	amod	I-Cancer
metastasis	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubj	O
was	VBD	ROOT	O
the	DT	det	O
aim	NN	attr	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
to	TO	mark	O
compare	VB	advcl	O
the	DT	det	O
value	NN	dobj	O
of	IN	case	O
measurement	NN	nmod	O
of	IN	case	O
glucose	NN	compound	O
metabolism	NN	nmod	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
measurement	NN	nmod	O
of	IN	case	O
123I	CD	compound	O
-	HYPH	punct	O
IMT	NN	compound	O
uptake	NN	nmod	O
for	IN	prep	O
the	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
invasive	JJ	amod	O
grading	NN	pobj	O
of	IN	prep	O
brain	NN	compound	O
tumours	NNS	pobj	O
.	.	punct	O
The	DT	det	O
average	JJ	amod	O
IMVD	NN	nsubj	O
had	VBD	ROOT	O
statistical	JJ	amod	O
difference	NN	dobj	O
in	IN	case	O
histological	JJ	amod	O
grading	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
analysis	NN	conj	O
by	IN	case	O
one	CD	nmod	O
to	IN	case	O
one	CD	nmod	O
,	,	punct	O
the	DT	det	O
average	JJ	amod	O
IMVD	NN	nsubj	O
had	VBD	parataxis	O
statistical	JJ	amod	O
difference	NN	dobj	O
between	IN	case	O
high	JJ	amod	O
and	CC	cc	O
median	JJ	conj	O
grading	NN	nmod	O
.	.	punct	O

VEGF	NN	compound	O
gene	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
capillary	JJ	amod	O
density	NN	conj	O
in	IN	case	O
the	DT	det	O
old	JJ	amod	O
donor	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
were	VBD	cop	O
lower	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
young	JJ	amod	O
donor	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
group	NN	nmod	O
but	CC	cc	O
higher	JJR	conj	O
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
Expression	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
positive	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
IMVD	NN	nmod	O
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
51	CD	nummod	O
,	,	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
01	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Irreversible	JJ	amod	O
PHT	NN	compound	O
cases	NNS	nsubj	O
were	VBD	cop	O
also	RB	advmod	O
more	RBR	advmod	O
likely	JJ	ROOT	O
to	TO	mark	O
show	VB	xcomp	O
compensatory	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
and	CC	cc	O
new	JJ	amod	O
small	JJ	amod	O
vessel	NN	compound	O
formation	NN	conj	O
at	IN	case	O
the	DT	det	O
sites	NNS	nmod	O
of	IN	case	O
native	JJ	amod	O
vessel	NN	compound	O
stenosis	NN	nmod	O
or	CC	cc	O
occlusion	NN	conj	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O
Statistical	JJ	amod	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
inverse	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
AI	NN	nmod	O
and	CC	cc	O
IMVD	NN	conj	O
(	-LRB-	punct	O
r	NN	dep	O
=	JJ	amod	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
53	CD	dep	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
find	VB	xcomp	O
the	DT	det	O
statistical	JJ	amod	O
difference	NN	dobj	O
between	IN	case	O
IMVD	NN	nmod	O
and	CC	cc	O
tumor	NN	conj	B-Cancer
T	NN	compound	O
-	HYPH	punct	O
stage	NN	dep	O
in	IN	case	O
LSCC	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
group	NN	nsubj	O
with	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
than	IN	case	O
the	DT	det	O
group	NN	nmod	O
without	IN	case	O
lymphatic	JJ	amod	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
IMVD	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
indicator	NN	appos	O
to	TO	mark	O
predict	VB	acl	O
cervical	JJ	amod	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
metastasis	NN	dobj	O
in	IN	case	O
LSCC	NN	nmod	B-Cancer
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
growth	NN	compound	O
factor	NN	appos	O
with	IN	case	O
significant	JJ	amod	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	O
tumor	NN	compound	O
angiogenesis	NN	compound	O
regulator	NN	ROOT	O
.	.	punct	O
VEGF	NNP	nsubj	B-Gene_or_gene_product
might	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
angiogenic	JJ	amod	O
factor	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
promote	VB	conj	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
in	IN	case	O
LSCC	NN	nmod	B-Cancer
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Angiostatin	NN	nsubj	O
and	CC	cc	O
thalidomide	NN	conj	O
inhibit	VBP	appos	O
tumor	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
might	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cancer
malignant	JJ	amod	O
progression	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
spontaneous	JJ	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
LSCC	NN	nmod	B-Cancer
.	.	punct	O

NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	ROOT	O
and	CC	cc	O
IKK	NN	conj	O
as	IN	case	O
therapeutic	JJ	amod	O
targets	NNS	nmod	O
in	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
The	DT	det	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
'	''	punct	O
s	NNS	ROOT	O
"	``	punct	O
power	NN	compound	O
plants	NNS	appos	O
"	''	punct	O
as	IN	prep	O
promising	VBG	pcomp	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
:	:	punct	O
an	DT	det	O
overview	NN	dep	O
.	.	punct	O

This	DT	det	O
collection	NN	nsubj	O
of	IN	prep	O
reviews	NNS	pobj	O
at	IN	prep	O
the	DT	det	O
front	NN	amod	O
-	HYPH	punct	O
edge	NN	pobj	O
of	IN	prep	O
scientific	JJ	amod	O
knowledge	NN	pobj	O
focuses	VBZ	ROOT	O
on	IN	case	O
host	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	O
cell	NN	compound	O
interactions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
disastrous	JJ	amod	O
consequences	NNS	nsubj	O
they	PRP	nsubj	O
can	MD	aux	O
produce	VB	relcl	O
and	CC	cc	O
approaches	VBZ	conj	O
the	DT	det	O
ways	NNS	dobj	O
to	TO	aux	O
break	VB	acl	O
up	RP	prt	O
these	DT	det	O
cellular	JJ	amod	O
conspiracies	NNS	dobj	O
,	,	punct	O
to	TO	aux	O
leave	VB	parataxis	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	dobj	O
unattended	VBD	conj	O
and	CC	cc	O
vulnerable	JJ	conj	O
.	.	punct	O
This	DT	det	O
introductory	JJ	amod	O
article	NN	nsubj	O
to	IN	prep	O
the	DT	det	O
review	NN	compound	O
series	NN	pobj	O
entitled	VBN	ROOT	O
"	``	punct	O
The	DT	det	O
Cancer	NNP	compound	B-Cell
Cell	NNP	compound	I-Cell
'	''	punct	O
s	VBZ	compound	O
Power	NNP	compound	O
Plants	NNS	dobj	O
as	IN	prep	O
Promising	NNP	compound	O
Therapeutic	NNP	compound	O
Targets	NNPS	pobj	O
"	''	punct	O
is	VBZ	auxpass	O
written	VBN	ccomp	O
while	IN	mark	O
more	JJR	amod	O
than	IN	quantmod	O
20	CD	compound	O
million	CD	nummod	O
people	NNS	nsubj	O
suffer	VBP	advcl	O
from	IN	prep	O
cancer	NN	pobj	B-Cancer
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
It	PRP	nsubj	O
summarizes	VBZ	ROOT	O
strategies	NNS	dobj	O
to	TO	mark	O
destroy	VB	xcomp	O
or	CC	cc	O
prevent	VB	conj	O
cancers	NNS	dobj	B-Cancer
by	IN	mark	O
targeting	VBG	advcl	O
their	PRP$	poss	O
energy	NN	compound	O
production	NN	compound	O
factories	NNS	dobj	O
,	,	punct	O
i	LS	appos	O
.	.	punct	O
e	LS	nsubj	O
.	.	ROOT	O
,	,	punct	O
"	``	punct	O
power	NN	compound	O
plants	NNS	appos	O
.	.	punct	O
"	''	ROOT	O
All	DT	det	O
nucleated	JJ	amod	O
animal	NN	compound	B-Organism
/	:	punct	O
human	JJ	amod	B-Organism
cells	NNS	nsubj	B-Cell
have	VBP	ROOT	O
two	CD	nummod	O
types	NNS	dobj	O
of	IN	prep	O
power	NN	compound	O
plants	NNS	pobj	O
,	,	punct	O
i	LS	appos	O
.	.	punct	O
e	LS	ROOT	O
.	.	punct	O
,	,	punct	O
systems	NNS	appos	O
that	WDT	nsubj	O
make	VBP	relcl	O
the	DT	det	O
"	``	punct	O
high	JJ	amod	O
energy	NN	compound	O
"	''	punct	O
compound	JJ	compound	O
ATP	NN	dobj	B-Simple_chemical
from	IN	case	O
ADP	NN	nmod	B-Simple_chemical
and	CC	cc	O
P	NN	conj	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
i	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cancer	NN	compound	O
cells	NNS	nsubj	O
depend	VBP	ROOT	O
mostly	RB	advmod	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
aerobic	JJ	amod	O
breakdown	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
into	IN	case	O
ATP	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
type	NN	nsubj	O
is	VBZ	ROOT	O
"	``	punct	O
glycolysis	NN	attr	O
,	,	punct	O
"	``	punct	O
the	DT	det	O
other	JJ	amod	O
the	DT	det	O
"	``	punct	O
mitochondria	NN	attr	B-Cellular_component
.	.	punct	O
"	''	ROOT	O
In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
most	RBS	advmod	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
where	WRB	advmod	O
the	DT	det	O
mitochondria	NN	nsubj	B-Cellular_component
are	VBP	cop	O
the	DT	det	O
major	JJ	amod	O
ATP	NN	compound	B-Simple_chemical
producers	NNS	acl:relcl	O
(	-LRB-	punct	O
>	NN	dep	O
90	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
in	IN	mark	O
fueling	VBG	advcl	O
growth	NN	dobj	O
,	,	punct	O
human	JJ	amod	B-Organism
cancers	NNS	nsubj	B-Cancer
detected	VBN	acl	O
via	IN	case	O
Positron	NNP	compound	O
Emission	NNP	compound	O
Tomography	NN	nmod	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
rely	VBP	ROOT	O
on	IN	case	O
both	DT	det	O
types	NNS	nmod	O
of	IN	case	O
power	NN	compound	O
plants	NNS	nmod	O
.	.	punct	O

Lactate	NN	nsubjpass	O
and	CC	cc	O
pyruvate	NN	conj	O
,	,	punct	O
the	DT	det	O
end	NN	compound	O
products	NNS	appos	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
highly	RB	advmod	O
produced	VBN	ROOT	O
by	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
oxygen	NN	nmod	O
.	.	punct	O
In	IN	case	O
such	JJ	amod	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
glycolysis	NN	nsubj	O
may	MD	aux	O
contribute	VB	ROOT	O
nearly	RB	advmod	O
half	PDT	nummod	O
the	DT	det	O
ATP	NN	dobj	B-Simple_chemical
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
oxygen	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
"	``	punct	O
Warburg	NN	compound	O
effect	NN	dep	O
"	''	punct	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Based	VBN	advcl	O
solely	RB	advmod	O
on	IN	prep	O
cell	NN	compound	B-Cell
energetics	NNS	pobj	O
,	,	punct	O
this	DT	nsubj	O
presents	VBZ	ROOT	O
a	DT	det	O
challenge	NN	dobj	O
to	TO	mark	O
identify	VB	acl	O
curative	JJ	amod	O
agents	NNS	dobj	O
that	WDT	nsubj	O
destroy	VBP	acl:relcl	O
only	JJ	advmod	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
as	IN	mark	O
they	PRP	nsubj	O
must	MD	aux	O
destroy	VB	advcl	O
both	DT	dobj	O
of	IN	prep	O
their	PRP$	poss	O
power	NN	compound	O
plants	NNS	pobj	O
causing	VBG	acl	O
"	``	punct	O
necrotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
"	''	punct	O
and	CC	cc	O
leave	VB	conj	O
normal	JJ	amod	O
cells	NNS	dobj	B-Cell
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cancer	NN	compound	O
cells	NNS	nsubj	O
depend	VBP	ROOT	O
mostly	RB	advmod	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
aerobic	JJ	amod	O
breakdown	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
into	IN	case	O
ATP	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
such	JJ	amod	O
agent	NN	nsubjpass	O
,	,	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bromopyruvate	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
analog	NN	appos	I-Simple_chemical
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
both	CC	cc:preconj	O
glycolytic	JJ	amod	O
and	CC	cc	O
mitochondrial	JJ	conj	B-Cellular_component
ATP	NN	compound	B-Simple_chemical
production	NN	dobj	O
in	IN	case	O
rapidly	RB	advmod	O
growing	VBG	amod	O
cancers	NNS	nmod	B-Cancer
(	-LRB-	punct	O
Ko	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
Cancer	NNP	compound	O
Letts	NNP	appos	O
.	NNP	punct	O
,	,	punct	O
173	CD	nummod	O
,	,	punct	O
83	CD	compound	O
-	SYM	punct	O
91	CD	conj	O
,	,	punct	O
2001	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
leave	VB	conj	O
normal	JJ	amod	O
cells	NNS	dobj	B-Cell
alone	RB	advmod	O
,	,	punct	O
and	CC	cc	O
eradicate	VB	conj	O
advanced	JJ	amod	O
cancers	NNS	dobj	B-Cancer
(	-LRB-	punct	O
19	CD	compound	O
of	IN	advmod	O
19	CD	appos	O
)	-RRB-	punct	O
in	IN	case	O
a	DT	det	O
rodent	JJ	amod	B-Organism
model	NN	nmod	O
(	-LRB-	punct	O
Ko	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
Biochem	NNP	appos	O
.	.	punct	O
Biophys	NNP	ROOT	O
.	.	punct	O
Res	NNP	ROOT	O
.	.	punct	O
Commun	NNP	ROOT	O
.	.	punct	O
,	,	punct	O
324	CD	conj	O
,	,	punct	O
269	CD	nummod	O
-	SYM	punct	O
275	CD	conj	O
,	,	punct	O
2004	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
altered	JJ	amod	O
energy	NN	compound	O
dependency	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
as	IN	prep	O
the	DT	det	O
"	``	punct	O
Warburg	NNP	compound	O
effect	NN	pobj	O
"	''	punct	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	conj	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
A	DT	det	O
second	JJ	amod	O
approach	NN	nsubj	O
is	VBZ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
only	JJ	amod	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
undergo	VB	xcomp	O
"	``	punct	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O
"	''	ROOT	O
Here	RB	ROOT	O
,	,	punct	O
mitochondria	NN	nsubj	B-Cellular_component
release	NN	intj	O
cell	NN	compound	B-Cell
death	NN	compound	O
inducing	NN	compound	O
factors	NNS	dobj	O
(	-LRB-	punct	O
e	NN	dep	O
.	.	punct	O
g	NN	ROOT	O
.	.	punct	O
,	,	punct	O
cytochrome	NN	compound	B-Gene_or_gene_product
c	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
should	MD	aux	O
diminish	VB	ROOT	O
apoptosis	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
In	IN	case	O
a	DT	det	O
third	JJ	amod	O
approach	NN	nmod	O
,	,	punct	O
cancer	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
induced	VBN	ROOT	O
to	TO	mark	O
die	VB	xcomp	O
by	IN	case	O
both	CC	cc:preconj	O
apoptotic	JJ	amod	O
and	CC	cc	O
necrotic	JJ	conj	O
events	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
doxorubicin	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
cell	NN	compound	O
death	NN	dobj	O
by	IN	case	O
apoptosis	NN	nmod	O
only	RB	advmod	O
at	IN	case	O
particular	JJ	amod	O
dose	NN	nmod	O
and	CC	cc	O
treatment	NN	compound	O
conditions	NNS	conj	O
and	CC	cc	O
imply	VBP	conj	O
a	DT	det	O
completely	RB	advmod	O
different	JJ	amod	O
cellular	JJ	amod	O
response	NN	dobj	O
following	VBG	case	O
bolus	NN	nmod	O
or	CC	cc	O
continuous	JJ	amod	O
exposure	NN	conj	O
to	TO	case	O
doxorubicin	NN	nmod	O
.	.	punct	O
In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
much	JJ	amod	O
effort	NN	nsubjpass	O
is	VBZ	aux	O
being	VBG	auxpass	O
focused	VBN	ROOT	O
on	IN	mark	O
identifying	VBG	advcl	O
agents	NNS	dobj	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
"	``	punct	O
necrotic	JJ	dobj	O
,	,	punct	O
"	''	punct	O
"	``	punct	O
apoptotic	JJ	amod	O
"	''	punct	O
or	CC	cc	O
apoptotic	JJ	amod	O
plus	CC	cc	O
necrotic	JJ	conj	O
cell	NN	compound	O
death	NN	dobj	O
only	RB	advmod	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Cancer	NNP	nsubjpass	O
is	VBZ	auxpass	O
no	RB	neg	O
longer	RBR	advmod	O
considered	VBN	ROOT	O
by	IN	agent	O
scientists	NNS	pobj	O
just	RB	advmod	O
a	DT	det	O
jumble	NN	nmod	O
of	IN	case	O
mutated	VBN	amod	O
cells	NNS	nmod	O
.	.	punct	O
Regardless	RB	advmod	O
how	WRB	advmod	O
death	NN	nsubjpass	O
is	VBZ	auxpass	O
inflicted	JJ	advcl	O
,	,	punct	O
every	DT	det	O
cancer	NN	compound	B-Cell
cell	NN	nsubj	I-Cell
must	MD	aux	O
die	VB	advcl	O
,	,	punct	O
be	VB	ROOT	O
it	PRP	nsubj	O
fast	JJ	acomp	O
or	CC	cc	O
slow	JJ	conj	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
blood	NN	compound	O
flow	NN	nmod	O
in	IN	case	O
linomide	NN	npadvmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
showed	VBD	ROOT	O
localization	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
almost	RB	advmod	O
exclusively	RB	advmod	O
to	TO	case	O
the	DT	det	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
tumors	NNS	nmod	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
vascular	JJ	amod	O
functionality	NN	nmod	O
and	CC	cc	O
vasodilation	NN	conj	O
.	.	punct	O
Pathological	JJ	amod	O
animal	NN	compound	O
models	NNS	ROOT	O
in	IN	case	O
the	DT	det	O
experimental	JJ	amod	O
evaluation	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
with	IN	case	O
magnetic	JJ	amod	O
resonance	NN	compound	O
imaging	VBG	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Antiangiogenic	JJ	amod	O
therapy	NN	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	dep	O
as	IN	case	O
an	DT	det	O
effective	JJ	amod	O
strategy	NN	nmod	O
for	IN	mark	O
controlling	VBG	acl	O
the	DT	det	O
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
applications	NNS	dobj	O
of	IN	case	O
magnetic	JJ	amod	O
resonance	NN	compound	O
imaging	NN	nmod	O
(	-LRB-	punct	O
MRI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
dynamic	JJ	amod	O
contrast	NN	nsubj	O
-	HYPH	punct	O
enhanced	VBN	amod	O
MRI	NN	conj	O
(	-LRB-	punct	O
DCE	NN	compound	O
-	:	punct	O
MRI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
assessment	NN	nmod	O
of	IN	case	O
tumour	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
by	IN	case	O
means	NNS	dep	O
of	IN	case	O
animal	NN	compound	O
tumour	NN	compound	B-Cancer
models	NNS	nmod	O
evaluated	VBN	acl	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
antiangiogenic	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
colon	NN	compound	O
cancers	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Forty	CD	compound	O
-	HYPH	punct	O
two	CD	nummod	O
MRI	NN	compound	O
exams	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
intravascular	JJ	amod	B-Immaterial_anatomical_entity
contrast	NN	compound	O
media	NNS	nmod	O
in	IN	case	O
21	CD	nummod	O
rats	NNS	nmod	B-Organism
:	:	punct	O
tumours	NNS	nsubjpass	B-Cancer
were	VBD	auxpass	O
induced	VBN	parataxis	O
by	IN	case	O
subcutaneous	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
7	CD	nummod	O
rats	NNS	nmod	B-Organism
and	CC	cc	O
mammary	JJ	amod	B-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
14	CD	nummod	O
rats	NNS	nmod	B-Organism
.	.	punct	O

sDll4	NN	nsubj	O
similarly	RB	advmod	O
induced	VBD	ROOT	O
defective	JJ	amod	O
vascular	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
implants	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
reduced	VBN	amod	O
tumor	NN	compound	O
growth	NN	nmod	O
.	.	punct	O
Perfusion	NN	nsubjpass	O
and	CC	cc	O
permeability	NN	conj	O
parameters	NNS	conj	O
of	IN	case	O
the	DT	det	O
implanted	VBN	amod	O
tumours	NNS	nmod	B-Cancer
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
two	CD	nummod	O
contrast	NN	compound	O
media	NNS	dobj	O
(	-LRB-	punct	O
B22956	NN	compound	B-Simple_chemical
/	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
and	CC	cc	O
Gd	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DTPA37	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
albumin	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
to	TO	mark	O
establish	VB	advcl	O
response	NN	dobj	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
antiangiogenic	JJ	amod	O
drugs	NNS	nmod	O
(	-LRB-	punct	O
tamoxifen	NN	dep	B-Simple_chemical
and	CC	cc	O
SU6668	NN	conj	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

By	IN	case	O
means	NNS	nmod	O
of	IN	case	O
intravital	JJ	amod	O
microscopy	NN	nmod	O
,	,	punct	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
alpha	NN	nmod:npmod	O
-	:	punct	O
stimulated	VBN	amod	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
ear	NN	amod	O
skin	NN	compound	O
microvessels	NNS	nmod	O
of	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
bearing	VBG	acl	O
small	JJ	amod	O
human	JJ	amod	O
LS174T	NN	compound	O
colon	NN	compound	O
carcinomas	NNS	dobj	O
and	CC	cc	O
in	IN	case	O
C57Bl	NN	compound	O
/	SYM	punct	O
6	CD	nummod	O
mice	NNS	conj	O
bearing	VBG	acl	O
murine	JJ	amod	O
B16F10	NN	compound	O
melanomas	NNS	dobj	O
.	.	punct	O
These	DT	det	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
histology	NN	nmod	O
to	TO	mark	O
obtain	VB	xcomp	O
a	DT	det	O
radiological	JJ	amod	O
-	HYPH	punct	O
histological	JJ	amod	O
map	NN	dobj	O
of	IN	prep	O
tumour	NN	compound	B-Tissue
microvasculature	NN	pobj	I-Tissue
.	.	punct	O

AIM	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
HER2	NN	nmod	O
and	CC	cc	O
bradykinin	NN	compound	O
B	NN	conj	O
(	-LRB-	punct	O
1	CD	appos	O
)	-RRB-	punct	O
receptors	NNS	dep	O
(	-LRB-	punct	O
B	NN	dep	O
(	-LRB-	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
R	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
pathogenic	JJ	amod	O
models	NNS	nmod	O
of	IN	case	O
gallbladder	NN	compound	O
cancer	NN	nmod	O
:	:	punct	O
the	DT	det	O
metaplasia	NN	compound	O
-	HYPH	punct	O
dysplasia	NN	compound	O
-	HYPH	punct	O
carcinoma	NN	dobj	O
and	CC	cc	O
the	DT	det	O
adenoma	NN	compound	O
-	HYPH	punct	O
carcinoma	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O
RESULTS	NNS	nsubj	O
:	:	punct	O
DCE	NN	compound	O
-	:	punct	O
MRI	NN	nsubj	O
revealed	VBD	ROOT	O
greater	JJR	amod	O
enhancement	NN	dobj	O
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	B-Organism_subdivision
area	NN	nmod	I-Organism_subdivision
than	IN	case	O
in	IN	case	O
the	DT	det	O
central	JJ	amod	B-Organism_subdivision
area	NN	nmod	I-Organism_subdivision
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
examined	VBN	amod	O
animal	NN	compound	O
models	NNS	nmod	O
.	.	punct	O

In	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
prevention	NN	pobj	O
and	CC	cc	O
intervention	NN	conj	O
experiments	NNS	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
diminution	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	O
size	NN	nmod	O
and	CC	cc	O
weight	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
drug	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
experiment	NN	nmod	O
,	,	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	conj	O
measured	VBN	acl	O
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
B22956	NN	nmod	B-Simple_chemical
/	:	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
animals	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
drug	NN	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
0043317	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
0040418	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	nsubj	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
less	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
untreated	JJ	amod	O
animals	NNS	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
0090460	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
0043680	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	compound	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	nmod	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
significant	JJ	amod	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
with	IN	case	O
Gd	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
DTPA	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
albumin	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
13	CD	nummod	O
.	.	punct	O
14	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
13	CD	dep	O
.	.	punct	O
94	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	conj	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
treated	VBN	amod	O
animals	NNS	nmod	O
and	CC	cc	O
18	CD	conj	O
.	.	punct	O
07	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
11	CD	nummod	O
.	.	punct	O
92	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	conj	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
in	IN	case	O
untreated	JJ	amod	O
animals	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

By	IN	case	O
means	NNS	nmod	O
of	IN	case	O
intravital	JJ	amod	O
microscopy	NN	nmod	O
,	,	punct	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
alpha	NN	nmod:npmod	O
-	:	punct	O
stimulated	VBN	amod	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
ear	NN	amod	O
skin	NN	compound	O
microvessels	NNS	nmod	O
of	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
bearing	VBG	acl	O
small	JJ	amod	O
human	JJ	amod	O
LS174T	NN	compound	O
colon	NN	compound	O
carcinomas	NNS	dobj	O
and	CC	cc	O
in	IN	case	O
C57Bl	NN	compound	O
/	SYM	punct	O
6	CD	nummod	O
mice	NNS	conj	O
bearing	VBG	acl	O
murine	JJ	amod	O
B16F10	NN	compound	O
melanomas	NNS	dobj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
colon	NN	compound	B-Cancer
carcinoma	NN	compound	I-Cancer
experiment	NN	nmod	O
,	,	punct	O
mean	NN	amod	O
permeability	NN	nsubj	O
and	CC	cc	O
perfusion	NN	conj	O
decreased	VBD	ROOT	O
by	IN	case	O
51	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
from	IN	prep	O
5	CD	pobj	O
.	.	punct	O
2	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	ROOT	O
.	.	punct	O
1	CD	meta	O
to	TO	dep	O
2	CD	dep	O
.	.	punct	O
5	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
8	CD	nummod	O
ml	NN	dep	O
/	SYM	punct	O
100	CD	nummod	O
ml	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
59	CD	nummod	O
%	NN	conj	O
(	-LRB-	punct	O
from	IN	prep	O
0	CD	pobj	O
.	.	punct	O
00165	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
5	CD	dep	O
.	.	punct	O
1	CD	meta	O
to	TO	dep	O
0	CD	dep	O
.	.	punct	O
0067	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	dep	O
.	.	punct	O
8	CD	nummod	O
ml	NN	compound	O
/	:	punct	O
min	NN	ROOT	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
ml	NN	dep	O
(	-LRB-	punct	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
tissue	NN	nmod	B-Tissue
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
all	DT	det	O
animals	NNS	nmod	O
after	IN	case	O
antiangiogenic	JJ	amod	O
drug	NN	compound	O
administration	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
blood	NN	compound	O
flow	NN	nmod	O
in	IN	case	O
linomide	NN	npadvmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
showed	VBD	ROOT	O
localization	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
almost	RB	advmod	O
exclusively	RB	advmod	O
to	TO	case	O
the	DT	det	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
tumors	NNS	nmod	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
vascular	JJ	amod	O
functionality	NN	nmod	O
and	CC	cc	O
vasodilation	NN	conj	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
DCE	NN	compound	O
-	HYPH	punct	O
MRI	NN	nsubj	O
permits	VBZ	appos	O
a	DT	det	O
noninvasive	JJ	amod	O
evaluation	NN	dobj	O
of	IN	prep	O
tumour	NN	compound	B-Cancer
microcirculation	NN	pobj	O
and	CC	cc	O
in	IN	case	O
particular	JJ	conj	O
of	IN	prep	O
its	PRP$	poss	O
dynamic	JJ	amod	O
characteristics	NNS	pobj	O
and	CC	cc	O
vascularity	NN	conj	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
antiangiogenic	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

An	DT	det	O
assay	NN	ROOT	O
to	TO	mark	O
measure	VB	acl	O
angiogenesis	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
fat	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O
Angiogenesis	NN	nsubj	O
in	IN	prep	O
the	DT	det	O
caprine	NN	compound	B-Organism
caruncles	NNS	pobj	B-Organism_subdivision
in	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
pregnant	JJ	pobj	O
and	CC	cc	O
pregnant	JJ	amod	O
normal	JJ	amod	O
and	CC	cc	O
swainsonine	NN	conj	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	conj	O
does	VBZ	ROOT	B-Organism
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
ovarian	JJ	amod	O
corrosion	NN	compound	O
casts	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
NS	NN	nsubj	O
-	HYPH	punct	O
398	CD	nummod	O
inhibited	VBD	ccomp	O
the	DT	det	O
establishment	NN	dobj	O
of	IN	case	O
luteal	JJ	amod	O
capillary	JJ	amod	O
vessels	NNS	nmod	O
following	VBG	case	O
the	DT	det	O
injection	NN	nmod	O
of	IN	case	O
hCG	NN	nmod	O
.	.	punct	O
Microvascular	JJ	amod	B-Tissue
corrosion	NN	compound	O
casts	NNS	nsubj	O
of	IN	prep	O
caruncles	NNS	pobj	B-Organism_subdivision
from	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
pregnant	JJ	amod	O
and	CC	cc	O
pregnant	JJ	conj	O
doe	NN	amod	O
goats	NNS	nsubjpass	B-Organism
at	IN	prep	O
4	CD	nummod	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
10	CD	conj	O
,	,	punct	O
13	CD	conj	O
,	,	punct	O
16	CD	pobj	O
,	,	punct	O
and	CC	cc	O
18	CD	nummod	O
weeks	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
with	IN	case	O
scanning	NN	compound	O
electron	NN	compound	O
microscopy	NN	nmod	O
.	.	punct	O

Blood	NN	compound	O
vessels	NNS	nsubjpass	O
,	,	punct	O
capillaries	NNS	conj	O
,	,	punct	O
and	CC	cc	O
endothelial	JJ	amod	O
pseudopods	NNS	conj	O
were	VBD	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
greater	JJR	amod	O
than	IN	dep	O
100	CD	nummod	O
microns	NNS	nmod	O
from	IN	case	O
the	DT	det	O
capsule	NN	nmod	O
(	-LRB-	punct	O
subcortex	JJ	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
internal	JJ	amod	O
convex	NN	amod	O
surface	NN	nsubjpass	O
of	IN	prep	O
the	DT	det	O
caruncles	NNS	pobj	B-Organism_subdivision
of	IN	prep	O
non	JJ	amod	O
-	HYPH	punct	O
pregnant	JJ	pobj	O
does	NNS	aux	B-Organism
was	VBD	auxpass	O
covered	VBN	ROOT	O
with	IN	prep	O
capillary	JJ	amod	B-Multi-tissue_structure
meshes	NNS	pobj	I-Multi-tissue_structure
of	IN	prep	O
regular	JJ	amod	O
diameter	NN	pobj	O
and	CC	cc	O
form	NN	conj	O
,	,	punct	O
without	IN	prep	O
crypts	NNS	pobj	O
.	.	punct	O

The	DT	det	O
cortex	NN	nsubj	O
within	IN	case	O
100	CD	nummod	O
microns	NNS	nmod	O
of	IN	case	O
the	DT	det	O
capsule	NN	nmod	O
had	VBD	ROOT	O
little	JJ	amod	O
vascularization	NN	dobj	O
.	.	punct	O
As	IN	mark	O
pregnancy	NN	nsubj	O
advanced	VBD	advcl	O
the	DT	det	O
complexity	NN	dobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	B-Multi-tissue_structure
increased	VBD	ROOT	O
:	:	punct	O
at	IN	prep	O
4	CD	nummod	O
weeks	NNS	pobj	O
the	DT	det	O
surface	NN	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
pattern	NN	dobj	O
of	IN	case	O
ridges	NNS	nmod	O
separated	VBN	acl	O
by	IN	case	O
troughs	NN	nmod	O
.	.	punct	O

After	IN	prep	O
7	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
pellets	NNS	nsubj	O
from	IN	prep	O
animals	NNS	pobj	O
fed	VBD	advcl	O
the	DT	det	O
control	JJ	compound	O
diet	NN	nsubjpass	O
were	VBD	auxpass	O
infiltrated	VBN	ROOT	O
by	IN	case	O
abundant	JJ	amod	O
branching	VBG	compound	O
networks	NNS	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
with	IN	case	O
patent	JJ	compound	O
lumen	NN	nmod	O
-	:	punct	O
containing	VBG	acl	O
RBCs	NNS	dobj	O
.	.	punct	O
At	IN	prep	O
later	JJ	amod	O
stages	NNS	pobj	O
,	,	punct	O
branches	NNS	nsubj	B-Multi-tissue_structure
of	IN	prep	O
radial	JJ	amod	B-Multi-tissue_structure
arteries	NNS	pobj	I-Multi-tissue_structure
penetrated	VBD	ROOT	O
the	DT	det	O
periphery	NN	dobj	O
forming	VBG	acl	O
an	DT	det	O
extensive	JJ	amod	O
mesh	NN	dobj	O
of	IN	prep	O
capillaries	NNS	pobj	B-Tissue
on	IN	prep	O
the	DT	det	O
concave	NN	compound	O
surface	NN	pobj	O
.	.	punct	O

In	IN	case	O
unchallenged	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
fibrillar	JJ	amod	O
collagen	NN	nsubj	O
induced	VBD	ROOT	O
robust	JJ	amod	O
capillary	JJ	amod	O
morphogenesis	NN	dobj	O
.	.	punct	O
Capillary	JJ	amod	B-Tissue
diameters	NNS	nsubj	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
during	IN	prep	O
pregnancy	NN	pobj	O
,	,	punct	O
especially	RB	advmod	O
after	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
,	,	punct	O
when	WRB	advmod	O
large	JJ	amod	O
flattened	VBN	amod	O
sinusoids	NNS	nsubj	B-Tissue
formed	VBN	advcl	O
.	.	punct	O

The	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
entirely	RB	advmod	O
supported	VBN	ROOT	O
by	IN	case	O
proliferated	VBN	amod	O
capillaries	NNS	nmod	O
and	CC	cc	O
arteries	NNS	conj	O
together	RB	advmod	O
with	IN	case	O
collagenous	JJ	amod	O
stroma	NN	nmod	O
.	.	punct	O
These	DT	det	O
sinusoids	NNS	nsubj	B-Tissue
had	VBD	ROOT	O
a	DT	det	O
great	JJ	amod	O
deal	NN	dobj	O
of	IN	case	O
surface	NN	compound	O
area	NN	nmod	O
for	IN	case	O
potential	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
the	DT	det	O
fetal	JJ	amod	B-Developing_anatomical_structure
component	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
identical	JJ	ROOT	O
to	TO	case	O
placental	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
The	DT	det	O
caprine	NN	compound	B-Organism
placenta	NN	nsubjpass	B-Organ
is	VBZ	auxpass	O
usually	RB	advmod	O
considered	VBN	ROOT	O
to	TO	mark	O
have	VB	aux	O
increased	VBN	xcomp	O
interhemal	JJ	amod	B-Immaterial_anatomical_entity
distance	NN	dobj	O
compared	VBN	case	O
with	IN	case	O
endotheliochorial	JJ	amod	B-Organ
and	CC	cc	O
hemochorial	JJ	conj	B-Organ
types	NNS	advcl	I-Organ
:	:	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	parataxis	O
that	IN	mark	O
the	DT	det	O
very	RB	advmod	O
extensive	JJ	amod	O
development	NN	nsubj	O
of	IN	case	O
sinusoids	NNS	nmod	B-Tissue
and	CC	cc	O
crypts	NNS	conj	B-Multi-tissue_structure
may	MD	aux	O
compensate	VB	ccomp	O
for	IN	case	O
any	DT	det	O
negative	JJ	amod	O
consequences	NNS	nmod	O
of	IN	case	O
the	DT	det	O
placental	JJ	amod	B-Organ
architecture	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
identical	JJ	ROOT	O
to	TO	case	O
placental	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Placental	JJ	amod	B-Organ
angiogenesis	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
physiologically	RB	advmod	O
normal	JJ	acl:relcl	O
,	,	punct	O
may	MD	aux	O
serve	VB	ROOT	O
as	IN	case	O
a	DT	det	O
general	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
in	IN	prep	O
other	JJ	amod	O
circumstances	NNS	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

At	IN	prep	O
week	NN	pobj	O
4	CD	nummod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
sinusoidal	JJ	amod	O
blood	NN	compound	O
volume	NN	nsubj	O
and	CC	cc	O
albumin	NN	compound	O
Disse	JJ	compound	O
space	NN	conj	O
in	IN	prep	O
tumor	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
livers	NNS	pobj	O
were	VBD	cop	O
slightly	RB	advmod	O
lower	JJR	ROOT	O
compared	VBN	case	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
shams	NNS	nmod	O
.	.	punct	O
The	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
swainsonine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
active	JJ	amod	O
compound	NN	dep	O
of	IN	case	O
locoweed	NN	nmod	B-Organism
and	CC	cc	O
a	DT	det	O
potential	JJ	amod	O
anticancer	NN	compound	B-Cancer
drug	NN	conj	O
)	-RRB-	punct	O
on	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
showed	VBD	ROOT	O
no	DT	neg	O
differences	NNS	dobj	O
in	IN	case	O
sinusoidal	JJ	amod	B-Tissue
diameters	NNS	nmod	O
at	IN	case	O
7	CD	nummod	O
weeks	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
a	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
capillary	JJ	amod	B-Tissue
density	NN	nmod	O
was	VBD	auxpass	O
noted	VBN	conj	O
.	.	punct	O

The	DT	det	O
cortex	NN	nsubj	O
within	IN	case	O
100	CD	nummod	O
microns	NNS	nmod	O
of	IN	case	O
the	DT	det	O
capsule	NN	nmod	O
had	VBD	ROOT	O
little	JJ	amod	O
vascularization	NN	dobj	O
.	.	punct	O
Swainsonine	NNP	nsubj	B-Simple_chemical
caused	VBD	ROOT	O
a	DT	det	O
great	JJ	amod	O
distortion	NN	dobj	O
to	TO	prep	O
the	DT	det	O
vasculature	NN	pobj	B-Multi-tissue_structure
at	IN	prep	O
18	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

SMI496	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
a	DT	det	O
control	JJ	amod	O
compound	NN	conj	O
,	,	punct	O
interfered	VBN	ROOT	O
with	IN	case	O
angiogenesis	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reversibly	RB	advmod	O
inhibiting	VBG	advcl	O
sprouting	NN	dobj	O
from	IN	prep	O
the	DT	det	O
axial	JJ	amod	O
vessels	NNS	pobj	O
.	.	punct	O
The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
compound	NN	nmod	O
on	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
lend	VBP	ROOT	O
credibility	NN	dobj	O
to	TO	case	O
its	PRP$	nmod:poss	O
potential	NN	nmod	O
as	IN	case	O
an	DT	det	O
anticancer	NN	compound	B-Cancer
agent	NN	nmod	O
.	.	punct	O

A	DT	det	O
high	JJ	amod	O
TP	NN	compound	O
expression	NN	nsubjpass	O
at	IN	case	O
tumor	NN	compound	O
sites	NNS	nmod	O
is	VBZ	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
induction	NN	xcomp	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
High	NNP	amod	O
-	HYPH	punct	O
grade	NN	compound	O
clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
has	VBZ	ROOT	O
a	DT	det	O
higher	JJR	amod	O
angiogenic	JJ	amod	O
activity	NN	dobj	O
than	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
based	VBN	case	O
on	IN	case	O
histomorphological	JJ	amod	O
quantification	NN	nmod	O
and	CC	cc	O
qRT	NN	compound	O
-	HYPH	punct	O
PCR	NN	compound	O
mRNA	NN	compound	O
expression	NN	compound	O
profile	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
(	-LRB-	punct	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	appos	I-Cancer
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
highly	RB	advmod	O
vascularised	VBN	amod	O
tumour	NN	ROOT	B-Cancer
and	CC	cc	O
is	VBZ	cop	O
therefore	RB	advmod	O
an	DT	det	O
attractive	JJ	amod	O
disease	NN	conj	O
to	TO	mark	O
study	VB	acl	O
angiogenesis	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
novel	JJ	amod	O
angiogenesis	NN	compound	O
inhibitors	NNS	dobj	O
in	IN	case	O
early	JJ	amod	O
clinical	JJ	amod	O
development	NN	nmod	O
.	.	punct	O

VEGF	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	mark	O
it	PRP	nsubj	O
promotes	VBZ	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
new	JJ	amod	O
blood	NN	compound	O
vessel	NN	compound	O
formation	NN	conj	O
.	.	punct	O
Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
serum	NN	compound	O
VEGF	NN	compound	O
level	NN	compound	O
(	-LRB-	punct	O
s	NNS	compound	O
-	:	punct	O
VEGF	NN	dobj	O
)	-RRB-	punct	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
(	-LRB-	punct	O
RCC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
angiogenesis	NN	compound	O
parameters	NNS	dobj	O
in	IN	case	O
low	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
87	CD	dep	O
)	-RRB-	punct	O
vs	CC	cc	O
high	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	conj	I-Cancer
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
63	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Tumor	NN	compound	O
sections	NNS	nsubjpass	O
were	VBD	auxpass	O
stained	VBN	ROOT	O
for	IN	case	O
:	:	punct	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
CD31	NN	nmod	O
and	CC	cc	O
PAS	NN	conj	O
or	CC	cc	O
hypoxia	NN	conj	O
inducible	JJ	amod	O
factor	NN	compound	O
1alpha	NN	conj	O
(	-LRB-	punct	O
HIF	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
A	DT	det	O
panel	NN	nsubjpass	O
of	IN	case	O
antibodies	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
immunohistochemistry	NN	nmod	O
:	:	punct	O
CD34	NN	dep	B-Gene_or_gene_product
/	:	punct	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	conj	I-Gene_or_gene_product
,	,	punct	O
carbonic	JJ	amod	B-Gene_or_gene_product
anhydrase	NN	appos	I-Gene_or_gene_product
IX	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

HT	NN	compound	O
-	HYPH	punct	O
29	CD	nummod	O
human	JJ	amod	O
colorectal	JJ	amod	O
cancer	NN	compound	O
xenograft	NN	compound	O
model	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
and	CC	cc	O
tumour	NN	compound	O
growth	NN	conj	O
,	,	punct	O
microvessel	NN	compound	O
density	NN	conj	O
and	CC	cc	O
VEGF	NN	compound	O
quantification	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	conj	O
in	IN	case	O
tumours	NNS	nmod	O
after	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
metronomic	JJ	amod	O
CPT	NN	nmod	O
-	:	punct	O
11	CD	dep	O
,	,	punct	O
L	NNP	compound	O
-	HYPH	punct	O
OHP	NNP	conj	O
,	,	punct	O
5	CD	nummod	O
-	HYPH	punct	O
FU	NNP	dep	O
and	CC	cc	O
their	PRP$	nmod:poss	O
simultaneous	JJ	amod	O
combination	NN	conj	O
.	.	punct	O
Vessel	NN	compound	B-Multi-tissue_structure
density	NN	nsubjpass	O
(	-LRB-	punct	O
MVD	NN	compound	O
-	:	punct	O
microvessel	NN	compound	B-Tissue
density	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	compound	O
fraction	NN	conj	O
(	-LRB-	punct	O
ECP	NN	compound	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
tumour	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	compound	O
fraction	NN	conj	O
(	-LRB-	punct	O
TCP	NN	compound	O
%	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
A	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nsubjpass	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	dep	O
from	IN	prep	O
the	DT	det	O
cartilage	NN	pobj	O
of	IN	prep	O
the	DT	det	O
blue	JJ	amod	O
shark	NN	pobj	O
(	-LRB-	punct	O
Prionace	NN	compound	O
glauca	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
mRNA	NN	compound	O
expression	NN	compound	O
levels	NNS	nsubjpass	O
of	IN	case	O
angiogenesis	NN	compound	O
stimulators	NNS	nmod	O
and	CC	cc	O
inhibitors	NNS	conj	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
quantitative	JJ	amod	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NN	nsubjpass	O
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	compound	O
samples	NNS	nmod	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
RCC	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
40	CD	nummod	O
patients	NNS	conj	O
without	IN	case	O
cancer	NN	nmod	O
(	-LRB-	punct	O
controls	NNS	appos	O
)	-RRB-	punct	O
using	VBG	xcomp	O
a	DT	det	O
sandwich	JJ	amod	O
enzyme	NN	npadvmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunoassay	NN	dobj	O
.	.	punct	O
High	NNP	amod	O
-	HYPH	punct	O
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nsubj	I-Cancer
showed	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
ECP	NN	compound	O
%	NN	dobj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
049	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
higher	JJR	amod	O
TCP	NN	compound	O
%	NN	appos	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
009	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
higher	JJR	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	appos	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
lower	JJR	amod	O
MVD	NN	appos	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
lower	JJR	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
002	CD	appos	O
)	-RRB-	punct	O
than	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
.	.	punct	O

s	NNS	compound	O
-	HYPH	punct	O
VEGF	NN	nsubjpass	O
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	compound	O
samples	NNS	nmod	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
40	CD	nummod	O
RCC	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
40	CD	nummod	O
patients	NNS	conj	O
without	IN	case	O
cancer	NN	nmod	O
(	-LRB-	punct	O
controls	NNS	appos	O
)	-RRB-	punct	O
using	VBG	xcomp	O
a	DT	det	O
sandwich	JJ	amod	O
enzyme	NN	npadvmod	O
-	HYPH	punct	O
linked	VBN	amod	O
immunoassay	NN	dobj	O
.	.	punct	O
Growth	NN	compound	O
factor	NN	compound	O
mRNA	NN	compound	O
expression	NN	compound	O
analyses	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
expression	NN	dobj	O
of	IN	case	O
angiopoietin	NN	nmod	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
.	.	punct	O

A	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
bone	NN	compound	O
volume	NN	compound	O
density	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	O
area	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
in	IN	conj	O
the	DT	det	O
oldest	JJS	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	O
area	NN	pobj	O
.	.	punct	O
Microvessel	NN	compound	B-Tissue
density	NN	nsubjpass	O
and	CC	cc	O
ECP	NN	compound	O
%	NN	conj	O
were	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
(	-LRB-	punct	O
Rho	NN	dep	O
=	JJ	amod	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
26	CD	nummod	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
age	NN	nsubj	O
and	CC	cc	O
oral	JJ	amod	O
habits	NNS	conj	O
of	IN	case	O
patients	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
tumor	NN	compound	O
site	NN	conj	O
and	CC	cc	O
size	NN	conj	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
correlated	VBN	xcomp	O
with	IN	case	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
or	CC	cc	O
VEGF	NN	compound	O
immunoreactivity	NN	nmod	O
.	.	punct	O
Because	IN	case	O
of	IN	pcomp	O
the	DT	det	O
imperfect	JJ	compound	O
association	NN	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	nmod	O
and	CC	cc	O
ECP	NN	compound	O
%	NN	conj	O
or	CC	cc	O
MVD	NN	conj	O
,	,	punct	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	conj	I-Cancer
was	VBD	auxpass	O
also	RB	advmod	O
grouped	VBN	ROOT	O
based	VBN	xcomp	O
on	IN	prep	O
low	JJ	amod	O
/	SYM	punct	O
high	JJ	amod	O
MVD	NN	nmod	O
and	CC	cc	O
ECP	NN	compound	O
%	NN	pobj	O
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
paraffin	NN	amod	O
sections	NNS	nsubjpass	O
from	IN	case	O
49	CD	nummod	O
subjects	NNS	nmod	O
with	IN	case	O
OSCC	NN	nmod	O
were	VBD	auxpass	O
subjected	VBN	dep	O
to	TO	case	O
immunohistochemical	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
highest	JJS	amod	O
MVD	NN	dobj	O
(	-LRB-	punct	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
immunoreactivity	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
This	DT	det	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
expression	NN	dobj	O
of	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
maturation	NN	nmod	O
and	CC	cc	O
stabilisation	NN	compound	O
factors	NNS	conj	O
(	-LRB-	punct	O
placental	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	dep	I-Gene_or_gene_product
,	,	punct	O
PDGFB1	NN	appos	B-Gene_or_gene_product
,	,	punct	O
angiopoietin	NN	appos	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
with	IN	case	O
high	JJ	amod	O
MVD	NN	nmod	O
,	,	punct	O
a	DT	det	O
group	NN	appos	O
of	IN	case	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
highly	RB	advmod	O
enriched	VBN	acl	O
in	IN	case	O
low	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	compound	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
,	,	punct	O
with	IN	case	O
low	JJ	amod	O
ECP	NN	compound	O
%	NN	nmod	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nmod	O
between	IN	case	O
the	DT	det	O
RCC	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
207	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
32	CD	nummod	O
.	.	punct	O
9	CD	npadvmod	O
vs	CC	cc	O
.	.	punct	O
71	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	ROOT	O
.	.	punct	O
1	CD	nummod	O
pg	TO	compound	O
/	SYM	punct	O
ml	NN	ROOT	O
,	,	punct	O
mean	NN	appos	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SE	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
005	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
tumor	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
renal	JJ	amod	O
veins	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
contralateral	JJ	amod	O
ones	NNS	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
pre	JJ	compound	O
-	HYPH	punct	O
and	CC	cc	O
post	JJ	amod	O
-	HYPH	punct	O
nephrectomy	NN	conj	O
situations	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
among	IN	case	O
the	DT	det	O
various	JJ	amod	O
parameters	NNS	conj	O
of	IN	case	O
tumor	NN	compound	O
status	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	O
extent	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
existence	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
heterogeneity	NN	dobj	O
in	IN	case	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
maturation	NN	conj	O
of	IN	case	O
CC	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
RCC	NN	nmod	I-Cancer
,	,	punct	O
to	TO	case	O
a	DT	det	O
large	JJ	amod	O
extent	NN	nmod	O
linked	VBN	acl	O
to	TO	case	O
nuclear	JJ	amod	B-Cellular_component
grade	NN	nmod	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
with	IN	case	O
probable	JJ	amod	O
therapeutic	JJ	amod	O
implications	NNS	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
especially	RB	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Deletion	NN	nsubj	O
of	IN	case	O
Tip30	NN	nmod	B-Gene_or_gene_product
leads	VBZ	ROOT	O
to	TO	case	O
rapid	JJ	amod	O
immortalization	NN	nmod	O
of	IN	case	O
murine	JJ	amod	B-Organism
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
ductal	JJ	amod	B-Pathological_formation
hyperplasia	NN	conj	I-Pathological_formation
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
.	.	punct	O

Better	JJR	amod	O
stem	NN	compound	O
cell	NN	nsubjpass	O
and	CC	cc	O
progenitor	NN	compound	O
cell	NN	compound	O
markers	NNS	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
ability	NN	conj	O
to	TO	case	O
specifically	RB	advmod	O
target	VB	compound	O
oncogenes	NNS	nmod	O
into	IN	case	O
different	JJ	amod	O
mammary	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
will	MD	aux	O
be	VB	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
spectrum	NN	dobj	O
of	IN	case	O
oncogene	NN	compound	O
transformation	NN	nmod	O
for	IN	case	O
stem	NN	compound	O
cells	NNS	nmod	O
versus	CC	cc	O
more	RBR	amod	O
differentiated	VBN	amod	O
cells	NNS	conj	O
.	.	punct	O
Transformation	NN	nsubj	O
of	IN	case	O
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
MECs	NNS	appos	B-Cell
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
normal	JJ	nmod	O
to	TO	case	O
the	DT	det	O
neoplastic	JJ	amod	O
stage	NN	nmod	O
requires	VBZ	ROOT	O
the	DT	det	O
dysregulation	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
genes	NNS	nmod	O
and	CC	cc	O
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	conj	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
Tip30	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	ROOT	O
that	WDT	nsubj	O
can	MD	aux	O
inhibit	VB	acl:relcl	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
transcription	NN	dobj	O
in	IN	case	O
MECs	NNS	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
MEC	NN	compound	B-Cell
proliferation	NN	nmod	O
remains	VBZ	conj	O
unknown	JJ	xcomp	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
especially	RB	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
deleting	VBG	csubj	O
the	DT	det	O
Tip30	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
leads	VBZ	ccomp	O
to	TO	case	O
ductal	JJ	amod	B-Pathological_formation
hyperplasia	NN	nmod	I-Pathological_formation
in	IN	case	O
mouse	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
glands	NNS	nmod	I-Organ
early	RB	amod	O
in	IN	case	O
life	NN	pobj	O
and	CC	cc	O
extensive	JJ	amod	O
mammary	JJ	amod	B-Pathological_formation
hyperplasia	NN	conj	I-Pathological_formation
with	IN	case	O
age	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
especially	RB	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Tip30	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
mammary	JJ	amod	O
glands	NNS	nsubj	O
transplanted	VBN	acl	O
into	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mammary	JJ	amod	B-Tissue
fat	JJ	compound	I-Tissue
pads	NNS	nmod	I-Tissue
also	RB	advmod	O
display	VBP	ROOT	O
mammary	JJ	amod	B-Multi-tissue_structure
trees	NNS	dobj	I-Multi-tissue_structure
with	IN	prep	O
extensive	JJ	amod	O
ductal	JJ	amod	B-Pathological_formation
hyperplasia	NN	pobj	I-Pathological_formation
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
MEF	NN	nmod	O
,	,	punct	O
and	CC	cc	O
MEF	NNP	compound	O
-	HYPH	punct	O
LMP1	NN	compound	O
(	-LRB-	punct	O
TRADD	NN	compound	O
)	-RRB-	punct	O
cells	NNS	nsubj	O
eventually	RB	advmod	O
enter	VBP	conj	O
growth	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O
Strikingly	RB	advmod	O
,	,	punct	O
Tip30	NN	compound	B-Gene_or_gene_product
deletion	NN	nsubj	O
promotes	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
MECs	NNS	nmod	B-Cell
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
rapid	JJ	amod	O
immortalization	NN	nmod	O
of	IN	case	O
MECs	NNS	nmod	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
relative	JJ	case	O
to	TO	case	O
wild	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
type	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
a	DT	det	O
three	CD	nummod	O
-	HYPH	punct	O
dimensional	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
breast	NN	compound	O
carcinogenesis	NN	nmod	O
,	,	punct	O
disorganized	VBN	ROOT	O
,	,	punct	O
proliferative	JJ	amod	O
transformed	VBN	amod	O
breast	NN	compound	O
epithelial	JJ	amod	O
cells	NNS	nsubj	O
express	VBP	conj	O
significantly	RB	advmod	O
higher	JJR	amod	O
expression	NN	dobj	O
of	IN	case	O
angiogenic	JJ	amod	O
genes	NNS	nmod	O
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
polarized	VBN	amod	O
,	,	punct	O
growth	NN	npadvmod	O
-	HYPH	punct	O
arrested	VBN	amod	O
nonmalignant	JJ	amod	O
counterparts	NNS	nmod	O
.	.	punct	O
Gene	NN	compound	O
array	NN	compound	O
analysis	NN	nsubj	O
identified	VBD	ROOT	O
significant	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
mammary	JJ	amod	B-Tissue
epithelial	JJ	amod	I-Tissue
growth	NN	compound	O
factors	NNS	nmod	O
Wisp2	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
Igf	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
in	IN	case	O
Tip30	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	nmod	O
.	.	punct	O

IGF	NNP	compound	O
-	:	punct	O
1	CD	nsubj	O
enhances	VBZ	ROOT	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O
Knockdown	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
Wisp2	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
Igf	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
using	VBG	acl	O
short	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	dobj	O
dramatically	RB	advmod	O
inhibited	VBD	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
Tip30	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
cells	NNS	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
especially	RB	advmod	O
susceptible	JJ	ccomp	O
to	TO	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Tip30	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
intrinsic	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
regulator	NN	nsubj	O
of	IN	case	O
MEC	NN	compound	B-Cell
proliferation	NN	nmod	O
partly	RB	advmod	O
through	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
Wisp2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Igf	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
absence	NN	conj	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	B-Organ
gland	NN	nmod	I-Organ
may	MD	aux	O
predispose	VB	ccomp	O
MECs	NNS	dobj	B-Cell
to	TO	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	O
.	.	punct	O
A	DT	det	O
pivotal	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
:	:	punct	O
balancing	NN	acl	O
aerobic	JJ	amod	O
respiration	NN	dobj	O
and	CC	cc	O
glycolysis	NN	conj	O
.	.	punct	O

To	TO	mark	O
maintain	VB	ROOT	O
an	DT	det	O
elevated	JJ	amod	O
glycolytic	JJ	amod	O
rate	NN	dobj	O
,	,	punct	O
cancerous	JJ	amod	O
or	CC	cc	O
proliferating	VBG	conj	O
cells	NNS	nsubj	O
alter	VBP	parataxis	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
rate	NN	compound	O
limiting	VBG	amod	O
glycolytic	JJ	amod	O
enzymes	NNS	nmod	O
.	.	punct	O
The	DT	det	O
genetic	JJ	amod	O
basis	NN	nsubj	O
of	IN	case	O
increased	VBN	amod	O
glycolytic	JJ	amod	O
activity	NN	nmod	O
observed	VBN	acl	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
result	NN	xcomp	O
of	IN	case	O
complex	JJ	amod	O
interactions	NNS	nmod	O
of	IN	case	O
multiple	JJ	amod	O
regulatory	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O

The	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
mitochondrial	JJ	amod	O
respiration	NN	conj	O
greatly	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	prep	O
the	DT	det	O
deficient	JJ	amod	O
respiration	NN	pobj	O
of	IN	prep	O
the	DT	det	O
predominance	NN	pobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
modulated	VBN	amod	O
antioxidant	JJ	amod	O
defense	NN	compound	O
mechanisms	NNS	nmod	O
contributes	VBZ	advcl	O
to	TO	case	O
mutagenesis	NN	nmod	O
and	CC	cc	O
additionally	RB	advmod	O
boosts	VBZ	conj	O
the	DT	det	O
carcinogenesis	NN	compound	O
process	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
recent	JJ	amod	O
evidence	NN	dobj	O
of	IN	case	O
a	DT	det	O
simple	JJ	amod	O
genetic	JJ	amod	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
p53	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	acl:relcl	O
mitochondrial	JJ	amod	B-Cellular_component
respiration	NN	dobj	O
with	IN	case	O
secondary	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
glycolysis	NN	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
reminiscent	NN	acl:relcl	O
of	IN	case	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	nmod	O
.	.	punct	O

By	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
means	NNS	conj	O
,	,	punct	O
p53	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
oxidative	JJ	amod	O
phosphorylation	NN	conj	O
,	,	punct	O
glutaminolysis	NN	conj	O
,	,	punct	O
insulin	NN	compound	O
sensitivity	NN	conj	O
,	,	punct	O
nucleotide	NN	compound	O
biosynthesis	NN	conj	O
,	,	punct	O
mitochondrial	JJ	amod	O
integrity	NN	conj	O
,	,	punct	O
fatty	JJ	amod	O
acid	NN	compound	O
oxidation	NN	conj	O
,	,	punct	O
antioxidant	JJ	amod	O
response	NN	conj	O
,	,	punct	O
autophagy	NN	conj	O
and	CC	cc	O
mTOR	NN	conj	O
signalling	NN	acl	O
.	.	punct	O
The	DT	det	O
biological	JJ	amod	O
significance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
major	JJ	amod	O
pathways	NNS	nmod	O
of	IN	case	O
energy	NN	compound	O
generation	NN	nmod	O
by	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
seen	VBN	xcomp	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
and	CC	cc	O
endothelial	JJ	amod	O
cells	NNS	conj	O
in	IN	case	O
orderly	JJ	amod	O
tumor	NN	compound	O
angiomorphogenesis	NN	nmod	O
is	VBZ	cop	O
highly	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
action	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
adhesion	NN	compound	O
molecules	NNS	nmod	O
mediating	VBG	acl	O
the	DT	det	O
adhesion	NN	dobj	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
which	WDT	nmod	O
remarkably	RB	advmod	O
retards	VBZ	ccomp	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O
The	DT	det	O
contribution	NN	ROOT	O
of	IN	prep	O
Harold	NNP	compound	O
F	NNP	pobj	O
.	.	punct	O
Dvorak	NN	ROOT	O
to	TO	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
and	CC	cc	O
stroma	NN	compound	B-Tissue
generation	NN	compound	O
mechanisms	NNS	conj	O
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
In	IN	prep	O
1983	CD	pobj	O
,	,	punct	O
Harold	NNP	compound	O
Dvorak	NNP	nsubj	O
and	CC	cc	O
his	PRP$	poss	O
colleagues	NNS	conj	O
were	VBD	ROOT	O
the	DT	det	O
first	JJ	attr	O
to	TO	aux	O
show	VB	xcomp	O
that	IN	mark	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
secreted	VBD	ccomp	O
vascular	JJ	amod	B-Gene_or_gene_product
permeability	NN	compound	I-Gene_or_gene_product
factor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
VPF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
that	IN	mark	O
a	DT	det	O
blocking	VBG	amod	O
antibody	NN	nsubj	O
to	TO	case	O
VPF	NN	nmod	B-Gene_or_gene_product
could	MD	aux	O
prevent	VB	conj	O
the	DT	det	O
edema	NN	dobj	B-Pathological_formation
and	CC	cc	O
fluid	NN	conj	B-Organism_substance
accumulation	NN	dep	O
that	WDT	nsubj	O
is	VBZ	cop	O
characteristic	JJ	acl:relcl	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

VPF	NNP	nsubj	O
/	:	punct	O
VEGF	NN	nsubj	O
induced	VBD	ROOT	O
dermal	JJ	amod	O
microvascular	JJ	amod	O
EC	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	O
and	CC	cc	O
beta3	NN	compound	O
integrin	NN	compound	O
subunits	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	O
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	nsubj	O
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	O
(	-LRB-	punct	O
OPN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	O
ligand	NN	appos	O
.	.	punct	O
In	IN	prep	O
1986	CD	pobj	O
,	,	punct	O
Dvorak	NNP	nsubj	O
went	VBD	ROOT	O
on	RP	prt	O
to	TO	aux	O
demonstrate	VB	advcl	O
that	IN	mark	O
VPF	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
secreted	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
proposed	VBD	conj	O
that	IN	mark	O
VPF	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
in	IN	case	O
part	NN	nmod	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
abnormal	JJ	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
seen	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
.	.	punct	O

VPF	NNP	nsubj	O
/	:	punct	O
VEGF	NN	nsubj	O
induced	VBD	ROOT	O
dermal	JJ	amod	O
microvascular	JJ	amod	O
EC	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	O
and	CC	cc	O
beta3	NN	compound	O
integrin	NN	compound	O
subunits	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	O
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	nsubj	O
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	O
(	-LRB-	punct	O
OPN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	O
ligand	NN	appos	O
.	.	punct	O
As	IN	prep	O
a	DT	det	O
result	NN	pobj	O
,	,	punct	O
he	PRP	nsubj	O
and	CC	cc	O
other	JJ	amod	O
investigators	NNS	conj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
VPF	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
stimulating	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

VPF	NNP	nsubj	O
/	:	punct	O
VEGF	NN	nsubj	O
induced	VBD	ROOT	O
dermal	JJ	amod	O
microvascular	JJ	amod	O
EC	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	O
and	CC	cc	O
beta3	NN	compound	O
integrin	NN	compound	O
subunits	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	O
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	nsubj	O
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	O
(	-LRB-	punct	O
OPN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	O
ligand	NN	appos	O
.	.	punct	O
These	DT	det	O
fundamental	JJ	amod	O
discoveries	NNS	nsubj	O
led	VBD	ROOT	O
to	TO	prep	O
additional	JJ	amod	O
research	NN	pobj	O
conducted	VBN	acl	O
by	IN	agent	O
Napoleone	NNP	compound	O
Ferrara	NNP	pobj	O
and	CC	cc	O
his	PRP$	poss	O
laboratory	NN	conj	O
,	,	punct	O
confirming	VBG	advcl	O
the	DT	det	O
cloning	NN	dobj	O
of	IN	case	O
VPF	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
renaming	VBG	conj	O
the	DT	det	O
protein	NN	compound	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
illustrate	VBP	ROOT	O
an	DT	det	O
operational	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
VPF	NNP	nmod	O
/	:	punct	O
VEGF	NN	compound	O
induction	NN	conj	O
of	IN	case	O
EC	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
VPF	NN	compound	O
/	:	punct	O
VEGF	NN	compound	O
enhancement	NN	conj	O
of	IN	case	O
microvascular	JJ	amod	O
permeability	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
these	DT	det	O
distinct	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nsubj	O
may	MD	aux	O
act	VB	ccomp	O
accordingly	RB	advmod	O
to	TO	mark	O
stimulate	VB	xcomp	O
EC	NN	compound	O
migration	NN	dobj	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
In	IN	prep	O
1986	CD	pobj	O
,	,	punct	O
Dvorak	NNP	nsubj	O
proposed	VBD	ROOT	O
that	IN	mark	O
by	IN	mark	O
secreting	VBG	advcl	O
VPF	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
induce	VBP	ccomp	O
angiogenesis	NN	dobj	O
by	IN	prep	O
turning	VBG	pcomp	O
on	IN	prep	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
healing	NN	compound	O
response	NN	pobj	O
.	.	punct	O

VPF	NNP	nsubj	O
/	:	punct	O
VEGF	NN	nsubj	O
induced	VBD	ROOT	O
dermal	JJ	amod	O
microvascular	JJ	amod	O
EC	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	O
and	CC	cc	O
beta3	NN	compound	O
integrin	NN	compound	O
subunits	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	O
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	nsubj	O
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	O
(	-LRB-	punct	O
OPN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	O
ligand	NN	appos	O
.	.	punct	O
He	PRP	nsubj	O
noted	VBD	ROOT	O
that	IN	det	O
wounds	NNS	dobj	B-Pathological_formation
,	,	punct	O
like	IN	prep	O
tumors	NNS	pobj	B-Cancer
,	,	punct	O
secrete	VBP	advcl	O
VPF	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
causing	VBG	advcl	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
to	TO	mark	O
leak	VB	advcl	O
plasma	NN	compound	B-Organism_substance
fibrinogen	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	dobj	O
and	CC	cc	O
provides	VBZ	conj	O
a	DT	det	O
matrix	NN	dobj	O
on	IN	case	O
which	WDT	nmod	O
they	PRP	nsubj	O
can	MD	aux	O
spread	VB	acl:relcl	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
illustrate	VBP	ROOT	O
an	DT	det	O
operational	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
VPF	NNP	nmod	O
/	:	punct	O
VEGF	NN	compound	O
induction	NN	conj	O
of	IN	case	O
EC	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
VPF	NN	compound	O
/	:	punct	O
VEGF	NN	compound	O
enhancement	NN	conj	O
of	IN	case	O
microvascular	JJ	amod	O
permeability	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
these	DT	det	O
distinct	JJ	amod	O
biological	JJ	amod	O
activities	NNS	nsubj	O
may	MD	aux	O
act	VB	ccomp	O
accordingly	RB	advmod	O
to	TO	mark	O
stimulate	VB	xcomp	O
EC	NN	compound	O
migration	NN	dobj	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
Unlike	IN	prep	O
wounds	NNS	pobj	B-Pathological_formation
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
that	DT	nsubj	O
turn	VBP	advcl	O
off	RP	case	O
VPF	NNP	compound	B-Gene_or_gene_product
production	NN	nmod	O
after	IN	case	O
healing	NN	nmod	O
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
did	VBD	aux	O
not	RB	neg	O
turn	VB	ROOT	O
off	RP	prt	O
their	PRP$	nmod:poss	O
VPF	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
and	CC	cc	O
instead	RB	advmod	O
continued	VBD	conj	O
to	TO	aux	O
make	VB	xcomp	O
large	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
VPF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
allowing	VBG	advcl	O
malignant	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
to	TO	mark	O
continue	VB	ccomp	O
to	TO	mark	O
induce	VB	xcomp	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
and	CC	cc	O
so	RB	advmod	O
to	TO	aux	O
grow	VB	conj	O
and	CC	cc	O
spread	VB	conj	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
behave	VBP	ROOT	O
like	IN	prep	O
wounds	NNS	pobj	B-Pathological_formation
that	WDT	nsubj	O
fail	VBP	relcl	O
to	TO	aux	O
heal	VB	xcomp	O
.	.	punct	O

Solid	JJ	amod	O
tumors	NNS	nsubj	O
must	MD	aux	O
establish	VB	ROOT	O
a	DT	det	O
blood	NN	compound	O
supply	NN	dobj	O
in	IN	mark	O
order	NN	pobj	O
to	TO	aux	O
proliferate	VB	advcl	O
and	CC	cc	O
grow	VB	conj	O
.	.	punct	O
This	DT	det	O
work	NN	nsubj	O
is	VBZ	ROOT	O
again	RB	advmod	O
extremely	RB	advmod	O
significant	JJ	acomp	O
for	IN	case	O
patients	NNS	nmod	B-Organism
worldwide	VBP	amod	O
,	,	punct	O
as	IN	mark	O
Dvorak	NNP	poss	O
'	POS	case	O
s	VBZ	nsubj	O
scientific	JJ	amod	O
research	NN	dobj	O
is	VBZ	aux	O
leading	VBG	advcl	O
his	PRP$	poss	O
colleagues	NNS	dobj	O
all	RB	advmod	O
over	IN	prep	O
the	DT	det	O
world	NN	pobj	O
to	TO	aux	O
examine	VB	advcl	O
how	WRB	advmod	O
to	TO	aux	O
treat	VB	advcl	O
a	DT	det	O
tumor	NN	dobj	B-Cancer
through	IN	prep	O
its	PRP$	poss	O
blood	NN	compound	B-Organism_substance
supply	NN	pobj	O
.	.	punct	O

Among	IN	case	O
a	DT	det	O
myriad	NN	nmod	O
of	IN	case	O
biological	JJ	amod	O
activities	NNS	nmod	O
described	VBN	acl	O
for	IN	case	O
xanthone	NN	compound	O
derivatives	NNS	nmod	O
,	,	punct	O
the	DT	det	O
anticancer	NN	compound	O
activity	NN	nsubj	O
is	VBZ	cop	O
quite	RB	advmod	O
remarkable	JJ	ROOT	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
clearly	RB	advmod	O
resolved	VBN	conj	O
.	.	punct	O
Melissoidesin	NN	compound	B-Simple_chemical
G	NN	nsubj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
diterpenoid	NN	appos	O
purified	VBN	acl	O
from	IN	case	O
Isodon	NN	compound	B-Organism
melissoides	NNS	nmod	I-Organism
,	,	punct	O
induces	VBZ	ROOT	O
leukemic	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
redox	NN	compound	O
imbalance	NN	nmod	O
and	CC	cc	O
exhibits	VBZ	conj	O
synergy	NN	dobj	O
with	IN	case	O
other	JJ	amod	O
anticancer	NN	compound	B-Cancer
agents	NNS	nmod	O
.	.	punct	O

Numerous	JJ	amod	O
products	NNS	nsubjpass	O
from	IN	prep	O
fruits	NNS	pobj	O
,	,	punct	O
vegetable	JJ	amod	O
and	CC	cc	O
traditional	JJ	amod	O
medicinal	JJ	amod	O
plants	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
which	WDT	nsubj	O
can	MD	aux	O
suppress	VB	ccomp	O
TNF	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
TNF	NN	compound	O
signaling	NN	conj	O
but	CC	cc	O
their	PRP$	nmod:poss	O
clinical	JJ	amod	O
potential	NN	nsubj	O
is	VBZ	cop	O
yet	RB	advmod	O
uncertain	JJ	conj	O
.	.	punct	O
Melissoidesin	NN	compound	B-Simple_chemical
G	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
MOG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
diterpenoid	NN	ROOT	O
purified	VBN	acl	O
from	IN	case	O
Isodon	NN	compound	B-Organism
melissoides	NNS	nmod	I-Organism
,	,	punct	O
a	DT	det	O
plant	NN	appos	O
used	VBN	acl	O
in	IN	prep	O
Chinese	JJ	amod	O
traditional	JJ	amod	O
medicine	NN	pobj	O
as	IN	prep	O
antitumor	NN	amod	B-Cancer
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	conj	O
agents	NNS	pobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
found	VBN	ROOT	O
that	IN	mark	O
sodium	NN	compound	O
fluoride	NN	nsubj	O
(	-LRB-	punct	O
NaF	NN	appos	O
)	-RRB-	punct	O
induced	VBD	ccomp	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
In	IN	case	O
our	PRP$	nmod:poss	O
study	NN	nmod	O
,	,	punct	O
MOG	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
specifically	RB	advmod	O
inhibit	VB	xcomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
leukemia	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
primary	JJ	amod	O
acute	JJ	amod	B-Cell
myeloid	JJ	amod	I-Cell
leukemia	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
AML	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
blasts	NNS	conj	I-Cell
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	nmod	O
,	,	punct	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	compound	I-Simple_chemical
production	NN	conj	O
,	,	punct	O
caspases	VBZ	compound	B-Gene_or_gene_product
activation	NN	conj	O
and	CC	cc	O
nuclear	JJ	amod	B-Cellular_component
fragmentation	NN	conj	O
.	.	punct	O

Caspase	NN	compound	O
activation	NN	nsubjpass	O
,	,	punct	O
mitochondrial	JJ	amod	O
depolarization	NN	conj	O
,	,	punct	O
and	CC	cc	O
cytochrome	NN	compound	O
c	NN	compound	O
release	NN	conj	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
thiol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
containing	VBG	amod	O
antioxidants	NNS	nsubj	O
completely	RB	advmod	O
blocked	VBD	ccomp	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	dobj	O
and	CC	cc	O
subsequent	JJ	amod	O
cell	NN	compound	B-Cell
apoptosis	NN	conj	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
by	IN	case	O
benzyloxy	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
carbonyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Val	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Ala	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Asp	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluoromethylketone	NN	nmod	I-Simple_chemical
only	RB	advmod	O
partially	RB	advmod	O
attenuated	VBN	advcl	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
redox	NN	compound	O
imbalance	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
early	JJ	amod	O
event	NN	ccomp	O
upstream	JJ	advmod	O
to	TO	case	O
mitochondrial	JJ	amod	B-Cellular_component
DeltaPsim	NNP	compound	O
loss	NN	nmod	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Intracellular	JJ	amod	O
glutathione	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
monochlorobimane	NN	nmod	O
,	,	punct	O
a	DT	det	O
glutathione	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
probe	NN	appos	O
.	.	punct	O
Consistently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
MOG	NN	nsubj	B-Simple_chemical
rapidly	RB	advmod	O
decreased	VBD	ccomp	O
the	DT	det	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
glutathione	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
GSH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
content	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
the	DT	det	O
significance	NN	nsubjpass	O
of	IN	case	O
GSH	NN	compound	B-Simple_chemical
depletion	NN	nmod	O
in	IN	case	O
MOG	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
further	RB	advmod	O
supported	VBN	conj	O
by	IN	case	O
the	DT	det	O
protective	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
tert	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butylhydroquinone	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
tBHQ	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
facilitative	JJ	amod	O
effects	NNS	conj	O
of	IN	case	O
DL	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
buthionine	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
S	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
R	NN	conj	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
sulfoximine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
BSO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
glutathione	NN	compound	O
depletion	NN	nsubjpass	O
and	CC	cc	O
extracellular	JJ	amod	O
signal	NN	compound	O
-	HYPH	punct	O
regulated	VBN	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
ERK	NN	appos	O
)	-RRB-	punct	O
inactivation	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
EPOX	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
showed	VBN	ROOT	O
that	IN	mark	O
GSH	NN	compound	B-Simple_chemical
depletion	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
MOG	NN	nmod	B-Simple_chemical
rendered	VBD	ccomp	O
some	DT	det	B-Cell
leukemia	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
more	RBR	advmod	O
sensitive	JJ	amod	O
to	TO	case	O
arsenic	JJ	amod	B-Simple_chemical
trioxide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
As2O3	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
doxorubicin	NN	conj	B-Simple_chemical
or	CC	cc	O
cisplatin	NN	conj	B-Simple_chemical
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Additionally	RB	advmod	O
,	,	punct	O
the	DT	det	O
synergistic	JJ	amod	O
apoptotic	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
MOG	NN	nmod	B-Simple_chemical
with	IN	case	O
As2O3	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
HL	NN	compound	B-Cell
-	:	punct	I-Cell
60	CD	nmod	I-Cell
and	CC	cc	O
primary	JJ	amod	B-Cell
AML	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	conj	B-Cell
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
selective	JJ	amod	O
toxicity	NN	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
combination	NN	nmod	O
to	TO	case	O
the	DT	det	O
malignant	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
no	DT	neg	O
additive	JJ	amod	O
or	CC	cc	O
synergistic	JJ	conj	O
effect	NN	dobj	O
when	WRB	advmod	O
the	DT	det	O
two	CD	nummod	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
combined	VBN	advcl	O
.	.	punct	O
Together	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
proposed	VBD	ROOT	O
that	IN	mark	O
MOG	NN	nsubj	B-Simple_chemical
alone	RB	advmod	O
or	CC	cc	O
administered	VBN	conj	O
with	IN	case	O
other	JJ	amod	O
anticancer	NN	compound	B-Cancer
agents	NNS	nmod	O
may	MD	aux	O
provide	VB	ccomp	O
a	DT	det	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
strategy	NN	dobj	O
for	IN	case	O
leukemia	NN	nmod	B-Cancer
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
Hedgehog	JJ	amod	B-Gene_or_gene_product
signaling	NN	ROOT	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-Organism
melanoma	NN	compound	B-Cancer
microenvironment	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
thus	RB	advmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
element	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	JJ	amod	O
signaling	NN	compound	O
network	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	nmod	O
proliferation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O
The	DT	det	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
intercellular	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nsubj	O
regulates	VBZ	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

The	DT	det	O
VEGF	NN	compound	O
pathway	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	nmod	O
and	CC	cc	O
best	RBS	conj	O
-	HYPH	punct	O
studied	VBN	amod	O
angiogenic	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O
This	DT	det	O
pathway	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
in	IN	case	O
embryonic	JJ	amod	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
development	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	O
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	O
progression	NN	dobj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	nsubjpass	O
in	IN	case	O
tumor	NN	compound	B-Cancer
related	JJ	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
microenvironment	NN	conj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
using	VBG	xcomp	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
B16F0	NN	compound	B-Cell
(	-LRB-	punct	O
murine	JJ	amod	B-Organism
melanoma	NN	appos	B-Cancer
)	-RRB-	punct	O
tumors	NNS	compound	B-Cancer
models	NNS	conj	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	O
subsequently	RB	advmod	O
proliferate	VBP	ROOT	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	mark	O
form	VB	xcomp	O
endothelial	JJ	amod	O
tubes	NNS	dobj	O
and	CC	cc	O
capillary	JJ	conj	O
-	HYPH	punct	O
like	JJ	conj	O
structures	NNS	pobj	O
.	.	punct	O
Use	NN	nsubj	O
of	IN	case	O
exogenous	JJ	amod	O
Sonic	JJ	amod	B-Gene_or_gene_product
hedgehog	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
Shh	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
peptide	NN	nmod	O
significantly	RB	advmod	O
increased	VBD	ROOT	O
BrdU	NN	compound	B-Simple_chemical
incorporation	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
a	DT	det	O
factor	NN	nmod	O
of	IN	case	O
2	CD	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
short	JJ	amod	O
treatments	NNS	nsubj	O
with	IN	case	O
LeTx	NN	nmod	O
only	RB	advmod	O
modestly	RB	advmod	O
affected	VBN	advcl	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
sustained	JJ	amod	O
treatment	NN	nsubj	O
markedly	RB	advmod	O
reduced	VBD	ROOT	O
cell	NN	compound	O
numbers	NNS	dobj	O
.	.	punct	O
The	DT	det	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
pathway	NN	compound	O
antagonist	NN	compound	O
cyclopamine	NN	nsubj	B-Simple_chemical
effectively	RB	advmod	O
reduced	VBD	ROOT	O
Shh	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
proliferation	NN	dobj	O
to	TO	case	O
control	NN	amod	O
levels	NNS	nmod	O
.	.	punct	O

Villani	NNP	ROOT	O
et	FW	dep	O
al	FW	conj	O
.	.	punct	O
define	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
IGF	NN	compound	O
regulatory	JJ	amod	O
protein	NN	compound	O
Igfbp2	NN	nmod	O
in	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
basal	JJ	amod	O
cell	NN	compound	O
carcinogenesis	NN	nmod	O
driven	VBN	acl	O
by	IN	case	O
targeted	VBN	amod	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
hedgehog	JJ	amod	O
signaling	NN	nmod	O
.	.	punct	O
To	TO	mark	O
study	VB	advcl	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
a	DT	det	O
hind	NN	amod	B-Cancer
limb	NN	compound	I-Cancer
tumor	NN	compound	I-Cancer
model	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
B16F0	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
was	VBD	auxpass	O
used	VBN	ROOT	O
.	.	punct	O

Growth	NN	compound	O
inhibition	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
cellular	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
extensive	JJ	amod	O
necrosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
mean	NN	compound	O
vessel	NN	compound	O
density	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
reduction	NN	conj	O
in	IN	case	O
serum	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
angioproliferative	JJ	amod	O
cytokines	NNS	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
with	IN	case	O
25	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	compound	O
cyclopamine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
attenuated	VBD	ROOT	O
BrdU	NN	compound	B-Simple_chemical
incorporation	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
threefold	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
related	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
threefold	RB	dep	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
004	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
delayed	VBN	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	prep	O
4	CD	nummod	O
days	NNS	pobj	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
tumors	NNS	nsubj	O
were	VBD	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	ROOT	O
.	.	punct	O
Immunohistochemistry	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
Hedgehog	NNP	compound	B-Gene_or_gene_product
receptor	NN	compound	O
Patched	NNP	nsubj	B-Gene_or_gene_product
was	VBD	aux	O
localized	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
stroma	NN	nmod	I-Tissue
and	CC	cc	O
that	IN	mark	O
B16F0	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	conj	O
Shh	NN	compound	B-Gene_or_gene_product
peptide	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TNFalpha	NN	compound	O
treatment	NN	nsubj	O
alone	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
suppressed	VBN	acl:relcl	O
by	IN	case	O
antioxidants	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblasts	NNS	nsubj	I-Cell
required	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
B16F0	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
express	VB	xcomp	O
Patched	VBN	dobj	B-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
co	NN	compound	O
-	HYPH	punct	O
culture	NN	compound	O
assay	NN	compound	O
system	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
interaction	NN	nsubj	O
of	IN	case	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
high	JJ	amod	O
invasive	JJ	amod	O
melanoma	NN	compound	O
cells	NNS	conj	O
with	IN	case	O
soluble	JJ	amod	O
recombinant	JJ	amod	O
DC	NN	nmod	O
-	:	punct	O
9	CD	nummod	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	nmod	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
MMP	NN	conj	O
-	:	punct	O
2	CD	nummod	O
.	.	punct	O
These	DT	det	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Shh	NN	compound	B-Gene_or_gene_product
peptide	NN	nsubj	O
produced	VBN	acl	O
by	IN	case	O
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
induces	VBZ	ccomp	O
Patched	VBN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Neovascularization	NN	nsubj	O
has	VBZ	dep	O
profound	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
To	TO	mark	O
study	VB	advcl	O
tumor	NN	compound	B-Cancer
related	JJ	amod	O
angiogenesis	NN	dobj	O
a	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
window	NN	compound	O
model	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
monitor	VB	xcomp	O
tumor	NN	compound	B-Cancer
vascularity	NN	dobj	O
.	.	punct	O

Newly	RB	amod	O
forming	VBG	compound	O
vessels	NNS	nsubj	O
have	VBP	ROOT	O
thin	JJ	amod	O
caliber	NN	dobj	O
,	,	punct	O
a	DT	det	O
markedly	RB	advmod	O
reduced	VBN	amod	O
vessel	NN	compound	O
lumen	NN	appos	O
,	,	punct	O
markedly	RB	advmod	O
reduced	VBD	amod	O
pericyte	NN	compound	O
recruitment	NN	dobj	O
,	,	punct	O
and	CC	cc	O
deficient	JJ	amod	O
vascular	JJ	amod	O
perfusion	NN	conj	O
.	.	punct	O
Treatment	NN	nsubj	O
with	IN	case	O
cyclopamine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
attenuated	VBD	ROOT	O
vascular	JJ	amod	B-Multi-tissue_structure
formation	NN	dobj	O
by	IN	case	O
a	DT	det	O
factor	NN	nmod	O
of	IN	case	O
2	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
and	CC	cc	O
altered	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
morphology	NN	conj	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
blood	NN	compound	O
flow	NN	nmod	O
in	IN	case	O
linomide	NN	npadvmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
showed	VBD	ROOT	O
localization	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
almost	RB	advmod	O
exclusively	RB	advmod	O
to	TO	case	O
the	DT	det	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
tumors	NNS	nmod	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
vascular	JJ	amod	O
functionality	NN	nmod	O
and	CC	cc	O
vasodilation	NN	conj	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
cyclopamine	NN	nsubj	B-Simple_chemical
reduced	VBD	ROOT	O
tumor	NN	compound	B-Multi-tissue_structure
blood	NN	compound	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
permeability	NN	dobj	O
to	TO	case	O
FITC	NN	nmod	B-Simple_chemical
labeled	VBD	amod	O
dextran	NN	dobj	B-Simple_chemical
while	IN	mark	O
having	VBG	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
normal	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
These	DT	det	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
regulates	VBZ	ccomp	O
melanoma	NN	compound	B-Cancer
related	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
formation	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

Vimentin	NN	nsubjpass	O
is	VBZ	auxpass	O
preferentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
with	IN	case	O
low	JJ	amod	O
estrogen	NN	compound	O
receptor	NN	nmod	O
and	CC	cc	O
high	JJ	amod	O
Ki	NN	compound	O
-	HYPH	punct	O
67	CD	nummod	O
growth	NN	compound	O
fraction	NN	conj	O
.	.	punct	O
Expression	NN	ROOT	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	conj	I-Gene_or_gene_product
in	IN	case	O
relationship	NN	nmod	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
pleomorphic	JJ	amod	B-Pathological_formation
adenoma	NN	nmod	I-Pathological_formation
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MMP	NN	compound	O
-	:	punct	O
9	CD	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	appos	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
but	CC	cc	O
the	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
staining	NN	nmod	O
was	VBD	cop	O
different	JJ	conj	O
.	.	punct	O
CONCLUSION	NN	nsubj	O
:	:	punct	O
Quantitative	JJ	amod	O
assessment	NN	nsubj	O
is	VBZ	cop	O
more	RBR	advmod	O
sensitive	JJ	ROOT	O
as	IN	case	O
a	DT	det	O
measure	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
protein	NN	compound	O
content	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
standard	JJ	amod	O
optical	JJ	amod	O
density	NN	compound	O
measurements	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	dobj	O
in	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
abilities	NNS	nmod	O
,	,	punct	O
responses	NNS	dep	O
to	TO	case	O
the	DT	dep	O
invasion	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
-	HYPH	punct	O
regulating	VBG	dep	O
growth	NN	compound	O
factor	NN	compound	O
TGFbeta	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
for	IN	case	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
enzymes	NNS	nmod	O
or	CC	cc	O
enzyme	NN	compound	O
inhibitors	NNS	conj	O
.	.	punct	O
The	DT	det	O
data	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	nsubj	O
increased	VBD	acl:relcl	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
early	JJ	amod	O
events	NNS	nmod	O
in	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
pleomorphic	JJ	amod	B-Pathological_formation
adenoma	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
PA	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	dep	O
between	IN	case	O
tumor	NN	compound	O
prognosis	NN	nmod	O
and	CC	cc	O
EGFR	NN	conj	O
,	,	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	conj	O
or	CC	cc	O
Fas	NN	conj	O
.	.	punct	O
OBJECTIVE	NN	ROOT	O
:	:	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
attempted	VBD	dep	O
to	TO	mark	O
identify	VB	xcomp	O
EGFR	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
expression	NN	dep	O
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
index	NN	conj	O
in	IN	case	O
carcinoma	NN	nmod	B-Cancer
ex	IN	case	I-Cancer
-	HYPH	punct	I-Cancer
pleomorphic	JJ	amod	I-Cancer
adenoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
Ca	NNP	compound	B-Cancer
ex	FW	case	I-Cancer
-	HYPH	punct	I-Cancer
PA	NN	appos	I-Cancer
)	-RRB-	punct	O
and	CC	cc	O
PA	NN	conj	B-Pathological_formation
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	dep	O
between	IN	case	O
tumor	NN	compound	O
prognosis	NN	nmod	O
and	CC	cc	O
EGFR	NN	conj	O
,	,	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	conj	O
or	CC	cc	O
Fas	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
compared	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
index	NN	conj	O
with	IN	case	O
clinical	JJ	amod	O
data	NNS	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
Using	VBG	dep	O
flow	NN	compound	O
cytometry	NN	dobj	O
we	PRP	nsubj	O
evaluated	VBD	conj	O
18	CD	nummod	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	dobj	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
surface	NN	compound	O
markers	NNS	nmod	O
on	IN	case	O
lung	NN	compound	O
cancers	NNS	nmod	O
suggested	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
possible	JJ	amod	O
prognostic	JJ	amod	O
parameters	NNS	xcomp	O
,	,	punct	O
including	VBG	case	O
epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
EGFR	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
intercellular	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	conj	O
1	CD	nummod	O
(	-LRB-	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	conj	O
and	CC	cc	O
CD40	NN	conj	O
.	.	punct	O
MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
tissues	NNS	nsubjpass	B-Tissue
were	VBD	auxpass	O
stained	VBN	dep	O
with	IN	case	O
monoclonal	JJ	amod	O
antibodies	NNS	nmod	O
to	TO	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	conj	I-Gene_or_gene_product
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
avidin	NN	compound	O
-	HYPH	punct	O
biotin	NN	compound	O
-	HYPH	punct	O
peroxidase	NN	compound	O
method	NN	dobj	O
,	,	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	appos	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
expression	NN	conj	O
in	IN	case	O
56	CD	nummod	O
samples	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
in	IN	case	O
22	CD	nummod	O
matched	VBN	amod	O
pairs	NNS	conj	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
using	VBG	xcomp	O
quantitative	JJ	amod	O
immunohistochemical	JJ	amod	O
analysis	NN	dobj	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
tissue	NN	compound	O
samples	NNS	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
patients	NNS	nmod:poss	O
'	POS	case	O
risk	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
course	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
analysed	VBD	ROOT	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
prognosis	NN	nmod	O
with	IN	case	O
clinical	JJ	amod	O
parameters	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
histological	JJ	amod	O
classification	NN	conj	O
of	IN	case	O
the	DT	det	O
carcinomatous	JJ	amod	B-Cancer
component	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
Using	VBG	dep	O
flow	NN	compound	O
cytometry	NN	dobj	O
we	PRP	nsubj	O
evaluated	VBD	conj	O
18	CD	nummod	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	dobj	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
surface	NN	compound	O
markers	NNS	nmod	O
on	IN	case	O
lung	NN	compound	O
cancers	NNS	nmod	O
suggested	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
possible	JJ	amod	O
prognostic	JJ	amod	O
parameters	NNS	xcomp	O
,	,	punct	O
including	VBG	case	O
epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
EGFR	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
intercellular	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	conj	O
1	CD	nummod	O
(	-LRB-	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
Fas	NN	conj	O
and	CC	cc	O
CD40	NN	conj	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
As	IN	mark	O
regards	VBZ	advcl	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
prognosis	NN	nmod	O
with	IN	case	O
EGFR	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
and	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
67	CD	nummod	I-Gene_or_gene_product
index	NN	conj	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
died	VBD	acl:relcl	O
or	CC	cc	O
had	VBD	conj	O
residual	JJ	amod	O
disease	NN	dobj	O
compared	VBN	case	O
with	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
were	VBD	cop	O
alive	JJ	acl:relcl	O
without	IN	case	O
disease	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	dep	O
between	IN	case	O
tumor	NN	compound	O
prognosis	NN	nmod	O
and	CC	cc	O
EGFR	NN	conj	O
,	,	punct	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	conj	O
or	CC	cc	O
Fas	NN	conj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
analysis	NN	nmod	O
of	IN	case	O
EGFR	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
Ki67	NN	conj	B-Gene_or_gene_product
index	NN	conj	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
Ca	NNP	compound	B-Cancer
ex	FW	case	I-Cancer
-	HYPH	punct	I-Cancer
PA	NNP	nmod	I-Cancer
,	,	punct	O
especially	RB	advmod	O
with	IN	case	O
adenocarcinoma	NN	nmod	B-Cancer
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
PA	NN	nmod	B-Pathological_formation
and	CC	cc	O
sialadenitis	NN	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Control	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
course	NN	nmod	O
of	IN	case	O
subretinal	JJ	amod	O
neovascularization	NN	nmod	O
(	-LRB-	punct	O
SRNV	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	O
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
difficult	JJ	appos	O
.	.	punct	O
CX3CR1	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
subretinal	JJ	amod	B-Cell
microglia	NNS	compound	I-Cell
cell	NN	compound	I-Cell
accumulation	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
cardinal	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Control	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
course	NN	nmod	O
of	IN	case	O
subretinal	JJ	amod	O
neovascularization	NN	nmod	O
(	-LRB-	punct	O
SRNV	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	O
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
difficult	JJ	appos	O
.	.	punct	O
The	DT	det	O
role	NN	nsubj	O
of	IN	case	O
retinal	JJ	amod	B-Cell
microglial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
MCs	NNS	appos	B-Cell
)	-RRB-	punct	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
pigment	NN	amod	O
epithelium	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
retina	NN	nmod	O
(	-LRB-	punct	O
RPE	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
optic	JJ	amod	O
cup	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
function	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
of	IN	prep	O
the	DT	det	O
eye	NN	pobj	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
all	DT	det	O
retinal	JJ	amod	B-Cell
MCs	NNS	nsubj	I-Cell
express	VBP	ccomp	O
CX3C	NN	compound	B-Gene_or_gene_product
chemokine	NN	compound	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
CX3CR1	JJ	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
that	IN	mark	O
homozygosity	NN	nsubj	O
for	IN	case	O
the	DT	det	O
CX3CR1	JJ	compound	B-Gene_or_gene_product
M280	NN	compound	O
allele	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
impaired	JJ	amod	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
,	,	punct	O
increases	VBZ	conj	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
AMD	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Control	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
course	NN	nmod	O
of	IN	case	O
subretinal	JJ	amod	O
neovascularization	NN	nmod	O
(	-LRB-	punct	O
SRNV	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	O
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
difficult	JJ	appos	O
.	.	punct	O
In	IN	case	O
humans	NNS	nmod	B-Organism
with	IN	case	O
AMD	NN	nmod	O
,	,	punct	O
MCs	NNS	ROOT	B-Cell
accumulated	VBD	acl	O
in	IN	case	O
the	DT	det	O
subretinal	JJ	amod	B-Immaterial_anatomical_entity
space	NN	nmod	I-Immaterial_anatomical_entity
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
degeneration	NN	nmod	O
and	CC	cc	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	conj	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
transgenic	JJ	amod	O
embryos	NNS	nmod	O
,	,	punct	O
RPE	NN	compound	O
cells	NNS	nsubj	O
proliferated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
anterior	JJ	amod	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
eye	NN	nmod	O
and	CC	cc	O
near	IN	conj	O
the	DT	det	O
optic	JJ	amod	O
nerve	NN	pobj	O
.	.	punct	O
In	IN	case	O
CX3CR1	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
MCs	NNS	nsubj	B-Cell
accumulated	VBD	ROOT	O
subretinally	RB	advmod	B-Immaterial_anatomical_entity
with	IN	case	O
age	NN	nmod	O
and	CC	cc	O
albino	NN	compound	O
background	NN	conj	O
and	CC	cc	O
after	IN	case	O
laser	NN	compound	O
impact	NN	conj	O
preceding	VBG	xcomp	O
retinal	JJ	amod	B-Multi-tissue_structure
degeneration	NN	dobj	O
.	.	punct	O

In	IN	case	O
3	CD	nummod	O
months	NNS	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
pigmented	VBN	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
spleen	NN	nmod	O
and	CC	cc	O
inguinal	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	conj	O
.	.	punct	O
Raising	VBG	csubj	O
the	DT	det	O
albino	NN	compound	O
mice	NNS	dobj	B-Organism
in	IN	case	O
the	DT	det	O
dark	NN	nmod	O
prevented	VBD	ROOT	O
both	DT	det	O
events	NNS	dobj	O
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
Using	VBG	dep	O
ICG	NN	compound	O
-	HYPH	punct	O
DEP	NN	dobj	O
,	,	punct	O
CNV	NN	compound	O
feeder	NN	compound	O
vessels	NNS	nsubjpass	O
were	VBD	auxpass	O
closed	VBN	ROOT	O
with	IN	prep	O
single	JJ	amod	O
pulse	NN	compound	O
laser	NN	compound	O
energy	NN	pobj	O
,	,	punct	O
delivering	VBG	advcl	O
as	RB	advmod	O
little	JJ	amod	O
as	IN	quantmod	O
0	CD	dobj	O
.	.	punct	O
6	CD	compound	O
to	TO	dep	O
1	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
J	NN	ROOT	O
of	IN	case	O
energy	NN	nmod	O
to	IN	prep	O
the	DT	det	O
fundus	NN	pobj	O
,	,	punct	O
producing	VBG	acl	O
no	DT	neg	O
visible	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
the	DT	det	O
fundus	NN	nmod	O
.	.	punct	O
The	DT	det	O
appearance	NN	nsubjpass	O
of	IN	case	O
lipid	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
bloated	VBN	amod	O
subretinal	JJ	amod	B-Cell
MCs	NNS	nmod	I-Cell
was	VBD	auxpass	O
drusen	VBN	ROOT	B-Pathological_formation
-	HYPH	punct	O
like	NN	case	O
on	IN	case	O
funduscopy	NN	nmod	O
of	IN	case	O
senescent	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
CX3CR1	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
MC	NN	compound	B-Cell
accumulation	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
an	DT	det	O
exacerbation	NN	nmod	O
of	IN	case	O
experimental	JJ	amod	O
CNV	NN	nmod	O
.	.	punct	O

In	IN	case	O
transgenic	JJ	amod	O
embryos	NNS	nmod	O
,	,	punct	O
RPE	NN	compound	O
cells	NNS	nsubj	O
proliferated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
anterior	JJ	amod	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
eye	NN	nmod	O
and	CC	cc	O
near	IN	conj	O
the	DT	det	O
optic	JJ	amod	O
nerve	NN	pobj	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
CX3CR1	JJ	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
accumulation	NN	ccomp	O
of	IN	case	O
subretinal	JJ	amod	B-Cell
MCs	NNS	compound	I-Cell
evokes	VBZ	compound	O
cardinal	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
AMD	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
support	VBP	ROOT	O
the	DT	det	O
implication	NN	dobj	O
of	IN	case	O
local	JJ	amod	O
advanced	JJ	amod	O
glycation	NN	compound	O
end	NN	compound	O
product	NN	compound	O
deposits	NNS	nmod	O
and	CC	cc	O
liberation	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	O
in	IN	case	O
that	DT	det	O
process	NN	nmod	O
.	.	punct	O
These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
what	WP	dobj	O
we	PRP	nsubj	O
believe	VBP	ccomp	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
novel	JJ	amod	O
pathogenic	JJ	amod	O
process	NN	xcomp	O
with	IN	case	O
important	JJ	amod	O
implications	NNS	nmod	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
AMD	NN	nmod	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nsubj	O
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	O
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	O
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	O
.	.	punct	O
Conditional	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
Smad1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Smad5	NN	conj	B-Gene_or_gene_product
in	IN	case	O
somatic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
male	JJ	amod	O
and	CC	cc	O
female	JJ	conj	O
gonads	NNS	nmod	B-Organ
leads	VBZ	ROOT	O
to	TO	case	O
metastatic	JJ	amod	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Members	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
TGF	NN	compound	O
)	-RRB-	punct	O
-	:	punct	O
beta	NN	compound	O
superfamily	NN	nmod	O
play	VBP	dep	O
critical	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
cellular	JJ	amod	O
functions	NNS	nmod	O
.	.	punct	O
The	DT	det	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TGFbeta	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
family	NN	nsubj	O
has	VBZ	ROOT	O
critical	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
fertility	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
many	JJ	amod	O
human	JJ	amod	O
carcinomas	NNS	nsubj	O
overexpress	VBP	ROOT	O
TGFbeta1	NN	dobj	O
and	CC	cc	O
this	DT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
poor	JJ	amod	O
patient	NN	compound	O
prognosis	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
frequency	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
pathogenesis	NN	nsubjpass	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
is	VBZ	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
misregulation	NN	nmod	O
of	IN	case	O
TGFbeta	NN	compound	B-Gene_or_gene_product
function	NN	nmod	O
and	CC	cc	O
SMAD2	NN	compound	B-Gene_or_gene_product
or	CC	cc	O
SMAD4	NN	conj	B-Gene_or_gene_product
mutations	NNS	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Bone	NN	compound	O
morphogenetic	JJ	amod	O
proteins	NNS	nsubj	O
(	-LRB-	punct	O
BMPs	NNS	appos	O
)	-RRB-	punct	O
exert	VBP	dep	O
osteoinductive	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	O
cancer	NN	nmod	O
(	-LRB-	punct	O
PC	NN	appos	O
)	-RRB-	punct	O
via	IN	case	O
uncharacterized	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
are	VBP	ROOT	O
limited	JJ	amod	O
mouse	NN	compound	B-Organism
models	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
BMP	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	I-Gene_or_gene_product
SMADs	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
BR	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMADs	NNS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
5	CD	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
8	CD	conj	B-Gene_or_gene_product
because	IN	case	O
of	IN	mwe	O
embryonic	JJ	amod	B-Developing_anatomical_structure
lethality	NN	advcl	O
and	CC	cc	O
suspected	VBN	amod	O
genetic	JJ	amod	O
redundancy	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
Evi	NNP	nsubj	O
-	SYM	punct	O
1	CD	nummod	O
represses	VBZ	ccomp	O
Smad	NNP	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
by	IN	mark	O
recruiting	VBG	advcl	O
CtBP	NN	dobj	O
as	IN	prep	O
a	DT	det	O
corepressor	NN	pobj	O
.	.	punct	O
Using	VBG	advcl	O
tissue	NN	nmod:npmod	B-Tissue
-	HYPH	punct	O
specific	JJ	amod	O
ablation	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
we	PRP	nsubj	O
deleted	VBD	ROOT	O
the	DT	det	O
BR	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMADs	NNS	dobj	I-Gene_or_gene_product
from	IN	case	O
somatic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
ovaries	NNS	nmod	B-Organ
and	CC	cc	O
testes	NNS	conj	B-Organ
.	.	punct	O

Smad1	NN	compound	O
/	SYM	punct	O
5	CD	appos	O
/	SYM	punct	O
8	CD	nummod	O
phosphorylation	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O
Single	JJ	amod	O
conditional	JJ	amod	O
knockouts	NNS	nsubj	O
for	IN	case	O
Smad1	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
Smad5	NN	conj	B-Gene_or_gene_product
or	CC	cc	O
mice	NNS	conj	B-Organism
homozygous	JJ	amod	O
null	NNS	nsubj	O
for	IN	case	O
Smad8	NN	nmod	B-Gene_or_gene_product
are	VBP	cop	O
viable	JJ	ROOT	O
and	CC	cc	O
fertile	JJ	conj	O
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nsubj	O
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	O
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	O
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	O
.	.	punct	O
Female	JJ	amod	O
double	JJ	amod	O
Smad1	NN	compound	B-Gene_or_gene_product
Smad5	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
triple	JJ	amod	O
Smad1	NN	compound	B-Gene_or_gene_product
Smad5	NN	compound	B-Gene_or_gene_product
Smad8	NN	compound	B-Gene_or_gene_product
conditional	JJ	amod	O
knockout	JJ	amod	O
mice	NNS	conj	O
become	VBP	ROOT	O
infertile	NN	xcomp	O
and	CC	cc	O
develop	VB	conj	O
metastatic	JJ	amod	O
granulosa	NN	compound	B-Cancer
cell	NN	compound	I-Cancer
tumors	NNS	dobj	I-Cancer
.	.	punct	O

Through	IN	case	O
this	DT	det	O
domain	NN	nmod	O
,	,	punct	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nsubj	O
physically	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
Smad3	NN	nmod	O
,	,	punct	O
an	DT	det	O
intracellular	JJ	amod	O
mediator	NN	appos	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
suppressing	VBG	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
Smad3	NN	nmod	O
.	.	punct	O
Male	JJ	amod	O
double	JJ	amod	O
Smad1	NN	compound	B-Gene_or_gene_product
Smad5	NN	compound	B-Gene_or_gene_product
conditional	JJ	amod	O
knockout	JJ	amod	O
mice	NNS	nsubj	O
are	VBP	cop	O
fertile	JJ	ROOT	O
but	CC	cc	O
demonstrate	VBP	conj	O
metastatic	JJ	amod	O
testicular	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
development	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	dobj	O
in	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
abilities	NNS	nmod	O
,	,	punct	O
responses	NNS	dep	O
to	TO	case	O
the	DT	dep	O
invasion	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
-	HYPH	punct	O
regulating	VBG	dep	O
growth	NN	compound	O
factor	NN	compound	O
TGFbeta	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
for	IN	case	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
enzymes	NNS	nmod	O
or	CC	cc	O
enzyme	NN	compound	O
inhibitors	NNS	conj	O
.	.	punct	O
Microarray	NN	compound	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
significant	JJ	amod	O
alterations	NNS	dobj	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
the	DT	det	O
TGFbeta	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
genes	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
infertility	NN	nmod	O
and	CC	cc	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
production	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
Evi	NNP	nsubj	O
-	SYM	punct	O
1	CD	nummod	O
represses	VBZ	ccomp	O
Smad	NNP	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
by	IN	mark	O
recruiting	VBG	advcl	O
CtBP	NN	dobj	O
as	IN	prep	O
a	DT	det	O
corepressor	NN	pobj	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
strongly	RB	advmod	O
implicate	VBP	ROOT	O
the	DT	det	O
BR	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMADs	NNS	dobj	I-Gene_or_gene_product
as	IN	case	O
part	NN	nmod	O
of	IN	case	O
a	DT	det	O
critical	JJ	amod	O
developmental	JJ	amod	O
pathway	NN	nmod	O
in	IN	case	O
ovaries	NNS	nmod	B-Organ
and	CC	cc	O
testis	NN	conj	B-Organ
that	IN	nsubj	O
,	,	punct	O
when	WRB	advmod	O
disrupted	VBN	advcl	O
,	,	punct	O
leads	VBZ	ccomp	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Ambiguity	NN	compound	O
role	NN	ROOT	O
of	IN	case	O
neutrophils	NNS	nmod	O
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O
[	-LRB-	punct	O
Clinical	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
disease	NN	nmod	O
]	-RRB-	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nsubj	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
proinflammatory	JJ	amod	O
cytokine	NN	ROOT	O
that	WDT	nsubj	O
produces	VBZ	acl:relcl	O
multifunctional	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

TNF	NN	compound	O
-	HYPH	punct	O
alpha	NN	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
essential	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
for	IN	case	O
protection	NN	nmod	O
from	IN	case	O
bacterial	JJ	amod	O
infection	NN	nmod	O
and	CC	cc	O
for	IN	case	O
immune	JJ	amod	O
cell	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
immune	JJ	amod	O
reactions	NNS	nmod	O
,	,	punct	O
hematopoiesis	NN	conj	O
and	CC	cc	O
inflammatory	JJ	amod	O
state	NN	conj	O
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
6	CD	nsubjpass	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
including	VBG	case	O
inhibition	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
apoptosis	NN	dep	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

TNFalpha	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
inflammation	NN	compound	O
cytokine	NN	ROOT	O
and	CC	cc	O
is	VBZ	cop	O
crucial	JJ	conj	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
inflammation	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Anti	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IL	NNP	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
therapy	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
strategy	NN	ROOT	O
in	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Clinical	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
elevated	JJ	amod	O
serum	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
concentrations	NNS	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	appos	I-Cancer
,	,	punct	O
colorectal	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
,	,	punct	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	appos	I-Cancer
,	,	punct	O
breast	NN	conj	B-Cancer
and	CC	cc	O
ovarian	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

The	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
elevated	JJ	amod	O
serum	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
100beta	CD	intj	O
,	,	punct	O
IL	NN	nmod	O
-	:	punct	O
6	CD	nummod	O
and	CC	cc	O
IL	NN	compound	O
-	:	punct	O
10	CD	conj	O
reflect	NN	ccomp	O
concurrent	JJ	amod	O
liver	NN	dobj	O
or	CC	cc	O
bone	NN	compound	O
metastases	NNS	conj	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
Serum	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cancer
stage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
survival	NN	conj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
article	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
focused	VBN	ROOT	O
on	IN	case	O
a	DT	det	O
role	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
6	CD	nmod	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
factor	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
such	JJ	case	O
as	IN	mwe	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
breast	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
,	,	punct	O
gastric	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
and	CC	cc	O
pancreatic	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

LMP1	NN	nsubj	O
of	IN	case	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	nmod	O
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
cooperatively	RB	advmod	O
transforms	VBZ	conj	O
the	DT	det	O
cells	NNS	dobj	O
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	O
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	O
oncogene	NN	nmod	O
.	.	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
CDK4	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
CDK2	NN	conj	B-Gene_or_gene_product
in	IN	case	O
mouse	NN	compound	B-Organism
oral	JJ	amod	B-Immaterial_anatomical_entity
cavity	NN	nmod	I-Immaterial_anatomical_entity
is	VBZ	auxpass	O
retained	VBN	ROOT	O
in	IN	case	O
adult	JJ	amod	O
pituitary	NN	nmod	B-Organ
with	IN	case	O
distinct	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
transgenic	JJ	amod	O
mouse	NN	compound	O
line	NN	dobj	O
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
simian	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
SV40	NN	appos	O
)	-RRB-	punct	O
transforming	NN	amod	O
sequences	NNS	dobj	O
under	IN	case	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
1	CD	nmod	O
.	.	punct	O
4	CD	nummod	O
kb	NN	compound	O
tyrosinase	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
protein	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
TRP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
promoter	NN	ROOT	O
,	,	punct	O
targeting	VBG	acl	O
expression	NN	dobj	O
of	IN	case	O
T	NN	compound	O
antigen	NN	nmod	O
(	-LRB-	punct	O
Tag	NN	appos	O
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
RPE	NN	nmod	O
.	.	punct	O
The	DT	det	O
keratin	NN	compound	B-Gene_or_gene_product
5	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
K5	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
promoter	NN	nsubj	O
drives	VBZ	ROOT	O
transgenic	JJ	amod	O
expression	NN	dobj	O
to	TO	case	O
the	DT	det	O
basal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
layer	NN	nmod	O
of	IN	case	O
stratified	JJ	amod	O
epithelia	NN	nmod	B-Tissue
.	.	punct	O

In	IN	case	O
transgenic	JJ	amod	O
embryos	NNS	nmod	O
,	,	punct	O
RPE	NN	compound	O
cells	NNS	nsubj	O
proliferated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
anterior	JJ	amod	O
part	NN	nmod	O
of	IN	case	O
the	DT	det	O
eye	NN	nmod	O
and	CC	cc	O
near	IN	conj	O
the	DT	det	O
optic	JJ	amod	O
nerve	NN	pobj	O
.	.	punct	O
Surprisingly	RB	advmod	O
,	,	punct	O
analysis	NN	nsubj	O
of	IN	case	O
K5CDK4	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
K5CDK2	NN	conj	B-Gene_or_gene_product
transgenic	JJ	amod	O
mouse	NN	compound	O
embryos	NNS	dep	B-Developing_anatomical_structure
showed	VBD	ROOT	O
CDK4	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
CDK2	NN	conj	B-Gene_or_gene_product
expression	NN	dobj	O
not	RB	neg	O
only	RB	cc:preconj	O
in	IN	case	O
the	DT	det	O
expected	VBN	amod	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
the	DT	det	O
adenohypophysis	NN	conj	B-Organ
.	.	punct	O

Neuroblastoma	NN	nsubjpass	O
is	VBZ	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
SNS	NN	compound	O
precursors	NNS	nmod	O
.	.	punct	O
This	DT	det	O
organ	NN	nsubjpass	B-Organ
is	VBZ	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
an	DT	det	O
upwards	NN	compound	O
growth	NN	nmod	O
of	IN	case	O
the	DT	det	O
primitive	JJ	amod	O
oropharynx	NN	nmod	B-Anatomical_system
,	,	punct	O
a	DT	det	O
K5	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
tissue	NN	appos	B-Tissue
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
CDK	NN	appos	O
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	O
(	-LRB-	punct	O
Ink4c	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	O
(	-LRB-	punct	O
Kip1	NN	appos	O
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	O
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
multiple	JJ	amod	O
endocrine	JJ	amod	O
neoplasia	NN	compound	O
(	-LRB-	punct	O
MEN	NN	appos	O
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
transgenic	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
CDKs	NNS	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-Developing_anatomical_structure
oral	JJ	amod	I-Developing_anatomical_structure
ectoderm	NN	nmod	I-Developing_anatomical_structure
is	VBZ	auxpass	O
specifically	RB	advmod	O
retained	VBN	ccomp	O
in	IN	case	O
undifferentiated	JJ	amod	O
cells	NNS	nmod	B-Cell
from	IN	case	O
the	DT	det	O
pars	NNS	amod	B-Multi-tissue_structure
intermedia	NN	nmod	I-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
adenohypophysis	NN	nmod	B-Organ
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
CDK	NN	appos	O
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	O
(	-LRB-	punct	O
Ink4c	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	O
(	-LRB-	punct	O
Kip1	NN	appos	O
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	O
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
multiple	JJ	amod	O
endocrine	JJ	amod	O
neoplasia	NN	compound	O
(	-LRB-	punct	O
MEN	NN	appos	O
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
K5CDK4	NN	compound	B-Gene_or_gene_product
mice	NNS	nsubj	O
show	VBP	ccomp	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
pituitary	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
even	RB	advmod	O
though	IN	mark	O
CDK4	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
not	RB	neg	O
expressed	VBN	advcl	O
in	IN	case	O
the	DT	det	O
stem	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
in	IN	case	O
transit	NN	compound	B-Cell
-	HYPH	punct	I-Cell
amplifying	VBG	dep	I-Cell
(	-LRB-	punct	I-Cell
TA	NN	conj	I-Cell
)	-RRB-	punct	I-Cell
-	:	punct	I-Cell
like	JJ	case	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
CDK	NN	appos	O
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	O
(	-LRB-	punct	O
Ink4c	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	O
(	-LRB-	punct	O
Kip1	NN	appos	O
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	O
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
multiple	JJ	amod	O
endocrine	JJ	amod	O
neoplasia	NN	compound	O
(	-LRB-	punct	O
MEN	NN	appos	O
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
CDK4	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nsubj	B-Cell
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
CDK2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	conj	B-Cell
,	,	punct	O
strongly	RB	advmod	O
synergize	VBP	ROOT	O
with	IN	case	O
lack	NN	nmod	O
of	IN	case	O
p27	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Kip1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
generate	VB	xcomp	O
pituitary	JJ	amod	B-Cancer
carcinomas	NNS	dobj	I-Cancer
that	WDT	nsubj	O
appear	VBP	acl:relcl	O
with	IN	case	O
shortened	JJ	amod	O
latency	NN	nmod	O
and	CC	cc	O
are	VBP	cop	O
drastically	RB	advmod	O
more	RBR	advmod	O
aggressive	JJ	conj	O
than	IN	case	O
those	DT	nmod	O
arising	VBG	acl	O
in	IN	case	O
p27	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
mice	NNS	dobj	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
lines	NNS	nmod	O
with	IN	case	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
fetal	JJ	amod	O
and	CC	cc	O
adult	JJ	conj	O
CNS	NN	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
transgenic	JJ	amod	O
neural	JJ	amod	O
stem	NN	compound	O
cells	NNS	nsubj	O
formed	VBD	ccomp	O
larger	JJR	amod	O
colonies	NNS	dobj	O
,	,	punct	O
more	JJR	advmod	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
divisions	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
more	JJR	amod	O
neurons	NNS	conj	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
deregulation	NN	nsubj	O
of	IN	case	O
CDK	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
primitive	JJ	amod	B-Tissue
oral	JJ	amod	I-Tissue
epithelium	NN	nmod	I-Tissue
plays	VBZ	ccomp	O
a	DT	det	O
unique	JJ	amod	O
function	NN	dobj	O
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
selective	JJ	amod	O
advantage	NN	dobj	O
that	WDT	nsubj	O
gives	VBZ	acl:relcl	O
rise	NN	dobj	O
to	TO	case	O
transgene	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
positive	JJ	amod	I-Cell
TA	NNP	nmod	I-Cell
-	HYPH	punct	I-Cell
like	IN	case	I-Cell
pituitary	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Mutant	JJ	amod	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
cyclin	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
CDK	NN	appos	O
)	-RRB-	punct	O
inhibitors	NNS	dobj	O
p18	NN	dep	O
(	-LRB-	punct	O
Ink4c	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	O
(	-LRB-	punct	O
Kip1	NN	appos	O
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
tumor	NN	compound	O
spectrum	NN	compound	O
reminiscent	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
multiple	JJ	amod	O
endocrine	JJ	amod	O
neoplasia	NN	compound	O
(	-LRB-	punct	O
MEN	NN	appos	O
)	-RRB-	punct	O
syndromes	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
retention	NN	nsubj	O
of	IN	case	O
CDK4	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
these	DT	det	O
TA	NNP	nmod	B-Cell
-	HYPH	punct	I-Cell
like	IN	mark	I-Cell
pituitary	JJ	amod	I-Cell
cells	NNS	nsubj	I-Cell
synergizes	VBZ	ROOT	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
p27	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
Kip1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
to	TO	mark	O
induce	VB	xcomp	O
pituitary	JJ	amod	B-Cancer
adenocarcinomas	NNS	dobj	I-Cancer
.	.	punct	O

LMP1	NN	nsubj	O
of	IN	case	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	nmod	O
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
cooperatively	RB	advmod	O
transforms	VBZ	conj	O
the	DT	det	O
cells	NNS	dobj	O
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	O
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	O
oncogene	NN	nmod	O
.	.	punct	O
This	DT	det	O
model	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	dobj	O
forced	VBN	amod	O
expression	NN	dep	O
of	IN	case	O
CDK4	NN	compound	B-Gene_or_gene_product
sensitizes	VBZ	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
synergizes	VBZ	conj	O
with	IN	case	O
a	DT	det	O
second	JJ	amod	O
change	NN	nmod	O
resulting	VBG	acl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Survivin	NN	nsubj	O
functions	VBZ	nsubj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
upstream	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
molecular	JJ	amod	O
targeting	NN	conj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
results	VBZ	appos	O
in	IN	case	O
anticancer	NN	compound	O
activity	NN	nmod	O
via	IN	case	O
a	DT	det	O
dual	JJ	amod	O
mechanism	NN	nmod	O
of	IN	case	O
induction	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nmod	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
Survivin	NN	compound	B-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
breast	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
:	:	punct	O
correlation	NN	dep	O
with	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Molecular	JJ	amod	O
antagonists	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
apoptosis	NN	compound	O
protein	NN	compound	O
survivin	NN	nmod	O
have	VBP	aux	O
shown	VBN	dep	O
promise	NN	dobj	O
as	IN	case	O
novel	JJ	amod	O
anticancer	NN	compound	O
strategies	NNS	nmod	O
for	IN	mark	O
triggering	VBG	acl	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	dobj	O
,	,	punct	O
dysregulating	VBG	advcl	O
mitotic	JJ	amod	O
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
inhibiting	VBG	conj	O
tumor	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
preclinical	JJ	amod	O
models	NNS	nmod	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
Survivin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
apoptosis	NN	nmod	O
commonly	RB	advmod	O
detected	VBN	acl	O
in	IN	case	O
tissues	NNS	nmod	B-Tissue
during	IN	case	O
fetal	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
cancer	NN	conj	B-Cancer
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
usually	RB	conj	O
in	IN	case	O
normal	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
for	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
prognostic	JJ	amod	O
significance	NN	ccomp	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
,	,	punct	O
colorectal	JJ	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
bladder	NN	conj	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
survivin	NN	amod	O
couples	NNS	nsubj	O
to	TO	prep	O
the	DT	det	O
cell	NN	compound	O
death	NN	compound	O
machinery	NN	pobj	O
has	VBZ	aux	O
remained	VBN	ROOT	O
elusive	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
relevant	JJ	amod	O
cellular	JJ	amod	O
targets	NNS	nsubjpass	O
of	IN	case	O
survivin	NN	compound	O
antagonists	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
completely	RB	advmod	O
elucidated	VBN	conj	O
.	.	punct	O
We	PRP	nsubj	O
assessed	VBD	ROOT	O
survivin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
correlating	NN	acl	O
results	NNS	dobj	O
with	IN	case	O
expression	NN	nmod	O
of	IN	prep	O
other	JJ	amod	O
antiapoptotic	JJ	amod	O
(	-LRB-	punct	O
bcl	NN	intj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
proapoptotic	JJ	amod	O
(	-LRB-	punct	O
bax	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
markers	NNS	conj	O
,	,	punct	O
with	IN	case	O
prognostic	JJ	amod	O
parameters	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
with	IN	case	O
prognosis	NN	conj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Molecular	JJ	amod	O
antagonists	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitor	NN	nmod	O
of	IN	case	O
apoptosis	NN	compound	O
protein	NN	compound	O
survivin	NN	nmod	O
have	VBP	aux	O
shown	VBN	dep	O
promise	NN	dobj	O
as	IN	case	O
novel	JJ	amod	O
anticancer	NN	compound	O
strategies	NNS	nmod	O
for	IN	mark	O
triggering	VBG	acl	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	dobj	O
,	,	punct	O
dysregulating	VBG	advcl	O
mitotic	JJ	amod	O
progression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
inhibiting	VBG	conj	O
tumor	NN	compound	O
growth	NN	dobj	O
in	IN	case	O
preclinical	JJ	amod	O
models	NNS	nmod	O
.	.	punct	O
DESIGN	NN	ROOT	O
:	:	punct	O
Paraffin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
sections	NNS	nsubjpass	B-Cancer
of	IN	case	O
37	CD	nummod	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
were	VBD	auxpass	O
immunostained	VBN	appos	O
for	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
bcl	NN	conj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
,	,	punct	O
bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
bax	NN	conj	B-Gene_or_gene_product
.	.	punct	O

PATIENTS	NNS	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
erbB2	NNP	dep	O
,	,	punct	O
evaluated	VBN	acl	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
in	IN	case	O
145	CD	compound	O
of	IN	advmod	O
173	CD	nummod	O
patients	NNS	nmod	O
randomly	RB	advmod	O
assigned	VBN	ROOT	O
to	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
year	NN	nmod	O
adjuvant	JJ	amod	O
tamoxifen	NN	dobj	O
or	CC	cc	O
no	DT	neg	O
further	JJ	amod	O
therapy	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
considered	VBN	conj	O
overexpressed	VBN	xcomp	O
if	IN	mark	O
greater	JJR	amod	O
than	IN	quantmod	O
10	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
showed	VBD	advcl	O
specific	JJ	amod	O
membrane	NN	compound	O
staining	NN	dobj	O
.	.	punct	O
Expression	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
carcinoma	NN	conj	B-Cancer
,	,	punct	O
nuclei	NNS	conj	B-Cellular_component
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
,	,	punct	O
as	IN	case	O
intensity	NN	nmod	O
(	-LRB-	punct	O
0	CD	compound	O
to	TO	dep	O
3	CD	dep	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
percentage	NN	conj	O
of	IN	case	O
positive	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
study	NN	nsubj	O
included	VBD	appos	O
60	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
a	DT	det	O
known	JJ	amod	O
prognosis	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
RESULTS	NNS	dep	O
:	:	punct	O
Survivin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
30	CD	nummod	O
(	-LRB-	punct	O
81	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	conj	I-Tissue
,	,	punct	O
in	IN	case	O
nuclei	NNS	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
cytoplasm	NN	conj	B-Organism_substance
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
avidin	NN	compound	O
-	HYPH	punct	O
biotin	NN	compound	O
-	HYPH	punct	O
peroxidase	NN	compound	O
method	NN	dobj	O
,	,	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	appos	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
expression	NN	conj	O
in	IN	case	O
56	CD	nummod	O
samples	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
in	IN	case	O
22	CD	nummod	O
matched	VBN	amod	O
pairs	NNS	conj	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumors	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
022	CD	dobj	O
)	-RRB-	punct	O
between	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	conj	I-Gene_or_gene_product
expression	NN	conj	O
;	:	punct	O
survivin	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
bcl	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nsubj	I-Gene_or_gene_product
tended	VBD	conj	O
to	TO	aux	O
correlate	VB	xcomp	O
with	IN	case	O
overall	JJ	amod	O
survival	NN	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
072	CD	dep	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
075	CD	dobj	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
19	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
18	CD	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
avidin	NN	compound	O
-	HYPH	punct	O
biotin	NN	compound	O
-	HYPH	punct	O
peroxidase	NN	compound	O
method	NN	dobj	O
,	,	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	appos	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
expression	NN	conj	O
in	IN	case	O
56	CD	nummod	O
samples	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
in	IN	case	O
22	CD	nummod	O
matched	VBN	amod	O
pairs	NNS	conj	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumors	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
of	IN	prep	O
survivin	NN	pobj	B-Gene_or_gene_product
with	IN	prep	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
bax	NN	conj	B-Gene_or_gene_product
expression	NN	pobj	O
,	,	punct	O
or	CC	cc	O
with	IN	case	O
other	JJ	amod	O
prognostic	JJ	amod	O
parameters	NNS	conj	O
(	-LRB-	punct	O
age	NN	dep	O
,	,	punct	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
,	,	punct	O
histologic	JJ	amod	O
type	NN	appos	O
,	,	punct	O
histologic	JJ	amod	O
grade	NN	appos	O
,	,	punct	O
nodal	JJ	amod	B-Multi-tissue_structure
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
stage	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
positive	JJ	amod	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	dobj	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
immunostaining	NN	conj	O
in	IN	case	O
44	CD	nmod	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
28	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
58	CD	conj	O
.	.	punct	O
9	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
the	DT	det	O
studied	VBN	amod	O
primary	JJ	amod	O
tumors	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
63	CD	conj	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
45	CD	appos	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
72	CD	conj	O
.	.	punct	O
7	CD	nummod	O
%	NN	ROOT	O
of	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastases	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
majority	NN	nsubj	O
(	-LRB-	punct	O
81	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
breast	NN	compound	B-Cancer
carcinomas	NNS	nmod	I-Cancer
show	VBP	dep	O
survivin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
which	WDT	nsubj	O
correlates	VBZ	acl:relcl	O
with	IN	case	O
bcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
x	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
another	DT	det	O
antiapoptotic	JJ	amod	O
marker	NN	conj	O
,	,	punct	O
and	CC	cc	O
both	DT	det	O
markers	NNS	nsubj	O
tend	VBP	parataxis	O
to	TO	mark	O
correlate	VB	xcomp	O
with	IN	case	O
prognosis	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	nsubj	O
:	:	punct	O
VEGF	NN	compound	O
-	HYPH	punct	O
A	NNP	nsubj	O
(	-LRB-	punct	O
165	CD	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	dep	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
angiogenesis	NN	compound	O
regulators	NNS	nmod	O
among	IN	case	O
the	DT	det	O
ligands	NNS	nmod:poss	O
'	POS	case	O
family	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
,	,	punct	O
whereas	IN	punct	O
its	PRP$	nmod:poss	O
receptors	NNS	appos	O
KDR	NN	dep	O
,	,	punct	O
and	CC	cc	O
most	RBS	advmod	O
probably	RB	advmod	O
Flt	NNP	compound	O
-	HYPH	punct	O
1	CD	conj	O
,	,	punct	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	compound	O
(	-LRB-	punct	O
angiogenic	JJ	amod	O
)	-RRB-	punct	O
phenotype	NN	nmod	O
,	,	punct	O
as	IN	mark	O
indicated	VBN	advcl	O
by	IN	case	O
their	PRP$	nmod:poss	O
upregulated	VBN	amod	O
MRNA	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
stage	NN	compound	O
III	CD	nummod	O
neuroblastoma	NN	nmod	O
.	.	punct	O
Functional	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
a	DT	dep	I-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
:	:	punct	O
role	NN	dep	O
in	IN	case	O
vasculogenic	JJ	amod	O
mimicry	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
platelet	NN	compound	O
counts	NNS	nsubjpass	O
and	CC	cc	O
systemic	JJ	amod	O
coagulation	NN	compound	O
activation	NN	conj	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
ovarian	JJ	amod	O
cancer	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
Ovarian	JJ	amod	B-Cancer
cancer	NN	nsubj	I-Cancer
is	VBZ	cop	O
a	DT	det	O
silent	JJ	amod	O
killer	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
shows	VBZ	conj	O
early	JJ	amod	O
extensive	JJ	amod	O
tumor	NN	compound	B-Cancer
invasion	NN	dobj	O
and	CC	cc	O
peritoneal	JJ	amod	B-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

Excessive	JJ	amod	O
vascular	JJ	amod	O
development	NN	nsubj	O
and	CC	cc	O
blood	NN	compound	O
vessel	NN	compound	O
remodeling	NN	conj	O
appears	VBZ	ROOT	O
in	IN	case	O
psoriasis	NN	nmod	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
diabetic	JJ	amod	O
retinopathy	NN	conj	O
and	CC	cc	O
solid	JJ	amod	O
tumors	NNS	compound	O
formation	NN	conj	O
.	.	punct	O
The	DT	det	O
microcirculation	NN	nsubj	O
of	IN	case	O
most	JJS	amod	O
tumors	NNS	nmod	B-Cancer
includes	VBZ	ROOT	O
cooperation	NN	dobj	O
of	IN	case	O
pre	JJ	compound	O
-	HYPH	punct	O
existing	VBG	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
intussusceptive	JJ	amod	O
microvascular	JJ	amod	B-Tissue
growth	NN	appos	O
,	,	punct	O
postnatal	JJ	amod	O
vasculogenesis	NN	conj	O
,	,	punct	O
glomeruloid	JJ	amod	B-Multi-tissue_structure
angiogenesis	NN	conj	O
and	CC	cc	O
vasculogenic	JJ	amod	O
mimicry	NN	conj	O
(	-LRB-	punct	O
VM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Solid	JJ	amod	O
tumors	NNS	nsubj	O
must	MD	aux	O
establish	VB	ROOT	O
a	DT	det	O
blood	NN	compound	O
supply	NN	dobj	O
in	IN	mark	O
order	NN	pobj	O
to	TO	aux	O
proliferate	VB	advcl	O
and	CC	cc	O
grow	VB	conj	O
.	.	punct	O
VM	NN	nsubj	O
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
blood	NN	compound	B-Organism_substance
supply	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
asscociated	VBN	conj	O
with	IN	case	O
aggressive	JJ	amod	O
features	NNS	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

At	IN	case	O
protein	NN	compound	O
level	NN	nmod	O
,	,	punct	O
VEGF	NN	compound	O
-	:	punct	O
B	NN	intj	O
and	CC	cc	O
C	NN	conj	O
,	,	punct	O
Flt	NNP	compound	O
-	HYPH	punct	O
1	CD	conj	O
,	,	punct	O
and	CC	cc	O
KDR	NN	conj	O
were	VBD	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
tissue	NN	compound	O
lysates	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NNP	compound	O
-	HYPH	punct	O
A	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	parataxis	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
.	.	punct	O
Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
highlight	VBP	ROOT	O
the	DT	det	O
plasticity	NN	dobj	O
of	IN	case	O
aggressive	JJ	amod	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
call	VB	conj	O
into	IN	prep	O
question	NN	pobj	O
the	DT	det	O
underlying	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
form	VB	acl	O
VM	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
induced	VBN	acl	O
by	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
a	DT	advmod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
RNA	NN	compound	O
transcripts	NNS	nmod	O
of	IN	case	O
type	NN	nmod	O
II	CD	nummod	O
-	HYPH	punct	O
like	IN	case	O
tumor	NN	compound	O
HK	NN	nmod	O
of	IN	case	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	ROOT	O
and	CC	cc	O
approximately	RB	advmod	O
4	CD	conj	O
.	.	punct	O
0	CD	nummod	O
kb	NN	ROOT	O
in	IN	case	O
these	DT	det	O
cancer	NN	compound	O
cells	NNS	compound	O
lines	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
muscle	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
L6	NN	compound	O
myoblast	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
studies	NNS	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
their	PRP$	nmod:poss	O
clinicalpathological	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
the	DT	det	O
cancers	NNS	nmod	B-Cancer
with	IN	case	O
human	JJ	amod	B-Organism
Paraffin	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
tumor	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
samples	NNS	nmod	I-Tissue
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
this	DT	det	O
possibility	NN	dobj	O
with	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	nmod	O
using	VBG	acl	O
human	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
a	DT	det	O
rodent	JJ	amod	O
hindlimb	JJ	compound	O
ischemia	NN	compound	O
model	NN	conj	O
.	.	punct	O
Results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
process	NN	nsubj	O
:	:	punct	O
VEGF	NNP	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
a	DT	det	I-Gene_or_gene_product
-	HYPH	punct	O
-	HYPH	punct	O
greater	JJR	amod	O
than	IN	prep	O
EphA2	CD	pobj	B-Gene_or_gene_product
-	HYPH	punct	O
-	HYPH	punct	O
greater	JJR	amod	O
than	IN	prep	O
MMPs	NNP	pobj	B-Gene_or_gene_product
-	HYPH	punct	O
-	HYPH	punct	O
greater	JJR	nsubj	O
than	IN	case	O
VM	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
main	JJ	amod	O
pathway	NN	nmod	O
for	IN	case	O
VM	NN	compound	O
formation	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
a	DT	det	I-Gene_or_gene_product
appears	VBZ	ccomp	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
VM	NN	nmod	O
based	VBN	case	O
on	IN	case	O
our	PRP$	nmod:poss	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
immunohistochemical	JJ	amod	O
analyses	NNS	conj	O
.	.	punct	O

Different	JJ	amod	O
antiangiogenic	JJ	amod	O
therapeutics	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
improve	VB	xcomp	O
tumor	NN	compound	O
control	NN	dobj	O
through	IN	case	O
vascular	JJ	amod	O
-	HYPH	punct	O
targeting	VBG	dep	O
agents	NNS	nmod	O
(	-LRB-	punct	O
VTA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
VM	NNP	npadvmod	O
-	HYPH	punct	O
targeting	NN	amod	O
strategies	NNS	nsubj	O
for	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
include	VBP	ROOT	O
anti	JJ	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
VEGF	NNP	dobj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
a	DT	det	I-Gene_or_gene_product
treatment	NN	appos	O
,	,	punct	O
knocking	VBG	xcomp	O
down	RP	case	O
the	DT	det	O
EphA2	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
using	VBG	conj	O
antibodies	NNS	dobj	B-Gene_or_gene_product
against	IN	case	I-Gene_or_gene_product
human	JJ	amod	I-Gene_or_gene_product
MMPs	NNS	nmod	I-Gene_or_gene_product
if	IN	mark	O
the	DT	det	O
tumor	NN	nsubj	B-Cancer
is	VBZ	cop	O
VM	NN	nmod:npmod	O
positive	JJ	advcl	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	O
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	O
progression	NN	dobj	O
.	.	punct	O
This	DT	det	O
strategy	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
significant	JJ	amod	O
value	NN	ROOT	O
in	IN	prep	O
laying	VBG	pcomp	O
the	DT	det	O
foundation	NN	dobj	O
for	IN	prep	O
a	DT	det	O
more	RBR	advmod	O
explicit	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	compound	O
therapy	NN	pobj	O
.	.	punct	O

Thrombospondin	NNP	nsubj	O
-	HYPH	punct	O
2	CD	nummod	O
plays	VBZ	ROOT	O
a	DT	det	O
protective	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
multistep	NN	compound	O
carcinogenesis	NN	nmod	O
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
host	NN	compound	O
anti	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	O
defense	NN	compound	O
mechanism	NN	dep	O
.	.	punct	O
A	DT	det	O
novel	JJ	amod	O
role	NN	nsubj	O
of	IN	case	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
:	:	punct	O
inhibit	VBP	ROOT	O
stroma	NN	compound	B-Tissue
reaction	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
activated	VBN	amod	O
fibroblasts	NNS	dobj	B-Cell
from	IN	case	O
invading	VBG	amod	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Thrombospondin	NN	nsubjpass	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TSP	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
different	JJ	amod	O
biological	JJ	amod	O
functions	NNS	dobj	O
on	IN	case	O
various	JJ	amod	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Tumor	NN	compound	O
fibroblasts	NNS	nsubjpass	O
(	-LRB-	punct	O
TF	NN	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
complex	JJ	amod	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
-	HYPH	punct	O
stroma	NN	compound	O
interactions	NNS	nmod	O
and	CC	cc	O
tumorigenesis	NN	conj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigate	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
stroma	NN	compound	B-Tissue
reaction	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
characterized	VBN	acl:relcl	O
by	IN	case	O
fibroblast	NN	compound	B-Cell
activation	NN	nmod	O
to	TO	mark	O
create	VB	xcomp	O
a	DT	det	O
permissive	JJ	amod	O
microenvironment	NN	dobj	O
for	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	O
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	O
and	CC	cc	O
Ras	NN	conj	O
.	.	punct	O
Immunohistochemistry	NN	compound	O
examinations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
surgical	JJ	amod	B-Cancer
specimens	NNS	nmod	I-Cancer
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
downregulation	NN	nsubjpass	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
during	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
emergence	NN	nmod	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
stroma	NN	compound	B-Gene_or_gene_product
markers	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	NN	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Transfection	NN	nsubj	O
of	IN	case	O
SiHa	NN	compound	B-Cell
cervical	JJ	amod	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
expressing	VBG	acl	O
the	DT	det	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	dobj	O
exhibited	VBD	ROOT	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
reduced	VBN	amod	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	B-Organism
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
vascularization	NN	nmod	O
and	CC	cc	O
lower	JJR	amod	O
expressions	NNS	conj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
than	IN	case	O
those	DT	nmod	O
in	IN	case	O
the	DT	det	O
vector	NN	compound	O
controls	NNS	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	O
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	O
and	CC	cc	O
Ras	NN	conj	O
.	.	punct	O
Transfection	NN	nsubj	O
with	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
purified	VBN	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
added	VBD	nsubj	O
to	TO	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
the	DT	det	O
protein	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
SMA	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
but	CC	cc	O
significantly	RB	advmod	O
inhibited	VBD	conj	O
matrix	NN	compound	B-Gene_or_gene_product
metalloprotease	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
activity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
quantified	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
alpha	NN	compound	O
-	:	punct	O
SMA	NN	nmod	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
myofibroblasts	NNS	nmod	O
in	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
factor	NN	appos	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
increased	VBN	amod	O
alpha	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
SMA	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
desmin	NN	conj	B-Gene_or_gene_product
expression	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	compound	O
beta	NN	nmod	O
(	-LRB-	punct	O
TGF	NN	compound	O
-	:	punct	O
beta	NN	appos	O
)	-RRB-	punct	O
by	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
The	DT	det	O
increased	VBN	amod	O
migration	NN	compound	O
ability	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
invasive	JJ	amod	O
ability	NN	conj	O
into	IN	case	O
tumor	NN	compound	B-Cancer
cluster	NN	nmod	O
of	IN	case	O
TGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	O
treated	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
were	VBD	cop	O
dose	NN	ROOT	O
dependently	RB	advmod	O
inhibited	VBN	acl	O
by	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	O
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	O
and	CC	cc	O
Ras	NN	conj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ectopic	JJ	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
SiHa	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
has	VBZ	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
invasive	JJ	amod	O
ability	NN	nmod	O
of	IN	case	O
the	DT	det	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

While	IN	mark	O
TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
tumor	NN	compound	O
differentiation	NN	dobj	O
or	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O
Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
to	TO	mark	O
inhibit	VB	acl	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
stroma	NN	compound	B-Tissue
reaction	NN	dobj	O
that	WDT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
attributed	VBN	acl:relcl	O
to	TO	case	O
the	DT	det	O
blockage	NN	nmod	O
of	IN	case	O
activated	VBN	amod	O
fibroblasts	NNS	nmod	B-Cell
from	IN	mark	O
invading	VBG	advcl	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
susceptibility	NN	dobj	O
to	TO	case	O
skin	NN	compound	O
carcinogenesis	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
accelerated	VBN	amod	O
and	CC	cc	O
increased	VBN	conj	O
tumor	NN	compound	O
formation	NN	nmod	O
.	.	punct	O
Targeting	VBG	ROOT	O
a	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
specific	JJ	amod	O
laminin	NN	compound	B-Gene_or_gene_product
domain	NN	dobj	O
critical	JJ	amod	O
for	IN	case	O
human	JJ	amod	B-Organism
carcinogenesis	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
head	NN	amod	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
using	VBG	acl	O
UM	NN	compound	O
-	HYPH	punct	O
SCC	NN	compound	O
-	:	punct	O
11A	NN	compound	O
cells	NNS	dobj	O
,	,	punct	O
2ME2	NN	nsubj	O
exhibited	VBD	ROOT	O
antitumor	NN	dobj	O
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	O
immunostaining	NN	nmod	O
.	.	punct	O
Laminin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
332	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
SCC	NN	appos	B-Cancer
)	-RRB-	punct	O
tumorigenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
targeting	VBG	conj	O
it	PRP	dobj	O
for	IN	case	O
cancer	NN	compound	B-Cancer
therapy	NN	nmod	O
has	VBZ	aux	O
been	VBN	cop	O
unachievable	JJ	conj	O
due	JJ	case	O
to	TO	case	O
key	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
laminin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
332	CD	nmod	I-Gene_or_gene_product
in	IN	mark	O
promoting	VBG	advcl	O
tissue	NN	compound	B-Tissue
integrity	NN	dobj	O
.	.	punct	O

During	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
proteolytic	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
stromal	JJ	amod	O
cells	NNS	conj	O
modify	VBP	ROOT	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	dobj	O
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
microenvironment	NN	amod	O
suitable	JJ	dobj	O
for	IN	case	O
their	PRP$	poss	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
portion	NN	nsubjpass	O
of	IN	case	O
laminin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
332	CD	nmod	I-Gene_or_gene_product
,	,	punct	O
termed	VBN	acl	O
G45	NN	xcomp	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
proteolytically	RB	advmod	O
removed	VBN	acl:relcl	O
and	CC	cc	O
absent	JJ	conj	O
in	IN	case	O
normal	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
,	,	punct	O
is	VBZ	auxpass	O
prominently	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
most	JJS	amod	O
human	JJ	amod	B-Organism
SCC	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
and	CC	cc	O
plays	VBZ	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
SCC	NN	compound	B-Cancer
tumorigenesis	NN	nmod	O
.	.	punct	O

Galpha	NN	nsubjpass	O
(	-LRB-	punct	O
12	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
alpha	NN	compound	O
-	HYPH	punct	O
subunit	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
G12	NN	compound	O
family	NN	nmod	O
of	IN	case	O
heterotrimeric	JJ	amod	O
G	NN	compound	O
proteins	NNS	nmod	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
neoplastic	JJ	amod	O
transformation	NN	conj	O
.	.	punct	O
Primary	JJ	amod	O
human	JJ	amod	B-Organism
keratinocytes	NNS	nsubj	O
lacking	VBG	acl	O
G45	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
DeltaG45	NN	appos	B-Cell
)	-RRB-	punct	O
showed	VBD	ROOT	O
alterations	NNS	dobj	O
of	IN	case	O
basal	JJ	amod	O
receptor	NN	compound	O
organization	NN	nmod	O
,	,	punct	O
impaired	JJ	amod	O
matrix	NN	compound	O
deposition	NN	conj	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
migration	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	dobj	O
in	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
abilities	NNS	nmod	O
,	,	punct	O
responses	NNS	dep	O
to	TO	case	O
the	DT	dep	O
invasion	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
-	HYPH	punct	O
regulating	VBG	dep	O
growth	NN	compound	O
factor	NN	compound	O
TGFbeta	NN	conj	O
and	CC	cc	O
changes	NNS	conj	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
for	IN	case	O
invasion	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
enzymes	NNS	nmod	O
or	CC	cc	O
enzyme	NN	compound	O
inhibitors	NNS	conj	O
.	.	punct	O
After	IN	case	O
SCC	NN	compound	B-Cancer
transformation	NN	nmod	O
,	,	punct	O
the	DT	det	O
absence	NN	nsubjpass	O
of	IN	case	O
G45	NN	compound	B-Gene_or_gene_product
domain	NN	nmod	O
in	IN	case	O
DeltaG45	NN	compound	B-Gene_or_gene_product
cells	NNS	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
deficient	JJ	amod	O
extracellular	JJ	amod	B-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
phosphotidylinositol	NN	compound	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PI3K	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathway	NN	compound	O
activation	NN	conj	O
,	,	punct	O
impaired	JJ	amod	O
invasion	NN	conj	O
,	,	punct	O
deficient	JJ	amod	O
metalloproteinase	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
,	,	punct	O
and	CC	cc	O
absent	JJ	amod	O
tumorgenicity	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	O
FOXO3a	NN	compound	O
expression	NN	nmod	O
reduced	VBD	ROOT	O
PI3K	NN	compound	O
/	:	punct	O
Akt	NN	compound	O
activity	NN	dobj	O
.	.	punct	O
Expression	NN	nsubj	O
of	IN	case	O
G45	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
activated	VBN	amod	O
PI3K	NN	compound	B-Gene_or_gene_product
subunit	NN	conj	O
in	IN	case	O
DeltaG45	NN	compound	B-Gene_or_gene_product
cells	NNS	nmod	O
reversed	VBD	ROOT	O
these	DT	det	O
abnormalities	NNS	dobj	O
.	.	punct	O

2G7	NN	nsubj	O
transiently	RB	advmod	O
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
MDA	NNP	compound	O
-	HYPH	punct	O
231	CD	nummod	O
subcutaneous	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
G45	NN	compound	B-Gene_or_gene_product
antibody	NN	compound	O
treatment	NN	nsubj	O
induced	VBD	ROOT	O
SCC	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
apoptosis	NN	dobj	O
,	,	punct	O
decreased	VBD	conj	O
SCC	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
proliferation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
markedly	RB	advmod	O
impaired	JJ	conj	O
human	JJ	amod	B-Organism
SCC	NN	compound	B-Cancer
tumorigenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
without	IN	mark	O
affecting	VBG	advcl	O
normal	JJ	amod	B-Tissue
tissue	NN	compound	I-Tissue
adhesion	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
possessed	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
UK	NN	nmod	O
,	,	punct	O
laminin	NN	conj	O
and	CC	cc	O
type	NN	compound	O
IV	CD	nummod	O
collagen	NN	conj	O
,	,	punct	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	O
membrane	NN	nmod	O
,	,	punct	O
disappeared	VBD	conj	O
from	IN	case	O
tumor	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
remarkable	JJ	amod	O
selectivity	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
for	IN	case	O
laminin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
332	CD	nummod	I-Gene_or_gene_product
G45	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
SCC	NN	compound	B-Cancer
tumorigenesis	NN	nmod	O
and	CC	cc	O
implicate	VB	conj	O
it	PRP	dobj	O
as	IN	case	O
a	DT	det	O
specific	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
anticancer	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Metronomic	NNP	amod	O
5	CD	nummod	O
-	HYPH	punct	O
fluorouracil	NN	ROOT	O
,	,	punct	O
oxaliplatin	NN	appos	O
and	CC	cc	O
irinotecan	NN	conj	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Management	NN	ROOT	O
of	IN	case	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
:	:	punct	O
therapeutic	JJ	amod	O
issues	NNS	dep	O
.	.	punct	O

The	DT	det	O
metronomic	JJ	amod	O
concept	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
universally	RB	advmod	O
apply	VB	ROOT	O
to	IN	case	O
every	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
and	CC	cc	O
metronomic	JJ	amod	O
combination	NN	compound	O
regimens	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
used	VBN	advcl	O
with	IN	prep	O
caution	NN	pobj	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
staging	NN	nsubjpass	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
therapeutic	JJ	amod	O
decision	NN	appos	O
making	VBG	acl	O
in	IN	prep	O
the	DT	det	O
management	NN	pobj	O
of	IN	prep	O
early	JJ	amod	O
and	CC	cc	O
advanced	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	pobj	I-Cancer
,	,	punct	O
and	CC	cc	O
dilemmas	NNS	conj	O
posed	VBN	acl	O
by	IN	case	O
drug	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
toxicity	NN	nmod	O
are	VBP	auxpass	O
discussed	VBN	dep	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
has	VBZ	aux	O
identified	VBN	appos	O
that	IN	mark	O
the	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
independent	JJ	amod	O
indicator	NN	ccomp	O
of	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
SUMMARY	NN	ROOT	O
:	:	punct	O
Staging	NN	nsubj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
occurs	VBZ	dep	O
after	IN	case	O
surgery	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
based	VBN	conj	O
on	IN	case	O
the	DT	det	O
extent	NN	nmod	O
of	IN	case	O
disease	NN	nmod	O
invasiveness	NN	dep	O
and	CC	cc	O
dissemination	NN	conj	O
.	.	punct	O

Prostate	NN	compound	O
cancer	NN	compound	O
dissemination	NN	nsubj	O
is	VBZ	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
and	CC	cc	O
few	JJ	amod	O
treatment	NN	compound	O
options	NNS	nsubj	O
exist	VBP	conj	O
for	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
advanced	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
.	.	punct	O
Surgery	NNP	nsubj	O
is	VBZ	cop	O
the	DT	det	O
primary	JJ	amod	O
treatment	NN	ROOT	O
for	IN	case	O
stage	NN	compound	O
I	CD	nummod	O
disease	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
p53	NN	nsubjpass	O
and	CC	cc	O
VEGF	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
with	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
stage	NN	nmod	O
II	CD	nummod	O
and	CC	cc	O
III	CD	nummod	O
SCC	NN	conj	O
of	IN	case	O
the	DT	det	O
esophagus	NN	nmod	O
.	.	punct	O
Adjuvant	JJ	amod	O
chemotherapy	NN	nsubjpass	O
is	VBZ	auxpass	O
recommended	VBN	ROOT	O
after	IN	case	O
resection	NN	nmod	O
in	IN	case	O
selected	VBN	amod	O
high	JJ	amod	O
-	HYPH	punct	O
risk	NN	compound	O
patients	NNS	nmod	B-Organism
with	IN	case	O
stage	NN	compound	O
II	CD	nummod	O
disease	NN	nmod	O
and	CC	cc	O
in	IN	case	O
all	DT	det	O
patients	NNS	conj	B-Organism
with	IN	case	O
stage	NN	compound	O
III	CD	nummod	O
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
metronomic	JJ	amod	O
concept	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
universally	RB	advmod	O
apply	VB	ROOT	O
to	IN	case	O
every	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
and	CC	cc	O
metronomic	JJ	amod	O
combination	NN	compound	O
regimens	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
used	VBN	advcl	O
with	IN	prep	O
caution	NN	pobj	O
.	.	punct	O
Convenience	NN	nsubj	O
of	IN	prep	O
administration	NN	pobj	O
,	,	punct	O
tolerability	NN	conj	O
,	,	punct	O
and	CC	cc	O
patient	NN	compound	B-Organism
factors	NNS	conj	O
not	RB	neg	O
necessarily	RB	advmod	O
age	NN	conj	O
may	MD	aux	O
be	VB	ROOT	O
considerations	NNS	attr	O
in	IN	case	O
decisions	NNS	nmod	O
about	IN	case	O
adjuvant	JJ	amod	O
therapy	NN	nmod	O
after	IN	case	O
resection	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
has	VBZ	aux	O
identified	VBN	appos	O
that	IN	mark	O
the	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
independent	JJ	amod	O
indicator	NN	ccomp	O
of	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Treatment	NN	nsubjpass	O
of	IN	case	O
stage	NN	compound	O
IV	CD	nummod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
type	NN	nmod	O
of	IN	case	O
prior	JJ	amod	O
therapy	NN	nmod	O
and	CC	cc	O
patient	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
specific	JJ	amod	O
factors	NNS	conj	O
.	.	punct	O

Cytotoxic	JJ	amod	O
chemotherapy	NN	compound	O
resistance	NN	nsubjpass	O
is	VBZ	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
limited	JJ	amod	O
therapeutic	JJ	amod	O
options	NNS	nmod	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
significant	JJ	amod	O
improvements	NNS	nsubjpass	O
in	IN	case	O
survival	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
achieved	VBN	ROOT	O
through	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
combination	NN	compound	O
chemotherapy	NN	nmod	O
and	CC	cc	O
monoclonal	JJ	amod	O
antibody	NN	compound	O
regimens	NNS	conj	O
.	.	punct	O

Predictive	JJ	amod	O
markers	NNS	nsubjpass	O
for	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NNP	compound	O
agents	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
yet	RB	advmod	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
questions	NNS	conj	O
regarding	VBG	prep	O
the	DT	det	O
usefulness	NN	pobj	O
of	IN	prep	O
bevacizumab	NN	pobj	O
in	IN	prep	O
the	DT	det	O
adjuvant	JJ	amod	O
setting	NN	pobj	O
as	RB	advmod	O
well	RB	advmod	O
as	IN	mark	O
its	PRP$	poss	O
continued	VBN	amod	O
use	NN	nsubj	O
beyond	IN	prep	O
progression	NN	pobj	O
remain	VBP	conj	O
unanswered	JJ	xcomp	O
,	,	punct	O
in	IN	case	O
spite	NN	dep	O
of	IN	case	O
negative	JJ	amod	O
data	NNS	nmod	O
on	IN	case	O
bevacizumab	NN	nmod	O
in	IN	mark	O
treating	VBG	acl	O
patients	NNS	dobj	O
with	IN	case	O
adjuvant	JJ	amod	O
colon	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Bevacizumab	NN	nsubj	B-Simple_chemical
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
chemotherapy	NN	nmod	O
is	VBZ	cop	O
first	RB	amod	O
-	HYPH	punct	O
line	NN	compound	O
therapy	NN	ROOT	O
for	IN	case	O
stage	NN	compound	O
IV	CD	nummod	O
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
metronomic	JJ	amod	O
concept	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
universally	RB	advmod	O
apply	VB	ROOT	O
to	IN	case	O
every	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
and	CC	cc	O
metronomic	JJ	amod	O
combination	NN	compound	O
regimens	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
used	VBN	advcl	O
with	IN	prep	O
caution	NN	pobj	O
.	.	punct	O
Age	NN	nsubj	O
alone	RB	advmod	O
should	MD	aux	O
not	RB	neg	O
preclude	VB	ROOT	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
chemotherapy	NN	nmod	O
in	IN	case	O
stage	NN	compound	O
IV	CD	nummod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
although	IN	mark	O
the	DT	det	O
ability	NN	nsubj	O
to	TO	case	O
tolerate	VB	amod	O
drug	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
toxicity	NN	nmod	O
may	MD	aux	O
be	VB	advcl	O
a	DT	det	O
consideration	NN	attr	O
.	.	punct	O

The	DT	det	O
metronomic	JJ	amod	O
concept	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
universally	RB	advmod	O
apply	VB	ROOT	O
to	IN	case	O
every	DT	det	O
cytotoxic	JJ	amod	O
drug	NN	nmod	O
in	IN	case	O
colorectal	JJ	amod	O
cancer	NN	nmod	O
and	CC	cc	O
metronomic	JJ	amod	O
combination	NN	compound	O
regimens	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
used	VBN	advcl	O
with	IN	prep	O
caution	NN	pobj	O
.	.	punct	O
The	DT	det	O
optimal	JJ	amod	O
duration	NN	nsubj	O
of	IN	case	O
chemotherapy	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
early	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
defined	VBN	acl	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
score	NN	nmod	O
identifies	VBZ	appos	O
a	DT	det	O
distinct	JJ	amod	O
group	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	O
cancers	NNS	nmod	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
(	-LRB-	punct	O
log	NN	compound	O
-	HYPH	punct	O
rank	NN	compound	O
test	NN	dep	O
,	,	punct	O
12	CD	appos	O
.	.	punct	O
22	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0005	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
optimal	JJ	amod	O
approach	NN	nsubj	O
to	TO	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
depends	VBZ	appos	O
on	IN	case	O
several	JJ	amod	O
considerations	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
patient	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
specific	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
skeletal	JJ	amod	O
muscle	NN	compound	O
glucose	NN	compound	O
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
.	.	punct	O
Serum	NN	ROOT	B-Organism_substance
and	CC	cc	O
urine	NN	conj	B-Organism_substance
levels	NNS	dep	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	dep	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Angiogenesis	NN	nsubj	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
many	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
Interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nsubjpass	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
and	CC	cc	O
pro	NN	npadvmod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
cytokine	NN	xcomp	O
,	,	punct	O
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
,	,	punct	O
prognosis	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	poss	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
NHL	NN	appos	B-Cancer
)	-RRB-	punct	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
fully	RB	advmod	O
determined	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
usefulness	NN	dobj	O
of	IN	mark	O
measuring	VBG	acl	O
serum	NN	dobj	B-Organism_substance
and	CC	cc	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
levels	NNS	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
NHL	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
differences	NNS	nsubj	O
in	IN	case	O
IL	NN	compound	O
-	HYPH	punct	O
12	CD	nummod	O
levels	NNS	nmod	O
were	VBD	cop	O
unremarkable	JJ	ROOT	O
.	.	punct	O
We	PRP	nsubj	O
developed	VBD	ROOT	O
reference	NN	compound	O
intervals	NNS	dobj	O
for	IN	case	O
serum	NN	nmod	B-Organism_substance
and	CC	cc	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
level	NN	conj	O
in	IN	case	O
131	CD	nummod	O
control	NN	amod	O
individuals	NNS	nmod	O
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
measured	VBD	ROOT	O
serum	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
urine	NN	conj	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
levels	NNS	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
NHL	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
compared	VBD	conj	O
the	DT	det	O
concentrations	NNS	dobj	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
reference	NN	compound	O
intervals	NNS	nsubj	O
for	IN	case	O
serum	NN	compound	B-Organism_substance
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
corrected	VBN	acl	O
by	IN	case	O
creatinine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
Cr	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
were	VBD	cop	O
15	CD	nummod	O
.	.	punct	O
9	CD	compound	O
-	SYM	punct	O
430	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
pg	NN	compound	O
/	:	punct	O
mL	NN	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
0	CD	compound	O
-	SYM	punct	O
28	CD	nummod	O
.	.	punct	O
4	CD	meta	O
pg	UH	dep	O
/	SYM	punct	O
mg	NN	compound	O
Cr	NN	ROOT	B-Simple_chemical
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
s	NNS	compound	O
-	HYPH	punct	O
VEGF	NNP	nmod	O
between	IN	case	O
the	DT	det	O
RCC	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
controls	NNS	conj	O
(	-LRB-	punct	O
207	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
32	CD	nummod	O
.	.	punct	O
9	CD	npadvmod	O
vs	CC	cc	O
.	.	punct	O
71	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	ROOT	O
.	.	punct	O
1	CD	nummod	O
pg	TO	compound	O
/	SYM	punct	O
ml	NN	ROOT	O
,	,	punct	O
mean	NN	appos	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
SE	NN	conj	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
005	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
tumor	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
renal	JJ	amod	O
veins	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
contralateral	JJ	amod	O
ones	NNS	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
pre	JJ	compound	O
-	HYPH	punct	O
and	CC	cc	O
post	JJ	amod	O
-	HYPH	punct	O
nephrectomy	NN	conj	O
situations	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
among	IN	case	O
the	DT	det	O
various	JJ	amod	O
parameters	NNS	conj	O
of	IN	case	O
tumor	NN	compound	O
status	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	O
extent	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
existence	NN	conj	O
of	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
concentrations	NNS	nsubj	O
of	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
Cr	NN	nmod	B-Simple_chemical
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
(	-LRB-	punct	O
48	CD	dep	O
.	.	punct	O
9	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
194	CD	dep	O
.	.	punct	O
4	CD	dep	O
vs	CC	cc	O
.	.	punct	O
5	LS	nummod	O
.	.	punct	O
2	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
13	CD	dep	O
.	.	punct	O
8	CD	nummod	O
pg	CC	dep	O
/	SYM	punct	O
mg	NN	compound	O
Cr	NN	dep	B-Simple_chemical
,	,	punct	O
P	NN	appos	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
liver	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
bone	NN	compound	O
metastases	NNS	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
median	JJ	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
S	NNP	compound	O
-	HYPH	punct	O
100beta	CD	intj	O
,	,	punct	O
IL	NN	compound	O
-	:	punct	O
6	CD	dep	O
and	CC	cc	O
IL	NN	conj	O
-	:	punct	O
10	CD	nmod	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
only	JJ	advmod	O
skin	NN	nmod	O
,	,	punct	O
nodal	NN	conj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
lung	NN	compound	O
involvement	NN	conj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
serum	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
concentrations	NNS	nmod	O
between	IN	case	O
NHL	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
and	CC	cc	O
controls	NNS	conj	O
(	-LRB-	punct	O
159	CD	dep	O
.	.	punct	O
2	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
40	CD	nummod	O
.	.	punct	O
4	CD	intj	O
vs	CC	cc	O
.	.	punct	O
99	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
107	CD	ROOT	O
.	.	punct	O
1	CD	nummod	O
pg	TO	compound	O
/	SYM	punct	O
mL	NN	ROOT	O
;	:	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
099	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
diagnostic	JJ	amod	O
performance	NN	nmod	O
was	VBD	ROOT	O
not	RB	neg	O
significant	JJ	acomp	O
on	IN	case	O
receiver	NN	compound	O
operating	VBG	amod	O
characteristic	JJ	amod	O
analysis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
>	NN	amod	O
0	CD	nummod	O
.	.	punct	O
4	LS	attr	O
)	-RRB-	punct	O
.	.	punct	O
Receiver	NN	compound	O
operating	NN	amod	O
characteristic	JJ	amod	O
(	-LRB-	punct	O
ROC	NN	dep	O
)	-RRB-	punct	O
analysis	NN	nsubj	O
gave	VBD	ROOT	O
0	CD	dobj	O
.	.	punct	O
83	CD	ROOT	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
43	CD	nummod	O
ROC	NN	compound	O
area	NN	compound	O
values	NNS	ROOT	O
for	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Cr	NN	nmod	B-Simple_chemical
and	CC	cc	O
serum	NN	conj	B-Organism_substance
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Pretreatment	NN	amod	O
IL	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
outcome	NN	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
serum	NN	nmod	B-Organism_substance
and	CC	cc	O
urine	NN	conj	B-Organism_substance
concentrations	NNS	dep	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
clinical	JJ	conj	O
variables	NNS	dep	O
,	,	punct	O
the	DT	det	O
only	JJ	amod	O
exception	NN	appos	O
being	VBG	cop	O
the	DT	det	O
international	JJ	amod	O
prognostic	JJ	amod	O
index	NN	nmod	O
(	-LRB-	punct	O
IPI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
a	DT	det	O
marginal	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
urine	NN	compound	B-Organism_substance
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Cr	JJ	compound	B-Simple_chemical
levels	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
07	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
This	DT	det	O
study	NN	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
urine	NN	compound	B-Organism_substance
IL	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
Cr	JJ	compound	B-Simple_chemical
levels	NNS	nsubj	O
might	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
as	IN	case	O
a	DT	det	O
diagnostic	JJ	amod	O
marker	NN	nmod	O
of	IN	case	O
NHL	NN	nmod	B-Cancer
.	.	punct	O

An	DT	det	O
assay	NN	ROOT	O
to	TO	mark	O
measure	VB	acl	O
angiogenesis	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
fat	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O
Microscopic	JJ	amod	O
technique	NN	ROOT	O
for	IN	case	O
the	DT	det	O
detection	NN	nmod	O
of	IN	case	O
nitric	JJ	amod	B-Simple_chemical
oxide	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	nmod	O
in	IN	case	O
an	DT	det	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
through	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
in	IN	case	O
vascular	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O
Nitric	JJ	amod	B-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
NO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
maintaining	VBG	advcl	O
vascular	JJ	amod	B-Multi-tissue_structure
homeostasis	NN	dobj	O
.	.	punct	O

Due	JJ	case	O
to	TO	aux	O
space	NN	advcl	O
limitations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
review	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
CNS	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
refer	VBP	conj	O
the	DT	det	O
reader	NN	dobj	O
to	IN	prep	O
other	JJ	amod	O
chapters	NNS	pobj	O
in	IN	prep	O
this	DT	det	O
book	NN	pobj	O
and	CC	cc	O
to	TO	conj	O
recent	JJ	amod	O
publications	NNS	pobj	O
on	IN	prep	O
the	DT	det	O
assembly	NN	pobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
NO	NN	nmod	B-Simple_chemical
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	B-Anatomical_system
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
several	JJ	amod	O
experimental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
establish	VBP	ROOT	O
that	IN	mark	O
acute	JJ	amod	O
ethanol	NN	compound	O
exposure	NN	nsubj	O
significantly	RB	advmod	O
impairs	VBZ	ccomp	O
angiogenesis	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
this	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
responsiveness	NN	nmod	O
to	TO	case	O
both	CC	cc:preconj	O
VEGF	NN	nmod	O
and	CC	cc	O
hypoxia	NN	conj	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
NO	NN	compound	B-Simple_chemical
metabolic	JJ	amod	O
pathway	NN	nsubj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
could	MD	aux	O
be	VB	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
main	JJ	amod	O
contributing	VBG	amod	O
factors	NNS	nmod	O
for	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
defines	VBZ	ROOT	O
the	DT	det	O
many	JJ	amod	O
steps	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	nmod:npmod	O
-	,	punct	O
derived	VBN	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
Although	IN	mark	O
several	JJ	amod	O
methods	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
used	VBN	advcl	O
for	IN	mark	O
measuring	VBG	advcl	O
in	FW	amod	O
vitro	FW	dep	O
angiogenesis	NN	dobj	O
,	,	punct	O
a	DT	det	O
proper	JJ	amod	O
technique	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
for	IN	mark	O
identifying	VBG	advcl	O
in	FW	amod	O
vivo	FW	dep	O
NO	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	O
humor	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
This	DT	det	O
chapter	NN	nsubj	O
provides	VBZ	ROOT	O
a	DT	det	O
new	JJ	amod	O
intravital	JJ	amod	O
microscopic	JJ	amod	O
method	NN	dobj	O
for	IN	mark	O
detecting	VBG	advcl	O
and	CC	cc	O
measuring	VBG	conj	O
NO	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	dobj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
naked	VBD	amod	O
DNA	NN	nsubjpass	O
encoding	VBG	acl	O
for	IN	case	O
VEGF	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
strategy	NN	nmod	O
of	IN	case	O
arterial	JJ	amod	O
gene	NN	compound	O
therapy	NN	nmod	O
to	TO	mark	O
stimulate	VB	xcomp	O
collateral	JJ	amod	O
artery	NN	compound	O
development	NN	dobj	O
.	.	punct	O
This	DT	det	O
technique	NN	nsubj	O
showed	VBD	ROOT	O
strong	JJ	amod	O
abdominal	JJ	amod	B-Organism_subdivision
neovascularization	NN	dobj	O
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mice	NNS	nmod	B-Organism
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
eNOS	NN	compound	B-Gene_or_gene_product
knockout	JJ	compound	O
mice	NNS	conj	O
,	,	punct	O
locally	RB	advmod	O
injected	VBN	advcl	O
with	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
stimulation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
NO	NN	compound	B-Simple_chemical
donor	NN	nmod:npmod	O
-	HYPH	punct	O
injected	VBN	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
VEGF	NNP	compound	O
-	HYPH	punct	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
over	IN	case	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
period	NN	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
alinidine	NN	nmod:npmod	O
-	HYPH	punct	O
stimulated	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O
This	DT	det	O
technique	NN	nsubj	O
also	RB	advmod	O
revealed	VBD	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
NOS	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
N	NN	compound	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
G	NN	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
iminoethyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
L	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
ornithine	NN	nmod	I-Simple_chemical
in	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nmod	O
.	.	punct	O

Physiological	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
signaling	NN	nmod	O
through	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
receptors	NNS	nmod	O
.	.	punct	O
This	DT	det	O
chapter	NN	compound	O
describes	VBZ	amod	O
intravital	JJ	amod	O
microscopy	NN	ROOT	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
imaging	NN	amod	O
technique	NN	nmod	O
for	IN	mark	O
detecting	VBG	acl	O
NO	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	dobj	O
in	IN	case	O
an	DT	det	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

Bee	NN	compound	O
venom	NN	nsubj	O
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
expression	NN	dobj	O
of	IN	case	O
cyclooxygenase	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
line	NN	compound	O
NCI	NN	compound	O
-	:	punct	O
H1299	NN	nmod	O
.	.	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
non	JJ	amod	O
-	HYPH	punct	O
selective	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
inhibitors	NNS	nmod	O
on	IN	case	O
proliferation	NN	compound	O
inhibition	NN	nmod	O
and	CC	cc	O
apoptosis	NN	compound	O
induction	NN	conj	O
of	IN	case	O
esophageal	JJ	amod	B-Cell
squamous	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Few	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
prognosis	NN	conj	O
in	IN	case	O
esophageal	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
objective	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
aspirin	NN	nmod	B-Simple_chemical
and	CC	cc	O
nimesulide	NN	conj	B-Simple_chemical
on	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
potential	JJ	amod	O
mechanisms	NNS	conj	O
in	IN	case	O
EC9706	NN	nmod	B-Cell
and	CC	cc	O
EC109	NN	conj	B-Cell
esophageal	VBP	conj	I-Cell
squamous	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Attenuating	NN	csubj	O
galectin	NN	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nsubj	O
by	IN	case	O
siRNA	NN	nmod	O
constrained	VBD	ROOT	O
PTTG	NN	compound	O
-	HYPH	punct	O
HA	NN	compound	O
/	:	punct	O
EC9706	NN	compound	O
cell	NN	compound	O
motility	NN	dobj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O
EC9706	NN	nsubjpass	B-Cell
and	CC	cc	O
EC109	NN	conj	B-Cell
cells	NNS	dep	I-Cell
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
varying	VBG	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
aspirin	NN	nmod	B-Simple_chemical
and	CC	cc	O
nimesulide	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
the	DT	det	O
effects	NNS	nsubjpass	O
on	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
were	VBD	auxpass	O
monitored	VBN	conj	O
by	IN	case	O
3	CD	nummod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
4	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethyl	JJ	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
thiazol	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
2yl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
5	CD	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
diphenyltetrazolium	NN	compound	I-Simple_chemical
bromide	NN	conj	I-Simple_chemical
and	CC	cc	O
flow	NN	conj	O
cytometry	NN	nmod	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
avidin	NN	compound	O
-	HYPH	punct	O
biotin	NN	compound	O
-	HYPH	punct	O
peroxidase	NN	compound	O
method	NN	dobj	O
,	,	punct	O
Bcl	NN	compound	O
-	HYPH	punct	O
xL	NN	appos	O
,	,	punct	O
Bax	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	O
expression	NN	conj	O
in	IN	case	O
56	CD	nummod	O
samples	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
and	CC	cc	O
in	IN	case	O
22	CD	nummod	O
matched	VBN	amod	O
pairs	NNS	conj	O
of	IN	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
tumors	NNS	nmod	O
.	.	punct	O
Reverse	JJ	amod	O
transcription	NN	compound	O
-	HYPH	punct	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubjpass	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	compound	O
assays	NNS	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
Bax	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
Prostaglandin	NN	compound	B-Gene_or_gene_product
E2	NN	compound	I-Gene_or_gene_product
production	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
enzyme	NN	compound	O
linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

Attenuating	NN	csubj	O
galectin	NN	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nsubj	O
by	IN	case	O
siRNA	NN	nmod	O
constrained	VBD	ROOT	O
PTTG	NN	compound	O
-	HYPH	punct	O
HA	NN	compound	O
/	:	punct	O
EC9706	NN	compound	O
cell	NN	compound	O
motility	NN	dobj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O
Pretreatment	NN	nsubj	O
with	IN	case	O
aspirin	NN	nmod	B-Simple_chemical
and	CC	cc	O
nimesulide	NN	conj	B-Simple_chemical
inhibited	VBD	ROOT	O
EC9706	NN	dobj	B-Cell
and	CC	cc	O
EC109	NN	conj	B-Cell
cell	NN	compound	I-Cell
growth	NN	dep	O
in	IN	case	O
a	DT	det	O
time	NN	nmod	O
and	CC	cc	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	conj	O
,	,	punct	O
accompanied	VBN	advcl	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
of	IN	case	O
prostaglandin	NN	compound	B-Gene_or_gene_product
E2	NN	compound	I-Gene_or_gene_product
production	NN	nmod	O
.	.	punct	O

Ciprofloxacin	NN	nsubj	O
mediated	VBD	ROOT	O
cell	NN	compound	O
growth	NN	compound	O
inhibition	NN	dobj	O
,	,	punct	O
S	NN	compound	O
/	:	punct	O
G2	NN	compound	O
-	:	punct	O
M	NN	compound	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	O
transitional	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
of	IN	case	O
the	DT	det	O
bladder	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
.	.	punct	O
In	IN	case	O
EC9706	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
aspirin	NN	nmod	B-Simple_chemical
and	CC	cc	O
nimesulide	NN	conj	B-Simple_chemical
induced	VBD	ROOT	O
growth	NN	compound	O
inhibition	NN	dobj	O
was	VBD	cop	O
a	DT	det	O
consequence	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
at	IN	case	O
the	DT	det	O
G	NN	nmod	O
(	-LRB-	punct	O
0	CD	dep	O
)	-RRB-	punct	O
/	:	punct	O
G	NN	appos	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
check	VB	conj	O
point	NN	dobj	O
.	.	punct	O

Glucose	NN	compound	O
deprivation	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
sensitization	NN	nsubjpass	O
to	TO	case	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
prevented	VBN	ROOT	O
in	IN	case	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
cells	NNS	nmod	O
overexpressing	VBG	acl	O
BCL	NN	dobj	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
In	IN	case	O
EC109	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
growth	NN	compound	O
arrest	NN	nsubj	O
was	VBD	cop	O
by	IN	case	O
induction	NN	ROOT	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
downregulation	NN	nmod	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Bax	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
percentage	NN	nsubj	O
of	IN	case	O
cell	NN	compound	O
apoptosis	NN	nmod	O
increased	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
enhancing	NN	nmod	O
of	IN	case	O
concentration	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
aspirin	NN	nsubj	B-Simple_chemical
and	CC	cc	O
nimesulide	NN	conj	B-Simple_chemical
could	MD	aux	O
inhibit	VB	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
esophageal	JJ	amod	B-Cell
squamous	JJ	amod	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Bee	NN	compound	O
venom	NN	nsubj	O
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
expression	NN	dobj	O
of	IN	case	O
cyclooxygenase	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
line	NN	compound	O
NCI	NN	compound	O
-	:	punct	O
H1299	NN	nmod	O
.	.	punct	O
Cyclooxygenase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
inhibitor	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
promising	JJ	amod	O
therapeutic	JJ	amod	O
agent	NN	ROOT	O
for	IN	case	O
human	JJ	amod	B-Organism
esophageal	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Neurotrophins	NNS	nsubj	O
mediate	VBP	appos	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Trk	NN	compound	O
family	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
affinity	NN	compound	O
nerve	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
p75	NN	conj	O
.	.	punct	O
Neurotrophin	JJ	amod	B-Gene_or_gene_product
p75	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
p75NTR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
promotes	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
angiogenesis	NN	dobj	O
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
diabetes	NNS	compound	O
-	HYPH	punct	O
induced	VBN	amod	O
impaired	JJ	amod	O
neovascularization	NN	nmod	O
in	IN	case	O
ischemic	JJ	amod	O
limb	NN	compound	B-Organ
muscles	NNS	nmod	I-Organ
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Insulin	NN	nsubj	O
increases	VBZ	appos	O
VEGF	NN	compound	O
mRNA	NN	dobj	O
and	CC	cc	O
secreted	VBN	amod	O
protein	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
RPE	NN	compound	O
cells	NNS	nmod	O
through	IN	case	O
enhanced	VBN	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Diabetes	NNS	nsubj	O
impairs	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
function	NN	dobj	O
and	CC	cc	O
reparative	JJ	amod	O
neovascularization	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Neurotrophins	NNS	nsubj	O
mediate	VBP	appos	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Trk	NN	compound	O
family	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
affinity	NN	compound	O
nerve	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
p75	NN	conj	O
.	.	punct	O
The	DT	det	O
p75	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
neurotrophins	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
p75	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
scarcely	RB	advmod	O
present	JJ	acl:relcl	O
in	IN	case	O
healthy	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
becomes	VBZ	ROOT	O
strongly	RB	advmod	O
expressed	VBN	xcomp	O
by	IN	case	O
capillary	JJ	amod	B-Cell
ECs	NNS	nmod	I-Cell
after	IN	case	O
induction	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	B-Tissue
ischemia	NN	nmod	O
in	IN	case	O
type	NN	compound	O
-	CD	punct	O
1	CD	nummod	O
diabetic	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
naked	VBN	amod	O
DNA	NN	nmod	O
encoding	VBG	acl	O
for	IN	case	O
three	CD	nummod	O
isoforms	NNS	nmod	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
stimulates	VBZ	ROOT	O
collateral	JJ	amod	O
development	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
gene	NN	compound	O
transfer	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
expression	NN	nsubj	O
impairs	VBZ	ccomp	O
the	DT	det	O
survival	NN	dobj	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
adhesion	NN	compound	O
capacities	NNS	conj	O
of	IN	case	O
cultured	VBN	amod	O
ECs	NNS	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
EPCs	NNS	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
inhibits	VBZ	conj	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Allogeneic	JJ	amod	O
injection	NN	nsubj	O
of	IN	case	O
fetal	JJ	amod	O
membrane	NN	nmod:npmod	O
-	:	punct	O
derived	VBN	amod	O
mesenchymal	JJ	amod	O
stem	NN	compound	O
cells	NNS	nmod	O
induces	VBZ	ROOT	O
therapeutic	JJ	amod	O
angiogenesis	NN	dobj	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	O
model	NN	nmod	O
of	IN	case	O
hind	NN	amod	O
limb	NN	compound	O
ischemia	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
intramuscular	JJ	amod	B-Immaterial_anatomical_entity
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
gene	NN	compound	O
delivery	NN	nsubj	O
impairs	VBZ	ROOT	O
neovascularization	NN	dobj	O
and	CC	cc	O
blood	NN	compound	B-Organism_substance
flow	NN	compound	O
recovery	NN	conj	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
limb	NN	compound	B-Organism_subdivision
ischemia	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
miRNAs	NN	nmod	O
in	IN	mark	O
regulating	VBG	acl	O
endothelial	JJ	amod	O
cell	NN	compound	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
function	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
angiogenesis	NN	nmod	O
.	.	punct	O
These	DT	det	O
disturbed	JJ	amod	O
functions	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
signaling	NN	compound	O
mechanisms	NNS	nmod	O
implicated	VBN	acl	O
in	IN	case	O
EC	NN	compound	B-Cell
survival	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

This	DT	det	O
potentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
kinase	NN	compound	O
insert	NN	compound	O
domain	NN	compound	O
-	:	punct	O
containing	VBG	amod	O
receptor	NN	dep	O
[	-LRB-	punct	O
KDR	NN	appos	O
]	-RRB-	punct	O
and	CC	cc	O
fms	NN	conj	O
-	HYPH	punct	O
like	IN	prep	O
tyrosine	NN	compound	O
kinase	NN	pobj	O
[	-LRB-	punct	O
Flt	NN	compound	O
-	:	punct	O
1	CD	nummod	O
]	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
fact	NN	nmod	O
,	,	punct	O
p75	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
depresses	VBZ	ROOT	O
the	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	compound	I-Gene_or_gene_product
/	SYM	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
eNOS	NN	compound	B-Gene_or_gene_product
/	:	punct	O
NO	NN	compound	B-Simple_chemical
pathway	NN	dobj	O
and	CC	cc	O
additionally	RB	advmod	O
reduces	VBZ	conj	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
ITGB1	NN	compound	B-Gene_or_gene_product
[	-LRB-	punct	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
]	-RRB-	punct	O
,	,	punct	O
BIRC5	NN	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
survivin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
PTTG1	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
securin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
VEZF1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Neurotrophins	NNS	nsubj	O
mediate	VBP	appos	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Trk	NN	compound	O
family	NN	nmod	O
of	IN	case	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
-	HYPH	punct	O
affinity	NN	compound	O
nerve	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
p75	NN	conj	O
.	.	punct	O
Diabetic	JJ	amod	O
mice	NNS	nsubj	B-Organism
,	,	punct	O
which	WDT	nsubj	O
typically	RB	advmod	O
show	VBP	acl:relcl	O
impaired	JJ	amod	O
postischemic	JJ	amod	O
muscular	JJ	amod	B-Organ
neovascularization	NN	dobj	O
and	CC	cc	O
blood	NN	compound	B-Organism_substance
perfusion	NN	compound	O
recovery	NN	conj	O
,	,	punct	O
have	VBP	ROOT	O
these	DT	det	O
defects	NNS	dobj	O
corrected	VBN	acl	O
by	IN	case	O
intramuscular	JJ	amod	B-Immaterial_anatomical_entity
gene	NN	compound	O
transfer	NN	nmod	O
of	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
p75	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
Collectively	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
newly	RB	advmod	O
demonstrate	VBP	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
action	NN	dobj	O
of	IN	case	O
p75	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
and	CC	cc	O
open	VB	amod	O
new	JJ	amod	O
avenues	NNS	conj	O
for	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
use	NN	nmod	O
of	IN	case	O
p75	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
NTR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
inhibition	NN	nmod	O
to	TO	case	O
combat	NN	compound	O
diabetes	NNS	nmod	O
-	:	punct	O
induced	VBN	amod	O
microvascular	JJ	amod	B-Tissue
liabilities	NNS	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
effects	NNS	nsubj	O
of	IN	case	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nmod	O
may	MD	aux	O
be	VB	auxpass	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
interference	NN	xcomp	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
HUVECs	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibition	NN	conj	O
of	IN	case	O
collagenolysis	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
cell	NN	compound	O
growth	NN	conj	O
.	.	punct	O
Tumor	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
targeted	VBN	amod	O
cyclic	JJ	amod	B-Simple_chemical
RGD	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
modified	VBN	amod	I-Simple_chemical
heparin	NN	compound	I-Simple_chemical
derivative	NN	ROOT	I-Simple_chemical
:	:	punct	O
inhibition	NN	dep	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
prepared	VBD	dep	O
tumor	NN	compound	B-Tissue
endothelium	NN	compound	I-Tissue
targeted	VBN	amod	O
cRGD	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
modified	VBN	amod	I-Simple_chemical
heparin	NN	compound	I-Simple_chemical
derivative	NN	dobj	I-Simple_chemical
(	-LRB-	punct	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
by	IN	mark	O
coupling	VBG	advcl	O
heparin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
lithocholic	JJ	amod	I-Simple_chemical
acid	NN	dobj	I-Simple_chemical
(	-LRB-	punct	O
HL	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
with	IN	case	O
cRGDyK	NN	nmod	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
evaluated	VBN	conj	O
inhibition	NN	compound	O
effects	NNS	dobj	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
on	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
.	.	punct	O

The	DT	det	O
soluble	JJ	amod	O
factors	NNS	nsubj	O
they	PRP	nsubj	O
release	VBP	ROOT	O
in	IN	case	O
its	PRP$	nmod:poss	O
presence	NN	compound	O
arrest	VBP	ccomp	O
the	DT	det	O
cycle	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
inhibit	VBP	conj	O
in	FW	amod	O
vitro	FW	dep	O
angiogenesis	NN	dobj	O
,	,	punct	O
negatively	RB	advmod	O
modulate	VB	parataxis	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	nmod	O
-	:	punct	O
9	CD	nummod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
of	IN	case	O
EC	NN	nmod	O
to	TO	mark	O
adhere	VB	acl	O
to	TO	case	O
vitronectin	NN	nmod	O
and	CC	cc	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	conj	O
ICAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
VCAM	NN	compound	O
-	:	punct	O
1	CD	conj	O
expression	NN	dep	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	advcl	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
performed	VBD	dep	O
tests	NNS	dobj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
,	,	punct	O
binding	NN	compound	O
affinity	NN	dobj	O
to	TO	case	O
purified	VBN	amod	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	intj	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
Matrigel	NNP	compound	O
plug	NN	compound	O
assay	NN	conj	O
.	.	punct	O

Growth	NN	compound	O
inhibition	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
cellular	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
extensive	JJ	amod	O
necrosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
mean	NN	compound	O
vessel	NN	compound	O
density	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
reduction	NN	conj	O
in	IN	case	O
serum	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
angioproliferative	JJ	amod	O
cytokines	NNS	nmod	O
.	.	punct	O
The	DT	det	O
antitumor	NN	compound	B-Cancer
activity	NN	nsubjpass	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
was	VBD	auxpass	O
also	RB	advmod	O
evaluated	VBN	ROOT	O
by	IN	mark	O
monitoring	VBG	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
formation	NN	conj	O
in	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	I-Cancer
SCC7	NN	appos	I-Cancer
)	-RRB-	punct	I-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Bovine	JJ	amod	O
aortic	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nsubjpass	O
(	-LRB-	punct	O
ECs	NNS	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
cultured	VBN	ROOT	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nsubj	I-Simple_chemical
significantly	RB	advmod	O
inhibited	VBD	dep	O
adhesion	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
vitronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
tubular	JJ	amod	B-Tissue
structures	NNS	conj	I-Tissue
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
peptide	NN	compound	O
ligand	NN	nsubjpass	O
,	,	punct	O
A5	NN	compound	O
-	:	punct	O
1	CD	appos	O
(	-LRB-	punct	O
VILVLF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
integrin	NN	compound	O
alpha5beta1	NN	nmod	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
hexapeptide	NN	amod	O
libraries	NNS	nmod	O
with	IN	case	O
this	DT	det	O
chip	NN	npadvmod	O
-	HYPH	punct	O
based	VBN	amod	O
screening	NN	amod	O
method	NN	nmod	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
a	DT	det	O
competitive	JJ	amod	O
inhibition	NN	compound	O
assay	NN	nmod	O
.	.	punct	O
Compared	VBN	case	O
to	TO	case	O
cRGDyK	NN	nmod	B-Simple_chemical
and	CC	cc	O
HL	NN	conj	B-Simple_chemical
,	,	punct	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nsubj	I-Simple_chemical
has	VBZ	ROOT	O
high	JJ	amod	O
binding	NN	compound	O
affinity	NN	dobj	O
to	TO	case	O
purified	VBN	amod	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	LS	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
integrin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
The	DT	det	O
enhanced	VBN	amod	O
antiangiogenic	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
Matrigel	NN	compound	O
assay	NN	nmod	O
by	IN	mark	O
showing	VBG	advcl	O
the	DT	det	O
significant	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
driven	VBN	amod	O
angiogenesis	NN	nmod	O
and	CC	cc	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
formation	NN	conj	O
.	.	punct	O

Prolonged	JJ	amod	O
culture	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
implantation	NN	nmod	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
into	IN	case	O
the	DT	det	O
monolayer	NN	nmod	O
of	IN	case	O
the	DT	det	O
F	NNP	compound	O
-	HYPH	punct	O
2	CD	nummod	O
cells	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	acl:relcl	O
mainly	RB	advmod	O
by	IN	case	O
alpha	NN	compound	O
(	-LRB-	punct	O
3	LS	nummod	O
)	-RRB-	punct	O
beta	NN	compound	O
(	-LRB-	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
-	:	punct	O
integrin	NN	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
was	VBD	auxpass	O
thought	VBN	ROOT	O
that	IN	mark	O
potent	JJ	amod	O
antiangiogenic	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
HL	NN	nmod	I-Simple_chemical
was	VBD	cop	O
probably	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
interference	NN	ccomp	O
of	IN	case	O
alpha	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
v	LS	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
interaction	NN	nmod	O
,	,	punct	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
enhanced	VBN	amod	O
antitumoral	JJ	amod	B-Cancer
activity	NN	nmod	O
against	IN	case	O
SCC7	NN	compound	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	dep	O
that	IN	mark	O
cRGD	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
modified	VBN	amod	I-Simple_chemical
heparin	NN	compound	I-Simple_chemical
derivative	NN	nsubj	I-Simple_chemical
enhanced	VBD	ccomp	O
anti	JJ	amod	O
-	HYPH	punct	O
angiotherapeutic	JJ	amod	O
effects	NNS	dobj	O
against	IN	case	O
solid	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
applied	VBN	conj	O
to	TO	mark	O
treat	VB	xcomp	O
various	JJ	amod	O
cancers	NNS	dobj	B-Cancer
and	CC	cc	O
angiogenic	JJ	amod	O
diseases	NNS	conj	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
ARF	NN	nmod	O
in	IN	case	O
oncogenesis	NN	nmod	O
]	-RRB-	punct	O
[	-LRB-	punct	O
Inhibitory	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
endostatin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
transfer	NN	nmod	O
on	IN	case	O
transplanted	VBN	amod	O
lung	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
]	-RRB-	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O
OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
endostatin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
transfer	NN	nmod	O
on	IN	case	O
transplanted	VBN	amod	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
its	PRP$	nmod:poss	O
mechanism	NN	conj	O
of	IN	case	O
action	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
impact	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	O
and	CC	cc	O
angiostatin	NN	conj	O
on	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Transplant	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	dep	O
by	IN	case	O
subcutaneous	JJ	amod	O
inoculation	NN	nmod	O
of	IN	case	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
Lewis	JJ	compound	B-Cell
lung	NN	compound	I-Cell
cancer	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
LLC	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
the	DT	det	O
back	NN	nmod	B-Organism_subdivision
of	IN	case	O
C57BL	NN	nmod	B-Organism
/	SYM	punct	I-Organism
6	CD	nummod	I-Organism
mice	NNS	dep	I-Organism
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
used	VBD	ROOT	O
rAAV2	NN	dobj	O
/	:	punct	O
5	CD	conj	O
to	TO	mark	O
deliver	VB	xcomp	O
vasostatin	NN	dobj	O
intratumorally	RB	advmod	O
or	CC	cc	O
systemically	RB	advmod	O
in	IN	prep	O
different	JJ	amod	O
mouse	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	compound	O
-	:	punct	O
-	HYPH	punct	O
subcutaneous	JJ	amod	O
,	,	punct	O
orthotopic	JJ	amod	O
xenograft	NN	conj	O
,	,	punct	O
and	CC	cc	O
spontaneous	JJ	amod	O
metastasis	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	conj	O
.	.	punct	O
The	DT	det	O
mice	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
treated	VBN	ROOT	O
by	IN	case	O
intratumoral	JJ	amod	B-Cancer
injection	NN	nmod	O
of	IN	case	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
9	CD	dep	O
)	-RRB-	punct	O
pfu	NN	compound	O
Ad	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mEndostatin	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Protein	NN	compound	O
up	RP	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
HER2	NN	nmod	O
in	IN	case	O
the	DT	det	O
epithelium	NN	nmod	O
with	IN	case	O
metaplasia	NN	nmod	O
or	CC	cc	O
carcinoma	NN	conj	O
in	FW	compound	O
situ	FW	advmod	O
was	VBD	auxpass	O
not	RB	neg	O
accompanied	VBN	ROOT	O
by	IN	case	O
HER2	NN	compound	O
gene	NN	compound	O
amplification	NN	nmod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
situ	FW	advmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
maintaining	VBG	amod	O
time	NN	conj	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
and	CC	cc	O
Western	NN	compound	O
Blot	NNP	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Preoperative	JJ	amod	O
serum	NN	nsubjpass	O
was	VBD	auxpass	O
collected	VBN	dep	O
from	IN	case	O
107	CD	nummod	O
gastric	JJ	amod	O
cancer	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
33	CD	nummod	O
normal	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O
The	DT	det	O
endostatin	NN	compound	B-Gene_or_gene_product
level	NN	nsubjpass	O
in	IN	case	O
serum	NN	nmod	B-Organism_substance
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O

Fractional	JJ	amod	O
tumor	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analysis	NN	nsubjpass	O
of	IN	case	O
tumors	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	conj	O
to	TO	mark	O
determine	VB	xcomp	O
degree	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
The	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
changes	NNS	conj	O
of	IN	case	O
survival	NN	nmod	O
were	VBD	auxpass	O
recorded	VBN	ROOT	O
and	CC	cc	O
the	DT	det	O
microvessel	NN	compound	B-Tissue
density	NN	nsubjpass	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
determined	VBN	conj	O
by	IN	case	O
histochemical	JJ	amod	O
stainingwith	NN	case	O
CD31	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
CD105	NN	conj	B-Gene_or_gene_product
antibodies	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

While	IN	mark	O
TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
tumor	NN	compound	O
differentiation	NN	dobj	O
or	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
tumor	NN	compound	B-Cancer
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
electron	NN	compound	O
microscopy	NN	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
used	VBD	ROOT	O
rAAV2	NN	dobj	O
/	:	punct	O
5	CD	conj	O
to	TO	mark	O
deliver	VB	xcomp	O
vasostatin	NN	dobj	O
intratumorally	RB	advmod	O
or	CC	cc	O
systemically	RB	advmod	O
in	IN	prep	O
different	JJ	amod	O
mouse	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	compound	O
-	:	punct	O
-	HYPH	punct	O
subcutaneous	JJ	amod	O
,	,	punct	O
orthotopic	JJ	amod	O
xenograft	NN	conj	O
,	,	punct	O
and	CC	cc	O
spontaneous	JJ	amod	O
metastasis	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	conj	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
intratumoral	JJ	amod	B-Cancer
injection	NN	nsubj	O
of	IN	case	O
Ad	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mEndostatin	NN	nmod	I-Gene_or_gene_product
significantly	RB	advmod	O
inhibited	VBD	dep	O
the	DT	det	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
prolonged	VBD	conj	O
the	DT	det	O
survival	NN	compound	O
rate	NN	dobj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
used	VBD	ROOT	O
rAAV2	NN	dobj	O
/	:	punct	O
5	CD	conj	O
to	TO	mark	O
deliver	VB	xcomp	O
vasostatin	NN	dobj	O
intratumorally	RB	advmod	O
or	CC	cc	O
systemically	RB	advmod	O
in	IN	prep	O
different	JJ	amod	O
mouse	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	compound	O
-	:	punct	O
-	HYPH	punct	O
subcutaneous	JJ	amod	O
,	,	punct	O
orthotopic	JJ	amod	O
xenograft	NN	conj	O
,	,	punct	O
and	CC	cc	O
spontaneous	JJ	amod	O
metastasis	NN	compound	O
lung	NN	compound	O
tumor	NN	compound	O
models	NNS	conj	O
.	.	punct	O
Strong	JJ	amod	O
positive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
mEndostatin	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
after	IN	case	O
injection	NN	nmod	O
of	IN	case	O
Ad	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mEndostatin	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
immunhistochemically	RB	advmod	O
ostained	VBN	advcl	O
by	IN	case	O
mouse	NN	compound	B-Organism
endostatin	NN	compound	B-Gene_or_gene_product
monoclonal	JJ	amod	I-Gene_or_gene_product
antibody	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
the	DT	det	O
control	NN	compound	O
groups	NNS	nsubj	O
showed	VBD	advcl	O
only	RB	advmod	O
very	RB	advmod	O
low	JJ	amod	O
expression	NN	dobj	O
or	CC	cc	O
absence	NN	conj	O
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	O
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	O
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O
Serum	NN	compound	B-Organism_substance
endostatin	NN	compound	B-Gene_or_gene_product
concentration	NN	nsubj	O
was	VBD	cop	O
1540	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
560	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	dep	O
at	IN	prep	O
the	DT	det	O
second	JJ	amod	O
week	NN	pobj	O
of	IN	prep	O
administration	NN	pobj	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
diminished	VBD	ROOT	O
a	DT	det	O
month	NN	npadvmod	O
later	RB	advmod	O
.	.	punct	O

Tumor	NN	compound	O
sections	NNS	nsubjpass	O
were	VBD	auxpass	O
stained	VBN	ROOT	O
for	IN	case	O
:	:	punct	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
CD31	NN	nmod	O
and	CC	cc	O
PAS	NN	conj	O
or	CC	cc	O
hypoxia	NN	conj	O
inducible	JJ	amod	O
factor	NN	compound	O
1alpha	NN	conj	O
(	-LRB-	punct	O
HIF	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
microvessel	NN	compound	B-Tissue
density	NN	nsubj	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
decreased	VBD	ROOT	O
from	IN	case	O
42	CD	nmod	O
.	.	punct	O
4	CD	meta	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	dep	O
.	.	punct	O
8	CD	compound	O
to	TO	dep	O
10	CD	dep	O
.	.	punct	O
5	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
3	CD	nummod	O
.	.	punct	O
2	CD	nummod	O
per	IN	prep	O
x	NN	cc	O
200	CD	conj	O
magnificetion	NN	compound	O
microscopic	JJ	amod	O
field	NN	ROOT	O
by	IN	case	O
CD10	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
and	CC	cc	O
from	IN	case	O
68	CD	nummod	O
.	.	punct	O
5	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	conj	O
.	.	punct	O
5	CD	compound	O
to	TO	dep	O
37	CD	dep	O
.	.	punct	O
5	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	nummod	O
.	.	punct	O
6	CD	ROOT	O
by	IN	case	O
CD31	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

While	IN	mark	O
TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
tumor	NN	compound	O
differentiation	NN	dobj	O
or	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O
More	RBR	amod	O
apoptotic	JJ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
seen	VBN	ROOT	O
under	IN	case	O
the	DT	det	O
transmission	NN	compound	O
electron	NN	compound	O
microscope	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mice	NNS	nsubj	O
bearing	VBG	acl	O
subcutaneous	JJ	amod	O
tumor	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	:	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NNP	compound	O
pretreated	VBD	amod	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
showed	VBD	appos	O
>	NN	amod	O
50	CD	compound	O
%	NN	compound	O
reduction	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
spontaneous	JJ	amod	O
pulmonary	JJ	amod	O
metastases	NNS	dobj	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
Endostatin	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
therapy	NN	nsubj	O
mediated	VBN	acl	O
by	IN	case	O
adenoviral	JJ	amod	O
vector	NN	nmod	O
efficiently	RB	advmod	O
induces	VBZ	dep	O
expression	NN	dobj	O
of	IN	case	O
endostatin	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
and	CC	cc	O
inhibits	VBZ	conj	O
the	DT	det	O
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
its	PRP$	nmod:poss	O
action	NN	nsubjpass	O
is	VBZ	auxpass	O
targeted	VBN	ccomp	O
to	TO	case	O
tumor	NN	compound	B-Multi-tissue_structure
neovasculature	JJ	nmod	I-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
is	VBZ	cop	O
inhibition	NN	ccomp	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	O
.	.	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
pigmentation	NN	nmod	O
,	,	punct	O
tanning	VBG	conj	O
and	CC	cc	O
melanoma	NN	conj	B-Cancer
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
has	VBZ	ccomp	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
skin	NN	compound	B-Organ
pigmentation	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
impact	VB	conj	O
on	IN	case	O
melanoma	NN	nmod	B-Cancer
at	IN	case	O
all	DT	det	O
stages	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
as	IN	mark	O
it	PRP	nsubj	O
'	''	punct	O
s	VBZ	compound	O
mutation	NN	compound	O
frequency	NN	dobj	O
in	IN	case	O
melanoma	NN	nmod	B-Cancer
is	VBZ	cop	O
low	JJ	conj	O
,	,	punct	O
it	PRP	nmod:poss	O
'	''	punct	O
s	VBZ	compound	O
role	NN	nsubj	O
has	VBZ	aux	O
been	VBN	ROOT	O
somewhat	RB	advmod	O
under	IN	advmod	O
-	HYPH	punct	O
appreciated	VBN	acomp	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p	NN	nmod:npmod	O
-	HYPH	punct	O
53	CD	npadvmod	O
-	HYPH	punct	O
independent	JJ	conj	O
functions	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
are	VBP	cop	O
under	IN	case	O
many	JJ	amod	O
studies	NNS	ROOT	O
.	.	punct	O
During	IN	case	O
normal	JJ	amod	O
skin	NN	compound	B-Organ
function	NN	nmod	O
,	,	punct	O
p53	NN	nsubj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
keratinocyte	NN	nmod	B-Cell
is	VBZ	cop	O
a	DT	det	O
transducer	NN	ROOT	O
of	IN	case	O
the	DT	det	O
skin	NN	compound	B-Organ
tanning	VBG	compound	O
signal	NN	nmod	O
and	CC	cc	O
an	DT	det	O
essential	JJ	amod	O
component	NN	conj	O
of	IN	prep	O
what	WP	nsubj	O
is	VBZ	pcomp	O
effectively	RB	advmod	O
a	DT	det	O
keratinocyte	NN	compound	B-Cell
-	HYPH	punct	O
melanocyte	NN	compound	B-Cell
signaling	NN	compound	O
cycle	NN	attr	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
skin	NN	compound	B-Organ
pigmentation	NN	dobj	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
long	RB	advmod	O
been	VBN	auxpass	O
noted	VBN	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
that	IN	mark	O
hair	NN	compound	O
follicle	NN	compound	O
cycling	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
prominent	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
skin	NN	compound	O
perfusion	NN	nmod	O
,	,	punct	O
that	IN	mark	O
the	DT	det	O
epithelial	JJ	amod	O
hair	NN	compound	O
bulbs	NN	nsubj	O
of	IN	case	O
anagen	NN	compound	O
follicles	NNS	nmod	O
display	VBP	ccomp	O
angiogenic	JJ	amod	O
properties	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
follicular	JJ	amod	O
dermal	JJ	amod	O
papilla	NN	nsubj	O
can	MD	aux	O
produce	VB	conj	O
angiogenic	JJ	amod	O
factors	NNS	dobj	O
.	.	punct	O
It	PRP	nsubj	O
is	VBZ	cop	O
clear	JJ	ROOT	O
that	IN	mark	O
this	DT	det	O
cycle	NN	compound	O
functions	NNS	ccomp	O
optimally	RB	advmod	O
in	IN	prep	O
skin	NN	pobj	B-Organ
of	IN	prep	O
dark	JJ	amod	O
pigmentation	NN	pobj	O
.	.	punct	O

The	DT	det	O
transformation	NN	nsubj	O
of	IN	case	O
normal	JJ	amod	O
melanocytes	NNS	nmod	O
,	,	punct	O
or	CC	cc	O
melanocyte	NN	compound	O
stem	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
to	TO	case	O
melanoma	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
complex	JJ	amod	O
process	NN	ROOT	O
involving	VBG	acl	O
multiple	JJ	amod	O
mechanisms	NNS	dobj	O
.	.	punct	O
When	WRB	advmod	O
melanin	NN	amod	B-Simple_chemical
biosynthesis	NN	nsubjpass	O
is	VBZ	auxpass	O
genetically	RB	advmod	O
disrupted	VBN	advcl	O
in	IN	case	O
skin	NN	nmod	B-Organ
of	IN	case	O
white	JJ	amod	B-Organism
complexion	NN	nmod	I-Organism
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
cycle	NN	nsubj	O
operates	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
promoter	NN	nmod	O
of	IN	case	O
melanocyte	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
The	DT	det	O
cell	NN	compound	B-Cell
autonomous	JJ	amod	O
function	NN	nsubjpass	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
melanocytes	NNS	nmod	B-Cell
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
described	VBN	advcl	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
balance	NN	nsubj	O
of	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
an	DT	det	O
effective	JJ	amod	O
tumor	NN	compound	B-Cancer
suppressor	NN	ccomp	O
and	CC	cc	O
the	DT	det	O
myriad	NN	nsubj	O
of	IN	case	O
mechanisms	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
dysregulated	VBN	acl:relcl	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
attests	VBZ	conj	O
to	IN	mark	O
it	PRP	nsubj	O
importance	VB	nmod	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
the	DT	det	O
tumor	NN	compound	O
suppressive	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	O
become	VBP	advcl	O
concerted	VBN	xcomp	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
cues	NNS	nmod	O
arriving	VBG	acl	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
during	IN	case	O
tissue	NN	compound	O
homeostasis	NN	nmod	O
,	,	punct	O
remains	VBZ	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
outline	VBP	ROOT	O
the	DT	det	O
known	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
impair	VBP	acl:relcl	O
p53	NN	dobj	B-Gene_or_gene_product
itself	PRP	dep	O
and	CC	cc	O
its	PRP$	nmod:poss	O
immediate	JJ	amod	O
regulators	NNS	conj	O
or	CC	cc	O
target	NN	compound	O
genes	NNS	conj	O
during	IN	case	O
melanomagenesis	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
does	VBZ	ROOT	O
so	RB	advmod	O
through	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O
Due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
importance	NN	nmod	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
clear	JJ	ROOT	O
that	IN	mark	O
p53	NN	compound	B-Gene_or_gene_product
disruptions	NNS	nsubj	O
may	MD	aux	O
relate	VB	ccomp	O
directly	RB	advmod	O
to	TO	case	O
a	DT	det	O
patient	NN	nmod:poss	B-Organism
'	''	punct	O
s	NNS	compound	O
prognosis	NN	nmod	O
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
factor	NN	nsubj	O
in	IN	case	O
the	DT	det	O
response	NN	nmod	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
chemotherapeutic	JJ	amod	O
drugs	NNS	nmod	O
is	VBZ	cop	O
the	DT	det	O
activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
a	DT	det	O
pathway	NN	appos	O
that	WDT	nsubj	O
is	VBZ	cop	O
often	RB	advmod	O
impaired	JJ	acl:relcl	O
in	IN	case	O
chemoresistant	JJ	amod	O
colon	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
This	DT	det	O
pathway	NN	nsubj	O
will	MD	aux	O
continue	VB	ROOT	O
to	TO	aux	O
be	VB	xcomp	O
a	DT	det	O
focus	NN	attr	O
of	IN	prep	O
investigation	NN	pobj	O
,	,	punct	O
particularly	RB	advmod	O
with	IN	case	O
respect	NN	advmod	O
to	TO	case	O
targeted	VBN	amod	O
experimental	JJ	amod	O
chemotherapeutics	NNS	nmod	O
.	.	punct	O

Downregulation	NN	ROOT	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	intj	O
sensitizes	VBZ	amod	O
DU145	NN	compound	O
prostate	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
Fas	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
Enhancement	NN	ROOT	O
of	IN	case	O
docetaxel	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cytotoxicity	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
by	IN	case	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	JJ	amod	I-Simple_chemical
retinoic	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
ATRA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
through	IN	case	O
downregulation	NN	nmod	O
of	IN	case	O
survivin	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
BIRC5	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
MCL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
and	CC	cc	O
LTbeta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
R	NN	conj	I-Gene_or_gene_product
in	IN	case	O
hormone	NN	nmod	O
-	HYPH	punct	O
and	CC	cc	O
drug	NN	conj	O
resistant	JJ	amod	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
,	,	punct	O
DU	NNP	compound	B-Cell
-	:	punct	I-Cell
145	CD	nummod	I-Cell
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Bone	NN	compound	O
morphogenetic	JJ	amod	O
proteins	NNS	nsubj	O
(	-LRB-	punct	O
BMPs	NNS	appos	O
)	-RRB-	punct	O
exert	VBP	dep	O
osteoinductive	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	O
cancer	NN	nmod	O
(	-LRB-	punct	O
PC	NN	appos	O
)	-RRB-	punct	O
via	IN	case	O
uncharacterized	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
management	NN	nsubj	O
of	IN	case	O
hormone	NN	npadvmod	B-Cancer
-	HYPH	punct	I-Cancer
refractory	JJ	amod	I-Cancer
prostate	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
HRPC	NN	appos	B-Cancer
)	-RRB-	punct	O
still	RB	advmod	O
remains	VBZ	dep	O
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
challenge	NN	nmod	O
of	IN	case	O
daily	JJ	amod	O
oncology	NN	compound	O
practice	NN	nmod	O
.	.	punct	O

Paclitaxel	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
agent	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	xcomp	O
against	IN	case	O
several	JJ	amod	O
tumours	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Docetaxel	NNP	nsubj	B-Simple_chemical
has	VBZ	aux	O
proved	VBN	ROOT	O
to	TO	aux	O
be	VB	xcomp	O
a	DT	det	O
first	JJ	amod	O
line	NN	compound	O
treatment	NN	compound	O
choice	NN	attr	O
.	.	punct	O

Vitamins	NNS	nsubj	O
regulate	VBP	ROOT	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
All	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	JJ	amod	I-Simple_chemical
retinoic	JJ	amod	I-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
ATRA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
could	MD	aux	O
potently	RB	advmod	O
inhibit	VB	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
combination	NN	nsubj	O
with	IN	case	O
various	JJ	amod	O
anticancer	NN	compound	B-Cancer
agents	NNS	nmod	O
results	VBZ	conj	O
in	IN	case	O
increased	VBN	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
no	DT	neg	O
additive	JJ	amod	O
or	CC	cc	O
synergistic	JJ	conj	O
effect	NN	dobj	O
when	WRB	advmod	O
the	DT	det	O
two	CD	nummod	O
agents	NNS	nsubjpass	O
were	VBD	auxpass	O
combined	VBN	advcl	O
.	.	punct	O
Based	VBN	case	O
on	IN	case	O
these	DT	det	O
data	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
synergistic	JJ	amod	O
/	SYM	punct	O
additive	JJ	dep	O
cytotoxic	JJ	amod	O
and	CC	cc	O
apoptotic	JJ	conj	O
effects	NNS	dobj	O
of	IN	case	O
combination	NN	nmod	O
of	IN	case	O
docetaxel	NN	nmod	B-Simple_chemical
and	CC	cc	O
ATRA	NN	conj	B-Simple_chemical
,	,	punct	O
in	IN	case	O
hormone	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
drug	NN	conj	O
refractory	JJ	amod	O
human	JJ	amod	B-Organism
DU	NN	compound	B-Cell
-	:	punct	I-Cell
145	CD	nummod	I-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	aux	O
investigate	VB	xcomp	O
in	IN	case	O
more	JJR	advmod	O
detail	NN	nmod	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
caspase	NN	compound	O
-	:	punct	O
3	CD	nmod	O
in	IN	case	O
apoptotic	JJ	amod	O
processes	NNS	nmod	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
cell	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
extracts	NNS	conj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
searched	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
underlying	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
by	IN	mark	O
demonstrating	VBG	advcl	O
apoptosis	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
genes	NNS	dobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
goal	NN	nsubj	O
of	IN	prep	O
this	DT	det	O
research	NN	pobj	O
was	VBD	appos	O
to	TO	mark	O
evaluate	VB	xcomp	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
agent	NN	dobj	O
for	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
based	VBN	case	O
on	IN	case	O
galectin	NN	nmod	O
-	,	punct	O
3	CD	nummod	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
tumorigenicity	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
METHODS	NNS	dep	O
:	:	punct	O
XTT	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	mark	O
showing	VBG	advcl	O
cytotoxicity	NN	dobj	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
measured	VBN	ROOT	O
by	IN	case	O
DNA	NN	compound	O
fragmentation	NN	nmod	O
and	CC	cc	O
microscope	NN	compound	O
examination	NN	conj	O
.	.	punct	O
For	IN	prep	O
verifying	VBG	pcomp	O
apoptosis	NN	dobj	O
,	,	punct	O
both	CC	cc:preconj	O
DNA	NN	compound	B-Cellular_component
Fragmentation	NN	nsubjpass	O
by	IN	case	O
ELISA	NN	compound	O
assay	NN	nmod	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
7	CD	nummod	B-Gene_or_gene_product
activity	NN	compound	O
measurement	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
alterations	NNS	nsubj	O
of	IN	case	O
Bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
family	NN	compound	O
proteins	NNS	nmod	O
were	VBD	cop	O
critical	JJ	ROOT	O
for	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
For	IN	mark	O
detecting	VBG	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
docetaxel	NN	compound	B-Simple_chemical
-	HYPH	punct	O
ATRA	NN	compound	B-Simple_chemical
combination	NN	nmod	O
,	,	punct	O
OligoGeArray	NNP	nsubjpass	O
which	WDT	nsubj	O
consists	VBZ	acl:relcl	O
of	IN	case	O
112	CD	nummod	O
apoptosis	NN	compound	O
related	JJ	amod	O
genes	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
.	.	punct	O

METHODOLOGY	NNP	compound	O
/	:	punct	O
PRINCIPAL	NNP	compound	O
FINDINGS	NNP	nsubj	O
:	:	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
HDAC	NN	compound	O
inhibitor	NN	dobj	O
,	,	punct	O
N	NN	compound	O
-	HYPH	punct	O
Hydroxy	NNP	compound	O
-	HYPH	punct	O
4	CD	nummod	O
-	:	punct	O
(	-LRB-	punct	O
4	CD	nummod	O
-	HYPH	punct	O
phenylbutyryl	NN	compound	O
-	HYPH	punct	O
amino	NN	compound	O
)	-RRB-	punct	O
benzamide	RB	appos	O
(	-LRB-	punct	O
HTPB	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
chemotherapeutic	JJ	amod	O
drug	NN	nmod	O
for	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
revealed	VBD	appos	O
that	IN	mark	O
docetaxel	NN	nsubj	B-Simple_chemical
and	CC	cc	O
ATRA	NN	conj	B-Simple_chemical
were	VBD	cop	O
synergistically	RB	advmod	O
cytotoxic	JJ	ccomp	O
and	CC	cc	O
apoptotic	JJ	conj	O
in	IN	case	O
DU	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
145	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod	O
-	:	punct	O
and	CC	cc	O
time	NN	nmod:npmod	O
dependent	JJ	conj	O
manner	NN	dep	O
.	.	punct	O

Using	VBG	ROOT	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	amod	O
anti	RB	amod	O
-	HYPH	punct	O
sense	NN	compound	O
oligonucleotides	NNS	dobj	O
to	IN	mark	O
down	RB	advmod	O
-	HYPH	punct	O
regulate	VB	advcl	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	dep	O
we	PRP	nsubj	O
sensitized	VBD	parataxis	O
DU145	NN	compound	O
cells	NNS	dobj	O
to	TO	case	O
CH	NN	nmod:npmod	O
-	HYPH	punct	O
11	CD	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
by	IN	case	O
our	PRP$	nmod:poss	O
studies	NNS	nmod	O
that	IN	mark	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ccomp	O
in	IN	case	O
DU	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
145	CD	nummod	I-Cell
prostate	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
significant	JJ	amod	O
cytotoxicity	NN	nmod	O
,	,	punct	O
no	RB	neg	O
matter	RB	ccomp	O
which	WDT	dobj	O
agent	NN	nsubj	O
applied	VBD	acl:relcl	O
first	RB	advmod	O
.	.	punct	O

In	IN	case	O
cervical	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
paclitaxel	NN	nsubj	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
through	IN	case	O
an	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
with	IN	case	O
prior	JJ	amod	O
G2	NN	dep	O
/	:	punct	O
M	NN	dep	O
arrest	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
out	RP	prt	O
that	DT	mark	O
docetaxel	NN	compound	B-Simple_chemical
-	HYPH	punct	O
ATRA	NN	compound	B-Simple_chemical
combination	NN	nsubj	O
significantly	RB	advmod	O
downregulates	VBZ	ccomp	O
survivin	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
BIRC5	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
myeloid	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
leukemia	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MCL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
lymphotoxin	NN	compound	B-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
LTbetaR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
genes	NNS	dobj	O
,	,	punct	O
which	WDT	nsubj	O
all	DT	det	O
three	CD	nsubj	O
have	VBP	acl:relcl	O
pivotal	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
support	NN	dobj	O
for	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
2ME2	NN	nmod	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
paclitaxel	NN	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
recurrent	JJ	amod	O
or	CC	cc	O
advanced	JJ	conj	O
head	NN	nmod	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	dep	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
strongly	RB	advmod	O
suggest	VBP	dep	O
that	IN	mark	O
docetaxel	NN	nsubj	B-Simple_chemical
and	CC	cc	O
ATRA	NN	compound	B-Simple_chemical
combination	NN	conj	O
is	VBZ	cop	O
a	DT	det	O
good	JJ	amod	O
candidate	NN	ccomp	O
for	IN	case	O
this	DT	det	O
challenging	JJ	amod	O
era	NN	nmod	O
of	IN	prep	O
daily	JJ	amod	O
oncologic	JJ	amod	O
practice	NN	pobj	O
.	.	punct	O

Antiangiogenesis	NN	compound	O
therapy	NN	nsubj	O
might	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
regional	JJ	amod	O
metastasis	NN	dobj	O
.	.	punct	O
Also	RB	advmod	O
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
docetaxel	NN	nmod	B-Simple_chemical
and	CC	cc	O
ATRA	NN	conj	B-Simple_chemical
might	MD	aux	O
allow	VB	ROOT	O
a	DT	det	O
reduction	NN	dobj	O
in	IN	case	O
docetaxel	NN	compound	B-Simple_chemical
doses	NNS	nmod	O
and	CC	cc	O
by	IN	prep	O
this	DT	det	O
way	NN	pobj	O
may	MD	aux	O
diminish	VB	ccomp	O
docetaxel	NN	compound	B-Simple_chemical
adverse	JJ	amod	O
effects	NNS	dobj	O
while	IN	mark	O
maintaining	VBG	advcl	O
the	DT	det	O
therapeutic	JJ	amod	O
effect	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
HRPC	NN	nmod	B-Cancer
.	.	punct	O

Urokinase	NN	compound	O
receptor	NN	ROOT	O
:	:	punct	O
a	DT	det	O
molecular	JJ	amod	O
organizer	NN	dep	O
in	IN	case	O
cellular	JJ	amod	O
communication	NN	nmod	O
.	.	punct	O
Diverse	JJ	amod	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
events	NNS	ROOT	O
modulated	VBN	acl	O
by	IN	case	O
perlecan	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Pericytes	NNS	nsubj	O
limit	VBP	ROOT	O
tumor	NN	compound	O
cell	NN	compound	O
metastasis	NN	dobj	O
.	.	punct	O
Perlecan	NNP	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
a	DT	det	O
ubiquitous	JJ	amod	O
pericellular	JJ	amod	B-Immaterial_anatomical_entity
proteoglycan	NN	attr	O
ideally	RB	advmod	O
placed	VBN	acl	O
to	TO	mark	O
mediate	VB	xcomp	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
events	NNS	dobj	O
controlling	VBG	acl	O
migration	NN	dobj	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
EGF	NN	appos	O
)	-RRB-	punct	O
binds	VBZ	ROOT	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
and	CC	cc	O
specificity	NN	conj	O
to	TO	case	O
a	DT	det	O
single	JJ	amod	O
site	NN	nmod	O
on	IN	case	O
the	DT	det	O
external	JJ	amod	O
domain	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
transmembrane	NN	compound	O
receptor	NN	nmod	O
to	TO	mark	O
activate	VB	xcomp	O
the	DT	det	O
tyrosine	NN	compound	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	O
portion	NN	nmod	O
.	.	punct	O
Its	PRP$	nmod:poss	O
control	NN	nsubj	O
of	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
signaling	NN	nmod	O
usually	RB	advmod	O
involves	VBZ	ROOT	O
interactions	NNS	dobj	O
with	IN	case	O
the	DT	det	O
heparan	NN	compound	O
sulfate	NN	compound	O
chains	NNS	nmod	O
covalently	RB	advmod	O
coupled	VBN	acl	O
to	TO	case	O
the	DT	det	O
protein	NN	compound	O
core	NN	compound	O
'	''	case	O
s	NNS	compound	O
N	NN	compound	O
-	HYPH	punct	O
terminus	NN	nmod	O
.	.	punct	O

Epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
EGF	NN	appos	O
)	-RRB-	punct	O
binds	VBZ	ROOT	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
and	CC	cc	O
specificity	NN	conj	O
to	TO	case	O
a	DT	det	O
single	JJ	amod	O
site	NN	nmod	O
on	IN	case	O
the	DT	det	O
external	JJ	amod	O
domain	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
transmembrane	NN	compound	O
receptor	NN	nmod	O
to	TO	mark	O
activate	VB	xcomp	O
the	DT	det	O
tyrosine	NN	compound	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	O
portion	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
this	DT	det	O
modular	JJ	amod	O
protein	NN	compound	O
core	NN	nsubj	O
also	RB	advmod	O
binds	VBZ	ROOT	O
with	IN	case	O
relatively	RB	advmod	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
surface	NN	compound	O
receptors	NNS	conj	O
,	,	punct	O
thereby	RB	advmod	O
stabilizing	VBG	advcl	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	O
links	NNS	dobj	O
.	.	punct	O

Interactions	NNS	nsubj	O
among	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
,	,	punct	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
extracellular	JJ	amod	O
matrix	NN	conj	O
regulate	VBP	ROOT	O
proliferation	NN	dobj	O
during	IN	case	O
normal	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
pathologies	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
atherosclerosis	NN	nmod	O
.	.	punct	O
This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
focus	VB	ROOT	O
on	IN	case	O
perlecan	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	O
growth	NN	compound	O
factor	NN	compound	O
interactions	NNS	nmod	O
and	CC	cc	O
describe	VBP	conj	O
recent	JJ	amod	O
advances	NNS	dobj	O
in	IN	case	O
our	PRP$	nmod:poss	O
understanding	NN	nmod	O
of	IN	case	O
this	DT	det	O
highly	RB	advmod	O
conserved	VBN	amod	O
proteoglycan	NN	nmod	O
during	IN	case	O
development	NN	nmod	O
,	,	punct	O
cancer	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
pro	NN	npadvmod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
capacities	NNS	nsubjpass	O
of	IN	case	O
perlecan	NN	nmod	B-Gene_or_gene_product
that	WDT	nsubj	O
involve	VBP	acl:relcl	O
proliferative	JJ	amod	O
and	CC	cc	O
migratory	JJ	conj	O
signals	NNS	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
bound	VBN	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
will	MD	aux	O
be	VB	auxpass	O
explored	VBN	ROOT	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
signals	NNS	conj	O
resulting	VBG	acl	O
from	IN	case	O
interactions	NNS	nmod	O
between	IN	case	O
the	DT	det	O
C	NN	nmod:npmod	O
-	HYPH	punct	O
terminal	JJ	amod	O
domain	NN	nmod	O
known	VBN	acl	O
as	IN	case	O
endorepellin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
integrins	NNS	conj	B-Gene_or_gene_product
that	WDT	nsubj	O
control	VBP	acl:relcl	O
adhesion	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
to	TO	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
.	.	punct	O

Angiogenin	NN	ROOT	O
,	,	punct	O
a	DT	quantmod	O
14	CD	appos	O
.	.	punct	O
2	CD	nummod	O
kD	NN	compound	O
polypeptide	NN	nsubjpass	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
originally	RB	advmod	O
noted	VBN	acl:relcl	O
for	IN	case	O
its	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
now	RB	advmod	O
increasingly	RB	advmod	O
recognized	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
multiplicity	NN	dobj	O
of	IN	case	O
biological	JJ	amod	O
roles	NNS	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
conditions	NNS	dobj	O
.	.	punct	O
These	DT	det	O
two	CD	nummod	O
somewhat	RB	advmod	O
diametrically	RB	advmod	O
opposed	VBD	amod	O
roles	NNS	nsubjpass	O
will	MD	aux	O
be	VB	auxpass	O
discussed	VBN	ROOT	O
in	IN	case	O
light	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
data	NNS	nmod	O
emerging	VBG	acl	O
from	IN	case	O
various	JJ	amod	O
fields	NNS	nmod	O
which	WDT	nsubj	O
converge	VBP	acl:relcl	O
on	IN	prep	O
perlecan	NN	pobj	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
cell	NN	nmod	B-Cell
growth	NN	dep	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
Thr654	NN	nmod	O
by	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	nmod	O
decreases	VBZ	ROOT	O
high	JJ	amod	O
affinity	NN	compound	O
EGF	NN	compound	O
binding	NN	dobj	O
and	CC	cc	O
EGF	NN	nmod:npmod	O
-	:	punct	O
stimulated	VBN	amod	O
tyrosine	NN	compound	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	conj	O
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
heterologous	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
EGF	NN	compound	O
receptor	NN	nmod	O
by	IN	case	O
tumor	NN	compound	O
promoters	NNS	nmod	O
and	CC	cc	O
other	JJ	amod	O
ligand	NN	compound	O
X	NN	compound	O
receptor	NN	compound	O
complexes	NNS	conj	O
.	.	punct	O
Activation	NN	nsubj	O
of	IN	case	O
signal	NN	compound	B-Gene_or_gene_product
transducer	NN	nmod	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
through	IN	case	O
a	DT	det	O
phosphomimetic	JJ	amod	O
serine	NN	nmod	B-Amino_acid
727	CD	nummod	I-Amino_acid
promotes	VBZ	ROOT	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
independent	JJ	amod	O
of	IN	case	O
tyrosine	NN	compound	B-Amino_acid
705	CD	nummod	I-Amino_acid
phosphorylation	NN	nmod	O
.	.	punct	O

Cytokines	NNS	nsubj	O
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
induce	VBP	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transducers	NNS	nmod	O
and	CC	cc	O
activators	NNS	compound	O
of	IN	amod	O
transcription	NN	conj	O
(	-LRB-	punct	O
STATs	NNS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Aberrantly	RB	advmod	O
activated	VBN	amod	O
signal	NN	compound	B-Gene_or_gene_product
transducer	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
transcription	NN	conj	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Stat3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Y705	NN	compound	B-Amino_acid
phosphorylation	NN	nsubjpass	O
is	VBZ	auxpass	O
conventionally	RB	advmod	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
Stat3	NN	nmod:npmod	B-Gene_or_gene_product
signal	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
seems	VBZ	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
some	DT	det	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Cytokines	NNS	nsubj	O
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
induce	VBP	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transducers	NNS	nmod	O
and	CC	cc	O
activators	NNS	compound	O
of	IN	amod	O
transcription	NN	conj	O
(	-LRB-	punct	O
STATs	NNS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
activated	VBN	ccomp	O
through	IN	case	O
novel	JJ	amod	O
and	CC	cc	O
noncanonical	JJ	conj	O
mechanisms	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
phosphorylation	NN	nmod	O
at	IN	case	O
S727	NN	nmod	B-Amino_acid
.	.	punct	O

Cytokines	NNS	nsubj	O
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
induce	VBP	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transducers	NNS	nmod	O
and	CC	cc	O
activators	NNS	compound	O
of	IN	amod	O
transcription	NN	conj	O
(	-LRB-	punct	O
STATs	NNS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigate	VBP	ROOT	O
S727	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
Stat3	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
subsequent	JJ	amod	O
effects	NNS	conj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
,	,	punct	O
independent	JJ	amod	O
of	IN	case	O
Y705	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
mutated	VBN	amod	O
Stat3	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
LNCaP	NN	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
how	WRB	advmod	O
survivin	NN	amod	O
couples	NNS	nsubj	O
to	TO	prep	O
the	DT	det	O
cell	NN	compound	O
death	NN	compound	O
machinery	NN	pobj	O
has	VBZ	aux	O
remained	VBN	ROOT	O
elusive	JJ	xcomp	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
relevant	JJ	amod	O
cellular	JJ	amod	O
targets	NNS	nsubjpass	O
of	IN	case	O
survivin	NN	compound	O
antagonists	NNS	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
completely	RB	advmod	O
elucidated	VBN	conj	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
mutation	NN	dobj	O
of	IN	case	O
S727	NN	nmod	B-Amino_acid
to	TO	case	O
the	DT	det	O
phosphomimetic	JJ	amod	O
residue	NN	compound	O
Glu	NNP	nmod	B-Amino_acid
,	,	punct	O
and	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
Y705	NN	nmod	B-Amino_acid
(	-LRB-	punct	O
Y705F	NN	compound	B-Amino_acid
/	:	punct	O
S727E	NN	appos	B-Amino_acid
)	-RRB-	punct	O
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
remarkable	JJ	amod	O
growth	NN	compound	O
advantage	NN	nmod	O
in	IN	case	O
low	JJ	amod	O
-	HYPH	punct	O
serum	NN	nmod	B-Organism_substance
,	,	punct	O
enhanced	VBD	amod	O
anchorage	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	appos	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
tumorigenicity	NN	conj	O
in	IN	case	O
nonobese	JJ	amod	B-Organism
diabetic	JJ	amod	I-Organism
/	:	punct	I-Organism
severe	JJ	amod	I-Organism
combined	JJ	amod	I-Organism
immunodeficient	JJ	compound	I-Organism
(	-LRB-	punct	I-Organism
NOD	NN	compound	I-Organism
/	:	punct	I-Organism
SCID	NN	appos	I-Organism
)	-RRB-	punct	I-Organism
mice	NNS	dep	I-Organism
,	,	punct	O
possibly	RB	advmod	O
by	IN	case	O
direct	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
downstream	JJ	amod	O
proto	NN	compound	O
-	HYPH	punct	O
oncogenes	NNS	compound	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
mcl	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
survivin	VB	conj	B-Gene_or_gene_product
.	.	punct	O

Cells	NNS	nsubjpass	O
stably	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	O
oncogene	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
STAT	NN	compound	O
protein	NN	compound	O
activation	NN	nmod	O
.	.	punct	O
Y705F	NN	compound	B-Amino_acid
/	:	punct	O
S727E	NN	amod	B-Amino_acid
mutant	JJ	amod	O
cells	NNS	nsubj	O
were	VBD	cop	O
more	RBR	advmod	O
invasive	JJ	ROOT	O
than	IN	case	O
Y705F	NN	nmod	B-Amino_acid
/	:	punct	O
S727A	NN	dep	B-Amino_acid
(	-LRB-	punct	O
inactivation	NN	dep	O
of	IN	case	O
Y705	NN	nmod	B-Amino_acid
and	CC	cc	O
S727	NN	conj	B-Amino_acid
)	-RRB-	punct	O
mutant	JJ	amod	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
more	JJR	amod	O
Y705F	NN	compound	B-Amino_acid
/	:	punct	O
S727E	NN	amod	B-Amino_acid
mutant	JJ	amod	O
Stat3	NN	conj	B-Gene_or_gene_product
was	VBD	aux	O
localized	JJ	conj	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	B-Cellular_component
relative	JJ	case	O
to	TO	case	O
Y705F	NN	compound	B-Amino_acid
/	:	punct	O
S727A	NN	amod	B-Amino_acid
mutant	JJ	amod	O
Stat3	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
steady	JJ	amod	O
state	NN	nmod	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
mutants	NNS	nmod	O
(	-LRB-	punct	O
CU2	NN	appos	O
)	-RRB-	punct	O
increases	VBZ	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	O
transport	NN	nmod	O
only	RB	advmod	O
slightly	RB	advmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
render	VB	conj	O
the	DT	det	O
infected	JJ	amod	O
cells	NNS	nsubj	O
fully	RB	advmod	O
anchorage	VBP	ccomp	O
independent	JJ	xcomp	O
or	CC	cc	O
tumorigenic	JJ	conj	O
(	-LRB-	punct	O
although	IN	mark	O
other	JJ	amod	O
transformation	NN	compound	O
parameters	NNS	nsubjpass	O
are	VBP	auxpass	O
fully	RB	advmod	O
induced	VBN	advcl	O
)	-RRB-	punct	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
Y705F	NN	preconj	B-Amino_acid
/	:	punct	O
S727E	NN	nsubj	B-Amino_acid
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
Y705F	NN	conj	B-Amino_acid
/	:	punct	O
S727A	NN	dep	B-Amino_acid
mutant	NN	dep	O
induced	VBD	ROOT	O
anchorage	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
of	IN	case	O
noncancerous	JJ	amod	B-Cell
prostate	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
RWPE	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Src	NN	nsubj	O
can	MD	aux	O
activate	VB	ccomp	O
STAT	NN	compound	O
signaling	NN	compound	O
pathways	NNS	dobj	O
and	CC	cc	O
raise	VBP	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
Stat3	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
oncogenesis	NN	nmod	O
by	IN	case	O
Src	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
further	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
phosphorylated	VBN	ccomp	O
at	IN	case	O
S727	NN	nmod	B-Amino_acid
in	IN	case	O
65	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Tissue
prostate	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
20	CD	dep	O
)	-RRB-	punct	O
relative	JJ	case	O
to	TO	case	O
25	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
normal	JJ	amod	B-Tissue
prostate	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
(	-LRB-	punct	O
n	NN	appos	O
=	JJ	amod	O
4	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Src	NN	nsubj	O
can	MD	aux	O
activate	VB	ccomp	O
STAT	NN	compound	O
signaling	NN	compound	O
pathways	NNS	dobj	O
and	CC	cc	O
raise	VBP	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
Stat3	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
oncogenesis	NN	nmod	O
by	IN	case	O
Src	NN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
phosphoS727	CD	compound	B-Amino_acid
-	:	punct	O
Stat3	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
Gleason	NN	compound	O
score	NN	conj	O
in	IN	case	O
these	DT	det	O
prostate	NN	compound	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
S727	NN	compound	B-Amino_acid
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	acl:relcl	O
to	TO	mark	O
activate	VB	xcomp	O
Stat3	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
thereby	RB	advmod	O
driving	VBG	advcl	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	dobj	O
independent	JJ	amod	O
of	IN	case	O
Y705	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	O
promotion	NN	nsubj	O
is	VBZ	cop	O
due	JJ	acomp	O
to	TO	case	O
induction	NN	ROOT	O
of	IN	case	O
inflammation	NN	nmod	O
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
enhanced	VBN	amod	O
pneumocyte	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
abrogated	VBN	conj	O
by	IN	case	O
IKKbeta	NN	compound	O
ablation	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
cells	NNS	nmod	O
or	CC	cc	O
inactivation	NN	conj	O
of	IN	case	O
JNK1	NN	nmod	O
.	.	punct	O
Allergic	JJ	amod	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nsubj	O
promotes	VBZ	ROOT	O
the	DT	det	O
recruitment	NN	dobj	O
of	IN	case	O
circulating	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Vascular	JJ	amod	O
adhesion	NN	compound	O
protein	NN	nsubj	O
-	:	punct	O
1	CD	dep	O
(	-LRB-	punct	O
VAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
regulates	VBZ	dep	O
leukocyte	NN	compound	O
tissue	NN	compound	O
infiltration	NN	dobj	O
.	.	punct	O
Allergen	NNP	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
respiratory	JJ	amod	B-Anatomical_system
inflammation	NN	nsubj	O
facilitates	NNS	ROOT	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
elicits	VBZ	conj	O
the	DT	det	O
extravasation	NN	dobj	O
of	IN	case	O
proinflammatory	JJ	amod	B-Cell
leukocytes	NNS	nmod	I-Cell
by	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
understood	VBN	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
the	DT	det	O
movement	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
.	.	punct	O

Bone	NN	compound	O
destruction	NN	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
osteoclastic	JJ	amod	O
bone	NN	compound	O
resorption	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cancer	NN	compound	O
cells	NNS	nsubj	O
stimulate	VBP	conj	O
the	DT	det	O
formation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
osteoclasts	NNS	nmod	O
next	RB	case	O
to	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
.	.	punct	O
The	DT	det	O
nonspecific	JJ	amod	O
character	NN	nsubj	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
led	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
hypothesize	VB	xcomp	O
that	IN	mark	O
circulating	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
use	VBP	ccomp	O
similar	JJ	amod	O
mechanisms	NNS	dobj	O
,	,	punct	O
promoting	VBG	advcl	O
secondary	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
formation	NN	dobj	O
at	IN	case	O
distal	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

Because	IN	mark	O
tumor	NN	compound	O
metastasis	NN	nsubj	O
requires	VBZ	advcl	O
angiogenesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
rk	RB	nsubj	O
-	SYM	punct	O
2	CD	nummod	O
could	MD	aux	O
inhibit	VB	ccomp	O
metastases	NNS	dobj	O
induced	VBN	acl	O
by	IN	case	O
injection	NN	nmod	O
of	IN	case	O
B16F10	NN	compound	O
melanoma	NN	compound	O
cells	NNS	nmod	O
into	IN	case	O
mice	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
the	DT	det	O
frequency	NN	nsubjpass	O
of	IN	case	O
metastasis	NN	nmod	O
to	TO	case	O
the	DT	det	O
lung	NN	nmod	B-Organ
as	IN	case	O
a	DT	det	O
function	NN	nmod	O
of	IN	case	O
allergic	JJ	amod	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nmod	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
following	VBG	case	O
the	DT	det	O
i	NN	nmod	B-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
v	LS	ROOT	I-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
injection	NN	ROOT	O
of	IN	case	O
B16	NN	compound	B-Cell
-	:	punct	I-Cell
F10	NN	compound	I-Cell
melanoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mice	NNS	nsubj	O
bearing	VBG	acl	O
subcutaneous	JJ	amod	O
tumor	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	:	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NNP	compound	O
pretreated	VBD	amod	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
showed	VBD	appos	O
>	NN	amod	O
50	CD	compound	O
%	NN	compound	O
reduction	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
spontaneous	JJ	amod	O
pulmonary	JJ	amod	O
metastases	NNS	dobj	O
.	.	punct	O
These	DT	det	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
allergen	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nsubj	O
resulted	VBD	ccomp	O
in	IN	case	O
a	DT	det	O
>	NN	amod	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
lung	NN	compound	B-Organ
metastases	NNS	nmod	O
.	.	punct	O

Intraperitoneal	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
2G7	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
mouse	NN	compound	O
spleen	NN	compound	O
NK	NN	compound	O
cell	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
This	DT	det	O
increase	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
CD4	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
activities	NNS	dep	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
occurred	VBD	parataxis	O
independent	JJ	xcomp	O
of	IN	case	O
the	DT	det	O
induced	VBN	amod	O
eosinophilia	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
allergen	NN	compound	O
provocation	NN	nmod	O
.	.	punct	O

Airway	NN	compound	O
angiogenesis	NN	nsubjpass	O
and	CC	cc	O
microvascular	JJ	amod	O
remodeling	NN	conj	O
are	VBP	auxpass	O
known	JJ	ROOT	O
features	NNS	dobj	O
of	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
structural	JJ	amod	O
alterations	NNS	nmod	O
are	VBP	aux	O
just	RB	advmod	O
beginning	VBG	conj	O
to	TO	aux	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O
Interventional	JJ	amod	O
strategies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
existing	VBG	amod	O
therapeutic	JJ	amod	O
modalities	NNS	nsubj	O
for	IN	case	O
asthma	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
inhaled	VBN	amod	O
corticosteroids	NNS	nmod	B-Simple_chemical
,	,	punct	O
were	VBD	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
block	VB	xcomp	O
the	DT	det	O
enhanced	VBN	amod	O
pulmonary	JJ	amod	B-Organ
recruitment	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
circulation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
with	IN	case	O
NIH3T3	NN	compound	O
cells	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Galpha	NN	nmod	O
(	-LRB-	punct	O
12	CD	appos	O
)	-RRB-	punct	O
readily	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
SET	NN	compound	O
protein	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O
Additional	JJ	amod	O
mechanistic	JJ	amod	O
studies	NNS	nsubj	O
further	RB	advmod	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
circulating	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
extravasate	VB	acl	O
to	TO	case	O
surrounding	VBG	amod	O
lung	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
was	VBD	auxpass	O
linked	VBN	ccomp	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
via	IN	case	O
one	CD	nmod	O
or	CC	cc	O
more	JJR	conj	O
Galpha	NNP	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
i	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	O
coupled	VBN	amod	O
receptors	NNS	dep	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
a	DT	det	O
survey	NN	nsubj	O
of	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
surgical	JJ	amod	O
database	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
incidence	NN	nsubj	O
of	IN	case	O
asthma	NN	nmod	O
was	VBD	cop	O
higher	JJR	ccomp	O
among	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
lung	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
decreased	VBD	ROOT	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
pulmonary	JJ	amod	O
metastasis	NN	conj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
fibrinolysis	NN	nmod	O
or	CC	cc	O
proteases	NNS	conj	O
increased	VBD	parataxis	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
foci	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lung	NN	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
allergic	JJ	amod	O
respiratory	JJ	amod	B-Anatomical_system
inflammation	NN	nsubj	O
may	MD	aux	O
represent	VB	ccomp	O
a	DT	det	O
risk	NN	compound	O
factor	NN	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
lung	NN	compound	B-Cancer
metastases	NNS	nmod	I-Cancer
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
amelioration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pulmonary	JJ	amod	B-Organ
inflammation	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
asthma	NN	nmod	O
will	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
direct	JJ	amod	O
and	CC	cc	O
immediate	JJ	conj	O
benefit	NN	dobj	O
to	IN	case	O
the	DT	det	O
7	CD	nummod	O
%	NN	pobj	O
to	TO	case	O
8	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
with	IN	case	O
this	DT	det	O
lung	NN	compound	B-Organ
disease	NN	nmod	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
energy	NN	compound	O
metabolism	NN	nmod	O
of	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
energy	NN	npadvmod	O
-	HYPH	punct	O
producing	NN	amod	O
pathways	NNS	nmod	O
of	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bromopyruvate	NN	ROOT	I-Simple_chemical
.	.	punct	O

Paclitaxel	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
agent	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	xcomp	O
against	IN	case	O
several	JJ	amod	O
tumours	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bromopyruvate	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
alkylating	VBG	amod	O
agent	NN	ROOT	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
tumoral	JJ	dep	B-Cancer
activity	NN	nmod	O
on	IN	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
using	VBG	acl	O
monolayer	JJ	compound	O
cultures	NNS	dobj	O
of	IN	case	O
human	JJ	amod	O
tumor	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
2	CD	nummod	O
-	HYPH	punct	O
DG	NNS	nsubj	O
selectively	RB	advmod	O
inhibits	VBZ	ccomp	O
energy	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
DNA	NN	compound	O
repair	NN	dobj	O
and	CC	cc	O
cellular	JJ	amod	O
recovery	NN	compound	O
processes	NNS	conj	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
This	DT	det	O
compound	NN	nsubj	O
inhibits	VBZ	ROOT	O
cellular	JJ	amod	B-Cell
ATP	NN	compound	B-Simple_chemical
production	NN	dobj	O
owing	VBG	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
action	NN	nmod	O
on	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
oxidative	JJ	amod	O
phosphorylation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
metabolic	JJ	amod	O
steps	NNS	dobj	O
and	CC	cc	O
mechanisms	NNS	conj	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	compound	I-Simple_chemical
action	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
particularly	RB	advmod	O
its	PRP$	nmod:poss	O
effects	NNS	appos	O
on	IN	prep	O
mitochondrial	JJ	amod	B-Cellular_component
energetics	NNS	pobj	O
,	,	punct	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

The	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
mitochondrial	JJ	amod	O
respiration	NN	conj	O
greatly	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	prep	O
the	DT	det	O
deficient	JJ	amod	O
respiration	NN	pobj	O
of	IN	prep	O
the	DT	det	O
predominance	NN	pobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
modulated	VBN	amod	O
antioxidant	JJ	amod	O
defense	NN	compound	O
mechanisms	NNS	nmod	O
contributes	VBZ	advcl	O
to	TO	case	O
mutagenesis	NN	nmod	O
and	CC	cc	O
additionally	RB	advmod	O
boosts	VBZ	conj	O
the	DT	det	O
carcinogenesis	NN	compound	O
process	NN	dobj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
incubation	NN	nsubj	O
of	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
for	IN	case	O
a	DT	det	O
short	JJ	amod	O
period	NN	nmod	O
(	-LRB-	punct	O
150	CD	nummod	O
microM	NN	dep	O
for	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
)	-RRB-	punct	O
significantly	RB	advmod	O
affected	VBD	ccomp	O
both	CC	cc:preconj	O
glycolysis	NN	dobj	O
and	CC	cc	O
mitochondrial	JJ	amod	B-Cellular_component
respiratory	JJ	amod	O
functions	NNS	conj	O
.	.	punct	O

Nonidet	NNP	compound	O
P	NN	compound	O
-	HYPH	punct	O
40	CD	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
glycolysis	NN	nmod	O
in	IN	case	O
cell	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
Ehrlich	NN	nmod	O
ascites	VBZ	conj	O
tumor	NN	compound	O
cells	NNS	dobj	O
to	TO	case	O
which	WDT	nmod	O
soluble	JJ	amod	O
mitochondrial	JJ	amod	O
ATPase	NN	nsubjpass	O
was	VBD	auxpass	O
added	VBN	acl:relcl	O
.	.	punct	O
The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
hexokinase	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
150	CD	nummod	O
microM	NN	compound	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
this	DT	det	O
concentration	NN	nsubj	O
caused	VBD	conj	O
more	JJR	amod	O
than	IN	quantmod	O
70	CD	compound	O
%	NN	amod	O
inhibition	NN	dobj	O
of	IN	case	O
GAPDH	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
glyceraldehyde	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
phosphate	NN	compound	I-Gene_or_gene_product
dehydrogenase	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
3	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
phosphoglycerate	JJ	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
activities	NNS	conj	O
.	.	punct	O

Presence	NN	nsubj	O
of	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
DG	NNS	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
mM	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
2	CD	compound	O
-	SYM	punct	O
4	CD	nummod	O
h	NN	nmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
glucose	NN	compound	O
usage	NN	dobj	O
and	CC	cc	O
lactate	NN	compound	O
production	NN	conj	O
by	IN	case	O
70	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
spheroids	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
a	DT	det	O
35	CD	nummod	O
%	NN	compound	O
reduction	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
monolayer	JJ	compound	O
cells	NNS	nmod	O
.	.	punct	O
Additionally	RB	advmod	O
,	,	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	compound	I-Simple_chemical
treatment	NN	nsubj	O
significantly	RB	advmod	O
impaired	VBD	ROOT	O
lactate	NN	compound	B-Simple_chemical
production	NN	dobj	O
by	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
even	RB	advmod	O
when	WRB	advmod	O
glucose	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
withdrawn	VBN	advcl	O
from	IN	case	O
the	DT	det	O
incubation	NN	compound	O
medium	NN	nmod	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
oxygen	NN	compound	O
utilization	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nmod	O
;	:	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
respiration	NN	nmod	O
.	.	punct	O
Oxygen	NN	compound	B-Simple_chemical
consumption	NN	nsubjpass	O
of	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
supported	VBN	acl	O
by	IN	case	O
either	DT	cc:preconj	O
pyruvate	NN	nmod	B-Simple_chemical
/	SYM	punct	O
malate	NN	conj	B-Simple_chemical
or	CC	cc	O
succinate	NN	conj	B-Simple_chemical
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
when	WRB	advmod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
pre	JJ	advmod	O
-	HYPH	punct	O
incubated	VBN	advcl	O
with	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
in	IN	prep	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
free	JJ	amod	O
medium	NN	pobj	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
oxygen	NN	compound	O
utilization	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nmod	O
;	:	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
respiration	NN	nmod	O
.	.	punct	O
On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
pre	JJ	advmod	O
-	HYPH	punct	O
incubated	VBN	advcl	O
in	IN	case	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
supplemented	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
oxygen	NN	compound	B-Simple_chemical
consumption	NN	nsubjpass	O
was	VBD	auxpass	O
affected	VBN	ROOT	O
only	RB	advmod	O
when	WRB	advmod	O
succinate	JJ	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
used	VBN	advcl	O
as	IN	prep	O
the	DT	det	O
oxidizable	JJ	amod	O
substrate	NN	pobj	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
oxygen	NN	compound	O
utilization	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nmod	O
;	:	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
respiration	NN	nmod	O
.	.	punct	O
An	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
oligomycin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
respiration	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
treated	VBN	acl	O
with	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
only	RB	advmod	O
when	WRB	advmod	O
incubated	VBN	advcl	O
in	IN	case	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
supplemented	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nsubj	I-Simple_chemical
induces	VBZ	ccomp	O
mitochondrial	JJ	amod	B-Cellular_component
proton	NN	compound	B-Simple_chemical
leakage	NN	dobj	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mark	O
blocking	VBG	advcl	O
the	DT	det	O
electron	NN	compound	B-Simple_chemical
transport	NN	compound	O
system	NN	dobj	O
.	.	punct	O

The	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
oxygen	NN	compound	O
utilization	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
0	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nmod	O
;	:	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
induced	VBD	ROOT	O
an	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
respiration	NN	nmod	O
.	.	punct	O
The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
70	CD	nummod	O
%	NN	nmod	O
by	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	compound	I-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
glutaminolysis	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
glycolysis	NN	dobj	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
combined	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BrPA	NN	nmod	I-Simple_chemical
on	IN	case	O
succinate	JJ	amod	B-Gene_or_gene_product
dehydrogenase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
on	IN	case	O
glycolysis	NN	conj	O
,	,	punct	O
inhibiting	VBG	acl	O
steps	NNS	dobj	O
downstream	RB	amod	O
of	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
play	VBP	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
HepG2	NN	compound	B-Cell
cell	NN	compound	I-Cell
death	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
in	IN	case	O
severe	JJ	amod	O
chronic	JJ	amod	O
central	JJ	amod	O
serous	JJ	amod	O
chorioretinopaty	NN	nmod	O
]	-RRB-	punct	O
[	-LRB-	punct	O
Retinochoroidopathy	NNS	ROOT	O
after	IN	prep	O
intravitreal	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
treatment	NN	pobj	O
]	-RRB-	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
report	VB	dep	O
on	IN	case	O
bevacizumab	NN	compound	O
treatment	NN	nmod	O
for	IN	prep	O
radiation	NN	compound	O
retinopathy	NN	pobj	O
affecting	VBG	acl	O
the	DT	det	O
macula	NN	dobj	O
.	.	punct	O
A	DT	det	O
74	CD	nummod	O
-	HYPH	punct	O
year	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
man	NN	ROOT	B-Organism
presented	VBN	acl	O
with	IN	prep	O
persistent	JJ	amod	O
metamorphopsias	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
right	JJ	amod	O
eye	NN	pobj	B-Organ
2	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	prep	O
intravitreal	JJ	amod	O
injection	NN	pobj	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
to	TO	mark	O
treat	VB	xcomp	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	dobj	O
due	JJ	case	O
to	TO	mwe	O
exudative	JJ	amod	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Bevacizumab	NN	compound	O
treatment	NN	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	dep	O
by	IN	case	O
reductions	NNS	nmod	O
in	IN	case	O
retinal	JJ	amod	O
hemorrhage	NN	nmod	O
,	,	punct	O
exudation	NN	conj	O
,	,	punct	O
and	CC	cc	O
edema	NN	conj	O
.	.	punct	O
The	DT	det	O
diagnosis	NN	nsubj	O
reached	VBD	acl	O
was	VBD	cop	O
retinochoroiditis	NN	ROOT	O
as	IN	case	O
an	DT	det	O
occult	JJ	amod	O
manifestation	NN	nmod	O
of	IN	case	O
sarcoidosis	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
resulting	VBG	advcl	O
from	IN	prep	O
an	DT	det	O
intravitreal	JJ	amod	O
injection	NN	pobj	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
.	.	punct	O

TEMF	NN	compound	O
treatment	NN	nsubj	O
continued	VBD	ROOT	O
for	IN	case	O
3	CD	nummod	O
additional	JJ	amod	O
weeks	NNS	nmod	O
.	.	punct	O
The	DT	det	O
patient	NN	nsubj	B-Organism
received	VBD	ROOT	O
a	DT	det	O
prescription	NN	dobj	O
for	IN	mark	O
100	CD	compound	O
mg	NN	compound	O
Ultralan	NNP	nsubjpass	B-Simple_chemical
to	TO	aux	O
be	VB	auxpass	O
taken	VBN	advcl	O
daily	RB	advmod	O
for	IN	prep	O
3	CD	nummod	O
days	NNS	pobj	O
and	CC	cc	O
then	RB	advmod	O
tapered	VBN	conj	O
in	IN	prep	O
3	CD	nummod	O
day	NN	compound	O
steps	NNS	pobj	O
.	.	punct	O

A	DT	det	O
Whipple	NNP	compound	O
procedure	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
complete	JJ	amod	O
resolution	NN	nmod	O
of	IN	case	O
these	DT	det	O
symptoms	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
return	NN	conj	O
of	IN	case	O
an	DT	det	O
elevated	JJ	amod	O
stomatostatin	NN	compound	O
level	NN	nmod	O
to	TO	case	O
normal	JJ	nmod	O
.	.	punct	O
During	IN	case	O
the	DT	det	O
further	JJ	amod	O
course	NN	nmod	O
no	DT	neg	O
deterioration	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
condition	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
morphological	JJ	amod	O
patterning	NN	nmod	O
on	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
Silencing	NN	ROOT	O
of	IN	case	O
directional	JJ	amod	O
migration	NN	nmod	O
in	IN	case	O
roundabout4	NN	compound	B-Gene_or_gene_product
knockdown	NN	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nsubj	O
2	CD	nummod	O
(	-LRB-	punct	O
VEGFR2	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
that	WDT	nsubj	O
regulates	VBZ	acl:relcl	O
vascular	JJ	amod	O
physiology	NN	dobj	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
Roundabouts	NNS	nsubj	B-Gene_or_gene_product
are	VBP	cop	O
axon	JJ	compound	O
guidance	NN	compound	O
molecules	NNS	appos	O
that	WDT	nsubjpass	O
have	VBP	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
identified	VBN	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
guidance	NN	nmod	O
as	RB	advmod	O
well	RB	mwe	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
miRNAs	NN	nmod	O
in	IN	mark	O
regulating	VBG	acl	O
endothelial	JJ	amod	O
cell	NN	compound	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
function	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
angiogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
gene	NN	compound	O
knockdown	NN	amod	O
analysis	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
Robos	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
roundabout	NN	nmod	B-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
robo4	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
predominant	JJ	amod	O
Robo	NNP	dobj	B-Gene_or_gene_product
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
using	VBG	acl	O
small	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	compound	O
technology	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
study	VB	dep	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
(	-LRB-	punct	O
SREBP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
critical	JJ	amod	O
role	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Robo1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Robo4	NN	compound	B-Gene_or_gene_product
knockdown	NN	compound	O
cells	NNS	conj	O
display	VBP	dep	O
distinct	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
wound	NN	advcl	O
migration	NN	nsubjpass	O
and	CC	cc	O
single	JJ	amod	O
-	HYPH	punct	O
cell	NN	compound	O
motility	NN	conj	O
by	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
compromised	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
knockdown	NN	nsubj	O
of	IN	case	O
robo4	NN	nmod	B-Gene_or_gene_product
abrogated	VBD	ROOT	O
the	DT	det	O
chemotactic	JJ	amod	O
response	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
serum	NN	nmod	B-Organism_substance
but	CC	cc	O
enhanced	VBD	conj	O
a	DT	det	O
chemokinetic	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
Slit2	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
while	IN	mark	O
robo1	NN	compound	B-Gene_or_gene_product
knockdown	NN	amod	O
cells	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
display	VB	advcl	O
chemotactic	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
serum	NN	nmod	B-Organism_substance
or	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
tested	VBN	ROOT	O
endocytic	JJ	amod	O
Rab	NN	compound	O
GTPases	NNS	dobj	O
for	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
VEGFR2	NN	compound	O
trafficking	NN	nmod	O
and	CC	cc	O
signaling	NN	conj	O
linked	VBN	acl	O
to	TO	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
Robo4	NN	nsubj	B-Gene_or_gene_product
knockdown	NN	nsubj	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
unexpectedly	RB	advmod	O
show	VBP	ROOT	O
up	RP	advmod	O
regulation	NN	dobj	O
of	IN	case	O
Rho	NN	compound	B-Gene_or_gene_product
GTPases	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

This	DT	det	O
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
most	RBS	advmod	O
likely	RB	advmod	O
based	VBN	ROOT	O
on	IN	case	O
decreased	VBN	amod	O
focal	JJ	amod	O
contact	NN	compound	O
turnover	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
p130Cas	NN	nmod	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
player	NN	appos	O
in	IN	case	O
directed	VBN	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
Zebrafish	JJ	amod	B-Organism
Robo4	NN	nsubj	B-Gene_or_gene_product
rescues	VBZ	ROOT	O
both	CC	cc:preconj	O
Rho	NN	compound	B-Gene_or_gene_product
GTPase	NN	compound	I-Gene_or_gene_product
homeostasis	NN	dobj	O
and	CC	cc	O
serum	NN	conj	B-Organism_substance
reduced	VBD	conj	O
chemotaxis	NN	dobj	O
in	IN	case	O
robo4	NN	compound	B-Gene_or_gene_product
knockdown	NN	amod	O
cells	NNS	nmod	O
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
GTPase	NN	compound	O
Arf6	NN	nsubj	O
primarily	RB	advmod	O
regulates	VBZ	ROOT	O
recycling	NN	dobj	O
of	IN	case	O
plasma	NN	compound	O
membrane	NN	compound	O
components	NNS	nmod	O
.	.	punct	O
Robo1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
Robo4	NN	conj	B-Gene_or_gene_product
interact	VBP	ROOT	O
and	CC	cc	O
share	NN	compound	O
molecules	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
Slit2	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Mena	NNP	conj	B-Gene_or_gene_product
and	CC	cc	O
Vilse	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
Cdc42	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
GAP	NNP	appos	I-Gene_or_gene_product
.	.	punct	O

p53	NN	compound	O
targets	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	compound	O
-	HYPH	punct	O
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
regulation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
both	DT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	ccomp	O
simultaneously	RB	advmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
mechanistically	RB	advmod	O
implicates	VBZ	ROOT	O
IRSp53	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
nexus	NN	nmod	O
between	IN	case	O
activated	VBN	amod	O
Cdc42	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Mena	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
both	DT	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
have	VBP	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
with	IN	case	O
Robo4	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
Rab5a	NN	compound	O
depletion	NN	nmod	O
but	CC	cc	O
decreased	VBD	conj	O
by	IN	case	O
Rab7a	NN	compound	O
depletion	NN	nmod	O
.	.	punct	O
CONCLUSION	NN	nsubj	O
:	:	punct	O
This	DT	det	O
study	NN	nsubj	O
identifies	VBZ	ROOT	O
specific	JJ	amod	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Robo	NNP	compound	B-Gene_or_gene_product
signaling	NN	compound	O
apparatus	NN	nmod	O
that	WDT	nsubj	O
work	VBP	acl:relcl	O
together	RB	advmod	O
to	TO	mark	O
guide	VB	xcomp	O
directional	JJ	amod	O
migration	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
property	NN	nsubjpass	O
of	IN	case	O
oral	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	O
and	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
status	NN	conj	O
of	IN	case	O
p53	NN	nmod	O
.	.	punct	O
p53	NN	compound	B-Gene_or_gene_product
hot	JJ	amod	O
-	HYPH	punct	O
spot	NN	compound	O
mutants	NNS	nsubj	O
increase	VBP	ROOT	O
tumor	NN	compound	B-Cancer
vascularization	NN	dobj	O
via	IN	case	O
ROS	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
mediated	VBN	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIF1	NN	compound	B-Gene_or_gene_product
/	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NN	compound	I-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	nsubj	O
plays	VBZ	ROOT	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
organism	NN	nmod	O
by	IN	mark	O
supervising	VBG	advcl	O
strict	JJ	amod	O
compliance	NN	dobj	O
of	IN	prep	O
individual	JJ	amod	O
cells	NNS	pobj	O
to	TO	aux	O
needs	NNS	advcl	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
organisms	NNS	pobj	O
.	.	punct	O
The	DT	det	O
function	NN	nsubjpass	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
is	VBZ	auxpass	O
often	RB	advmod	O
altered	VBN	ROOT	O
in	IN	case	O
various	JJ	amod	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
predominantly	RB	advmod	O
through	IN	case	O
missense	NN	compound	O
-	HYPH	punct	O
mutations	NNS	nmod	O
resulting	VBG	acl	O
in	IN	case	O
accumulation	NN	nmod	O
of	IN	case	O
mutant	JJ	amod	O
proteins	NNS	nmod	O
.	.	punct	O

Tumor	NN	compound	O
vessels	NNS	nsubj	O
are	VBP	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
their	PRP$	nmod:poss	O
normal	JJ	amod	O
counterparts	NNS	nmod	O
morphologically	RB	advmod	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mwe	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
level	NN	advcl	O
.	.	punct	O
We	PRP	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	O
with	IN	case	O
amino	NN	compound	O
-	HYPH	punct	O
acid	NN	compound	O
substitutions	NNS	nmod	O
at	IN	case	O
codons	NNS	nmod	O
175	CD	nummod	O
(	-LRB-	punct	O
R175H	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
248	CD	conj	O
(	-LRB-	punct	O
R248W	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
273	CD	conj	O
(	-LRB-	punct	O
R273H	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
representing	VBG	acl	O
the	DT	det	O
hot	JJ	amod	O
-	HYPH	punct	O
spots	NNS	dobj	O
of	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
various	JJ	amod	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
,	,	punct	O
increased	VBD	ccomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
vessels	NNS	nmod	B-Multi-tissue_structure
in	IN	case	O
HCT116	JJ	compound	B-Cancer
human	JJ	amod	I-Cancer
colon	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
xenografts	NNS	advmod	I-Cancer
and	CC	cc	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
accelerated	VBD	conj	O
their	PRP$	poss	O
growth	NN	dobj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	O
-	HYPH	punct	O
malignant	JJ	amod	O
tumor	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	O
-	:	punct	O
2	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Stimulation	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
was	VBD	auxpass	O
connected	VBN	ROOT	O
with	IN	case	O
about	RB	advmod	O
2	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
level	NN	nmod	O
of	IN	case	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod	I-Simple_chemical
(	-LRB-	punct	O
ROS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
tumor	NN	nmod:npmod	O
-	HYPH	punct	O
suppressive	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
rAAV2	NN	compound	O
/	SYM	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NN	nmod	O
in	IN	case	O
subcutaneous	JJ	amod	O
human	JJ	amod	O
lung	NN	compound	O
tumor	NN	compound	O
A549	NN	compound	O
xenograft	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
vessels	NNS	nmod	O
in	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
Antioxidant	JJ	amod	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
l	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
NAC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
decreased	VBD	ROOT	O
vessels	NNS	compound	B-Multi-tissue_structure
number	NN	dobj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
formed	VBN	acl	O
by	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
inactivated	VBN	amod	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
inhibited	VBD	conj	O
their	PRP$	nmod:poss	O
growth	NN	dobj	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
property	NN	nsubjpass	O
of	IN	case	O
oral	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	O
and	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
status	NN	conj	O
of	IN	case	O
p53	NN	nmod	O
.	.	punct	O
Effect	NN	nsubjpass	O
of	IN	case	O
ROS	NN	nmod	B-Simple_chemical
on	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
hot	JJ	amod	O
-	HYPH	punct	O
spot	NN	compound	O
p53	NN	compound	B-Gene_or_gene_product
mutants	NNS	dobj	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
increase	VB	acl	O
a	DT	det	O
content	NN	dobj	O
of	IN	case	O
HIF1	NN	compound	B-Gene_or_gene_product
transcriptional	JJ	amod	O
factor	NN	nmod	O
responsible	JJ	amod	O
for	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	DT	compound	I-Gene_or_gene_product
mRNAs	NNS	nmod	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
hypoxic	JJ	amod	O
tumor	NN	compound	O
environments	NNS	nsubj	O
induce	VBP	acl:relcl	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
expression	NN	dobj	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O
The	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubj	O
assures	VBZ	ROOT	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
a	DT	det	O
glucose	NN	compound	B-Simple_chemical
-	HYPH	punct	O
and	CC	cc	O
reoxygenation	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
in	IN	case	O
irradiated	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Hypoxia	NN	nsubj	O
-	HYPH	punct	O
induced	VBN	amod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O
Transcriptional	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
hypoxia	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
in	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
after	IN	case	O
ionizing	VBG	amod	O
radiation	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
response	NN	dobj	O
remains	VBZ	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
vector	NN	compound	O
system	NN	nsubj	O
,	,	punct	O
5xHRE	NN	compound	O
/	SYM	punct	O
SV40	NN	appos	O
/	:	punct	O
sTie2	NN	appos	O
,	,	punct	O
might	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
tool	NN	ccomp	O
for	IN	case	O
down	RB	advmod	O
-	HYPH	punct	O
regulating	VBG	amod	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
under	IN	case	O
hypoxic	JJ	amod	O
condition	NN	nmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
performed	VBD	ROOT	O
a	DT	det	O
series	NN	dobj	O
of	IN	case	O
molecular	JJ	amod	O
imaging	NN	amod	O
experiments	NNS	nmod	O
using	VBG	acl	O
a	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
reporter	NN	compound	O
gene	NN	dobj	O
,	,	punct	O
5HREp	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ODD	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
luc	NN	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
found	VBD	conj	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
hypoxic	JJ	amod	O
tumor	NN	compound	O
environments	NNS	nsubj	O
induce	VBP	acl:relcl	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
expression	NN	dobj	O
are	VBP	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O
Hypoxic	JJ	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
distant	JJ	nsubjpass	O
from	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
were	VBD	auxpass	O
dramatically	RB	advmod	O
reoxygenated	JJ	ROOT	O
at	IN	case	O
24	CD	nummod	O
h	NN	compound	O
postirradiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nsubj	O
increased	VBD	conj	O
as	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
accumulated	VBD	acl	O
in	IN	case	O
the	DT	det	O
reoxygenated	JJ	amod	O
regions	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
glycogen	NN	nsubjpass	O
was	VBD	auxpass	O
depleted	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
low	JJ	amod	O
glucose	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
but	CC	cc	O
conserved	VBN	conj	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O
The	DT	det	O
accumulation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
nonmetabolizable	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
analog	NN	nmod	O
,	,	punct	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
d	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	appos	I-Simple_chemical
,	,	punct	O
through	IN	case	O
the	DT	det	O
suppression	NN	nmod	O
of	IN	case	O
radiation	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
reoxygenated	JJ	amod	O
regions	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
lactate	NN	nsubj	O
and	CC	cc	O
pyruvate	VB	conj	O
regulate	NN	ccomp	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
independently	RB	advmod	O
of	IN	case	O
hypoxia	NN	nmod	O
by	IN	mark	O
stimulating	VBG	advcl	O
the	DT	det	O
accumulation	NN	dobj	O
of	IN	case	O
hypoxia	NN	compound	O
-	HYPH	punct	O
inducible	JJ	amod	O
Factor	NN	compound	O
1alpha	NN	nmod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1alpha	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Akt	JJ	compound	B-Gene_or_gene_product
knockdown	NN	nsubj	O
and	CC	cc	O
an	DT	det	O
mTOR	NN	compound	B-Gene_or_gene_product
inhibitor	NN	conj	O
revealed	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
postirradiation	NN	compound	O
accumulation	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

As	IN	mark	O
HIF	NN	compound	O
-	HYPH	punct	O
2alpha	NN	compound	O
activity	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	advcl	O
not	RB	neg	O
only	RB	cc:preconj	O
with	IN	case	O
hypoxic	JJ	nmod	O
but	CC	cc	O
also	RB	advmod	O
with	IN	case	O
hypoglycemic	JJ	amod	O
conditions	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
putative	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
,	,	punct	O
glucose	NN	compound	O
depletion	NN	conj	O
,	,	punct	O
and	CC	cc	O
HIF	NN	compound	O
-	HYPH	punct	O
2alpha	NN	conj	O
on	IN	case	O
the	DT	det	O
neuroblastoma	NN	compound	O
phenotype	NN	nmod	O
.	.	punct	O
In	FW	amod	O
vitro	FW	dep	O
experiments	NNS	nsubj	O
confirmed	VBD	ROOT	O
that	IN	mark	O
an	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
availability	NN	nmod	O
induced	VBD	ccomp	O
Akt	JJ	compound	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
under	IN	case	O
reoxygenated	JJ	amod	O
conditions	NNS	nmod	O
and	CC	cc	O
consequently	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
translation	NN	conj	O
.	.	punct	O

In	IN	case	O
human	JJ	amod	O
gliomas	NNS	nmod	O
and	CC	cc	O
other	JJ	amod	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	conj	O
,	,	punct	O
the	DT	det	O
accumulation	NN	nsubj	O
of	IN	case	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
protein	NN	nmod	O
under	IN	case	O
aerobic	JJ	amod	O
conditions	NNS	nmod	O
requires	VBZ	ROOT	O
the	DT	det	O
metabolism	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
to	TO	mark	O
pyruvate	VB	advcl	O
that	WDT	nsubj	O
prevents	VBZ	ccomp	O
the	DT	det	O
aerobic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
protein	NN	nmod	O
,	,	punct	O
activates	VBZ	conj	O
HIF	NN	compound	O
-	:	punct	O
1	CD	nummod	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
HIF	NN	nmod:npmod	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
activated	VBN	amod	O
genes	NNS	nmod	O
including	VBG	case	O
erythropoietin	NN	nmod	O
,	,	punct	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	conj	O
,	,	punct	O
glucose	NN	compound	O
transporter	NN	conj	O
3	CD	nummod	O
,	,	punct	O
and	CC	cc	O
aldolase	NN	compound	O
A	NN	conj	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
both	CC	cc:preconj	O
the	DT	det	O
accelerated	VBN	amod	O
translation	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
previously	RB	advmod	O
reported	VBN	amod	O
reactive	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
species	NNS	nmod:npmod	I-Simple_chemical
-	:	punct	O
mediated	VBN	amod	O
stabilization	NN	conj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
were	VBD	cop	O
essential	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
HIF	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
glycolysis	NN	nsubjpass	O
and	CC	cc	O
GLUT	NN	conj	O
-	:	punct	O
1	CD	nummod	O
can	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
induced	VBN	ROOT	O
independent	JJ	xcomp	O
of	IN	case	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	nmod	O
by	IN	case	O
other	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
c	NN	compound	O
-	HYPH	punct	O
Myc	NNP	nmod	O
and	CC	cc	O
phosphorylated	VBD	amod	O
Akt	NNP	conj	O
(	-LRB-	punct	O
pAkt	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
All	DT	nsubj	O
of	IN	case	O
these	DT	det	O
results	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product
/	SYM	punct	O
mTOR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
translation	NN	nsubj	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
postirradiation	NN	compound	O
up	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
intratumoral	JJ	amod	B-Cancer
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
activity	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
radiation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
alterations	NNS	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
oxygen	NN	compound	B-Simple_chemical
availability	NN	conj	O
in	IN	case	O
a	DT	det	O
solid	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Estradiol	NN	nsubj	B-Simple_chemical
increases	VBZ	ROOT	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
secretion	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
breast	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nsubjpass	I-Gene_or_gene_product
or	CC	cc	O
CXCL8	NN	conj	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
,	,	punct	O
metastasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
angiogenin	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
progression	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
,	,	punct	O
through	IN	case	O
its	PRP$	nmod:poss	O
relationship	NN	nmod	O
with	IN	case	O
ER	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	conj	O
for	IN	case	O
tamoxifen	NN	nmod	O
.	.	punct	O
Estrogen	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
crucial	JJ	ROOT	O
in	IN	case	O
breast	NN	compound	B-Organism_subdivision
carcinogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Whether	IN	mark	O
sex	NN	compound	O
steroids	NNS	nsubj	O
affect	VBP	advcl	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
secretion	NN	nsubjpass	O
of	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
or	CC	cc	O
breast	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

9E3	NN	compound	O
/	:	punct	O
CEF4	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
released	VBN	acl:relcl	O
from	IN	case	O
transformed	VBN	amod	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
CEF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
platelet	NN	compound	O
factor	NN	compound	O
4	CD	nummod	O
family	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	O
proteins	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
avian	JJ	amod	O
homolog	NN	conj	O
of	IN	case	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nmod	O
.	.	punct	O
Several	JJ	amod	O
cell	NN	compound	B-Cell
types	NNS	ROOT	O
in	IN	case	O
a	DT	det	O
tissue	NN	compound	B-Tissue
secrete	NN	amod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Hence	RB	advmod	O
,	,	punct	O
regulatory	JJ	amod	O
mechanisms	NNS	nsubj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
need	VBP	ROOT	O
to	TO	aux	O
be	VB	auxpass	O
investigated	VBN	xcomp	O
in	IN	prep	O
whole	JJ	amod	O
tissue	NN	pobj	B-Tissue
.	.	punct	O

Interleukins	NNS	nsubj	O
(	-LRB-	punct	O
ILs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
mediate	VB	ROOT	O
regression	NN	dobj	O
or	CC	cc	O
progression	NN	conj	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
used	VBD	ROOT	O
microdialysis	NN	dobj	O
to	TO	mark	O
sample	VB	advcl	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
in	FW	compound	O
situ	FW	advmod	O
in	IN	case	O
pre	JJ	nmod	O
-	HYPH	punct	O
and	CC	cc	O
postmenopausal	JJ	amod	O
women	NNS	conj	B-Organism
,	,	punct	O
preoperatively	RB	advmod	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
of	IN	case	O
women	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
in	IN	case	O
experimental	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
positive	JJ	amod	O
correlation	NN	dobj	O
between	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
estradiol	NN	conj	B-Simple_chemical
in	IN	case	O
normal	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
hormone	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
dependent	JJ	amod	I-Cancer
breast	NN	compound	I-Cancer
cancer	NN	conj	I-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Ex	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
estradiol	NN	compound	B-Simple_chemical
exposure	NN	nsubj	O
increased	VBD	ROOT	O
the	DT	det	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
secretion	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
whole	JJ	amod	O
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
In	IN	case	O
experimental	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
estradiol	NN	nsubj	B-Simple_chemical
increased	VBD	ROOT	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
whereas	IN	mark	O
the	DT	det	O
anti	JJ	compound	O
-	HYPH	punct	O
estrogen	NN	compound	B-Simple_chemical
tamoxifen	NN	nsubj	B-Simple_chemical
inhibited	VBD	advcl	O
the	DT	det	O
secretion	NN	dobj	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	dep	O
and	CC	cc	O
extracellularly	RB	conj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
tumors	NNS	dobj	B-Cancer
of	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	conj	O
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
HIF	NN	compound	O
-	:	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	xcomp	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
An	DT	det	O
anti	JJ	amod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
IL	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
8	CD	nummod	I-Simple_chemical
Ab	NN	nsubj	I-Simple_chemical
inhibited	VBD	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	nmod	I-Cell
produced	VBD	xcomp	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	dobj	I-Gene_or_gene_product
and	CC	cc	O
tumors	NNS	conj	B-Cancer
with	IN	case	O
low	JJ	amod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
exhibited	VBD	conj	O
decreased	VBN	amod	O
angiogenesis	NN	dobj	O
.	.	punct	O

alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nsubj	O
alone	RB	advmod	O
had	VBD	ROOT	O
little	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
coincubation	NN	nsubj	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
led	VBD	parataxis	O
to	TO	case	O
marked	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	O
-	:	punct	O
8	CD	nummod	O
secretion	NN	nmod	O
(	-LRB-	punct	O
at	IN	case	O
most	JJS	advmod	O
288	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
152	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
treatment	NN	nmod	O
with	IN	case	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
919	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
157	CD	dep	O
ng	NN	compound	O
/	:	punct	O
mL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
estradiol	NN	nsubj	B-Simple_chemical
has	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	dep	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
angiogenin	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
progression	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
,	,	punct	O
through	IN	case	O
its	PRP$	nmod:poss	O
relationship	NN	nmod	O
with	IN	case	O
ER	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	conj	O
for	IN	case	O
tamoxifen	NN	nmod	O
.	.	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
present	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
estrogen	NN	nmod:npmod	B-Simple_chemical
driven	JJ	amod	O
breast	NN	compound	B-Organism_subdivision
carcinogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
progression	NN	conj	O
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
Chemokine	NN	compound	O
receptor	NN	compound	O
CXCR4	NN	compound	B-Gene_or_gene_product
expression	NN	ROOT	O
,	,	punct	O
function	NN	conj	O
,	,	punct	O
and	CC	cc	O
clinical	JJ	amod	O
implications	NNS	conj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
The	DT	det	O
chemokine	NN	compound	O
receptor	NN	compound	O
CXCR4	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
biological	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
,	,	punct	O
but	CC	cc	O
few	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
addressed	VBN	conj	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
impact	NN	conj	O
on	IN	case	O
disease	NN	compound	O
prognosis	NN	nmod	O
.	.	punct	O

Hematogenous	JJ	amod	O
metastasis	NN	nsubj	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
requires	VBZ	ROOT	O
isolated	VBN	amod	O
tumor	NN	compound	O
cells	NNS	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
.	.	punct	O
We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
using	VBG	acl	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	dobj	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
and	CC	cc	O
confocal	JJ	amod	O
microscopy	NN	conj	O
in	IN	case	O
five	CD	nummod	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
examined	VBD	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
activity	NN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
stromal	JJ	amod	B-Gene_or_gene_product
cell	NN	nmod:npmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
derived	VBN	dep	I-Gene_or_gene_product
factor	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
SDF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
evaluated	VBN	conj	O
SDF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
/	:	punct	O
CXCR4	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathways	NNS	dobj	O
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
CXCR4	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinical	JJ	amod	O
features	NNS	conj	O
of	IN	case	O
221	CD	nummod	O
gastric	JJ	amod	B-Tissue
cancer	NN	compound	I-Tissue
tissue	NN	compound	I-Tissue
samples	NNS	nmod	I-Tissue
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
CXCR4	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nsubj	O
and	CC	cc	O
proteins	NNS	conj	O
were	VBD	cop	O
detectable	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
five	CD	nummod	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
MKN	NN	compound	B-Cell
-	HYPH	punct	I-Cell
28	CD	dep	I-Cell
,	,	punct	O
MKN	NNP	conj	B-Cell
-	:	punct	I-Cell
45	CD	dep	I-Cell
,	,	punct	O
MKN	NN	compound	B-Cell
-	HYPH	punct	I-Cell
74	CD	conj	I-Cell
,	,	punct	O
and	CC	cc	O
SNU16	NN	conj	B-Cell
cells	NNS	nsubj	I-Cell
did	VBD	aux	O
not	RB	neg	O
express	VB	ROOT	O
membrane	NN	compound	B-Cellular_component
CXCR4	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
KATO	NN	compound	B-Cell
III	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
membrane	NN	compound	B-Cellular_component
CXCR4	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

TRAP	NNP	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
platelets	NNS	nsubj	O
stimulated	VBD	ROOT	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
SKOV3	NN	compound	O
cell	NN	compound	O
invasion	NN	nmod	O
.	.	punct	O
In	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
,	,	punct	O
SDF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
migration	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
AMD3100	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
SDF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nsubj	I-Gene_or_gene_product
induced	VBD	ROOT	O
rapid	JJ	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
Erk1	NN	compound	B-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
MAPK	NN	nmod	I-Gene_or_gene_product
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
promote	VB	conj	O
phosphorylation	NN	dobj	O
of	IN	case	O
Stat3	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
Akt	NNP	conj	B-Gene_or_gene_product
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
ITCs	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
and	CC	cc	O
bone	NN	compound	O
marrow	NN	conj	O
even	RB	advmod	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Gastric	JJ	amod	B-Tissue
cancer	NN	compound	I-Tissue
tissue	NN	compound	I-Tissue
samples	NNS	nsubj	I-Tissue
expressed	VBD	ROOT	O
CXCR4	NN	dobj	B-Gene_or_gene_product
with	IN	case	O
variable	JJ	amod	O
intensities	NNS	nmod	O
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
Strong	JJ	amod	O
CXCR4	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
028	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
higher	JJR	amod	O
stages	NNS	conj	O
III	CD	dep	O
/	SYM	punct	O
IV	CD	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
047	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
further	RB	advmod	O
tended	VBD	conj	O
to	TO	mark	O
be	VB	auxpass	O
correlated	VBN	xcomp	O
with	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
5	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
survival	NN	compound	O
rate	NN	nmod	O
(	-LRB-	punct	O
42	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
%	NN	dep	O
vs	CC	cc	O
.	.	punct	O
53	CD	ROOT	O
.	.	punct	O
9	CD	nummod	O
%	NN	ROOT	O
;	:	punct	O
P	NN	nsubj	O
=	JJ	appos	O
0	CD	dobj	O
.	.	punct	O
1	LS	dobj	O
)	-RRB-	punct	O
.	.	punct	O

PTHrP	NN	nsubj	O
also	RB	advmod	O
influenced	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	O
factor	NN	compound	O
CXCR4	NN	nmod	O
,	,	punct	O
and	CC	cc	O
coexpression	NN	nsubj	O
of	IN	case	O
PTHrP	NN	nmod	O
and	CC	cc	O
CXCR4	NN	conj	O
was	VBD	cop	O
crucial	JJ	conj	O
for	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
CXCR4	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
strong	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
CXCR4	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
CXCR4	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
during	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	O
metalloproteinase	NN	compound	O
activity	NN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
profile	NN	conj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
-	:	punct	O
2	CD	intj	O
and	CC	cc	O
-	SYM	conj	O
9	CD	conj	O
and	CC	cc	O
tissue	NN	compound	O
inhibitor	NN	nmod	O
of	IN	case	O
metalloproteinase	NN	compound	O
-	:	punct	O
1	CD	nmod	O
during	IN	case	O
human	JJ	amod	O
dermal	JJ	amod	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Effect	NN	ROOT	O
of	IN	case	O
estrogen	NN	nmod	B-Simple_chemical
and	CC	cc	O
progesterone	NN	conj	B-Simple_chemical
on	IN	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
during	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
wounds	NNS	nsubj	O
are	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
secondary	JJ	amod	O
complication	NN	attr	O
for	IN	prep	O
many	JJ	amod	O
people	NNS	pobj	O
with	IN	prep	O
impaired	JJ	amod	O
mobility	NN	pobj	O
.	.	punct	O
Age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
impaired	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
substantial	JJ	amod	O
morbidity	NN	nmod	O
and	CC	cc	O
mortality	NN	conj	O
along	IN	prep	O
with	IN	prep	O
a	DT	det	O
large	JJ	amod	O
financial	JJ	amod	O
burden	NN	pobj	O
to	IN	prep	O
health	NN	compound	O
services	NNS	pobj	O
.	.	punct	O

Chronic	JJ	amod	O
wounds	NNS	nsubj	O
are	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
secondary	JJ	amod	O
complication	NN	attr	O
for	IN	prep	O
many	JJ	amod	O
people	NNS	pobj	O
with	IN	prep	O
impaired	JJ	amod	O
mobility	NN	pobj	O
.	.	punct	O
There	EX	expl	O
is	VBZ	ROOT	O
accumulating	VBG	amod	O
evidence	NN	nsubj	O
that	IN	mark	O
the	DT	det	O
tissue	NN	compound	B-Tissue
damage	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
chronic	JJ	amod	O
wounds	NNS	nmod	B-Pathological_formation
is	VBZ	auxpass	O
initiated	VBN	ccomp	O
and	CC	cc	O
propagated	VBN	conj	O
by	IN	case	O
an	DT	det	O
inappropriately	RB	advmod	O
excessive	JJ	amod	O
inflammatory	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
poor	JJ	amod	O
skin	NN	compound	O
wound	NN	compound	O
healing	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
diabetes	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	xcomp	O
from	IN	case	O
impaired	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
treatments	NNS	nsubj	O
that	WDT	nsubj	O
improve	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
could	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
clinical	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O
Research	NN	nsubj	O
on	IN	prep	O
age	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
impaired	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	pobj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
decline	NN	nsubj	O
in	IN	case	O
sex	NN	compound	B-Simple_chemical
steroid	NN	compound	I-Simple_chemical
hormones	NNS	nmod	I-Simple_chemical
with	IN	case	O
age	NN	nmod	O
may	MD	aux	O
have	VB	ccomp	O
a	DT	det	O
substantial	JJ	amod	O
influence	NN	dobj	O
on	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Juice	NNP	nsubj	O
and	CC	cc	O
peels	NNS	conj	O
,	,	punct	O
for	IN	prep	O
example	NN	pobj	O
,	,	punct	O
possess	VBP	ROOT	O
potent	JJ	amod	O
antioxidant	JJ	amod	O
properties	NNS	dobj	O
,	,	punct	O
while	IN	mark	O
juice	NN	nsubj	O
,	,	punct	O
peel	NN	conj	O
and	CC	cc	O
oil	NN	conj	O
are	VBP	advcl	O
all	DT	advmod	O
weakly	RB	advmod	O
estrogenic	JJ	acomp	O
and	CC	cc	O
heuristically	RB	advmod	O
of	IN	prep	O
interest	NN	pobj	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
menopausal	JJ	amod	O
symptoms	NNS	nmod	O
and	CC	cc	O
sequellae	NNS	conj	O
.	.	punct	O
Topical	JJ	amod	O
and	CC	cc	O
systemic	JJ	conj	O
estrogen	NN	compound	B-Simple_chemical
treatments	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
an	DT	det	O
increased	VBN	amod	O
rate	NN	dobj	O
of	IN	case	O
healing	VBG	nmod	O
by	IN	mark	O
reducing	VBG	advcl	O
inflammation	NN	dobj	O
,	,	punct	O
however	RB	advmod	O
the	DT	det	O
underlying	JJ	amod	O
mechanisms	NNS	nsubjpass	O
are	VBP	auxpass	O
little	JJ	advmod	O
understood	VBN	parataxis	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
selective	JJ	amod	O
COX	NN	compound	O
-	:	punct	O
I	NN	compound	O
inhibitor	NN	nsubj	O
,	,	punct	O
SC	NN	compound	O
-	HYPH	punct	O
560	CD	appos	O
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
serum	NN	compound	O
progesterone	NN	compound	O
concentrations	NNS	nmod	O
.	.	punct	O
In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
progesterone	NN	nsubj	B-Simple_chemical
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	advcl	O
inflammation	NN	dobj	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Macrophages	NNS	nsubj	B-Cell
are	VBP	cop	O
essential	JJ	amod	O
mediators	NNS	ROOT	O
of	IN	case	O
inflammation	NN	nmod	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
analysis	NN	nsubj	O
suggested	VBD	ROOT	O
a	DT	det	O
specific	JJ	amod	O
activation	NN	dobj	O
or	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
resident	JJ	amod	O
macrophages	NNS	nmod	O
by	IN	case	O
apoptotic	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Macrophages	NNS	nsubjpass	B-Cell
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
classical	JJ	amod	O
or	CC	cc	O
alternative	JJ	conj	O
manner	NN	nmod	O
in	IN	case	O
parallel	NN	nmod	O
with	IN	case	O
the	DT	det	O
T	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
H	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
1	CD	nummod	I-Cell
/	:	punct	O
T	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
H	NN	appos	I-Cell
)	-RRB-	punct	I-Cell
2	CD	nummod	I-Cell
dichotomy	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Using	VBG	ROOT	O
a	DT	det	O
murine	JJ	amod	B-Organism
incisional	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	compound	O
model	NN	dobj	O
this	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	parataxis	O
out	RP	prt	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
estrogen	NN	nmod	B-Simple_chemical
and	CC	cc	O
progesterone	NN	conj	B-Simple_chemical
on	IN	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
during	IN	case	O
the	DT	det	O
wound	NN	compound	B-Pathological_formation
healing	NN	compound	O
response	NN	nmod	O
.	.	punct	O

All	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
parameters	NNS	nmod	O
were	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
COX	NN	compound	O
-	HYPH	punct	O
II	CD	nummod	O
inhibitors	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
vasculature	NN	nmod	O
are	VBP	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
serum	NN	compound	O
progesterone	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
with	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
steroid	NN	compound	B-Simple_chemical
hormones	NNS	nmod	I-Simple_chemical
following	VBG	case	O
ovariectomy	NN	nmod	O
,	,	punct	O
alternatively	RB	advmod	O
activated	VBN	amod	O
macrophage	NN	compound	B-Cell
markers	NNS	nsubjpass	O
(	-LRB-	punct	O
Fizz1	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
Ym1	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
reduced	VBN	parataxis	O
,	,	punct	O
with	IN	case	O
this	DT	det	O
effect	NN	nsubjpass	O
being	VBG	auxpass	O
reversed	VBN	conj	O
with	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
estrogen	NN	nmod	B-Simple_chemical
or	CC	cc	O
progesterone	NN	conj	B-Simple_chemical
;	:	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
with	IN	case	O
the	DT	det	O
reduction	NN	nsubjpass	O
of	IN	case	O
steroid	NN	compound	B-Simple_chemical
hormones	NNS	compound	I-Simple_chemical
macrophages	NNS	nmod	B-Cell
are	VBP	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
classical	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
promoting	VBG	xcomp	O
inflammation	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
estrogen	NN	nsubj	B-Simple_chemical
or	CC	cc	O
progesterone	NN	conj	B-Simple_chemical
are	VBP	aux	O
contributing	VBG	advcl	O
toward	IN	case	O
macrophage	NN	compound	B-Cell
activation	NN	nmod	O
in	IN	case	O
an	DT	det	O
alternative	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
driving	VBG	advcl	O
wound	NN	compound	B-Pathological_formation
repair	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
remodeling	NN	conj	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
Effect	NN	ROOT	O
of	IN	case	O
platelet	NN	compound	B-Organism_substance
-	HYPH	punct	I-Organism_substance
rich	JJ	amod	I-Organism_substance
plasma	NN	compound	I-Organism_substance
and	CC	cc	O
fibrin	NN	conj	B-Gene_or_gene_product
glue	NN	nmod	O
on	IN	case	O
healing	NN	nmod	O
of	IN	case	O
critical	JJ	amod	O
-	HYPH	punct	O
size	NN	amod	O
calvarial	JJ	amod	B-Organ
bone	NN	compound	I-Organ
defects	NNS	nmod	O
.	.	punct	O

Platelets	NNS	nsubj	O
release	VBP	ROOT	O
several	JJ	amod	O
growth	NN	compound	O
factors	NNS	dobj	O
and	CC	cc	O
bioactive	JJ	amod	O
agents	NNS	conj	O
that	WDT	nsubj	O
play	VBP	acl:relcl	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
development	NN	nmod	O
of	IN	case	O
not	RB	neg	O
only	RB	cc:preconj	O
thrombus	NN	nmod	O
but	CC	cc	O
also	RB	conj	O
of	IN	case	O
intimal	JJ	amod	O
thickening	NN	nmod	O
.	.	punct	O
Despite	IN	case	O
the	DT	det	O
insufficient	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
experimental	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
platelet	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	I-Organism_substance
rich	JJ	amod	I-Organism_substance
plasma	NN	appos	I-Organism_substance
(	-LRB-	punct	O
PRP	NN	appos	B-Organism_substance
)	-RRB-	punct	O
including	VBG	case	O
high	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
is	VBZ	auxpass	O
introduced	VBN	ROOT	O
to	TO	case	O
clinical	JJ	amod	O
use	NN	nmod	O
rapidly	RB	advmod	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
compare	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
PRP	NN	nmod	B-Organism_substance
and	CC	cc	O
platelet	NN	compound	B-Organism_substance
-	HYPH	punct	I-Organism_substance
poor	JJ	amod	I-Organism_substance
plasma	NN	conj	I-Organism_substance
(	-LRB-	punct	O
PPP	NN	appos	B-Organism_substance
)	-RRB-	punct	O
on	IN	case	O
healing	NN	nmod	O
of	IN	case	O
critical	JJ	amod	O
-	HYPH	punct	O
size	NN	compound	O
bone	NN	compound	B-Organ
defects	NNS	nmod	O
.	.	punct	O
Bilateral	NNP	amod	O
full	RB	amod	O
-	HYPH	punct	O
thickness	NN	nsubjpass	O
,	,	punct	O
critical	JJ	amod	O
-	HYPH	punct	O
size	NN	compound	O
bone	NN	compound	B-Organ
defects	NNS	nsubjpass	O
were	VBD	auxpass	O
created	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
parietal	JJ	amod	B-Organ
bones	NNS	nmod	I-Organ
of	IN	case	O
32	CD	nummod	O
rabbits	NNS	nmod	B-Organism
,	,	punct	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
studied	VBN	acl:relcl	O
in	IN	case	O
4	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

All	DT	det	O
wounds	NNS	nsubj	O
were	VBD	auxpass	O
fully	RB	advmod	O
re	NN	advmod	O
-	HYPH	punct	O
epithelialized	VBN	ROOT	O
by	IN	agent	O
10	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
.	.	punct	O
Saline	NN	ROOT	B-Simple_chemical
,	,	punct	O
thrombin	NN	compound	B-Gene_or_gene_product
solution	NN	conj	O
,	,	punct	O
PPP	NN	conj	B-Organism_substance
,	,	punct	O
and	CC	cc	O
PRP	NN	nsubjpass	B-Organism_substance
were	VBD	auxpass	O
applied	VBN	conj	O
to	TO	case	O
the	DT	det	O
created	VBN	amod	O
defects	NNS	nmod	O
before	IN	case	O
closure	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
distraction	NN	compound	O
rates	NNS	nsubjpass	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	dep	O
and	CC	cc	O
1	CD	conj	O
mm	NN	dep	O
/	SYM	punct	O
day	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
and	CC	cc	O
for	IN	case	O
each	DT	det	O
group	NN	conj	O
three	CD	nummod	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	parataxis	O
.	.	punct	O
Radiologic	JJ	amod	O
defect	NN	compound	O
area	NN	compound	O
measurement	NN	nsubj	O
results	VBZ	nsubjpass	O
at	IN	case	O
0	CD	nmod	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
and	CC	cc	O
16	CD	nummod	O
weeks	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
between	IN	prep	O
the	DT	det	O
groups	NNS	pobj	O
.	.	punct	O

Correlation	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
between	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
parameters	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
formed	VBN	acl	O
during	IN	case	O
distraction	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
densities	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
newly	RB	advmod	O
formed	VBN	amod	O
bones	NNS	pobj	B-Organ
at	IN	case	O
16th	JJ	amod	O
week	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
distraction	NN	compound	O
rate	NN	nmod	O
on	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
growth	NN	nmod	O
in	IN	case	O
intramembraneous	JJ	amod	O
ossification	NN	nmod	O
after	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
.	.	punct	O
Histologic	JJ	amod	O
parameters	NNS	nsubjpass	O
(	-LRB-	punct	O
primary	JJ	dep	O
and	CC	cc	O
secondary	JJ	conj	O
bone	NN	compound	B-Tissue
trabecula	NN	dep	I-Tissue
,	,	punct	O
neovascularization	NN	conj	O
,	,	punct	O
and	CC	cc	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	conj	I-Multi-tissue_structure
and	CC	cc	O
connective	JJ	conj	B-Tissue
tissue	NN	compound	I-Tissue
formation	NN	dep	O
)	-RRB-	punct	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
between	IN	case	O
4	CD	nummod	O
-	:	punct	O
and	CC	cc	O
16	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
groups	NNS	nmod	O
.	.	punct	O
More	RBR	advmod	O
rapid	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
defect	NN	compound	O
size	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
groups	NNS	nmod	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
than	IN	case	O
in	IN	case	O
groups	NNS	conj	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
,	,	punct	O
both	CC	nmod	O
in	IN	prep	O
the	DT	det	O
4th	JJ	amod	O
and	CC	cc	O
16th	JJ	conj	O
weeks	NNS	pobj	O
.	.	punct	O

A	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
between	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
bone	NN	compound	O
volume	NN	compound	O
density	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
younger	JJR	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	O
area	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
in	IN	conj	O
the	DT	det	O
oldest	JJS	amod	O
new	JJ	amod	O
-	HYPH	punct	O
bone	NN	compound	O
area	NN	pobj	O
.	.	punct	O
Newly	RB	advmod	O
formed	VBN	amod	O
bone	NN	compound	B-Organ
densities	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
higher	JJR	xcomp	O
in	IN	case	O
these	DT	det	O
2	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

Correlation	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
between	IN	case	O
blood	NN	compound	O
vessel	NN	compound	O
parameters	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
amount	NN	conj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
formed	VBN	acl	O
during	IN	case	O
distraction	NN	nmod	O
.	.	punct	O
New	JJ	compound	O
bone	NN	compound	B-Organ
formation	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
more	RBR	advmod	O
rapid	JJ	xcomp	O
considering	VBG	xcomp	O
histologic	JJ	amod	O
parameters	NNS	dobj	O
,	,	punct	O
in	IN	case	O
groups	NNS	nmod	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
at	IN	case	O
4th	JJ	nmod	O
and	CC	cc	O
16th	JJ	conj	O
weeks	NNS	dep	O
.	.	punct	O
Study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
PRP	NN	nsubj	B-Organism_substance
and	CC	cc	O
PPP	NN	conj	B-Organism_substance
might	MD	aux	O
have	VB	ccomp	O
favorable	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
bone	NN	compound	B-Organ
healing	NN	nmod	O
.	.	punct	O

Both	DT	det	O
groups	NNS	nsubj	O
believe	VBP	ROOT	O
that	IN	mark	O
pulp	JJ	amod	O
revascularization	NN	nsubj	O
and	CC	cc	O
regeneration	NN	conj	O
will	MD	aux	O
be	VB	ccomp	O
viable	JJ	amod	O
treatment	NN	compound	O
modalities	NNS	attr	O
in	IN	prep	O
the	DT	det	O
future	NN	pobj	O
.	.	punct	O
Although	IN	mark	O
we	PRP	nsubj	O
cannot	RB	advmod	O
reveal	VBP	advcl	O
any	DT	det	O
statistical	JJ	amod	O
difference	NN	dobj	O
between	IN	case	O
these	DT	det	O
2	CD	nummod	O
substances	NNS	nmod	O
considering	VBG	acl	O
osteoinductive	JJ	amod	O
potential	NN	dobj	O
,	,	punct	O
PRP	NN	compound	B-Organism_substance
group	NN	nsubj	O
has	VBZ	aux	O
demonstrated	VBN	ROOT	O
superior	JJ	amod	O
results	NNS	dobj	O
compared	VBN	case	O
with	IN	case	O
fibrin	NN	compound	B-Gene_or_gene_product
glue	NN	compound	O
group	NN	advcl	O
.	.	punct	O

Exposure	NN	nsubj	O
to	TO	case	O
activated	VBN	amod	O
platelet	NN	compound	O
membranes	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
soluble	JJ	amod	O
proteins	NNS	conj	O
contained	VBN	csubj	O
in	IN	case	O
activated	VBN	amod	O
platelet	NN	nmod	O
releasate	VBP	ROOT	O
both	CC	cc:preconj	O
contributed	VBD	xcomp	O
to	TO	case	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nmod	O
in	IN	case	O
invasion	NN	nmod	O
.	.	punct	O
Higher	JJR	amod	O
platelet	NN	compound	B-Cell
concentrations	NNS	nsubj	O
may	MD	aux	O
expose	VB	ROOT	O
beneficial	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
PRP	NN	nmod	B-Organism_substance
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
reveal	VBP	ROOT	O
upregulation	NN	dobj	O
of	IN	case	O
an	DT	det	O
endogenous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
during	IN	case	O
multi	NN	amod	O
step	NN	compound	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
identify	VB	conj	O
enhanced	VBN	amod	O
stromal	JJ	amod	O
TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
expression	NN	dobj	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
host	NN	compound	O
anti	NN	compound	O
-	HYPH	punct	O
tumor	NN	compound	O
defense	NN	compound	O
mechanism	NN	nmod	O
.	.	punct	O
Host	NN	npadvmod	O
-	HYPH	punct	O
derived	VBN	amod	O
angiopoietin	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
affects	VBZ	ROOT	O
early	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
maturation	NN	conj	O
but	CC	cc	O
is	VBZ	cop	O
dispensable	JJ	conj	O
for	IN	case	O
later	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

Tie1	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
orphan	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptor	NN	ROOT	O
expressed	VBN	acl	O
almost	RB	advmod	O
exclusively	RB	advmod	O
in	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
normal	JJ	amod	O
vascular	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
maintenance	NN	conj	O
.	.	punct	O
The	DT	det	O
angiopoietin	NN	nsubjpass	B-Gene_or_gene_product
/	:	punct	O
Tie2	NN	compound	B-Gene_or_gene_product
system	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
second	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
-	HYPH	punct	O
specific	JJ	amod	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
system	NN	nmod	O
controlling	VBG	compound	O
vessel	NN	compound	B-Multi-tissue_structure
assembly	NN	dep	O
,	,	punct	O
maturation	NN	conj	O
,	,	punct	O
and	CC	cc	O
quiescence	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	O
(	-LRB-	punct	O
Ang	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
-	SYM	punct	O
2	CD	nummod	O
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
Angiopoietin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
Ang	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
prominently	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
host	NN	nmod:npmod	O
-	HYPH	punct	O
derived	VBN	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
of	IN	case	O
most	JJS	amod	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
making	VBG	xcomp	O
it	PRP	nsubj	O
an	DT	det	O
attractive	JJ	amod	O
candidate	NN	ccomp	O
for	IN	case	O
antiangiogenic	JJ	amod	O
intervention	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	O
(	-LRB-	punct	O
Ang	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
-	SYM	punct	O
2	CD	nummod	O
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
Yet	CC	advmod	O
,	,	punct	O
the	DT	det	O
net	JJ	amod	O
outcome	NN	nsubjpass	O
of	IN	prep	O
Ang	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
functions	NNS	pobj	O
on	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
to	TO	aux	O
be	VB	xcomp	O
contextual	JJ	acomp	O
depending	VBG	prep	O
on	IN	prep	O
the	DT	det	O
local	JJ	amod	O
cytokine	NN	compound	O
milieu	NN	pobj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	O
(	-LRB-	punct	O
Ang	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
-	SYM	punct	O
2	CD	nummod	O
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
Correspondingly	RB	advmod	O
,	,	punct	O
Ang	NNP	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
manipulatory	JJ	amod	O
therapies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
protumorigenic	JJ	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
antitumorigenic	JJ	amod	O
effects	NNS	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
considerable	JJ	amod	O
attentions	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
devoted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
physiological	JJ	amod	O
roles	NNS	nmod	O
of	IN	case	O
angiopoietin	NN	nmod	O
(	-LRB-	punct	O
Ang	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
and	CC	cc	O
-	SYM	punct	O
2	CD	nummod	O
as	IN	case	O
regulatory	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
To	TO	mark	O
clarify	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
for	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
in	IN	case	O
a	DT	det	O
definite	JJ	amod	O
genetic	JJ	amod	O
experimental	JJ	amod	O
setting	NN	nmod	O
,	,	punct	O
the	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
aimed	VBN	ROOT	O
at	IN	mark	O
comparatively	RB	advmod	O
studying	VBG	advcl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
tumors	NNS	nmod	B-Cancer
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
and	CC	cc	O
Ang	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	conj	O
.	.	punct	O

Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	ROOT	O
.	.	punct	O
Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nsubj	I-Cancer
,	,	punct	O
MT	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
ret	JJ	amod	I-Cancer
melanomas	NNS	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
B16F10	NN	compound	B-Cancer
melanomas	NNS	conj	I-Cancer
all	DT	nsubj	O
grew	VBD	ROOT	O
slower	JJR	dobj	O
in	IN	prep	O
Ang	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	pobj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	O
-	HYPH	punct	O
malignant	JJ	amod	O
tumor	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	O
-	:	punct	O
2	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Yet	RB	advmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
growth	NN	nsubj	O
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	nmod	O
and	CC	cc	O
Ang	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	conj	O
dissociated	VBN	ROOT	O
during	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
tumor	NN	compound	B-Cancer
growth	NN	compound	O
rates	NNS	nsubj	O
during	IN	case	O
later	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
were	VBD	cop	O
similar	JJ	parataxis	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
nuclear	JJ	amod	O
magnetic	JJ	amod	O
resonance	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
blood	NN	compound	O
flow	NN	nmod	O
in	IN	case	O
linomide	NN	npadvmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
showed	VBD	ROOT	O
localization	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
almost	RB	advmod	O
exclusively	RB	advmod	O
to	TO	case	O
the	DT	det	O
periphery	NN	nmod	O
of	IN	case	O
the	DT	det	O
poorly	RB	advmod	O
vascularized	VBN	amod	O
tumors	NNS	nmod	O
with	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
vascular	JJ	amod	O
functionality	NN	nmod	O
and	CC	cc	O
vasodilation	NN	conj	O
.	.	punct	O
Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
intratumoral	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
architecture	NN	nmod	I-Multi-tissue_structure
revealed	VBD	ROOT	O
no	DT	neg	O
major	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
microvessel	NN	compound	B-Tissue
density	NN	nmod	O
and	CC	cc	O
perfusion	NN	compound	O
characteristics	NNS	conj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	O
-	HYPH	punct	O
malignant	JJ	amod	O
tumor	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	O
-	:	punct	O
2	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
diameters	NNS	nsubj	O
of	IN	case	O
intratumoral	JJ	amod	B-Tissue
microvessels	NNS	nmod	I-Tissue
were	VBD	cop	O
smaller	JJR	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
grown	VBN	acl	O
in	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
vasculature	NN	nsubj	B-Multi-tissue_structure
had	VBD	conj	O
an	DT	det	O
altered	JJ	amod	O
pattern	NN	dobj	O
of	IN	case	O
pericyte	NN	compound	B-Cell
recruitment	NN	nmod	O
and	CC	cc	O
maturation	NN	conj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	O
-	HYPH	punct	O
malignant	JJ	amod	O
tumor	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	O
-	:	punct	O
2	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Ang	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
2	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
tumor	NN	compound	O
vessels	NNS	nsubj	O
had	VBD	ROOT	O
higher	JJR	amod	O
pericyte	NN	compound	B-Cell
coverage	NN	compound	O
indices	NNS	dobj	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
tumor	NN	compound	O
cell	NN	compound	O
expression	NN	nsubj	O
of	IN	case	O
NCAM	NN	nmod	O
in	IN	case	O
a	DT	det	O
fibrosarcoma	NN	compound	O
model	NN	nmod	O
(	-LRB-	punct	O
T241	NN	appos	O
)	-RRB-	punct	O
improved	VBD	ROOT	O
pericyte	NN	compound	O
recruitment	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
perivascular	JJ	amod	O
deposition	NN	conj	O
of	IN	case	O
ECM	NN	compound	O
molecules	NNS	nmod	O
.	.	punct	O
Recruited	JJ	amod	O
pericytes	NNS	nsubj	B-Cell
were	VBD	ROOT	O
desmin	NN	attr	B-Gene_or_gene_product
and	CC	cc	O
NG2	NN	compound	B-Gene_or_gene_product
positive	JJ	conj	O
and	CC	cc	O
predominately	RB	advmod	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
smooth	NN	amod	I-Gene_or_gene_product
muscle	NN	compound	I-Gene_or_gene_product
actin	NN	compound	I-Gene_or_gene_product
negative	JJ	conj	O
,	,	punct	O
indicative	JJ	acomp	O
of	IN	case	O
a	DT	det	O
more	RBR	advmod	O
mature	JJ	amod	O
pericyte	NN	compound	B-Cell
phenotype	NN	nmod	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
pre	JJ	advmod	O
-	HYPH	punct	O
malignant	JJ	amod	O
tumor	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
tumor	NN	compound	O
angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
enhanced	VBN	conj	O
in	IN	case	O
TSP	NN	nmod:npmod	O
-	:	punct	O
2	CD	intj	O
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Collectively	RB	advmod	O
,	,	punct	O
the	DT	det	O
experiments	NNS	nsubj	O
define	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
during	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
and	CC	cc	O
establish	VB	conj	O
a	DT	det	O
better	JJR	amod	O
rationale	NN	dobj	O
for	IN	case	O
combination	NN	compound	O
therapies	NNS	nmod	O
involving	VBG	acl	O
Ang	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
manipulatory	JJ	amod	O
therapies	NNS	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
tumor	NN	compound	O
lymphangiogenesis	NN	nmod	O
during	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Liposomal	JJ	amod	B-Cellular_component
honokiol	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
VEGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
D	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
lymphangiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
xenograft	NN	amod	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
RPE	NN	compound	O
tumor	NN	compound	O
cells	NNS	nsubj	O
metastasize	VBP	ccomp	O
to	TO	case	O
lymph	NN	compound	O
node	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O
Lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	compound	I-Multi-tissue_structure
metastasis	NN	nsubj	O
of	IN	case	O
tumor	NN	nmod	B-Cancer
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
crucial	JJ	amod	O
early	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
,	,	punct	O
induced	VBD	amod	O
overexpression	NN	ROOT	O
of	IN	case	O
VEGF	NN	compound	O
-	HYPH	punct	O
C	NN	nmod	O
in	IN	case	O
LAPC	NN	compound	O
-	HYPH	punct	O
9	CD	nummod	O
enhanced	VBN	amod	O
tumor	NN	compound	O
lymphangiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O
Induction	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	nmod	O
by	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
D	NN	nmod	I-Gene_or_gene_product
may	MD	aux	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
promoting	VBG	advcl	O
tumor	NN	compound	B-Cancer
metastasis	NN	dobj	O
to	TO	case	O
regional	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
these	DT	det	O
processes	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
inactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
VEGFR	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Antiangiogenesis	NN	compound	O
therapy	NN	nsubj	O
might	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
regional	JJ	amod	O
metastasis	NN	dobj	O
.	.	punct	O
Honokiol	NNP	nsubjpass	B-Simple_chemical
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
possess	VB	xcomp	O
potent	JJ	amod	O
antiangiogenesis	NN	dobj	O
and	CC	cc	O
antitumor	NN	compound	B-Cancer
properties	NNS	conj	O
in	IN	case	O
several	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
xenograft	NN	amod	B-Cancer
tumor	NN	compound	I-Cancer
models	NNS	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
tumor	NN	compound	O
lymphangiogenesis	NN	nmod	O
during	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
lymphangiogenesis	NN	nmod	O
and	CC	cc	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	conj	O
remains	VBZ	ROOT	O
unclear	JJ	xcomp	O
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
-	:	punct	O
C	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	appos	O
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymphangiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
established	VBD	ROOT	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	compound	O
models	NNS	dobj	O
by	IN	mark	O
injecting	VBG	advcl	O
overexpressing	VBG	xcomp	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
D	NNP	compound	I-Gene_or_gene_product
Lewis	NN	compound	B-Cell
lung	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
into	IN	case	O
C57BL	NN	nmod	B-Organism
/	SYM	punct	I-Organism
6	CD	nummod	I-Organism
mice	NNS	dep	I-Organism
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
honokiol	NN	nmod	B-Simple_chemical
on	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
lymphangiogenesis	NN	nmod	O
and	CC	cc	O
related	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
metastatic	JJ	amod	O
ability	NN	nsubjpass	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
remarkably	RB	advmod	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumor	NN	compound	O
growth	NN	nmod	O
(	-LRB-	punct	O
subcutaneous	JJ	amod	O
tumor	NN	compound	O
formation	NN	dep	O
in	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
)	-RRB-	punct	O
accompanied	VBN	acl	O
by	IN	case	O
increased	VBN	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
gene	NN	compound	O
amplification	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
-	HYPH	punct	O
derived	VBN	amod	O
K	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
oncogene	NN	nmod	O
,	,	punct	O
while	IN	mark	O
it	PRP	nsubj	O
declined	VBD	advcl	O
gradually	RB	advmod	O
as	IN	mark	O
the	DT	det	O
passage	NN	compound	O
number	NN	nsubj	O
increased	VBD	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
with	IN	case	O
corresponding	JJ	amod	O
decreases	NNS	nmod	O
of	IN	case	O
gene	NN	compound	O
amplification	NN	nmod	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
.	.	punct	O
The	DT	det	O
underlying	JJ	amod	O
mechanisms	NNS	nsubjpass	O
were	VBD	auxpass	O
systematically	RB	advmod	O
investigated	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
tumor	NN	compound	O
lymphangiogenesis	NN	nmod	O
during	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
In	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
study	NN	nmod	O
,	,	punct	O
liposomal	JJ	amod	B-Cellular_component
honokiol	NN	nsubj	B-Simple_chemical
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
associated	VBN	amod	O
lymphangiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
Lewis	NN	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
model	NN	nmod	O
.	.	punct	O

RNA	NN	compound	O
interference	NN	nsubj	O
targeting	VBG	acl	O
Met	VBN	dobj	O
in	IN	case	O
these	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
A	DT	det	O
remarkable	JJ	amod	O
delay	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
prolonged	JJ	amod	O
life	NN	compound	O
span	NN	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
In	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
study	NN	nmod	O
,	,	punct	O
honokiol	NN	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
D	NNP	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
survival	NN	dobj	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
tube	NN	compound	B-Tissue
-	HYPH	punct	I-Tissue
formation	NN	conj	O
of	IN	case	O
both	CC	cc:preconj	O
human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HUVECs	NNS	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
lymphatic	JJ	amod	B-Cell
vascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
HLECs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
ethanol	NN	compound	O
exposure	NN	nsubj	O
decreased	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
VEGF	NN	compound	O
receptor	NN	nmod	O
-	:	punct	O
2	CD	nummod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
VEGF	NN	compound	O
receptor	NN	compound	O
-	:	punct	O
2	CD	nummod	O
phosphorylation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
Western	NN	compound	O
blotting	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
liposomal	JJ	amod	B-Cellular_component
honokiol	NN	nsubj	B-Simple_chemical
-	HYPH	punct	O
inhibited	VBD	ccomp	O
Akt	NNP	compound	B-Gene_or_gene_product
and	CC	cc	O
MAPK	NN	conj	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
in	IN	case	O
2	CD	nummod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
downregulated	VBD	conj	O
expressions	NNS	dobj	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
of	IN	case	O
human	JJ	amod	B-Organism
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
of	IN	case	O
lymphatic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
,	,	punct	O
induced	VBD	amod	O
overexpression	NN	ROOT	O
of	IN	case	O
VEGF	NN	compound	O
-	HYPH	punct	O
C	NN	nmod	O
in	IN	case	O
LAPC	NN	compound	O
-	HYPH	punct	O
9	CD	nummod	O
enhanced	VBN	amod	O
tumor	NN	compound	O
lymphangiogenesis	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
honokiol	NN	nsubj	B-Simple_chemical
provided	VBD	acl:relcl	O
therapeutic	JJ	amod	O
benefit	NN	dobj	O
not	RB	neg	O
only	RB	cc:preconj	O
by	IN	case	O
direct	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
antiangiogenesis	NN	conj	O
but	CC	cc	O
also	RB	advmod	O
by	IN	mark	O
inhibiting	VBG	conj	O
lymphangiogenesis	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
via	IN	case	O
the	DT	det	O
VEGFR	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
lymphatics	NNS	nmod	O
.	.	punct	O
The	DT	det	O
present	JJ	amod	O
findings	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
importance	NN	ROOT	O
to	TO	mark	O
investigate	VB	acl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
the	DT	det	O
spread	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
via	IN	case	O
the	DT	det	O
lymphatics	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
explore	VB	conj	O
the	DT	det	O
therapeutical	JJ	amod	O
strategy	NN	dobj	O
of	IN	case	O
honokiol	NN	nmod	B-Simple_chemical
on	IN	case	O
antilymphangiogenesis	NN	nmod	O
and	CC	cc	O
antimetastasis	NN	conj	O
.	.	punct	O

Proliferative	JJ	amod	O
diabetic	JJ	amod	O
retinopathy	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
ocular	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
agent	NN	compound	O
pigment	NN	compound	O
epithelium	NN	compound	O
-	HYPH	punct	O
derived	VBN	amod	O
factor	NN	nmod	O
(	-LRB-	punct	O
PEDF	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
aqueous	JJ	amod	O
humor	NN	nmod	O
.	.	punct	O
Short	JJ	amod	B-Gene_or_gene_product
pigment	NN	amod	I-Gene_or_gene_product
epithelial	NN	amod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
peptide	NN	nsubj	I-Gene_or_gene_product
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
.	.	punct	O

Angiogenic	JJ	compound	O
activity	NN	nsubj	O
in	IN	case	O
samples	NNS	nmod	O
of	IN	case	O
patients	NNS	nmod	O
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
was	VBD	cop	O
generally	RB	advmod	O
inhibitory	JJ	ROOT	O
due	JJ	case	O
to	TO	case	O
PEDF	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
PURPOSE	NN	ROOT	O
:	:	punct	O
Pigment	NN	amod	B-Gene_or_gene_product
epithelial	NN	amod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
PEDF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	dep	O
with	IN	case	O
multiple	JJ	amod	O
other	JJ	amod	O
functions	NNS	nmod	O
,	,	punct	O
some	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
enhance	VBP	dep	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
previous	JJ	amod	O
studies	NNS	nsubj	O
mapped	VBD	ROOT	O
PEDF	NN	nmod:npmod	B-Gene_or_gene_product
antiangiogenic	JJ	xcomp	O
and	CC	cc	O
prosurvival	NN	conj	O
activities	NNS	dep	O
to	TO	case	O
distinct	JJ	amod	O
epitopes	NNS	nmod	O
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
in	IN	case	O
diabetics	NNS	nmod	O
without	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
aimed	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
minimal	JJ	amod	O
fragment	NN	dobj	O
of	IN	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
maintains	VBZ	acl:relcl	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumor	JJ	conj	B-Cancer
efficacy	NN	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
impact	NN	dobj	O
of	IN	case	O
thalidomide	NN	nmod	O
and	CC	cc	O
angiostatin	NN	conj	O
on	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
analyzed	VBD	ROOT	O
antigenicity	NN	dobj	O
,	,	punct	O
hydrophilicity	NN	conj	O
,	,	punct	O
and	CC	cc	O
charge	VB	conj	O
distribution	NN	dobj	O
of	IN	case	O
the	DT	det	O
angioinhibitory	JJ	amod	O
epitope	NN	nmod	O
(	-LRB-	punct	O
the	DT	det	O
34	CD	nummod	O
-	HYPH	punct	O
mer	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
designed	VBN	conj	O
three	CD	nummod	O
peptides	NNS	dobj	O
covering	VBG	acl	O
its	PRP$	nmod:poss	O
COOH	NN	compound	O
terminus	NN	dobj	O
,	,	punct	O
P14	NN	appos	B-Gene_or_gene_product
,	,	punct	O
P18	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
P23	NN	conj	B-Gene_or_gene_product
.	.	punct	O

This	DT	nsubj	O
usually	RB	advmod	O
involves	VBZ	ROOT	O
screening	NN	dobj	O
of	IN	case	O
potential	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
compounds	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
analyzed	VBD	ROOT	O
their	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	mark	O
block	VB	acl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
chemotaxis	NN	dobj	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
antiangiogenic	JJ	amod	O
activity	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
integrin	NN	compound	O
alpha5beta1	NN	compound	O
antagonistic	JJ	amod	O
peptide	NN	ROOT	O
,	,	punct	O
A5	NN	compound	O
-	:	punct	O
1	CD	appos	O
,	,	punct	O
screened	VBN	acl	O
by	IN	case	O
Protein	NN	compound	O
Chip	NN	compound	O
system	NN	nmod	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O
The	DT	det	O
selected	VBN	amod	O
peptide	NN	nsubjpass	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
antitumor	NN	compound	B-Cancer
activity	NN	nmod	O
against	IN	case	O
mildly	RB	advmod	O
aggressive	JJ	amod	O
xenografted	JJ	amod	O
prostate	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
highly	RB	advmod	O
aggressive	JJ	amod	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
.	.	punct	O

Angiogenic	JJ	compound	O
activity	NN	nsubj	O
in	IN	case	O
samples	NNS	nmod	O
of	IN	case	O
patients	NNS	nmod	O
from	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
was	VBD	cop	O
generally	RB	advmod	O
inhibitory	JJ	ROOT	O
due	JJ	case	O
to	TO	case	O
PEDF	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
to	TO	case	O
PEDF	NN	nmod	O
.	.	punct	O
To	TO	mark	O
verify	VB	advcl	O
that	IN	mark	O
P18	NN	nsubj	B-Gene_or_gene_product
acts	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
manner	NN	nmod	O
as	IN	case	O
PEDF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
immunohistochemistry	NN	dobj	O
to	TO	mark	O
measure	VB	xcomp	O
PEDF	NN	compound	B-Gene_or_gene_product
targets	NNS	dobj	I-Gene_or_gene_product
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	appos	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
CD95	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	I-Gene_or_gene_product
expression	NN	conj	O
in	IN	case	O
P18	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
treated	VBN	amod	O
vasculature	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
study	VB	dep	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
(	-LRB-	punct	O
SREBP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
critical	JJ	amod	O
role	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
P14	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
P18	NN	conj	B-Gene_or_gene_product
blocked	VBD	appos	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
chemotaxis	NN	dobj	O
;	:	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
P23	NN	conj	B-Gene_or_gene_product
induced	VBD	parataxis	O
apoptosis	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
functional	JJ	amod	O
collaboration	NN	nsubj	O
exists	VBZ	ccomp	O
between	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
Men1	NN	conj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
Men1	NN	nsubj	O
may	MD	aux	O
regulate	VB	ccomp	O
additional	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
p27	NN	conj	O
differently	RB	advmod	O
.	.	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
showed	VBD	ROOT	O
the	DT	det	O
highest	JJS	amod	O
IC50	NN	dobj	O
and	CC	cc	O
blocked	VBD	conj	O
angiogenesis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
:	:	punct	O
P23	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
inactive	JJ	parataxis	O
and	CC	cc	O
P14	NN	conj	B-Gene_or_gene_product
was	VBD	cop	O
proangiogenic	JJ	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
functional	JJ	amod	O
collaboration	NN	nsubj	O
exists	VBZ	ccomp	O
between	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
Men1	NN	conj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
Men1	NN	nsubj	O
may	MD	aux	O
regulate	VB	ccomp	O
additional	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
p27	NN	conj	O
differently	RB	advmod	O
.	.	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
increased	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
CD95	NN	compound	B-Gene_or_gene_product
ligand	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
reduced	VBD	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
functional	JJ	amod	O
collaboration	NN	nsubj	O
exists	VBZ	ccomp	O
between	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
Men1	NN	conj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
Men1	NN	nsubj	O
may	MD	aux	O
regulate	VB	ccomp	O
additional	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
p18	NN	nmod	O
and	CC	cc	O
p27	NN	conj	O
differently	RB	advmod	O
.	.	punct	O
In	IN	case	O
tumor	NN	compound	B-Cancer
studies	NNS	nmod	O
,	,	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	ROOT	O
in	IN	mark	O
blocking	VBG	advcl	O
the	DT	det	O
angiogenesis	NN	dobj	O
and	CC	cc	O
growth	NN	conj	O
of	IN	case	O
the	DT	det	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
than	IN	case	O
parental	JJ	amod	B-Gene_or_gene_product
34	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
mer	NN	nmod	I-Gene_or_gene_product
;	:	punct	O
in	IN	case	O
the	DT	det	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
strongly	RB	advmod	O
decreased	VBD	parataxis	O
angiogenesis	NN	dobj	O
and	CC	cc	O
halted	VBD	conj	O
the	DT	det	O
progression	NN	dobj	O
of	IN	case	O
established	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Both	DT	det	O
agents	NNS	nsubj	O
inhibited	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
induced	VBD	amod	O
apoptosis	NN	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
tumors	NNS	nmod	O
from	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
P18	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
potent	JJ	conj	O
antiangiogenic	JJ	amod	O
biotherapeutic	JJ	amod	O
agent	NN	appos	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
potential	JJ	dobj	O
to	TO	mark	O
be	VB	auxpass	O
developed	VBN	acl	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
prostate	NN	nmod	B-Cancer
and	CC	cc	O
renal	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

Promoting	VBG	ROOT	O
angiogenesis	NN	dobj	O
via	IN	case	O
manipulation	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	O
responsiveness	NN	nmod	O
with	IN	case	O
notch	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O
Distinct	JJ	amod	O
role	NN	ROOT	O
of	IN	case	O
PLCbeta3	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
directional	JJ	amod	O
migration	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
sprouting	NN	conj	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
defines	VBZ	ROOT	O
the	DT	det	O
many	JJ	amod	O
steps	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	nmod:npmod	O
-	,	punct	O
derived	VBN	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nsubj	O
and	CC	cc	O
migration	NN	conj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
to	TO	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
mitogen	NN	ROOT	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
exclusively	RB	advmod	O
on	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Typically	RB	advmod	O
,	,	punct	O
proliferation	NN	nsubjpass	O
and	CC	cc	O
chemotaxis	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
is	VBZ	auxpass	O
driven	VBN	ROOT	O
by	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
mitogen	NN	ROOT	O
that	WDT	nsubj	O
acts	VBZ	acl:relcl	O
exclusively	RB	advmod	O
on	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product
activates	VBZ	ROOT	O
phospholipases	NNS	dobj	B-Gene_or_gene_product
(	-LRB-	punct	O
PLCs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
specifically	RB	advmod	O
PLCgamma1	NN	dep	B-Gene_or_gene_product
-	:	punct	O
that	WDT	nsubj	O
are	VBP	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
tubulogenesis	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	conj	O
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
receptor	NN	nsubj	O
,	,	punct	O
VEGFR	NN	compound	O
-	:	punct	O
2	CD	nummod	O
/	:	punct	O
KDR	NN	appos	O
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
VEGF	NNP	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product
,	,	punct	O
specifically	RB	advmod	O
through	IN	case	O
VEGFR2	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
induces	VBZ	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
serine	NN	compound	O
residues	NNS	nmod	O
on	IN	case	O
PLCbeta3	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
confirmed	VBN	conj	O
in	IN	case	O
an	DT	det	O
ex	FW	amod	O
vivo	FW	dep	O
embryoid	JJ	amod	B-Developing_anatomical_structure
body	NN	compound	I-Developing_anatomical_structure
model	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
direct	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
key	JJ	amod	O
enzymes	NNS	nmod	O
to	TO	case	O
glycogen	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
pentose	NN	compound	O
phosphate	NN	compound	O
pathways	NNS	conj	O
reduced	VBD	ccomp	O
HUVEC	NN	compound	O
viability	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O
Knockdown	NN	nsubj	O
of	IN	case	O
PLCbeta3	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
HUVEC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
affects	VBZ	ROOT	O
IP3	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
,	,	punct	O
actin	NN	compound	B-Gene_or_gene_product
reorganization	NN	conj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
proliferation	NN	conj	O
;	:	punct	O
whereas	IN	dep	O
migration	NN	nsubjpass	O
is	VBZ	auxpass	O
inhibited	VBN	parataxis	O
,	,	punct	O
proliferation	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	parataxis	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	O
arrests	NNS	ccomp	O
monomeric	JJ	amod	O
collagen	NN	npadvmod	O
-	HYPH	punct	O
supported	VBN	dep	O
smooth	JJ	amod	O
muscle	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
G1	NN	compound	O
-	HYPH	punct	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
an	DT	det	O
effect	NN	nmod	O
on	IN	case	O
cell	NN	compound	O
shape	NN	nmod	O
or	CC	cc	O
on	IN	case	O
levels	NNS	conj	O
of	IN	case	O
cyclin	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
kinase	NN	compound	O
inhibitors	NNS	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
enhanced	VBN	amod	O
proliferation	NN	nsubjpass	O
is	VBZ	auxpass	O
precipitated	VBN	ccomp	O
by	IN	case	O
an	DT	det	O
accelerated	VBN	amod	O
cell	NN	compound	B-Cell
cycle	NN	nmod	O
,	,	punct	O
and	CC	cc	O
decreased	VBD	conj	O
migration	NN	dobj	O
by	IN	case	O
an	DT	det	O
inability	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
CDC42	NN	dobj	B-Gene_or_gene_product
.	.	punct	O

Physiological	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
various	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
signaling	NN	nmod	O
through	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
receptors	NNS	nmod	O
.	.	punct	O
Given	VBN	mark	O
that	IN	mark	O
PLCbeta3	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
typically	RB	advmod	O
known	VBN	advcl	O
as	IN	case	O
an	DT	det	O
effector	NN	nmod	O
of	IN	case	O
heterotrimeric	JJ	amod	B-Gene_or_gene_product
G	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
unique	JJ	amod	O
crosstalk	NN	dobj	O
between	IN	case	O
the	DT	dep	O
G	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
protein	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	compound	O
(	-LRB-	punct	O
RTK	NN	appos	O
)	-RRB-	punct	O
axes	NNS	conj	O
and	CC	cc	O
reveal	VBP	conj	O
a	DT	det	O
novel	JJ	amod	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
and	CC	cc	O
,	,	punct	O
thus	RB	advmod	O
,	,	punct	O
angiogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
selected	VBN	amod	O
novel	JJ	amod	O
classes	NNS	nsubjpass	O
of	IN	case	O
antivascular	JJ	amod	O
therapies	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
targeting	VBG	acl	O
tumor	NN	compound	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
and	CC	cc	O
other	JJ	amod	O
components	NNS	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
vasculature	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O
Antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	ROOT	O
of	IN	case	O
microtubule	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
binding	VBG	compound	I-Simple_chemical
drugs	NNS	nmod	I-Simple_chemical
.	.	punct	O

Different	JJ	amod	O
antiangiogenic	JJ	amod	O
therapeutics	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
improve	VB	xcomp	O
tumor	NN	compound	O
control	NN	dobj	O
through	IN	case	O
vascular	JJ	amod	O
-	HYPH	punct	O
targeting	VBG	dep	O
agents	NNS	nmod	O
(	-LRB-	punct	O
VTA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Microtubule	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
binding	VBG	compound	I-Simple_chemical
drugs	NNS	nsubjpass	I-Simple_chemical
(	-LRB-	punct	O
MBD	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
are	VBP	auxpass	O
widely	RB	advmod	O
used	VBN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cancer
chemotherapy	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
have	VBP	conj	O
clinically	RB	advmod	O
relevant	JJ	amod	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
vascular	JJ	conj	B-Multi-tissue_structure
-	HYPH	punct	O
disrupting	VBG	compound	O
properties	NNS	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
selected	VBN	amod	O
novel	JJ	amod	O
classes	NNS	nsubjpass	O
of	IN	case	O
antivascular	JJ	amod	O
therapies	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
targeting	VBG	acl	O
tumor	NN	compound	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
and	CC	cc	O
other	JJ	amod	O
components	NNS	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
vasculature	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O
These	DT	det	O
antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	nsubj	O
are	VBP	cop	O
due	JJ	ROOT	O
in	IN	case	O
part	NN	nmod	O
to	TO	case	O
direct	VB	amod	O
effects	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
all	DT	det	O
MBDs	NNS	nsubj	B-Simple_chemical
(	-LRB-	punct	O
both	CC	cc:preconj	O
microtubule	JJ	compound	B-Cellular_component
-	HYPH	punct	O
stabilizing	NN	nsubj	O
and	CC	cc	O
microtubule	JJ	compound	B-Cellular_component
-	HYPH	punct	O
destabilizing	VBG	conj	O
)	-RRB-	punct	O
inhibit	VBP	conj	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
actions	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
correspond	VB	xcomp	O
to	TO	case	O
therapeutic	JJ	amod	O
antiangiogenic	JJ	amod	O
actions	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
SMI496	NN	nsubj	O
caused	VBD	ROOT	O
cell	NN	compound	O
retraction	NN	dobj	O
and	CC	cc	O
cytoskeletal	JJ	amod	O
collapse	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
delayed	VBN	amod	O
endothelial	JJ	amod	O
cell	NN	compound	O
wound	NN	compound	O
healing	NN	conj	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
microtubule	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
destabilizing	VBG	amod	I-Simple_chemical
agents	NNS	nsubj	I-Simple_chemical
cause	VBP	ROOT	O
prominent	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
morphology	NN	nmod	O
,	,	punct	O
an	DT	det	O
action	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
rapid	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
collapse	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
SMI496	NN	nsubj	O
caused	VBD	ROOT	O
cell	NN	compound	O
retraction	NN	dobj	O
and	CC	cc	O
cytoskeletal	JJ	amod	O
collapse	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
delayed	VBN	amod	O
endothelial	JJ	amod	O
cell	NN	compound	O
wound	NN	compound	O
healing	NN	conj	O
.	.	punct	O
The	DT	det	O
effects	NNS	nsubj	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
occur	VBP	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
at	IN	case	O
low	JJ	amod	O
drug	NN	compound	O
concentrations	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
do	VBP	aux	O
not	RB	neg	O
affect	VB	acl:relcl	O
microtubule	JJ	compound	B-Cellular_component
gross	JJ	amod	O
morphology	NN	dobj	O
,	,	punct	O
do	VBP	aux	O
not	RB	neg	O
cause	VB	conj	O
microtubule	JJ	compound	B-Cellular_component
bundling	NN	dobj	O
or	CC	cc	O
microtubule	JJ	compound	B-Cellular_component
loss	NN	conj	O
and	CC	cc	O
do	VBP	aux	O
not	RB	neg	O
induce	VB	conj	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
or	CC	cc	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

This	DT	det	O
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
most	RBS	advmod	O
likely	RB	advmod	O
based	VBN	ROOT	O
on	IN	case	O
decreased	VBN	amod	O
focal	JJ	amod	O
contact	NN	compound	O
turnover	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
p130Cas	NN	nmod	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
player	NN	appos	O
in	IN	case	O
directed	VBN	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
Rather	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
,	,	punct	O
at	IN	case	O
low	JJ	amod	O
concentrations	NNS	nmod	O
,	,	punct	O
MBDs	NNS	nsubj	B-Simple_chemical
produce	VBP	ccomp	O
more	RBR	amod	O
subtle	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
microtubule	JJ	compound	B-Cellular_component
dynamics	NNS	nmod	O
,	,	punct	O
block	VBP	conj	O
critical	JJ	amod	O
cell	NN	compound	B-Cell
signaling	NN	compound	O
pathways	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
prevent	VB	conj	O
the	DT	det	O
microtubules	NNS	dobj	B-Cellular_component
from	IN	mark	O
properly	RB	advmod	O
interacting	VBG	advcl	O
with	IN	case	O
transient	JJ	amod	O
subcellular	JJ	amod	B-Cellular_component
assemblies	NNS	nmod	I-Cellular_component
(	-LRB-	punct	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	dep	I-Cellular_component
and	CC	cc	O
adherens	NNS	conj	B-Cellular_component
junctions	NNS	dep	I-Cellular_component
)	-RRB-	punct	O
whose	WP$	nmod:poss	O
subsequent	JJ	amod	O
stabilization	NN	nsubjpass	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
maturation	NN	conj	O
are	VBP	auxpass	O
required	VBN	conj	O
for	IN	case	O
cell	NN	compound	B-Cell
motility	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
interactions	NNS	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
selected	VBN	amod	O
novel	JJ	amod	O
classes	NNS	nsubjpass	O
of	IN	case	O
antivascular	JJ	amod	O
therapies	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
those	DT	nmod	O
targeting	VBG	acl	O
tumor	NN	compound	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
and	CC	cc	O
other	JJ	amod	O
components	NNS	conj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	O
vasculature	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
summarized	VBN	ROOT	O
.	.	punct	O
This	DT	det	O
review	NN	nsubj	O
will	MD	aux	O
focus	VB	ROOT	O
on	IN	case	O
recent	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
define	VB	acl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
for	IN	case	O
the	DT	det	O
antivascular	JJ	amod	B-Multi-tissue_structure
actions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
MBDs	NNS	nmod	B-Simple_chemical
,	,	punct	O
information	NN	dobj	O
that	WDT	nsubj	O
could	MD	aux	O
be	VB	cop	O
useful	JJ	acl:relcl	O
in	IN	case	O
the	DT	dep	O
identification	NN	nmod	O
or	CC	cc	O
design	NN	conj	O
of	IN	case	O
agents	NNS	nmod	O
whose	WP$	nmod:poss	O
actions	NNS	nsubj	O
more	RBR	advmod	O
selectively	RB	advmod	O
target	VBP	acl:relcl	O
the	DT	det	O
tumor	NN	compound	B-Multi-tissue_structure
vasculature	NN	dobj	I-Multi-tissue_structure
.	.	punct	O

Promoting	VBG	ROOT	O
angiogenesis	NN	dobj	O
via	IN	case	O
manipulation	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	O
responsiveness	NN	nmod	O
with	IN	case	O
notch	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O
Neurovascular	JJ	amod	B-Multi-tissue_structure
effects	NNS	ROOT	O
of	IN	case	O
CD47	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
:	:	punct	O
promotion	NN	dep	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
,	,	punct	O
inflammation	NN	conj	O
,	,	punct	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
brain	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Due	JJ	case	O
to	TO	aux	O
space	NN	advcl	O
limitations	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
can	MD	aux	O
not	RB	neg	O
review	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
CNS	NN	compound	O
angiogenesis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
refer	VBP	conj	O
the	DT	det	O
reader	NN	dobj	O
to	IN	prep	O
other	JJ	amod	O
chapters	NNS	pobj	O
in	IN	prep	O
this	DT	det	O
book	NN	pobj	O
and	CC	cc	O
to	TO	conj	O
recent	JJ	amod	O
publications	NNS	pobj	O
on	IN	prep	O
the	DT	det	O
assembly	NN	pobj	O
of	IN	prep	O
the	DT	det	O
vasculature	NN	pobj	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
concept	NN	nsubj	O
of	IN	case	O
the	DT	det	O
neurovascular	JJ	amod	B-Multi-tissue_structure
unit	NN	nmod	O
emphasizes	VBZ	ROOT	O
that	IN	mark	O
common	JJ	amod	O
signals	NNS	nsubj	O
and	CC	cc	O
substrates	NNS	conj	O
underlie	VBP	ccomp	O
the	DT	det	O
physiology	NN	dobj	O
and	CC	cc	O
pathophysiology	NN	conj	O
of	IN	case	O
neuronal	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
endothelial	JJ	conj	B-Multi-tissue_structure
compartments	NNS	nmod	I-Multi-tissue_structure
in	IN	case	O
brain	NN	nmod	B-Organ
.	.	punct	O

LRP	NN	compound	O
-	:	punct	O
1	CD	nsubjpass	O
also	RB	advmod	O
is	VBZ	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
integrin	NN	compound	O
maturation	NN	nmod	O
.	.	punct	O
Recent	JJ	amod	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
integrin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
associated	VBN	amod	O
protein	NN	nmod	O
CD47	NN	dep	B-Gene_or_gene_product
promotes	VBZ	ccomp	O
neuronal	JJ	amod	B-Cell
cell	NN	compound	I-Cell
death	NN	dobj	O
.	.	punct	O

Unusual	JJ	advmod	O
in	IN	case	O
healthy	JJ	amod	O
individuals	NNS	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
presence	NN	nsubj	O
in	IN	case	O
elevated	JJ	amod	O
numbers	NNS	nmod	O
often	RB	advmod	O
indicates	VBZ	ROOT	O
substantial	JJ	amod	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
perturbation	NN	dobj	O
.	.	punct	O
Is	VBZ	ROOT	O
it	PRP	nsubj	O
possible	JJ	acomp	O
that	IN	mark	O
CD47	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
also	RB	advmod	O
negatively	RB	advmod	O
affect	VB	ccomp	O
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	dobj	I-Cell
?	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Exposure	NN	nsubj	O
of	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
primary	JJ	amod	O
mouse	NN	compound	B-Organism
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
the	DT	det	O
CD47	NN	compound	B-Gene_or_gene_product
ligand	NN	compound	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
induced	VBD	ROOT	O
an	DT	det	O
increasing	VBG	amod	O
amount	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
cytotoxicity	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	parataxis	O
in	IN	case	O
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
derived	VBN	acl	O
from	IN	case	O
CD47	NN	compound	B-Gene_or_gene_product
knockout	JJ	compound	O
mice	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	nmod	O
(	-LRB-	punct	O
PKC	NN	appos	O
)	-RRB-	punct	O
induces	VBZ	ROOT	O
phenotypic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
morphology	NN	nmod	O
of	IN	case	O
microvascular	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
that	WDT	nsubj	O
affect	VBP	acl:relcl	O
major	JJ	amod	O
functions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
microvasculature	NN	nmod	O
.	.	punct	O
The	DT	det	O
specific	JJ	amod	O
CD47	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
activating	VBG	amod	O
peptide	NN	nsubj	O
,	,	punct	O
4N1K	NN	appos	B-Gene_or_gene_product
,	,	punct	O
similarly	RB	advmod	O
induced	VBD	ROOT	O
cell	NN	compound	B-Cell
death	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
brain	NN	compound	B-Cell
microvascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Promotion	NN	nsubjpass	O
of	IN	case	O
inflammation	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
involved	VBN	ROOT	O
because	IN	mark	O
lower	JJR	amod	O
TSP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
able	JJ	advcl	O
to	TO	nmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulate	VB	advcl	O
the	DT	det	O
adhesion	NN	compound	O
molecules	NNS	dobj	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	dep	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
cell	NN	compound	I-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Tumor	NN	compound	O
angiogenesis	NN	nsubj	O
modulates	VBZ	ROOT	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
endothelial	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
CD47	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
may	MD	aux	O
suppress	VB	ROOT	O
angiogenesis	NN	dobj	O
because	IN	mark	O
4N1K	NN	nsubj	B-Gene_or_gene_product
significantly	RB	advmod	O
inhibited	VBD	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
this	DT	det	O
possibility	NN	dobj	O
with	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	nmod	O
using	VBG	acl	O
human	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	dobj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
a	DT	det	O
rodent	JJ	amod	O
hindlimb	JJ	compound	O
ischemia	NN	compound	O
model	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
CD47	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
can	MD	aux	O
negatively	RB	advmod	O
affect	VB	ccomp	O
the	DT	det	O
viability	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
further	RB	advmod	O
supporting	VBG	advcl	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
CD47	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
potential	JJ	amod	O
neurovascular	JJ	amod	B-Multi-tissue_structure
target	NN	ccomp	O
for	IN	case	O
stroke	NN	nmod	O
and	CC	cc	O
brain	NN	compound	B-Organ
injury	NN	conj	O
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Cisplatin	NN	nsubj	B-Simple_chemical
reduces	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
via	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
matrix	NN	compound	I-Gene_or_gene_product
metalloproteinase	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
study	VB	dep	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
(	-LRB-	punct	O
SREBP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
critical	JJ	amod	O
role	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
AIMS	NNS	dep	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cisplatin	NN	nmod	B-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
process	NN	appos	O
for	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
remodeling	NN	nmod	O
and	CC	cc	O
regeneration	NN	conj	O
in	IN	case	O
several	JJ	amod	O
physiological	JJ	amod	O
and	CC	cc	O
pathological	JJ	conj	O
situations	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
study	VB	dep	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
(	-LRB-	punct	O
SREBP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
critical	JJ	amod	O
role	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O
MATERIAL	NNP	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-Cell
umbilical	JJ	amod	I-Cell
vein	NN	compound	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
HUVEC	NN	appos	B-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
cisplatin	NN	nmod	B-Simple_chemical
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	conj	O
analyzed	VBN	acl	O
by	IN	case	O
fluorescence	NN	nmod	O
and	CC	cc	O
scratch	NN	conj	B-Pathological_formation
-	HYPH	punct	I-Pathological_formation
wound	NN	conj	I-Pathological_formation
migration	NN	compound	O
assay	NN	dep	O
.	.	punct	O

Mitogen	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
protein	NN	compound	O
kinase	NN	compound	O
(	-LRB-	punct	O
MAPK	NN	appos	O
)	-RRB-	punct	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
.	.	punct	O
MMP2	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
MMP9	NN	conj	B-Gene_or_gene_product
activity	NN	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
zymographic	NN	amod	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
MAPK	NN	compound	B-Gene_or_gene_product
activation	NN	conj	O
by	IN	case	O
Western	NN	compound	O
blotting	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	dep	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
(	-LRB-	punct	O
HUVEC	NN	appos	O
)	-RRB-	punct	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
TNF	NN	compound	O
alpha	NN	nmod	O
in	IN	case	O
chicken	NN	compound	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
(	-LRB-	punct	O
CAM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
cisplatin	NN	nsubj	B-Simple_chemical
provoked	VBD	ccomp	O
a	DT	det	O
time	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
decrease	NN	dobj	O
of	IN	case	O
HUVEC	NN	compound	B-Cell
migration	NN	nmod	O
;	:	punct	O
this	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
clearly	RB	advmod	O
independent	JJ	parataxis	O
from	IN	case	O
its	PRP$	nmod:poss	O
well	RB	advmod	O
known	JJ	amod	O
cytotoxic	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Hypoxia	NN	nsubj	O
rapidly	RB	advmod	O
induced	VBD	ROOT	O
both	CC	cc:preconj	O
JNK1	NN	compound	O
and	CC	cc	O
p38	NN	conj	O
activity	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
cisplatin	NN	nsubj	B-Simple_chemical
markedly	RB	advmod	O
reduced	VBD	ROOT	O
MMP2	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
conditioned	JJ	amod	O
media	NNS	nmod	O
and	CC	cc	O
cell	NN	compound	B-Organism_substance
lysates	NNS	conj	I-Organism_substance
,	,	punct	O
increased	VBN	amod	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
JNK	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	conj	O
,	,	punct	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
ERK	NN	compound	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
wound	NN	advcl	O
migration	NN	nsubjpass	O
and	CC	cc	O
single	JJ	amod	O
-	HYPH	punct	O
cell	NN	compound	O
motility	NN	conj	O
by	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
compromised	VBN	ROOT	O
.	.	punct	O
Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
was	VBD	auxpass	O
attenuated	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
GM6001	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
specific	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
MMPs	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
by	IN	case	O
a	DT	det	O
selective	JJ	amod	O
anti	NN	amod	O
-	HYPH	punct	O
MMP2	NN	compound	B-Gene_or_gene_product
antibody	NN	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
direct	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
key	JJ	amod	O
enzymes	NNS	nmod	O
to	TO	case	O
glycogen	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
pentose	NN	compound	O
phosphate	NN	compound	O
pathways	NNS	conj	O
reduced	VBD	ccomp	O
HUVEC	NN	compound	O
viability	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
treatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
SB202190	NN	nmod	B-Simple_chemical
or	CC	cc	O
SP600125	NN	conj	B-Simple_chemical
,	,	punct	O
inhibitors	NNS	appos	O
of	IN	case	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
JNK	NN	conj	B-Gene_or_gene_product
respectively	RB	advmod	O
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
HUVEC	NN	compound	B-Cell
migration	NN	dobj	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Angiostatin	NN	nsubj	O
inhibited	VBD	ROOT	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
by	IN	case	O
50	CD	compound	O
-	HYPH	punct	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggested	VBD	dep	O
that	IN	mark	O
cisplatin	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
a	DT	det	O
reduction	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
through	IN	case	O
an	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
MMP2	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
by	IN	case	O
downstream	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
independent	JJ	amod	O
of	IN	case	O
JNK	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p38	NN	compound	B-Gene_or_gene_product
MAPK	NN	compound	I-Gene_or_gene_product
activation	NN	conj	O
.	.	punct	O

Thrombin	NN	nsubj	O
decreases	VBZ	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
to	TO	mark	O
attach	VB	acl	O
to	TO	mark	O
basement	NN	xcomp	O
membrane	NN	compound	O
proteins	NNS	dobj	O
.	.	punct	O
The	DT	det	O
modulation	NN	ROOT	O
of	IN	case	O
platelet	NN	nmod	B-Cell
and	CC	cc	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	conj	O
to	TO	case	O
vascular	JJ	amod	B-Multi-tissue_structure
graft	NN	compound	I-Multi-tissue_structure
materials	NNS	nmod	O
by	IN	prep	O
perlecan	NN	pobj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Controlled	JJ	amod	O
neo	NN	compound	O
-	HYPH	punct	O
endothelialisation	NN	nsubj	O
is	VBZ	cop	O
critical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
patency	NN	nmod	O
of	IN	case	O
small	JJ	amod	O
diameter	NN	compound	O
vascular	JJ	amod	B-Multi-tissue_structure
grafts	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Thrombin	NN	nsubj	O
decreases	VBZ	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
to	TO	mark	O
attach	VB	acl	O
to	TO	mark	O
basement	NN	xcomp	O
membrane	NN	compound	O
proteins	NNS	dobj	O
.	.	punct	O
Endothelialisation	NN	nsubjpass	O
and	CC	cc	O
platelet	NN	compound	B-Cell
adhesion	NN	conj	O
to	TO	case	O
purified	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	,	punct	O
derived	VBN	amod	O
perlecan	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
heparan	NN	compound	B-Gene_or_gene_product
sulfate	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
HS	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
proteoglycan	JJ	appos	I-Gene_or_gene_product
in	IN	case	O
basement	NN	compound	B-Cellular_component
membranes	NNS	nmod	I-Cellular_component
,	,	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
using	VBG	xcomp	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vitro	FW	dep	O
assays	NNS	conj	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Expanded	VBN	amod	O
polytetrafluoroethylene	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
ePTFE	LS	appos	B-Simple_chemical
)	-RRB-	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
grafts	NNS	nsubjpass	I-Multi-tissue_structure
were	VBD	auxpass	O
coated	VBN	ROOT	O
with	IN	case	O
perlecan	JJ	nmod	B-Gene_or_gene_product
and	CC	cc	O
tested	VBN	conj	O
in	IN	case	O
an	DT	det	O
ovine	JJ	compound	B-Organism
carotid	NN	compound	B-Multi-tissue_structure
interposition	NN	compound	O
model	NN	nmod	O
for	IN	case	O
a	DT	det	O
period	NN	nmod	O
of	IN	case	O
6	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
assessed	VBN	conj	O
using	VBG	xcomp	O
light	NN	amod	O
and	CC	cc	O
scanning	NN	conj	O
microscopy	NN	dobj	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Enhanced	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
growth	NN	nsubjpass	O
and	CC	cc	O
reduced	VBD	amod	O
platelet	NN	compound	B-Cell
adhesion	NN	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
perlecan	JJ	nmod	B-Gene_or_gene_product
coated	JJ	acl	O
grafts	NNS	dep	B-Multi-tissue_structure
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
uncoated	JJ	amod	O
controls	NNS	nmod	O
implanted	VBN	acl	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
sheep	NN	nmod	B-Organism
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
5	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

So	RB	advmod	O
we	PRP	nsubj	O
established	VBD	ROOT	O
that	IN	mark	O
these	DT	det	O
pathways	NNS	nsubj	O
were	VBD	cop	O
crucial	JJ	ccomp	O
to	TO	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	nmod	O
under	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	compound	O
(	-LRB-	punct	O
FGF	NN	appos	O
)	-RRB-	punct	O
stimulation	NN	nmod	O
.	.	punct	O
Perlecan	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
over	IN	case	O
a	DT	det	O
period	NN	nmod	O
of	IN	case	O
6	CD	nummod	O
days	NNS	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
plasma	NN	compound	B-Organism_substance
proteins	NNS	nmod	O
and	CC	cc	O
fibroblastic	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
however	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
growth	NN	nmod	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
maintained	VBN	conj	O
during	IN	case	O
this	DT	det	O
period	NN	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
to	TO	case	O
activated	VBN	amod	O
platelet	NN	compound	O
membranes	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
soluble	JJ	amod	O
proteins	NNS	conj	O
contained	VBN	csubj	O
in	IN	case	O
activated	VBN	amod	O
platelet	NN	nmod	O
releasate	VBP	ROOT	O
both	CC	cc:preconj	O
contributed	VBD	xcomp	O
to	TO	case	O
the	DT	det	O
observed	VBN	amod	O
increase	NN	nmod	O
in	IN	case	O
invasion	NN	nmod	O
.	.	punct	O
Perlecan	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
anti	JJ	amod	O
-	HYPH	punct	O
adhesive	JJ	xcomp	O
for	IN	prep	O
platelets	NNS	pobj	B-Cell
,	,	punct	O
however	RB	advmod	O
after	IN	case	O
removal	NN	nmod	O
of	IN	case	O
the	DT	det	O
HS	NN	compound	O
chains	NNS	nmod	O
attached	VBN	acl	O
to	TO	case	O
perlecan	VB	nmod	B-Gene_or_gene_product
,	,	punct	O
platelet	NN	compound	B-Cell
adhesion	NN	nsubjpass	O
and	CC	cc	O
aggregation	NN	conj	O
were	VBD	auxpass	O
supported	VBN	advcl	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
SPARC	NN	nsubj	O
inhibits	VBZ	ccomp	O
human	JJ	amod	O
arterial	JJ	amod	O
smooth	NN	amod	O
muscle	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
stimulated	VBN	acl	O
by	IN	case	O
platelet	NN	compound	O
-	HYPH	punct	O
derived	VBN	amod	O
growth	NN	compound	O
factor	NN	nmod	O
or	CC	cc	O
by	IN	case	O
adhesion	NN	conj	O
to	TO	case	O
monomeric	JJ	amod	O
type	NN	compound	O
I	CD	nummod	O
collagen	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
HS	NN	compound	O
chains	NNS	nmod	O
of	IN	case	O
perlecan	NN	nmod	B-Gene_or_gene_product
in	IN	mark	O
improving	VBG	acl	O
graft	NN	compound	B-Multi-tissue_structure
patency	NN	dobj	O
by	IN	mark	O
selectively	RB	advmod	O
promoting	VBG	advcl	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
while	IN	mark	O
modulating	VBG	advcl	O
platelet	NN	compound	B-Cell
adhesion	NN	dobj	O
.	.	punct	O

The	DT	det	O
marked	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
glioblastomas	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
necessary	JJ	amod	O
part	NN	ccomp	O
of	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
brain	NN	compound	O
tumour	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
remain	VBP	parataxis	O
unresolved	JJ	xcomp	O
.	.	punct	O
Tumour	NN	compound	B-Cancer
angiogenesis	NN	ROOT	O
:	:	punct	O
its	PRP$	nmod:poss	O
mechanism	NN	dep	O
and	CC	cc	O
therapeutic	JJ	amod	O
implications	NNS	conj	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
marked	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
glioblastomas	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
necessary	JJ	amod	O
part	NN	ccomp	O
of	IN	case	O
malignant	JJ	amod	O
progression	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
brain	NN	compound	O
tumour	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
remain	VBP	parataxis	O
unresolved	JJ	xcomp	O
.	.	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
event	NN	attr	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
entirely	RB	advmod	O
supported	VBN	ROOT	O
by	IN	case	O
proliferated	VBN	amod	O
capillaries	NNS	nmod	O
and	CC	cc	O
arteries	NNS	conj	O
together	RB	advmod	O
with	IN	case	O
collagenous	JJ	amod	O
stroma	NN	nmod	O
.	.	punct	O
The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
proliferation	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
histological	JJ	amod	O
diagnosis	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	B-Cancer
multiforme	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Tumour	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
involves	VBZ	ROOT	O
multiple	JJ	amod	O
cellular	JJ	amod	B-Cell
processes	NNS	dobj	O
including	VBG	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
reorganisation	NN	conj	O
of	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
and	CC	cc	O
tube	NN	conj	B-Tissue
formation	NN	dep	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O
These	DT	det	O
processes	NNS	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
numerous	JJ	amod	O
pro	NN	compound	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
growth	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
to	TO	mark	O
interrupt	VB	xcomp	O
the	DT	det	O
angiogenic	JJ	amod	O
process	NN	dobj	O
at	IN	case	O
the	DT	det	O
growth	NN	compound	O
factor	NN	nmod	O
,	,	punct	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	conj	O
and	CC	cc	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
kinase	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O
Other	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
therapies	NNS	nsubj	O
alter	VBP	ROOT	O
the	DT	det	O
immune	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
endogeneous	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

Nonetheless	RB	advmod	O
,	,	punct	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
therapy	NN	nsubj	O
has	VBZ	aux	O
enhanced	VBN	ROOT	O
the	DT	det	O
arsenal	NN	dobj	O
of	IN	case	O
anticancer	NN	compound	O
therapies	NNS	nmod	O
and	CC	cc	O
has	VBZ	aux	O
provided	VBN	conj	O
new	JJ	amod	O
insights	NNS	dobj	O
into	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
malignancy	NN	nmod	O
.	.	punct	O
Most	JJS	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
therapies	NNS	nsubj	O
for	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
are	VBP	cop	O
in	IN	case	O
Phase	NN	compound	O
I	CD	nummod	O
/	SYM	punct	O
II	CD	nummod	O
trials	NNS	ROOT	O
and	CC	cc	O
only	RB	advmod	O
modest	JJ	amod	O
efficacies	NNS	nsubjpass	O
are	VBP	auxpass	O
reported	VBN	conj	O
for	IN	prep	O
monotherapies	NNS	pobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
The	DT	det	O
greatest	JJS	amod	O
potential	NN	nsubj	O
for	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
may	MD	aux	O
lie	VB	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
combine	VB	acl	O
safely	RB	advmod	O
with	IN	case	O
chemotherapy	NN	nmod	O
and	CC	cc	O
radiotherapy	NN	conj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
by	IN	case	O
thrombospondin	NN	nmod	O
-	SYM	punct	O
1	CD	nummod	O
.	.	punct	O
Regulation	NN	ROOT	O
of	IN	case	O
thrombospondin	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
by	IN	case	O
natural	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
progestins	NNS	nmod	B-Simple_chemical
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
the	DT	det	O
angiogenic	JJ	amod	O
property	NN	nsubjpass	O
of	IN	case	O
oral	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
VEGF	NN	nmod	O
and	CC	cc	O
the	DT	det	O
functional	JJ	amod	O
status	NN	conj	O
of	IN	case	O
p53	NN	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
recent	JJ	amod	O
studies	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
progestins	NNS	nsubj	B-Simple_chemical
induce	VBP	ccomp	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
express	VBP	acl:relcl	O
mutant	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
transforming	VBG	amod	O
growth	NN	compound	O
factor	NN	compound	O
beta	NN	nmod	O
(	-LRB-	punct	O
TGF	NN	compound	O
-	:	punct	O
beta	NN	appos	O
)	-RRB-	punct	O
by	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
natural	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
progestins	NNS	nsubj	B-Simple_chemical
also	RB	advmod	O
induce	VBP	ccomp	O
thrombospondin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
mRNA	NN	dep	O
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
T47	NN	compound	B-Cell
-	HYPH	punct	I-Cell
D	NN	nmod	I-Cell
and	CC	cc	O
BT	NNP	conj	B-Cell
-	HYPH	punct	I-Cell
474	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Antiprogestin	NN	compound	B-Simple_chemical
RU	NN	nsubj	I-Simple_chemical
-	:	punct	I-Simple_chemical
486	CD	nummod	I-Simple_chemical
inhibits	VBZ	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
TSP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
by	IN	case	O
progestins	NNS	nmod	B-Simple_chemical
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
this	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
progestin	NN	nmod	B-Simple_chemical
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
progesterone	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
PR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	O
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	O
and	CC	cc	O
Ras	NN	conj	O
.	.	punct	O
Actinomycin	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	nsubj	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
puromycin	NN	conj	B-Simple_chemical
,	,	punct	O
also	RB	advmod	O
blocks	VBZ	ROOT	O
progestin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
dependent	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
TSP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
TSP	NN	nmod	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	ROOT	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	xcomp	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
p53	NN	appos	O
,	,	punct	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	conj	O
by	IN	agent	O
oncogenes	NNS	pobj	O
such	JJ	amod	O
as	IN	prep	O
Myc	NNP	pobj	O
and	CC	cc	O
Ras	NN	conj	O
.	.	punct	O
A	DT	det	O
putative	JJ	amod	O
progestin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
response	NN	compound	O
element	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
promoter	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
consistent	JJ	acl:relcl	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
a	DT	det	O
progestin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
PR	NN	compound	B-Gene_or_gene_product
complex	NN	nsubj	O
might	MD	aux	O
directly	RB	advmod	O
regulate	VB	ccomp	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
cells	NNS	nmod	B-Cell
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Conditioned	JJ	amod	O
medium	NN	nsubj	O
from	IN	case	O
progestin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
stimulates	VBZ	ROOT	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
though	IN	mark	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
antibody	NN	nmod	B-Gene_or_gene_product
to	TO	case	I-Gene_or_gene_product
TSP	NN	nmod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
TSP	NN	nsubj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
secreted	VBN	acl	O
by	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
could	MD	aux	O
be	VB	cop	O
pro	NN	advmod	O
-	HYPH	punct	O
angiogenic	NN	ccomp	O
.	.	punct	O

TSP	NN	nsubj	O
-	:	punct	O
1	CD	nummod	O
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
apoptosis	NN	dobj	O
.	.	punct	O
Since	IN	mark	O
tumor	NN	nsubj	B-Cell
cell	NN	dep	I-Cell
-	:	punct	O
derived	VBN	amod	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
has	VBZ	advcl	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
promote	VB	acl	O
angiogenesis	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
microenvironment	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
potential	JJ	amod	O
target	NN	ROOT	O
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
therapy	NN	nmod	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
through	IN	case	O
LEF1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
HOXB9	NN	conj	B-Gene_or_gene_product
mediates	VBZ	ROOT	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	compound	I-Cancer
metastasis	NN	dobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
poor	JJ	amod	O
prognosis	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
lung	NN	compound	O
cancer	NN	nmod	O
is	VBZ	cop	O
related	JJ	appos	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
regional	JJ	amod	O
and	CC	cc	O
distant	JJ	conj	O
metastasis	NN	nmod	O
.	.	punct	O
Metastasis	NN	nsubj	O
from	IN	case	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
can	MD	aux	O
occur	VB	ROOT	O
swiftly	RB	advmod	O
to	TO	case	O
multiple	JJ	amod	O
organs	NNS	nmod	B-Organ
within	IN	case	O
months	NNS	nmod	O
of	IN	case	O
diagnosis	NN	nmod	O
.	.	punct	O

Mice	NNS	nsubj	O
that	WDT	nsubj	O
received	VBD	acl:relcl	O
either	CC	cc:preconj	O
IR	NN	dobj	O
or	CC	cc	O
TEMF	NN	conj	O
had	VBD	ROOT	O
significantly	RB	advmod	O
fewer	JJR	amod	O
lung	NN	compound	O
metastatic	JJ	amod	O
sites	NNS	dobj	O
and	CC	cc	O
slower	JJR	conj	O
tumor	NN	compound	O
growth	NN	dobj	O
than	IN	mark	O
did	VBD	advcl	O
untreated	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O
The	DT	det	O
mechanisms	NNS	nsubj	O
that	WDT	nsubj	O
confer	VBP	acl:relcl	O
this	DT	det	O
rapid	JJ	amod	O
metastatic	JJ	amod	O
capacity	NN	dobj	O
to	TO	case	O
lung	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
are	VBP	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
Activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
canonical	JJ	amod	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
is	VBZ	auxpass	O
identified	VBN	ROOT	O
here	RB	advmod	O
as	IN	case	O
a	DT	det	O
determinant	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
to	TO	case	O
brain	NN	nmod	B-Organ
and	CC	cc	O
bone	NN	conj	B-Tissue
during	IN	case	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
observed	VBD	ROOT	O
that	IN	mark	O
FOXO3a	NN	compound	O
gene	NN	compound	O
inactivation	NN	nsubj	O
occurs	VBZ	ccomp	O
frequently	RB	advmod	O
in	IN	case	O
carcinogen	NN	compound	O
-	HYPH	punct	O
induced	VBN	amod	O
lung	NN	compound	O
adenocarcinoma	NN	nmod	O
(	-LRB-	punct	O
LAC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Gene	NN	compound	O
expression	NN	compound	O
signatures	VBZ	nsubjpass	O
denoting	VBG	acl	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
relapse	NN	nmod	O
to	TO	case	O
multiple	JJ	amod	O
organs	NNS	nmod	B-Organ
in	IN	case	O
primary	JJ	amod	O
lung	NN	compound	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
Metastatic	JJ	amod	O
subpopulations	NNS	nsubj	O
isolated	VBN	acl	O
from	IN	case	O
independent	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
-	HYPH	punct	O
derived	VBN	amod	O
lung	NN	compound	B-Cell
adenocarcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
harbor	VBP	ROOT	O
a	DT	det	O
hyperactive	JJ	amod	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
pathway	NN	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mice	NNS	nsubj	O
bearing	VBG	acl	O
subcutaneous	JJ	amod	O
tumor	NN	dobj	O
of	IN	case	O
rAAV2	NN	compound	O
/	:	punct	O
5	CD	nummod	O
-	HYPH	punct	O
VAS	NNP	compound	O
pretreated	VBD	amod	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
showed	VBD	appos	O
>	NN	amod	O
50	CD	compound	O
%	NN	compound	O
reduction	NN	dobj	O
in	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	O
volume	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
spontaneous	JJ	amod	O
pulmonary	JJ	amod	O
metastases	NNS	dobj	O
.	.	punct	O
Reduction	NN	nsubj	O
of	IN	case	O
TCF	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
attenuates	VBZ	ROOT	O
their	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	mark	O
form	VB	acl	O
brain	NN	dobj	B-Organ
and	CC	cc	O
bone	NN	compound	B-Organ
metastases	NNS	conj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
independently	RB	advmod	O
of	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
in	IN	case	O
the	DT	det	O
lungs	NNS	nmod	B-Organ
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
The	DT	det	O
WNT	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nsubjpass	O
HOXB9	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
LEF1	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
mediators	NNS	nmod	O
of	IN	case	O
chemotactic	JJ	amod	O
invasion	NN	nmod	O
and	CC	cc	O
colony	NN	compound	B-Cancer
outgrowth	NN	conj	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
findings	NNS	nsubj	O
establish	VBP	ROOT	O
Wnt	NN	compound	O
signaling	NN	dobj	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
regulator	NN	nmod	O
in	IN	case	O
melanoma	NN	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
a	DT	det	O
distinct	JJ	amod	O
WNT	NN	compound	B-Gene_or_gene_product
/	:	punct	O
TCF	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
program	NN	nsubj	O
through	IN	case	O
LEF1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
HOXB9	NN	conj	B-Gene_or_gene_product
enhances	VBZ	ROOT	O
the	DT	det	O
competence	NN	dobj	O
of	IN	case	O
lung	NN	compound	B-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
to	TO	mark	O
colonize	VB	acl	O
the	DT	det	O
bones	NNS	dobj	B-Organ
and	CC	cc	O
the	DT	det	O
brain	NN	conj	B-Organ
.	.	punct	O

Disclosure	NN	nsubjpass	O
of	IN	case	O
potential	JJ	amod	O
conflicts	NNS	nmod	O
of	IN	case	O
interest	NN	nmod	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
this	DT	det	O
article	NN	nmod	O
.	.	punct	O
For	IN	prep	O
a	DT	det	O
video	JJ	amod	O
summary	NN	pobj	O
of	IN	prep	O
this	DT	det	O
article	NN	pobj	O
,	,	punct	O
see	VB	ROOT	O
the	DT	det	O
PaperFlick	NNP	compound	O
file	NN	dobj	O
available	JJ	amod	O
with	IN	prep	O
the	DT	det	O
online	JJ	amod	O
Supplemental	NNP	compound	O
Data	NNP	pobj	O
.	.	punct	O

Targeting	VBG	ROOT	O
angiogenesis	NN	dobj	O
:	:	punct	O
progress	NN	dep	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
large	JJ	amod	O
molecules	NNS	nmod	O
.	.	punct	O
Angiogenesis	NN	ROOT	O
-	HYPH	punct	O
a	DT	det	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
approach	NN	appos	O
for	IN	case	O
ischemic	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
through	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
in	IN	case	O
vascular	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
biologic	JJ	amod	O
process	NN	attr	O
of	IN	prep	O
forming	VBG	pcomp	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

Excessive	JJ	amod	O
vascular	JJ	amod	O
development	NN	nsubj	O
and	CC	cc	O
blood	NN	compound	O
vessel	NN	compound	O
remodeling	NN	conj	O
appears	VBZ	ROOT	O
in	IN	case	O
psoriasis	NN	nmod	O
,	,	punct	O
rheumatoid	JJ	amod	O
arthritis	NN	conj	O
,	,	punct	O
diabetic	JJ	amod	O
retinopathy	NN	conj	O
and	CC	cc	O
solid	JJ	amod	O
tumors	NNS	compound	O
formation	NN	conj	O
.	.	punct	O
Undoubtedly	RB	advmod	O
,	,	punct	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	compound	I-Multi-tissue_structure
growth	NN	compound	O
regulation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
vital	JJ	amod	O
aspect	NN	ROOT	O
in	IN	prep	O
health	NN	pobj	O
and	CC	cc	O
disease	NN	conj	O
.	.	punct	O

After	IN	ROOT	O
the	DT	det	O
completion	NN	pobj	O
of	IN	prep	O
skin	NN	compound	O
development	NN	pobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
i	LS	intj	O
.	.	punct	O
e	LS	npadvmod	O
.	.	punct	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubjpass	O
of	IN	prep	O
new	JJ	amod	O
capillaries	NNS	pobj	O
from	IN	prep	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
existing	VBG	amod	O
blood	NN	compound	O
vessels	NNS	pobj	O
,	,	punct	O
is	VBZ	auxpass	O
held	VBN	ROOT	O
to	TO	aux	O
occur	VB	xcomp	O
in	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
only	RB	advmod	O
under	IN	prep	O
pathologic	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O
Under	IN	case	O
physiological	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
local	JJ	amod	O
balance	NN	nmod	O
between	IN	case	O
endogenous	JJ	amod	O
stimulators	NNS	nmod	O
and	CC	cc	O
inhibitors	NNS	conj	O
of	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ischemia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
.	.	punct	O
In	IN	case	O
many	JJ	amod	O
diseases	NNS	nmod	O
state	NN	compound	O
body	NN	compound	B-Organism_subdivision
loses	NNS	nsubj	O
control	VBP	ROOT	O
over	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
through	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
critical	JJ	ROOT	O
in	IN	case	O
vascular	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O
Angiogenesis	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
diseases	NNS	nsubj	O
result	VBP	ROOT	O
when	WRB	advmod	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nsubj	I-Multi-tissue_structure
either	CC	dep	O
grow	VBP	ccomp	O
excessively	RB	advmod	O
or	CC	cc	O
insufficiently	RB	advmod	O
.	.	punct	O

Aberrant	JJ	amod	O
angiogenesis	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ischemia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
.	.	punct	O
Insufficient	JJ	amod	O
angiogenesis	NN	nsubj	O
occurs	VBZ	ROOT	O
in	IN	case	O
diseases	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
coronary	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
disease	NN	nmod	O
,	,	punct	O
stroke	NN	conj	O
and	CC	cc	O
chronic	JJ	amod	O
wounds	NNS	conj	B-Pathological_formation
.	.	punct	O

An	DT	det	O
alternative	NN	amod	O
and	CC	cc	O
rather	RB	conj	O
obvious	JJ	conj	O
strategy	NN	nsubj	O
to	TO	case	O
treat	VB	compound	O
ischemia	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
endogenous	JJ	amod	O
angiogenic	JJ	dep	O
or	CC	cc	O
arteriogenic	JJ	conj	O
pathways	NNS	dobj	O
to	TO	mark	O
stimulate	VB	advcl	O
revascularization	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	nmod	O
.	.	punct	O
Myocardial	JJ	amod	B-Multi-tissue_structure
ischemia	NN	nsubjpass	O
both	CC	cc:preconj	O
acute	JJ	dep	O
and	CC	cc	O
chronic	JJ	conj	O
has	VBZ	aux	O
been	VBN	auxpass	O
clearly	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
angiogenesis	NN	dobj	O
in	IN	case	O
many	JJ	amod	O
experimental	JJ	amod	O
models	NNS	nmod	O
.	.	punct	O

Therapeutic	JJ	amod	O
angiogenesis	NN	ROOT	O
:	:	punct	O
a	DT	det	O
complex	JJ	amod	O
problem	NN	dep	O
requiring	VBG	acl	O
a	DT	det	O
sophisticated	JJ	amod	O
approach	NN	dobj	O
.	.	punct	O
Therapeutic	JJ	amod	O
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
biological	JJ	amod	O
agents	NNS	ROOT	O
or	CC	cc	O
bioactive	JJ	amod	O
material	NN	conj	O
to	TO	mark	O
stimulate	VB	acl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Many	JJ	amod	O
observations	NNS	nsubj	O
in	IN	case	O
various	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	O
support	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
remodeling	NN	nsubj	O
of	IN	prep	O
preexisting	VBG	pcomp	O
collateral	JJ	amod	O
vessels	NNS	dobj	O
is	VBZ	cop	O
the	DT	det	O
mechanism	NN	ccomp	O
of	IN	case	O
collateral	JJ	amod	O
artery	NN	compound	O
formation	NN	nmod	O
.	.	punct	O
Traditional	JJ	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
revascularization	NN	compound	O
therapies	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
coronary	JJ	amod	B-Multi-tissue_structure
angioplasty	NN	nmod	O
or	CC	cc	O
bypass	NN	conj	B-Multi-tissue_structure
graft	NN	compound	I-Multi-tissue_structure
surgery	NN	conj	O
,	,	punct	O
act	VB	ROOT	O
by	IN	mark	O
restoring	VBG	advcl	O
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
through	IN	case	O
the	DT	det	O
preexisting	JJ	amod	O
coronary	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

An	DT	det	O
alternative	NN	amod	O
and	CC	cc	O
rather	RB	conj	O
obvious	JJ	conj	O
strategy	NN	nsubj	O
to	TO	case	O
treat	VB	compound	O
ischemia	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
endogenous	JJ	amod	O
angiogenic	JJ	dep	O
or	CC	cc	O
arteriogenic	JJ	conj	O
pathways	NNS	dobj	O
to	TO	mark	O
stimulate	VB	advcl	O
revascularization	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
limitation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
approaches	NNS	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
failure	NN	ROOT	O
to	TO	mark	O
normalize	VB	acl	O
myocardial	JJ	amod	B-Multi-tissue_structure
perfusion	NN	dobj	O
,	,	punct	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
concomitant	JJ	amod	O
presence	NN	nmod	O
or	CC	cc	O
small	JJ	conj	O
of	IN	case	O
resistance	NN	compound	O
vessel	NN	compound	B-Multi-tissue_structure
disease	NN	nmod	O
.	.	punct	O

An	DT	det	O
alternative	NN	amod	O
and	CC	cc	O
rather	RB	conj	O
obvious	JJ	conj	O
strategy	NN	nsubj	O
to	TO	case	O
treat	VB	compound	O
ischemia	NN	nmod	O
is	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
endogenous	JJ	amod	O
angiogenic	JJ	dep	O
or	CC	cc	O
arteriogenic	JJ	conj	O
pathways	NNS	dobj	O
to	TO	mark	O
stimulate	VB	advcl	O
revascularization	NN	dobj	O
of	IN	case	O
the	DT	det	O
tissue	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
therapeutic	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
concept	NN	nmod	O
that	IN	mark	O
coronary	JJ	amod	B-Multi-tissue_structure
collateral	JJ	amod	I-Multi-tissue_structure
development	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
stimulated	VBN	acl	O
by	IN	case	O
pharmacological	JJ	nmod	O
or	CC	cc	O
molecular	JJ	conj	O
means	NNS	dep	O
and	CC	cc	O
can	MD	aux	O
limit	VB	conj	O
myocardial	JJ	amod	B-Multi-tissue_structure
ischemia	NN	dobj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
that	IN	mark	O
adult	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
-	HYPH	punct	O
derived	VBN	amod	O
stem	NN	compound	O
cells	NNS	nsubj	O
and	CC	cc	O
endothelial	JJ	amod	O
progenitor	NN	compound	O
cells	NNS	conj	O
participate	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
called	VBN	conj	O
neoangiogenesis	NN	xcomp	O
or	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O
Studies	NNS	nsubj	O
,	,	punct	O
both	CC	appos	O
in	IN	case	O
human	JJ	amod	B-Organism
and	CC	cc	O
animal	NN	conj	O
models	NNS	nmod	O
support	VBP	ROOT	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
,	,	punct	O
various	JJ	amod	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factors	NNS	nsubj	O
and	CC	cc	O
progenitor	NN	compound	B-Cell
cells	NNS	conj	I-Cell
can	MD	aux	O
enhance	VB	ccomp	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

VEGF	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	mark	O
it	PRP	nsubj	O
promotes	VBZ	advcl	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
new	JJ	amod	O
blood	NN	compound	O
vessel	NN	compound	O
formation	NN	conj	O
.	.	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubjpass	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
recombinant	JJ	amod	O
proteins	NNS	conj	O
and	CC	cc	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
stem	NN	compound	I-Cell
cells	NNS	conj	I-Cell
are	VBP	auxpass	O
currently	RB	advmod	O
used	VBN	ROOT	O
therapeutic	JJ	amod	O
stimulators	NNS	dobj	O
for	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
application	NN	nmod	O
of	IN	case	O
therapeutic	JJ	amod	O
angiogenesis	NN	nmod	O
for	IN	mark	O
treating	VBG	acl	O
ischemic	JJ	amod	O
muscle	NN	compound	O
disease	NN	dobj	O
and	CC	cc	O
includes	VBZ	conj	O
a	DT	det	O
critical	JJ	amod	O
evaluation	NN	dobj	O
of	IN	case	O
the	DT	det	O
parameters	NNS	nmod	O
and	CC	cc	O
limitations	NNS	conj	O
of	IN	prep	O
current	JJ	amod	O
procedures	NNS	pobj	O
.	.	punct	O
As	IN	mark	O
coronary	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
disease	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
cause	NN	nsubj	O
of	IN	case	O
death	NN	nmod	O
in	IN	case	O
the	DT	det	O
developed	VBN	amod	O
societies	NNS	nmod	O
and	CC	cc	O
also	RB	advmod	O
an	DT	det	O
emerging	VBG	amod	O
health	NN	compound	O
problem	NN	conj	O
in	IN	prep	O
developing	VBG	pcomp	O
countries	NNS	dobj	O
like	IN	prep	O
Bangladesh	NN	amod	O
therapeutic	JJ	amod	O
angiogenesis	NN	pobj	O
may	MD	aux	O
provide	VB	ROOT	O
hope	NN	dobj	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
treatment	NN	compound	O
modality	NN	nmod	O
for	IN	case	O
ischemic	JJ	amod	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
with	IN	dep	O
or	CC	cc	O
in	IN	conj	O
place	NN	pobj	O
of	IN	prep	O
current	JJ	amod	O
therapies	NNS	pobj	O
.	.	punct	O

The	DT	det	O
genetics	NNS	ROOT	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
SV	NNP	nmod	O
40	CD	nummod	O
.	.	punct	O
Use	NN	ROOT	O
of	IN	case	O
uteroglobin	NN	nmod	B-Gene_or_gene_product
for	IN	case	O
the	DT	det	O
engineering	NN	nmod	O
of	IN	case	O
polyvalent	JJ	nmod	O
,	,	punct	O
polyspecific	JJ	amod	O
fusion	NN	compound	O
proteins	NNS	conj	O
.	.	punct	O

BAG	NNP	nsubjpass	O
-	:	punct	O
1	CD	nummod	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
ubiquitously	RB	advmod	O
in	IN	case	O
human	JJ	amod	O
cells	NNS	nmod	O
as	IN	case	O
three	CD	nummod	O
major	JJ	amod	O
isoforms	NNS	nmod	O
of	IN	case	O
50	CD	nummod	O
kDa	NN	compound	O
(	-LRB-	punct	O
BAG	NN	compound	O
-	:	punct	O
1L	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
46	CD	nummod	O
kDa	NN	appos	O
(	-LRB-	punct	O
BAG	NN	compound	O
-	:	punct	O
1M	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
36	CD	nummod	O
kDa	NN	conj	O
(	-LRB-	punct	O
BAG	NN	compound	O
-	:	punct	O
1S	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
a	DT	det	O
single	JJ	amod	O
mRNA	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
report	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
strategy	NN	dobj	O
to	TO	case	O
engineer	NN	nmod	O
and	CC	cc	O
express	VBP	conj	O
stable	JJ	amod	O
and	CC	cc	O
soluble	JJ	conj	O
human	JJ	amod	B-Organism
recombinant	JJ	amod	O
polyvalent	JJ	dep	O
/	SYM	punct	O
polyspecific	JJ	dep	O
fusion	NN	compound	O
proteins	NNS	dobj	O
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
The	DT	det	O
procedure	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
a	DT	det	O
central	JJ	amod	O
skeleton	NN	nmod	O
of	IN	case	O
uteroglobin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
small	JJ	amod	O
and	CC	cc	O
very	RB	advmod	O
soluble	JJ	conj	O
covalently	RB	advmod	O
linked	VBN	dep	O
homodimeric	JJ	amod	O
protein	NN	appos	O
that	WDT	nsubj	O
is	VBZ	cop	O
very	RB	advmod	O
resistant	JJ	acl:relcl	O
to	TO	case	O
proteolytic	JJ	amod	O
enzymes	NNS	nmod	O
and	CC	cc	O
to	TO	case	O
pH	NN	compound	O
variations	NNS	conj	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
in	FW	amod	O
vitro	FW	dep	O
M	NN	compound	O
-	HYPH	punct	O
CSF	NN	nsubj	O
induces	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
-	HYPH	punct	O
active	JJ	amod	O
VEGF	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
monocytes	NNS	nmod	O
.	.	punct	O
Using	VBG	advcl	O
a	DT	det	O
human	JJ	amod	B-Organism
recombinant	JJ	amod	O
antibody	NN	dobj	O
(	-LRB-	punct	O
scFv	NN	appos	O
)	-RRB-	punct	O
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
angiogenesis	NN	compound	O
marker	NN	compound	O
domain	NN	compound	O
B	NN	nmod	O
of	IN	case	O
fibronectin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
interleukin	NN	appos	B-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
an	DT	det	O
scFv	NN	conj	O
able	JJ	amod	O
to	TO	mark	O
neutralize	VB	xcomp	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
various	JJ	amod	O
biologically	RB	advmod	O
active	JJ	amod	O
uteroglobin	NN	compound	B-Gene_or_gene_product
fusion	NN	compound	O
proteins	NNS	dobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
produced	VBD	ROOT	O
a	DT	det	O
neutralizing	VBG	amod	O
antibody	NN	dobj	O
,	,	punct	O
1B3	NN	appos	O
,	,	punct	O
directed	VBN	acl	O
against	IN	case	O
mouse	NN	compound	O
PDGFRbeta	NN	nmod	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
to	TO	mark	O
generate	VB	acl	O
monospecific	JJ	amod	O
divalent	NN	dobj	O
and	CC	cc	O
tetravalent	JJ	conj	O
antibodies	NNS	dep	O
,	,	punct	O
immunocytokines	NNS	conj	O
,	,	punct	O
and	CC	cc	O
dual	JJ	amod	O
specificity	NN	compound	O
tetravalent	JJ	amod	O
antibodies	NNS	conj	O
.	.	punct	O

Dioleoyl	NN	compound	O
phosphatidylethanolamine	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
lipoplexes	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
give	VB	xcomp	O
low	JJ	amod	O
expression	NN	dobj	O
,	,	punct	O
apparently	RB	advmod	O
because	IN	case	O
of	IN	mwe	O
an	DT	det	O
immediate	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
integrity	NN	nmod	O
in	IN	case	O
serum	NN	nmod	O
,	,	punct	O
without	IN	case	O
lipid	NN	compound	O
-	HYPH	punct	O
DNA	NN	compound	O
dissociation	NN	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
similar	JJ	amod	O
fusion	NN	compound	O
proteins	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
uteroglobin	NN	nsubjpass	B-Gene_or_gene_product
was	VBD	auxpass	O
not	RB	neg	O
used	VBN	acl:relcl	O
,	,	punct	O
the	DT	det	O
use	NN	nsubj	O
of	IN	case	O
uteroglobin	NN	nmod	B-Gene_or_gene_product
improved	JJ	ROOT	O
properties	NNS	dobj	O
of	IN	case	O
solubility	NN	nmod	O
and	CC	cc	O
stability	NN	conj	O
.	.	punct	O

Dioleoyl	NN	compound	O
phosphatidylethanolamine	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
lipoplexes	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
give	VB	xcomp	O
low	JJ	amod	O
expression	NN	dobj	O
,	,	punct	O
apparently	RB	advmod	O
because	IN	case	O
of	IN	mwe	O
an	DT	det	O
immediate	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
integrity	NN	nmod	O
in	IN	case	O
serum	NN	nmod	O
,	,	punct	O
without	IN	case	O
lipid	NN	compound	O
-	HYPH	punct	O
DNA	NN	compound	O
dissociation	NN	nmod	O
.	.	punct	O
Indeed	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
reported	VBN	amod	O
cases	NNS	nmod	O
it	PRP	nsubj	O
was	VBD	cop	O
possible	JJ	ROOT	O
to	TO	mark	O
vacuum	VB	xcomp	O
dry	JJ	dobj	O
and	CC	cc	O
reconstitute	VBP	conj	O
the	DT	det	O
proteins	NNS	dobj	O
without	IN	case	O
any	DT	det	O
aggregation	NN	nmod	O
or	CC	cc	O
loss	NN	conj	O
in	IN	case	O
protein	NN	nmod	O
and	CC	cc	O
biological	JJ	conj	O
activity	NN	dep	O
.	.	punct	O

The	DT	det	O
interleukin	NN	compound	O
(	-LRB-	punct	O
IL	NN	compound	O
)	-RRB-	punct	O
2	CD	nummod	O
-	:	punct	O
and	CC	cc	O
beta	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
-	:	punct	O
microglobulin	NN	compound	O
(	-LRB-	punct	O
beta	NN	compound	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
m	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
deficient	JJ	dep	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	dep	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
m	NN	dep	O
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
spontaneously	RB	advmod	O
develop	VBP	ROOT	O
colon	NN	compound	O
cancer	NN	dobj	O
in	IN	case	O
the	DT	det	O
setting	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
UC	NN	nmod	O
.	.	punct	O
Netrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
in	IN	case	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
diseases	NNS	nmod	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
inflammation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
common	JJ	amod	O
underlying	VBG	amod	O
condition	NN	ROOT	O
for	IN	case	O
human	JJ	amod	O
tumor	NN	compound	O
development	NN	nmod	O
,	,	punct	O
accounting	VBG	advcl	O
for	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Chronic	JJ	amod	O
inflammation	NN	nsubjpass	O
and	CC	cc	O
cancer	NN	conj	B-Cancer
are	VBP	auxpass	O
intimately	RB	advmod	O
associated	VBN	ROOT	O
.	.	punct	O

Folate	JJ	compound	O
supplementation	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	O
dysplasia	NN	nmod	O
and	CC	cc	O
cancer	NN	conj	O
in	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
ulcerative	JJ	amod	O
colitis	NN	nmod	O
(	-LRB-	punct	O
UC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
This	DT	nsubj	O
is	VBZ	ROOT	O
particularly	RB	advmod	O
true	JJ	acomp	O
for	IN	case	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
diseases	NNS	nmod	O
(	-LRB-	punct	O
IBD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	nmod	I-Pathological_formation
and	CC	cc	O
Crohn	NN	nmod:poss	O
'	POS	case	O
s	NNS	compound	O
disease	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
show	VBP	acl:relcl	O
a	DT	det	O
major	JJ	amod	O
increased	VBN	amod	O
risk	NN	dobj	O
for	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
interleukin	NN	compound	O
(	-LRB-	punct	O
IL	NN	compound	O
)	-RRB-	punct	O
2	CD	nummod	O
-	:	punct	O
and	CC	cc	O
beta	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
-	:	punct	O
microglobulin	NN	compound	O
(	-LRB-	punct	O
beta	NN	compound	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
m	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
deficient	JJ	dep	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
null	NN	amod	O
)	-RRB-	punct	O
x	NN	nummod	O
beta	NN	dep	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
m	NN	dep	O
(	-LRB-	punct	O
null	NN	dep	O
)	-RRB-	punct	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
spontaneously	RB	advmod	O
develop	VBP	ROOT	O
colon	NN	compound	O
cancer	NN	dobj	O
in	IN	case	O
the	DT	det	O
setting	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
UC	NN	nmod	O
.	.	punct	O
While	IN	mark	O
the	DT	det	O
understanding	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
pathogenesis	NN	nmod	O
of	IN	case	O
IBD	NN	nmod	O
has	VBZ	aux	O
recently	RB	advmod	O
improved	VBN	advcl	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubj	O
that	WDT	nsubj	O
link	VBP	acl:relcl	O
these	DT	det	O
chronic	JJ	amod	O
inflammatory	JJ	amod	O
states	NNS	dobj	O
to	TO	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
are	VBP	cop	O
in	IN	case	O
large	JJ	amod	O
part	NN	compound	O
unknown	JJ	ROOT	O
.	.	punct	O

A	DT	det	O
role	NN	nsubj	O
for	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
control	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
promotion	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
/	:	punct	O
metastasis	NN	conj	O
.	.	punct	O
One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
mechanisms	NNS	nmod	O
is	VBZ	cop	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
pathway	NN	compound	O
activation	NN	ROOT	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
may	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
tumor	NN	compound	B-Cancer
formation	NN	nmod	O
by	IN	mark	O
providing	VBG	advcl	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
survival	NN	compound	O
signals	NNS	dobj	O
to	TO	case	O
the	DT	det	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
role	NN	nsubj	O
for	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
control	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
promotion	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
invasion	NN	nmod	O
/	:	punct	O
metastasis	NN	conj	O
.	.	punct	O
Based	VBN	case	O
on	IN	case	O
the	DT	det	O
observation	NN	advcl	O
that	IN	mark	O
netrin	NN	nsubjpass	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
ligand	NN	appos	O
for	IN	case	O
the	DT	det	O
dependence	NN	compound	O
receptors	NNS	nmod	O
DCC	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
UNC5H	NN	conj	B-Gene_or_gene_product
is	VBZ	auxpass	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ccomp	O
in	IN	case	O
colonic	JJ	amod	B-Organ
crypts	NNS	nmod	I-Organ
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	nsubj	I-Cancer
from	IN	case	O
inflammatory	JJ	amod	O
bowel	NN	compound	B-Organ
diseases	NNS	compound	O
patients	NNS	nmod	B-Organism
have	VBP	aux	O
selected	VBN	ccomp	O
up	RP	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	prep	O
netrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
.	.	punct	O

Chronic	JJ	amod	O
inflammation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
common	JJ	amod	O
underlying	VBG	amod	O
condition	NN	ROOT	O
for	IN	case	O
human	JJ	amod	O
tumor	NN	compound	O
development	NN	nmod	O
,	,	punct	O
accounting	VBG	advcl	O
for	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
inflammation	NN	compound	O
-	HYPH	punct	O
driven	VBN	amod	O
netrin	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	nsubj	O
is	VBZ	cop	O
causal	JJ	ccomp	O
for	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
as	IN	case	O
interference	NN	nmod	O
with	IN	case	O
netrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
autocrine	NN	compound	O
loop	NN	nmod	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
for	IN	case	O
ulcerative	JJ	amod	B-Pathological_formation
colitis	NN	compound	O
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
while	IN	mark	O
showing	VBG	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
inflammation	NN	nmod	O
,	,	punct	O
inhibits	VBZ	conj	O
colorectal	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
progression	NN	dobj	O
.	.	punct	O

[	-LRB-	punct	O
Activation	NN	ROOT	O
of	IN	case	O
sterol	NN	amod	O
regulatory	JJ	amod	O
element	NN	compound	O
binding	NN	compound	O
protein	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
involvement	NN	conj	O
in	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	nmod	O
]	-RRB-	punct	O
[	-LRB-	punct	O
Prognostic	JJ	amod	O
significance	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-Cell
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
]	-RRB-	punct	O

These	DT	det	O
events	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
short	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
support	VBP	conj	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
a	DT	det	O
cooperative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
BCR	NN	compound	O
-	:	punct	O
ABL	NN	nmod	O
with	IN	case	O
molecular	JJ	amod	O
RUNX1	NN	compound	O
abnormalities	NNS	nmod	O
on	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
arrest	NN	compound	O
phenotype	NN	nmod	O
observed	VBN	acl	O
during	IN	case	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
and	CC	cc	O
in	IN	case	O
BCR	NN	compound	O
-	HYPH	punct	O
ABL	NN	conj	O
+	CC	cc	O
ALL	NN	conj	O
.	.	punct	O
INTRODUCTION	NN	ROOT	O
:	:	punct	O
Increased	VBN	amod	O
angiogenesis	NN	nsubj	O
in	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
is	VBZ	cop	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
characteristics	NNS	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
(	-LRB-	punct	O
CML	NN	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
clonal	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	appos	O
that	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
a	DT	det	O
chimeric	JJ	amod	O
bcr	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
abl	NN	compound	I-Gene_or_gene_product
protein	NN	dobj	O
.	.	punct	O

Among	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	nsubj	O
of	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	cop	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	ROOT	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
potent	JJ	nmod	O
and	CC	cc	O
a	DT	det	O
specific	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
which	WDT	nsubj	O
principally	RB	advmod	O
targets	VBZ	acl:relcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
regulates	VBZ	conj	O
several	JJ	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
functions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
mitogenesis	NN	nmod	O
,	,	punct	O
permeability	NN	conj	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

Previously	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
that	IN	mark	O
in	FW	amod	O
vitro	FW	dep	O
M	NN	compound	O
-	HYPH	punct	O
CSF	NN	nsubj	O
induces	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
-	HYPH	punct	O
active	JJ	amod	O
VEGF	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
monocytes	NNS	nmod	O
.	.	punct	O
The	DT	det	O
impact	NN	nsubj	O
of	IN	case	O
elevated	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
on	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-Cancer
myeloid	JJ	amod	I-Cancer
leukaemia	NN	nmod	I-Cancer
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	O
isoforms	NNS	nsubjpass	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod:poss	O
'	POS	case	O
mRNA	NN	conj	O
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
neuroblastoma	NN	nmod	O
and	CC	cc	O
control	NN	conj	O
tissues	NNS	dep	O
.	.	punct	O
OBJECTIVE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	cop	O
the	DT	det	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	appos	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	prep	O
CML	NN	pobj	B-Cancer
.	.	punct	O

METHODOLOGY	NN	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
M	NN	nmod:npmod	O
-	HYPH	punct	O
CSF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	compound	O
production	NN	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
studied	VBD	dep	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
of	IN	case	O
85	CD	nummod	O
CML	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
median	JJ	amod	O
age	NN	dep	O
50	CD	nummod	O
years	NNS	dep	O
,	,	punct	O
range	VBP	dep	O
16	CD	compound	O
-	SYM	punct	O
75	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
RII	NN	compound	O
mRNA	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
RNase	NN	compound	O
protection	NN	nmod	O
,	,	punct	O
with	IN	case	O
comparison	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
the	DT	det	O
chronic	JJ	nmod	O
,	,	punct	O
accelerated	VBN	conj	O
and	CC	cc	O
blast	NN	conj	O
phases	NNS	dep	O
of	IN	case	O
CML	NN	nmod	O
,	,	punct	O
showed	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
RII	NN	compound	O
transcript	NN	compound	O
levels	NNS	nmod	O
during	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
At	IN	case	O
the	DT	det	O
commencement	NN	nmod	O
of	IN	case	O
the	DT	det	O
study	NN	nmod	O
,	,	punct	O
29	CD	nummod	O
patients	NNS	nsubj	B-Organism
were	VBD	cop	O
in	IN	case	O
chronic	JJ	amod	O
phase	NN	ROOT	O
(	-LRB-	punct	O
CP	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
25	CD	appos	O
in	IN	case	O
an	DT	det	O
accelerated	VBN	amod	O
phase	NN	nmod	O
(	-LRB-	punct	O
AP	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
31	CD	conj	O
in	IN	case	O
the	DT	det	O
blast	NN	compound	O
crisis	NN	nmod	O
(	-LRB-	punct	O
BC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
negative	JJ	amod	O
growth	NN	compound	O
regulator	NN	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
investigations	NNS	nsubjpass	O
were	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
inactivation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
by	IN	case	O
microsatellite	NN	compound	O
alteration	NN	nmod	O
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
.	.	punct	O
The	DT	det	O
temporal	JJ	amod	O
expression	NN	nsubjpass	O
(	-LRB-	punct	O
percentage	NN	compound	O
positivity	NN	dep	O
per	IN	case	O
1000	CD	nummod	O
analysed	VBN	amod	O
cells	NNS	nmod	B-Cell
)	-RRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
proteins	NNS	dep	O
over	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
immunohistochemical	JJ	amod	O
technique	NN	dobj	O
utilizing	VBG	acl	O
relevant	JJ	amod	O
monoclonal	JJ	amod	O
antibodies	NNS	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
mean	NN	amod	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
level	NN	nsubj	O
for	IN	case	O
cancer	NN	compound	O
patients	NNS	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	dep	O
relative	JJ	case	O
to	TO	case	O
controls	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
decreased	VBD	conj	O
with	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
laboratory	NN	nmod	O
(	-LRB-	punct	O
Hb	NN	dep	B-Gene_or_gene_product
,	,	punct	O
WBC	NN	compound	B-Cell
and	CC	cc	O
platelet	NN	conj	B-Cell
counts	NNS	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
percentage	NN	conj	O
of	IN	case	O
blasts	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
clinical	JJ	amod	O
parameters	NNS	conj	O
(	-LRB-	punct	O
organomegaly	JJ	dep	O
,	,	punct	O
duration	NN	dep	O
of	IN	case	O
CP	NN	nmod	O
,	,	punct	O
AP	NN	conj	O
,	,	punct	O
and	CC	cc	O
BC	NN	conj	O
)	-RRB-	punct	O
of	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
VEGF	NN	compound	O
expression	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
rat	NN	compound	O
retinal	JJ	amod	O
VEGF	NN	compound	O
transcripts	NNS	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	compound	O
ofVEGF	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
was	VBD	auxpass	O
most	RBS	advmod	O
pronounced	JJ	dep	O
in	IN	case	O
AP	NN	nmod	O
(	-LRB-	punct	O
ANOVA	NN	dep	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
033	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	O
isoforms	NNS	nsubjpass	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod:poss	O
'	POS	case	O
mRNA	NN	conj	O
were	VBD	auxpass	O
expressed	VBN	dep	O
in	IN	case	O
neuroblastoma	NN	nmod	O
and	CC	cc	O
control	NN	conj	O
tissues	NNS	dep	O
.	.	punct	O
The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
correlated	VBD	ROOT	O
inversely	RB	advmod	O
with	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
splenomegaly	NN	nmod	B-Pathological_formation
(	-LRB-	punct	O
Pearson	NN	dep	O
,	,	punct	O
r	NN	nsubj	O
=	JJ	conj	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
400	CD	dep	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
011	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	O
expression	NN	nmod	O
.	.	punct	O
High	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
correlated	VBD	ROOT	O
with	IN	case	O
a	DT	det	O
shorter	JJR	amod	O
overall	JJ	amod	O
survival	NN	nmod	O
(	-LRB-	punct	O
log	NN	nummod	O
rank	NN	dep	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
042	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
.	.	punct	O
CONCLUSION	NN	nsubj	O
:	:	punct	O
Immunohistochemically	RB	advmod	O
confirmed	VBN	ROOT	O
significance	NN	nsubj	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
dependence	NN	nmod	O
of	IN	case	O
the	DT	det	O
CML	NN	compound	B-Cancer
stage	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
of	IN	case	O
clinical	JJ	amod	O
importance	NN	dobj	O
in	IN	mark	O
deciding	VBG	advcl	O
on	IN	case	O
the	DT	det	O
timing	NN	amod	O
therapy	NN	nmod	O
.	.	punct	O

Finally	RB	ROOT	O
,	,	punct	O
mutating	VBG	xcomp	O
the	DT	det	O
Sp1	NN	compound	O
binding	NN	compound	O
sites	NNS	dobj	O
within	IN	case	O
the	DT	det	O
VEGF	NN	compound	O
promoter	NN	nmod	O
or	CC	cc	O
inhibiting	VBG	conj	O
ERK	NN	dobj	O
decreased	VBD	amod	O
VEGF	NN	compound	O
promoter	NN	compound	O
activity	NN	conj	O
in	IN	case	O
M	NN	nmod:npmod	O
-	HYPH	punct	O
CSF	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
human	JJ	amod	O
monocytes	NNS	nmod	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
biology	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-Cancer
and	CC	cc	O
that	IN	mark	O
VEGF	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubjpass	O
should	MD	aux	O
be	VB	auxpass	O
investigated	VBN	conj	O
in	IN	case	O
CML	NN	nmod	B-Cancer
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Pbx1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
downstream	JJ	amod	O
target	NN	ROOT	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	O
progenitors	NNS	nmod	B-Cell
and	CC	cc	O
leukemic	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Ecotropic	JJ	amod	B-Gene_or_gene_product
viral	JJ	amod	I-Gene_or_gene_product
integration	NN	compound	I-Gene_or_gene_product
site	NN	nsubj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
nuclear	JJ	amod	B-Cellular_component
transcription	NN	compound	O
factor	NN	ROOT	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
/	:	punct	O
maintenance	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
HSCs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Aberrant	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	prep	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	pobj	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
frequently	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
myeloid	JJ	amod	B-Cancer
leukemia	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
poor	JJ	amod	O
patient	NN	compound	B-Organism
survival	NN	nmod	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Recently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
reported	VBD	ROOT	O
candidate	NN	compound	O
target	NN	compound	O
genes	NNS	dobj	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
shared	VBN	acl	O
in	IN	case	O
HSCs	NNS	nmod	B-Cell
and	CC	cc	O
leukemic	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
using	VBG	xcomp	O
gene	NN	compound	O
expression	NN	compound	O
profiling	NN	compound	O
analysis	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
identifies	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
as	IN	case	O
a	DT	det	O
member	NN	nmod	O
of	IN	case	O
corepressor	NN	compound	O
complexes	NNS	nmod	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
aberrant	JJ	amod	O
recruitment	NN	nsubj	O
of	IN	case	O
corepressors	NNS	nmod	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	intj	O
-	HYPH	punct	O
induced	VBN	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
Pbx1	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	appos	O
in	IN	case	O
hematopoietic	JJ	amod	B-Pathological_formation
malignancy	NN	nmod	I-Pathological_formation
,	,	punct	O
as	IN	case	O
a	DT	det	O
target	NN	compound	O
gene	NN	nmod	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Overexpression	NN	nsubj	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
increased	VBD	ROOT	O
Pbx1	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
hematopoietic	JJ	amod	B-Cell
stem	NN	compound	I-Cell
/	:	punct	O
progenitor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
An	DT	det	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Pbx1	NN	compound	B-Gene_or_gene_product
promoter	NN	compound	O
region	NN	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
Evi	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
upregulates	VBZ	ccomp	O
Pbx1	NN	compound	B-Gene_or_gene_product
transcription	NN	dobj	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
reduction	NN	nsubj	O
of	IN	case	O
Pbx1	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
through	IN	case	O
RNAi	NNS	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
knockdown	NN	nmod	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
Evi	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	dobj	O
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
Pbx1	NN	nmod	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
impair	VB	ROOT	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transformation	NN	dobj	O
by	IN	case	O
E2A	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
HLF	NN	conj	B-Gene_or_gene_product
or	CC	cc	O
AML1	NN	conj	B-Gene_or_gene_product
/	:	punct	O
ETO	NN	conj	B-Gene_or_gene_product
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Pbx1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
specifically	RB	advmod	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
maintenance	NN	nmod	O
of	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transformation	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
histone	NN	compound	O
deacetylase	NN	compound	O
(	-LRB-	punct	O
HDAc	NNS	appos	O
)	-RRB-	punct	O
inhibitor	NN	nsubj	O
,	,	punct	O
trichostatin	NN	compound	O
A	NN	appos	O
(	-LRB-	punct	O
TSA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
alleviates	VBZ	ROOT	O
Evi	NNP	nmod:npmod	O
-	SYM	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
repression	NN	dobj	O
of	IN	case	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	compound	O
signaling	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
HDAc	NNS	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcriptional	JJ	amod	O
repression	NN	nmod	O
by	IN	case	O
Evi	NNP	compound	O
-	SYM	punct	O
1	CD	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Pbx1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
target	NN	compound	O
gene	NN	ccomp	O
of	IN	case	O
Evi	NNP	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
involved	VBN	acl	O
in	IN	case	O
Evi	NNP	npadvmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O

Targeting	VBG	ROOT	O
angiogenesis	NN	dobj	O
:	:	punct	O
progress	NN	dep	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
large	JJ	amod	O
molecules	NNS	nmod	O
.	.	punct	O
Tumor	NNP	compound	B-Cancer
Angiogenesis	NNP	ROOT	O
:	:	punct	O
Initiation	NN	compound	O
and	CC	cc	O
Targeting	NNP	compound	O
-	HYPH	punct	O
Therapeutic	NNP	conj	O
Targeting	NNP	appos	O
of	IN	prep	O
an	DT	det	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Binding	NNP	compound	I-Gene_or_gene_product
Protein	NNP	pobj	I-Gene_or_gene_product
,	,	punct	O
an	DT	det	O
Angiogenic	NNP	compound	O
Switch	NNP	compound	O
Molecule	NNP	appos	O
,	,	punct	O
and	CC	cc	O
Indicator	NN	conj	O
of	IN	prep	O
Early	JJ	amod	O
Stages	NNS	pobj	O
of	IN	prep	O
Gastrointestinal	NNP	compound	B-Cancer
Adenocarcinomas	NNPS	pobj	I-Cancer
-	:	punct	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
development	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
new	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
for	IN	mark	O
inhibiting	VBG	advcl	O
tumor	NN	compound	O
neovascularization	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
tumor	NN	compound	O
progression	NN	dobj	O
.	.	punct	O
Tumor	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
has	VBZ	aux	O
been	VBN	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
initiation	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
progression	NN	conj	O
toward	IN	case	O
more	RBR	advmod	O
aggressive	JJ	amod	O
behavior	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
tumors	NNS	nmod	B-Cancer
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
is	VBZ	cop	O
crucial	JJ	ROOT	O
for	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
previously	RB	advmod	O
characterized	VBD	ROOT	O
a	DT	det	O
secreted	VBN	amod	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	preconj	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
as	IN	case	O
a	DT	det	O
chaperone	NN	compound	O
molecule	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
various	JJ	amod	O
FGFs	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
enhances	VBZ	conj	O
FGF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
biochemical	JJ	amod	O
and	CC	cc	O
biologic	JJ	conj	O
events	NNS	dobj	O
and	CC	cc	O
importantly	RB	advmod	O
is	VBZ	cop	O
a	DT	det	O
crucial	JJ	amod	O
rate	NN	npadvmod	O
-	HYPH	punct	O
limiting	VBG	amod	O
factor	NN	conj	O
for	IN	case	O
tumor	NN	nmod:npmod	B-Cancer
-	HYPH	punct	O
dependent	JJ	amod	O
angiogenesis	NN	nmod	O
.	.	punct	O

Fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	nsubjpass	O
-	:	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
FGF	NN	dep	O
-	:	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
multiple	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
different	JJ	amod	O
biological	JJ	amod	O
processes	NNS	nmod	O
during	IN	case	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	nmod	O
(	-LRB-	punct	O
CNS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
We	PRP	nsubj	O
generated	VBD	ROOT	O
monoclonal	JJ	amod	O
antibodies	NNS	dobj	O
that	WDT	nsubj	O
target	VBP	acl:relcl	O
FGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
BP	NN	compound	I-Gene_or_gene_product
protein	NN	dobj	O
and	CC	cc	O
used	VBD	conj	O
them	PRP	dobj	O
as	IN	case	O
a	DT	det	O
tool	NN	nmod	O
to	TO	mark	O
evaluate	VB	acl	O
frequency	NN	dobj	O
and	CC	cc	O
pattern	NN	conj	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
malignant	JJ	amod	O
progression	NN	nmod	O
of	IN	case	O
pancreas	NN	nmod	B-Cancer
and	CC	cc	O
colorectal	JJ	amod	B-Cancer
carcinoma	NN	conj	I-Cancer
in	IN	case	O
archival	NN	compound	O
tissue	NN	compound	B-Tissue
samples	NNS	nmod	I-Tissue
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
occurs	VBZ	ROOT	O
within	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
from	IN	case	O
FGF	NN	compound	O
-	:	punct	O
2	CD	nummod	O
treatment	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
ERK1	NN	nmod	O
/	SYM	punct	O
2	CD	nummod	O
pathway	NN	dep	O
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
stimulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
early	JJ	amod	O
growth	NN	compound	O
response	NN	compound	O
-	:	punct	O
1	CD	nummod	O
(	-LRB-	punct	O
Egr	NN	compound	O
-	SYM	punct	O
1	CD	dep	O
)	-RRB-	punct	O
transcription	NN	compound	O
factor	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	nsubjpass	I-Gene_or_gene_product
is	VBZ	auxpass	O
dramatically	RB	advmod	O
upregulated	VBN	ccomp	O
during	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
and	CC	cc	O
pancreatic	JJ	conj	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
switch	NN	nsubjpass	O
during	IN	case	O
tumorigenesis	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
the	DT	det	O
balance	NN	nmod	O
of	IN	case	O
pro	NN	amod	O
-	HYPH	punct	O
angiogenic	JJ	amod	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
factors	NNS	nmod	O
.	.	punct	O
Crucial	JJ	amod	O
genetic	JJ	amod	O
events	NNS	nsubjpass	O
underlying	VBG	acl	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
and	CC	cc	O
pancreatic	JJ	conj	B-Cancer
adenocarcinoma	NN	nmod	I-Cancer
with	IN	case	O
a	DT	det	O
particular	JJ	amod	O
focus	NN	nmod	O
on	IN	case	O
the	DT	det	O
modulation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
antiangiogenic	JJ	amod	O
therapies	NNS	conj	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Using	VBG	advcl	O
human	JJ	amod	O
neuroblastoma	NN	compound	O
cell	NN	compound	O
line	NN	dobj	O
,	,	punct	O
SK	NN	compound	O
-	HYPH	punct	O
N	NNP	compound	O
-	HYPH	punct	O
MC	NNP	appos	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
FGF	NN	nmod	O
-	:	punct	O
2	CD	nummod	O
resulted	VBD	ccomp	O
in	IN	case	O
early	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
Id	NN	compound	O
-	:	punct	O
1	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
upregulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
secreted	VBN	amod	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
during	IN	case	O
early	JJ	amod	O
phases	NNS	nmod	O
of	IN	case	O
pancreas	NN	nmod	B-Cancer
and	CC	cc	O
colon	NN	compound	B-Cancer
cancer	NN	conj	I-Cancer
could	MD	aux	O
make	VB	ccomp	O
this	DT	det	O
protein	NN	dobj	O
a	DT	det	O
possible	JJ	amod	O
serum	NN	compound	B-Organism_substance
marker	NN	dobj	O
indicating	VBG	acl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
risk	NN	amod	O
premalignant	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Id	NN	compound	O
-	:	punct	O
1	CD	nummod	O
expression	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
/	:	punct	O
M	NN	dep	O
accumulation	NN	nmod	O
of	IN	case	O
FGF	NN	compound	O
-	:	punct	O
2	CD	nummod	O
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	O
and	CC	cc	O
delayed	VBN	amod	O
cell	NN	compound	O
death	NN	conj	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
biological	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
FGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
BP	NN	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
neutralized	VBN	ROOT	O
by	IN	case	O
monoclonal	JJ	amod	O
antibodies	NNS	nmod	O
suggesting	VBG	acl	O
the	DT	det	O
potential	NN	dobj	O
for	IN	case	O
antibody	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
therapeutic	JJ	amod	O
targeting	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
ethanol	NN	compound	O
exposure	NN	nsubj	O
caused	VBD	ROOT	O
both	CC	cc:preconj	O
decreased	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
hypoxia	NN	conj	O
in	IN	case	O
wounds	NNS	nmod	O
.	.	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
hypoxia	NN	nmod	O
in	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butoxyethanol	NN	npadvmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
hemangiosarcoma	NN	nmod	B-Cancer
.	.	punct	O

2	CD	nummod	O
-	HYPH	punct	O
Methoxyestradiol	NN	nsubj	O
(	-LRB-	punct	O
2ME2	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
natural	JJ	amod	O
compound	NN	ROOT	O
with	IN	case	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
inhibitory	JJ	amod	O
activity	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
evaluated	VBN	acl:relcl	O
in	IN	case	O
phase	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
2	CD	nummod	O
clinical	JJ	amod	O
trials	NNS	conj	O
for	IN	case	O
advanced	JJ	amod	O
solid	JJ	amod	O
tumors	NNS	nmod	O
and	CC	cc	O
multiple	JJ	amod	O
myeloma	NN	conj	O
.	.	punct	O
To	TO	mark	O
understand	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
compound	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
hemangiosarcomas	NNS	dobj	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
human	JJ	amod	B-Organism
relevance	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
systems	NNS	compound	O
biology	NN	compound	O
approach	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	conj	O
using	VBG	xcomp	O
transcriptomics	NNS	dobj	O
and	CC	cc	O
Causal	NNP	compound	O
Network	NNP	compound	O
Modeling	VBG	conj	O
from	IN	case	O
mice	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butoxyethanol	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

2	CD	nummod	O
-	HYPH	punct	O
DG	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
cell	NN	compound	O
cycle	NN	compound	O
delay	NN	dobj	O
in	IN	case	O
monolayers	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
a	DT	det	O
transient	JJ	amod	O
G	NN	compound	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
delay	NN	nsubj	O
was	VBD	cop	O
apparent	JJ	advcl	O
in	IN	case	O
spheroids	NNS	nmod	O
.	.	punct	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	nsubj	I-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
hemolytic	JJ	amod	O
agent	NN	ROOT	O
that	WDT	nsubj	O
induces	VBZ	acl:relcl	O
hemangiosarcomas	NNS	dobj	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
head	NN	amod	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
using	VBG	acl	O
UM	NN	compound	O
-	HYPH	punct	O
SCC	NN	compound	O
-	:	punct	O
11A	NN	compound	O
cells	NNS	dobj	O
,	,	punct	O
2ME2	NN	nsubj	O
exhibited	VBD	ROOT	O
antitumor	NN	dobj	O
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	O
immunostaining	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
hemolysis	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	nmod	I-Simple_chemical
would	MD	aux	O
result	VB	ccomp	O
in	IN	case	O
local	JJ	amod	O
tissue	NN	compound	B-Tissue
hypoxia	NN	nmod	O
,	,	punct	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
documented	VBN	amod	O
trigger	NN	appos	O
for	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
hemangiosarcoma	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
compares	VBZ	ROOT	O
the	DT	det	O
radiomodification	NN	dobj	O
by	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
DG	NNS	nmod	O
in	IN	case	O
monolayer	JJ	compound	O
cultures	NNS	nmod	O
and	CC	cc	O
spheroids	NNS	conj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	O
glioma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
(	-LRB-	punct	O
BMG	NN	compound	O
-	:	punct	O
1	CD	nummod	O
)	-RRB-	punct	O
to	TO	mark	O
gain	VB	advcl	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
in	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
Gene	NN	compound	O
expression	NN	compound	O
data	NNS	nsubjpass	O
from	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
BM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
,	,	punct	O
liver	NN	conj	B-Organ
,	,	punct	O
and	CC	cc	O
spleen	NN	conj	B-Organ
of	IN	case	O
mice	NNS	nmod	B-Organism
exposed	VBN	acl	O
to	TO	case	O
a	DT	det	O
single	JJ	amod	O
dose	NN	nmod	O
(	-LRB-	punct	O
4	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
seven	CD	nummod	O
daily	JJ	amod	O
doses	NNS	conj	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	nmod	I-Simple_chemical
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
develop	VB	xcomp	O
a	DT	det	O
mechanistic	JJ	amod	O
model	NN	dobj	O
of	IN	case	O
hemangiosarcoma	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
other	JJ	amod	O
induced	VBN	amod	O
genes	NNS	nsubj	O
revealed	VBD	ROOT	O
a	DT	det	O
whole	JJ	amod	O
set	NN	dobj	O
of	IN	case	O
biologically	RB	advmod	O
meaningful	JJ	amod	O
genes	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
macrophage	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
TH1	NN	compound	O
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O
The	DT	det	O
resulting	VBG	amod	O
mechanistic	JJ	amod	O
model	NN	nsubj	O
confirms	VBZ	ROOT	O
previous	JJ	amod	O
work	NN	dobj	O
proposing	VBG	acl	O
that	IN	mark	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NN	nsubj	I-Simple_chemical
induces	VBZ	ccomp	O
macrophage	NN	compound	B-Cell
activation	NN	dobj	O
and	CC	cc	O
inflammation	NN	conj	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	B-Organ
.	.	punct	O

PMN	NNP	npadvmod	O
-	HYPH	punct	O
triggered	VBN	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
local	JJ	amod	O
injection	NN	nmod	O
and	CC	cc	O
daily	RB	advmod	O
i	NN	conj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
administration	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Hyp	NN	compound	O
salt	NN	nmod	O
in	IN	case	O
an	DT	det	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	nummod	O
-	HYPH	punct	O
induced	VBN	amod	O
murine	JJ	amod	O
model	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
model	NN	nsubj	O
supports	VBZ	ROOT	O
local	JJ	amod	O
tissue	NN	compound	B-Tissue
hypoxia	NN	dobj	O
in	IN	case	O
the	DT	dep	O
liver	NN	nmod	B-Organ
and	CC	cc	O
spleen	NN	conj	B-Organ
,	,	punct	O
coupled	VBN	advcl	O
with	IN	case	O
increased	VBN	amod	O
erythropoeitin	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
and	CC	cc	O
erythropoiesis	NN	conj	O
in	IN	case	O
the	DT	det	O
spleen	NN	nmod	B-Organ
and	CC	cc	O
BM	NN	conj	B-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
genomic	JJ	amod	O
stability	NN	nmod	O
,	,	punct	O
events	NNS	dobj	O
that	WDT	nsubj	O
could	MD	aux	O
be	VB	aux	O
contributing	VBG	acl:relcl	O
factors	NNS	dobj	O
to	TO	case	O
hemangiosarcoma	NN	compound	B-Cancer
formation	NN	nmod	O
.	.	punct	O

HIF	NN	compound	O
-	HYPH	punct	O
2alpha	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
hypoxic	JJ	nmod	O
and	CC	cc	O
in	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
oxygenized	VBN	amod	O
neuroblastoma	NN	compound	O
cells	NNS	conj	O
and	CC	cc	O
tissue	NN	conj	O
,	,	punct	O
presumably	RB	advmod	O
reflecting	VBG	advcl	O
their	PRP$	nmod:poss	O
embryonic	JJ	amod	O
features	NNS	dobj	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
an	DT	det	O
immunohistochemistry	NN	compound	O
method	NN	nsubj	O
(	-LRB-	punct	O
Hypoxyprobe	NN	appos	O
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
tissue	NN	compound	B-Tissue
hypoxia	NN	nsubj	O
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
the	DT	dep	O
spleen	NN	nmod	B-Organ
and	CC	cc	O
BM	NN	conj	B-Multi-tissue_structure
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
head	NN	amod	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
using	VBG	acl	O
UM	NN	compound	O
-	HYPH	punct	O
SCC	NN	compound	O
-	:	punct	O
11A	NN	compound	O
cells	NNS	dobj	O
,	,	punct	O
2ME2	NN	nsubj	O
exhibited	VBD	ROOT	O
antitumor	NN	dobj	O
and	CC	cc	O
antiangiogenic	JJ	conj	O
activity	NN	dep	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
CD31	NN	compound	O
immunostaining	NN	nmod	O
.	.	punct	O
Together	RB	advmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
identify	VBP	ROOT	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
initiate	VBP	acl:relcl	O
hemangiosarcoma	NN	dobj	B-Cancer
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
step	NN	appos	O
in	IN	prep	O
understanding	VBG	pcomp	O
safety	NN	compound	O
concerns	NNS	dep	O
that	WDT	nsubj	O
can	MD	aux	O
impact	VB	acl:relcl	O
drug	NN	compound	O
decision	NN	compound	O
processes	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
identified	VBD	conj	O
hypoxia	NN	dobj	O
as	IN	case	O
a	DT	det	O
possible	JJ	amod	O
contributing	VBG	amod	O
factor	NN	nmod	O
for	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
BE	NNP	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
hemangiosarcoma	NN	nmod	B-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
detected	VBD	ROOT	O
strong	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
AKT	NN	nmod	O
in	IN	case	O
allograft	NN	compound	O
tumors	NNS	nmod	O
specifically	RB	advmod	O
AKT2	NN	dobj	O
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
isoform	NN	nmod	O
involved	VBN	acl	O
.	.	punct	O
Pancreatic	JJ	amod	B-Cancer
endocrine	JJ	amod	I-Cancer
tumors	NNS	ROOT	I-Cancer
:	:	punct	O
expression	NN	dep	O
profiling	NN	acl	O
evidences	VBZ	dobj	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
AKT	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Dependence	NN	nsubj	O
on	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	appos	O
of	IN	case	O
malignant	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
PURPOSE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
global	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
panel	NN	nmod	O
of	IN	case	O
pancreatic	JJ	amod	B-Cancer
endocrine	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
(	-LRB-	punct	O
PETs	NNS	appos	B-Cancer
)	-RRB-	punct	O
aimed	VBN	acl	O
at	IN	mark	O
identifying	VBG	advcl	O
new	JJ	amod	O
potential	JJ	amod	O
targets	NNS	dobj	O
for	IN	case	O
therapy	NN	nmod	O
and	CC	cc	O
biomarkers	NNS	conj	O
to	TO	mark	O
predict	VB	advcl	O
patient	NN	compound	B-Organism
outcome	NN	dobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	dep	O
to	TO	mark	O
reconcile	VB	xcomp	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
findings	NNS	dobj	O
with	IN	case	O
the	DT	det	O
recent	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
allelic	JJ	amod	O
deletion	NN	nmod	O
in	IN	case	O
human	JJ	amod	O
colon	NN	compound	O
cancers	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Using	VBG	dep	O
a	DT	det	O
custom	NN	compound	O
microarray	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	parataxis	O
72	CD	nummod	O
primary	JJ	amod	O
PETs	NNS	dobj	B-Cancer
,	,	punct	O
seven	CD	nummod	O
matched	VBN	amod	O
metastases	NNS	conj	O
,	,	punct	O
and	CC	cc	O
10	CD	nummod	O
normal	JJ	amod	O
pancreatic	JJ	amod	B-Multi-tissue_structure
samples	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

Differentially	RB	advmod	O
expressed	VBN	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
subset	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
by	IN	case	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	nmod	O
PCR	NN	dep	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O
Relevant	JJ	amod	O
differentially	RB	advmod	O
expressed	VBD	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
validated	VBN	ROOT	O
by	IN	case	O
either	CC	cc:preconj	O
quantitative	JJ	amod	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
or	CC	cc	O
immunohistochemistry	NN	conj	O
on	IN	case	O
tissue	NN	compound	B-Tissue
microarrays	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
PTEN	NN	nmod	O
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
its	PRP$	nmod:poss	O
epigenetic	JJ	amod	O
microsatellite	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
and	CC	cc	O
explore	VBP	conj	O
their	PRP$	nmod:poss	O
roles	NNS	dobj	O
in	IN	case	O
progression	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
showed	VBD	dep	O
that	IN	mark	O
:	:	punct	O
tuberous	JJ	amod	B-Gene_or_gene_product
sclerosis	NN	nsubjpass	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
TSC2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
phosphatase	NN	conj	B-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
tensin	NN	compound	I-Gene_or_gene_product
homolog	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PTEN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
downregulated	VBN	ccomp	O
in	IN	case	O
most	JJS	nmod	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
low	JJ	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
shorter	JJR	amod	O
disease	NN	compound	O
-	HYPH	punct	O
free	JJ	amod	O
and	CC	cc	O
overall	JJ	conj	O
survival	NN	nmod	O
;	:	punct	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
SSTR2	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
was	VBD	cop	O
absent	JJ	parataxis	O
or	CC	cc	O
very	RB	advmod	O
low	JJ	conj	O
in	IN	case	O
insulinomas	NNS	nmod	B-Cancer
compared	VBN	case	O
with	IN	case	O
nonfunctioning	JJ	amod	O
tumors	NNS	nmod	B-Cancer
;	:	punct	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
fibroblast	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
13	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
FGF13	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
associated	VBN	conj	O
with	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
liver	NN	compound	B-Organ
metastasis	NN	nmod	O
and	CC	cc	O
shorter	JJR	amod	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	conj	O
.	.	punct	O

Substantial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
can	MD	aux	O
inhibit	VB	ccomp	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
many	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
TSC2	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	conj	B-Gene_or_gene_product
are	VBP	cop	O
two	CD	nummod	O
key	JJ	amod	O
inhibitors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
mammalian	JJ	amod	B-Gene_or_gene_product
target	NN	nmod	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
rapamycin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
mTOR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathway	NN	nmod	O
and	CC	cc	O
the	DT	det	O
specific	JJ	amod	O
inhibition	NN	conj	O
of	IN	case	O
mTOR	NN	nmod	B-Gene_or_gene_product
with	IN	case	O
rapamycin	NN	nmod	B-Simple_chemical
or	CC	cc	O
RAD001	NN	conj	B-Simple_chemical
inhibited	VBD	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
of	IN	case	O
PET	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
apoptotic	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	O
inhibited	VBD	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NN	nmod	O
and	CC	cc	O
mTOR	NN	conj	O
and	CC	cc	O
was	VBD	auxpass	O
followed	VBN	conj	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
S6K1	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	JJ	amod	O
target	NN	acl:relcl	O
of	IN	case	O
mTOR	NN	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
strongly	RB	advmod	O
support	VBP	appos	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	conj	B-Gene_or_gene_product
/	:	punct	O
mTOR	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
in	IN	case	O
PET	NN	nmod	B-Cancer
,	,	punct	O
which	WDT	nsubj	O
ties	VBZ	acl:relcl	O
in	IN	case	O
with	IN	case	O
the	DT	det	O
fact	NN	nmod	O
that	IN	mark	O
mTOR	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nsubj	O
have	VBP	aux	O
reached	VBN	ccomp	O
phase	NN	compound	O
III	CD	nummod	O
trials	NNS	dobj	O
in	IN	case	O
neuroendocrine	JJ	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
ligands	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	advcl	O
in	IN	case	O
stages	NNS	nmod	O
III	CD	nummod	O
and	CC	cc	O
IV	CD	conj	O
,	,	punct	O
the	DT	det	O
receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
only	RB	advmod	O
.	.	punct	O
The	DT	det	O
finding	NN	nsubj	O
of	IN	case	O
differential	JJ	amod	O
SSTR	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
raises	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
for	IN	case	O
SSTR	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
to	TO	mark	O
be	VB	auxpass	O
evaluated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
response	NN	nmod	O
to	TO	case	O
somatostatin	NN	compound	B-Gene_or_gene_product
analogs	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	O
expression	NN	nmod	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
FGF13	NN	dobj	B-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	nmod	O
that	WDT	nsubj	O
predicted	VBD	acl:relcl	O
poorer	NN	compound	O
outcome	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
who	WP	nsubjpass	O
were	VBD	auxpass	O
clinically	RB	advmod	O
considered	VBN	acl:relcl	O
free	JJ	advmod	O
from	IN	case	O
disease	NN	nmod	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
rk	RB	compound	O
-	SYM	punct	O
2	CD	nsubj	O
diminished	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	compound	O
-	:	punct	O
2	CD	dep	O
and	CC	cc	O
-	SYM	punct	O
9	CD	nmod	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	O
lung	NN	nmod	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
tumor	NN	compound	O
metastasis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
enhances	VBZ	ROOT	O
the	DT	det	O
migratory	JJ	amod	O
and	CC	cc	O
invasive	JJ	conj	O
potential	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
small	JJ	amod	I-Cell
cell	NN	compound	I-Cell
lung	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
inducing	VBG	advcl	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dobj	I-Gene_or_gene_product
via	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
and	CC	cc	O
CREB	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
endothelial	JJ	amod	O
cell	NN	compound	O
(	-LRB-	punct	O
EC	NN	appos	O
)	-RRB-	punct	O
adhesion	NN	compound	O
molecules	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	nmod	O
is	VBZ	auxpass	O
suppressed	VBN	ROOT	O
in	IN	case	O
malignancies	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	nsubjpass	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
radio	NN	compound	O
-	HYPH	punct	O
resistance	NN	nmod	O
and	CC	cc	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	conj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
to	TO	mark	O
understand	VB	advcl	O
their	PRP$	nmod:poss	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
invasion	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
them	PRP	dobj	O
collectively	RB	advmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
ICAM	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
has	VBZ	ccomp	O
an	DT	det	O
additional	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
because	IN	mark	O
molecules	NNS	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
ICAM	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
are	VBP	auxpass	O
known	VBN	advcl	O
as	IN	case	O
regulators	NNS	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
migration	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
.	.	punct	O

Substantial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
can	MD	aux	O
inhibit	VB	ccomp	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
of	IN	case	O
many	JJ	amod	O
cancer	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
examine	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
NCI	NN	compound	B-Cell
-	HYPH	punct	I-Cell
H1299	NN	compound	I-Cell
non	NN	amod	I-Cell
-	HYPH	punct	I-Cell
small	JJ	amod	I-Cell
cell	NN	compound	I-Cell
lung	NN	compound	I-Cell
cancer	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
NSCLC	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cell	NN	compound	I-Cell
line	NN	dobj	I-Cell
(	-LRB-	punct	O
p53	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	compound	B-Gene_or_gene_product
null	JJ	amod	O
cell	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
constructed	VBD	conj	O
an	DT	det	O
ICAM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
over	IN	advmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
stable	JJ	amod	O
transfectant	NN	dobj	B-Cell
,	,	punct	O
which	WDT	nsubj	O
exhibited	VBD	acl:relcl	O
increased	VBN	amod	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
interaction	NN	nsubj	O
of	IN	case	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
high	JJ	amod	O
invasive	JJ	amod	O
melanoma	NN	compound	O
cells	NNS	conj	O
with	IN	case	O
soluble	JJ	amod	O
recombinant	JJ	amod	O
DC	NN	nmod	O
-	:	punct	O
9	CD	nummod	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	nmod	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
MMP	NN	conj	O
-	:	punct	O
2	CD	nummod	O
.	.	punct	O
The	DT	det	O
increased	VBN	amod	O
migration	NN	nsubj	O
and	CC	cc	O
invasion	NN	conj	O
resulted	VBD	ROOT	O
from	IN	case	O
up	RB	amod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
and	CC	cc	O
activities	NNS	conj	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

In	IN	case	O
immunohistochemical	JJ	amod	O
analysis	NN	ROOT	O
,	,	punct	O
rk	RB	compound	O
-	SYM	punct	O
2	CD	nummod	O
reduced	VBD	amod	O
expression	NN	appos	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
angiogenic	JJ	amod	O
activator	NN	acl:relcl	O
and	CC	cc	O
neovascularization	NN	conj	O
in	IN	case	O
the	DT	det	O
mouse	NN	compound	O
lung	NN	nmod	O
.	.	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
also	RB	advmod	O
increased	VBD	ROOT	O
Akt	JJ	compound	B-Gene_or_gene_product
phosphorylation	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
caused	VBD	acl:relcl	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
cellular	JJ	amod	B-Cell
migration	NN	nmod	O
/	:	punct	O
invasion	NN	conj	O
and	CC	cc	O
MMP	NN	compound	B-Gene_or_gene_product
activities	NNS	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
a	DT	det	O
reduction	NN	nsubjpass	O
in	IN	case	O
tumor	NN	compound	O
volume	NN	nmod	O
of	IN	case	O
Grm1	NN	compound	O
-	HYPH	punct	O
mouse	NN	compound	O
-	HYPH	punct	O
melanocytic	JJ	amod	O
-	HYPH	punct	O
allografts	NNS	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
AKT2	NN	compound	O
RNA	NN	nmod	O
(	-LRB-	punct	O
siAKT2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Activity	NN	nsubjpass	O
of	IN	case	O
several	JJ	amod	O
transcriptional	JJ	amod	O
factors	NNS	nmod	O
located	JJ	amod	O
downstream	RB	advmod	O
in	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
tested	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
constitutive	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
adenosine	NN	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
'	''	punct	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
5	CD	nummod	I-Gene_or_gene_product
'	''	punct	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
monophosphate	NN	amod	I-Gene_or_gene_product
response	NN	compound	I-Gene_or_gene_product
element	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
binding	NN	compound	I-Gene_or_gene_product
protein	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
CREB	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
ICAM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	conj	I-Gene_or_gene_product
was	VBD	auxpass	O
detected	VBN	conj	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
endogenous	JJ	amod	O
FOXO3a	NN	compound	O
expression	NN	nmod	O
reduced	VBD	ROOT	O
PI3K	NN	compound	O
/	:	punct	O
Akt	NN	compound	O
activity	NN	dobj	O
.	.	punct	O
Blockage	NNP	nsubj	O
of	IN	case	O
the	DT	det	O
Akt	NNP	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
attenuated	VBD	ROOT	O
CREB	NN	compound	B-Gene_or_gene_product
activation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
CREB	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
reduced	VBD	conj	O
cellular	JJ	amod	B-Cell
migration	NN	dobj	O
/	:	punct	O
invasion	NN	conj	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
MMPs	NNS	nmod	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
increased	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	O
-	HYPH	punct	O
9	CD	dep	O
was	VBD	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
in	IN	case	O
CNE1	NN	compound	O
-	HYPH	punct	O
GL	NN	compound	O
cells	NNS	nmod	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O
This	DT	det	O
result	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
CREB	NN	compound	B-Gene_or_gene_product
functions	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
between	IN	case	O
Akt	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
PTEN	NN	nsubj	O
had	VBD	aux	O
played	VBN	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
migration	NN	conj	O
and	CC	cc	O
invasion	NN	conj	O
dependent	JJ	amod	O
on	IN	case	O
its	PRP$	nmod:poss	O
phosphatase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
also	RB	advmod	O
showed	VBD	ROOT	O
ICAM	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
in	IN	case	O
NCI	NN	compound	B-Cell
-	:	punct	I-Cell
H460	NN	compound	I-Cell
NSCLC	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
p53	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	compound	B-Gene_or_gene_product
cell	NN	conj	O
)	-RRB-	punct	O
through	IN	case	O
the	DT	det	O
same	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
PTEN	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
proliferating	VBG	amod	O
cell	NN	compound	O
nuclear	JJ	amod	O
antigen	NN	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
Erk1	NN	nmod	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
Akt	NNP	conj	O
.	.	punct	O
Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubj	I-Gene_or_gene_product
stimulates	VBZ	ccomp	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	compound	O
/	:	punct	O
invasion	NN	dobj	O
via	IN	case	O
ICAM	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	SYM	punct	O
CREB	NN	compound	B-Gene_or_gene_product
/	:	punct	O
MMP	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
regardless	RB	advmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	conj	B-Gene_or_gene_product
status	NN	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
reflects	VBZ	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nsubjpass	I-Gene_or_gene_product
could	MD	aux	O
be	VB	auxpass	O
considered	VBN	ccomp	O
as	IN	case	O
a	DT	det	O
candidate	NN	nmod	O
for	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
drug	NN	compound	O
development	NN	nmod	O
and	CC	cc	O
as	IN	case	O
a	DT	det	O
cancer	NN	compound	B-Cancer
diagnostic	JJ	amod	O
marker	NN	conj	O
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	O
.	.	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	nsubj	O
plays	VBZ	ROOT	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
organism	NN	nmod	O
by	IN	mark	O
supervising	VBG	advcl	O
strict	JJ	amod	O
compliance	NN	dobj	O
of	IN	prep	O
individual	JJ	amod	O
cells	NNS	pobj	O
to	TO	aux	O
needs	NNS	advcl	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
organisms	NNS	pobj	O
.	.	punct	O
The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
functions	VBZ	ROOT	O
to	TO	mark	O
prevent	VB	xcomp	O
tumour	NN	compound	B-Cancer
development	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
outgrowth	NN	dobj	O
of	IN	case	O
stressed	JJ	amod	O
or	CC	cc	O
damaged	VBN	conj	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	pobj	O
to	TO	dep	O
well	RB	advmod	O
established	VBN	amod	O
functions	NNS	nmod	O
to	TO	mark	O
block	VB	acl	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
revealed	VBN	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
pathways	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
.	.	punct	O

Intriguingly	RB	advmod	O
,	,	punct	O
metabolic	JJ	amod	O
stress	NN	nsubj	O
triggers	VBZ	ROOT	O
primarily	RB	advmod	O
an	DT	det	O
adaptive	NN	dobj	O
(	-LRB-	punct	O
rather	RB	cc	O
than	IN	mwe	O
pro	NN	dep	O
-	HYPH	punct	O
apoptotic	JJ	dep	O
)	-RRB-	punct	O
p53	NN	compound	O
response	NN	conj	O
,	,	punct	O
and	CC	cc	O
p53	NN	nsubj	O
is	VBZ	aux	O
emerging	VBG	conj	O
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
homeostasis	NN	nmod	O
.	.	punct	O
The	DT	det	O
metabolic	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
resist	VBP	ROOT	O
the	DT	det	O
shift	NN	dobj	O
to	TO	case	O
glycolysis	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
characteristically	RB	advmod	O
seen	VBN	acl:relcl	O
in	IN	case	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
help	VBP	conj	O
cells	NNS	nsubj	B-Cell
adapt	VB	dobj	O
to	TO	dep	O
and	CC	cc	O
survive	VB	conj	O
limited	JJ	amod	O
periods	NNS	dobj	O
of	IN	prep	O
metabolic	JJ	amod	O
stress	NN	pobj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
indicate	VBP	ROOT	O
that	IN	mark	O
even	RB	advmod	O
under	IN	case	O
normal	JJ	amod	O
physiological	JJ	amod	O
conditions	NNS	nsubj	O
certain	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	O
participate	VBP	ccomp	O
in	IN	case	O
homeostatic	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
metabolic	JJ	amod	O
processes	NNS	nmod	O
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
activities	NNS	nsubj	O
are	VBP	cop	O
important	JJ	conj	O
for	IN	case	O
prevention	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Such	JJ	amod	O
activities	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
would	MD	aux	O
not	RB	neg	O
only	RB	advmod	O
help	VB	ROOT	O
to	TO	aux	O
prevent	VB	xcomp	O
cancer	NN	compound	B-Cancer
development	NN	dobj	O
,	,	punct	O
but	CC	cc	O
might	MD	aux	O
also	RB	advmod	O
contribute	VB	conj	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
related	JJ	amod	O
roles	NNS	nmod	O
for	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
longevity	NN	nmod	O
.	.	punct	O

These	DT	det	O
novel	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	O
help	NN	ROOT	O
to	TO	mark	O
align	VB	xcomp	O
metabolic	JJ	amod	O
processes	NNS	dobj	O
with	IN	case	O
the	DT	dep	O
proliferation	NN	nmod	O
and	CC	cc	O
energy	NN	compound	O
status	NN	conj	O
,	,	punct	O
to	TO	mark	O
maintain	VB	advcl	O
optimal	JJ	amod	O
mode	NN	dobj	O
of	IN	case	O
glucose	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
to	TO	aux	O
boost	VB	conj	O
the	DT	det	O
energy	NN	nmod:npmod	O
efficient	JJ	amod	O
mitochondrial	JJ	amod	O
respiration	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
ATP	NN	compound	O
deficiency	NN	nmod	O
.	.	punct	O
These	DT	det	O
new	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
are	VBP	aux	O
providing	VBG	ROOT	O
interesting	JJ	amod	O
possibilities	NNS	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	O
/	:	punct	O
Erk	NN	conj	O
and	CC	cc	O
PI3K	NN	conj	O
/	:	punct	O
Akt	NN	compound	O
signaling	NN	conj	O
.	.	punct	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	compound	I-Gene_or_gene_product
Overexpression	NN	nsubjpass	O
and	CC	cc	O
abnormal	JJ	amod	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
poor	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
in	IN	case	O
stage	NN	compound	B-Cancer
I	CD	nummod	I-Cancer
non	JJ	advmod	I-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
their	PRP$	poss	O
functions	NNS	pobj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
play	VBP	ccomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cancers	NNS	nmod	O
.	.	punct	O
Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nsubj	I-Gene_or_gene_product
interacted	VBD	ccomp	O
with	IN	case	O
other	JJ	amod	O
key	JJ	amod	O
cellular	JJ	amod	B-Cell
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
tumors	NNS	nsubj	O
with	IN	case	O
beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	compound	O
stabilization	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
melanomas	NNS	nmod	O
.	.	punct	O
Knowledge	NN	nsubjpass	O
of	IN	prep	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	pobj	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	B-Tissue
tumor	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
is	VBZ	auxpass	O
limited	JJ	ROOT	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
small	JJ	amod	O
cell	NN	compound	O
lung	NN	compound	O
cancer	NN	nmod	O
(	-LRB-	punct	O
NSCLC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
significance	NN	conj	O
of	IN	prep	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	pobj	I-Gene_or_gene_product
in	IN	case	O
stage	NN	nmod	O
I	CD	nummod	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	dep	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
45	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
NSCLC	NN	nmod	O
and	CC	cc	O
adjacent	JJ	amod	O
tissue	NN	conj	O
of	IN	case	O
NSCLC	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
lung	NN	compound	O
tissue	NN	conj	O
was	VBD	auxpass	O
checked	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
Specimens	NNS	nsubjpass	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
and	CC	cc	O
adjacent	JJ	amod	O
normal	JJ	amod	B-Tissue
lung	NN	compound	I-Tissue
tissues	NNS	conj	I-Tissue
were	VBD	auxpass	O
collected	VBN	ROOT	O
from	IN	case	O
110	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
screened	VBD	dep	O
the	DT	det	O
expression	NN	compound	O
profile	NN	dobj	O
of	IN	case	O
AQP0	NN	compound	O
-	:	punct	O
12	CD	dep	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
tissues	NNS	nmod	O
and	CC	cc	O
corresponding	VBG	conj	O
normal	JJ	amod	O
tissues	NNS	dobj	O
by	IN	case	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blotting	NN	conj	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O
The	DT	det	O
expressions	NNS	nsubjpass	O
of	IN	case	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
western	NN	compound	O
blotting	NN	nmod	O
,	,	punct	O
double	JJ	amod	O
labeling	NN	compound	O
immunofluorescence	NN	appos	O
,	,	punct	O
confocal	JJ	amod	O
laser	NN	compound	O
scanning	NN	compound	O
microscopy	NN	conj	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

Serum	NN	compound	O
VEGF	NN	compound	O
protein	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	nmod	O
III	CD	nummod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
upregulated	VBN	ROOT	O
in	IN	case	O
stage	NN	compound	B-Cancer
I	CD	nummod	I-Cancer
NSCLC	NNP	nmod	I-Cancer
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
HSP27	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
stage	NN	conj	O
,	,	punct	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
and	CC	cc	O
histological	JJ	amod	O
grade	NN	conj	O
.	.	punct	O
Further	RB	advmod	O
,	,	punct	O
the	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nmod	I-Gene_or_gene_product
correlated	VBD	ROOT	O
with	IN	case	O
histological	JJ	amod	O
grades	NNS	nmod	O
,	,	punct	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
and	CC	cc	O
poor	JJ	amod	O
clinical	JJ	amod	O
outcome	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	O
/	:	punct	O
Erk	NN	conj	O
and	CC	cc	O
PI3K	NN	conj	O
/	:	punct	O
Akt	NN	compound	O
signaling	NN	conj	O
.	.	punct	O
Abnormal	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
poor	JJ	amod	O
differentiation	NN	nmod	O
and	CC	cc	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	conj	O
.	.	punct	O

Highly	RB	advmod	O
metastatic	JJ	amod	O
tumors	NNS	nsubj	O
with	IN	case	O
beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	compound	O
stabilization	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
melanomas	NNS	nmod	O
.	.	punct	O
Abnormal	JJ	amod	O
beta	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
significantly	RB	advmod	O
with	IN	case	O
positive	JJ	amod	O
14	CD	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	mark	O
altering	VBG	acl	O
metastasis	NN	dobj	O
,	,	punct	O
beta	NN	compound	O
-	:	punct	O
catenin	NN	compound	O
levels	NNS	nsubj	O
control	VBP	ROOT	O
tumor	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
regulate	VB	conj	O
both	CC	cc:preconj	O
MAPK	NN	dobj	O
/	:	punct	O
Erk	NN	conj	O
and	CC	cc	O
PI3K	NN	conj	O
/	:	punct	O
Akt	NN	compound	O
signaling	NN	conj	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
might	MD	aux	O
have	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
development	NN	nmod	O
,	,	punct	O
progression	NN	conj	O
and	CC	cc	O
metastatic	JJ	amod	O
process	NN	conj	O
of	IN	case	O
NSCLC	NNP	nmod	B-Cancer
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Merlin	NN	compound	O
protein	NN	nsubj	O
might	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
of	IN	case	O
NSCLC	NN	nmod	O
.	.	punct	O
14	CD	nummod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3zeta	NN	nsubjpass	I-Gene_or_gene_product
might	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
prognostic	JJ	amod	O
biomarkers	NNS	nmod	O
for	IN	case	O
NSCLC	NNP	nmod	B-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
metabolically	RB	advmod	O
-	HYPH	punct	O
altered	JJ	amod	O
islet	NN	compound	O
endothelium	NN	nsubj	O
might	MD	aux	O
affect	VB	ROOT	O
the	DT	det	O
beta	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
microenvironment	NN	dobj	O
and	CC	cc	O
contribute	VBP	conj	O
to	TO	case	O
progressive	JJ	amod	O
type	NN	compound	O
2	CD	nummod	O
diabetic	JJ	amod	O
beta	NN	compound	O
-	:	punct	O
cell	NN	compound	O
dysfunction	NN	nmod	O
in	IN	case	O
GK	NN	compound	O
rats	NNS	nmod	O
.	.	punct	O
p24	NN	compound	B-Gene_or_gene_product
family	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
transmembrane	NN	compound	I-Gene_or_gene_product
proteins	NNS	nsubjpass	I-Gene_or_gene_product
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
biosynthesis	NN	nmod	O
and	CC	cc	O
secretion	NN	conj	O
in	IN	case	O
pancreatic	JJ	amod	B-Cell
beta	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Among	IN	case	O
the	DT	det	O
members	NNS	nmod	O
of	IN	case	O
this	DT	det	O
superfamily	NN	nmod	O
there	EX	expl	O
are	VBP	ROOT	O
proteins	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ras	NN	nmod	O
,	,	punct	O
and	CC	cc	O
proteins	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
vesicular	JJ	amod	O
trafficking	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
family	NN	nmod	O
of	IN	case	O
rab	JJ	compound	O
proteins	NNS	nmod	O
.	.	punct	O
The	DT	det	O
p24	NN	compound	B-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
family	NN	nsubj	I-Gene_or_gene_product
have	VBP	ROOT	O
multiple	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
protein	NN	compound	O
transport	NN	nmod	O
in	IN	case	O
the	DT	det	O
early	JJ	amod	O
secretory	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
p24	NN	compound	B-Gene_or_gene_product
proteins	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
transport	NN	nmod	O
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	O
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	O
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O
Several	JJ	amod	O
members	NNS	nsubjpass	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
insulinoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
rat	NN	compound	B-Organism
islets	NNS	conj	B-Multi-tissue_structure
and	CC	cc	O
expression	NN	compound	O
levels	NNS	conj	O
positively	RB	advmod	O
correlated	VBD	conj	O
with	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
abundance	NN	nmod	O
,	,	punct	O
particularly	RB	advmod	O
for	IN	case	O
p24delta1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
p24beta1	NN	conj	B-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
down	JJ	amod	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
p21WAF1	JJ	nmod	O
closely	RB	advmod	O
correlated	VBD	ROOT	O
with	IN	case	O
poly	NN	amod	O
(	-LRB-	punct	O
ADP	NN	compound	O
-	HYPH	punct	O
ribose	NN	amod	O
)	-RRB-	punct	O
polymerase	NN	compound	O
cleavage	NN	nmod	O
and	CC	cc	O
CPP32	NN	compound	O
activation	NN	conj	O
.	.	punct	O
Knocking	VBG	ROOT	O
down	RP	prt	O
p24delta1	NN	dobj	B-Gene_or_gene_product
in	IN	case	O
insulinoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
also	RB	advmod	O
resulted	VBD	acl:relcl	O
in	IN	case	O
the	DT	det	O
concomitant	JJ	amod	O
knock	NN	compound	O
-	HYPH	punct	O
down	RB	nmod	O
of	IN	case	O
other	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
,	,	punct	O
impaired	JJ	amod	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
insulin	NN	compound	B-Gene_or_gene_product
secretion	NN	conj	O
,	,	punct	O
decreased	VBD	conj	O
total	JJ	amod	O
cellular	JJ	amod	B-Cell
insulin	NN	compound	B-Gene_or_gene_product
content	NN	dobj	O
and	CC	cc	O
reduced	VBD	amod	O
proinsulin	NN	compound	B-Gene_or_gene_product
biosynthesis	NN	conj	O
.	.	punct	O

Glycolysis	NNP	nsubjpass	O
was	VBD	auxpass	O
affected	VBN	ROOT	O
by	IN	case	O
pharmacological	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
Myc	NNP	nmod	O
and	CC	cc	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	conj	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
effect	NN	nsubj	O
on	IN	case	O
overall	JJ	amod	O
protein	NN	compound	O
biosynthesis	NN	nmod	O
or	CC	cc	O
ER	NN	compound	B-Gene_or_gene_product
stress	NN	conj	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
further	JJ	amod	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
on	IN	case	O
addition	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
was	VBD	auxpass	O
greatly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
p24delta1	NN	nsubjpass	B-Gene_or_gene_product
and	CC	cc	O
possibly	RB	advmod	O
other	JJ	amod	O
p24	NN	compound	B-Gene_or_gene_product
family	NN	compound	I-Gene_or_gene_product
proteins	NNS	conj	I-Gene_or_gene_product
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
normal	JJ	amod	O
insulin	NN	compound	B-Gene_or_gene_product
biosynthesis	NN	nmod	O
and	CC	cc	O
subsequent	JJ	amod	O
secretion	NN	conj	O
in	IN	case	O
pancreatic	JJ	amod	B-Cell
beta	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
transfection	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	O
can	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MMP	NN	compound	O
-	HYPH	punct	O
9	CD	nmod	O
in	IN	case	O
CNE1	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Expression	NN	ROOT	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
relations	NNS	conj	O
to	TO	case	O
metastasis	NN	nmod	O
and	CC	cc	O
survival	NN	conj	O
.	.	punct	O

MTSS1	NN	nsubjpass	O
(	-LRB-	punct	O
metastasis	NN	compound	O
suppressor	NN	nsubjpass	O
-	:	punct	O
1	CD	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
missing	VBG	nmod	O
in	IN	case	O
metastatic	JJ	amod	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
KISS1	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product
metalloproteinase	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
may	MD	aux	O
play	VB	ROOT	O
important	JJ	amod	O
roles	NNS	dobj	O
as	IN	case	O
metastasis	NN	compound	O
suppressor	NN	nmod	O
and	CC	cc	O
metastasis	NN	compound	O
promoter	NN	compound	O
genes	NNS	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Many	JJ	nsubj	O
of	IN	prep	O
their	PRP$	poss	O
functions	NNS	pobj	O
suggest	VBP	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
play	VBP	ccomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
cancers	NNS	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
little	JJ	amod	O
information	NN	nsubj	O
about	IN	case	O
their	PRP$	nmod:poss	O
possible	JJ	amod	O
roles	NNS	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
clinical	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
small	JJ	amod	O
cell	NN	compound	O
lung	NN	compound	O
cancer	NN	nmod	O
(	-LRB-	punct	O
NSCLC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
goals	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
expressions	NNS	dobj	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
in	IN	case	O
NSCLC	NNP	nmod	B-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
relations	NNS	conj	O
to	TO	case	O
metastasis	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
45	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
NSCLC	NN	nmod	O
and	CC	cc	O
adjacent	JJ	amod	O
tissue	NN	conj	O
of	IN	case	O
NSCLC	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
lung	NN	compound	O
tissue	NN	conj	O
was	VBD	auxpass	O
checked	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O
The	DT	det	O
mRNA	NN	compound	O
and	CC	cc	O
protein	NN	conj	O
expressions	NNS	nsubjpass	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
protein	NN	conj	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
respectively	RB	advmod	O
in	IN	case	O
85	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
NSCLC	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
matched	VBN	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	compound	O
rates	NNS	nsubj	O
of	IN	case	O
Merlin	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
NSCLC	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
lung	NN	compound	O
tissue	NN	compound	O
sections	NNS	conj	O
were	VBD	appos	O
73	CD	attr	O
.	.	punct	O
33	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
15	CD	conj	O
.	.	punct	O
56	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
Expressions	NNS	nsubj	O
of	IN	case	O
KISS1	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
low	JJ	amod	O
TNM	NN	compound	O
stages	NNS	nmod	O
of	IN	case	O
NSCLC	NNP	nmod	B-Cancer
(	-LRB-	punct	O
I	CD	compound	O
-	SYM	punct	O
II	CD	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
to	TO	case	O
more	RBR	advmod	O
advanced	JJ	amod	O
stages	NNS	advcl	O
(	-LRB-	punct	O
III	CD	compound	O
-	SYM	punct	O
IV	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
between	IN	case	O
nm23	NN	compound	O
-	HYPH	punct	O
H1	NN	compound	O
gene	NN	compound	O
product	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
lymph	NN	compound	O
nodes	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
patients	NNS	compound	O
survival	NN	conj	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
in	IN	case	O
advanced	JJ	amod	O
TNM	NN	compound	O
stages	NNS	nmod	O
,	,	punct	O
cases	NNS	nsubj	O
without	IN	case	O
metastasis	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
KISS1	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	dobj	O
compared	VBN	case	O
to	TO	case	O
those	DT	nmod	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
MMP	NN	compound	O
-	:	punct	O
9	CD	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	appos	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
but	CC	cc	O
the	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
staining	NN	nmod	O
was	VBD	cop	O
different	JJ	conj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
stage	NN	compound	O
III	CD	nummod	O
-	SYM	punct	O
IV	CD	nummod	O
NSCLC	NNP	compound	B-Cancer
cases	NNS	nmod	O
compared	VBN	mark	O
to	TO	mark	O
stage	NN	advcl	O
I	CD	compound	O
-	HYPH	punct	O
II	CD	nummod	O
tumors	NNS	dobj	B-Cancer
(	-LRB-	punct	O
p	NN	dep	O
<	CD	amod	O
0	CD	nummod	O
.	.	punct	O
05	CD	conj	O
)	-RRB-	punct	O
and	CC	cc	O
higher	JJR	conj	O
in	IN	case	O
NSCLC	NN	compound	B-Cancer
cases	NNS	nmod	O
with	IN	case	O
metastasis	NN	nmod	O
than	IN	case	O
those	DT	nmod	O
without	IN	case	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
transfection	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	O
can	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MMP	NN	compound	O
-	HYPH	punct	O
9	CD	nmod	O
in	IN	case	O
CNE1	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
negative	JJ	amod	O
correction	NN	nsubj	O
between	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	conj	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
high	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
WT1	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
acute	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O
The	DT	det	O
5	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
survival	NN	compound	O
rate	NN	nsubj	O
in	IN	case	O
cases	NNS	nmod	O
with	IN	case	O
higher	JJR	amod	O
KISS1	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
with	IN	case	O
low	JJ	amod	O
expression	NN	nmod	O
(	-LRB-	punct	O
20	CD	nummod	O
.	.	punct	O
9	CD	nmod	O
vs	CC	cc	O
.	.	punct	O
2	LS	nummod	O
.	.	punct	O
4	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
p	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
01	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
positive	JJ	amod	O
rates	NNS	nsubj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
MMP	NN	compound	O
-	HYPH	punct	O
9	CD	nmod	O
in	IN	case	O
CNE1	NN	compound	O
and	CC	cc	O
CNE1	NN	compound	O
-	HYPH	punct	O
GL	NN	conj	O
cells	NNS	nmod	O
were	VBD	cop	O
30	CD	ROOT	O
.	.	punct	O
2	CD	nummod	O
%	NN	ROOT	O
and	CC	cc	O
98	CD	conj	O
.	.	punct	O
2	CD	nummod	O
%	NN	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
5	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
survival	NN	compound	O
rate	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
protein	NN	compound	O
expression	NN	nmod	O
were	VBD	cop	O
lower	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
with	IN	case	O
low	JJ	amod	O
expression	NN	nmod	O
(	-LRB-	punct	O
19	CD	nummod	O
vs	CC	cc	O
.	.	punct	O
4	LS	conj	O
.	.	punct	O
7	CD	nummod	O
%	NN	dep	O
,	,	punct	O
p	NN	dep	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
transfection	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	O
can	MD	aux	O
increase	VB	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
MMP	NN	compound	O
-	HYPH	punct	O
9	CD	nmod	O
in	IN	case	O
CNE1	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
KISS1	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
MMP	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	nsubj	I-Gene_or_gene_product
may	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
potential	JJ	amod	O
prognostic	JJ	amod	O
and	CC	cc	O
therapeutic	JJ	conj	O
markers	NNS	nmod	O
in	IN	case	O
lung	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
between	IN	case	O
p53	NN	nmod	O
and	CC	cc	O
VEGF	NN	conj	O
expressions	NNS	dep	O
and	CC	cc	O
poor	JJ	amod	O
prognosis	NN	conj	O
was	VBD	auxpass	O
found	VBN	ROOT	O
.	.	punct	O
Relationship	NN	compound	O
and	CC	cc	O
prognostic	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
protein	NN	compound	O
expression	NN	ROOT	O
in	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

SPARC	NN	nsubj	O
(	-LRB-	punct	O
secreted	VBN	amod	O
protein	NN	dep	O
,	,	punct	O
acidic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
rich	JJ	conj	O
in	IN	case	O
cysteine	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
SPARC	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
secreted	VBN	amod	B-Gene_or_gene_product
protein	NN	dep	I-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
acidic	JJ	appos	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
rich	JJ	conj	I-Gene_or_gene_product
in	IN	case	I-Gene_or_gene_product
cysteine	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
closely	RB	advmod	O
related	JJ	appos	O
with	IN	case	O
the	DT	det	O
progress	NN	nmod	O
,	,	punct	O
invasion	NN	conj	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

SPARC	NN	nsubj	O
(	-LRB-	punct	O
secreted	VBN	amod	O
protein	NN	dep	O
,	,	punct	O
acidic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
rich	JJ	conj	O
in	IN	case	O
cysteine	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
Using	VBG	dep	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Tissue
adenocarcinoma	NN	compound	I-Tissue
tissues	NNS	dobj	I-Tissue
(	-LRB-	punct	O
hereinafter	NN	dep	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
)	-RRB-	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
corresponding	JJ	amod	O
non	JJ	amod	B-Tissue
-	HYPH	punct	I-Tissue
diseased	JJ	amod	I-Tissue
colon	NN	conj	I-Tissue
from	IN	case	O
114	CD	nummod	O
patients	NNS	nmod:poss	B-Organism
'	POS	case	O
biopsies	NNS	nmod	B-Tissue
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
investigated	VBN	parataxis	O
by	IN	case	O
immunohistochemistry	NN	compound	O
staining	NN	nmod	O
to	TO	mark	O
assessment	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
their	PRP$	nmod:poss	O
prognostic	JJ	amod	O
significance	NN	conj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
.	.	punct	O

PATIENTS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
paraffin	NN	amod	O
sections	NNS	nsubjpass	O
from	IN	case	O
49	CD	nummod	O
subjects	NNS	nmod	O
with	IN	case	O
OSCC	NN	nmod	O
were	VBD	auxpass	O
subjected	VBN	dep	O
to	TO	case	O
immunohistochemical	JJ	amod	O
studies	NNS	nmod	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
highest	JJS	amod	O
MVD	NN	dobj	O
(	-LRB-	punct	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
immunoreactivity	NN	conj	O
of	IN	case	O
VEGF	NN	nmod	O
.	.	punct	O
Evaluation	NN	nsubjpass	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
expression	NN	compound	O
level	NN	nmod	O
with	IN	case	O
the	DT	det	O
same	JJ	amod	O
tissues	NNS	nmod	B-Tissue
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
establish	VB	xcomp	O
the	DT	det	O
antigenic	JJ	amod	O
profiles	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
marker	NN	nsubjpass	O
of	IN	case	O
CD34	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
was	VBD	auxpass	O
used	VBN	conj	O
as	IN	case	O
an	DT	det	O
indicator	NN	nmod	O
of	IN	case	O
microvessel	NN	compound	B-Tissue
density	NN	nmod	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
invasion	NN	nsubjpass	O
,	,	punct	O
apoptosis	NN	conj	O
and	CC	cc	O
levels	NNS	conj	O
of	IN	case	O
uPA	NN	compound	O
,	,	punct	O
MMP	NN	conj	O
-	:	punct	O
2	CD	nummod	O
and	CC	cc	O
MMP	NN	conj	O
-	:	punct	O
9	CD	nmod	O
were	VBD	auxpass	O
determined	VBN	dep	O
by	IN	case	O
invasion	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	conj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	appos	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
fluorescence	NN	compound	O
quantitative	JJ	amod	O
PCR	NN	conj	O
respectively	RB	advmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
SPARC	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
mainly	RB	advmod	O
in	IN	case	O
the	DT	det	O
stromal	JJ	amod	B-Cell
cells	NNS	dep	I-Cell
surrounding	VBG	acl	O
the	DT	det	O
colon	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
,	,	punct	O
and	CC	cc	O
was	VBD	cop	O
significant	JJ	amod	O
difference	NN	conj	O
in	IN	case	O
those	DT	det	O
tissues	NNS	nmod	B-Tissue
with	IN	case	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
and	CC	cc	O
differentiation	NN	compound	O
degree	NN	conj	O
of	IN	case	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

SPARC	NN	nsubj	O
(	-LRB-	punct	O
secreted	VBN	amod	O
protein	NN	dep	O
,	,	punct	O
acidic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
rich	JJ	conj	O
in	IN	case	O
cysteine	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
SPARC	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
MVD	NN	conj	B-Gene_or_gene_product
in	IN	case	O
colon	NN	compound	B-Tissue
cancer	NN	compound	I-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

SPARC	NN	nsubj	O
(	-LRB-	punct	O
secreted	VBN	amod	O
protein	NN	dep	O
,	,	punct	O
acidic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
rich	JJ	conj	O
in	IN	case	O
cysteine	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Patients	NNS	nsubj	B-Organism
with	IN	case	O
low	JJ	pobj	O
or	CC	cc	O
absence	NN	conj	O
expressing	VBG	amod	O
SPARC	NN	nmod	B-Gene_or_gene_product
had	VBD	aux	O
significantly	RB	advmod	O
worse	JJR	ROOT	O
overall	JJ	amod	O
survival	NN	dobj	O
and	CC	cc	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	conj	O
in	IN	case	O
a	DT	det	O
Single	NNP	compound	O
Factor	NNP	compound	O
Analysis	NNP	nmod	O
;	:	punct	O
Cox	NNP	compound	O
Regression	NNP	compound	O
Analysis	NNP	conj	O
,	,	punct	O
SPARC	NN	nsubj	B-Gene_or_gene_product
emerged	VBD	parataxis	O
as	IN	case	O
an	DT	det	O
overall	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
disease	NN	conj	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nmod:npmod	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	conj	O
for	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
MMP	NN	compound	O
/	:	punct	O
TIMP	NN	compound	O
profile	NN	nsubj	O
defined	VBN	acl	O
by	IN	case	O
hierarchical	JJ	amod	O
cluster	NN	compound	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunohistochemical	JJ	amod	O
score	NN	nmod	O
identifies	VBZ	appos	O
a	DT	det	O
distinct	JJ	amod	O
group	NN	dobj	O
of	IN	case	O
colorectal	JJ	amod	O
cancers	NNS	nmod	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
(	-LRB-	punct	O
log	NN	compound	O
-	HYPH	punct	O
rank	NN	compound	O
test	NN	dep	O
,	,	punct	O
12	CD	appos	O
.	.	punct	O
22	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
0005	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
low	JJ	amod	O
expression	NN	nsubj	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
stromal	JJ	amod	B-Cell
SPARC	NN	nmod	B-Gene_or_gene_product
was	VBD	cop	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	appos	O
for	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
of	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

SPARC	NN	nsubj	O
(	-LRB-	punct	O
secreted	VBN	amod	O
protein	NN	dep	O
,	,	punct	O
acidic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
rich	JJ	conj	O
in	IN	case	O
cysteine	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
matrix	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
glycoprotein	NN	ROOT	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
the	DT	det	O
adhesion	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
vascular	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
SPARC	VBP	nsubj	B-Gene_or_gene_product
maybe	RB	advmod	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
angiogenesis	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
it	PRP	nsubj	O
may	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
treatment	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
novel	JJ	amod	O
distinctive	JJ	amod	O
marker	NN	conj	O
.	.	punct	O

Bmi	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
expression	NN	nsubj	O
is	VBZ	cop	O
elevated	JJ	ROOT	O
in	IN	case	O
most	JJS	amod	O
human	JJ	amod	O
gliomas	NNS	nmod	O
,	,	punct	O
irrespective	RB	amod	O
of	IN	case	O
grade	NN	nmod	O
,	,	punct	O
raising	VBG	advcl	O
the	DT	det	O
question	NN	dobj	O
of	IN	prep	O
whether	IN	mark	O
Bmi	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	pcomp	O
to	TO	aux	O
promote	VB	xcomp	O
self	NN	compound	O
-	HYPH	punct	O
renewal	NN	dobj	O
or	CC	cc	O
tumorigenesis	NN	conj	O
by	IN	case	O
CNS	NN	compound	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
fate	NN	compound	O
determinant	NN	nsubj	O
TLX	NN	nsubj	B-Gene_or_gene_product
promotes	VBZ	ROOT	O
tumorigenesis	NN	dobj	O
and	CC	cc	O
genesis	NN	conj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
resembling	VBG	acl	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
A	DT	det	O
growing	VBG	amod	O
body	NN	nsubj	B-Organism_subdivision
of	IN	case	O
evidence	NN	nmod	O
indicates	VBZ	ROOT	O
that	IN	mark	O
deregulation	NN	nsubj	O
of	IN	case	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
fate	NN	compound	O
determinants	NNS	nmod	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ccomp	O
of	IN	case	O
many	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
lines	NNS	nmod	O
with	IN	case	O
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
fetal	JJ	amod	O
and	CC	cc	O
adult	JJ	conj	O
CNS	NN	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
transgenic	JJ	amod	O
neural	JJ	amod	O
stem	NN	compound	O
cells	NNS	nsubj	O
formed	VBD	ccomp	O
larger	JJR	amod	O
colonies	NNS	dobj	O
,	,	punct	O
more	JJR	advmod	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
divisions	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
more	JJR	amod	O
neurons	NNS	conj	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O
The	DT	det	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
fate	NN	compound	O
determinant	NN	nsubj	O
TLX	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ROOT	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
neurogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
adult	JJ	amod	O
brain	NN	nmod	B-Organ
by	IN	mark	O
maintaining	VBG	advcl	O
neural	JJ	amod	B-Cell
stem	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
ING4	NN	nsubj	O
has	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
brain	NN	compound	O
tumour	NN	compound	O
pathogenesis	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
a	DT	det	O
tumorigenic	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
TLX	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
brain	NN	nmod	B-Cancer
tumor	NN	compound	I-Cancer
initiation	NN	dep	O
and	CC	cc	O
progression	NN	conj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
ING4	NN	nmod	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
brain	NN	compound	O
tissue	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
reduction	NN	nmod	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
from	IN	case	O
lower	JJR	nmod	O
to	IN	case	O
higher	JJR	amod	O
grades	NNS	nmod	O
of	IN	prep	O
tumours	NNS	pobj	O
.	.	punct	O
Increased	VBN	amod	O
TLX	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
poor	JJ	amod	O
survival	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gliomas	NNS	nmod	B-Cancer
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
LeTx	NN	nsubj	O
decreased	VBD	ROOT	O
MAPK	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
blocked	VBD	conj	O
fibrosarcoma	NN	compound	O
growth	NN	dobj	O
.	.	punct	O
Ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
TLX	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
U87MG	NN	compound	B-Cell
glioma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
Ink4a	NN	amod	B-Gene_or_gene_product
/	:	punct	O
Arf	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mouse	NN	compound	O
astrocytes	NNS	conj	O
(	-LRB-	punct	O
Ink4a	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Arf	NNP	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	dep	O
)	-RRB-	punct	O
astrocytes	NNS	appos	O
)	-RRB-	punct	O
induced	VBD	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
with	IN	case	O
a	DT	det	O
concomitant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
accelerated	VBN	conj	O
foci	NNS	compound	B-Cell
formation	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
formation	NN	conj	O
in	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
transplantation	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

The	DT	det	O
more	RBR	advmod	O
pronounced	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
Bmi	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
over	IN	dep	O
-	HYPH	punct	O
expression	NN	nmod	O
in	IN	case	O
culture	NN	nmod	O
were	VBD	cop	O
largely	RB	advmod	O
attributable	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
attenuated	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
p16	NN	nmod	O
(	-LRB-	punct	O
Ink4a	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p19	NN	conj	O
(	-LRB-	punct	O
Arf	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
proteins	NNS	dep	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
generally	RB	advmod	O
not	RB	neg	O
expressed	VBN	acl:relcl	O
by	IN	case	O
neural	JJ	amod	O
stem	NN	compound	O
/	:	punct	O
progenitor	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
young	JJ	amod	O
mice	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
TLX	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Ink4a	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Arf	NNP	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	nummod	O
)	-RRB-	punct	O
astrocytes	NNS	nmod	O
inhibited	VBD	ROOT	O
cell	NN	compound	B-Cell
migration	NN	dobj	O
and	CC	cc	O
invasion	NN	conj	O
and	CC	cc	O
promoted	VBD	conj	O
neurosphere	JJ	amod	B-Cell
formation	NN	dobj	O
and	CC	cc	O
Nestin	NN	compound	B-Gene_or_gene_product
expression	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
hallmark	JJ	amod	O
characteristics	NNS	acl:relcl	O
of	IN	case	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
under	IN	case	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
culture	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
LeTx	NN	nsubj	O
decreased	VBD	ROOT	O
MAPK	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
blocked	VBD	conj	O
fibrosarcoma	NN	compound	O
growth	NN	dobj	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TLX	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
glioma	NN	compound	B-Cell
stem	NN	compound	I-Cell
cell	NN	compound	I-Cell
genesis	NN	nmod	O
and	CC	cc	O
represents	VBZ	conj	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
this	DT	det	O
type	NN	nmod	O
of	IN	case	O
malignancy	NN	nmod	B-Cancer
.	.	punct	O

Metabolic	JJ	amod	O
alterations	NNS	ROOT	O
in	IN	case	O
a	DT	det	O
noncachectic	JJ	amod	O
animal	NN	compound	O
tumor	NN	compound	O
system	NN	nmod	O
.	.	punct	O
Expression	NN	ROOT	O
profiling	VBG	acl	O
in	IN	case	O
progressive	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
fumarate	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
hydratase	NN	compound	I-Gene_or_gene_product
deficiency	NN	nmod	O
:	:	punct	O
the	DT	det	O
contribution	NN	dep	O
of	IN	case	O
metabolic	JJ	amod	O
changes	NNS	nmod	O
to	TO	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
subsequent	JJ	amod	O
identification	NN	nsubj	O
of	IN	case	O
germline	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
gene	NN	compound	O
encoding	NN	compound	O
fumarase	NN	nmod	O
-	HYPH	punct	O
-	:	punct	O
another	DT	det	O
TCA	NN	compound	O
cycle	NN	compound	O
enzyme	NN	conj	O
-	:	punct	O
-	:	punct	O
in	IN	case	O
a	DT	det	O
new	JJ	amod	O
hereditary	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
susceptibility	NN	nmod	O
to	TO	case	O
renal	JJ	amod	O
,	,	punct	O
uterine	JJ	conj	O
and	CC	cc	O
cutaneous	JJ	conj	O
tumors	NNS	nmod	O
has	VBZ	aux	O
highlighted	VBN	ROOT	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCA	NN	compound	O
cycle	NN	nmod	O
and	CC	cc	O
,	,	punct	O
more	RBR	advmod	O
generally	RB	advmod	O
,	,	punct	O
of	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Hereditary	JJ	amod	B-Cancer
leiomyomatosis	NN	nsubjpass	I-Cancer
and	CC	cc	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
(	-LRB-	punct	O
HLRCC	NN	appos	B-Cancer
)	-RRB-	punct	O
is	VBZ	auxpass	O
caused	VBN	ROOT	O
by	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
Krebs	NN	compound	O
cycle	NN	compound	O
enzyme	NN	nmod	O
fumarate	NN	conj	B-Gene_or_gene_product
hydratase	NN	dobj	I-Gene_or_gene_product
(	-LRB-	punct	O
FH	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

Hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
1	CD	nummod	O
activation	NN	nsubj	O
by	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
implicates	VBZ	ROOT	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
"	``	punct	O
pseudohypoxic	JJ	amod	O
"	``	punct	O
stabilization	NN	nsubj	O
of	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
fumarate	NN	amod	B-Simple_chemical
accumulation	NN	nmod	O
contributes	VBZ	ccomp	O
to	TO	case	O
tumorigenesis	NN	nmod	O
in	IN	case	O
HLRCC	NN	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
mortality	NN	nsubj	O
observed	VBN	acl	O
in	IN	case	O
the	DT	det	O
folate	JJ	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
group	NN	nmod	O
precludes	VBZ	ROOT	O
a	DT	det	O
definitive	JJ	amod	O
conclusion	NN	dobj	O
concerning	VBG	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
folate	JJ	compound	O
deficiency	NN	nmod	O
on	IN	case	O
UC	NNP	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
colorectal	JJ	amod	O
carcinogenesis	NN	nmod	O
in	IN	case	O
this	DT	det	O
model	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
an	DT	det	O
additional	JJ	amod	O
direct	JJ	amod	O
consequence	NN	nsubj	O
of	IN	case	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
establishment	NN	ccomp	O
of	IN	case	O
a	DT	det	O
biosynthetic	JJ	amod	O
milieu	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	O
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	O
(	-LRB-	punct	O
TRADD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	O
.	.	punct	O
To	TO	mark	O
investigate	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
primary	JJ	amod	B-Cell
mouse	NN	compound	I-Cell
embryonic	JJ	amod	I-Cell
fibroblast	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
MEF	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
lines	NNS	dobj	I-Cell
from	IN	case	O
Fh1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
JNK1	NN	nmod	O
or	CC	cc	O
p38	NN	conj	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
expression	NN	dobj	O
.	.	punct	O
As	IN	mark	O
predicted	VBN	advcl	O
,	,	punct	O
these	DT	det	O
MEFs	NNS	nsubj	B-Cell
upregulated	VBD	ROOT	O
Hif	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
HIF	NN	conj	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	dobj	O
directly	RB	advmod	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	nmod	O
.	.	punct	O

As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
,	,	punct	O
these	DT	det	O
tumors	NNS	nsubj	O
generate	VBP	ROOT	O
more	JJR	amod	O
lactate	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
effluxed	VBN	acl:relcl	O
from	IN	case	O
cells	NNS	nmod	O
by	IN	case	O
monocarboxylate	JJ	amod	O
transporters	NNS	nmod	O
(	-LRB-	punct	O
MCTs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
detailed	VBD	amod	O
metabolic	JJ	amod	O
assessment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
MEFs	NNS	nmod	B-Cell
confirmed	VBD	ROOT	O
their	PRP$	nmod:poss	O
dependence	NN	dobj	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
elevated	JJ	amod	O
rate	NN	conj	O
of	IN	case	O
lactate	NN	amod	B-Simple_chemical
efflux	NN	nmod	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
glycolytic	JJ	amod	B-Gene_or_gene_product
enzymes	NNS	nmod	I-Gene_or_gene_product
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Increases	NNS	nsubj	O
in	IN	case	O
these	DT	det	O
mRNA	NN	compound	O
levels	NNS	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
tumors	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
low	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
Correspondingly	RB	advmod	O
,	,	punct	O
Fh1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
benign	JJ	amod	O
murine	JJ	amod	O
renal	JJ	amod	O
cysts	NNS	nsubj	O
and	CC	cc	O
an	DT	det	O
advanced	JJ	amod	O
human	JJ	amod	B-Organism
HLRCC	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
related	JJ	amod	I-Cancer
renal	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
manifested	VBD	ROOT	O
a	DT	det	O
prominent	JJ	amod	O
and	CC	cc	O
progressive	JJ	conj	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
genes	NNS	conj	O
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
relevant	JJ	xcomp	O
to	TO	case	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

LDH5	NN	compound	O
overexpression	NN	nsubj	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
induces	VBZ	ROOT	O
an	DT	det	O
upregulated	VBN	amod	O
glycolytic	JJ	amod	O
metabolism	NN	dobj	O
and	CC	cc	O
reduced	VBN	amod	O
dependence	NN	conj	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
oxygen	NN	nmod	O
.	.	punct	O
In	IN	case	O
accord	NN	nmod	O
with	IN	case	O
our	PRP$	nmod:poss	O
hypothesis	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
FH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
tissues	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
a	DT	det	O
novel	JJ	amod	O
murine	JJ	amod	B-Organism
model	NN	nmod	O
of	IN	case	O
Fh1	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
smooth	NN	amod	O
muscle	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
striking	JJ	amod	O
and	CC	cc	O
progressive	JJ	conj	O
upregulation	NN	dobj	O
of	IN	case	O
a	DT	det	O
tumorigenic	JJ	amod	O
metabolic	JJ	amod	O
profile	NN	nmod	O
,	,	punct	O
as	IN	mark	O
manifested	VBN	advcl	O
by	IN	case	O
increased	VBN	amod	O
PKM2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
LDHA	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
.	.	punct	O

The	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
mitochondrial	JJ	amod	O
respiration	NN	conj	O
greatly	RB	advmod	O
accounts	VBZ	ROOT	O
for	IN	prep	O
the	DT	det	O
deficient	JJ	amod	O
respiration	NN	pobj	O
of	IN	prep	O
the	DT	det	O
predominance	NN	pobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
(	-LRB-	punct	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
deficiency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
modulated	VBN	amod	O
antioxidant	JJ	amod	O
defense	NN	compound	O
mechanisms	NNS	nmod	O
contributes	VBZ	advcl	O
to	TO	case	O
mutagenesis	NN	nmod	O
and	CC	cc	O
additionally	RB	advmod	O
boosts	VBZ	conj	O
the	DT	det	O
carcinogenesis	NN	compound	O
process	NN	dobj	O
.	.	punct	O
Based	VBN	advcl	O
on	IN	prep	O
the	DT	det	O
models	NNS	pobj	O
assessed	VBN	acl	O
herein	RB	advmod	B-Simple_chemical
,	,	punct	O
we	PRP	nsubj	O
infer	VBP	ROOT	O
that	IN	mark	O
that	IN	mark	O
FH	NN	compound	B-Gene_or_gene_product
deficiency	NN	compound	O
compels	NNS	compound	O
cells	NNS	nsubj	B-Cell
to	TO	mark	O
adopt	VB	csubj	O
an	DT	det	O
early	JJ	amod	O
,	,	punct	O
reversible	JJ	conj	O
,	,	punct	O
and	CC	cc	O
progressive	JJ	amod	O
protumorigenic	JJ	compound	O
metabolic	JJ	amod	O
milieu	NN	dobj	O
that	WDT	nsubj	O
is	VBZ	cop	O
reminiscent	NN	ccomp	O
of	IN	case	O
that	DT	nmod	O
driving	VBG	acl	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
FdG	NN	compound	O
-	HYPH	punct	O
PET	NN	nmod	O
or	CC	cc	O
primary	JJ	amod	O
breast	NN	compound	O
cancers	NNS	conj	O
,	,	punct	O
rates	NNS	nsubj	O
of	IN	case	O
glycolysis	NN	nmod	O
were	VBD	cop	O
diverse	JJ	ROOT	O
,	,	punct	O
being	VBG	cop	O
higher	JJR	advcl	O
in	IN	case	O
cells	NNS	nmod	O
expressing	VBG	acl	O
both	CC	cc:preconj	O
c	NN	compound	O
-	HYPH	punct	O
Myc	NNP	dobj	O
and	CC	cc	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	conj	O
and	CC	cc	O
lower	JJR	conj	O
in	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
low	JJ	amod	O
or	CC	cc	O
negative	JJ	conj	O
in	IN	case	O
both	CC	det	O
transcription	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O
Targets	NNS	nsubj	O
identified	VBN	ROOT	O
in	IN	case	O
these	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
diverse	JJ	conj	O
FH	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	dep	O
models	NNS	nmod	O
represent	VBP	conj	O
excellent	JJ	amod	O
potential	JJ	amod	O
candidates	NNS	dobj	O
for	IN	case	O
further	JJ	advmod	O
mechanistic	JJ	amod	O
investigation	NN	nmod	O
and	CC	cc	O
therapeutic	JJ	amod	O
metabolic	JJ	amod	O
manipulation	NN	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Stat3	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
Src	NN	compound	O
transformation	NN	nmod	O
.	.	punct	O
A	DT	det	O
STAT3	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
metabolic	JJ	amod	O
switch	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
tumour	NN	compound	B-Cancer
transformation	NN	nmod	O
and	CC	cc	O
STAT3	NN	compound	B-Gene_or_gene_product
addiction	NN	conj	O
.	.	punct	O

Cytokines	NNS	nsubj	O
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
induce	VBP	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transducers	NNS	nmod	O
and	CC	cc	O
activators	NNS	compound	O
of	IN	amod	O
transcription	NN	conj	O
(	-LRB-	punct	O
STATs	NNS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
directly	RB	advmod	O
activate	VBP	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O
The	DT	det	O
pro	NN	amod	O
-	HYPH	punct	O
oncogenic	JJ	amod	O
transcription	NN	compound	O
factor	NN	compound	O
STAT3	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
tumours	NNS	nmod	B-Cancer
that	WDT	nsubj	O
often	RB	advmod	O
become	VBP	acl:relcl	O
addicted	JJ	acomp	O
to	TO	prep	O
its	PRP$	nmod:poss	O
activity	NN	pobj	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
unifying	JJ	amod	O
view	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
core	NN	compound	O
function	NN	nmod	O
determining	VBG	acl	O
this	DT	det	O
widespread	JJ	amod	O
STAT3	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
dependence	NN	dobj	O
has	VBZ	aux	O
yet	RB	advmod	O
emerged	VBN	conj	O
.	.	punct	O

Assays	NNS	nsubj	O
of	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
,	,	punct	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
and	CC	cc	O
antigenicity	NN	conj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Stat3	NN	nsubjpass	O
or	CC	cc	O
a	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
STAT	NN	compound	O
family	NN	compound	O
member	NN	conj	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	O
oncoprotein	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
constitutively	RB	advmod	O
active	JJ	amod	O
STAT3	NN	nsubj	B-Gene_or_gene_product
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
master	NN	amod	O
regulator	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
metabolism	NN	nmod	O
,	,	punct	O
inducing	VBG	xcomp	O
aerobic	JJ	amod	O
glycolysis	NN	dobj	O
and	CC	cc	O
down	RB	advmod	O
-	HYPH	punct	O
regulating	VBG	amod	O
mitochondrial	JJ	amod	B-Cellular_component
activity	NN	conj	O
both	CC	cc:preconj	O
in	IN	case	O
primary	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
and	CC	cc	O
in	IN	case	O
STAT3	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
tumour	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

Glucose	NN	compound	O
deprivation	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
sensitization	NN	nsubjpass	O
to	TO	case	O
apoptosis	NN	nmod	O
was	VBD	auxpass	O
prevented	VBN	ROOT	O
in	IN	case	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
cells	NNS	nmod	O
overexpressing	VBG	acl	O
BCL	NN	dobj	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
As	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
cells	NNS	nsubjpass	B-Cell
are	VBP	auxpass	O
protected	VBN	ROOT	O
from	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
senescence	NN	conj	O
while	IN	mark	O
becoming	VBG	advcl	O
highly	RB	advmod	O
sensitive	JJ	xcomp	O
to	TO	case	O
glucose	NN	compound	B-Simple_chemical
deprivation	NN	nmod	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
FdG	NN	compound	O
-	HYPH	punct	O
PET	NN	nmod	O
or	CC	cc	O
primary	JJ	amod	O
breast	NN	compound	O
cancers	NNS	conj	O
,	,	punct	O
rates	NNS	nsubj	O
of	IN	case	O
glycolysis	NN	nmod	O
were	VBD	cop	O
diverse	JJ	ROOT	O
,	,	punct	O
being	VBG	cop	O
higher	JJR	advcl	O
in	IN	case	O
cells	NNS	nmod	O
expressing	VBG	acl	O
both	CC	cc:preconj	O
c	NN	compound	O
-	HYPH	punct	O
Myc	NNP	dobj	O
and	CC	cc	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	conj	O
and	CC	cc	O
lower	JJR	conj	O
in	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
low	JJ	amod	O
or	CC	cc	O
negative	JJ	conj	O
in	IN	case	O
both	CC	det	O
transcription	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
enhanced	VBN	amod	O
glycolysis	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
up	RB	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
,	,	punct	O
while	IN	mark	O
reduced	VBN	amod	O
mitochondrial	JJ	amod	B-Cellular_component
activity	NN	nsubj	O
is	VBZ	cop	O
HIF	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
independent	JJ	amod	O
and	CC	cc	O
likely	RB	conj	O
caused	VBN	dep	O
by	IN	case	O
STAT3	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	dep	O
down	RB	advmod	O
-	HYPH	punct	O
regulation	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
proteins	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cancer	NN	compound	O
cells	NNS	nsubj	O
depend	VBP	ROOT	O
mostly	RB	advmod	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
aerobic	JJ	amod	O
breakdown	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
into	IN	case	O
ATP	NN	nmod	O
.	.	punct	O
The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
STAT3	NN	compound	B-Gene_or_gene_product
pro	NN	compound	O
-	HYPH	punct	O
oncogenic	JJ	amod	O
activities	NNS	nmod	O
,	,	punct	O
since	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
STAT3	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	nmod	O
in	IN	case	O
the	DT	det	O
tumour	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
down	RB	advmod	O
-	HYPH	punct	O
regulates	VBZ	advcl	O
glycolysis	NN	dobj	O
prior	RB	mark	O
to	TO	mark	O
leading	VBG	advcl	O
to	TO	case	O
growth	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
death	NN	conj	O
,	,	punct	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Emerging	VBG	amod	O
evidence	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
oncogenes	NNS	nsubj	O
that	WDT	nsubj	O
drive	VBP	acl:relcl	O
the	DT	det	O
cancer	NN	compound	O
-	HYPH	punct	O
promoting	VBG	amod	O
signals	NNS	dobj	O
also	RB	advmod	O
drive	VBP	ccomp	O
the	DT	det	O
altered	JJ	amod	O
metabolism	NN	dobj	O
.	.	punct	O
We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
novel	JJ	amod	O
,	,	punct	O
central	JJ	dep	O
metabolic	JJ	amod	O
role	NN	nsubj	O
is	VBZ	cop	O
at	IN	case	O
the	DT	det	O
core	NN	ccomp	O
of	IN	case	O
the	DT	det	O
addiction	NN	nmod	O
for	IN	case	O
STAT3	NN	nmod	B-Gene_or_gene_product
shown	VBN	acl	O
by	IN	case	O
so	RB	advmod	O
many	JJ	amod	O
biologically	RB	advmod	O
different	JJ	amod	O
tumours	NNS	nmod	B-Cancer
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
Roles	NNS	ROOT	O
of	IN	prep	O
brca2	NN	pobj	B-Gene_or_gene_product
(	-LRB-	punct	O
fancd1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
oocyte	NN	compound	B-Cellular_component
nuclear	JJ	amod	I-Cellular_component
architecture	NN	nmod	O
,	,	punct	O
gametogenesis	NN	conj	O
,	,	punct	O
gonad	NN	amod	B-Cancer
tumors	NNS	conj	I-Cancer
,	,	punct	O
and	CC	cc	O
genome	NN	compound	O
stability	NN	conj	O
in	IN	case	O
zebrafish	NN	nmod	B-Organism
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Mild	JJ	amod	O
mutations	NNS	nsubj	O
in	IN	case	O
BRCA2	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
FANCD1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
cause	VBP	ROOT	O
Fanconi	JJ	amod	O
anemia	NN	dobj	O
(	-LRB-	punct	O
FA	NN	appos	O
)	-RRB-	punct	O
when	WRB	advmod	O
homozygous	JJ	advcl	O
,	,	punct	O
while	IN	mark	O
severe	JJ	amod	O
mutations	NNS	nsubj	O
cause	VBP	advcl	O
common	JJ	amod	O
cancers	NNS	dobj	B-Cancer
including	VBG	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
ovarian	JJ	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
prostate	NN	compound	B-Cancer
cancers	NNS	conj	I-Cancer
when	WRB	advmod	O
heterozygous	JJ	advcl	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
a	DT	det	O
zebrafish	NN	compound	O
brca2	NN	compound	B-Gene_or_gene_product
insertional	JJ	amod	O
mutant	NN	dobj	O
that	WDT	nsubj	O
shares	VBZ	acl:relcl	O
phenotypes	NNS	dobj	O
with	IN	case	O
human	JJ	amod	B-Organism
patients	NNS	nmod	I-Organism
and	CC	cc	O
identifies	VBZ	conj	O
a	DT	det	O
novel	JJ	amod	O
brca2	NN	compound	B-Gene_or_gene_product
function	NN	dobj	O
in	IN	case	O
oogenesis	NN	nmod	O
.	.	punct	O

TNFalpha	NN	compound	O
treatment	NN	nsubj	O
in	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
gene	NN	compound	O
mutations	NNS	nmod	O
,	,	punct	O
gene	NN	compound	O
amplification	NN	conj	O
,	,	punct	O
micronuclei	NNS	compound	O
formation	NN	conj	O
and	CC	cc	O
chromosomal	JJ	amod	O
instability	NN	conj	O
.	.	punct	O
Experiments	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
mutant	JJ	amod	B-Developing_anatomical_structure
embryos	NNS	nsubj	I-Developing_anatomical_structure
and	CC	cc	O
mutant	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
culture	NN	nmod	O
experienced	JJ	ccomp	O
genome	NN	compound	O
instability	NN	dobj	O
,	,	punct	O
as	IN	mark	O
do	VBP	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
FA	NN	compound	O
patients	NNS	nmod	B-Organism
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
detected	VBD	ROOT	O
only	RB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	compound	O
and	CC	cc	O
nm23	NN	compound	O
-	HYPH	punct	O
H2	NN	conj	O
mRNA	NN	dobj	O
.	.	punct	O
In	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
zebrafish	NN	nmod	B-Organism
,	,	punct	O
meiotic	JJ	amod	O
cells	NNS	nsubj	B-Cell
expressed	VBD	ROOT	O
brca2	NN	dobj	B-Gene_or_gene_product
;	:	punct	O
and	CC	cc	O
,	,	punct	O
unexpectedly	RB	advmod	O
,	,	punct	O
transcripts	NNS	nsubj	O
in	IN	case	O
oocytes	NNS	nmod	B-Cell
localized	VBD	conj	O
asymmetrically	RB	advmod	O
to	TO	case	O
the	DT	det	O
animal	NN	compound	B-Cellular_component
pole	NN	nmod	I-Cellular_component
.	.	punct	O

Despite	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
these	DT	det	O
signal	NN	compound	O
transducers	NNS	nmod	O
,	,	punct	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nsubj	O
of	IN	case	O
females	NNS	nmod	O
expressing	VBG	acl	O
exogenous	JJ	amod	O
Tsg101	NN	dobj	O
developed	VBN	ROOT	O
normally	RB	advmod	O
throughout	IN	case	O
the	DT	det	O
reproductive	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O
In	IN	case	O
juvenile	JJ	amod	O
brca2	NN	compound	B-Gene_or_gene_product
mutants	NNS	nmod	O
,	,	punct	O
oocytes	NNS	nsubj	B-Cell
failed	VBD	ROOT	O
to	TO	mark	O
progress	VB	xcomp	O
through	IN	case	O
meiosis	NN	nmod	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
female	NN	amod	O
-	:	punct	O
to	IN	dep	O
-	HYPH	punct	O
male	JJ	amod	O
sex	NN	compound	O
reversal	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
mutant	NN	nsubj	O
with	IN	case	O
an	DT	det	O
LMP1	NN	compound	O
site	NN	compound	O
-	:	punct	O
specific	JJ	amod	O
mutation	NN	nmod	O
at	IN	case	O
TES2	NN	nmod	O
,	,	punct	O
LMP1	NN	appos	O
(	-LRB-	punct	O
TRADD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
initially	RB	advmod	O
stimulates	VBZ	ccomp	O
cell	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
significantly	RB	advmod	O
extends	VBZ	conj	O
the	DT	det	O
life	NN	compound	O
span	NN	dobj	O
of	IN	case	O
MEF	NNP	nmod	O
.	.	punct	O
Adult	JJ	amod	B-Organism
mutants	NNS	nsubj	I-Organism
became	VBD	ROOT	O
sterile	JJ	amod	O
males	NNS	attr	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
meiotic	JJ	amod	O
arrest	NN	advcl	O
of	IN	case	O
spermatocytes	NNS	nmod	B-Cell
,	,	punct	O
which	WDT	nsubj	O
then	RB	advmod	O
died	VBD	acl:relcl	O
by	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
followed	VBN	acl	O
by	IN	case	O
neoplastic	JJ	amod	B-Cancer
proliferation	NN	nmod	O
of	IN	case	O
gonad	JJ	amod	B-Cell
somatic	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
was	VBD	cop	O
similar	JJ	acl:relcl	O
to	TO	case	O
neoplasia	VB	nmod	B-Pathological_formation
observed	VBN	acl	O
in	IN	mark	O
ageing	VBG	advcl	O
dead	JJ	amod	B-Gene_or_gene_product
end	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
dnd	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
knockdown	NN	amod	O
males	NNS	dobj	O
,	,	punct	O
which	WDT	nsubj	O
lack	VBP	acl:relcl	O
germ	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
The	DT	det	O
construction	NN	nsubj	O
of	IN	case	O
animals	NNS	nmod	B-Organism
doubly	RB	advmod	I-Organism
mutant	JJ	ROOT	I-Organism
for	IN	case	O
brca2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
apoptotic	JJ	amod	O
gene	NN	compound	O
tp53	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
p53	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
rescued	VBD	conj	O
brca2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
sex	NN	compound	O
reversal	NN	dobj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
how	WRB	advmod	O
p18	NN	nsubj	O
and	CC	cc	O
p27	NN	conj	O
genetically	RB	advmod	O
interact	VBP	ccomp	O
with	IN	case	O
Men1	NN	nmod	O
,	,	punct	O
the	DT	det	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	appos	O
mutated	VBN	acl	O
in	IN	case	O
familial	JJ	amod	O
MEN1	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
p18	NN	compound	O
-	:	punct	O
Men1	NN	dobj	O
and	CC	cc	O
p27	NN	compound	O
-	:	punct	O
Men1	NN	conj	O
double	JJ	amod	O
mutant	JJ	amod	O
mice	NNS	dep	O
.	.	punct	O
Double	JJ	amod	B-Organism
mutants	NNS	nsubj	I-Organism
developed	VBD	ROOT	O
oocytes	NNS	dobj	B-Cell
and	CC	cc	O
became	VBD	conj	O
sterile	JJ	amod	O
females	NNS	nsubj	O
that	WDT	nsubj	O
produced	VBD	acl:relcl	O
only	RB	advmod	O
aberrant	JJ	amod	O
embryos	NNS	dobj	B-Developing_anatomical_structure
and	CC	cc	O
showed	VBD	conj	O
elevated	JJ	amod	O
risk	NN	dobj	O
for	IN	case	O
invasive	JJ	amod	O
ovarian	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
cellular	JJ	amod	O
functions	NNS	nsubjpass	O
of	IN	case	O
VASP	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O
Oocytes	NNS	nsubj	B-Cell
in	IN	case	O
double	JJ	amod	B-Organism
-	HYPH	punct	I-Organism
mutant	JJ	amod	I-Organism
females	NNS	nmod	I-Organism
showed	VBD	ROOT	O
normal	JJ	amod	O
localization	NN	dobj	O
of	IN	case	O
brca2	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
pou5f1	JJ	conj	B-Gene_or_gene_product
transcripts	NNS	nmod	O
to	TO	case	O
the	DT	det	O
animal	NN	compound	B-Cellular_component
pole	NN	nmod	I-Cellular_component
and	CC	cc	O
vasa	JJ	amod	O
transcripts	NNS	conj	O
to	TO	case	O
the	DT	det	O
vegetal	JJ	amod	B-Cellular_component
pole	NN	nmod	I-Cellular_component
,	,	punct	O
but	CC	cc	O
had	VBD	conj	O
a	DT	det	O
polarized	VBN	amod	O
rather	RB	cc	O
than	IN	mwe	O
symmetrical	JJ	amod	O
nucleus	NN	dobj	B-Cellular_component
with	IN	case	O
the	DT	det	O
distribution	NN	nmod	O
of	IN	case	O
nucleoli	JJ	nmod	B-Cellular_component
and	CC	cc	O
chromosomes	NNS	conj	B-Cellular_component
to	TO	case	O
opposite	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
poles	NNS	nmod	I-Cellular_component
;	:	punct	O
this	DT	det	O
result	NN	nsubj	O
revealed	VBD	parataxis	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
Brca2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
establishing	VBG	nmod	O
or	CC	cc	O
maintaining	VBG	conj	O
oocyte	NN	compound	B-Cell
nuclear	JJ	amod	B-Cellular_component
architecture	NN	dobj	O
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
Mutating	VBG	amod	O
tp53	NN	nsubj	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
rescue	VB	ROOT	O
the	DT	det	O
infertility	NN	compound	O
phenotype	NN	dobj	O
in	IN	case	O
brca2	NN	compound	B-Gene_or_gene_product
mutant	JJ	amod	O
males	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
brca2	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
zebrafish	NN	compound	B-Organism
spermatogenesis	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
genetic	JJ	amod	O
ablation	NN	nsubj	O
of	IN	case	O
Brk1	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
dramatic	JJ	amod	O
defects	NNS	nmod	O
in	IN	case	O
embryo	NN	compound	O
compaction	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
protein	NN	nmod	O
in	IN	case	O
actin	NN	compound	O
dynamics	NNS	nmod	O
.	.	punct	O
Overall	RB	advmod	O
,	,	punct	O
this	DT	det	O
work	NN	nsubj	O
verified	VBD	ROOT	O
zebrafish	NN	dobj	B-Organism
as	IN	case	O
a	DT	det	O
model	NN	nmod	O
for	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
Brca2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
human	JJ	amod	B-Organism
disease	NN	nmod	O
and	CC	cc	O
uncovered	VBD	conj	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
Brca2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
vertebrate	JJ	amod	O
oocyte	NN	compound	B-Cellular_component
nuclear	JJ	amod	I-Cellular_component
architecture	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
tumors	NNS	nmod	O
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	ROOT	O
and	CC	cc	O
expression	NN	conj	O
as	IN	case	O
tumor	NN	compound	B-Cancer
stratification	NN	compound	O
biomarkers	NNS	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
outcome	NN	compound	O
prognosticators	NNS	conj	O
for	IN	case	O
bladder	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

MTSS1	NN	nsubjpass	O
(	-LRB-	punct	O
metastasis	NN	compound	O
suppressor	NN	nsubjpass	O
-	:	punct	O
1	CD	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
missing	VBG	nmod	O
in	IN	case	O
metastatic	JJ	amod	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
KISS1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
gene	NN	ROOT	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
lost	VBN	acl:relcl	O
in	IN	case	O
several	JJ	amod	O
malignancies	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
bladder	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PTEN	NN	compound	O
promoter	NN	compound	O
hypermethylation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
mechanism	NN	ROOT	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
epigenetic	JJ	amod	O
silencing	NN	compound	O
hypothesis	NN	dobj	O
and	CC	cc	O
evaluated	VBD	conj	O
the	DT	det	O
biological	JJ	amod	O
influence	NN	dobj	O
of	IN	case	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	nmod	O
on	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
relevance	NN	conj	O
in	IN	case	O
bladder	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

MTSS1	NN	nsubjpass	O
(	-LRB-	punct	O
metastasis	NN	compound	O
suppressor	NN	nsubjpass	O
-	:	punct	O
1	CD	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
first	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
missing	VBG	nmod	O
in	IN	case	O
metastatic	JJ	amod	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
hypermethylation	NN	nsubj	O
was	VBD	cop	O
frequent	JJ	ROOT	O
in	IN	case	O
bladder	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
analyzed	VBN	acl	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
PCR	NN	nmod	O
and	CC	cc	O
bisulfite	JJ	amod	B-Simple_chemical
sequencing	NN	conj	O
and	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
low	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
being	VBG	auxpass	O
restored	VBN	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	mark	O
demethylating	VBG	advcl	O
azacytidine	NN	dobj	B-Simple_chemical
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
tumors	NNS	nmod	O
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O
Hypermethylation	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
frequently	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
bladder	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
(	-LRB-	punct	O
83	CD	nummod	O
.	.	punct	O
1	CD	nummod	O
%	NN	dep	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	parataxis	O
804	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
PTEN	NN	compound	O
promoter	NN	compound	O
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
surgical	JJ	amod	O
specimens	NNS	nmod	O
of	IN	case	O
CCMs	NNS	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
69	CD	dep	O
)	-RRB-	punct	O
by	IN	case	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increasing	VBG	amod	O
stage	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
grade	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
010	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nsubj	O
revealed	VBD	ROOT	O
PTEN	NN	compound	O
promoter	NN	compound	O
methylation	NN	dobj	O
in	IN	case	O
15	CD	nmod	O
.	.	punct	O
9	CD	nummod	O
%	NN	amod	O
CCMs	NNS	ROOT	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
low	JJ	amod	O
KISS1	NN	compound	B-Gene_or_gene_product
transcript	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
quantitative	JJ	amod	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
037	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
AQP5	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
cellular	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
lymph	NN	compound	O
node	NN	compound	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
clinicopathological	JJ	amod	O
staging	NN	conj	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
transcript	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
histopathological	JJ	amod	O
tumor	NN	compound	B-Cancer
stage	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
0005	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
tumors	NNS	nmod	O
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O
Low	JJ	amod	O
transcript	NN	compound	O
expression	NN	ROOT	O
alone	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
003	CD	appos	O
)	-RRB-	punct	O
or	CC	cc	O
combined	VBN	conj	O
with	IN	case	O
methylation	NN	nmod	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
019	CD	dep	O
)	-RRB-	punct	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
poor	JJ	amod	O
disease	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
survival	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
205	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	O
expression	NN	nmod	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
transcript	NN	compound	O
expression	NN	nsubj	O
remained	VBD	ROOT	O
an	DT	det	O
independent	JJ	amod	O
prognosticator	NN	dobj	O
in	IN	case	O
multivariate	JJ	amod	O
analyses	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
017	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
Dss1	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
elevated	JJ	xcomp	O
in	IN	case	O
skin	NN	compound	O
papillomas	NNS	nmod	O
relative	JJ	case	O
to	TO	case	O
normal	JJ	amod	O
skins	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
further	RB	advmod	O
increased	VBN	conj	O
in	IN	case	O
squamous	JJ	amod	O
cell	NN	compound	O
malignancies	NNS	nmod	O
.	.	punct	O
KISS1	NN	compound	B-Gene_or_gene_product
hypermethylation	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
bladder	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
potential	JJ	amod	O
mechanistic	JJ	amod	O
explanation	NN	dobj	O
(	-LRB-	punct	O
epigenetic	JJ	amod	O
silencing	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
the	DT	det	O
observed	VBN	amod	O
loss	NN	nmod	O
of	IN	case	O
KISS1	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
uroepithelial	JJ	amod	B-Cancer
malignancies	NNS	nmod	I-Cancer
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
tumors	NNS	nmod	O
demonstrating	VBG	acl	O
concurrent	JJ	amod	O
methylation	NN	dobj	O
of	IN	case	O
more	JJR	advmod	O
than	IN	quantmod	O
half	NN	nmod	O
of	IN	case	O
their	PRP$	nmod:poss	O
genes	NNS	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
poorer	VBN	amod	O
survival	NN	dobj	O
and	CC	cc	O
earlier	JJR	amod	O
recurrence	NN	conj	O
.	.	punct	O
Associations	NNS	nsubj	O
of	IN	case	O
KISS1	NN	compound	B-Gene_or_gene_product
methylation	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
expression	NN	conj	O
with	IN	case	O
histopathological	JJ	amod	O
variables	NNS	nmod	O
and	CC	cc	O
poor	JJ	amod	O
survival	NN	conj	O
suggest	VBP	ROOT	O
the	DT	det	O
utility	NN	dobj	O
of	IN	mark	O
incorporating	VBG	acl	O
KISS1	NN	compound	B-Gene_or_gene_product
measurement	NN	dobj	O
using	VBG	acl	O
paraffin	NN	amod	B-Simple_chemical
-	HYPH	punct	O
embedded	JJ	amod	O
material	NN	dobj	O
for	IN	case	O
tumor	NN	compound	B-Cancer
stratification	NN	nmod	O
and	CC	cc	O
clinical	JJ	amod	O
outcome	NN	compound	O
prognosis	NN	conj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
uroepithelial	JJ	amod	B-Cancer
neoplasias	NNS	nmod	I-Cancer
.	.	punct	O

Microvascular	JJ	amod	O
density	NN	ROOT	O
and	CC	cc	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
immunoreactivity	NN	conj	O
as	IN	case	O
predictors	NNS	nmod	O
of	IN	case	O
regional	JJ	amod	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
from	IN	case	O
betel	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
oral	JJ	amod	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O
Correlation	NN	ROOT	O
of	IN	case	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
with	IN	case	O
nodal	JJ	amod	B-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
papillary	JJ	amod	B-Cancer
thyroid	NN	compound	I-Cancer
microcarcinoma	NN	nmod	I-Cancer
.	.	punct	O

Vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
-	:	punct	O
C	NN	nsubj	O
(	-LRB-	punct	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	appos	O
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymphangiogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
not	RB	neg	O
only	RB	cc:preconj	O
the	DT	det	O
intratumoral	JJ	amod	B-Cancer
and	CC	cc	O
peritumoral	JJ	conj	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	dobj	O
(	-LRB-	punct	O
ILD	NN	dep	O
and	CC	cc	O
PLD	NN	conj	O
)	-RRB-	punct	O
but	CC	cc	O
also	RB	advmod	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGFs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
to	TO	mark	O
test	VB	conj	O
their	PRP$	nmod:poss	O
correlation	NN	dobj	O
with	IN	case	O
regional	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodal	JJ	amod	I-Multi-tissue_structure
metastases	NNS	nmod	O
in	IN	case	O
papillary	JJ	amod	B-Cancer
thyroid	NN	compound	I-Cancer
microcarcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
PTMC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
fate	NN	nsubjpass	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
multiple	JJ	amod	O
endocrine	JJ	amod	O
neoplasia	NN	nmod	O
of	IN	case	O
type	NN	compound	O
II	CD	nummod	O
A	NN	compound	O
(	-LRB-	punct	O
MEN	NN	compound	O
II	CD	nummod	O
A	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
determined	VBN	dep	O
by	IN	case	O
medullary	JJ	amod	O
thyroid	NN	compound	O
carcinoma	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
in	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
.	.	punct	O
METHODS	NNS	ROOT	O
:	:	punct	O
A	DT	det	O
clinicopathologic	JJ	amod	O
data	NNS	compound	O
review	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	dep	O
in	IN	case	O
60	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
PTMC	NN	nmod	B-Cancer
treated	VBN	acl	O
with	IN	case	O
total	JJ	amod	O
thyroidectomies	NNS	nmod	O
involving	VBG	acl	O
neck	NN	compound	B-Organism_subdivision
dissections	NNS	dobj	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
lymphatics	NNS	nmod	O
.	.	punct	O
The	DT	det	O
patterns	NNS	nsubjpass	O
of	IN	case	O
lymphatic	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
the	DT	det	O
expression	NN	appos	O
of	IN	case	O
VEGFs	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
correlation	NN	conj	O
with	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastases	NNS	nmod	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
assessed	VBD	dep	O
antiapoptotic	JJ	amod	O
and	CC	cc	O
proapoptotic	JJ	conj	O
markers	NNS	dobj	O
in	IN	case	O
vascular	JJ	amod	O
and	CC	cc	O
perivascular	JJ	conj	O
cells	NNS	nmod	O
in	IN	case	O
lung	NN	compound	O
biopsy	NN	compound	O
samples	NNS	nmod	O
from	IN	case	O
18	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
CHD	NN	nmod	O
,	,	punct	O
7	CD	advmod	O
with	IN	case	O
reversible	JJ	nmod	O
and	CC	cc	O
11	CD	conj	O
with	IN	case	O
irreversible	JJ	amod	O
PHT	NN	nmod	O
,	,	punct	O
and	CC	cc	O
6	CD	nummod	O
control	NN	amod	O
patients	NNS	conj	O
.	.	punct	O
RESULTS	NNS	dep	O
:	:	punct	O
PLD	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
ILD	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
.	.	punct	O
001	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Both	CC	cc:preconj	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
immunoreactivity	NN	nsubjpass	O
were	VBD	auxpass	O
statistically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
012	CD	ROOT	O
and	CC	cc	O
.	.	punct	O
037	CD	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O
Patients	NNS	nsubj	B-Organism
with	IN	case	O
high	JJ	amod	O
PLD	NN	nmod	O
(	-LRB-	punct	O
>	NN	dep	O
8	CD	dep	O
.	.	punct	O
0	CD	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
higher	JJR	amod	O
rates	NNS	dobj	O
of	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastases	NNS	nmod	O
than	IN	case	O
low	JJ	amod	O
PLD	NN	nmod	O
(	-LRB-	punct	O
<	JJR	dep	O
=	JJ	amod	O
8	CD	dobj	O
.	.	punct	O
0	CD	ROOT	O
)	-RRB-	punct	O
(	-LRB-	punct	O
74	CD	dep	O
.	.	punct	O
0	CD	nummod	O
%	NN	ROOT	O
vs	CC	cc	O
46	CD	conj	O
.	.	punct	O
8	CD	nummod	O
%	NN	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
.	.	punct	O
03	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
alpha	NN	compound	O
-	:	punct	O
SMA	NN	nsubjpass	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
were	VBD	auxpass	O
identified	VBN	ccomp	O
as	IN	case	O
independent	JJ	amod	O
predictive	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Univariate	NN	amod	O
and	CC	cc	O
multivariate	JJ	conj	O
analyses	NNS	nsubj	O
revealed	VBD	ROOT	O
high	JJ	amod	O
PLD	NN	dobj	O
as	IN	case	O
the	DT	det	O
only	RB	advmod	O
independent	JJ	amod	O
variable	JJ	amod	O
predictive	JJ	xcomp	O
of	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
lymphatics	NNS	nmod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
VEGFs	NN	nmod	B-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
either	CC	cc:preconj	O
lymphatic	JJ	amod	B-Organ
density	NN	nmod	O
or	CC	cc	O
neck	NN	conj	B-Organism_subdivision
metastasis	NN	conj	O
.	.	punct	O

Both	CC	cc:preconj	O
h	NN	compound	O
-	HYPH	punct	O
MVD	NN	compound	O
and	CC	cc	O
VEGF	NN	conj	O
immunoreactivity	NN	nsubjpass	O
were	VBD	auxpass	O
statistically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.	.	punct	O
012	CD	ROOT	O
and	CC	cc	O
.	.	punct	O
037	CD	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O
CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
PLD	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
potential	JJ	amod	O
benefit	NN	dep	O
in	IN	case	O
the	DT	det	O
prediction	NN	nmod	O
of	IN	case	O
neck	NN	compound	B-Organism_subdivision
metastasis	NN	nmod	O
in	IN	case	O
PTMC	NN	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
beclin	NN	nsubj	O
1	CD	nummod	O
is	VBZ	cop	O
a	DT	det	O
haplo	JJ	amod	O
-	HYPH	punct	O
insufficient	JJ	amod	O
tumor	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
gene	NN	ccomp	O
and	CC	cc	O
provide	VB	conj	O
genetic	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
autophagy	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	ccomp	O
of	IN	case	O
cell	NN	compound	O
-	HYPH	punct	O
growth	NN	compound	O
control	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
suppression	NN	conj	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
autophagy	NN	nmod	O
potentiates	VBZ	ROOT	O
the	DT	det	O
antitumor	NN	compound	B-Cancer
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
multikinase	NN	compound	O
inhibitor	NN	compound	O
sorafenib	NN	nmod	B-Simple_chemical
in	IN	case	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
Multikinase	NN	compound	O
inhibitor	NN	compound	O
sorafenib	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
by	IN	mark	O
suppressing	VBG	advcl	O
the	DT	det	O
Raf	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
MEK	NN	compound	B-Gene_or_gene_product
/	:	punct	O
ERK	NN	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	dobj	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	B-Amino_acid
kinase	NN	conj	O
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
It	PRP	nsubj	O
significantly	RB	advmod	O
prolongs	VBZ	ROOT	O
median	JJ	amod	O
survival	NN	dobj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
advanced	JJ	amod	O
hepatocellular	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
HCC	NN	appos	B-Cancer
)	-RRB-	punct	O
but	CC	cc	O
the	DT	det	O
response	NN	nsubj	O
is	VBZ	cop	O
disease	NN	compound	O
-	HYPH	punct	O
stabilizing	NN	conj	O
and	CC	cc	O
cytostatic	JJ	conj	O
rather	RB	cc	O
than	IN	mwe	O
one	CD	conj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
regression	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
as	IN	advmod	O
yet	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
genetic	JJ	amod	O
evidence	NN	nsubj	O
for	IN	case	O
a	DT	det	O
role	NN	nmod	O
of	IN	case	O
autophagy	JJ	compound	O
genes	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	O
suppression	NN	nmod	O
.	.	punct	O
To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
the	DT	det	O
relative	JJ	amod	O
resistance	NN	dobj	O
in	IN	case	O
HCC	NN	nmod	B-Cancer
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
autophagy	NN	nmod	O
,	,	punct	O
an	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
self	NN	compound	O
-	HYPH	punct	O
digestion	NN	compound	O
pathway	NN	appos	O
,	,	punct	O
in	IN	case	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Sunitinib	NNP	nsubj	O
markedly	RB	advmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
PC12	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O
Sorafenib	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
led	VBD	ROOT	O
to	TO	case	O
accumulation	NN	nmod	O
of	IN	case	O
autophagosomes	NNS	nmod	B-Cellular_component
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
conversion	NN	nmod	O
from	IN	case	O
LC3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
I	PRP	nmod	I-Gene_or_gene_product
to	TO	dep	O
LC3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	pobj	I-Gene_or_gene_product
observed	VBN	acl	O
by	IN	case	O
immunoblot	NN	nmod	O
in	IN	case	O
Huh7	NN	nmod	B-Cell
,	,	punct	O
HLF	NN	conj	B-Cell
and	CC	cc	O
PLC	NN	conj	B-Cell
/	:	punct	I-Cell
PRF	NN	conj	I-Cell
/	SYM	punct	I-Cell
5	CD	nummod	I-Cell
cells	NNS	appos	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	ROOT	O
,	,	punct	O
silencing	NN	intj	O
of	IN	case	O
S6K1	NN	compound	O
induced	VBD	amod	O
apoptosis	NN	nmod	O
accompanied	VBN	acl	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
BAD	NN	nmod	O
and	CC	cc	O
Bcl	NN	conj	O
-	SYM	punct	O
2	CD	dep	O
,	,	punct	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
sunitinib	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O
This	DT	det	O
induction	NN	nsubj	O
was	VBD	cop	O
due	JJ	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
autophagic	JJ	amod	O
flux	NN	nmod	O
,	,	punct	O
as	IN	mark	O
there	EX	expl	O
was	VBD	cop	O
further	JJ	advmod	O
increase	NN	conj	O
in	IN	case	O
LC3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
upon	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
lysosomal	JJ	amod	O
inhibitors	NNS	nmod	O
,	,	punct	O
clear	JJ	amod	O
decline	NN	conj	O
of	IN	case	O
the	DT	det	O
autophagy	JJ	compound	O
substrate	NN	compound	O
p62	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
an	DT	det	O
mRFP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
GFP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
LC3	NN	compound	B-Gene_or_gene_product
fluorescence	NN	compound	O
change	NN	conj	O
in	IN	case	O
sorafenib	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Sunitinib	NNP	nsubj	O
markedly	RB	advmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
PC12	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O
Sorafenib	NNP	nsubj	B-Simple_chemical
inhibited	VBD	ROOT	O
the	DT	det	O
mammalian	JJ	amod	B-Gene_or_gene_product
target	NN	dobj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
rapamycin	NN	compound	I-Gene_or_gene_product
complex	NN	nmod	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
inhibition	NN	nsubj	O
led	VBD	conj	O
to	TO	case	O
accumulation	NN	nmod	O
of	IN	case	O
LC3	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
II	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Glycolysis	NNP	nsubjpass	O
was	VBD	auxpass	O
affected	VBN	ROOT	O
by	IN	case	O
pharmacological	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
Myc	NNP	nmod	O
and	CC	cc	O
HIF	NN	compound	O
-	HYPH	punct	O
1alpha	NN	conj	O
.	.	punct	O
Pharmacological	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
autophagic	JJ	amod	O
flux	NN	nmod	O
by	IN	case	O
chloroquine	NN	nmod	B-Simple_chemical
increased	VBD	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
decreased	VBN	amod	O
cell	NN	compound	B-Cell
viability	NN	conj	O
in	IN	case	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Meanwhile	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	prep	O
HDGF	NN	pobj	O
,	,	punct	O
an	DT	det	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	amod	O
protein	NN	nsubj	O
and	CC	cc	O
a	DT	det	O
target	NN	conj	O
of	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappaB	NN	nmod	O
,	,	punct	O
induced	VBD	ROOT	O
cell	NN	compound	O
apoptosis	NN	dobj	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
HCC	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
siRNA	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
knockdown	NN	nsubj	O
of	IN	case	O
the	DT	det	O
ATG7	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
also	RB	advmod	O
sensitized	VBD	ROOT	O
hepatoma	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
sorafenib	VB	xcomp	B-Simple_chemical
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
apoptotic	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
sunitinib	NN	nsubj	O
inhibited	VBD	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
Akt	NN	nmod	O
and	CC	cc	O
mTOR	NN	conj	O
and	CC	cc	O
was	VBD	auxpass	O
followed	VBN	conj	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
S6K1	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	JJ	amod	O
target	NN	acl:relcl	O
of	IN	case	O
mTOR	NN	nmod	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
sorafenib	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
autophagy	NN	dobj	O
in	IN	case	O
Huh7	NN	compound	B-Cancer
xenograft	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
and	CC	cc	O
coadministration	NN	conj	O
with	IN	case	O
chloroquine	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
suppressed	VBD	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
compared	VBN	case	O
with	IN	case	O
sorafenib	NN	nmod	B-Simple_chemical
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	ROOT	O
,	,	punct	O
silencing	NN	intj	O
of	IN	case	O
S6K1	NN	compound	O
induced	VBD	amod	O
apoptosis	NN	nmod	O
accompanied	VBN	acl	O
by	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
BAD	NN	nmod	O
and	CC	cc	O
Bcl	NN	conj	O
-	SYM	punct	O
2	CD	dep	O
,	,	punct	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
sunitinib	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
sorafenib	NN	compound	B-Simple_chemical
administration	NN	nsubj	O
induced	VBD	ROOT	O
autophagosome	NN	compound	B-Cellular_component
formation	NN	dobj	O
and	CC	cc	O
enhanced	VBN	conj	O
autophagic	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
conferred	VBD	acl:relcl	O
a	DT	det	O
survival	NN	compound	O
advantage	NN	dobj	O
to	IN	case	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
as	IN	advmod	O
yet	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	neg	O
genetic	JJ	amod	O
evidence	NN	nsubj	O
for	IN	case	O
a	DT	det	O
role	NN	nmod	O
of	IN	case	O
autophagy	JJ	compound	O
genes	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	O
suppression	NN	nmod	O
.	.	punct	O
Concomitant	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
autophagy	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
attractive	JJ	amod	O
strategy	NN	ROOT	O
for	IN	mark	O
unlocking	VBG	advcl	O
the	DT	det	O
antitumor	JJ	amod	B-Cancer
potential	NN	dobj	O
of	IN	case	O
sorafenib	NN	nmod	B-Simple_chemical
in	IN	case	O
HCC	NN	nmod	B-Cancer
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	O
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	O
ester	NN	compound	O
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	O
.	.	punct	O
Desensitization	NN	ROOT	O
of	IN	case	O
prostaglandin	NN	compound	B-Simple_chemical
F2	NN	compound	I-Simple_chemical
alpha	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
stimulated	VBN	amod	O
inositol	NN	compound	B-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
generation	NN	nmod	O
in	IN	case	O
NIH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3T3	NN	compound	I-Cell
fibroblasts	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ki	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
N	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	conj	I-Gene_or_gene_product
genes	NNS	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	O
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	O
ester	NN	compound	O
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	O
.	.	punct	O
The	DT	det	O
stimulation	NN	nsubjpass	O
of	IN	case	O
inositol	NN	compound	B-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
generation	NN	nmod	O
in	IN	case	O
control	NN	nmod	B-Cell
and	CC	cc	O
ras	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
gene	NN	conj	O
-	HYPH	punct	O
transformed	VBN	dep	O
NIH	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
3T3	NN	compound	I-Cell
cells	NNS	dep	I-Cell
by	IN	case	O
prostaglandin	NN	compound	B-Simple_chemical
F2	NN	compound	I-Simple_chemical
alpha	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
PGF2	NN	compound	B-Simple_chemical
alpha	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
basal	JJ	amod	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
substrate	NN	nmod	O
of	IN	case	O
relative	JJ	amod	O
molecular	JJ	amod	O
mass	NN	nmod	O
(	-LRB-	punct	O
Mr	NN	appos	O
)	-RRB-	punct	O
80	CD	nummod	O
,	,	punct	O
000	CD	dep	O
(	-LRB-	punct	O
80K	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
Compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
a	DT	det	O
desensitization	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
response	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
overexpression	NN	nmod	O
of	IN	case	O
N	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
,	,	punct	O
Ha	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
Ki	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
genes	NNS	nmod	O
.	.	punct	O

Cotreatment	NN	nsubj	O
of	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
with	IN	case	O
a	DT	det	O
hormone	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
antagonist	NN	conj	O
blocked	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
.	.	punct	O
This	DT	det	O
desensitization	NN	nsubj	O
was	VBD	cop	O
without	IN	case	O
effect	NN	ROOT	O
upon	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
causing	VBG	acl	O
half	NN	nummod	O
-	HYPH	punct	O
maximal	JJ	amod	O
effect	NN	dobj	O
(	-LRB-	punct	O
EC50	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
dissociation	NN	compound	O
constant	NN	conj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
number	NN	conj	O
of	IN	case	O
PGF2	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
COX	NN	compound	O
-	:	punct	O
2	CD	nummod	O
mRNA	NN	nmod	O
and	CC	cc	O
synthesis	NN	conj	O
of	IN	case	O
PGE	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
BV	NN	nmod	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
PG	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
was	VBD	cop	O
without	IN	case	O
effect	NN	ROOT	O
upon	IN	case	O
desensitization	NN	nmod	O
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
effect	NN	nsubj	O
was	VBD	auxpass	O
not	RB	neg	O
agonist	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	ccomp	O
.	.	punct	O

The	DT	det	O
short	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
response	NN	nsubj	O
of	IN	case	O
Swiss	JJ	compound	O
3T3	NN	compound	O
cells	NNS	nmod	O
to	TO	case	O
an	DT	det	O
activator	NN	nmod	O
of	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	nmod	O
also	RB	advmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	xcomp	O
of	IN	case	O
growth	NN	compound	O
state	NN	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
50	CD	nummod	O
%	NN	amod	O
effective	JJ	amod	O
dose	NN	nsubj	O
for	IN	case	O
PDBu	NN	compound	O
inhibition	NN	nmod	O
of	IN	case	O
EGF	NN	compound	O
binding	NN	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
was	VBD	cop	O
approximately	RB	advmod	O
7	CD	nummod	O
nM	NN	advcl	O
for	IN	case	O
both	CC	det	O
growth	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O
Desensitization	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
in	IN	prep	O
NIH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
3T3	NN	compound	I-Cell
cells	NNS	pobj	I-Cell
by	IN	prep	O
culturing	VBG	pcomp	O
under	IN	prep	O
conditions	NNS	pobj	O
where	WRB	advmod	O
the	DT	det	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
all	RB	relcl	O
in	IN	case	O
the	DT	det	O
exponential	JJ	amod	O
growth	NN	compound	O
phase	NN	nmod	O
,	,	punct	O
or	CC	cc	O
by	IN	case	O
a	DT	det	O
12	CD	nummod	O
h	NN	compound	O
exposure	NN	conj	O
to	TO	case	O
a	DT	det	O
C	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	O
activating	VBG	amod	O
phorbol	NN	compound	B-Simple_chemical
ester	NN	nmod	I-Simple_chemical
.	.	punct	O

Elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
diacylglycerol	NN	nmod	O
and	CC	cc	O
decreased	VBD	conj	O
phorbol	NN	compound	O
ester	NN	compound	O
sensitivity	NN	dobj	O
in	IN	case	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
desensitization	NN	nsubj	O
of	IN	case	O
certain	JJ	amod	O
agonist	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
inositol	NN	compound	B-Simple_chemical
phospholipid	JJ	compound	I-Simple_chemical
responses	NNS	nmod	O
in	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
is	VBZ	cop	O
a	DT	det	O
consequence	NN	ccomp	O
of	IN	case	O
increased	VBN	amod	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
and	CC	cc	O
associated	VBN	amod	O
amplification	NN	conj	O
in	IN	case	O
C	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
an	DT	det	O
indirect	JJ	amod	O
consequence	NN	conj	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
ras	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Glucose	NN	ROOT	O
and	CC	cc	O
lactate	NN	conj	O
metabolism	NN	conj	O
in	IN	case	O
C6	NN	compound	O
glioma	NN	compound	O
cells	NNS	nmod	O
:	:	punct	O
evidence	NN	dep	O
for	IN	case	O
the	DT	det	O
preferential	JJ	amod	O
utilization	NN	nmod	O
of	IN	case	O
lactate	NN	nmod	O
for	IN	case	O
cell	NN	compound	O
oxidative	JJ	amod	O
metabolism	NN	nmod	O
.	.	punct	O
Relationship	NN	ROOT	O
between	IN	case	O
of	IN	case	O
blood	NN	compound	B-Organism_substance
flow	NN	nmod	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	conj	O
,	,	punct	O
protein	NN	compound	O
synthesis	NN	conj	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
and	CC	cc	O
ATP	NN	compound	B-Simple_chemical
content	NN	conj	O
in	IN	case	O
experimentally	RB	advmod	O
-	HYPH	punct	O
induced	VBN	amod	O
glioma	NN	nmod	B-Cancer
(	-LRB-	punct	O
RG1	NN	appos	B-Cancer
2	CD	nummod	I-Cancer
.	.	punct	I-Cancer
2	LS	nummod	I-Cancer
)	-RRB-	punct	O
of	IN	case	O
rat	NN	compound	B-Organism
brain	NN	nmod	B-Organ
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	O
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	O
acid	NN	compound	O
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
respiration	NN	conj	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O
In	IN	case	O
experimental	JJ	amod	O
RG1	NN	ROOT	B-Cancer
2	CD	nummod	I-Cancer
.	.	punct	I-Cancer
2	CD	nummod	I-Cancer
glioma	NN	nsubjpass	I-Cancer
of	IN	case	O
rat	NN	compound	B-Organism
brain	NN	nmod	B-Organ
,	,	punct	O
local	JJ	amod	O
blood	NN	compound	B-Organism_substance
flow	NN	conj	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
utilization	NN	conj	O
,	,	punct	O
protein	NN	compound	O
synthesis	NN	conj	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
and	CC	cc	O
ATP	NN	compound	B-Simple_chemical
content	NN	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
triple	JJ	amod	O
tracer	NN	compound	O
autoradiography	NN	nmod	O
and	CC	cc	O
bioluminescence	NN	amod	O
technique	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
to	TO	mark	O
determine	VB	xcomp	O
hemodynamic	JJ	amod	O
and	CC	cc	O
metabolic	JJ	conj	O
thresholds	NNS	dobj	O
for	IN	case	O
local	JJ	amod	O
tumor	NN	compound	B-Cancer
energy	NN	compound	O
failure	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
glucose	NN	nsubjpass	O
and	CC	cc	O
alanine	NN	compound	O
kinetics	NNS	conj	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
tracer	NN	compound	O
methodology	NN	nmod	O
in	IN	case	O
a	DT	det	O
sarcoma	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
rat	NN	compound	O
model	NN	nmod	O
.	.	punct	O
Perfusion	NN	compound	O
thresholds	NNS	nsubjpass	O
were	VBD	auxpass	O
estimated	VBN	ROOT	O
at	IN	case	O
tumor	NN	compound	B-Cancer
blood	NN	compound	B-Organism_substance
flow	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
69	CD	nmod	O
.	.	punct	O
0	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	ROOT	O
.	.	punct	O
1	CD	nummod	O
ml	NN	compound	O
/	SYM	punct	O
100	CD	nummod	O
g	NN	compound	O
/	SYM	punct	O
min	NN	ROOT	O
(	-LRB-	punct	O
estimate	NN	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	HYPH	punct	O
standard	JJ	amod	O
error	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
of	IN	conj	O
69	CD	pobj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
7	CD	nummod	O
.	.	punct	O
1	CD	nummod	O
ml	NN	compound	O
/	SYM	punct	O
100	CD	nummod	O
g	NN	appos	O
/	:	punct	O
min	NN	ROOT	O
for	IN	case	O
the	DT	det	O
beginning	NN	nmod	O
of	IN	case	O
the	DT	det	O
decline	NN	nmod	O
in	IN	case	O
regional	JJ	amod	O
ATP	NN	nmod	B-Simple_chemical
and	CC	cc	O
glucose	NN	compound	B-Simple_chemical
content	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
on	IN	case	O
aerobic	JJ	amod	O
glucose	NN	compound	O
consumption	NN	nmod	O
,	,	punct	O
lactic	JJ	amod	O
acid	NN	compound	O
formation	NN	conj	O
,	,	punct	O
content	NN	appos	O
of	IN	case	O
total	JJ	intj	O
(	-LRB-	punct	O
T	NN	compound	O
-	HYPH	punct	O
SH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
non	JJ	amod	O
-	HYPH	punct	O
protein	NN	compound	O
thiol	NN	compound	O
groups	NNS	nmod	O
(	-LRB-	punct	O
NP	NN	compound	O
-	HYPH	punct	O
SH	NNP	appos	O
)	-RRB-	punct	O
,	,	punct	O
endogenous	JJ	amod	O
respiration	NN	conj	O
and	CC	cc	O
the	DT	det	O
level	NN	conj	O
of	IN	case	O
ATP	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
incubated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O
Metabolic	JJ	amod	O
thresholds	NNS	nsubjpass	O
were	VBD	auxpass	O
derived	VBN	ROOT	O
at	IN	case	O
tumor	NN	compound	B-Cancer
glucose	NN	compound	B-Simple_chemical
utilization	NN	compound	O
values	NNS	nmod	O
of	IN	case	O
70	CD	nmod	O
.	.	punct	O
6	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
8	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
mumol	NN	compound	O
/	:	punct	O
100	CD	nummod	O
g	NN	compound	O
/	:	punct	O
min	NN	ROOT	O
for	IN	case	O
reduced	VBN	amod	O
protein	NN	compound	O
synthesis	NN	nmod	O
,	,	punct	O
of	IN	case	O
55	CD	nmod	O
.	.	punct	O
0	CD	ROOT	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
2	CD	nummod	O
mumol	NN	compound	O
/	:	punct	O
100	CD	nummod	O
g	NN	compound	O
/	:	punct	O
min	NN	ROOT	O
for	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
content	NN	nmod	O
,	,	punct	O
and	CC	cc	O
34	CD	dep	O
.	.	punct	O
7	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	nummod	O
.	.	punct	O
7	CD	nummod	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	compound	O
/	:	punct	O
min	NN	conj	O
for	IN	case	O
decline	NN	nmod	O
in	IN	case	O
ATP	NN	compound	B-Simple_chemical
content	NN	nmod	O
.	.	punct	O

Tumors	NNS	nsubj	O
display	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
and	CC	cc	O
glycolysis	NN	conj	O
.	.	punct	O
Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
blood	NN	compound	B-Organism_substance
flow	NN	nsubj	O
limits	VBZ	ccomp	O
glucose	NN	compound	B-Simple_chemical
supply	NN	dobj	O
to	TO	case	O
tumor	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
at	IN	case	O
much	RB	advmod	O
higher	JJR	amod	O
flow	NN	compound	O
rates	NNS	nmod	O
than	IN	case	O
in	IN	case	O
normal	JJ	amod	O
brain	NN	advcl	B-Organ
which	WDT	nsubjpass	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
glucose	NN	compound	B-Simple_chemical
utilization	NN	nmod	O
.	.	punct	O

Tumors	NNS	nsubj	O
display	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
rate	NN	dobj	O
of	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
and	CC	cc	O
glycolysis	NN	conj	O
.	.	punct	O
A	DT	det	O
reduction	NN	nsubj	O
and	CC	cc	O
not	RB	cc	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
glucose	NN	compound	B-Simple_chemical
availability	NN	nmod	O
could	MD	aux	O
be	VB	ROOT	O
a	DT	det	O
more	RBR	advmod	O
appropriate	JJ	amod	O
strategy	NN	attr	O
for	IN	prep	O
the	DT	det	O
induction	NN	pobj	O
of	IN	case	O
energy	NN	compound	O
failure	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Erbb2	NN	nsubj	O
suppresses	VBZ	ROOT	O
DNA	NN	compound	O
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	O
skin	NN	compound	O
tumorigenesis	NN	dobj	O
.	.	punct	O
Inactivation	NN	nsubj	O
of	IN	case	O
androgen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
regulator	NN	compound	O
ARD1	NN	nmod	B-Gene_or_gene_product
inhibits	VBZ	ROOT	O
androgen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
acetylation	NN	dobj	O
and	CC	cc	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	conj	O
.	.	punct	O

Prostate	NN	compound	O
cancer	NN	compound	O
dissemination	NN	nsubj	O
is	VBZ	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
and	CC	cc	O
few	JJ	amod	O
treatment	NN	compound	O
options	NNS	nsubj	O
exist	VBP	conj	O
for	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
advanced	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
.	.	punct	O
Androgen	NN	compound	B-Simple_chemical
signaling	NN	nsubj	O
through	IN	case	O
androgen	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
AR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
critical	JJ	ROOT	O
for	IN	case	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

Prostate	NN	compound	O
cancer	NN	compound	O
dissemination	NN	nsubj	O
is	VBZ	cop	O
difficult	JJ	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
,	,	punct	O
and	CC	cc	O
few	JJ	amod	O
treatment	NN	compound	O
options	NNS	nsubj	O
exist	VBP	conj	O
for	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
advanced	JJ	amod	O
-	HYPH	punct	O
stage	NN	compound	O
disease	NN	nmod	O
.	.	punct	O
Given	VBN	mark	O
that	IN	mark	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	advcl	O
by	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
coregulators	NNS	nmod	O
,	,	punct	O
inactivation	NN	nsubj	O
of	IN	case	O
those	DT	det	O
coregulators	NNS	nmod	O
is	VBZ	aux	O
emerging	VBG	ROOT	O
as	IN	case	O
a	DT	det	O
promising	JJ	amod	O
therapy	NN	nmod	O
for	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
PCa	NNS	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
VEGF	NNP	compound	O
-	HYPH	punct	O
C	NNP	nsubj	O
seems	VBZ	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
prostate	NN	compound	O
cancer	NN	compound	O
metastasis	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
acetyltransferase	NN	compound	I-Gene_or_gene_product
arrest	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
defect	NN	compound	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	dep	O
(	-LRB-	punct	O
ARD1	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
unique	JJ	amod	O
AR	NN	compound	B-Gene_or_gene_product
regulator	NN	nmod	O
in	IN	case	O
PCa	JJ	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
VEGF	NNP	compound	O
-	HYPH	punct	O
C	NNP	nsubj	O
seems	VBZ	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
prostate	NN	compound	O
cancer	NN	compound	O
metastasis	NN	nmod	O
.	.	punct	O
ARD1	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
PCa	NNS	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
biopsies	NNS	conj	I-Cancer
.	.	punct	O

Cotreatment	NN	nsubj	O
of	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
with	IN	case	O
a	DT	det	O
hormone	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
antagonist	NN	conj	O
blocked	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
ARD1	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
augmented	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
synthetic	JJ	amod	O
androgen	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
R1881	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
unless	IN	mark	O
AR	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
deficient	JJ	advcl	O
or	CC	cc	O
is	VBZ	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
specific	JJ	amod	O
siRNA	NN	nmod	O
or	CC	cc	O
androgen	NN	compound	B-Simple_chemical
inhibitor	NN	compound	O
bicalutamide	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
Casodex	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Growth	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
histologic	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
gene	NN	nmod:npmod	O
-	HYPH	punct	O
modified	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	compound	O
(	-LRB-	punct	O
SCID	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
restricted	JJ	ROOT	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O
Depletion	NN	nsubj	O
of	IN	case	O
ARD1	NN	nmod	B-Gene_or_gene_product
by	IN	case	O
shRNA	NN	nmod	O
suppressed	VBD	ROOT	O
PCa	NNS	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
,	,	punct	O
anchorage	NN	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
xenograft	NN	amod	B-Cancer
tumor	NN	compound	I-Cancer
formation	NN	conj	O
in	IN	case	O
SCID	NN	compound	B-Organism
mice	NNS	nmod	I-Organism
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
ARD1	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
is	VBZ	cop	O
biologically	RB	advmod	O
germane	JJ	ccomp	O
.	.	punct	O

Eleven	CD	amod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
whose	WP$	nmod:poss	O
expression	NN	nsubj	O
changed	VBD	ccomp	O
significantly	RB	advmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
carcinogen	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O
Notably	RB	advmod	O
,	,	punct	O
ARD1	NN	nsubj	B-Gene_or_gene_product
was	VBD	cop	O
critical	JJ	ROOT	O
for	IN	mark	O
transcriptionally	RB	advmod	O
regulating	VBG	advcl	O
a	DT	det	O
number	NN	dobj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
TEL	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
invasiveness	NN	dobj	O
of	IN	case	O
Ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
ARD1	NN	nsubj	B-Gene_or_gene_product
interacted	VBD	ROOT	O
physically	RB	advmod	O
with	IN	advmod	O
and	CC	cc	O
acetylated	VBD	conj	O
the	DT	det	O
AR	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
Erbb2	NN	compound	O
activation	NN	nsubj	O
increases	VBZ	ROOT	O
skin	NN	compound	O
tumorigenesis	NN	dobj	O
through	IN	case	O
inhibitory	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
Chk1	NN	nmod	O
,	,	punct	O
Cdc25a	NN	compound	O
maintenance	NN	conj	O
,	,	punct	O
and	CC	cc	O
suppression	NN	conj	O
of	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	nmod	O
via	IN	case	O
a	DT	det	O
PI3K	NN	nmod:npmod	O
/	:	punct	O
Akt	NNP	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O
Because	IN	mark	O
AR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ARD1	NN	compound	B-Gene_or_gene_product
interaction	NN	nsubj	O
facilitated	VBD	advcl	O
the	DT	det	O
AR	NN	compound	B-Gene_or_gene_product
binding	VBG	dobj	O
to	TO	case	O
its	PRP$	nmod:poss	O
targeted	VBN	amod	O
promoters	NNS	nmod	O
for	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
ARD1	NN	nsubj	B-Gene_or_gene_product
functions	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
unique	JJ	amod	O
AR	NN	compound	B-Gene_or_gene_product
regulator	NN	nmod	O
and	CC	cc	O
forms	VBZ	conj	O
a	DT	det	O
positive	JJ	amod	O
feedback	NN	compound	O
loop	NN	dobj	O
for	IN	case	O
AR	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
prostate	NN	compound	B-Organ
tumorigenesis	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
may	MD	aux	O
provide	VB	ROOT	O
clinical	JJ	amod	O
benefits	NNS	dobj	O
to	TO	case	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O
Disruption	NN	nsubj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
ARD1	NN	compound	B-Gene_or_gene_product
interactions	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
intervention	NN	ROOT	O
for	IN	case	O
androgen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
PCa	NNS	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

The	DT	det	O
threshold	NN	compound	O
level	NN	ROOT	O
of	IN	case	O
adenomatous	JJ	amod	O
polyposis	NN	compound	O
coli	NN	compound	O
protein	NN	nmod	O
for	IN	case	O
mouse	NN	compound	O
intestinal	JJ	amod	O
tumorigenesis	NN	nmod	O
.	.	punct	O
The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
Hes	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
in	IN	case	O
intestinal	JJ	amod	B-Multi-tissue_structure
development	NN	nmod	O
,	,	punct	O
homeostasis	NN	conj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
formation	NN	conj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
Notch	NN	compound	O
signaling	NN	nmod	O
remains	VBZ	ROOT	O
poorly	RB	advmod	O
understood	VBN	xcomp	O
.	.	punct	O
Notch	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
regulates	VBZ	ROOT	O
intestinal	JJ	amod	B-Multi-tissue_structure
development	NN	dobj	O
,	,	punct	O
homeostasis	NN	conj	O
and	CC	cc	O
tumorigenesis	NN	conj	O
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
precise	JJ	amod	O
downstream	JJ	amod	O
mechanism	NN	nsubj	O
remains	VBZ	conj	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
considerable	JJ	amod	O
debate	NN	attr	O
concerning	VBG	acl	O
where	WRB	pcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
Notch	NN	compound	O
functions	NNS	nmod	O
and	CC	cc	O
what	WP	dobj	O
proteins	NNS	nsubj	O
serve	VBP	conj	O
as	IN	prep	O
effectors	NNS	pobj	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	O
signal	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
inactivation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Notch	NN	compound	B-Gene_or_gene_product
effectors	NNS	compound	O
Hes1	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Hes3	NN	appos	B-Gene_or_gene_product
and	CC	cc	O
Hes5	NN	conj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Hes1	NN	conj	B-Gene_or_gene_product
alone	RB	advmod	O
,	,	punct	O
led	VBD	ccomp	O
to	TO	case	O
reduced	VBN	amod	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
secretory	JJ	amod	B-Cell
cell	NN	compound	I-Cell
formation	NN	conj	O
and	CC	cc	O
altered	JJ	amod	O
intestinal	JJ	amod	B-Tissue
structures	NNS	conj	I-Tissue
in	IN	case	O
adult	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Although	IN	mark	O
both	CC	det	O
hypomorphic	JJ	amod	O
heterozygotes	NNS	nsubj	O
developed	VBD	advcl	O
intestinal	JJ	amod	O
polyps	NN	dobj	O
,	,	punct	O
tumor	NN	compound	O
multiplicities	NNS	nsubj	O
were	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
Apc	NN	compound	O
(	-LRB-	punct	O
Delta716	JJ	amod	O
)	-RRB-	punct	O
mice	NNS	nmod	O
,	,	punct	O
heterozygotes	NNS	xcomp	O
of	IN	case	O
an	DT	det	O
Apc	NN	compound	O
null	JJ	amod	O
allele	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
in	IN	case	O
Apc	NN	compound	B-Gene_or_gene_product
mutation	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
intestinal	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
inactivation	NN	nsubj	O
of	IN	case	O
Hes1	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
for	IN	mark	O
reducing	VBG	advcl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
inducing	VBG	conj	O
differentiation	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
into	IN	case	O
all	DT	det	O
types	NNS	nmod	O
of	IN	case	O
intestinal	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
without	IN	mark	O
affecting	VBG	conj	O
the	DT	det	O
homeostasis	NN	dobj	O
of	IN	case	O
normal	JJ	amod	O
crypts	NNS	nmod	B-Multi-tissue_structure
owing	VBG	acl	O
to	TO	case	O
genetic	JJ	amod	O
redundancy	NN	nmod	O
.	.	punct	O

With	IN	case	O
regard	NN	dep	O
to	TO	case	O
differentiation	NN	nmod	O
,	,	punct	O
hypoxic	JJ	amod	O
cells	NNS	nsubj	O
lost	VBD	ROOT	O
their	PRP$	nmod:poss	O
neuronal	JJ	amod	O
/	SYM	punct	O
neuroendocrine	JJ	dep	O
features	NNS	dobj	O
and	CC	cc	O
gained	VBD	conj	O
marker	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
,	,	punct	O
neural	JJ	dep	O
crest	NN	dep	O
-	HYPH	punct	O
like	IN	dep	O
phenotype	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Hes	NN	compound	B-Gene_or_gene_product
genes	NNS	nsubj	O
cooperatively	RB	advmod	O
regulate	VBP	ccomp	O
intestinal	JJ	amod	B-Multi-tissue_structure
development	NN	dobj	O
and	CC	cc	O
homeostasis	NN	conj	O
and	CC	cc	O
raised	VBD	conj	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
Hes1	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
promising	JJ	amod	O
target	NN	ccomp	O
to	TO	mark	O
induce	VB	acl	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Erbb2	NN	nsubj	O
suppresses	VBZ	ROOT	O
DNA	NN	compound	O
damage	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
checkpoint	NN	amod	O
activation	NN	dobj	O
and	CC	cc	O
UV	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
mouse	NN	compound	O
skin	NN	compound	O
tumorigenesis	NN	dobj	O
.	.	punct	O
Activation	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
induced	VBN	amod	I-Gene_or_gene_product
cytidine	NN	compound	I-Gene_or_gene_product
deaminase	NN	ROOT	I-Gene_or_gene_product
in	IN	case	O
antibody	NN	compound	O
diversification	NN	nmod	O
and	CC	cc	O
chromosome	NN	compound	B-Cellular_component
translocation	NN	conj	O
.	.	punct	O

Although	IN	mark	O
several	JJ	amod	O
hypotheses	NNS	nsubjpass	O
for	IN	case	O
human	JJ	amod	O
carcinogenesis	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	advcl	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
genetic	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
cause	VBP	acl:relcl	O
normal	JJ	amod	O
cells	NNS	dobj	O
to	TO	mark	O
become	VB	advcl	O
cancer	NN	compound	O
cells	NNS	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O
DNA	NN	compound	B-Cellular_component
damage	NN	nsubj	O
,	,	punct	O
rearrangement	NN	conj	O
,	,	punct	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
genome	NN	nmod	O
are	VBP	cop	O
the	DT	det	O
basis	NN	ROOT	O
of	IN	case	O
carcinogenesis	NN	nmod	O
and	CC	cc	O
thought	VBN	conj	O
to	TO	mark	O
be	VB	auxpass	O
avoided	VBN	xcomp	O
at	IN	case	O
all	DT	det	O
costs	NNS	nmod	O
.	.	punct	O

Simian	JJ	amod	O
virus	NN	compound	O
40	CD	nummod	O
large	JJ	amod	O
T	NN	compound	O
antigen	NN	nsubj	O
and	CC	cc	O
two	CD	nummod	O
independent	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
antigen	NN	compound	O
segments	NNS	nsubj	O
sensitize	VBP	ROOT	O
cells	NNS	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
genotoxic	JJ	amod	O
damage	NN	nmod	O
.	.	punct	O
An	DT	det	O
exception	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
adaptive	JJ	amod	O
immune	JJ	amod	B-Anatomical_system
system	NN	ROOT	I-Anatomical_system
where	WRB	advmod	O
lymphocytes	NNS	nsubj	B-Cell
utilize	VBP	acl:relcl	O
programmed	VBN	amod	O
DNA	NN	compound	B-Cellular_component
damage	NN	dobj	O
to	TO	mark	O
effect	VB	advcl	O
antigen	NN	compound	O
receptor	NN	compound	O
diversification	NN	dobj	O
.	.	punct	O

The	DT	det	O
members	NNS	nsubj	O
of	IN	case	O
an	DT	det	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	compound	O
microRNA	NN	compound	O
cluster	NN	nmod	O
cooperate	VBP	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
B	NN	compound	O
lymphocytes	NNS	dobj	O
.	.	punct	O
Both	CC	cc:preconj	O
B	NN	compound	B-Cell
and	CC	cc	O
T	NN	conj	B-Cell
lymphocytes	NNS	nsubj	I-Cell
diversify	VBP	ROOT	O
their	PRP$	nmod:poss	O
antigen	NN	compound	O
receptors	NNS	dobj	O
through	IN	case	O
RAG1	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
2	CD	nummod	B-Gene_or_gene_product
mediated	JJ	amod	O
recombination	NN	conj	O
,	,	punct	O
but	CC	cc	O
B	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
undergo	VBP	conj	O
two	CD	nummod	O
additional	JJ	amod	O
processes	NNS	compound	O
-	HYPH	punct	O
-	HYPH	punct	O
somatic	JJ	amod	O
hypermutation	NN	dobj	O
(	-LRB-	punct	O
SHM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
class	NN	compound	O
-	HYPH	punct	O
switch	NN	compound	O
recombination	NN	conj	O
(	-LRB-	punct	O
CSR	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
both	DT	dep	O
initiated	VBN	acl	O
by	IN	case	O
activation	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
induced	VBN	amod	I-Gene_or_gene_product
cytidine	NN	compound	I-Gene_or_gene_product
deaminase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
AID	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

TP	NN	nsubj	O
catalyzes	VBZ	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
of	IN	case	O
thymidine	NN	nmod	O
to	TO	case	O
thymine	NN	nmod	O
and	CC	cc	O
doxyribose	NN	amod	O
-	,	punct	O
1	CD	nummod	O
-	HYPH	punct	O
phosphate	NN	conj	O
(	-LRB-	punct	O
dR	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
P	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
AID	NN	nsubj	B-Gene_or_gene_product
deaminates	NNS	ROOT	O
cytidines	NNS	dobj	B-Simple_chemical
in	IN	case	O
DNA	NN	nmod	B-Cellular_component
resulting	VBG	acl	O
in	IN	case	O
U	NN	nmod	O
:	:	punct	O
G	NN	nsubj	O
mismatches	NNS	parataxis	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
processed	VBN	ccomp	O
into	IN	case	O
point	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
SHM	NN	nmod	O
or	CC	cc	O
double	JJ	amod	O
-	HYPH	punct	O
strand	NN	compound	O
breaks	NNS	conj	O
in	IN	case	O
CSR	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
oncogene	NN	compound	O
interaction	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	O
leukemogenesis	NN	nmod	O
.	.	punct	O
Although	IN	mark	O
AID	NN	compound	B-Gene_or_gene_product
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	advcl	O
at	IN	case	O
Immunoglobulin	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
Ig	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	compound	O
loci	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
also	RB	advmod	O
targets	VBZ	ROOT	O
a	DT	det	O
wide	JJ	amod	O
array	NN	dobj	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
Ig	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
including	VBG	case	O
oncogenes	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
lymphomas	NNS	nmod	B-Cancer
.	.	punct	O

During	IN	case	O
lymphomagenesis	NN	nmod	O
,	,	punct	O
induction	NN	nsubj	O
of	IN	case	O
persistent	JJ	amod	O
telomerase	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
activity	NN	conj	O
may	MD	aux	O
occur	VB	ROOT	O
before	IN	nmod	O
or	CC	cc	O
after	IN	conj	O
telomere	RB	compound	O
shortening	VBG	dobj	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
different	JJ	amod	O
mechanisms	NNS	nmod	O
through	IN	case	O
which	WDT	nmod	O
transforming	NN	amod	O
factors	NNS	nsubj	O
/	:	punct	O
agents	NNS	conj	O
may	MD	aux	O
activate	VB	acl:relcl	O
telomerase	NN	dobj	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
AID	NN	compound	B-Gene_or_gene_product
regulation	NN	nmod	O
,	,	punct	O
targeting	NN	conj	O
,	,	punct	O
and	CC	cc	O
initiation	NN	conj	O
of	IN	case	O
CSR	NN	nmod	O
and	CC	cc	O
SHM	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
AID	NN	nmod:poss	B-Gene_or_gene_product
'	POS	case	O
s	VBZ	compound	O
role	NN	conj	O
in	IN	mark	O
generating	VBG	acl	O
chromosome	NN	compound	B-Cellular_component
translocations	NNS	dobj	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
lymphomagenesis	NN	nmod	O
.	.	punct	O

beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	compound	O
signaling	NN	nsubj	O
controls	VBZ	ROOT	O
metastasis	NN	dobj	O
in	IN	case	O
Braf	NNP	compound	O
-	HYPH	punct	O
activated	VBN	amod	O
Pten	NNP	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
melanomas	NNS	nmod	O
.	.	punct	O
Incidence	NN	ROOT	O
of	IN	case	O
BRAF	NN	compound	B-Gene_or_gene_product
p	NN	nmod	O
.	.	punct	O
Val600Glu	NN	ROOT	B-Amino_acid
and	CC	cc	O
p	NN	conj	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
mutations	NNS	ROOT	O
in	IN	case	O
a	DT	det	O
consecutive	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
183	CD	nummod	O
metastatic	JJ	amod	O
melanoma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
from	IN	case	O
a	DT	det	O
high	JJ	amod	O
incidence	NN	compound	O
region	NN	nmod	O
.	.	punct	O

While	IN	mark	O
many	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	advcl	O
in	IN	case	O
melanoma	NN	nmod	O
,	,	punct	O
the	DT	det	O
relevant	JJ	amod	O
molecular	JJ	amod	O
events	NNS	nsubjpass	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O
AIM	NN	ROOT	O
:	:	punct	O
Approximately	RB	advmod	O
40	CD	quantmod	O
-	SYM	punct	O
60	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
melanomas	NNS	nmod	B-Cancer
from	IN	case	O
Caucasian	JJ	amod	O
populations	NNS	nmod	O
carry	VBP	dep	O
activating	VBG	amod	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
BRAF	NN	compound	B-Gene_or_gene_product
oncogene	NN	nmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	advcl	O
being	VBG	cop	O
the	DT	det	O
p	NN	nmod	O
.	.	punct	O
Val600Glu	NN	compound	B-Amino_acid
(	-LRB-	punct	O
V600E	NN	appos	B-Amino_acid
)	-RRB-	punct	O
hotspot	VBP	compound	O
mutation	NN	ROOT	O
in	IN	case	O
exon	NN	nmod	O
15	CD	nummod	O
.	.	punct	O

While	IN	mark	O
many	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	advcl	O
in	IN	case	O
melanoma	NN	nmod	O
,	,	punct	O
the	DT	det	O
relevant	JJ	amod	O
molecular	JJ	amod	O
events	NNS	nsubjpass	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
the	DT	det	O
less	RBR	advmod	O
common	JJ	amod	O
p	NN	nmod	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
(	-LRB-	punct	O
V600K	NN	compound	B-Amino_acid
)	-RRB-	punct	O
mutation	NN	ROOT	O
in	IN	case	O
metastatic	JJ	amod	O
melanoma	NN	nmod	B-Cancer
from	IN	case	O
a	DT	det	O
high	JJ	amod	O
incidence	NN	compound	O
region	NN	nmod	O
.	.	punct	O

MET	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
melanoma	NN	nmod	O
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O
METHOD	NN	ROOT	O
:	:	punct	O
Dideoxy	NN	compound	O
sequencing	NN	nsubjpass	O
and	CC	cc	O
fluorescent	JJ	amod	O
single	JJ	amod	O
strand	NN	compound	O
conformation	NN	compound	O
analysis	NN	conj	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
screen	VB	xcomp	O
for	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
exon	NN	nmod	O
15	CD	nummod	O
of	IN	case	O
BRAF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
183	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
metastatic	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
positive	JJ	amod	O
c	NN	compound	O
-	HYPH	punct	O
kit	NN	compound	O
protein	NN	compound	O
expression	NN	nsubj	O
and	CC	cc	O
c	NN	compound	O
-	HYPH	punct	O
kit	NN	compound	O
gene	NN	compound	O
mutation	NN	compound	O
rates	NNS	conj	O
were	VBD	cop	O
97	CD	appos	O
.	.	punct	O
6	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
80	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
41	CD	conj	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
(	-LRB-	punct	O
34	CD	nummod	O
/	SYM	punct	O
82	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
overall	JJ	amod	O
incidence	NN	nsubj	O
of	IN	case	O
BRAF	NN	compound	B-Gene_or_gene_product
mutation	NN	nmod	O
(	-LRB-	punct	O
89	CD	nummod	O
/	SYM	punct	O
183	CD	nummod	O
,	,	punct	O
49	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
very	RB	advmod	O
similar	JJ	appos	O
to	TO	case	O
other	JJ	amod	O
large	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
Caucasian	JJ	amod	O
populations	NNS	nmod	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
However	RB	ROOT	O
,	,	punct	O
the	DT	det	O
frequency	NN	intj	O
of	IN	case	O
the	DT	det	O
p	NN	nmod	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
mutation	NN	nsubj	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
most	JJS	amod	O
other	JJ	amod	O
studies	NNS	nmod	O
and	CC	cc	O
comprised	VBD	conj	O
almost	RB	advmod	O
one	CD	nummod	O
-	HYPH	punct	O
third	NN	dobj	O
of	IN	case	O
all	DT	det	O
BRAF	NN	compound	B-Gene_or_gene_product
mutations	NNS	nmod	O
in	IN	case	O
our	PRP$	nmod:poss	O
cohort	NN	nmod	O
(	-LRB-	punct	O
27	CD	nummod	O
/	SYM	punct	O
89	CD	nummod	O
,	,	punct	O
30	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

beta	NN	compound	O
-	HYPH	punct	O
catenin	NN	compound	O
signaling	NN	nsubj	O
controls	VBZ	ROOT	O
metastasis	NN	dobj	O
in	IN	case	O
Braf	NNP	compound	O
-	HYPH	punct	O
activated	VBN	amod	O
Pten	NNP	nmod:npmod	O
-	HYPH	punct	O
deficient	JJ	amod	O
melanomas	NNS	nmod	O
.	.	punct	O
CONCLUSION	NN	ROOT	O
:	:	punct	O
BRAF	NN	compound	B-Gene_or_gene_product
p	NN	dep	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
mutations	NNS	nsubj	O
were	VBD	cop	O
present	JJ	ROOT	O
at	IN	case	O
a	DT	det	O
relatively	RB	advmod	O
high	JJ	amod	O
frequency	NN	nmod	O
in	IN	case	O
this	DT	det	O
cohort	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
melanoma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
27	CD	dep	O
/	SYM	punct	O
183	CD	conj	O
,	,	punct	O
15	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
RAF265	NN	nsubj	O
is	VBZ	cop	O
highly	RB	advmod	O
efficacious	JJ	ccomp	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
melanoma	NN	nmod	O
and	CC	cc	O
decreases	VBZ	conj	O
glucose	NN	compound	O
metabolism	NN	dobj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
DNA	NN	compound	O
microarray	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
cell	NN	compound	O
culture	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
and	CC	cc	O
small	JJ	amod	O
animal	NN	compound	O
FDG	NN	compound	O
PET	NN	compound	O
scans	NNS	conj	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
1	CD	nummod	O
day	NN	nmod	O
after	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
Assays	NNS	nsubj	O
used	VBN	acl	O
to	TO	mark	O
screen	VB	xcomp	O
for	IN	case	O
BRAF	NN	compound	B-Gene_or_gene_product
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
clinic	NN	nmod	O
should	MD	aux	O
be	VB	ROOT	O
robust	JJ	acomp	O
enough	RB	acomp	O
to	TO	aux	O
detect	VB	advcl	O
the	DT	det	O
p	NN	dobj	O
.	.	punct	O
Val600Lys	NN	compound	B-Amino_acid
mutation	NN	ROOT	O
,	,	punct	O
as	IN	mark	O
this	DT	nsubj	O
may	MD	aux	O
have	VB	advcl	O
therapeutic	JJ	amod	O
implications	NNS	dobj	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
skeletal	JJ	amod	O
muscle	NN	compound	O
glucose	NN	compound	O
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
.	.	punct	O
Alterations	NNS	ROOT	O
in	IN	case	O
carbohydrate	NN	amod	B-Simple_chemical
metabolism	NN	nmod	O
in	IN	case	O
canine	NN	compound	B-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
skeletal	JJ	amod	O
muscle	NN	compound	O
glucose	NN	compound	O
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
.	.	punct	O
Following	VBG	prep	O
an	DT	det	O
overnight	JJ	amod	O
fast	NN	dobj	O
,	,	punct	O
blood	NN	compound	B-Organism_substance
samples	NNS	nsubjpass	I-Organism_substance
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
14	CD	nummod	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
previously	RB	advmod	O
untreated	JJ	amod	O
lymphoma	NN	nmod	B-Cancer
before	IN	advmod	O
and	CC	cc	O
5	CD	conj	O
,	,	punct	O
15	CD	conj	O
,	,	punct	O
30	CD	conj	O
,	,	punct	O
45	CD	conj	O
,	,	punct	O
60	CD	conj	O
,	,	punct	O
and	CC	cc	O
90	CD	nummod	O
minutes	NNS	conj	O
following	VBG	case	O
an	DT	det	O
intravenous	JJ	amod	B-Multi-tissue_structure
challenge	NN	nmod	O
with	IN	case	O
500	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
dextrose	NN	nmod	B-Simple_chemical
.	.	punct	O

Four	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
islet	NN	dep	O
gene	NN	compound	O
analysis	NN	nsubjpass	O
and	CC	cc	O
pancreas	NN	compound	O
immunochemistry	NN	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O
Samples	NNS	nsubjpass	B-Organism_substance
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
lactate	NN	conj	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
insulin	NN	compound	B-Gene_or_gene_product
concentrations	NNS	conj	O
and	CC	cc	O
compared	VBN	conj	O
statistically	RB	advmod	O
with	IN	case	O
ten	CD	nummod	O
control	NN	compound	O
dogs	NNS	nmod	B-Organism
of	IN	case	O
similar	JJ	amod	O
weight	NN	nmod	O
and	CC	cc	O
age	NN	conj	O
undergoing	VBG	acl	O
an	DT	det	O
identical	JJ	amod	O
dextrose	NN	compound	B-Simple_chemical
challenge	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Dogs	NNS	nsubj	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
had	VBD	ROOT	O
similar	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
curves	NNS	dobj	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
skeletal	JJ	amod	O
muscle	NN	compound	O
glucose	NN	compound	O
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
.	.	punct	O
Lactate	NN	compound	B-Simple_chemical
concentrations	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
at	IN	case	O
baseline	NN	nmod	O
and	CC	cc	O
all	DT	det	O
time	NN	compound	O
periods	NNS	conj	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
test	NN	nmod	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
,	,	punct	O
[	-LRB-	punct	O
18F	NN	nummod	O
]	-RRB-	punct	O
FDG	NN	compound	O
uptake	NN	compound	O
rates	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	dep	O
in	IN	prep	O
overnight	JJ	amod	O
fasting	NN	intj	O
and	CC	cc	O
euglycemic	JJ	amod	O
hyperinsulinemic	JJ	amod	O
clamp	NN	conj	O
(	-LRB-	punct	O
38	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
versus	CC	cc	O
41	CD	conj	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	dep	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	nmod	O
/	SYM	punct	O
minute	NN	dep	O
,	,	punct	O
not	RB	neg	O
significant	JJ	amod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
glucose	NN	compound	O
uptake	NN	nsubjpass	O
in	IN	case	O
skeletal	JJ	amod	O
muscle	NN	nmod	O
was	VBD	auxpass	O
increased	VBN	parataxis	O
by	IN	case	O
insulin	NN	nmod	O
(	-LRB-	punct	O
1	CD	dep	O
.	.	punct	O
7	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nmod	O
.	.	punct	O
2	CD	dep	O
versus	CC	cc	O
3	CD	conj	O
.	.	punct	O
8	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	nummod	O
.	.	punct	O
5	CD	nummod	O
mumol	NN	dep	O
/	:	punct	O
100	CD	nummod	O
g	NN	dep	O
/	SYM	punct	O
minute	NN	ROOT	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
012	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O
Rise	NN	nsubj	O
in	IN	case	O
lactate	NN	compound	B-Simple_chemical
concentrations	NNS	nmod	O
over	IN	case	O
baseline	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
30	CD	nummod	O
minutes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
test	NN	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
011	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
effects	NNS	ROOT	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
skeletal	JJ	amod	O
muscle	NN	compound	O
glucose	NN	compound	O
metabolism	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
.	.	punct	O
Insulin	NN	compound	B-Gene_or_gene_product
concentrations	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
at	IN	case	O
baseline	NN	nmod	O
and	CC	cc	O
at	IN	conj	O
the	DT	det	O
5	CD	pobj	O
-	HYPH	punct	O
,	,	punct	O
45	CD	conj	O
-	:	punct	O
,	,	punct	O
60	CD	conj	O
-	HYPH	punct	O
,	,	punct	O
and	CC	cc	O
90	CD	nummod	O
-	HYPH	punct	O
minute	NN	amod	O
time	NN	compound	O
periods	NNS	dobj	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
test	NN	nmod	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
Rise	NN	nsubj	O
in	IN	case	O
insulin	NN	compound	B-Gene_or_gene_product
concentrations	NNS	nmod	O
over	IN	case	O
baseline	NN	nmod	O
in	IN	case	O
the	DT	det	O
first	JJ	amod	O
5	CD	nummod	O
minutes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
tolerance	NN	compound	O
test	NN	nmod	O
were	VBD	cop	O
also	RB	advmod	O
significantly	RB	advmod	O
greater	JJR	ROOT	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
021	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
carbohydrate	NN	amod	B-Simple_chemical
metabolism	NN	nsubjpass	O
is	VBZ	auxpass	O
altered	VBN	ccomp	O
in	IN	case	O
dogs	NNS	nmod	B-Organism
with	IN	case	O
lymphoma	NN	nmod	B-Cancer
.	.	punct	O

Although	IN	mark	O
insulin	NN	compound	O
sensitivity	NN	nsubjpass	O
of	IN	case	O
skeletal	JJ	amod	O
muscle	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	advcl	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoma	NN	nmod	O
,	,	punct	O
the	DT	det	O
net	JJ	amod	O
insulin	NN	compound	O
effect	NN	nsubj	O
may	MD	aux	O
counteract	VB	ROOT	O
imbalance	NN	dobj	O
between	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
muscle	NN	conj	O
,	,	punct	O
offering	VBG	advcl	O
a	DT	det	O
potential	JJ	amod	O
means	NNS	dobj	O
to	TO	aux	O
circumvent	VB	xcomp	O
at	IN	case	O
least	JJS	nmod:npmod	O
some	DT	det	O
metabolic	JJ	amod	O
abnormalities	NNS	dobj	O
found	VBN	acl	O
in	IN	case	O
cancer	NN	nmod	O
.	.	punct	O
Many	JJ	nsubj	O
of	IN	case	O
these	DT	det	O
alterations	NNS	nmod	O
parallel	VBP	ROOT	O
those	DT	dobj	O
observed	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
patients	NNS	nmod	I-Organism
suffering	VBG	acl	O
from	IN	case	O
cancer	NN	compound	B-Organism_substance
cachexia	NN	nmod	I-Organism_substance
making	VBG	acl	O
canine	NN	compound	B-Organism
lymphoma	NN	dobj	B-Cancer
a	DT	det	O
potential	JJ	amod	O
model	NN	dobj	O
for	IN	case	O
further	JJ	amod	O
study	NN	nmod	O
of	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
and	CC	cc	O
therapy	NN	conj	O
of	IN	case	O
cancer	NN	compound	B-Organism_substance
cachexia	NN	nmod	I-Organism_substance
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	O
and	CC	cc	O
MYC	NN	conj	O
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O
Members	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
src	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
oncogene	NN	compound	O
families	NNS	dep	O
supplant	VBP	ROOT	O
the	DT	det	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
requirement	NN	dobj	O
of	IN	case	O
BALB	NN	nmod	B-Organism
/	:	punct	I-Organism
MK	NN	compound	I-Organism
-	:	punct	I-Organism
2	CD	nummod	I-Organism
keratinocytes	NNS	nmod	B-Cell
and	CC	cc	O
induce	VBP	conj	O
distinct	JJ	amod	O
alterations	NNS	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
terminal	JJ	amod	O
differentiation	NN	compound	O
program	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
grown	VBN	acl:relcl	O
in	IN	case	O
medium	NN	nmod	O
containing	VBG	acl	O
1	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	compound	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	dobj	O
developed	VBD	ROOT	O
colony	NN	npadvmod	O
-	HYPH	punct	O
forming	VBG	amod	O
capacity	NN	dobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
containing	VBG	acl	O
epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	dobj	O
.	.	punct	O
BALB	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
/	:	punct	I-Organism
MK	NN	compound	I-Organism
-	:	punct	I-Organism
2	CD	nummod	I-Organism
mouse	NN	appos	I-Organism
epidermal	JJ	amod	B-Cell
keratinocytes	NNS	nsubj	I-Cell
required	VBD	ROOT	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	dobj	I-Gene_or_gene_product
for	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
terminally	RB	advmod	O
differentiated	VBN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
high	JJ	amod	O
Ca2	NN	nmod	B-Simple_chemical
+	CC	cc	O
concentration	NN	conj	O
.	.	punct	O

Cells	NNS	ROOT	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
release	NN	compound	O
transforming	VBG	amod	O
growth	NN	compound	O
factors	NNS	dobj	O
.	.	punct	O
Infection	NN	nsubj	O
with	IN	case	O
retroviruses	NNS	nmod	B-Organism
containing	VBG	acl	O
transforming	VBG	amod	O
genes	NNS	dobj	O
of	IN	case	O
the	DT	dep	O
src	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
oncogene	NN	compound	O
families	NNS	dep	O
led	VBD	ROOT	O
to	TO	case	O
rapid	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
dependence	NN	nmod	O
,	,	punct	O
in	IN	case	O
some	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
morphology	NN	nmod	O
.	.	punct	O

LMP1	NN	nsubj	O
of	IN	case	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	nmod	O
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
cooperatively	RB	advmod	O
transforms	VBZ	conj	O
the	DT	det	O
cells	NNS	dobj	O
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	O
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	O
oncogene	NN	nmod	O
.	.	punct	O
The	DT	det	O
virus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
altered	JJ	amod	O
cells	NNS	nsubj	B-Cell
continued	VBD	ROOT	O
to	TO	mark	O
proliferate	VB	xcomp	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
calcium	NN	nmod	B-Simple_chemical
but	CC	cc	O
exhibited	VBD	conj	O
alterations	NNS	dobj	O
in	IN	case	O
normal	JJ	amod	O
keratinocyte	NN	compound	B-Cell
terminal	JJ	amod	O
differentiation	NN	nmod	O
that	WDT	nsubj	O
appear	VBP	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
specific	JJ	xcomp	O
to	TO	case	O
the	DT	det	O
particular	JJ	amod	O
oncogene	NN	nmod	O
.	.	punct	O

With	IN	case	O
regard	NN	dep	O
to	TO	case	O
differentiation	NN	nmod	O
,	,	punct	O
hypoxic	JJ	amod	O
cells	NNS	nsubj	O
lost	VBD	ROOT	O
their	PRP$	nmod:poss	O
neuronal	JJ	amod	O
/	SYM	punct	O
neuroendocrine	JJ	dep	O
features	NNS	dobj	O
and	CC	cc	O
gained	VBD	conj	O
marker	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
an	DT	det	O
immature	JJ	amod	O
,	,	punct	O
neural	JJ	dep	O
crest	NN	dep	O
-	HYPH	punct	O
like	IN	dep	O
phenotype	NN	nmod	O
.	.	punct	O
These	DT	det	O
alterations	NNS	nsubj	O
bore	VBD	ROOT	O
similarities	NNS	dobj	O
to	TO	case	O
abnormalities	NNS	nmod	O
in	IN	case	O
differentiation	NN	nmod	O
observed	VBN	acl	O
in	IN	case	O
naturally	RB	advmod	O
occurring	VBG	amod	O
squamous	JJ	amod	B-Cancer
epithelial	JJ	amod	I-Cancer
malignancies	NNS	nmod	I-Cancer
.	.	punct	O

Interleukin	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
receptor	NN	compound	O
antagonist	NN	nsubj	O
inhibits	VBZ	ROOT	O
ischaemic	JJ	amod	O
and	CC	cc	O
excitotoxic	JJ	conj	O
neuronal	JJ	amod	O
damage	NN	dobj	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	O
.	.	punct	O
Experimental	JJ	amod	O
drug	NN	compound	O
therapy	NN	ROOT	O
of	IN	case	O
peritumoral	JJ	amod	B-Pathological_formation
brain	NN	compound	I-Pathological_formation
edema	NN	nmod	I-Pathological_formation
.	.	punct	O

Toxicity	NN	nsubjpass	O
,	,	punct	O
pharmacokinetic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
organ	NN	compound	O
biodistribution	NN	compound	O
studies	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Four	CD	nummod	O
drugs	NNS	nsubjpass	O
with	IN	case	O
potential	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
peritumoral	JJ	amod	B-Pathological_formation
brain	NN	compound	I-Pathological_formation
edema	NN	compound	I-Pathological_formation
activity	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
VX2	NN	compound	B-Cancer
rabbit	NN	compound	B-Organism
brain	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	dobj	O
.	.	punct	O

Cyclooxygenase	NN	compound	O
-	HYPH	punct	O
2	CD	nummod	O
(	-LRB-	punct	O
COX	NN	compound	O
-	:	punct	O
2	CD	appos	O
)	-RRB-	punct	O
inhibitors	NNS	nsubj	O
are	VBP	cop	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
agents	NNS	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
have	VBP	acl:relcl	O
potent	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
,	,	punct	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	conj	O
and	CC	cc	O
analgesic	JJ	conj	O
properties	NNS	dobj	O
yet	RB	advmod	O
do	VBP	aux	O
not	RB	neg	O
affect	VB	ROOT	O
platelet	NN	compound	O
function	NN	dobj	O
in	IN	case	O
the	DT	det	O
manner	NN	nmod	O
of	IN	case	O
traditional	JJ	amod	O
non	JJ	amod	O
-	HYPH	punct	O
steroidal	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
drugs	NNS	nmod	O
.	.	punct	O
Meclofenamate	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
indomethacin	NN	conj	B-Simple_chemical
were	VBD	auxpass	O
tested	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
attempt	NN	nmod	O
to	TO	mark	O
confirm	VB	acl	O
recent	JJ	amod	O
reports	NNS	dobj	O
of	IN	prep	O
anti	JJ	amod	O
-	HYPH	punct	O
edema	NN	compound	B-Pathological_formation
activity	NN	pobj	O
in	IN	prep	O
non	JJ	amod	B-Simple_chemical
steroidal	JJ	amod	I-Simple_chemical
anti	JJ	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
inflammatory	JJ	amod	I-Simple_chemical
drugs	NNS	pobj	I-Simple_chemical
(	-LRB-	punct	O
NSAID	NN	compound	B-Simple_chemical
'	POS	punct	I-Simple_chemical
s	NNS	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
taxol	NN	nmod	O
,	,	punct	O
cobalt	NN	compound	O
chloride	NN	conj	O
and	CC	cc	O
a	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	compound	O
combination	NN	conj	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	O
tissue	NN	compound	O
assay	NN	nmod	O
and	CC	cc	O
compared	VBN	conj	O
to	TO	case	O
the	DT	det	O
validated	VBN	amod	O
human	JJ	amod	O
placental	JJ	amod	O
vein	NN	compound	O
angiogenesis	NN	compound	O
model	NN	nmod	O
(	-LRB-	punct	O
HPVAM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
'	``	punct	O
angiostatic	JJ	amod	O
'	''	punct	O
steroids	NNS	nsubjpass	O
17	CD	nummod	B-Simple_chemical
hydroxyprogesterone	NN	dep	I-Simple_chemical
and	CC	cc	O
epicortisol	NN	conj	B-Simple_chemical
were	VBD	auxpass	O
tested	VBN	ROOT	O
because	IN	case	O
of	IN	mwe	O
their	PRP$	nmod:poss	O
lack	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-Simple_chemical
and	CC	cc	O
mineralocorticoid	NN	conj	B-Simple_chemical
effects	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
structural	JJ	amod	O
similarity	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	B-Simple_chemical
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
with	IN	case	O
histology	NN	nmod	O
and	CC	cc	O
electron	NN	compound	O
microscopy	NN	conj	O
.	.	punct	O
The	DT	det	O
protein	NN	nsubjpass	O
and	CC	cc	O
water	NN	compound	O
component	NN	conj	O
of	IN	prep	O
brain	NN	compound	B-Pathological_formation
edema	NN	pobj	I-Pathological_formation
were	VBD	auxpass	O
indirectly	RB	advmod	O
quantitated	VBN	ROOT	O
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
None	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
test	NN	compound	O
drugs	NNS	pobj	O
demonstrated	VBD	ROOT	O
significant	JJ	amod	O
anti	JJ	amod	O
-	HYPH	punct	O
edema	NN	compound	B-Pathological_formation
activity	NN	dobj	O
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
This	DT	det	O
work	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
confirm	VB	ROOT	O
reports	NNS	dobj	O
that	IN	mark	O
NSAID	NN	compound	B-Simple_chemical
'	POS	punct	O
s	NNS	nsubj	O
have	VBP	ccomp	O
anti	JJ	amod	O
-	HYPH	punct	O
edema	NN	compound	B-Pathological_formation
activity	NN	dobj	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
there	EX	expl	O
may	MD	aux	O
be	VB	cop	O
no	DT	neg	O
correlation	NN	ccomp	O
between	IN	case	O
'	``	punct	O
angiostatic	JJ	amod	O
'	''	punct	O
and	CC	cc	O
anti	JJ	amod	O
-	HYPH	punct	O
edema	NN	compound	B-Pathological_formation
activity	NN	nmod	O
in	IN	case	O
certain	JJ	amod	O
steroid	NN	compound	B-Simple_chemical
compounds	NNS	nmod	I-Simple_chemical
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
the	DT	det	O
putative	JJ	amod	O
transforming	NN	amod	O
protein	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
leukemia	NN	compound	O
viruses	NNS	nmod	O
HTLV	NN	dep	O
-	:	punct	O
I	CD	dep	O
and	CC	cc	O
HTLV	NN	compound	O
-	:	punct	O
II	CD	conj	O
.	.	punct	O
Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
small	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
sufficient	JJ	acl:relcl	O
for	IN	case	O
transforming	VBG	amod	O
potential	NN	amod	O
and	CC	cc	O
growth	NN	compound	O
-	HYPH	punct	O
stimulating	NN	conj	O
activity	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
v	NN	det	O
-	HYPH	punct	O
erbA	NN	compound	O
and	CC	cc	O
v	NN	compound	O
-	HYPH	punct	O
myb	NN	nsubj	O
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	O
cells	NNS	nmod	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O
To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
structure	NN	compound	O
-	HYPH	punct	O
function	NN	compound	O
relationship	NN	dobj	O
for	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
in	IN	case	O
-	HYPH	punct	O
frame	NN	compound	O
insertion	NN	dobj	O
and	CC	cc	O
deletion	NN	compound	O
mutants	NNS	conj	O
of	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
carried	VBN	acl	O
by	IN	case	O
FBJ	NN	compound	B-Organism
-	HYPH	punct	I-Organism
MuSV	NN	nmod	I-Organism
,	,	punct	O
and	CC	cc	O
expressed	VBD	conj	O
them	PRP	dobj	O
in	IN	case	O
chicken	NN	compound	B-Organism
primary	JJ	amod	O
cells	NNS	nmod	B-Cell
using	VBG	acl	O
retrovirus	NN	compound	O
vectors	NNS	dobj	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
v	NN	det	O
-	HYPH	punct	O
erbA	NN	compound	O
and	CC	cc	O
v	NN	compound	O
-	HYPH	punct	O
myb	NN	nsubj	O
can	MD	aux	O
induce	VB	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	O
cells	NNS	nmod	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
these	DT	det	O
mutations	NNS	nmod	O
on	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
to	TO	mark	O
transform	VB	acl	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	dobj	I-Cell
and	CC	cc	O
to	TO	mark	O
stimulate	VB	conj	O
cellular	JJ	amod	B-Cell
proliferation	NN	dobj	O
of	IN	case	O
chicken	NN	compound	B-Organism
neuroretinal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Conversion	NN	nsubj	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
to	TO	case	O
alanine	NN	compound	O
residues	NNS	nmod	O
greatly	RB	advmod	O
reduced	VBD	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
although	IN	mark	O
the	DT	det	O
mutant	JJ	amod	O
55	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
protein	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
p53	NN	nmod	O
at	IN	case	O
normal	JJ	amod	O
levels	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
somewhat	RB	advmod	O
defective	JJ	conj	O
for	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
p53	NN	compound	O
transactivation	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
The	DT	det	O
mutant	NN	nsubj	O
which	WDT	nsubj	O
retains	VBZ	acl:relcl	O
only	RB	advmod	O
the	DT	det	O
central	JJ	amod	O
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
(	-LRB-	punct	O
Met111	NN	compound	B-Amino_acid
-	:	punct	O
Ile206	NN	appos	B-Amino_acid
)	-RRB-	punct	O
have	VBP	ROOT	O
both	DT	det	O
activities	NNS	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mutants	NNS	nsubj	O
which	WDT	nsubj	O
have	VBP	acl:relcl	O
deletions	NNS	dobj	O
in	IN	case	O
this	DT	det	O
region	NN	nmod	O
,	,	punct	O
and	CC	cc	O
one	CD	conj	O
of	IN	case	O
the	DT	det	O
mutants	NNS	nmod	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
four	CD	nummod	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
insertion	NN	dobj	O
in	IN	case	O
it	PRP	nmod	O
,	,	punct	O
lost	VBD	conj	O
both	DT	det	O
activities	NNS	dobj	O
.	.	punct	O

As	IN	mark	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nsubj	O
are	VBP	cop	O
devoid	JJ	advcl	O
of	IN	case	O
EGF	NN	compound	O
receptors	NNS	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
potentiated	VBN	ROOT	O
by	IN	case	O
EGF	NN	nmod	O
.	.	punct	O
The	DT	det	O
central	JJ	amod	O
region	NN	nsubj	O
that	WDT	nsubj	O
is	VBZ	cop	O
sufficient	JJ	acl:relcl	O
for	IN	case	O
these	DT	det	O
activities	NNS	nmod	O
includes	VBZ	ROOT	O
the	DT	det	O
evolutionarily	RB	advmod	O
highly	RB	advmod	O
conserved	VBN	amod	O
region	NN	dobj	O
among	IN	case	O
human	JJ	amod	B-Organism
,	,	punct	O
mouse	NN	conj	B-Organism
and	CC	cc	O
chicken	NN	compound	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	conj	I-Gene_or_gene_product
proteins	NNS	nmod	O
.	.	punct	O

Homeobox	NN	compound	O
genes	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
strikingly	RB	advmod	O
conserved	VBN	amod	O
61	CD	nummod	O
-	HYPH	punct	O
amino	NN	compound	O
acid	NN	compound	O
sequence	NN	dobj	O
,	,	punct	O
encoding	VBG	advcl	O
DNA	NN	compound	O
-	HYPH	punct	O
binding	NN	compound	O
domain	NN	dobj	O
.	.	punct	O
Additionally	RB	advmod	O
,	,	punct	O
this	DT	det	O
sequence	NN	nsubj	O
shares	VBZ	ROOT	O
some	DT	det	O
homology	NN	dobj	O
with	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
binding	NN	compound	O
domain	NN	nmod	O
of	IN	case	O
GCN4	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
protein	NN	conj	O
.	.	punct	O

As	IN	mark	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nsubj	O
are	VBP	cop	O
devoid	JJ	advcl	O
of	IN	case	O
EGF	NN	compound	O
receptors	NNS	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
potentiated	VBN	ROOT	O
by	IN	case	O
EGF	NN	nmod	O
.	.	punct	O
The	DT	det	O
truncated	VBN	amod	O
fos	NN	compound	B-Gene_or_gene_product
protein	NN	nsubjpass	O
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
only	JJ	advmod	O
part	NN	dobj	O
of	IN	case	O
the	DT	det	O
central	JJ	amod	O
region	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
phosphorylated	VBN	ROOT	O
in	IN	case	O
chicken	NN	compound	B-Organism
embryo	NN	compound	B-Cell
fibroblasts	NNS	nmod	I-Cell
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
phosphorylation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
fos	NN	compound	B-Gene_or_gene_product
protein	NN	nmod	O
is	VBZ	cop	O
not	RB	neg	O
necessary	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
transforming	NN	amod	O
activity	NN	nmod	O
.	.	punct	O

A	DT	det	O
synthetic	JJ	amod	O
tetracycline	NN	nsubj	O
,	,	punct	O
doxycycline	NN	appos	O
,	,	punct	O
inhibits	VBZ	ROOT	O
migration	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
MDA	NN	compound	O
-	HYPH	punct	O
MB	NNP	compound	O
-	:	punct	O
435	CD	nummod	O
breast	NN	compound	O
adenocarcinoma	NN	compound	O
cells	NNS	nmod	O
through	IN	case	O
a	DT	det	O
reconstituted	VBN	amod	O
basement	NN	compound	O
membrane	NN	nmod	O
(	-LRB-	punct	O
Matrigel	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
assay	NN	appos	O
used	VBN	acl	O
as	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
surrogate	NN	nmod	O
for	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
process	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
invasion	NN	nmod	O
through	IN	case	O
basement	NN	compound	O
membranes	NNS	nmod	O
.	.	punct	O
Inhibition	NN	ROOT	O
by	IN	case	O
retinoic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
of	IN	case	O
type	NN	compound	O
IV	CD	nummod	O
collagenolysis	NN	nmod	O
and	CC	cc	O
invasion	NN	conj	O
through	IN	case	O
reconstituted	VBN	amod	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
by	IN	case	O
metastatic	JJ	amod	O
rat	NN	compound	B-Organism
mammary	JJ	amod	B-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
MMP	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
favoring	VBG	acl	O
proteolytic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	O
membrane	NN	nmod	O
and	CC	cc	O
extracellular	JJ	amod	O
matrix	NN	conj	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
angiogenesis	NN	conj	O
,	,	punct	O
whereas	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
MMP	NN	compound	O
activity	NN	nmod	O
appears	VBZ	advcl	O
to	TO	mark	O
restrict	VB	xcomp	O
these	DT	det	O
processes	NNS	dobj	O
.	.	punct	O
The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagenase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
enables	VBZ	acl:relcl	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
degrade	VB	xcomp	O
collagen	NN	compound	B-Gene_or_gene_product
type	NN	dobj	I-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
subendothelial	JJ	amod	B-Cellular_component
basement	NN	compound	I-Cellular_component
membrane	NN	nmod	I-Cellular_component
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
potential	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
rat	NN	compound	B-Organism
13762NF	NN	nummod	B-Cell
mammary	JJ	amod	I-Cell
adenocarcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
and	CC	cc	O
its	PRP$	nmod:poss	O
clones	NNS	conj	B-Cell
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
fibrinolysis	NN	nmod	O
in	IN	case	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	O
.	.	punct	O
In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	JJ	amod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
retinoic	JJ	amod	I-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
all	DT	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
other	JJ	amod	O
retinoids	NNS	conj	O
,	,	punct	O
which	WDT	nsubj	O
exhibit	VBP	acl:relcl	O
antitumor	NN	compound	B-Cancer
activity	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
affect	VBP	ccomp	O
the	DT	det	O
collagenolytic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
metastatic	JJ	amod	O
rat	NN	compound	B-Organism
13762NF	NN	nummod	B-Cell
mammary	JJ	amod	I-Cell
adenocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
clone	NN	nsubj	O
of	IN	prep	O
NIH3T3	NN	compound	O
transformant	NN	intj	O
(	-LRB-	punct	O
H	NN	compound	O
-	:	punct	O
3	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
obtained	VBN	acl	O
by	IN	mark	O
transfecting	VBG	advcl	O
genomic	JJ	amod	O
DNA	NN	dobj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	O
colon	NN	compound	O
carcinoma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
,	,	punct	O
contains	VBZ	ROOT	O
human	JJ	amod	O
K	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
oncogene	NN	dobj	O
and	CC	cc	O
yields	VBZ	conj	O
metastatic	JJ	amod	O
pulmonary	JJ	amod	O
nodules	NNS	dobj	O
after	IN	case	O
intravenous	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
into	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Cells	NNS	ROOT	B-Cell
of	IN	case	O
the	DT	det	O
highly	RB	advmod	O
metastatic	JJ	amod	O
lung	NN	compound	B-Organ
-	HYPH	punct	O
colonizing	VBG	compound	O
clone	NN	compound	B-Cell
MTF7	NN	nmod	I-Cell
.	.	punct	I-Cell
T35	NN	ROOT	I-Cell
.	.	punct	I-Cell
3	CD	nsubjpass	I-Cell
,	,	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
13762NF	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
for	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
with	IN	case	O
0	CD	nmod	O
.	.	punct	O
1	CD	nsubj	O
,	,	punct	O
1	CD	conj	O
,	,	punct	O
or	CC	cc	O
10	CD	nummod	O
microM	NN	conj	O
all	RB	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	dep	I-Simple_chemical
,	,	punct	O
harvested	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
seeded	VBD	conj	O
on	RP	case	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
proline	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
deposited	VBN	acl	O
by	IN	case	O
cultured	VBN	amod	O
rat	NN	compound	B-Organism
lung	NN	compound	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
on	IN	case	O
a	DT	det	O
film	NN	conj	O
of	IN	case	O
purified	VBN	amod	O
[	-LRB-	punct	B-Simple_chemical
3H	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
proline	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
The	DT	det	O
amount	NN	nsubjpass	O
of	IN	prep	O
radioactivity	NN	pobj	O
released	VBN	acl	O
into	IN	case	O
the	DT	det	O
medium	NN	nmod	O
during	IN	case	O
the	DT	det	O
subsequent	JJ	amod	O
24	CD	compound	O
to	TO	dep	O
72	CD	nummod	O
h	NN	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	conj	O
that	IN	mark	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	compound	I-Simple_chemical
treatment	NN	nsubj	O
inhibited	VBD	ccomp	O
degradation	NN	dobj	O
of	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
and	CC	cc	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	conj	I-Gene_or_gene_product
by	IN	case	O
50	CD	compound	O
to	TO	dep	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
grown	VBN	acl:relcl	O
in	IN	case	O
medium	NN	nmod	O
containing	VBG	acl	O
1	CD	nummod	O
ng	NN	compound	O
/	:	punct	O
ml	NN	compound	O
TGF	NN	compound	O
-	HYPH	punct	O
beta	NN	dobj	O
developed	VBD	ROOT	O
colony	NN	npadvmod	O
-	HYPH	punct	O
forming	VBG	amod	O
capacity	NN	dobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
containing	VBG	acl	O
epidermal	JJ	amod	O
growth	NN	compound	O
factor	NN	dobj	O
.	.	punct	O
This	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
whether	IN	mark	O
the	DT	det	O
cells	NNS	nsubjpass	B-Cell
had	VBD	aux	O
been	VBN	auxpass	O
treated	VBN	ccomp	O
with	IN	case	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	nmod	I-Simple_chemical
in	IN	case	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
medium	NN	nmod	O
or	CC	cc	O
in	IN	case	O
medium	NN	conj	O
supplemented	VBN	acl	O
with	IN	case	O
heat	NN	nmod:npmod	O
-	HYPH	punct	O
inactivated	VBN	nmod	O
or	CC	cc	O
acid	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
fetal	JJ	amod	B-Developing_anatomical_structure
bovine	JJ	amod	B-Organism
serum	NN	conj	B-Organism_substance
.	.	punct	O

Thalidomide	NN	ROOT	O
in	IN	case	O
concentrations	NNS	nmod	O
from	IN	case	O
0	CD	nmod	O
.	.	punct	O
1	CD	nummod	O
microM	NN	nsubj	O
to	TO	case	O
10	CD	nummod	O
microM	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
change	VB	ROOT	O
cell	NN	compound	O
proliferation	NN	dobj	O
of	IN	case	O
72	CD	nummod	O
-	HYPH	punct	O
h	NN	compound	O
cell	NN	compound	O
cultures	NNS	nmod	O
.	.	punct	O
The	DT	det	O
growth	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
except	IN	case	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
10	CD	nummod	O
microM	NN	nmod	O
all	RB	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	dep	I-Simple_chemical
in	IN	case	O
serum	NN	nmod:npmod	B-Organism_substance
-	HYPH	punct	O
free	JJ	amod	O
medium	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
The	DT	det	O
reduction	NN	nsubjpass	O
in	IN	case	O
collagenolytic	JJ	amod	O
activity	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
viable	JJ	amod	O
cells	NNS	nmod	B-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
conditioned	JJ	amod	O
medium	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
A	DT	det	O
24	CD	nummod	O
-	HYPH	punct	O
h	NN	compound	O
exposure	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
to	TO	case	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	nmod	I-Simple_chemical
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
cause	VB	xcomp	O
a	DT	det	O
30	CD	compound	O
%	NN	compound	O
decrease	NN	dobj	O
in	IN	case	O
the	DT	det	O
collagenolytic	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubj	O
was	VBD	cop	O
reversible	JJ	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
The	DT	det	O
direct	JJ	amod	O
addition	NN	nsubj	O
of	IN	case	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	nmod	I-Simple_chemical
to	TO	case	O
conditioned	JJ	amod	O
medium	NN	nmod	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
secreted	VBN	amod	O
collagenase	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
The	DT	det	O
apparent	JJ	amod	O
molecular	JJ	amod	O
weights	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
collagenolytic	JJ	amod	O
enzymes	NNS	nmod	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
electrophoresis	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Organism_substance
extracts	NNS	nmod	I-Organism_substance
and	CC	cc	O
concentrated	VBD	amod	O
conditioned	JJ	amod	O
medium	NN	conj	O
in	IN	case	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	O
embedded	JJ	amod	O
polyacrylamide	NN	compound	B-Simple_chemical
gels	NNS	nmod	O
followed	VBN	acl	O
by	IN	case	O
renaturation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
enzymes	NNS	nmod	O
within	IN	case	O
the	DT	det	O
gels	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
U	NNP	compound	O
-	HYPH	punct	O
995	CD	nummod	O
(	-LRB-	punct	O
30	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	nsubj	O
)	-RRB-	punct	O
markedly	RB	advmod	O
prevented	VBD	ROOT	O
collagenase	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
collagenolysis	NN	dobj	O
.	.	punct	O
Two	CD	nummod	O
major	JJ	amod	O
type	NN	compound	O
IV	CD	nummod	O
collagenolytic	JJ	amod	O
metalloproteinases	NNS	nsubjpass	B-Gene_or_gene_product
exhibiting	VBG	acl	O
molecular	JJ	amod	O
weights	NNS	dobj	O
of	IN	case	O
64	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
and	CC	cc	O
88	CD	nummod	O
,	,	punct	O
000	CD	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
by	IN	case	O
this	DT	det	O
method	NN	nmod	O
.	.	punct	O

This	DT	det	O
difference	NN	nsubjpass	O
in	IN	case	O
invasiveness	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
caused	VBN	ROOT	O
by	IN	case	O
differences	NNS	nmod	O
in	IN	case	O
gelatinase	NN	compound	O
production	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
constant	JJ	acl:relcl	O
within	IN	case	O
each	DT	det	O
group	NN	nmod	O
of	IN	case	O
transfectants	NNS	nmod	O
.	.	punct	O
These	DT	det	O
two	CD	nummod	O
enzymes	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
specificity	NN	dobj	O
for	IN	case	O
gelatin	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
a	DT	det	O
major	JJ	amod	O
cellular	JJ	amod	O
protein	NN	nmod	O
of	IN	case	O
Mr	NN	nmod	O
36	CD	nummod	O
,	,	punct	O
000	CD	appos	O
in	IN	case	O
cells	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
partially	RB	advmod	O
transforming	VBG	amod	O
mutants	NNS	nmod	O
of	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	nmod	O
.	.	punct	O
The	DT	det	O
Mr	NNP	compound	O
64	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
enzyme	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
extracted	VBN	ROOT	O
from	IN	case	O
viable	JJ	amod	O
cells	NNS	nmod	B-Cell
(	-LRB-	punct	O
presumably	RB	advmod	O
from	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	appos	I-Cellular_component
)	-RRB-	punct	O
by	IN	case	O
2	CD	nummod	O
%	NN	nmod	O
1	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butanol	NN	dep	I-Simple_chemical
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
conditioned	JJ	amod	O
media	NNS	nsubj	O
induce	VBP	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
proapoptotic	JJ	amod	O
mediators	NNS	nmod	O
in	IN	case	O
the	DT	det	O
Chang	NNP	compound	O
hepatocytes	NNS	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
with	IN	case	O
all	DT	det	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trans	NN	amod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
RA	NN	nmod	I-Simple_chemical
decreased	VBD	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cellular	JJ	nmod	B-Cell
,	,	punct	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
,	,	punct	O
and	CC	cc	O
conditioned	JJ	amod	O
medium	NN	compound	O
compartments	NNS	conj	O
.	.	punct	O
(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
400	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Glutamine	NN	nsubj	O
and	CC	cc	O
glucose	NN	conj	O
as	IN	case	O
energy	NN	compound	O
substrates	NNS	nmod	O
for	IN	prep	O
Ehrlich	NN	pobj	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
.	.	punct	O
Malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	JJ	compound	B-Simple_chemical
cycle	NN	nsubj	O
during	IN	case	O
glycolysis	NN	nmod	O
and	CC	cc	O
glutaminolysis	NN	conj	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Energy	NN	compound	O
metabolism	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
0	CD	conj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	JJ	amod	B-Simple_chemical
cycle	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
during	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
and	CC	cc	O
glutaminolysis	NN	conj	O
in	IN	case	O
a	DT	det	O
strain	NN	nmod	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
malate	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
aspartate	NN	compound	B-Simple_chemical
shuttle	JJ	amod	O
system	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

Energy	NN	compound	O
metabolism	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
0	CD	conj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
experimental	JJ	amod	O
approach	NN	nsubj	O
includes	VBZ	ROOT	O
:	:	punct	O
estimation	NN	dep	O
of	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
NAD	NN	compound	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
P	NN	appos	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
+	CC	cc	O
-	HYPH	punct	O
dependent	JJ	amod	O
malic	JJ	amod	O
enzyme	NN	compound	O
activity	NN	nmod	O
;	:	punct	O
respiratory	JJ	amod	O
activity	NN	dep	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
or	CC	cc	O
fasted	VBN	conj	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
of	IN	case	O
isolated	VBN	amod	O
mitochondria	NN	conj	B-Cellular_component
;	:	punct	O
and	CC	cc	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
metabolites	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
and	CC	cc	O
glutaminolytic	JJ	conj	O
pathways	NNS	nmod	O
.	.	punct	O

Large	JJ	amod	O
amounts	NNS	nsubjpass	O
of	IN	case	O
cytosolic	JJ	amod	O
NADH	NN	nmod	O
were	VBD	auxpass	O
oxidized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	O
respiratory	JJ	amod	O
chain	NN	nmod	O
via	IN	case	O
the	DT	det	O
NADH	NN	compound	O
shuttle	NN	nmod	O
,	,	punct	O
comprising	VBG	xcomp	O
anywhere	RB	advmod	O
from	IN	prep	O
about	RB	quantmod	O
20	CD	quantmod	O
to	TO	dep	O
80	CD	nummod	O
%	NN	pobj	O
of	IN	prep	O
the	DT	det	O
total	JJ	amod	O
flow	NN	pobj	O
of	IN	prep	O
reducing	VBG	pcomp	O
equivalents	NNS	dobj	O
to	TO	case	O
oxygen	NN	nmod	O
in	IN	case	O
these	DT	det	O
tumors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
this	DT	det	O
strain	NN	nmod	B-Cell
,	,	punct	O
the	DT	det	O
malate	JJ	npadvmod	B-Simple_chemical
-	HYPH	punct	O
citrate	NN	compound	B-Simple_chemical
shuttle	NN	nsubj	O
is	VBZ	ccomp	O
not	RB	neg	O
an	DT	det	O
effective	JJ	amod	O
pathway	NN	attr	O
for	IN	prep	O
transferring	VBG	pcomp	O
glycolytic	JJ	amod	O
reducing	NN	compound	O
equivalents	NNS	dobj	O
from	IN	case	O
cytosol	NN	nmod	B-Organism_substance
to	TO	case	O
mitochondria	VB	nmod	B-Cellular_component
.	.	punct	O

Glucose	NNP	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	O
utilization	NN	nmod	O
by	IN	case	O
34	CD	nummod	O
%	NN	nmod	O
.	.	punct	O
Less	JJR	advmod	O
than	IN	quantmod	O
15	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
was	VBD	auxpass	O
affected	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
1	CD	preconj	B-Simple_chemical
,	,	punct	I-Simple_chemical
2	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
benzenetricarboxylate	NN	amod	I-Simple_chemical
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	NN	compound	B-Simple_chemical
shuttle	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
glutaminolysis	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
glycolysis	NN	dobj	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
the	DT	det	O
malate	JJ	compound	B-Simple_chemical
-	HYPH	punct	O
citrate	JJ	amod	B-Simple_chemical
cycle	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
glutaminolytic	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
the	DT	det	O
rates	NNS	nsubj	O
of	IN	case	O
oxygen	NN	compound	O
uptake	NN	nmod	O
,	,	punct	O
the	DT	det	O
CO2	NN	compound	O
evolution	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
changes	NNS	conj	O
in	IN	case	O
the	DT	det	O
redox	NN	compound	O
states	NNS	nmod	O
of	IN	case	O
cytochromes	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
glucose	NN	nsubjpass	O
is	VBZ	auxpass	O
preferred	VBN	ccomp	O
by	IN	case	O
Ehrlich	NN	nmod	O
ascites	VBZ	xcomp	O
tumour	NN	compound	O
cells	NNS	dobj	O
as	IN	case	O
energy	NN	compound	O
substrate	NN	nmod	O
.	.	punct	O
The	DT	det	O
present	JJ	amod	O
work	NN	nsubj	O
supports	VBZ	ROOT	O
and	CC	cc	O
extends	VBZ	conj	O
the	DT	det	O
finding	NN	dobj	O
of	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
results	NNS	nsubj	O
showed	VBD	advcl	O
that	IN	mark	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nsubj	O
depressed	VBD	ccomp	O
the	DT	det	O
oxidative	JJ	amod	O
processes	NNS	dobj	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	conj	I-Cancer
tumor	NN	compound	I-Cancer
mitochondria	NN	dobj	B-Cellular_component
,	,	punct	O
not	RB	neg	O
only	RB	advmod	O
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
glutamine	NN	nmod	B-Amino_acid
.	.	punct	O

Glucose	NNP	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
rate	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	O
utilization	NN	nmod	O
by	IN	case	O
34	CD	nummod	O
%	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
glutamine	NN	compound	B-Amino_acid
uptake	NN	nsubjpass	O
was	VBD	auxpass	O
maintained	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
.	.	punct	O

Rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nsubjpass	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
transformed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
gene	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
EJ	NN	compound	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
were	VBD	auxpass	O
fused	VBN	ROOT	O
with	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	O
fibroblasts	NNS	nmod	O
.	.	punct	O
N	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosourea	NN	npadvmod	I-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	nsubjpass	O
of	IN	case	O
rat	NN	compound	B-Organism
urothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
is	VBZ	auxpass	O
not	RB	neg	O
mediated	VBN	ROOT	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
ras	NN	compound	B-Gene_or_gene_product
oncogenes	NNS	nmod	O
.	.	punct	O

Rat	NN	compound	O
6	CD	nummod	O
cells	NNS	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
transformed	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	VBN	amod	O
carcinogens	NNS	compound	O
benzo	NN	nmod	O
[	-LRB-	punct	O
a	DT	det	O
]	-RRB-	punct	O
pyrene	NN	dep	O
(	-LRB-	punct	O
BP	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
N	NN	compound	O
-	HYPH	punct	O
methyl	NN	compound	O
-	HYPH	punct	O
N	NNP	compound	O
-	HYPH	punct	O
nitro	NN	compound	O
-	HYPH	punct	O
N	NNP	compound	O
'	''	punct	O
-	HYPH	punct	O
nitrosoguanidine	NN	conj	O
(	-LRB-	punct	O
MNNG	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
Adult	JJ	amod	O
rat	NN	compound	B-Organism
urothelial	JJ	amod	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
transformed	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
following	VBG	case	O
treatment	NN	nmod	O
with	IN	case	O
a	DT	det	O
single	JJ	amod	O
dose	NN	nmod	O
of	IN	case	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosourea	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
MNU	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
or	CC	cc	O
MNU	NN	compound	B-Simple_chemical
treatment	NN	conj	O
followed	VBN	acl	O
by	IN	case	O
promotion	NN	nmod	O
with	IN	case	O
sodium	NN	compound	B-Simple_chemical
saccharin	NN	nmod	I-Simple_chemical
.	.	punct	O

Rat	NN	compound	O
6	CD	nummod	O
cells	NNS	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
transformed	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
known	VBN	amod	O
carcinogens	NNS	compound	O
benzo	NN	nmod	O
[	-LRB-	punct	O
a	DT	det	O
]	-RRB-	punct	O
pyrene	NN	dep	O
(	-LRB-	punct	O
BP	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
N	NN	compound	O
-	HYPH	punct	O
methyl	NN	compound	O
-	HYPH	punct	O
N	NNP	compound	O
-	HYPH	punct	O
nitro	NN	compound	O
-	HYPH	punct	O
N	NNP	compound	O
'	''	punct	O
-	HYPH	punct	O
nitrosoguanidine	NN	conj	O
(	-LRB-	punct	O
MNNG	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
This	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
transformation	NN	compound	O
process	NN	nsubj	O
involves	VBZ	ROOT	O
multiple	JJ	amod	O
steps	NNS	dobj	O
:	:	punct	O
slow	JJ	amod	O
-	HYPH	punct	O
growing	VBG	nmod:poss	O
'	''	case	O
pre	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
'	POS	punct	O
epithelial	JJ	amod	B-Cell
foci	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
induced	VBN	conj	O
70	CD	compound	O
-	SYM	punct	O
100	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
MNU	NN	compound	B-Simple_chemical
treatment	NN	dep	O
and	CC	cc	O
from	IN	case	O
such	JJ	amod	O
foci	NNS	amod	B-Cell
rapidly	RB	advmod	O
proliferating	VBG	amod	O
immortal	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
established	VBN	conj	O
,	,	punct	O
some	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
became	VBD	parataxis	O
tumorigenic	JJ	xcomp	O
after	IN	prep	O
a	DT	det	O
further	JJ	amod	O
latent	JJ	amod	O
period	NN	pobj	O
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
LMP1	NN	compound	O
gene	NN	nsubj	O
of	IN	case	O
EBV	NN	nmod	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transform	VB	xcomp	O
certain	JJ	amod	O
established	JJ	amod	O
rodent	JJ	amod	O
fibroblast	NN	compound	O
cell	NN	compound	O
lines	NNS	dobj	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
tumorigenicity	NN	dobj	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	O
epithelial	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
A	DT	det	O
series	NN	nsubjpass	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
a	DT	det	O
single	JJ	amod	O
fibroblast	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	conj	I-Cell
established	VBN	acl	O
in	IN	case	O
this	DT	det	O
way	NN	nmod	O
were	VBD	auxpass	O
analysed	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
transforming	VBG	amod	O
genes	NNS	nmod	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
transfection	NN	nmod	O
into	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
by	IN	case	O
ectopically	RB	advmod	O
constitutive	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Dss1	NN	nmod	O
in	IN	case	O
JB6	NN	compound	O
Cl	NN	compound	O
41	CD	nummod	O
-	HYPH	punct	O
5a	NN	compound	O
preneoplastic	JJ	amod	O
cells	NNS	nmod	O
strongly	RB	advmod	O
increased	VBD	ROOT	O
focus	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
and	CC	cc	O
enhanced	VBN	amod	O
efficiency	NN	conj	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
.	.	punct	O
None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
induced	VBD	ROOT	O
foci	NNS	dobj	B-Cell
in	IN	case	O
a	DT	det	O
focus	NN	compound	B-Cell
formation	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	det	O
issue	NN	dobj	O
,	,	punct	O
an	DT	det	O
activated	VBN	amod	O
neu	NN	compound	O
oncogene	NN	nsubjpass	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
an	DT	det	O
immortalized	VBN	amod	O
nontumorigenic	JJ	amod	O
human	JJ	amod	O
breast	NN	compound	O
epithelial	JJ	amod	O
cell	NN	compound	O
line	NN	nmod	O
(	-LRB-	punct	O
184B5	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
single	JJ	amod	O
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
epithelial	JJ	amod	I-Cell
line	NN	nsubj	I-Cell
induced	VBD	ROOT	O
foci	NNS	dobj	B-Cell
and	CC	cc	O
was	VBD	auxpass	O
found	VBN	conj	O
to	TO	mark	O
contain	VB	xcomp	O
an	DT	det	O
activated	VBN	amod	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ki	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	dobj	O
with	IN	case	O
a	DT	det	O
G	NN	compound	B-Simple_chemical
-	HYPH	punct	O
-	HYPH	punct	O
-	SYM	punct	O
-	HYPH	punct	O
A	NN	compound	B-Simple_chemical
transition	NN	nmod	O
in	IN	case	O
codon	NN	nmod	O
12	CD	nummod	O
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
LMP1	NN	compound	O
gene	NN	nsubj	O
of	IN	case	O
EBV	NN	nmod	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transform	VB	xcomp	O
certain	JJ	amod	O
established	JJ	amod	O
rodent	JJ	amod	O
fibroblast	NN	compound	O
cell	NN	compound	O
lines	NNS	dobj	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
tumorigenicity	NN	dobj	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	O
epithelial	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
assay	VB	advcl	O
for	IN	case	O
the	DT	det	O
possible	JJ	amod	O
presence	NN	nmod	O
of	IN	case	O
transforming	VBG	amod	O
genes	NNS	nmod	O
which	WDT	nsubj	O
were	VBD	cop	O
not	RB	neg	O
active	JJ	acl:relcl	O
in	IN	case	O
a	DT	det	O
focus	NN	compound	B-Cell
formation	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
two	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
epithelial	JJ	amod	B-Cell
lines	NNS	nmod	I-Cell
were	VBD	auxpass	O
analysed	VBN	ROOT	O
further	RB	advmod	O
by	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
transfection	NN	nmod	O
with	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
selectable	JJ	amod	O
marker	NN	nmod	O
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
selection	NN	nmod	O
and	CC	cc	O
inoculation	NN	conj	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
by	IN	case	O
a	DT	det	O
tumorigenicity	NN	compound	O
assay	NN	nmod	O
using	VBG	acl	O
NIH3T3	NN	compound	O
cells	NNS	dobj	O
transfected	VBN	acl	O
with	IN	case	O
DNA	NN	nmod	O
from	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	compound	O
patient	NN	nmod	O
.	.	punct	O
No	DT	det	O
tumours	NNS	nsubjpass	B-Cancer
were	VBD	auxpass	O
induced	VBN	ROOT	O
within	IN	prep	O
the	DT	det	O
latent	JJ	amod	O
period	NN	pobj	O
for	IN	case	O
tumour	NN	compound	B-Cancer
production	NN	nmod	O
by	IN	case	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transfected	VBN	acl	O
with	IN	case	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
DNA	NN	nmod	B-Cellular_component
(	-LRB-	punct	O
40	CD	compound	O
-	SYM	punct	O
60	CD	nummod	O
days	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nsubjpass	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
transformed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
gene	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
EJ	NN	compound	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
were	VBD	auxpass	O
fused	VBN	ROOT	O
with	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	O
fibroblasts	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
cell	NN	compound	B-Cell
type	NN	compound	O
specificity	NN	nsubj	O
for	IN	case	O
oncogene	NN	compound	O
activation	NN	nmod	O
during	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
rat	NN	compound	B-Organism
bladder	NN	compound	B-Organ
transformation	NN	nmod	O
initiated	VBN	acl	O
by	IN	case	O
a	DT	det	O
single	JJ	amod	O
carcinogen	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
ras	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
activation	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
necessary	JJ	amod	O
step	NN	conj	O
in	IN	case	O
urothelial	JJ	amod	B-Cell
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Hypoxia	NN	nmod:npmod	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	compound	O
1	CD	nummod	O
activation	NN	nsubj	O
by	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
implicates	VBZ	ROOT	O
the	DT	det	O
Warburg	NNP	compound	O
effect	NN	dobj	O
in	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O
Low	JJ	amod	O
-	HYPH	punct	O
level	NN	compound	O
X	NN	compound	O
-	HYPH	punct	O
radiation	NN	compound	O
effects	NNS	ROOT	O
on	IN	case	O
functional	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
changes	NNS	nmod	O
in	IN	case	O
Syrian	JJ	amod	B-Organism
hamster	NN	compound	I-Organism
cheek	NN	compound	B-Tissue
pouch	JJ	amod	I-Tissue
epithelium	NN	nmod	I-Tissue
during	IN	case	O
hydrocarbon	NN	compound	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	nmod	O
(	-LRB-	punct	O
PKC	NN	appos	O
)	-RRB-	punct	O
induces	VBZ	ROOT	O
phenotypic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
morphology	NN	nmod	O
of	IN	case	O
microvascular	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
that	WDT	nsubj	O
affect	VBP	acl:relcl	O
major	JJ	amod	O
functions	NNS	dobj	O
of	IN	case	O
the	DT	det	O
microvasculature	NN	nmod	O
.	.	punct	O
Effects	NNS	nsubjpass	O
of	IN	case	O
repeated	VBN	amod	O
low	JJ	amod	O
-	HYPH	punct	O
level	NN	compound	O
X	NN	compound	O
radiation	NN	nmod	O
on	IN	case	O
functional	JJ	amod	O
microvascular	JJ	amod	B-Tissue
changes	NNS	nmod	O
in	IN	case	O
hamster	NN	compound	B-Organism
cheek	NN	compound	B-Tissue
pouch	JJ	amod	I-Tissue
epithelium	NN	nmod	I-Tissue
during	IN	nmod	O
and	CC	cc	O
following	VBG	conj	O
carcinogenesis	NN	nmod	O
by	IN	case	O
7	CD	nmod	B-Simple_chemical
,	,	punct	I-Simple_chemical
12	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylbenz	NN	conj	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
anthracene	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
DMBA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

Cancer	NN	compound	O
neoangiogenesis	NN	nsubjpass	O
is	VBZ	cop	O
often	RB	advmod	O
disordered	VBN	ROOT	O
and	CC	cc	O
abnormal	JJ	conj	O
,	,	punct	O
with	IN	case	O
evidence	NN	nmod	O
of	IN	mark	O
coexisting	VBG	acl	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
dysfunction	NN	dobj	O
.	.	punct	O
Prior	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
enhancement	NN	dobj	O
of	IN	case	O
such	JJ	amod	O
carcinogenesis	NN	nmod	O
by	IN	case	O
repeated	VBN	amod	O
20	CD	nummod	O
rad	NN	compound	O
head	NN	nmod	B-Organism_subdivision
and	CC	cc	O
neck	NN	conj	B-Organism_subdivision
X	NN	compound	O
-	HYPH	punct	O
radiation	NN	compound	O
exposures	NNS	conj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
proposed	VBN	conj	O
that	IN	mark	O
one	CD	nummod	O
possible	JJ	amod	O
mechanism	NN	nsubj	O
was	VBD	cop	O
radiogenic	JJ	amod	O
alteration	NN	ccomp	O
of	IN	case	O
the	DT	det	O
functional	JJ	amod	O
microvasculature	NN	nmod	B-Tissue
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
which	WDT	nsubj	O
favored	VBD	acl:relcl	O
subsequent	JJ	amod	O
tumor	NN	compound	B-Cancer
development	NN	dobj	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Hamsters	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
either	DT	det	O
radiation	NN	nmod	O
,	,	punct	O
DMBA	NN	conj	B-Simple_chemical
,	,	punct	O
radiation	NN	conj	O
+	CC	cc	O
DMBA	NN	conj	B-Simple_chemical
,	,	punct	O
or	CC	cc	O
no	DT	neg	O
treatment	NN	conj	O
.	.	punct	O

TEMF	NN	compound	O
treatment	NN	nsubj	O
continued	VBD	ROOT	O
for	IN	case	O
3	CD	nummod	O
additional	JJ	amod	O
weeks	NNS	nmod	O
.	.	punct	O
Animals	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
sacrificed	VBN	ROOT	O
at	IN	prep	O
3	CD	nummod	O
-	HYPH	punct	O
week	NN	compound	O
intervals	NNS	pobj	O
from	IN	prep	O
0	CD	quantmod	O
to	TO	quantmod	O
39	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	mark	O
treatments	NNS	nsubj	O
began	VBD	advcl	O
.	.	punct	O

Leukocyte	NN	compound	O
-	HYPH	punct	O
vessel	NN	compound	O
wall	NN	compound	O
interactions	NNS	nsubjpass	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
both	CC	cc:preconj	O
within	IN	nmod	O
and	CC	cc	O
outside	IN	conj	O
small	JJ	amod	O
tumors	NNS	nmod	O
growing	VBG	acl	O
in	IN	prep	O
the	DT	det	O
ear	NN	pobj	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
ear	NN	amod	O
microvessels	NNS	conj	O
of	IN	case	O
mice	NNS	nmod	O
with	IN	case	O
a	DT	det	O
large	JJ	amod	O
tumor	NN	nmod	O
growing	VBG	acl	O
on	IN	prep	O
their	PRP$	poss	O
flank	NN	pobj	O
.	.	punct	O
Pouch	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
volume	NN	nsubjpass	O
and	CC	cc	O
permeability	NN	compound	O
changes	NNS	conj	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
fractional	JJ	amod	O
distributions	NNS	nmod	O
of	IN	case	O
radiotracers	NNS	nmod	O
and	CC	cc	O
were	VBD	auxpass	O
analyzed	VBN	conj	O
by	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
statistical	JJ	amod	O
methods	NNS	nmod	O
which	WDT	nsubj	O
explored	VBD	acl:relcl	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
parameters	NNS	dobj	O
,	,	punct	O
treatment	NN	compound	O
types	NNS	appos	O
,	,	punct	O
elapsed	VBD	amod	O
time	NN	conj	O
,	,	punct	O
presence	NN	appos	O
of	IN	case	O
the	DT	det	O
carcinogen	NN	nmod	O
,	,	punct	O
and	CC	cc	O
histopathologic	JJ	amod	O
changes	NNS	conj	O
.	.	punct	O

Mice	NNS	nsubjpass	O
primed	VBN	acl	O
with	IN	prep	O
dimethyl	JJ	amod	O
-	HYPH	punct	O
benz	NN	compound	O
[	-LRB-	punct	O
a	DT	det	O
]	-RRB-	punct	O
anthracene	NN	nsubjpass	O
(	-LRB-	punct	O
DMBA	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
topically	RB	advmod	O
exposed	VBN	ROOT	O
to	IN	case	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod	O
(	-LRB-	punct	O
82	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
micromol	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
positive	JJ	amod	O
control	NN	conj	O
,	,	punct	O
12	CD	nummod	O
-	HYPH	punct	O
O	NNP	compound	O
-	HYPH	punct	O
tetradecanoylphorbol	NN	compound	O
-	:	punct	O
13	CD	nummod	O
-	HYPH	punct	O
acetate	NN	appos	O
(	-LRB-	punct	O
TPA	NN	dep	O
,	,	punct	O
17	CD	nummod	O
nmol	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
twice	RB	advmod	O
weekly	RB	advmod	O
for	IN	case	O
29	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O
All	DT	det	O
treatments	NNS	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
significant	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	nmod	O
with	IN	case	O
time	NN	nmod	O
,	,	punct	O
while	IN	mark	O
only	RB	advmod	O
DMBA	JJ	compound	B-Simple_chemical
treatments	NNS	nsubj	O
alone	RB	advmod	O
resulted	VBD	advcl	O
in	IN	case	O
significant	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	nmod	O
with	IN	case	O
time	NN	nmod	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Prior	JJ	advmod	O
to	IN	prep	O
the	DT	det	O
appearances	NNS	pobj	O
of	IN	prep	O
frank	JJ	compound	O
neoplasms	NNS	pobj	B-Cancer
,	,	punct	O
volumetric	JJ	amod	O
changes	NNS	nsubj	O
in	IN	case	O
DMBA	NN	nmod	B-Simple_chemical
only	RB	advmod	O
and	CC	cc	O
radiation	NN	conj	O
only	JJ	amod	O
groups	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	ROOT	O
,	,	punct	O
while	IN	mark	O
volume	NN	compound	O
changes	NNS	nsubj	O
in	IN	case	O
DMBA	NN	compound	B-Simple_chemical
+	CC	cc	O
radiation	NN	compound	O
groups	NNS	nmod	O
increased	VBD	advcl	O
slowly	RB	advmod	O
to	IN	prep	O
a	DT	det	O
peak	NN	pobj	O
later	RB	advmod	O
than	IN	mwe	O
in	IN	prep	O
other	JJ	amod	O
groups	NNS	pobj	O
and	CC	cc	O
then	RB	advmod	O
declined	VBD	conj	O
steadily	RB	advmod	O
to	TO	case	O
levels	NNS	nmod	O
similar	JJ	amod	O
to	TO	case	O
the	DT	det	O
radiation	NN	nmod	O
only	JJ	advmod	O
group	NN	npadvmod	O
.	.	punct	O

In	IN	case	O
mice	NNS	nmod	O
,	,	punct	O
xenografts	NNS	nsubj	O
of	IN	case	O
human	JJ	amod	O
glioblastoma	NN	compound	O
U87MG	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	aux	O
decreased	VBN	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
ING4	NN	nmod	O
,	,	punct	O
grow	VBP	ROOT	O
significantly	RB	advmod	O
faster	RBR	acomp	O
and	CC	cc	O
have	VBP	conj	O
higher	JJR	amod	O
vascular	JJ	amod	O
volume	NN	compound	O
fractions	NNS	dobj	O
than	IN	prep	O
control	NN	compound	O
tumours	NNS	pobj	O
.	.	punct	O
As	IN	case	O
in	IN	case	O
prior	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	compound	O
differences	NNS	nsubj	O
between	IN	case	O
DMBA	NN	nmod	B-Simple_chemical
and	CC	cc	O
DMBA	NN	conj	B-Simple_chemical
+	CC	cc	O
radiation	NN	compound	O
groups	NNS	conj	O
of	IN	case	O
tumor	NN	npadvmod	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
cheek	JJ	compound	B-Organism_subdivision
pouches	NNS	nmod	I-Organism_subdivision
.	.	punct	O

A	DT	det	O
greater	JJR	amod	O
accumulation	NN	nsubjpass	O
of	IN	case	O
peroxidative	JJ	amod	O
products	NNS	nmod	O
(	-LRB-	punct	O
thiobarbituric	JJ	amod	O
acid	NN	nmod:npmod	O
-	HYPH	punct	O
reactive	JJ	amod	O
substances	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
inflammation	NN	conj	O
and	CC	cc	O
decreased	VBN	amod	O
levels	NNS	conj	O
of	IN	case	O
GSH	NN	nmod	O
and	CC	cc	O
total	JJ	amod	O
antioxidant	JJ	amod	O
reserves	NNS	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
skin	NN	nmod	O
of	IN	case	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
DMBA	JJ	compound	B-Simple_chemical
maxima	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
those	DT	nmod	O
of	IN	case	O
DMBA	NN	nmod	B-Simple_chemical
+	CC	cc	O
radiation	NN	conj	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Radiation	NN	nsubj	O
significantly	RB	advmod	O
affected	VBD	ROOT	O
DMBA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
associated	VBN	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
volume	NN	dobj	O
and	CC	cc	O
permeability	NN	compound	O
changes	NNS	conj	O
during	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Several	JJ	amod	O
possible	JJ	amod	O
explanations	NNS	nsubj	O
for	IN	case	O
the	DT	det	O
relationship	NN	nmod	O
of	IN	case	O
these	DT	det	O
changes	NNS	nmod	O
to	TO	case	O
the	DT	det	O
enhancement	NN	nmod	O
of	IN	case	O
DMBA	NN	compound	B-Simple_chemical
carcinogenesis	NN	nmod	O
include	VBP	ROOT	O
:	:	punct	O
radiation	NN	dep	O
blocking	VBG	acl	O
normal	JJ	amod	O
capillary	JJ	amod	B-Tissue
proliferative	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
dilatory	NN	amod	O
responses	NNS	conj	O
to	TO	case	O
inflammation	NN	nmod	O
secondary	JJ	amod	O
to	TO	case	O
neoplastic	JJ	amod	O
changes	NNS	nmod	O
;	:	punct	O
radiation	NN	nsubj	O
-	HYPH	punct	O
induced	VBN	amod	O
focal	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
the	DT	det	O
pericapillary	JJ	amod	B-Tissue
connective	JJ	amod	I-Tissue
tissue	NN	compound	I-Tissue
histohematic	JJ	amod	B-Multi-tissue_structure
barrier	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
stimulating	VBG	xcomp	O
angiogenesis	NN	dobj	O
but	CC	cc	O
reducing	VBG	conj	O
nutrient	JJ	amod	O
diffusion	NN	dobj	O
;	:	punct	O
radiation	NN	compound	O
exposures	NNS	nsubj	O
sensitizing	VBG	acl	O
vascular	JJ	amod	B-Tissue
endothelium	NN	dobj	I-Tissue
to	TO	case	O
subsequent	JJ	amod	O
angiogenic	JJ	amod	O
stimulation	NN	nmod	O
from	IN	case	O
premalignant	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
;	:	punct	O
DMBA	NN	compound	B-Simple_chemical
vascular	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
epithelial	JJ	conj	B-Tissue
effects	NNS	dep	O
partially	RB	advmod	O
or	CC	advmod	O
completely	RB	advmod	O
blocking	VBG	parataxis	O
radiation	NN	compound	O
effects	NNS	dobj	O
on	IN	case	O
epithelial	JJ	amod	B-Cell
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
endothelial	JJ	conj	B-Cell
cells	NNS	nmod	I-Cell
;	:	punct	O
and	CC	cc	O
radiation	NN	compound	O
damage	NN	nsubj	O
to	IN	case	O
vessel	NN	compound	B-Multi-tissue_structure
walls	NNS	nmod	I-Multi-tissue_structure
partially	RB	advmod	O
or	CC	advmod	O
fully	RB	advmod	O
inhibiting	VBG	conj	O
normal	JJ	amod	O
physiologic	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	mark	O
repairing	VBG	acl	O
DMBA	JJ	compound	B-Simple_chemical
damage	NN	dobj	O
to	IN	case	O
the	DT	det	O
vessels	NNS	nmod	B-Multi-tissue_structure
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
the	DT	det	O
integrin	NN	compound	O
alpha2beta1	NN	nmod	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O
Scanning	NN	compound	O
electron	NN	compound	O
microscopy	NN	ROOT	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
casts	NNS	nmod	O
in	IN	case	O
experimental	JJ	amod	O
ocular	JJ	amod	B-Organ
vasoproliferation	NN	nmod	O
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Scanning	NN	compound	O
electron	NN	compound	O
microscopy	NN	nsubjpass	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
casts	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
three	CD	nummod	O
experimental	JJ	amod	O
models	NNS	dobj	O
of	IN	case	O
neovascularization	NN	nmod	O
.	.	punct	O

Formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
bone	NN	nmod	O
during	IN	case	O
vertical	JJ	amod	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mandible	NN	nmod	O
is	VBZ	cop	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
.	.	punct	O
In	IN	case	O
each	DT	det	O
experimental	JJ	amod	O
situation	NN	nmod	O
,	,	punct	O
the	DT	det	O
casts	NNS	nsubj	O
provided	VBD	ROOT	O
a	DT	det	O
valuable	JJ	amod	O
three	CD	nummod	O
dimensional	JJ	amod	O
representation	NN	dobj	O
of	IN	case	O
the	DT	det	O
newly	RB	advmod	O
formed	VBN	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
permitted	VBN	amod	O
subclassification	NN	conj	O
of	IN	case	O
the	DT	det	O
vessels	NNS	nmod	B-Multi-tissue_structure
within	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
proliferating	VBG	conj	O
vascular	JJ	amod	B-Multi-tissue_structure
networks	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Tumor	NN	compound	O
vessels	NNS	nsubj	O
are	VBP	cop	O
distinct	JJ	ROOT	O
from	IN	case	O
their	PRP$	nmod:poss	O
normal	JJ	amod	O
counterparts	NNS	nmod	O
morphologically	RB	advmod	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mwe	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
level	NN	advcl	O
.	.	punct	O
They	PRP	nsubj	O
defined	VBD	ROOT	O
also	RB	advmod	O
the	DT	det	O
predominant	JJ	amod	O
origin	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
from	IN	case	O
venules	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
capillaries	NNS	conj	B-Tissue
,	,	punct	O
and	CC	cc	O
enabled	VBD	conj	O
the	DT	det	O
evolution	NN	dobj	O
of	IN	case	O
proliferating	VBG	amod	O
vessels	NNS	nmod	B-Multi-tissue_structure
into	IN	case	O
arterioles	NNS	nmod	B-Multi-tissue_structure
and	CC	cc	O
venules	NNS	conj	B-Multi-tissue_structure
to	TO	mark	O
be	VB	auxpass	O
documented	VBN	acl	O
.	.	punct	O

Choroidal	JJ	amod	O
hyperpermeability	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
every	DT	det	O
case	NN	nmod	O
.	.	punct	O
Although	IN	mark	O
vascular	JJ	amod	B-Multi-tissue_structure
casts	NNS	nsubjpass	O
must	MD	aux	O
be	VB	auxpass	O
interpreted	VBN	advcl	O
with	IN	case	O
caution	NN	nmod	O
in	IN	case	O
light	NN	nmod	O
of	IN	case	O
the	DT	det	O
possibility	NN	nmod	O
of	IN	prep	O
incomplete	JJ	amod	O
filling	NN	pobj	O
and	CC	cc	O
other	JJ	amod	O
artifacts	NNS	conj	O
,	,	punct	O
they	PRP	nsubj	O
are	VBP	ROOT	O
a	DT	det	O
valuable	JJ	amod	O
tool	NN	attr	O
in	IN	case	O
the	DT	det	O
study	NN	nmod	O
of	IN	case	O
ocular	JJ	amod	B-Organ
vasoproliferation	NN	nmod	O
.	.	punct	O

Conversion	NN	nsubj	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
to	TO	case	O
alanine	NN	compound	O
residues	NNS	nmod	O
greatly	RB	advmod	O
reduced	VBD	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
although	IN	mark	O
the	DT	det	O
mutant	JJ	amod	O
55	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
protein	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
p53	NN	nmod	O
at	IN	case	O
normal	JJ	amod	O
levels	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
somewhat	RB	advmod	O
defective	JJ	conj	O
for	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
p53	NN	compound	O
transactivation	NN	compound	O
activity	NN	nmod	O
.	.	punct	O
Participation	NN	ROOT	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
cellular	JJ	amod	B-Cell
tumour	NN	compound	B-Cancer
antigen	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
embryonic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	O
.	.	punct	O
The	DT	det	O
cellular	JJ	amod	B-Cell
tumour	NN	compound	B-Cancer
antigen	NN	compound	O
p53	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
found	VBN	ROOT	O
at	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
(	-LRB-	punct	O
for	IN	case	O
reviews	NNS	nsubj	O
see	VBP	conj	O
refs	NNS	dobj	O
1	CD	nummod	O
,	,	punct	O
2	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	O
.	.	punct	O
Very	RB	advmod	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
yet	RB	advmod	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
precise	JJ	amod	O
relationship	NN	nmod	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
believed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E1B	NN	compound	O
-	HYPH	punct	O
55kDa	JJ	amod	O
protein	NN	nmod	O
in	IN	case	O
transformation	NN	nmod	O
is	VBZ	ccomp	O
to	TO	mark	O
protect	VB	xcomp	O
against	IN	case	O
p53	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
apoptosis	NN	nmod	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	dep	O
and	CC	cc	O
inactivating	VBG	conj	O
p53	NN	dobj	O
.	.	punct	O
Although	IN	mark	O
the	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
secondary	JJ	amod	O
by	IN	case	O
-	HYPH	punct	O
product	NN	advcl	O
of	IN	prep	O
the	DT	det	O
transformed	VBN	amod	O
state	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
equally	RB	advmod	O
possible	JJ	ROOT	O
that	IN	mark	O
p53	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
actively	RB	advmod	O
involved	VBN	ccomp	O
in	IN	mark	O
altering	VBG	advcl	O
cellular	JJ	amod	B-Cell
growth	NN	compound	O
properties	NNS	dobj	O
,	,	punct	O
especially	RB	advmod	O
as	IN	mark	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	advcl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
test	VB	xcomp	O
whether	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
could	MD	aux	O
behave	VB	ccomp	O
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
known	JJ	amod	O
genes	NNS	nmod	O
in	IN	case	O
a	DT	det	O
biological	JJ	amod	O
test	NN	compound	O
system	NN	nmod	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
demonstrate	VBP	conj	O
here	RB	advmod	O
that	IN	mark	O
p53	NN	nsubj	B-Gene_or_gene_product
can	MD	aux	O
cooperate	VB	ccomp	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
to	TO	mark	O
transform	VB	xcomp	O
normal	JJ	amod	O
embryonic	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
mouse	NN	compound	O
p10	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
foci	NNS	compound	O
formation	NN	dobj	O
and	CC	cc	O
anchorage	NN	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	conj	O
in	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
mouse	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
antitransforming	VBG	amod	O
properties	NNS	nsubj	O
of	IN	case	O
mouse	NN	compound	O
p10	NN	nmod	O
are	VBP	cop	O
also	RB	advmod	O
p53	NN	compound	O
-	HYPH	punct	O
dependent	JJ	conj	O
.	.	punct	O
The	DT	det	O
resultant	JJ	amod	O
foci	NNS	compound	B-Cell
contain	VBP	amod	O
cells	NNS	ROOT	B-Cell
of	IN	case	O
a	DT	det	O
markedly	RB	advmod	O
altered	JJ	amod	O
morphology	NN	nmod	O
which	WDT	nsubj	O
produce	VBP	acl:relcl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
Cell	NN	compound	B-Cell
lines	NNS	nsubj	I-Cell
established	VBN	acl	O
from	IN	case	O
such	JJ	amod	O
foci	NNS	compound	B-Cell
elicit	NN	compound	O
tumours	NNS	ROOT	B-Cancer
in	IN	prep	O
syngeneic	JJ	amod	O
animals	NNS	pobj	O
.	.	punct	O

Chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	ROOT	O
and	CC	cc	O
hamster	NN	compound	O
BHK	NN	compound	O
cells	NNS	conj	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
RSV	NN	appos	O
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
CEF	NN	appos	O
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	O
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Interaction	NN	ROOT	O
between	IN	case	O
cellular	JJ	nmod	B-Cell
and	CC	cc	O
viral	JJ	conj	B-Organism
genes	NNS	dep	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	compound	O
-	HYPH	punct	O
specific	JJ	amod	O
cell	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
surface	NN	compound	I-Cellular_component
antigen	NN	compound	O
VCSA	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	ROOT	O
and	CC	cc	O
hamster	NN	compound	O
BHK	NN	compound	O
cells	NNS	conj	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
RSV	NN	appos	O
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
CEF	NN	appos	O
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	O
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Transformation	NN	nsubj	O
of	IN	case	O
BHK	NN	compound	B-Cell
hamster	NN	compound	I-Cell
fibroblasts	NNS	nmod	I-Cell
by	IN	case	O
an	DT	det	O
env	NN	compound	O
-	HYPH	punct	O
strain	NN	nmod	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
(	-LRB-	punct	O
RSV	NN	appos	B-Organism
)	-RRB-	punct	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
appearance	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
virus	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
induced	VBN	amod	I-Gene_or_gene_product
nonvirion	NN	compound	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VCSA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
specific	JJ	xcomp	O
for	IN	case	O
transformation	NN	nmod	O
,	,	punct	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
controlled	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
src	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	ROOT	O
and	CC	cc	O
hamster	NN	compound	O
BHK	NN	compound	O
cells	NNS	conj	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
RSV	NN	appos	O
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
CEF	NN	appos	O
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	O
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Previous	JJ	amod	O
work	NN	nsubj	O
has	VBZ	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
rabbit	NN	compound	B-Organism
anti	JJ	compound	O
-	HYPH	punct	O
VCSA	NN	compound	B-Gene_or_gene_product
serum	NN	compound	B-Organism_substance
lyses	NNS	ccomp	I-Organism_substance
specifically	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
complement	NN	nmod	O
,	,	punct	O
51Cr	NN	appos	B-Simple_chemical
-	:	punct	O
labelled	VBN	amod	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
from	IN	case	O
different	JJ	amod	O
animal	NN	compound	O
species	NNS	nmod	O
.	.	punct	O

Chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	ROOT	O
and	CC	cc	O
hamster	NN	compound	O
BHK	NN	compound	O
cells	NNS	conj	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
RSV	NN	appos	O
)	-RRB-	punct	O
release	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
culture	NN	compound	O
media	NNS	compound	O
growth	NN	compound	O
factors	NNS	nmod	O
which	WDT	nsubj	O
enhance	VBP	acl:relcl	O
markedly	RB	advmod	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
gelified	VBN	amod	O
medium	NN	nmod	O
,	,	punct	O
at	IN	case	O
the	DT	det	O
restrictive	JJ	amod	O
temperature	NN	nmod	O
(	-LRB-	punct	O
41	CD	nummod	O
degrees	NNS	compound	O
5	CD	nummod	O
C	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
of	IN	case	O
chicken	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
CEF	NN	appos	O
)	-RRB-	punct	O
infected	VBN	acl	O
by	IN	case	O
RSV	NN	compound	O
mutants	NNS	nmod	O
with	IN	case	O
a	DT	det	O
ts	IN	compound	O
mutation	NN	nmod	O
of	IN	case	O
the	DT	det	O
src	NN	compound	O
gene	NN	nmod	O
.	.	punct	O
Now	RB	advmod	O
,	,	punct	O
by	IN	case	O
competition	NN	compound	O
experiments	NNS	nmod	O
with	IN	case	O
a	DT	det	O
panel	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
unlabelled	JJ	amod	O
cells	NNS	nmod	B-Cell
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
VCSA	NN	nsubj	B-Gene_or_gene_product
expressed	VBN	acl	O
on	IN	case	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
hamster	NN	compound	B-Organism
fibroblasts	NNS	nmod	B-Cell
is	VBZ	cop	O
a	DT	det	O
complex	NN	ccomp	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
distinct	JJ	amod	O
antigenic	JJ	amod	O
specificities	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
one	CD	dep	O
expressed	VBN	acl	O
on	IN	case	O
all	DT	det	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
regardless	RB	advmod	O
their	PRP$	nmod:poss	O
species	NNS	dobj	O
and	CC	cc	O
the	DT	det	O
subgroup	NN	conj	O
or	CC	cc	O
strain	NN	conj	O
of	IN	case	O
the	DT	det	O
transforming	NN	amod	O
virus	NN	nmod	B-Organism
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
one	CD	nummod	O
cross	NN	compound	O
-	HYPH	punct	O
reacting	VBG	ccomp	O
with	IN	case	O
a	DT	det	O
cell	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
surface	NN	compound	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
CSA	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expressed	VBN	acl	O
at	IN	case	O
various	JJ	amod	O
degrees	NNS	nmod	O
on	IN	case	O
untransformed	JJ	amod	O
avian	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
on	IN	case	O
mammalian	JJ	amod	B-Cell
fibroblasts	NNS	conj	I-Cell
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
one	CD	nummod	O
species	NNS	nmod:npmod	O
-	:	punct	O
specific	JJ	amod	O
,	,	punct	O
present	JJ	amod	O
only	RB	advmod	O
on	IN	case	O
RSV	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
transformed	VBN	amod	O
hamster	NN	compound	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

These	DT	det	O
RNAs	NNS	nsubj	O
were	VBD	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
reticuloendotheliosis	NN	compound	O
virus	NN	compound	O
-	HYPH	punct	O
transformed	VBN	amod	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
VCSA	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
complex	NN	ccomp	O
of	IN	case	O
several	JJ	amod	O
antigenic	JJ	amod	O
determinants	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
some	DT	nsubj	O
of	IN	case	O
these	DT	nmod	O
differ	VBP	conj	O
in	IN	case	O
different	JJ	amod	O
cells	NNS	nmod	B-Cell
transformed	VBN	acl	O
by	IN	case	O
RSV	NN	nmod	B-Organism
.	.	punct	O

This	DT	det	O
action	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
with	IN	case	O
uninfected	JJ	amod	O
CEF	NN	nmod	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
appears	VBZ	conj	O
to	TO	mark	O
require	VB	xcomp	O
some	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	O
src	NN	compound	O
gene	NN	nmod	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
This	DT	det	O
observation	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
VCSA	NN	compound	B-Gene_or_gene_product
expression	NN	nsubj	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
is	VBZ	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
result	NN	xcomp	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
the	DT	det	O
viral	JJ	amod	B-Organism
src	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
product	NN	nmod	O
pp60src	NN	dep	B-Gene_or_gene_product
with	IN	case	O
host	NN	compound	O
cell	NN	compound	B-Cell
gene	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
or	CC	cc	O
gene	NN	compound	O
product	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
,	,	punct	O
rather	RB	cc	O
than	IN	mwe	O
the	DT	det	O
simple	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
this	DT	det	O
molecule	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

Rearrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
gene	NN	nmod	O
was	VBD	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
plasmacytomas	NNS	nmod	O
,	,	punct	O
implying	VBG	advcl	O
a	DT	det	O
synergistic	JJ	amod	O
role	NN	dobj	O
for	IN	prep	O
myc	NN	pobj	O
and	CC	cc	O
bcl	NN	conj	O
-	SYM	punct	O
2	CD	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	conj	O
in	IN	case	O
the	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O
The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
translocations	NNS	nmod	O
on	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
Burkitt	NN	compound	B-Cancer
lymphomas	NNS	nmod	I-Cancer
.	.	punct	O

Rearrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
gene	NN	nmod	O
was	VBD	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
plasmacytomas	NNS	nmod	O
,	,	punct	O
implying	VBG	advcl	O
a	DT	det	O
synergistic	JJ	amod	O
role	NN	dobj	O
for	IN	prep	O
myc	NN	pobj	O
and	CC	cc	O
bcl	NN	conj	O
-	SYM	punct	O
2	CD	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	conj	O
in	IN	case	O
the	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O
Chromosomal	JJ	amod	B-Cellular_component
translocations	NNS	nsubjpass	O
are	VBP	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
characteristic	JJ	amod	O
feature	NN	xcomp	O
of	IN	case	O
Burkitt	NN	compound	B-Cancer
lymphomas	NNS	nmod	I-Cancer
.	.	punct	O

Rearrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
gene	NN	nmod	O
was	VBD	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
plasmacytomas	NNS	nmod	O
,	,	punct	O
implying	VBG	advcl	O
a	DT	det	O
synergistic	JJ	amod	O
role	NN	dobj	O
for	IN	prep	O
myc	NN	pobj	O
and	CC	cc	O
bcl	NN	conj	O
-	SYM	punct	O
2	CD	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	conj	O
in	IN	case	O
the	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O
Similar	JJ	amod	O
translocations	NNS	nsubjpass	O
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
mouse	NN	compound	B-Organism
plasmacytomas	NNS	nmod	B-Cancer
and	CC	cc	O
both	DT	det	O
diseases	NNS	nsubj	O
involve	VBP	conj	O
interchanges	NNS	dobj	O
between	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
loci	NNS	nmod	O
and	CC	cc	O
DNA	NN	conj	B-Cellular_component
in	IN	case	O
the	DT	det	O
vicinity	NN	nmod	O
of	IN	case	O
the	DT	det	O
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Members	NNS	nsubjpass	O
of	IN	prep	O
the	DT	det	O
Runx	NNP	nmod	O
and	CC	cc	O
MYC	NN	conj	O
families	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	mark	O
collaborating	VBG	advcl	O
oncogenes	NNS	dobj	O
.	.	punct	O
The	DT	det	O
structure	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
elucidated	VBN	ROOT	O
from	IN	case	O
studies	NNS	nmod	O
on	IN	case	O
translocated	VBN	amod	O
versions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
.	.	punct	O

Rearrangement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
gene	NN	nmod	O
was	VBD	cop	O
common	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
plasmacytomas	NNS	nmod	O
,	,	punct	O
implying	VBG	advcl	O
a	DT	det	O
synergistic	JJ	amod	O
role	NN	dobj	O
for	IN	prep	O
myc	NN	pobj	O
and	CC	cc	O
bcl	NN	conj	O
-	SYM	punct	O
2	CD	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
etiology	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	conj	O
in	IN	case	O
the	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O
Activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
transformation	NN	nmod	O
by	IN	mark	O
promoting	VBG	advcl	O
growth	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
bearing	VBG	acl	O
the	DT	det	O
rearranged	VBN	amod	O
chromosomes	NNS	dobj	B-Cellular_component
.	.	punct	O

Glutamine	NN	nsubj	O
and	CC	cc	O
glucose	NN	conj	O
as	IN	case	O
energy	NN	compound	O
substrates	NNS	nmod	O
for	IN	prep	O
Ehrlich	NN	pobj	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
.	.	punct	O
Inhibition	NN	nsubj	O
by	IN	case	O
N	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
phosphonacetyl	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nmod	I-Simple_chemical
of	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	ROOT	I-Cancer
tumour	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
glucose	NN	compound	B-Simple_chemical
transport	NN	conj	O
.	.	punct	O

Energy	NN	compound	O
metabolism	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
in	IN	case	O
the	DT	dep	O
presence	NN	dep	O
of	IN	case	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
0	CD	conj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
Phosphonacetyl	NNP	compound	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
L	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aspartate	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
PALA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
suppressed	VBD	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ccomp	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Transformation	NN	nsubj	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
dramatic	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
rate	NN	nmod	O
at	IN	case	O
which	WDT	nmod	O
the	DT	det	O
transformed	VBN	amod	O
cells	NNS	nsubj	O
transport	VBP	acl:relcl	O
glucose	NN	dobj	O
across	IN	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
.	.	punct	O
Simultaneously	RB	advmod	O
as	IN	mark	O
the	DT	det	O
growth	NN	compound	O
rate	NN	nsubj	O
decreased	VBD	advcl	O
,	,	punct	O
the	DT	det	O
cellular	JJ	amod	B-Cell
uptake	NN	nsubjpass	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
the	DT	det	O
density	NN	conj	O
of	IN	case	O
a	DT	det	O
class	NN	nmod	O
of	IN	case	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
reversible	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
for	IN	case	O
cytochalasin	NN	compound	B-Simple_chemical
B	NN	nmod	I-Simple_chemical
on	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
reduced	VBN	xcomp	O
.	.	punct	O

CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
induce	VB	ccomp	O
major	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
glucose	NN	compound	O
uptake	NN	nmod	O
of	IN	case	O
lymphomatous	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
highly	RB	advmod	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
magnitude	NN	nmod	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytochalasin	NN	compound	B-Simple_chemical
B	NN	compound	I-Simple_chemical
binding	NN	compound	O
sites	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
magnitude	NN	conj	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
.	.	punct	O

Low	JJ	amod	O
glucose	NN	nsubj	O
potentiated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O
The	DT	det	O
physiological	JJ	amod	O
significance	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
observations	NNS	nmod	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Glutamine	NN	nsubj	O
and	CC	cc	O
glucose	NN	conj	O
as	IN	case	O
energy	NN	compound	O
substrates	NNS	nmod	O
for	IN	prep	O
Ehrlich	NN	pobj	O
ascites	VBZ	ROOT	O
tumour	NN	compound	O
cells	NNS	dobj	O
.	.	punct	O
Effects	NNS	nsubj	O
of	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
chloromethylthiochromone	NN	compound	I-Simple_chemical
-	,	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxide	NN	nmod	I-Simple_chemical
on	IN	case	O
nucleic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
,	,	punct	O
protein	NN	conj	O
,	,	punct	O
and	CC	cc	O
aerobic	JJ	amod	O
and	CC	cc	O
anaerobic	VBN	conj	O
metabolism	NN	conj	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
ATP	NNP	npadvmod	O
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	O
ascites	VBZ	nmod	O
and	CC	cc	O
L1210	NN	compound	O
murine	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	conj	O
.	.	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
Chloromethylthiochromone	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
,	,	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dioxide	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
observed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
Ehrlich	NN	nmod	B-Cancer
ascites	VBZ	acl	I-Cancer
carcinoma	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
a	DT	det	O
moderate	JJ	amod	O
inhibitor	NN	conj	O
of	IN	case	O
P	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
388	CD	nummod	I-Cancer
lymphocytic	JJ	amod	I-Cancer
leukemia	NN	compound	I-Cancer
growth	NN	nmod	O
at	IN	case	O
10	CD	compound	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	nmod	O
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
ATP	NNP	npadvmod	O
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	O
ascites	VBZ	nmod	O
and	CC	cc	O
L1210	NN	compound	O
murine	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	conj	O
.	.	punct	O
Preliminary	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
agents	NNS	nsubj	O
significantly	RB	advmod	O
inhibited	VBD	ccomp	O
RNA	NN	dobj	B-Simple_chemical
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	conj	O
in	IN	case	O
Ehrlich	NN	compound	B-Cell
ascites	VBZ	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Treated	VBN	amod	O
animals	NNS	nsubj	O
also	RB	advmod	O
displayed	VBD	ROOT	O
a	DT	det	O
2	CD	nummod	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
reduction	NN	dobj	O
of	IN	case	O
tumor	NN	compound	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
mRNA	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O
In	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
after	IN	case	O
dosing	VBG	nmod	O
on	IN	case	O
Days	NN	nmod	O
6	CD	nummod	O
,	,	punct	O
7	CD	nummod	O
,	,	punct	O
and	CC	cc	O
8	CD	conj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
reductions	NNS	dobj	O
in	IN	case	O
nucleic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
synthesis	NN	nmod	O
and	CC	cc	O
a	DT	det	O
moderate	JJ	amod	O
reduction	NN	conj	O
in	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

3H	NN	compound	O
-	HYPH	punct	O
Cytosine	NN	compound	O
arabinoside	NN	amod	O
incorporation	NN	nsubjpass	O
into	IN	case	O
the	DT	det	O
DNA	NN	nmod	O
was	VBD	auxpass	O
enhanced	VBN	ROOT	O
1	CD	dobj	O
.	.	punct	O
33	CD	compound	O
-	HYPH	punct	O
to	TO	quantmod	O
18	CD	ROOT	O
.	.	punct	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	ROOT	O
over	RP	prep	O
respective	JJ	amod	O
controls	NNS	pobj	O
in	IN	case	O
14	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O
The	DT	det	O
primary	JJ	amod	O
site	NN	nsubj	O
of	IN	case	O
nucleic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
synthesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	acl:relcl	O
by	IN	case	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
chloromethylthiochromone	NN	nmod	I-Simple_chemical
,	,	punct	O
was	VBD	cop	O
at	IN	case	O
orotidine	NN	amod	B-Gene_or_gene_product
monophosphate	NN	compound	I-Gene_or_gene_product
decarboxylase	NN	ROOT	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
primidine	NN	compound	B-Simple_chemical
pathway	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
glucose	NN	compound	O
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
step	NN	advcl	O
in	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
hexokinase	NN	conj	O
(	-LRB-	punct	O
HK	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
first	JJ	amod	O
rate	NN	compound	O
limiting	VBG	amod	O
glycolytic	JJ	amod	O
enzyme	NN	appos	O
,	,	punct	O
can	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
key	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O
Other	JJ	amod	O
enzymes	NNS	nsubj	O
,	,	punct	O
in	IN	case	O
anaerobic	JJ	amod	O
and	CC	cc	O
aerobic	JJ	conj	O
glycolysis	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
blocked	VBN	acl:relcl	O
include	VBP	ROOT	O
hexokinase	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
phosphofructokinase	NN	conj	B-Gene_or_gene_product
,	,	punct	O
succinic	JJ	amod	B-Gene_or_gene_product
and	CC	cc	O
alpha	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ketoglutarate	NN	conj	I-Gene_or_gene_product
dehydrogenases	NNS	conj	I-Gene_or_gene_product
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
States	NNP	conj	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
of	IN	case	O
oxidative	JJ	amod	O
phosphorylation	NN	nmod	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
Mast	NN	compound	B-Cell
cell	NN	compound	I-Cell
heparin	NN	nsubj	B-Simple_chemical
stimulates	VBZ	ROOT	O
migration	NN	dobj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	O
humor	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Migration	NN	nsubj	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubjpass	O
are	VBP	auxpass	O
discussed	VBN	ROOT	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
previous	JJ	amod	O
morphologic	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
reports	NNS	appos	O
of	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
mast	NN	nmod:npmod	O
-	HYPH	punct	O
cell	NN	npadvmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
tumor	NN	compound	O
cytotoxicity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
of	IN	case	O
mast	NN	compound	O
cells	NNS	nmod	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
connective	JJ	amod	O
tissue	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O
Increased	VBN	amod	O
numbers	NNS	nsubjpass	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
have	VBP	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
a	DT	det	O
quantitative	JJ	amod	O
assay	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
to	TO	mark	O
demonstrate	VB	advcl	O
that	IN	mark	O
mast	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
release	VBP	ccomp	O
a	DT	det	O
factor	NN	dobj	O
that	WDT	nsubj	O
significantly	RB	advmod	O
increases	VBZ	acl:relcl	O
bovine	JJ	amod	B-Organism
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
The	DT	det	O
factor	NN	nsubj	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
medium	NN	nmod	O
conditioned	VBN	acl	O
by	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
lysates	NNS	conj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
stimulatory	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
on	IN	case	O
migration	NN	nmod	O
is	VBZ	cop	O
specific	JJ	ROOT	O
for	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
mast	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
have	VBP	ROOT	O
no	DT	neg	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
Of	IN	case	O
all	PDT	predet	O
the	DT	det	O
secretory	JJ	amod	O
products	NNS	ROOT	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
tested	VBN	acl	O
,	,	punct	O
only	RB	advmod	O
heparin	NN	compound	B-Simple_chemical
stimulated	VBD	amod	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	appos	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
recombinant	JJ	amod	O
human	JJ	amod	O
prothrombin	NN	compound	O
kringle	NN	compound	O
-	,	punct	O
2	CD	nsubj	O
(	-LRB-	punct	O
rk	RB	compound	O
-	SYM	punct	O
2	CD	appos	O
)	-RRB-	punct	O
inhibited	VBD	ccomp	O
bovine	JJ	amod	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
with	IN	case	O
an	DT	det	O
IC	NN	nmod	O
(	-LRB-	punct	O
50	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
concentration	NN	dobj	O
for	IN	case	O
half	JJ	nummod	O
maximal	JJ	amod	O
inhibition	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
38	CD	nummod	O
nM	NN	nmod	O
and	CC	cc	O
inhibited	VBD	conj	O
adhesion	NN	dobj	O
to	TO	case	O
extracellular	JJ	amod	O
matrix	NN	compound	O
(	-LRB-	punct	O
ECM	NN	appos	O
)	-RRB-	punct	O
proteins	NNS	nmod	O
.	.	punct	O
Heparin	NN	compound	B-Simple_chemical
preparations	NNS	nsubj	O
from	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
sources	NNS	nmod	O
stimulated	VBD	ROOT	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
degree	NN	nmod	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
stimulate	VB	conj	O
migration	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
other	JJ	amod	O
cell	NN	compound	B-Cell
types	NNS	nmod	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
factor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
reside	VB	xcomp	O
in	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
granules	NNS	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
identified	VBN	conj	O
as	IN	case	O
heparin	NN	nmod	O
by	IN	case	O
sequential	JJ	amod	O
purification	NN	nmod	O
and	CC	cc	O
enzymatic	JJ	amod	O
degradation	NN	conj	O
.	.	punct	O
The	DT	det	O
migration	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
and	CC	cc	O
mast	NN	compound	B-Cell
cell	NN	nmod:npmod	I-Cell
conditioned	JJ	amod	O
medium	NN	conj	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
specific	JJ	amod	O
antagonists	NNS	nmod	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
protamine	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
heparinase	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
chondroitinase	NN	compound	B-Gene_or_gene_product
ABC	NNP	conj	I-Gene_or_gene_product
.	.	punct	O

Conditioned	JJ	amod	O
media	NNS	nsubj	O
prepared	VBN	acl	O
from	IN	case	O
colon	NN	compound	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
an	DT	det	O
adenosine	NN	compound	O
analog	NN	nmod	O
increased	VBD	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
.	.	punct	O
The	DT	det	O
migration	NN	compound	O
activity	NN	nsubj	O
of	IN	case	O
mast	NN	compound	B-Cell
cell	NN	compound	I-Cell
conditioned	JJ	amod	O
medium	NN	nmod	O
was	VBD	cop	O
resistant	JJ	ROOT	O
to	TO	case	O
heat	NN	nmod	O
(	-LRB-	punct	O
100	CD	nummod	O
degrees	NNS	compound	O
C	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
incubation	NN	conj	O
with	IN	case	O
proteolytic	JJ	amod	O
enzymes	NNS	nmod	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	O
humor	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
mast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
angiogenesis	NN	nmod	O
may	MD	aux	O
be	VB	ccomp	O
to	TO	mark	O
enhance	VB	xcomp	O
migration	NN	dobj	O
of	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
growing	VBG	amod	O
capillaries	NNS	nmod	B-Tissue
.	.	punct	O

Metabolic	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
p53	NN	nmod	O
.	.	punct	O
Cancer	NN	compound	B-Cancer
progression	NN	ROOT	O
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Reduced	VBN	amod	O
growth	NN	compound	O
-	HYPH	punct	O
factor	NN	nmod:npmod	O
dependent	JJ	nmod	O
,	,	punct	O
autonomous	JJ	amod	O
cell	NN	compound	O
growth	NN	nsubj	O
forms	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
defining	VBG	compound	O
point	NN	dobj	O
at	IN	case	O
which	WDT	nmod	O
a	DT	det	O
normal	JJ	amod	O
cell	NN	compound	O
turns	VBZ	acl:relcl	O
into	IN	case	O
an	DT	det	O
oncogenic	JJ	amod	O
one	NN	nmod	O
.	.	punct	O
In	IN	case	O
a	DT	det	O
complex	JJ	amod	O
organism	NN	nmod	O
,	,	punct	O
somatic	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
under	IN	case	O
intermittent	JJ	amod	O
selection	NN	compound	O
pressure	NN	ROOT	O
for	IN	case	O
the	DT	det	O
emergence	NN	nmod	O
of	IN	case	O
mutants	NNS	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
survive	VB	acl:relcl	O
environmental	JJ	amod	O
insults	NNS	dobj	O
and	CC	cc	O
that	WDT	nsubj	O
can	MD	aux	O
grow	VB	conj	O
autonomously	RB	advmod	O
despite	IN	prep	O
adverse	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Repeated	VBN	amod	O
rounds	NNS	nsubj	O
of	IN	case	O
mutation	NN	nmod	O
,	,	punct	O
selection	NN	conj	O
,	,	punct	O
and	CC	cc	O
proliferation	NN	conj	O
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	nsubj	O
plays	VBZ	ROOT	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
organism	NN	nmod	O
by	IN	mark	O
supervising	VBG	advcl	O
strict	JJ	amod	O
compliance	NN	dobj	O
of	IN	prep	O
individual	JJ	amod	O
cells	NNS	pobj	O
to	TO	aux	O
needs	NNS	advcl	O
of	IN	prep	O
the	DT	det	O
whole	JJ	amod	O
organisms	NNS	pobj	O
.	.	punct	O
The	DT	det	O
organism	NN	nsubj	O
prevents	VBZ	ROOT	O
malignant	JJ	amod	O
transformation	NN	dobj	O
by	IN	mark	O
assuring	VBG	advcl	O
accurate	JJ	amod	O
DNA	NN	compound	B-Cellular_component
repair	NN	dobj	O
before	IN	case	O
cell	NN	compound	B-Cell
division	NN	nmod	O
,	,	punct	O
by	IN	mark	O
forcing	VBG	advcl	O
the	DT	det	O
death	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
excessive	JJ	amod	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
by	IN	conj	O
placing	VBG	pcomp	O
limits	NNS	dobj	O
on	IN	prep	O
the	DT	det	O
replicative	JJ	amod	O
lifespans	NNS	pobj	O
of	IN	prep	O
most	JJS	amod	O
somatic	JJ	amod	B-Cell
cells	NNS	pobj	I-Cell
.	.	punct	O

p53	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	xcomp	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
apoptosis	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
maintenance	NN	conj	O
of	IN	case	O
genetic	JJ	amod	O
stability	NN	nmod	O
.	.	punct	O
The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
"	``	punct	O
guardian	NN	advmod	O
of	IN	prep	O
the	DT	det	O
genome	NN	pobj	O
"	''	punct	O
-	:	punct	O
-	:	punct	O
it	PRP	nsubj	O
regulates	VBZ	ROOT	O
multiple	JJ	amod	O
components	NNS	dobj	O
of	IN	case	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
damage	NN	compound	O
control	NN	compound	O
response	NN	nmod	O
and	CC	cc	O
promotes	VBZ	conj	O
cellular	JJ	amod	B-Cell
senescence	NN	dobj	O
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
Disabling	JJ	amod	O
mutations	NNS	nsubj	O
and	CC	cc	O
deletions	NNS	conj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
occur	VBP	ROOT	O
in	IN	case	O
50	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
genetic	JJ	amod	O
alterations	NNS	nsubj	O
found	VBN	acl	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
are	VBP	cop	O
p53	NN	compound	O
tumor	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
mutations	NNS	ROOT	O
.	.	punct	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
cancers	NNS	nsubj	O
are	VBP	cop	O
often	RB	advmod	O
unstable	JJ	ROOT	O
,	,	punct	O
aggressive	JJ	conj	O
,	,	punct	O
and	CC	cc	O
resistant	JJ	conj	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

MET	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
melanoma	NN	nmod	O
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O
The	DT	det	O
Met	NNP	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
mesenchymal	JJ	ROOT	B-Cell
to	TO	case	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
conversion	NN	nmod	O
.	.	punct	O

MET	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
rarely	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
human	JJ	amod	O
melanoma	NN	nmod	O
but	CC	cc	O
is	VBZ	auxpass	O
frequently	RB	advmod	O
observed	VBN	conj	O
in	IN	case	O
metastatic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O
Coexpression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
Met	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
ligand	NN	conj	O
,	,	punct	O
hepatocyte	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
/	:	punct	O
scatter	NN	compound	B-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
(	-LRB-	punct	O
HGF	NN	appos	B-Gene_or_gene_product
/	:	punct	O
SF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
fibroblasts	NNS	nmod	I-Cell
causes	VBZ	ROOT	O
the	DT	det	O
cells	NNS	dobj	B-Cell
to	TO	mark	O
become	VB	xcomp	O
tumorigenic	JJ	xcomp	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
The	DT	det	O
resultant	JJ	amod	O
tumors	NNS	nsubj	B-Cancer
display	VBP	ROOT	O
lumen	NN	dobj	B-Immaterial_anatomical_entity
-	HYPH	punct	O
like	IN	case	O
morphology	NN	conj	O
,	,	punct	O
contain	VBP	dep	O
carcinoma	NN	dobj	B-Cancer
-	HYPH	punct	O
like	IN	case	O
focal	JJ	amod	B-Cellular_component
areas	NNS	nmod	I-Cellular_component
with	IN	prep	O
intercellular	JJ	amod	B-Cellular_component
junctions	NNS	pobj	I-Cellular_component
resembling	VBG	acl	O
desmosomes	NNS	dobj	B-Cellular_component
,	,	punct	O
and	CC	cc	O
coexpress	VB	conj	O
epithelial	JJ	amod	B-Cell
(	-LRB-	punct	O
cytokeratin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
mesenchymal	JJ	compound	B-Cell
(	-LRB-	punct	O
vimentin	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
cytoskeletal	JJ	amod	B-Cellular_component
markers	NNS	dep	O
.	.	punct	O

Fluorescence	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
cell	NN	compound	O
sorter	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
isolated	VBN	amod	O
tumor	NN	compound	O
ECs	NNS	nsubj	O
have	VBP	aux	O
suppressed	VBN	ccomp	O
levels	NNS	dobj	O
of	IN	case	O
intercellular	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	nmod	O
1	CD	nummod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
ECs	NNS	nmod	O
from	IN	case	O
normal	JJ	amod	O
mouse	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O
The	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
also	RB	advmod	O
display	VBP	ROOT	O
enhanced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
desmosomal	JJ	amod	B-Cellular_component
and	CC	cc	O
tight	JJ	conj	B-Cellular_component
-	HYPH	punct	I-Cellular_component
junction	NN	dep	I-Cellular_component
proteins	NNS	nmod	O
.	.	punct	O

RNA	NN	compound	O
interference	NN	nsubj	O
targeting	VBG	acl	O
Met	VBN	dobj	O
in	IN	case	O
these	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
delay	NN	nmod	O
in	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
control	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
apparent	JJ	amod	O
mesenchymal	JJ	nsubj	B-Cell
to	TO	case	O
epithelial	JJ	amod	B-Cell
conversion	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
mimics	VBZ	ROOT	O
the	DT	det	O
conversion	NN	dobj	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
during	IN	case	O
embryonic	JJ	amod	B-Organ
kidney	NN	compound	I-Organ
development	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Met	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
HGF	NN	compound	B-Gene_or_gene_product
/	:	punct	O
SF	NN	compound	B-Gene_or_gene_product
signaling	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
tumors	NNS	conj	B-Cancer
that	WDT	nsubj	O
express	VBP	acl:relcl	O
both	CC	cc:preconj	O
epithelial	JJ	amod	B-Cell
and	CC	cc	O
mesenchymal	JJ	conj	B-Cell
markers	NNS	dobj	O
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
melanoma	NN	compound	O
skin	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Ultraviolet	NN	compound	O
B	NN	compound	O
irradiation	NN	nsubj	O
promotes	VBZ	ROOT	O
tumorigenic	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
properties	NNS	dobj	O
in	IN	case	O
primary	JJ	amod	O
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
via	IN	case	O
induction	NN	nmod	O
of	IN	case	O
interleukin	NN	nmod	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
melanoma	NN	compound	O
skin	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
UV	NN	compound	O
radiation	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
malignant	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
to	TO	case	O
the	DT	det	O
metastatic	JJ	amod	O
state	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
very	RB	advmod	O
well	RB	advmod	O
defined	VBN	conj	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Erbb2	NN	nmod	O
in	IN	case	O
v	CD	compound	O
-	HYPH	punct	O
ras	NN	compound	O
(	-LRB-	punct	O
Ha	NN	compound	O
)	-RRB-	punct	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
before	IN	case	O
UV	NN	compound	O
exposure	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
both	DT	dep	O
56	CD	nummod	O
%	NN	nmod	O
fewer	JJR	amod	O
skin	NN	compound	O
tumors	NNS	dep	O
and	CC	cc	O
tumors	NNS	conj	O
that	WDT	nsubj	O
were	VBD	cop	O
70	CD	nummod	O
%	NN	nmod:npmod	O
smaller	JJR	ccomp	O
.	.	punct	O
Although	IN	mark	O
previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
concentrated	VBN	advcl	O
on	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	nmod	O
on	IN	case	O
the	DT	det	O
host	NN	compound	O
immune	JJ	amod	O
response	NN	nmod	O
,	,	punct	O
the	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	nmod	O
on	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
not	RB	neg	O
elucidated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
Erbb2	NN	compound	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
UV	NN	compound	O
irradiation	NN	nmod	O
,	,	punct	O
the	DT	det	O
primary	JJ	amod	O
cause	NN	appos	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
melanoma	NN	compound	O
skin	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O
Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	nsubj	O
can	MD	aux	O
induce	VB	ccomp	O
interleukin	NN	compound	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
mRNA	NN	dep	O
and	CC	cc	O
protein	NN	compound	O
secretion	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
with	IN	case	O
negligible	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Histological	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	O
from	IN	case	O
linomide	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
animals	NNS	nmod	O
revealed	VBD	ROOT	O
marked	JJ	amod	O
avascularity	NN	dobj	O
.	.	punct	O
UV	NN	compound	O
-	HYPH	punct	O
B	NNP	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	ROOT	O
60	CD	nummod	O
days	NNS	dobj	O
after	IN	case	O
irradiation	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
implanted	VBN	acl	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Since	IN	mark	O
AP	NN	compound	O
-	:	punct	O
1	CD	dep	O
and	CC	cc	O
NF	NN	compound	O
-	HYPH	punct	O
kappa	NN	compound	O
B	NN	nsubj	O
are	VBP	cop	O
key	JJ	amod	O
elements	NNS	advcl	O
in	IN	mark	O
controlling	VBG	acl	O
interleukin	NN	compound	O
-	HYPH	punct	O
8	CD	intj	O
(	-LRB-	punct	O
IL	NN	compound	O
-	:	punct	O
8	CD	dobj	O
)	-RRB-	punct	O
transcription	NN	dobj	O
,	,	punct	O
human	JJ	amod	O
fibroblasts	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
alpha	NN	compound	O
-	HYPH	punct	O
MSH	NN	nmod	O
and	CC	cc	O
IL	NN	compound	O
-	:	punct	O
1	CD	nummod	O
beta	NN	conj	O
for	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
cytokine	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
supernatants	NNS	nmod	O
were	VBD	auxpass	O
measured	VBN	conj	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O
Induction	NN	nsubj	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
was	VBD	cop	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	compound	O
dose	NN	nmod:npmod	O
dependent	JJ	ROOT	O
and	CC	cc	O
blocked	VBN	conj	O
by	IN	case	O
cyclohexamide	NN	nmod	B-Simple_chemical
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
its	PRP$	nmod:poss	O
expression	NN	nmod	O
.	.	punct	O

Erbb2	NN	compound	O
ablation	NN	nsubj	O
reduced	VBD	ROOT	O
the	DT	det	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
activation	NN	dobj	O
of	IN	case	O
PI3K	NN	nmod	O
while	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	nmod	O
/	:	punct	O
Akt	NNP	nsubj	O
increased	VBD	advcl	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O
The	DT	det	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
irradiated	JJ	amod	O
cells	NNS	nsubj	B-Cell
demonstrated	VBD	ROOT	O
enhanced	VBN	amod	O
tumorigenicity	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
potential	NN	conj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
lymphatics	NNS	nmod	O
.	.	punct	O
The	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
tumorigenicity	NN	pobj	O
and	CC	cc	O
metastatic	JJ	conj	O
ability	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
increase	NN	nmod	O
in	IN	case	O
Mr	NNP	nmod	O
72	CD	nummod	O
,	,	punct	O
000	CD	compound	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagenase	NN	compound	I-Gene_or_gene_product
activity	NN	dep	O
and	CC	cc	O
angiogenesis	NN	conj	O
attributed	VBN	acl	O
to	TO	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
IL	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
after	IN	case	O
irradiation	NN	nmod	O
.	.	punct	O

p53	NN	nsubj	O
and	CC	cc	O
PCNA	NN	conj	O
status	NN	dep	O
do	VBP	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
topo	IN	compound	O
I	NN	nummod	O
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
topo	NN	nsubj	O
I	PRP	nsubj	O
has	VBZ	conj	O
no	DT	neg	O
apparent	JJ	amod	O
association	NN	dobj	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
a	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O
The	DT	det	O
acquisition	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	nmod	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
abnormalities	NNS	nmod	O
in	IN	case	O
the	DT	dep	O
p53	NN	compound	B-Gene_or_gene_product
or	CC	cc	O
MTS	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
p16INK4	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
genes	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
Erbb2	NN	compound	O
activation	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
UV	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
skin	NN	compound	O
tumorigenesis	NN	nmod	O
by	IN	mark	O
suppressing	VBG	advcl	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	dobj	O
.	.	punct	O
To	IN	prep	O
the	DT	det	O
best	JJS	pobj	O
of	IN	prep	O
our	PRP$	poss	O
knowledge	NN	pobj	O
,	,	punct	O
this	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	attr	O
to	TO	mark	O
show	VB	acl	O
that	IN	mark	O
UV	NN	compound	O
-	HYPH	punct	O
B	NN	nsubj	O
can	MD	aux	O
increase	VB	ccomp	O
the	DT	det	O
aggressiveness	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
cutaneous	JJ	amod	B-Cancer
melanoma	NN	nmod	I-Cancer
for	IN	case	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

MTSS1	NN	ROOT	O
:	:	punct	O
a	DT	det	O
multifunctional	JJ	amod	O
protein	NN	dep	O
and	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	conj	O
in	IN	case	O
cancer	NN	compound	O
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
Cancer	NN	compound	B-Cancer
metastasis	NN	ROOT	O
:	:	punct	O
negative	JJ	amod	O
regulation	NN	dep	O
by	IN	case	O
an	DT	det	O
invasion	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
complex	NN	nmod	O
.	.	punct	O

A	DT	det	O
characteristic	NN	nsubj	O
of	IN	case	O
malignant	JJ	amod	O
cells	NNS	nmod	O
is	VBZ	cop	O
their	PRP$	nmod:poss	O
capacity	NN	ROOT	O
to	TO	mark	O
invade	VB	acl	O
their	PRP$	nmod:poss	O
surrounding	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
metastasize	VB	conj	O
to	TO	prep	O
distant	JJ	amod	O
organs	NNS	pobj	O
.	.	punct	O
Invasion	NN	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
hallmark	NN	attr	O
of	IN	prep	O
tumor	NN	compound	B-Cancer
malignancy	NN	pobj	O
.	.	punct	O

Invasion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
uterus	NN	nmod	O
by	IN	case	O
first	JJ	amod	O
trimester	NN	compound	O
human	JJ	amod	O
placental	JJ	amod	O
extravillous	JJ	amod	O
trophoblast	NN	compound	O
(	-LRB-	punct	O
EVT	NN	compound	O
)	-RRB-	punct	O
cells	NNS	nmod	O
depends	VBZ	ROOT	O
on	IN	case	O
mechanisms	NNS	nmod	O
shared	VBN	acl	O
by	IN	case	O
malignant	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
situate	VBP	ROOT	O
invasion	NN	dobj	O
within	IN	case	O
microecosystems	NNS	nmod	O
comprising	VBG	acl	O
neoplastic	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
host	NN	compound	O
cells	NNS	conj	B-Cell
.	.	punct	O

This	DT	nsubj	O
contrasts	VBZ	ROOT	O
with	IN	case	O
recent	JJ	amod	O
evidence	NN	nmod	O
suggesting	VBG	acl	O
that	IN	mark	O
the	DT	det	O
Wave	NN	compound	O
complex	NN	nsubj	O
may	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
an	DT	det	O
invasion	NN	compound	O
suppressor	NN	nmod	O
in	IN	case	O
epithelial	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Modulation	NN	nsubjpass	O
of	IN	prep	O
invasion	NN	pobj	O
within	IN	case	O
such	JJ	amod	O
systems	NNS	nmod	O
is	VBZ	auxpass	O
ascribed	VBN	ROOT	O
to	TO	case	O
balances	NNS	nmod	O
between	IN	case	O
promoter	NN	compound	O
and	CC	cc	O
suppressor	NN	conj	O
pathways	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
contrasts	VBZ	ROOT	O
with	IN	case	O
recent	JJ	amod	O
evidence	NN	nmod	O
suggesting	VBG	acl	O
that	IN	mark	O
the	DT	det	O
Wave	NN	compound	O
complex	NN	nsubj	O
may	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
an	DT	det	O
invasion	NN	compound	O
suppressor	NN	nmod	O
in	IN	case	O
epithelial	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
The	DT	det	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
/	:	punct	O
alpha	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
,	,	punct	O
beta	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
,	,	punct	O
gamma	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
complex	NN	nsubj	O
has	VBZ	ROOT	O
an	DT	det	O
invasion	NN	compound	O
-	HYPH	punct	O
suppressor	NN	compound	O
function	NN	dobj	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
transfections	NNS	nmod	O
either	CC	cc:preconj	O
with	IN	case	O
sense	NN	amod	O
cDNA	NN	nmod	O
encoding	VBG	acl	O
these	DT	det	O
molecules	NNS	dobj	O
or	CC	cc	O
with	IN	case	O
antisense	JJ	amod	O
cDNA	NN	conj	O
inhibiting	VBG	acl	O
their	PRP$	nmod:poss	O
expression	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
Loss	NN	nsubjpass	O
of	IN	case	O
heterozygosity	NN	nmod	O
at	IN	case	O
the	DT	det	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Cadherin	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
uvo	NN	appos	O
)	-RRB-	punct	O
locus	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
seem	VBP	conj	O
to	TO	mark	O
be	VB	cop	O
rare	JJ	xcomp	O
.	.	punct	O

Instead	RB	advmod	O
,	,	punct	O
regulation	NN	nsubj	O
occurred	VBD	ROOT	O
at	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	nmod	O
.	.	punct	O
Downregulation	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod	I-Gene_or_gene_product
occurred	VBD	ROOT	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
transcription	NN	nmod	O
or	CC	cc	O
of	IN	case	O
mRNA	NN	compound	O
stability	NN	conj	O
.	.	punct	O

Cell	NN	compound	O
lines	NNS	nsubjpass	O
were	VBD	auxpass	O
established	VBN	ROOT	O
from	IN	case	O
tumor	NN	nmod	O
and	CC	cc	O
metastases	NNS	conj	O
and	CC	cc	O
kept	VBD	conj	O
in	IN	case	O
culture	NN	nmod	O
for	IN	case	O
more	JJR	amod	O
than	IN	quantmod	O
2	CD	nummod	O
months	NNS	nmod	O
.	.	punct	O
Ex	FW	amod	O
vivo	FW	dep	O
cultures	NNS	nsubj	B-Cell
from	IN	case	O
invasive	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
or	CC	cc	O
metastases	NNS	conj	O
produced	VBD	ROOT	O
cells	NNS	dobj	B-Cell
that	WDT	nsubj	O
were	VBD	cop	O
homogeneously	RB	advmod	O
E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	acl:relcl	O
and	CC	cc	O
noninvasive	JJ	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

This	DT	nsubj	O
contrasts	VBZ	ROOT	O
with	IN	case	O
recent	JJ	amod	O
evidence	NN	nmod	O
suggesting	VBG	acl	O
that	IN	mark	O
the	DT	det	O
Wave	NN	compound	O
complex	NN	nsubj	O
may	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
an	DT	det	O
invasion	NN	compound	O
suppressor	NN	nmod	O
in	IN	case	O
epithelial	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
These	DT	det	O
observations	NNS	nsubj	O
have	VBP	aux	O
led	VBN	ROOT	O
to	IN	case	O
the	DT	det	O
idea	NN	nmod	O
that	IN	mark	O
factors	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
host	NN	nmod	O
downmodulate	VB	ccomp	O
the	DT	det	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
complex	NN	dobj	O
and	CC	cc	O
promote	VBP	conj	O
invasion	NN	dobj	O
most	RBS	advmod	O
probably	RB	advmod	O
in	IN	prep	O
a	DT	det	O
transient	JJ	amod	O
way	NN	pobj	O
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
Heparin	NN	compound	B-Simple_chemical
-	HYPH	punct	O
steroid	NN	compound	B-Simple_chemical
conjugates	NNS	ROOT	O
:	:	punct	O
new	JJ	amod	O
angiogenesis	NN	compound	O
inhibitors	NNS	dep	O
with	IN	case	O
antitumor	NN	compound	B-Cancer
activity	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	compound	O
inhibitors	NNS	nsubj	O
have	VBP	dep	O
strong	JJ	amod	O
therapeutic	JJ	dep	O
potential	NN	dobj	O
as	IN	case	O
antitumor	JJ	compound	O
agents	NNS	nmod	O
in	IN	mark	O
suppressing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastatic	JJ	amod	O
progression	NN	conj	O
.	.	punct	O
Inhibitors	NNS	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
hold	VBP	ROOT	O
potential	NN	dobj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
other	JJ	amod	O
diseases	NNS	conj	O
where	WRB	advmod	O
the	DT	det	O
disease	NN	nsubjpass	O
is	VBZ	auxpass	O
caused	VBN	acl:relcl	O
or	CC	cc	O
maintained	VBN	conj	O
by	IN	case	O
the	DT	det	O
inappropriate	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

This	DT	det	O
process	NN	nsubj	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
considerable	JJ	amod	O
effort	NN	nsubjpass	O
is	VBZ	aux	O
being	VBG	auxpass	O
expended	VBN	conj	O
to	TO	mark	O
find	VB	xcomp	O
inhibitors	NNS	dobj	O
of	IN	case	O
tumor	NN	compound	O
angiogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
inhibitor	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
was	VBD	auxpass	O
synthesized	VBN	ROOT	O
by	IN	mark	O
covalently	RB	advmod	O
linking	VBG	advcl	O
a	DT	det	O
nonanticoagulating	JJ	amod	O
derivative	NN	dobj	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
,	,	punct	O
heparin	NN	compound	B-Simple_chemical
adipic	NN	amod	I-Simple_chemical
hydrazide	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
HAH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
by	IN	case	O
an	DT	det	O
acid	NN	nmod:npmod	O
-	HYPH	punct	O
labile	JJ	amod	O
bond	NN	nmod	O
to	TO	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
steroid	NN	compound	B-Simple_chemical
,	,	punct	O
cortisol	NN	nmod	B-Simple_chemical
.	.	punct	O

The	DT	det	O
response	NN	nsubj	O
to	TO	case	O
taxol	NN	amod	O
and	CC	cc	O
heparin	NN	conj	O
-	HYPH	punct	O
steroid	NN	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
HPVAM	NNP	nmod	O
,	,	punct	O
a	DT	det	O
validated	JJ	amod	O
angiogenesis	NN	compound	O
assay	NN	appos	O
.	.	punct	O
The	DT	det	O
rationale	NN	nsubj	O
was	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
heparin	NN	compound	B-Simple_chemical
derivative	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
sulfated	JJ	amod	O
polyanion	NN	compound	O
receptors	NNS	nmod	O
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
should	MD	aux	O
concentrate	VB	ccomp	O
the	DT	det	O
steroid	NN	dobj	B-Simple_chemical
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
should	MD	aux	O
diminish	VB	ROOT	O
apoptosis	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Endocytosis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
conjugate	NN	nmod	O
and	CC	cc	O
decomposition	NN	conj	O
of	IN	prep	O
the	DT	det	O
acid	NN	npadvmod	O
-	HYPH	punct	O
labile	JJ	amod	O
linkage	NN	pobj	O
inside	IN	prep	O
lysosomes	NNS	pobj	B-Cellular_component
and	CC	cc	O
other	JJ	amod	O
acidic	JJ	amod	O
intracellular	JJ	amod	B-Cellular_component
compartments	NNS	conj	I-Cellular_component
should	MD	aux	O
then	RB	advmod	O
lead	VB	ROOT	O
to	TO	case	O
release	VB	nmod	O
of	IN	case	O
the	DT	det	O
cortisol	NN	nmod	B-Simple_chemical
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
antiproliferative	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

After	IN	case	O
2	CD	nummod	O
h	NN	compound	O
incubation	NN	nsubj	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
the	DT	det	O
drop	NN	dep	O
in	IN	case	O
the	DT	det	O
ATP	NN	compound	O
level	NN	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
.	.	punct	O
Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
stability	NN	nmod	O
of	IN	case	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
showed	VBD	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
was	VBD	cop	O
stable	JJ	ccomp	O
at	IN	case	O
pH	NN	nmod	O
7	CD	nummod	O
.	.	punct	O
4	CD	ROOT	O
and	CC	cc	O
broke	VBD	conj	O
down	RP	advmod	O
rapidly	RB	advmod	O
(	-LRB-	punct	O
t1	NN	dep	O
/	:	punct	O
2	CD	nummod	O
15	CD	nummod	O
min	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
pH	NN	nmod	O
4	CD	nummod	O
.	.	punct	O
8	CD	dep	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
of	IN	case	O
murine	JJ	amod	B-Organism
pulmonary	JJ	amod	B-Cell
capillary	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
5	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
cortisol	NN	nmod	B-Simple_chemical
)	-RRB-	punct	O
suppressed	VBD	ROOT	O
their	PRP$	nmod:poss	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
by	IN	case	O
50	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
inhibited	VBD	conj	O
their	PRP$	nmod:poss	O
migration	NN	dobj	O
into	IN	case	O
wounded	JJ	amod	B-Pathological_formation
areas	NNS	nmod	I-Pathological_formation
of	IN	case	O
confluent	JJ	amod	O
monolayers	NNS	nmod	B-Cell
.	.	punct	O

Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	ROOT	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
unrelated	JJ	acl	O
to	TO	case	O
cytotoxicity	NN	nmod	O
for	IN	case	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nsubj	I-Simple_chemical
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
4	LS	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	dep	O
to	TO	case	O
cortisol	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
suppress	VB	ROOT	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
of	IN	case	O
Lewis	NN	compound	B-Cell
lung	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Vascularization	NN	nsubjpass	O
of	IN	case	O
subcutaneous	JJ	amod	O
Matrigel	NNP	compound	O
implants	VBZ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	O
angiogenesis	NN	conj	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O
Daily	RB	ROOT	O
i	LS	dobj	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
injections	NNS	ROOT	O
of	IN	case	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
into	IN	case	O
mice	NNS	nmod	B-Organism
bearing	VBG	acl	O
s	NNS	dobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
sponge	JJ	compound	O
implants	NNS	nsubj	O
retarded	VBD	ROOT	O
vascularization	NN	dobj	O
of	IN	prep	O
the	DT	det	O
sponge	NN	pobj	O
,	,	punct	O
and	CC	cc	O
injections	NNS	nsubj	O
directly	RB	advmod	O
into	IN	prep	O
the	DT	det	O
sponge	NN	pobj	O
abolished	VBD	conj	O
vascularization	NN	dobj	O
for	IN	prep	O
as	RB	advmod	O
long	RB	pcomp	O
as	IN	mark	O
the	DT	det	O
injections	NNS	nsubjpass	O
were	VBD	auxpass	O
continued	VBN	advcl	O
.	.	punct	O

The	DT	det	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
agents	NNS	nsubjpass	O
p	NN	dep	O
-	:	punct	O
(	-LRB-	punct	O
3	CD	dep	O
,	,	punct	O
3	CD	nummod	O
-	HYPH	punct	O
dimethyl	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
triazeno	NN	conj	O
)	-RRB-	punct	O
benzoic	JJ	amod	O
acid	NN	compound	O
potassium	NN	compound	O
salt	NN	dep	O
(	-LRB-	punct	O
DM	NN	compound	O
-	HYPH	punct	O
COOK	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
5	CD	conj	O
-	SYM	punct	O
(	-LRB-	punct	O
3	CD	dep	O
,	,	punct	O
3	CD	nummod	O
-	HYPH	punct	O
dimethyl	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
triazeno	NN	dep	O
)	-RRB-	punct	O
imidazole	NN	amod	O
-	SYM	punct	O
4	CD	nummod	O
-	HYPH	punct	O
carboxamide	NN	dep	O
(	-LRB-	punct	O
DTIC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	nummod	O
-	HYPH	punct	O
di	NN	conj	O
(	-LRB-	punct	O
3	CD	nummod	O
,	,	punct	O
5	CD	nummod	O
-	HYPH	punct	O
dioxopiperazin	NN	amod	O
-	HYPH	punct	O
1	CD	nummod	O
-	HYPH	punct	O
yl	NN	dep	O
)	-RRB-	punct	O
propane	NN	dep	O
(	-LRB-	punct	O
ICRF	NN	compound	O
-	:	punct	O
159	CD	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
markedly	RB	advmod	O
depress	VB	xcomp	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
spontaneous	JJ	amod	O
hematogenous	JJ	amod	O
metastases	NNS	nmod	O
in	IN	case	O
mice	NNS	nmod	O
bearing	VBG	acl	O
s	NNS	dobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O
Daily	NNP	ROOT	O
i	LS	dobj	B-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
v	LS	ROOT	I-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
injections	NNS	nsubj	O
of	IN	case	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
at	IN	case	O
doses	NNS	nmod	O
causing	VBG	acl	O
no	DT	neg	O
apparent	JJ	amod	O
toxicity	NN	dobj	O
retarded	VBD	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	prep	O
solid	JJ	amod	O
s	NNS	pobj	O
.	.	punct	O
c	LS	ROOT	O
.	.	punct	O

Hemostasis	NN	ROOT	O
and	CC	cc	O
mechanism	NN	conj	O
of	IN	case	O
action	NN	nmod	O
of	IN	case	O
selective	JJ	amod	O
antimetastatic	JJ	amod	O
drugs	NNS	nmod	O
in	IN	case	O
mice	NNS	nmod	O
bearing	VBG	acl	O
Lewis	JJ	compound	O
lung	NN	compound	O
carcinoma	NN	dobj	O
.	.	punct	O
Lewis	JJ	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	ROOT	I-Cancer
in	IN	case	O
mice	NNS	nmod	B-Organism
by	IN	case	O
up	RB	advmod	O
to	TO	quantmod	O
65	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Cotreatment	NN	nsubj	O
of	IN	case	O
cell	NN	compound	O
lines	NNS	nmod	O
with	IN	case	O
a	DT	det	O
hormone	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
specific	JJ	amod	O
antagonist	NN	conj	O
blocked	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
.	.	punct	O
In	IN	case	O
all	DT	nmod	O
of	IN	case	O
these	DT	det	O
assays	NNS	nmod	O
,	,	punct	O
equivalent	JJ	amod	O
treatments	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
mixture	NN	nmod	O
of	IN	case	O
the	DT	det	O
HAH	NN	nmod	B-Simple_chemical
plus	CC	cc	O
cortisol	NN	conj	B-Simple_chemical
was	VBD	cop	O
significantly	RB	advmod	O
less	RBR	advmod	O
effective	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubj	O
subsequently	RB	advmod	O
proliferate	VBP	ROOT	O
and	CC	cc	O
differentiate	VBP	conj	O
to	TO	mark	O
form	VB	xcomp	O
endothelial	JJ	amod	O
tubes	NNS	dobj	O
and	CC	cc	O
capillary	JJ	conj	O
-	HYPH	punct	O
like	JJ	conj	O
structures	NNS	pobj	O
.	.	punct	O
The	DT	det	O
antiproliferative	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
appeared	VBD	ROOT	O
independent	JJ	xcomp	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-Simple_chemical
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
steroid	NN	nmod	B-Simple_chemical
since	IN	mark	O
HAH	NN	nsubj	B-Simple_chemical
conjugated	VBN	advcl	O
to	TO	case	O
5	CD	compound	B-Simple_chemical
beta	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
pregnane	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
3	CD	nummod	I-Simple_chemical
alpha	NN	compound	I-Simple_chemical
,	,	punct	I-Simple_chemical
17	CD	nummod	I-Simple_chemical
alpha	NN	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
21	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
triol	NN	conj	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
20	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
one	CD	dobj	I-Simple_chemical
,	,	punct	O
a	DT	det	O
steroid	NN	appos	B-Simple_chemical
lacking	VBG	acl	O
glucocorticoid	NN	compound	B-Simple_chemical
or	CC	cc	O
mineralocorticoid	NN	conj	B-Simple_chemical
activity	NN	dobj	O
,	,	punct	O
was	VBD	cop	O
even	RB	advmod	O
more	RBR	advmod	O
effective	JJ	conj	O
at	IN	mark	O
inhibiting	VBG	advcl	O
DNA	NN	compound	B-Cellular_component
synthesis	NN	dobj	O
by	IN	case	O
murine	JJ	amod	B-Organism
pulmonary	JJ	amod	B-Cell
capillary	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
than	IN	mark	O
was	VBD	cop	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nmod	I-Simple_chemical
.	.	punct	O

Taxol	NN	ROOT	O
at	IN	prep	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
M	NN	nsubj	O
completely	RB	advmod	O
inhibited	VBD	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
while	IN	mark	O
Taxol	NN	nsubj	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
8	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
and	CC	cc	O
the	DT	det	O
heparin	NN	compound	O
-	HYPH	punct	O
steroid	NN	conj	O
partially	RB	advmod	O
inhibited	VBD	advcl	O
angiogenesis	NN	dobj	O
.	.	punct	O
In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
HAH	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
cortisol	NN	nsubj	I-Simple_chemical
represents	VBZ	ROOT	O
the	DT	det	O
prototype	NN	dobj	O
of	IN	case	O
a	DT	det	O
new	JJ	amod	O
class	NN	nmod	O
of	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
other	JJ	amod	O
angiogenic	JJ	amod	O
diseases	NNS	conj	O
.	.	punct	O

The	DT	det	O
latter	JJ	amod	O
phenomenon	NN	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
mdr	NN	amod	O
-	HYPH	punct	O
1	CD	nummod	O
mRNA	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
cellular	JJ	amod	O
glutathione	NN	compound	O
level	NN	conj	O
,	,	punct	O
and	CC	cc	O
glutathione	NN	compound	O
S	NN	compound	O
-	HYPH	punct	O
transferase	NN	compound	O
activity	NN	conj	O
.	.	punct	O
Selenoperoxidase	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
glutathione	NN	compound	B-Simple_chemical
cycle	NN	compound	O
activity	NN	ROOT	O
in	IN	case	O
peroxide	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
challenged	VBN	amod	O
leukemia	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
main	JJ	amod	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
investigation	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
a	DT	det	O
homologous	JJ	amod	O
series	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
-	HYPH	punct	O
alkylpyrrolidine	NN	compound	O
N	NN	compound	O
-	:	punct	O
oxides	NNS	nmod	O
on	IN	case	O
ATP	NNP	npadvmod	O
-	HYPH	punct	O
producing	VBG	amod	O
processes	NNS	nmod	O
in	IN	case	O
Ehrlich	NN	compound	O
ascites	VBZ	nmod	O
and	CC	cc	O
L1210	NN	compound	O
murine	JJ	amod	O
leukemia	NN	compound	O
cells	NNS	conj	O
.	.	punct	O
Murine	JJ	amod	B-Organism
leukemia	NN	compound	B-Cell
L1210	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
rendered	VBD	ROOT	O
deficient	JJ	xcomp	O
in	IN	case	O
glutathione	NN	compound	B-Gene_or_gene_product
peroxidase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
GPX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
phospholipid	JJ	amod	B-Gene_or_gene_product
hydroperoxide	NN	compound	I-Gene_or_gene_product
glutathione	NN	compound	I-Gene_or_gene_product
peroxidase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
PHGPX	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
by	IN	case	O
Se	NN	compound	B-Simple_chemical
deprivation	NN	nmod	O
(	-LRB-	punct	O
L	NN	dep	B-Cell
.	.	punct	I-Cell
Se	NNP	compound	I-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nsubjpass	I-Cell
)	-RRB-	punct	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
more	RBR	advmod	O
sensitive	JJ	xcomp	O
to	TO	case	O
tert	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butyl	NN	compound	I-Simple_chemical
hydroperoxide	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
t	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
BuOOH	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
cytotoxicity	NN	nmod	O
than	IN	case	O
Se	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
replete	JJ	amod	O
controls	NNS	nmod	O
(	-LRB-	punct	O
L	NN	dep	B-Cell
.	.	punct	I-Cell
Se	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
+	CC	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	ROOT	I-Cell
)	-RRB-	punct	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod	O
reduced	VBD	ccomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
glutathione	NN	nmod	O
(	-LRB-	punct	O
GSH	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
mouse	NN	compound	O
epidermal	JJ	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
JB6	NN	compound	O
P	NN	dep	O
+	CC	cc	O
)	-RRB-	punct	O
and	CC	cc	O
caused	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
AP	NN	nmod	O
-	SYM	punct	O
1	CD	nummod	O
.	.	punct	O
Human	JJ	amod	B-Organism
K562	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
PHGPX	NN	dobj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
GPX	NN	conj	B-Gene_or_gene_product
,	,	punct	O
were	VBD	cop	O
also	RB	advmod	O
more	RBR	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
t	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
BuOOH	NN	nmod	I-Simple_chemical
in	IN	case	O
the	DT	det	O
Se	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
deficient	JJ	nmod	O
(	-LRB-	punct	O
K	NN	dep	B-Cell
.	.	punct	I-Cell
Se	NNP	ROOT	I-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
)	-RRB-	punct	O
than	IN	case	O
Se	NNP	nsubj	B-Simple_chemical
-	HYPH	punct	O
satisfied	JJ	amod	O
(	-LRB-	punct	O
K	NN	nmod	B-Cell
.	.	punct	I-Cell
Se	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
+	CC	dep	I-Cell
)	-RRB-	punct	I-Cell
)	-RRB-	punct	O
condition	NN	ROOT	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
to	IN	case	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod	O
reduced	VBD	ccomp	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
glutathione	NN	nmod	O
(	-LRB-	punct	O
GSH	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
mouse	NN	compound	O
epidermal	JJ	amod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
JB6	NN	compound	O
P	NN	dep	O
+	CC	cc	O
)	-RRB-	punct	O
and	CC	cc	O
caused	VBD	conj	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
AP	NN	nmod	O
-	SYM	punct	O
1	CD	nummod	O
.	.	punct	O
In	IN	prep	O
examining	VBG	pcomp	O
the	DT	det	O
metabolic	JJ	amod	O
basis	NN	dobj	O
for	IN	prep	O
selenoperoxidase	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
resistance	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
glucose	NN	compound	B-Simple_chemical
-	HYPH	punct	O
replete	JJ	amod	O
Se	NNP	compound	B-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nsubj	I-Cell
reduce	VBP	ccomp	O
t	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
BuOOH	NN	dobj	I-Simple_chemical
to	TO	prep	O
t	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butanol	NN	pobj	I-Simple_chemical
far	RB	advmod	O
more	RBR	advmod	O
slowly	RB	advmod	O
than	IN	case	O
Se	NNP	compound	B-Cell
(	-LRB-	punct	I-Cell
+	CC	dep	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
the	DT	det	O
ratio	NN	appos	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
-	HYPH	punct	O
order	NN	compound	O
rate	NN	compound	O
constants	NNS	nmod	O
approximating	VBG	acl	O
that	DT	dobj	O
of	IN	case	O
the	DT	det	O
GPX	NN	compound	B-Gene_or_gene_product
activities	NNS	nmod	O
(	-LRB-	punct	O
L1210	NN	compound	B-Cell
cells	NNS	appos	I-Cell
)	-RRB-	punct	O
or	CC	cc	O
PHGPX	NN	compound	B-Gene_or_gene_product
activities	NNS	conj	O
(	-LRB-	punct	O
K562	NN	compound	B-Cell
cells	NNS	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Intracellular	JJ	amod	O
glutathione	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
monochlorobimane	NN	nmod	O
,	,	punct	O
a	DT	det	O
glutathione	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
probe	NN	appos	O
.	.	punct	O
Monitoring	VBG	csubj	O
peroxide	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
changes	NNS	nsubj	O
in	IN	case	O
GSH	NN	nmod	B-Simple_chemical
and	CC	cc	O
GSSG	NN	conj	B-Simple_chemical
gave	VBD	ROOT	O
consistent	JJ	amod	O
results	NNS	dobj	O
;	:	punct	O
e	NN	dep	O
.	.	punct	O
g	NN	ROOT	O
.	.	punct	O
,	,	punct	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
depleted	VBN	amod	O
L	NN	conj	O
.	.	punct	O
Se	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
+	CC	cc	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nsubj	I-Cell
exhibited	VBD	ROOT	O
a	DT	det	O
first	JJ	amod	O
order	NN	compound	O
loss	NN	dobj	O
of	IN	case	O
GSH	NN	nmod	B-Simple_chemical
that	WDT	nsubj	O
was	VBD	cop	O
substantially	RB	advmod	O
faster	JJR	acl:relcl	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
depleted	VBN	amod	O
L	NN	nmod	B-Cell
.	.	punct	I-Cell
Se	NNP	compound	I-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	ROOT	I-Cell
.	.	punct	O

Intracellular	JJ	amod	O
glutathione	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
monochlorobimane	NN	nmod	O
,	,	punct	O
a	DT	det	O
glutathione	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
probe	NN	appos	O
.	.	punct	O
Under	IN	case	O
the	DT	det	O
conditions	NNS	pobj	O
used	VBN	acl	O
,	,	punct	O
peroxide	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
conversion	NN	nsubjpass	O
of	IN	case	O
GSH	NN	nmod	B-Simple_chemical
to	TO	case	O
GSSG	NN	nmod	B-Simple_chemical
could	MD	aux	O
be	VB	auxpass	O
stoichiometrically	RB	advmod	O
reversed	VBN	ROOT	O
by	IN	mark	O
resupplying	VBG	advcl	O
D	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	dobj	I-Simple_chemical
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
no	DT	neg	O
significant	JJ	amod	O
lysis	NN	nsubj	O
or	CC	cc	O
GSSG	NN	compound	B-Simple_chemical
efflux	NN	conj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
interchange	NN	conj	O
had	VBD	aux	O
taken	VBN	ccomp	O
place	NN	dobj	O
.	.	punct	O

Intracellular	JJ	amod	O
glutathione	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
monochlorobimane	NN	nmod	O
,	,	punct	O
a	DT	det	O
glutathione	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
probe	NN	appos	O
.	.	punct	O
The	DT	det	O
apparent	JJ	amod	O
first	JJ	amod	O
-	HYPH	punct	O
order	NN	compound	O
rate	NN	compound	O
constant	NN	nsubj	O
for	IN	case	O
GSH	NN	compound	B-Simple_chemical
decay	NN	nmod	O
increased	VBD	ROOT	O
progressively	RB	advmod	O
for	IN	case	O
L1210	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
a	DT	det	O
range	NN	dobj	O
of	IN	case	O
GPX	NN	compound	B-Gene_or_gene_product
activities	NNS	nmod	O
from	IN	case	O
approximately	RB	advmod	O
5	CD	nummod	O
%	NN	nmod	O
to	TO	dep	O
100	CD	nummod	O
%	NN	dep	O
,	,	punct	O
demonstrating	VBG	advcl	O
that	IN	mark	O
peroxide	NN	compound	B-Simple_chemical
detoxification	NN	nsubj	O
is	VBZ	cop	O
strictly	RB	advmod	O
dependent	JJ	ccomp	O
on	IN	case	O
enzyme	NN	compound	O
content	NN	nmod	O
.	.	punct	O

The	DT	det	O
13C	NN	nummod	O
enrichment	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	O
metabolites	NNS	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
after	IN	case	O
a	DT	det	O
4	CD	nummod	O
-	HYPH	punct	O
h	NN	compound	O
incubation	NN	nmod	O
in	IN	case	O
media	NNS	nmod	O
containing	VBG	acl	O
5	CD	dobj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubjpass	O
and	CC	cc	O
11	CD	nummod	O
mM	NN	amod	O
lactate	NN	conj	O
,	,	punct	O
each	DT	det	O
metabolite	NN	nsubjpass	O
being	VBG	auxpass	O
alternatively	RB	advmod	O
labelled	VBN	ROOT	O
with	IN	case	O
either	DT	cc:preconj	O
[	-LRB-	punct	O
1	CD	compound	O
-	HYPH	punct	O
13C	NN	nummod	O
]	-RRB-	punct	O
D	NN	compound	O
-	HYPH	punct	O
glucose	NN	nmod	O
or	CC	cc	O
[	-LRB-	punct	O
3	CD	compound	O
-	HYPH	punct	O
13C	NN	dep	O
]	-RRB-	punct	O
L	NN	compound	O
-	HYPH	punct	O
lactate	NN	conj	O
.	.	punct	O
The	DT	det	O
initial	JJ	amod	O
rate	NN	nsubj	O
of	IN	case	O
14CO2	JJ	compound	B-Simple_chemical
release	NN	nmod	O
from	IN	case	O
D	NN	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
1	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
14C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
supplied	VBN	acl	O
in	IN	case	O
the	DT	det	O
medium	NN	nmod	O
was	VBD	cop	O
much	RB	advmod	O
greater	JJR	ROOT	O
for	IN	case	O
L	NN	nmod	B-Cell
.	.	punct	I-Cell
Se	NN	ROOT	I-Cell
(	-LRB-	punct	I-Cell
+	CC	cc	I-Cell
)	-RRB-	punct	I-Cell
or	CC	cc	O
K	NN	conj	B-Cell
.	.	punct	I-Cell
Se	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
+	CC	appos	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	ROOT	I-Cell
than	IN	case	O
for	IN	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
Se	NNP	compound	B-Cell
(	-LRB-	punct	I-Cell
-	:	punct	I-Cell
)	-RRB-	punct	I-Cell
counterparts	NNS	nmod	O
,	,	punct	O
consistent	JJ	amod	O
with	IN	prep	O
greater	JJR	amod	O
hexose	NN	amod	B-Simple_chemical
monophosphate	JJ	compound	I-Simple_chemical
shunt	NN	compound	O
activity	NN	pobj	O
in	IN	prep	O
the	DT	det	O
former	JJ	pobj	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
glutathione	NN	compound	O
depletion	NN	nsubjpass	O
and	CC	cc	O
extracellular	JJ	amod	O
signal	NN	compound	O
-	HYPH	punct	O
regulated	VBN	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
ERK	NN	appos	O
)	-RRB-	punct	O
inactivation	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
EPOX	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
highlight	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
selenoperoxidase	NN	compound	B-Gene_or_gene_product
action	NN	nmod	O
in	IN	case	O
the	DT	det	O
glutathione	NN	compound	B-Simple_chemical
cycle	NN	nmod	O
as	IN	case	O
a	DT	det	O
means	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
cope	VBP	acl:relcl	O
with	IN	case	O
hydroperoxide	NN	compound	B-Simple_chemical
stress	NN	nmod	O
.	.	punct	O

IMPLICATIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
findings	NNS	nsubj	O
also	RB	advmod	O
contrast	VBP	dep	O
with	IN	case	O
the	DT	det	O
demonstration	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
metastasis	NN	compound	O
suppressor	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
murine	JJ	amod	O
melanoma	NN	nmod	O
and	CC	cc	O
with	IN	case	O
the	DT	det	O
correlation	NN	conj	O
of	IN	case	O
loss	NN	nmod	O
of	IN	case	O
nm23	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O
Differential	JJ	amod	O
expression	NN	ROOT	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
NME	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
in	IN	case	O
autologous	JJ	amod	O
cultured	VBN	amod	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
different	JJ	amod	O
metastatic	JJ	amod	O
potentials	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
total	JJ	amod	O
nm23	NN	compound	O
messenger	NN	compound	O
RNA	NN	dep	O
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ccomp	O
to	TO	case	O
similar	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
colon	NN	compound	O
tumors	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
high	JJ	amod	O
and	CC	cc	O
low	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
The	DT	det	O
putative	JJ	amod	O
metastasis	NN	compound	O
suppressor	NN	compound	O
genes	NNS	nsubjpass	O
,	,	punct	O
NME1	NN	appos	B-Gene_or_gene_product
(	-LRB-	punct	O
nm23	NN	dep	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
NME2	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
nm23	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
model	NN	compound	O
system	NN	nmod	O
we	PRP	nsubj	O
developed	VBD	conj	O
to	TO	mark	O
approximate	VB	xcomp	O
the	DT	det	O
dissemination	NN	dobj	O
of	IN	case	O
melanoma	NN	nmod	B-Cancer
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
skin	NN	compound	B-Cancer
tumor	NN	nmod	I-Cancer
.	.	punct	O

Malignant	JJ	amod	O
melanoma	NN	nsubjpass	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
frequent	JJ	amod	O
metastasis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
specific	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
this	DT	det	O
process	NN	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
clearly	RB	advmod	O
delineated	VBN	parataxis	O
.	.	punct	O
We	PRP	nsubj	O
utilized	VBD	ROOT	O
two	CD	nummod	O
autologous	JJ	amod	O
human	JJ	amod	B-Organism
melanoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	dobj	I-Cell
,	,	punct	O
IV	CD	nummod	B-Cell
Cl	NN	appos	I-Cell
1	CD	nummod	I-Cell
and	CC	cc	O
IV	CD	nummod	B-Cell
Cl	NN	conj	I-Cell
3	CD	nummod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
displayed	VBD	acl:relcl	O
qualitatively	RB	advmod	O
different	JJ	amod	O
metastatic	JJ	amod	O
phenotypes	NNS	dobj	O
following	VBG	case	O
subdermal	JJ	amod	B-Organism_subdivision
inoculation	NN	nmod	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

We	PRP	nsubj	O
performed	VBD	ROOT	O
comparative	JJ	amod	O
proteomic	JJ	amod	O
and	CC	cc	O
pathway	NN	conj	O
analysis	NN	dobj	O
of	IN	case	O
four	CD	nummod	O
human	JJ	amod	O
metastatic	JJ	amod	O
HCC	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
to	TO	mark	O
identify	VB	advcl	O
metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	dobj	O
.	.	punct	O
Highly	RB	advmod	O
metastatic	JJ	amod	O
IV	CD	nummod	B-Cell
Cl	NN	compound	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
expressed	VBD	ROOT	O
approximately	RB	advmod	O
5	CD	nmod:npmod	O
fold	RB	amod	O
lower	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
protein	NN	nmod	O
encoded	VBN	acl	O
by	IN	case	O
NME	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
than	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
IV	CD	nummod	B-Cell
Cl	NN	compound	I-Cell
3	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
total	JJ	amod	O
nm23	NN	compound	O
messenger	NN	compound	O
RNA	NN	dep	O
(	-LRB-	punct	O
mRNA	NN	appos	O
)	-RRB-	punct	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ccomp	O
to	TO	case	O
similar	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
colon	NN	compound	O
tumors	NNS	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
high	JJ	amod	O
and	CC	cc	O
low	JJ	conj	O
metastatic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O
Similar	JJ	amod	O
differences	NNS	nsubjpass	O
in	IN	case	O
NME	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
dimensional	JJ	amod	O
electrophoresis	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
-	HYPH	punct	O
DE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
MALDI	NN	compound	O
-	HYPH	punct	O
TOF	NN	compound	O
mass	NN	compound	O
spectrometry	NN	conj	O
,	,	punct	O
a	DT	det	O
total	NN	appos	O
of	IN	case	O
125	CD	nummod	O
proteins	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
post	JJ	nmod:npmod	O
-	HYPH	punct	O
translational	JJ	amod	O
modification	NN	compound	O
forms	NNS	conj	O
or	CC	cc	O
isoforms	NNS	conj	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
differentially	RB	advmod	O
expressed	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
There	EX	expl	O
were	VBD	ROOT	O
no	DT	neg	O
differences	NNS	nsubj	O
in	IN	case	O
NME	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
between	IN	case	O
these	DT	det	O
two	CD	nummod	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
is	VBZ	auxpass	O
regulated	VBN	ccomp	O
at	IN	case	O
a	DT	det	O
post	JJ	amod	O
-	HYPH	punct	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
may	MD	aux	O
be	VB	ROOT	O
that	IN	mark	O
metastasis	NN	compound	O
suppression	NN	nsubj	O
by	IN	case	O
the	DT	det	O
nm23	NN	compound	O
gene	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
tissue	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
phenomenon	NN	ccomp	O
.	.	punct	O
We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
ser122	NN	compound	B-Amino_acid
-	HYPH	punct	O
pro	NN	amod	B-Amino_acid
mutation	NN	dobj	O
in	IN	case	O
the	DT	det	O
NME2	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
IV	CD	nummod	B-Cell
Cl	NN	compound	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
leave	VBP	ROOT	O
unexplained	JJ	xcomp	O
the	DT	det	O
observation	NN	dobj	O
that	IN	mark	O
nm23	NN	compound	O
-	:	punct	O
H1	NN	compound	O
allelic	JJ	amod	O
deletion	NN	nsubj	O
correlates	VBZ	ccomp	O
with	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
of	IN	case	O
colon	NN	compound	O
carcinomas	NNS	nmod	O
.	.	punct	O
A	DT	det	O
similar	JJ	amod	O
ser120	NN	compound	B-Amino_acid
-	:	punct	O
gly	NN	compound	B-Amino_acid
mutation	NN	nsubjpass	O
in	IN	case	O
NME1	NN	nmod	B-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
neuroblastoma	NN	nmod	B-Cancer
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
mutation	NN	nsubj	O
in	IN	case	O
this	DT	det	O
region	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
general	JJ	amod	O
phenomenon	NN	ccomp	O
related	JJ	amod	O
to	TO	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
nearby	JJ	amod	O
residue	NN	nsubj	O
,	,	punct	O
Thr	NNP	compound	O
-	HYPH	punct	O
495	CD	appos	O
,	,	punct	O
also	RB	advmod	O
appears	VBZ	ccomp	O
to	TO	mark	O
be	VB	auxpass	O
phosphorylated	VBN	xcomp	O
.	.	punct	O
These	DT	det	O
mutations	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
functional	JJ	amod	O
consequences	NNS	dobj	O
since	IN	mark	O
they	PRP	nsubj	O
eliminate	VBP	advcl	O
potential	JJ	amod	O
phosphorylation	NN	compound	O
sites	NNS	dobj	O
and	CC	cc	O
may	MD	aux	O
affect	VB	conj	O
the	DT	det	O
tertiary	JJ	amod	O
structure	NN	dobj	O
of	IN	case	O
mature	JJ	amod	O
protein	NN	compound	O
complexes	NNS	nmod	O
.	.	punct	O

Runx2	NN	nsubj	O
and	CC	cc	O
MYC	NN	conj	O
collaborate	NN	ROOT	O
in	IN	case	O
lymphoma	NN	compound	O
development	NN	nmod	O
by	IN	mark	O
suppressing	VBG	advcl	O
apoptotic	JJ	amod	O
and	CC	cc	O
growth	NN	conj	O
arrest	NN	compound	O
pathways	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
/	:	punct	O
bcl	NN	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
cooperates	VBZ	ROOT	O
with	IN	case	O
myc	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
generation	NN	nmod	O
of	IN	case	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
in	IN	case	O
transgenic	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

In	IN	case	O
T	NN	compound	O
-	HYPH	punct	O
cell	NN	compound	O
ALL	NN	nmod	O
with	IN	case	O
t	NN	compound	O
(	-LRB-	punct	O
10	CD	dep	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	nmod	O
,	,	punct	O
the	DT	det	O
HOX	NN	compound	O
11	CD	nummod	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
deregulated	VBN	ROOT	O
.	.	punct	O
The	DT	det	O
chromosomal	JJ	amod	B-Cellular_component
translocation	NN	compound	O
t	NN	nsubjpass	O
(	-LRB-	punct	O
11	CD	nummod	O
:	:	punct	O
14	CD	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
human	JJ	amod	B-Organism
lymphoid	JJ	amod	B-Pathological_formation
neoplasia	NN	nmod	I-Pathological_formation
affecting	VBG	acl	O
centrocytic	JJ	amod	B-Cell
B	NN	compound	I-Cell
-	:	punct	I-Cell
cells	NNS	dobj	I-Cell
of	IN	case	O
intermediate	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

E	NNP	compound	O
mu	NNP	compound	O
-	HYPH	punct	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	O
-	HYPH	punct	O
B	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	O
cells	NNS	dep	O
.	.	punct	O
As	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
the	DT	det	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	LS	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
juxtaposed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
heavy	JJ	amod	I-Gene_or_gene_product
chain	NN	compound	I-Gene_or_gene_product
enhancer	NN	compound	I-Gene_or_gene_product
E	NN	compound	I-Gene_or_gene_product
mu	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

E	NNP	compound	O
mu	NNP	compound	O
-	HYPH	punct	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	O
-	HYPH	punct	O
B	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	O
cells	NNS	dep	O
.	.	punct	O
To	TO	mark	O
show	VB	ROOT	O
that	IN	mark	O
transcriptional	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	nmod	I-Gene_or_gene_product
is	VBZ	auxpass	O
causally	RB	advmod	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
generation	NN	nmod	O
of	IN	case	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
neoplasia	NN	nmod	I-Cancer
we	PRP	nsubj	O
have	VBP	aux	O
generated	VBN	ccomp	O
transgenic	JJ	amod	B-Organism
mice	NNS	dobj	I-Organism
that	WDT	nsubj	O
carry	VBP	acl:relcl	O
a	DT	det	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
gene	NN	dobj	O
under	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
E	NN	compound	B-Gene_or_gene_product
mu	NN	compound	I-Gene_or_gene_product
element	NN	nmod	O
.	.	punct	O

E	NNP	compound	O
mu	NNP	compound	O
-	HYPH	punct	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	O
-	HYPH	punct	O
B	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	O
cells	NNS	dep	O
.	.	punct	O
E	NN	compound	B-Gene_or_gene_product
mu	NN	compound	I-Gene_or_gene_product
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nsubj	O
show	VBP	ROOT	O
only	RB	advmod	O
very	RB	advmod	O
subtle	JJ	amod	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
cycling	VBG	amod	O
behaviour	NN	nmod	O
of	IN	case	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
populations	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
compared	VBN	case	O
with	IN	case	O
normal	JJ	amod	O
mice	NNS	nmod	B-Organism
and	CC	cc	O
do	VBP	aux	O
not	RB	neg	O
develop	VB	conj	O
lymphoid	JJ	amod	B-Cancer
tumours	NNS	dobj	I-Cancer
.	.	punct	O

E	NNP	compound	O
mu	NNP	compound	O
-	HYPH	punct	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	O
-	HYPH	punct	O
B	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	O
cells	NNS	dep	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
E	NNP	nmod:npmod	B-Gene_or_gene_product
mu	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
directed	VBN	amod	O
coexpression	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
N	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
MYC	NNP	compound	I-Gene_or_gene_product
or	CC	cc	O
L	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
MYC	NNP	conj	I-Gene_or_gene_product
in	IN	case	O
double	JJ	amod	O
transgenic	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
reveals	VBZ	ROOT	O
a	DT	det	O
strong	JJ	amod	O
cooperative	JJ	amod	O
effect	NN	dobj	O
between	IN	case	O
MYC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	conj	I-Gene_or_gene_product
provoking	VBG	acl	O
the	DT	det	O
rapid	JJ	amod	O
development	NN	dobj	O
of	IN	case	O
clonal	JJ	amod	O
pre	JJ	compound	B-Cancer
-	HYPH	punct	I-Cancer
B	NN	compound	I-Cancer
and	CC	cc	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphomas	NNS	nmod	I-Cancer
.	.	punct	O

E	NNP	compound	O
mu	NNP	compound	O
-	HYPH	punct	O
bcl	NN	compound	O
-	SYM	punct	O
2	CD	nummod	O
transgene	NN	nsubj	O
facilitates	VBZ	ROOT	O
spontaneous	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
pre	JJ	compound	O
-	HYPH	punct	O
B	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
-	HYPH	punct	O
secreting	NN	compound	O
cells	NNS	conj	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	O
cells	NNS	dep	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
crossing	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	compound	I-Gene_or_gene_product
transgenic	JJ	amod	O
mice	NNS	nmod	O
with	IN	case	O
E	NN	compound	B-Gene_or_gene_product
mu	NN	compound	I-Gene_or_gene_product
L	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
transgenics	NNS	nmod	O
that	WDT	nsubj	O
express	VBP	acl:relcl	O
their	PRP$	nmod:poss	O
transgene	NN	dobj	O
in	IN	case	O
both	DT	cc:preconj	O
B	NN	compound	B-Cell
-	:	punct	I-Cell
and	CC	cc	O
T	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cells	NNS	nmod	I-Cell
but	CC	cc	O
predominantly	RB	advmod	O
develop	VBP	conj	O
T	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
tumours	NNS	nsubj	I-Cancer
leads	VBZ	ROOT	O
in	IN	prep	O
double	JJ	amod	O
transgenics	NNS	pobj	B-Organism
exclusively	RB	advmod	O
to	IN	prep	O
B	NN	compound	B-Cell
-	HYPH	punct	I-Cell
cell	NN	compound	I-Cell
neoplasia	NN	pobj	I-Cell
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
kinase	NN	nmod	O
is	VBZ	cop	O
one	CD	nummod	O
mechanism	NN	ccomp	O
by	IN	case	O
which	WDT	nmod	O
oncogenes	NNS	nsubj	O
transform	VBP	acl:relcl	O
cells	NNS	dobj	O
.	.	punct	O
The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
here	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
transcriptional	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	nmod	I-Gene_or_gene_product
can	MD	aux	O
oncogenically	RB	advmod	O
transform	VB	ccomp	O
B	NN	compound	B-Cell
-	:	punct	I-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
concert	NN	dep	O
with	IN	case	O
a	DT	det	O
myc	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Disturbances	NNS	nsubj	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
proteins	NNS	nmod	O
take	VBP	ROOT	O
part	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
many	JJ	amod	O
human	JJ	amod	O
malignancies	NNS	nmod	O
.	.	punct	O
They	PRP	nsubj	O
establish	VBP	ROOT	O
cyclin	NN	compound	B-Gene_or_gene_product
D1	NN	dobj	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nmod	O
whose	WP$	nmod:poss	O
activity	NN	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
depend	VB	xcomp	O
on	IN	case	O
a	DT	det	O
specific	JJ	amod	O
cell	NN	compound	B-Cell
type	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
on	IN	case	O
a	DT	det	O
specific	JJ	amod	O
cooperating	VBG	amod	O
partner	NN	conj	O
and	CC	cc	O
link	NN	conj	O
disturbances	NNS	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	nmod	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nsubjpass	O
which	WDT	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
transformed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
activated	VBN	amod	O
Ha	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
gene	NN	nmod	O
from	IN	case	O
human	JJ	amod	O
EJ	NN	compound	O
bladder	NN	compound	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
were	VBD	auxpass	O
fused	VBN	ROOT	O
with	IN	case	O
diploid	JJ	amod	O
embryonic	JJ	amod	O
rat	NN	compound	O
fibroblasts	NNS	nmod	O
.	.	punct	O
Elevated	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
junB	NN	compound	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogene	NN	nmod	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod:npmod	I-Gene_or_gene_product
induced	VBD	amod	O
transformation	NN	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Suppression	NN	ROOT	O
and	CC	cc	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	conj	O
of	IN	case	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
in	IN	case	O
hybrids	NNS	nmod	O
of	IN	case	O
HA	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
transformed	VBN	amod	O
rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nmod	O
and	CC	cc	O
early	JJ	amod	O
-	HYPH	punct	O
passage	NN	conj	O
rat	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	conj	O
.	.	punct	O
We	PRP	nsubj	O
previously	RB	advmod	O
described	VBD	ROOT	O
the	DT	det	O
isolation	NN	dobj	O
of	IN	case	O
non	JJ	advmod	O
-	HYPH	punct	O
tumorigenic	JJ	amod	O
revertants	NNS	nmod	O
from	IN	case	O
mutagenized	VBN	amod	O
populations	NNS	nmod	O
of	IN	case	O
v	CD	nummod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
Zarbl	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
1987	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
kinase	NN	nmod	O
is	VBZ	cop	O
one	CD	nummod	O
mechanism	NN	ccomp	O
by	IN	case	O
which	WDT	nmod	O
oncogenes	NNS	nsubj	O
transform	VBP	acl:relcl	O
cells	NNS	dobj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
the	DT	det	O
revertant	JJ	amod	B-Cell
phenotype	NN	nsubj	O
resulted	VBD	ccomp	O
from	IN	case	O
mutations	NNS	nmod	O
that	WDT	nsubj	O
altered	VBD	acl:relcl	O
the	DT	det	O
expression	NN	dobj	O
or	CC	cc	O
activities	NNS	conj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
or	CC	cc	O
junB	NN	conj	B-Gene_or_gene_product
proto	NN	compound	O
-	:	punct	O
oncogenes	NNS	nmod	O
.	.	punct	O

Transformants	NNS	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	O
-	HYPH	punct	O
azacytidine	NN	pobj	O
lost	VBD	ROOT	O
c	NN	nmod:npmod	O
-	HYPH	punct	O
myc	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
levels	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	cop	O
unchanged	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
revertants	NNS	nmod	B-Cell
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
transformed	VBN	amod	O
parental	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
and	CC	cc	O
ectopic	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	nmod	I-Gene_or_gene_product
failed	VBD	conj	O
to	TO	aux	O
retransform	VB	xcomp	O
the	DT	det	O
revertants	NNS	dobj	B-Cell
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
SWAP	NNP	nmod	O
-	:	punct	O
70	CD	dep	O
in	IN	case	O
oncogenic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
mouse	NN	compound	O
embryo	NN	compound	O
fibroblasts	NNS	nmod	O
(	-LRB-	punct	O
MEFs	NNS	appos	O
)	-RRB-	punct	O
by	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
Src	NNP	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
use	NN	nmod	O
of	IN	case	O
MEFs	NNS	nmod	O
defective	JJ	amod	O
in	IN	case	O
SWAP	NNP	compound	O
-	:	punct	O
70	CD	nmod	O
.	.	punct	O
Although	IN	mark	O
one	CD	nummod	O
mutant	JJ	amod	O
allele	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	advcl	O
in	IN	case	O
revertant	JJ	amod	B-Cell
EMS	NN	nmod	I-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
-	SYM	punct	I-Cell
19	CD	dep	I-Cell
,	,	punct	O
overexpression	NN	appos	O
of	IN	case	O
this	DT	det	O
mutant	JJ	amod	O
allele	NN	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	nmod:npmod	I-Gene_or_gene_product
induced	VBD	amod	O
cell	NN	compound	B-Cell
transformation	NN	dobj	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
MnSO4	NN	nsubj	O
only	RB	advmod	O
induced	VBD	ROOT	O
transformation	NN	dobj	O
in	IN	case	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
cells	NNS	dobj	O
.	.	punct	O
Together	RB	advmod	O
these	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
revertant	JJ	amod	B-Cell
phenotype	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
result	VB	ccomp	O
from	IN	case	O
altered	JJ	amod	O
expression	NN	nmod	O
or	CC	cc	O
mutations	NNS	conj	O
in	IN	case	O
the	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
.	.	punct	O

Protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
levels	NNS	nsubj	O
in	IN	case	O
several	JJ	amod	O
transformed	VBN	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
were	VBD	cop	O
subject	JJ	ROOT	O
to	TO	mark	O
down	JJ	advcl	O
modulation	NN	dobj	O
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
growth	NN	compound	O
state	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O
In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
results	NNS	nmod	O
obtained	VBN	acl	O
with	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
jun	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
junB	NN	compound	B-Gene_or_gene_product
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
reduced	VBN	xcomp	O
two	CD	nummod	O
-	HYPH	punct	O
or	CC	cc	O
threefold	RB	conj	O
in	IN	case	O
revertant	JJ	amod	B-Cell
EMS	NN	compound	I-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
-	SYM	punct	I-Cell
19	CD	dobj	I-Cell
.	.	punct	O

Suppression	NN	ROOT	O
and	CC	cc	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	conj	O
of	IN	case	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
in	IN	case	O
hybrids	NNS	nmod	O
of	IN	case	O
HA	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
transformed	VBN	amod	O
rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nmod	O
and	CC	cc	O
early	JJ	amod	O
-	HYPH	punct	O
passage	NN	conj	O
rat	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	conj	O
.	.	punct	O
Ectopic	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
junB	NN	compound	B-Gene_or_gene_product
induced	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
revertant	JJ	amod	O
EMS	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
-	SYM	punct	I-Cell
19	CD	dep	I-Cell
,	,	punct	O
but	CC	cc	O
failed	VBD	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
v	NN	compound	O
-	HYPH	punct	O
erbA	NN	nsubj	O
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
inducing	VBG	advcl	O
an	DT	det	O
erythroleukemia	NN	dobj	O
when	WRB	advmod	O
expressed	VBN	advcl	O
by	IN	case	O
a	DT	det	O
high	JJ	amod	O
titer	NN	compound	O
bicistronic	JJ	amod	O
retrovirus	NN	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
virus	NN	compound	O
spreading	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
its	PRP$	nmod:poss	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
transforming	VBG	amod	O
potential	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
enhanced	VBN	conj	O
by	IN	case	O
v	NN	compound	O
-	HYPH	punct	O
myb	VBN	nmod	O
.	.	punct	O
Moreover	RB	advmod	O
,	,	punct	O
about	RB	advmod	O
10	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	compound	I-Gene_or_gene_product
transformed	JJ	amod	O
cells	NNS	nmod	B-Cell
transfected	VBN	acl	O
with	IN	case	O
vectors	NNS	nmod	O
that	WDT	nsubj	O
express	VBP	acl:relcl	O
antisense	JJ	amod	O
junB	NN	compound	B-Gene_or_gene_product
mRNA	NN	dobj	O
acquired	VBD	ROOT	O
a	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
.	.	punct	O

DNA	NN	nsubj	O
of	IN	case	O
the	DT	det	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	amod	O
cell	NN	compound	O
hybrids	NNS	nmod	O
transformed	VBD	ROOT	O
Rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	dobj	O
to	TO	mark	O
anchorage	VB	xcomp	O
-	HYPH	punct	O
independent	JJ	amod	O
proliferation	NN	dobj	O
as	IN	mark	O
expected	VBN	advcl	O
for	IN	case	O
the	DT	det	O
transforming	VBG	amod	O
human	JJ	amod	O
Ha	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
gene	NN	nmod	O
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
donor	NN	amod	O
DNA	NN	nmod	O
.	.	punct	O
Together	RB	advmod	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
junB	NN	nmod	B-Gene_or_gene_product
above	IN	case	O
a	DT	det	O
threshold	NN	compound	O
level	NN	nmod	O
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
v	CD	det	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
fos	NN	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
transformation	NN	nmod	O
of	IN	case	O
Rat	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
fibroblasts	NNS	nmod	I-Cell
.	.	punct	O

[	-LRB-	ROOT	O
Autologous	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
stem	NN	compound	O
cell	NN	intj	O
or	CC	cc	O
peripheral	JJ	amod	O
blood	NN	compound	O
endothelial	JJ	amod	O
progenitor	NN	compound	O
cell	NN	compound	O
therapy	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
peripheral	JJ	amod	O
limb	NN	compound	O
ischaemia	NN	nmod	O
]	-RRB-	punct	O
[	-LRB-	punct	O
Treatment	NN	ROOT	O
of	IN	case	O
the	DT	det	O
diabetic	JJ	amod	O
foot	NN	nmod	B-Organism_subdivision
by	IN	case	O
hyperbaric	JJ	amod	B-Simple_chemical
oxygen	NN	nmod	I-Simple_chemical
]	-RRB-	punct	O

Because	IN	mark	O
poor	JJ	amod	O
skin	NN	compound	O
wound	NN	compound	O
healing	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
diabetes	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	xcomp	O
from	IN	case	O
impaired	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
treatments	NNS	nsubj	O
that	WDT	nsubj	O
improve	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
could	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
clinical	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O
Diabetic	JJ	amod	O
foot	NN	compound	B-Pathological_formation
wounds	NNS	nsubj	I-Pathological_formation
are	VBP	ROOT	O
consequences	NNS	attr	O
of	IN	prep	O
the	DT	det	O
neuropathy	NN	pobj	O
and	CC	cc	O
the	DT	det	O
small	JJ	amod	O
and	CC	cc	O
large	JJ	conj	O
vessel	NN	compound	B-Multi-tissue_structure
disease	NN	conj	O
that	WDT	nsubj	O
complicate	NN	acl:relcl	O
diabetes	NNS	dobj	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
ethanol	NN	compound	O
exposure	NN	nsubj	O
caused	VBD	ROOT	O
both	CC	cc:preconj	O
decreased	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
hypoxia	NN	conj	O
in	IN	case	O
wounds	NNS	nmod	O
.	.	punct	O
At	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
level	NN	nmod	O
,	,	punct	O
the	DT	det	O
result	NN	nsubj	O
is	VBZ	cop	O
hypoxia	NN	ROOT	O
which	WDT	nsubj	O
impairs	VBZ	acl:relcl	O
wound	NN	compound	B-Pathological_formation
healing	NN	dobj	O
.	.	punct	O

Chronic	JJ	amod	O
wounds	NNS	nsubj	O
are	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
secondary	JJ	amod	O
complication	NN	attr	O
for	IN	prep	O
many	JJ	amod	O
people	NNS	pobj	O
with	IN	prep	O
impaired	JJ	amod	O
mobility	NN	pobj	O
.	.	punct	O
Hyperbaric	JJ	amod	O
oxygenation	NN	nsubj	O
(	-LRB-	punct	O
HBO	NN	appos	O
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
adjuvant	NN	ROOT	O
to	TO	aux	O
wound	VB	acl	B-Pathological_formation
care	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
Oxygent	JJ	nsubj	O
increases	VBZ	ccomp	O
TET	NN	compound	O
epithelial	JJ	amod	O
PtO	NN	dobj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
improves	VBZ	ccomp	O
epithelial	JJ	amod	O
metabolism	NN	dobj	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
impair	VB	conj	O
angiogenesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
tends	VBZ	conj	O
to	TO	case	O
slow	VB	amod	O
cartilage	NN	compound	O
tissue	NN	compound	O
formation	NN	nmod	O
.	.	punct	O
It	PRP	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
enhanced	VBN	amod	O
oxygenation	NN	nmod	O
of	IN	case	O
the	DT	det	O
affected	VBN	amod	O
tissues	NNS	nmod	B-Tissue
,	,	punct	O
has	VBZ	conj	O
an	DT	det	O
antiseptic	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
reduces	VBZ	conj	O
edema	NN	dobj	B-Pathological_formation
,	,	punct	O
and	CC	cc	O
accelerates	VBZ	conj	O
collagen	NN	compound	B-Gene_or_gene_product
production	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
,	,	punct	O
thus	RB	advmod	O
enhancing	VBG	advcl	O
tissue	NN	compound	B-Tissue
repair	NN	dobj	O
.	.	punct	O

Because	IN	mark	O
poor	JJ	amod	O
skin	NN	compound	O
wound	NN	compound	O
healing	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
diabetes	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	xcomp	O
from	IN	case	O
impaired	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
treatments	NNS	nsubj	O
that	WDT	nsubj	O
improve	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
could	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
clinical	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O
14	CD	nummod	O
diabetics	NNS	nsubjpass	O
with	IN	case	O
chronic	JJ	amod	B-Pathological_formation
nonhealing	NN	compound	I-Pathological_formation
wounds	NNS	nmod	I-Pathological_formation
which	WDT	nsubj	O
did	VBD	aux	O
not	RB	neg	O
respond	VB	acl:relcl	O
to	TO	case	O
treatment	NN	nmod	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
3	CD	nummod	O
months	NNS	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
by	IN	case	O
HBO	NNP	nmod	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	O
(	-LRB-	punct	O
14	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
regained	VBD	ROOT	O
2	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
lines	NNS	dobj	O
of	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
.	.	punct	O
All	DT	nsubj	O
had	VBD	ROOT	O
palpable	JJ	amod	O
pedal	JJ	compound	O
pulses	NNS	dobj	O
.	.	punct	O

Partial	JJ	amod	O
tissue	NN	compound	O
oxygen	NN	compound	O
tension	NN	nsubjpass	O
(	-LRB-	punct	O
PtO	NN	appos	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
with	IN	case	O
polarographic	JJ	amod	O
microprobes	NNS	nmod	O
;	:	punct	O
epithelial	JJ	amod	O
metabolism	NN	nsubjpass	O
was	VBD	auxpass	O
monitored	VBN	conj	O
by	IN	case	O
microdialysis	NN	nmod	O
inside	IN	case	O
the	DT	det	O
TET	NN	compound	O
epithelium	NN	nmod	O
perfused	VBN	acl	O
with	IN	case	O
the	DT	det	O
medium	NN	compound	O
underneath	NN	nmod	O
.	.	punct	O
Transcutaneous	JJ	amod	O
measurements	NNS	nsubj	O
of	IN	case	O
tissue	NN	compound	B-Tissue
pO2	NN	nmod	O
showed	VBD	ROOT	O
elevation	NN	dobj	O
from	IN	case	O
20	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
10	CD	dep	O
mm	NN	dep	O
Hg	NN	nmod	O
during	IN	case	O
air	NN	compound	O
breathing	NN	pobj	O
to	IN	case	O
643	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
242	CD	nummod	O
mm	NN	compound	O
Hg	NNP	dobj	O
while	IN	mark	O
breathing	VBG	advcl	O
pure	JJ	amod	O
oxygen	NN	dobj	B-Simple_chemical
at	IN	case	O
2	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
ATA	NN	ROOT	O
.	.	punct	O

Six	CD	nummod	O
edentulous	JJ	amod	O
patients	NNS	ROOT	O
(	-LRB-	punct	O
aged	JJ	dep	O
60	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
9	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
severely	RB	advmod	O
atrophic	JJ	amod	O
mandible	NN	amod	O
underwent	VBD	amod	O
bone	NN	compound	O
augmentation	NN	conj	O
with	IN	case	O
distraction	NN	compound	O
osteogenesis	NN	nmod	O
.	.	punct	O
They	PRP	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
HBO	NNP	nmod	O
in	IN	prep	O
56	CD	pobj	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
10	CD	nummod	O
consecutive	JJ	amod	O
HBO	NNP	compound	O
sessions	NNS	pobj	O
.	.	punct	O

All	DT	det	O
wounds	NNS	nsubj	O
were	VBD	auxpass	O
fully	RB	advmod	O
re	NN	advmod	O
-	HYPH	punct	O
epithelialized	VBN	ROOT	O
by	IN	agent	O
10	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
.	.	punct	O
In	IN	prep	O
11	CD	pobj	O
there	EX	expl	O
was	VBD	ROOT	O
complete	JJ	amod	O
wound	NN	compound	B-Pathological_formation
healing	NN	attr	O
,	,	punct	O
while	IN	mark	O
in	IN	prep	O
1	CD	pobj	O
there	EX	expl	O
was	VBD	advcl	O
partial	JJ	amod	O
response	NN	nsubj	O
,	,	punct	O
in	IN	case	O
1	CD	nummod	O
minimal	JJ	amod	O
response	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
1	CD	nummod	O
a	DT	det	O
transient	JJ	amod	O
response	NN	conj	O
.	.	punct	O

For	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
limb	NN	compound	O
threatening	VBG	compound	O
ischaemia	NN	nmod	O
the	DT	det	O
only	JJ	amod	O
option	NN	nsubj	O
for	IN	prep	O
relief	NN	pobj	O
of	IN	prep	O
rest	NN	compound	O
pain	NN	pobj	O
or	CC	cc	O
gangraena	NN	conj	O
is	VBZ	ROOT	O
amputation	NN	attr	O
.	.	punct	O
HBO	NNP	nsubj	O
is	VBZ	cop	O
useful	JJ	ROOT	O
in	IN	case	O
chronic	JJ	amod	B-Pathological_formation
nonhealing	NN	amod	I-Pathological_formation
wounds	NNS	nmod	I-Pathological_formation
of	IN	case	O
the	DT	det	O
diabetic	JJ	amod	O
foot	NN	nmod	B-Organism_subdivision
and	CC	cc	O
of	IN	case	O
the	DT	det	O
diabetic	JJ	amod	O
foot	NN	conj	B-Organism_subdivision
with	IN	prep	O
impending	VBG	pcomp	O
amputation	NN	dobj	O
.	.	punct	O

Because	IN	mark	O
poor	JJ	amod	O
skin	NN	compound	O
wound	NN	compound	O
healing	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
diabetes	NNS	nmod	O
is	VBZ	auxpass	O
thought	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	xcomp	O
from	IN	case	O
impaired	JJ	amod	O
angiogenesis	NN	nmod	O
,	,	punct	O
treatments	NNS	nsubj	O
that	WDT	nsubj	O
improve	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
could	MD	aux	O
have	VB	ROOT	O
important	JJ	amod	O
clinical	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O
It	PRP	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
safe	JJ	amod	O
mode	NN	attr	O
of	IN	case	O
therapy	NN	nmod	O
,	,	punct	O
but	CC	cc	O
further	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
required	VBN	conj	O
to	TO	aux	O
establish	VB	xcomp	O
its	PRP$	nmod:poss	O
efficacy	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
ascertain	VB	conj	O
which	WDT	mark	O
diabetic	JJ	amod	O
patients	NNS	nsubj	B-Organism
and	CC	cc	O
wounds	NNS	conj	B-Pathological_formation
will	MD	aux	O
benefit	VB	ccomp	O
the	DT	det	O
most	JJS	dobj	O
from	IN	prep	O
it	PRP	pobj	O
.	.	punct	O

Transformants	NNS	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	O
-	HYPH	punct	O
azacytidine	NN	pobj	O
lost	VBD	ROOT	O
c	NN	nmod:npmod	O
-	HYPH	punct	O
myc	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
Appearance	NN	ROOT	O
of	IN	case	O
tumorous	JJ	amod	B-Cancer
phenotypes	NNS	nmod	O
in	IN	case	O
goldfish	JJ	amod	B-Organism
erythrophores	NNS	nmod	B-Cell
transfected	VBN	acl	O
with	IN	case	O
ras	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
src	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
myc	NN	compound	B-Gene_or_gene_product
oncogenes	NNS	conj	O
and	CC	cc	O
spontaneous	JJ	amod	O
differentiation	NN	conj	O
of	IN	case	O
the	DT	det	O
transformants	NNS	nmod	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Normal	JJ	amod	O
cells	NNS	nsubj	O
contain	VBP	ROOT	O
suppressor	NN	compound	O
gene	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
which	WDT	nsubj	O
safeguard	VBP	acl:relcl	O
these	DT	det	O
cells	NNS	dobj	O
against	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
the	DT	det	O
product	NN	nmod	O
of	IN	case	O
the	DT	det	O
transforming	NN	amod	O
Ha	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	HYPH	punct	O
1	CD	nummod	O
oncogene	NN	nmod	O
.	.	punct	O
When	WRB	advmod	O
goldfish	JJ	amod	B-Organism
erythrophores	NNS	nsubjpass	B-Cell
isolated	VBN	acl	O
from	IN	prep	O
the	DT	det	O
skin	NN	pobj	B-Organ
by	IN	case	O
tissue	NN	compound	B-Tissue
digestion	NN	nmod	O
and	CC	cc	O
centrifugation	NN	conj	O
in	IN	case	O
a	DT	det	O
Percoll	NN	compound	O
density	NN	compound	O
gradient	NN	nmod	O
were	VBD	auxpass	O
transfected	VBN	advcl	O
in	IN	case	O
a	DT	det	O
monolayer	JJ	compound	B-Cell
-	HYPH	punct	O
culture	NN	nmod	O
with	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ha	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
v	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
src	NN	compound	I-Gene_or_gene_product
oncogene	NN	conj	O
either	CC	cc:preconj	O
singly	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
v	CD	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
calcium	NN	compound	B-Simple_chemical
phosphate	NN	compound	I-Simple_chemical
-	HYPH	punct	O
DNA	NNP	compound	B-Cellular_component
co	NN	compound	O
-	HYPH	punct	O
precipitation	NN	nmod	O
,	,	punct	O
there	EX	expl	O
appeared	VBD	ROOT	O
a	DT	det	O
certain	JJ	amod	O
number	NN	dobj	O
of	IN	case	O
transformants	NNS	nmod	B-Cell
manifesting	VBG	acl	O
a	DT	det	O
chromatoblast	NN	amod	B-Cell
-	HYPH	punct	O
like	JJ	amod	O
profile	NN	dobj	O
and	CC	cc	O
tumorous	JJ	amod	B-Cancer
phenotypes	NNS	conj	O
as	IN	mark	O
seen	VBN	advcl	O
in	IN	case	O
the	DT	det	O
capability	NN	nmod	O
for	IN	case	O
unlimited	JJ	amod	O
growth	NN	nmod	O
,	,	punct	O
and	CC	cc	O
piling	VBG	conj	O
-	HYPH	punct	O
up	RP	prt	O
in	IN	prep	O
a	DT	det	O
monolayer	JJ	compound	B-Cell
-	HYPH	punct	O
culture	NN	pobj	O
or	CC	cc	O
colony	NN	compound	B-Cell
formation	NN	conj	O
in	IN	prep	O
semi	NN	npadvmod	O
-	HYPH	punct	O
solid	JJ	amod	O
soft	JJ	amod	O
agar	NN	pobj	O
.	.	punct	O

The	DT	det	O
remaining	VBG	amod	O
SVLT	NN	compound	O
mutants	NNS	nsubj	O
presented	VBD	ROOT	O
different	JJ	amod	O
degrees	NNS	dobj	O
of	IN	case	O
ability	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
differentiation	NN	dobj	O
(	-LRB-	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
markers	NNS	nmod	O
in	IN	case	O
transformants	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O
After	IN	case	O
successive	JJ	amod	O
growth	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
for	IN	case	O
longer	JJR	advmod	O
than	IN	quantmod	O
one	CD	nummod	O
month	NN	nmod	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
scarcely	RB	advmod	O
observed	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
erythrophores	NNS	nmod	B-Cell
,	,	punct	O
the	DT	det	O
vast	JJ	amod	O
majority	NN	nsubj	O
of	IN	prep	O
such	JJ	amod	O
transformants	NNS	pobj	B-Cell
began	VBD	ROOT	O
to	TO	mark	O
differentiate	VB	xcomp	O
into	IN	case	O
erythrophores	NNS	nmod	B-Cell
and	CC	cc	O
ceased	VBN	conj	O
proliferation	NN	dobj	O
spontaneously	RB	advmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
The	DT	det	O
onset	NN	nsubjpass	O
of	IN	case	O
their	PRP$	nmod:poss	O
differentiation	NN	nmod	O
was	VBD	auxpass	O
ascertained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
deposition	NN	nmod	O
of	IN	case	O
marker	NN	compound	O
pteridine	NN	compound	B-Simple_chemical
pigments	NNS	nmod	O
.	.	punct	O

The	DT	det	O
remaining	VBG	amod	O
SVLT	NN	compound	O
mutants	NNS	nsubj	O
presented	VBD	ROOT	O
different	JJ	amod	O
degrees	NNS	dobj	O
of	IN	case	O
ability	NN	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
differentiation	NN	dobj	O
(	-LRB-	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
markers	NNS	nmod	O
in	IN	case	O
transformants	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O
None	NN	ROOT	O
of	IN	prep	O
the	DT	det	O
transformants	NNS	pobj	B-Cell
differentiated	VBN	acl	O
into	IN	prep	O
melanophores	NNS	pobj	B-Cell
or	CC	cc	O
iridophores	NNS	conj	B-Cell
or	CC	cc	O
other	JJ	amod	O
neural	JJ	amod	B-Tissue
crest	NN	compound	I-Tissue
derivatives	NNS	conj	O
as	IN	mark	O
seen	VBN	advcl	O
in	IN	case	O
goldfish	JJ	amod	B-Organism
erythrophoroma	NN	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
detected	VBN	ROOT	O
transforming	NN	amod	O
activity	NN	dobj	O
by	IN	case	O
a	DT	det	O
tumorigenicity	NN	compound	O
assay	NN	nmod	O
using	VBG	acl	O
NIH3T3	NN	compound	O
cells	NNS	dobj	O
transfected	VBN	acl	O
with	IN	case	O
DNA	NN	nmod	O
from	IN	case	O
a	DT	det	O
chronic	JJ	amod	O
myeloproliferative	JJ	amod	O
disorder	NN	compound	O
patient	NN	nmod	O
.	.	punct	O
Little	JJ	amod	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
their	PRP$	nmod:poss	O
transforming	VBG	amod	O
efficiency	NN	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
.	.	punct	O
2	CD	nummod	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
3	CD	nummod	O
transformants	NNS	nsubj	B-Cell
/	SYM	punct	O
micrograms	NNS	compound	O
DNA	NN	appos	B-Cellular_component
)	-RRB-	punct	O
between	IN	case	O
the	DT	det	O
combinations	NNS	nmod	O
of	IN	case	O
oncogenes	NNS	nmod	O
applied	VBD	ROOT	O
but	CC	cc	O
a	DT	det	O
tendency	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	conj	O
that	IN	mark	O
cells	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
ras	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
src	NN	conj	B-Gene_or_gene_product
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
myc	NN	nmod	B-Gene_or_gene_product
developed	VBD	ccomp	O
the	DT	det	O
capacity	NN	dobj	O
to	TO	aux	O
grow	VB	acl	O
for	IN	prep	O
a	DT	det	O
longer	JJR	amod	O
period	NN	pobj	O
and	CC	cc	O
differentiated	VBD	conj	O
at	IN	case	O
a	DT	det	O
later	JJ	amod	O
stage	NN	nmod	O
than	IN	case	O
those	DT	nmod	O
transfected	VBN	acl	O
solely	RB	advmod	O
with	IN	case	O
ras	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
src	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Cells	NNS	nsubjpass	O
stably	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
Src	NN	compound	O
oncogene	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
STAT	NN	compound	O
protein	NN	compound	O
activation	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
cell	NN	compound	B-Cell
line	NN	nsubj	I-Cell
(	-LRB-	punct	O
ESM	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	appos	I-Cell
)	-RRB-	punct	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
erythrophores	NNS	nmod	B-Cell
transfected	VBN	acl	O
with	IN	case	O
src	NN	nmod	B-Gene_or_gene_product
/	SYM	punct	O
myc	NN	nsubj	B-Gene_or_gene_product
grew	VBD	ROOT	O
successively	RB	advmod	O
over	IN	prep	O
nine	CD	nummod	O
months	NNS	pobj	O
,	,	punct	O
indicating	VBG	advcl	O
its	PRP$	poss	O
acquisition	NN	dobj	O
of	IN	case	O
immortality	NN	nmod	O
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	det	O
issue	NN	dobj	O
,	,	punct	O
an	DT	det	O
activated	VBN	amod	O
neu	NN	compound	O
oncogene	NN	nsubjpass	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
an	DT	det	O
immortalized	VBN	amod	O
nontumorigenic	JJ	amod	O
human	JJ	amod	O
breast	NN	compound	O
epithelial	JJ	amod	O
cell	NN	compound	O
line	NN	nmod	O
(	-LRB-	punct	O
184B5	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
transfected	VBN	amod	O
oncogenes	NNS	nmod	O
in	IN	case	O
this	DT	det	O
cell	NN	compound	B-Cell
line	NN	nmod	I-Cell
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
the	DT	det	O
erythrophoroma	NN	amod	B-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
Western	NN	nmod	O
and	CC	cc	O
Northern	NN	compound	O
blot	NN	compound	O
analyses	NNS	conj	O
.	.	punct	O

All	DT	det	O
markers	NNS	nsubj	O
for	IN	case	O
stimulated	VBN	amod	O
wounds	NNS	nmod	O
showed	VBD	ROOT	O
increased	VBN	amod	O
activity	NN	dobj	O
relative	JJ	case	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
stimulated	VBN	amod	O
control	NN	compound	O
wounds	NNS	nmod	O
between	IN	case	O
7	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
days	NNS	nmod	O
following	VBG	case	O
injury	NN	nmod	O
,	,	punct	O
with	IN	case	O
peak	NN	amod	O
activity	NN	nmod	O
at	IN	case	O
14	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O
Immune	JJ	amod	O
consequences	NNS	ROOT	O
of	IN	prep	O
burn	NN	compound	O
injury	NN	pobj	O
.	.	punct	O

TNF	NN	compound	O
-	HYPH	punct	O
alpha	NN	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
an	DT	det	O
essential	JJ	amod	O
component	NN	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
for	IN	case	O
protection	NN	nmod	O
from	IN	case	O
bacterial	JJ	amod	O
infection	NN	nmod	O
and	CC	cc	O
for	IN	case	O
immune	JJ	amod	O
cell	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
cytotoxicity	NN	conj	O
.	.	punct	O
The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	B-Anatomical_system
system	NN	nmod	I-Anatomical_system
is	VBZ	ROOT	O
to	TO	mark	O
protect	VB	xcomp	O
cells	NNS	dobj	B-Cell
from	IN	case	O
invasion	NN	nmod	O
by	IN	case	O
microorganisms	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
group	NN	nsubj	O
seeks	VBZ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
basic	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
ES	NN	compound	O
wound	NN	compound	O
therapy	NN	dobj	O
,	,	punct	O
an	DT	det	O
area	NN	appos	O
where	WRB	advmod	O
understanding	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
limited	JJ	acl:relcl	O
.	.	punct	O
The	DT	det	O
body	NN	nsubj	B-Organism_subdivision
has	VBZ	ROOT	O
three	CD	nummod	O
equally	RB	advmod	O
important	JJ	amod	O
interactive	JJ	amod	O
immune	JJ	amod	B-Anatomical_system
defense	NN	compound	I-Anatomical_system
systems	NNS	dobj	I-Anatomical_system
,	,	punct	O
all	DT	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	auxpass	O
profoundly	RB	advmod	O
disrupted	VBN	parataxis	O
with	IN	prep	O
major	JJ	amod	O
burn	NN	compound	O
injury	NN	pobj	O
.	.	punct	O

The	DT	det	O
pathophysiology	NN	nsubj	O
involves	VBZ	ROOT	O
inflammation	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O
The	DT	det	O
immune	JJ	amod	O
response	NN	nsubj	O
to	TO	mark	O
burn	VB	acl	O
injury	NN	dobj	O
is	VBZ	cop	O
immediate	JJ	ROOT	O
,	,	punct	O
prolonged	JJ	conj	O
,	,	punct	O
and	CC	cc	O
severe	JJ	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
group	NN	nsubj	O
seeks	VBZ	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
basic	JJ	amod	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
ES	NN	compound	O
wound	NN	compound	O
therapy	NN	dobj	O
,	,	punct	O
an	DT	det	O
area	NN	appos	O
where	WRB	advmod	O
understanding	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
limited	JJ	acl:relcl	O
.	.	punct	O
The	DT	det	O
end	NN	nsubj	O
result	NN	nsubj	O
in	IN	prep	O
individuals	NNS	compound	O
surviving	VBG	compound	O
burn	NN	compound	O
shock	NN	pobj	O
is	VBZ	cop	O
immunosuppression	NN	ROOT	O
,	,	punct	O
with	IN	case	O
increased	VBN	amod	O
susceptibility	NN	nmod	O
to	TO	case	O
potentially	RB	advmod	O
fatal	JJ	amod	O
systemic	JJ	amod	O
burn	NN	nmod	B-Pathological_formation
wound	NN	dep	I-Pathological_formation
or	CC	cc	O
pulmonary	JJ	amod	B-Organ
sepsis	NN	conj	O
.	.	punct	O

The	DT	det	O
therapeutic	JJ	amod	O
options	NNS	nsubj	O
available	JJ	amod	O
in	IN	case	O
this	DT	det	O
regard	NN	nmod	O
include	VBP	ROOT	O
measures	NNS	dobj	O
that	WDT	mark	O
:	:	punct	O
down	RB	advmod	O
-	HYPH	punct	O
regulate	VB	amod	O
serum	NN	compound	O
free	JJ	amod	O
IGF	NNP	compound	O
-	:	punct	O
I	PRP	nsubj	O
;	:	punct	O
suppress	VBP	ccomp	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
mevalonic	JJ	amod	O
acid	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
certain	JJ	amod	O
derivatives	NNS	conj	O
thereof	RB	advmod	O
;	:	punct	O
modulate	VB	conj	O
arachidonate	NN	compound	O
metabolism	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
5	CD	nummod	O
-	HYPH	punct	O
lipoxygenase	NN	dobj	O
,	,	punct	O
12	CD	nummod	O
-	HYPH	punct	O
lipoxygenase	NN	conj	O
,	,	punct	O
or	CC	cc	O
COX	NN	conj	O
-	:	punct	O
2	CD	nummod	O
;	:	punct	O
antagonize	VB	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
AP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
transcription	NN	compound	O
factors	NNS	nmod	O
;	:	punct	O
promote	VBP	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
PPAR	NN	compound	O
-	:	punct	O
gamma	NN	compound	O
transcription	NN	compound	O
factors	NNS	nmod	O
;	:	punct	O
and	CC	cc	O
that	IN	nsubj	O
suppress	VBP	conj	O
angiogenesis	NN	dobj	O
by	IN	case	O
additional	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O
Nursing	VBG	amod	O
actions	NNS	nsubj	O
to	TO	aux	O
support	VB	acl	O
the	DT	det	O
humoral	JJ	npadvmod	O
and	CC	cc	O
cell	NN	conj	B-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
immune	JJ	amod	B-Anatomical_system
system	NN	dobj	I-Anatomical_system
of	IN	case	O
the	DT	det	O
burned	VBN	amod	O
patient	NN	nmod	B-Organism
include	VBP	ROOT	O
providing	VBG	xcomp	O
nutritional	JJ	amod	O
support	NN	dobj	O
to	TO	mark	O
maintain	VB	acl	O
serum	NN	compound	B-Organism_substance
protein	NN	compound	O
levels	NNS	dobj	O
at	IN	case	O
optimal	JJ	amod	O
levels	NNS	nmod	O
;	:	punct	O
measures	NNS	dep	O
to	TO	mark	O
decrease	VB	xcomp	O
edema	NN	dobj	B-Pathological_formation
and	CC	cc	O
promote	VB	conj	O
angiogenesis	NN	dobj	O
in	IN	prep	O
areas	NNS	pobj	O
of	IN	prep	O
partial	JJ	amod	O
-	HYPH	punct	O
thickness	NN	compound	O
injury	NN	pobj	O
;	:	punct	O
meticulous	JJ	amod	O
treatment	NN	dobj	O
of	IN	case	O
the	DT	det	O
wound	NN	nmod	B-Pathological_formation
to	TO	mark	O
prevent	VB	acl	O
infection	NN	dobj	O
and	CC	cc	O
promote	VB	conj	O
healing	NN	dobj	O
;	:	punct	O
monitoring	NN	dep	O
of	IN	case	O
antibiotic	JJ	amod	O
use	NN	nmod	O
;	:	punct	O
conservative	JJ	amod	O
use	NN	dep	O
of	IN	case	O
invasive	JJ	amod	O
techniques	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
intubation	NN	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
access	NN	compound	O
devices	NNS	conj	O
;	:	punct	O
maintenance	NN	dep	O
of	IN	case	O
fluid	NN	nmod	B-Organism_substance
and	CC	cc	O
electrolyte	NN	conj	O
balance	NN	dep	O
and	CC	cc	O
body	NN	compound	B-Organism_subdivision
temperature	NN	conj	O
;	:	punct	O
and	CC	cc	O
energy	NN	compound	O
conservation	NN	compound	O
measures	NNS	conj	O
.	.	punct	O

Reciprocal	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
transplants	NNS	nsubj	O
that	WDT	nsubj	O
involved	VBD	acl:relcl	O
both	CC	cc:preconj	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
and	CC	cc	O
PECAM	NN	nmod:npmod	O
-	:	punct	O
1	CD	npadvmod	O
-	HYPH	punct	O
deficient	JJ	conj	O
mice	NNS	dobj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
impaired	JJ	amod	O
angiogenic	JJ	amod	O
response	NN	nsubj	O
resulted	VBD	ccomp	O
from	IN	case	O
a	DT	det	O
loss	NN	nmod	O
of	IN	case	O
endothelial	JJ	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
leukocyte	NN	conj	O
,	,	punct	O
PECAM	NN	appos	O
-	:	punct	O
1	CD	dep	O
.	.	punct	O
Autocrine	NN	compound	O
angiogenic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
prosthesis	NN	ROOT	O
with	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
transplantation	NN	nmod	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Synthetic	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
prostheses	NNS	nsubj	O
are	VBP	ccomp	O
foreign	JJ	amod	O
bodies	NNS	attr	O
,	,	punct	O
so	IN	mark	O
that	IN	mark	O
blood	NN	compound	B-Organism_substance
coagulation	NN	nsubj	O
can	MD	aux	O
occur	VB	ROOT	O
on	IN	prep	O
their	PRP$	nmod:poss	O
luminal	JJ	amod	B-Multi-tissue_structure
surfaces	NNS	pobj	I-Multi-tissue_structure
,	,	punct	O
causing	VBG	advcl	O
graft	NN	compound	B-Multi-tissue_structure
occlusion	NN	dobj	O
very	RB	advmod	O
frequently	RB	advmod	O
in	IN	prep	O
prostheses	NNS	pobj	O
of	IN	prep	O
small	JJ	amod	O
diameter	NN	pobj	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
level	NN	compound	O
many	JJ	amod	O
actions	NNS	nsubj	O
of	IN	case	O
thrombin	NN	nmod	O
can	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
.	.	punct	O
A	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
prosthesis	NN	nsubj	O
needs	VBZ	ROOT	O
angiogenesis	NN	dobj	O
for	IN	case	O
endothelialization	NN	nmod	O
of	IN	case	O
the	DT	det	O
luminal	JJ	amod	B-Multi-tissue_structure
surface	NN	nmod	I-Multi-tissue_structure
,	,	punct	O
as	IN	mark	O
endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
have	VBP	advcl	O
natural	JJ	amod	O
and	CC	cc	O
permanent	JJ	conj	O
antithrombogenic	JJ	amod	O
properties	NNS	dobj	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
To	TO	mark	O
induce	VB	advcl	O
capillary	JJ	amod	B-Tissue
growth	NN	dobj	O
into	IN	prep	O
the	DT	det	O
graft	NN	pobj	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
a	DT	det	O
method	NN	dobj	O
of	IN	case	O
transplanting	VBG	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
primitive	JJ	acl:relcl	O
,	,	punct	O
strong	JJ	conj	O
enough	RB	advmod	O
to	TO	aux	O
survive	VB	xcomp	O
,	,	punct	O
and	CC	cc	O
create	NN	conj	O
blood	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
inducement	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
growth	NN	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
evidence	NN	nsubj	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
clinical	JJ	conj	O
studies	NNS	nmod	O
that	IN	mark	O
adult	JJ	amod	O
bone	NN	compound	O
marrow	NN	compound	O
-	HYPH	punct	O
derived	VBN	amod	O
stem	NN	compound	O
cells	NNS	nsubj	O
and	CC	cc	O
endothelial	JJ	amod	O
progenitor	NN	compound	O
cells	NNS	conj	O
participate	VBP	acl:relcl	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
called	VBN	conj	O
neoangiogenesis	NN	xcomp	O
or	CC	cc	O
neovascularization	NN	conj	O
.	.	punct	O
In	IN	case	O
an	DT	det	O
animal	NN	compound	O
experiment	NN	nmod	O
,	,	punct	O
marrow	NN	compound	B-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
infiltrated	VBN	ROOT	O
into	IN	case	O
the	DT	det	O
walls	NNS	nmod	O
of	IN	case	O
long	JJ	amod	O
-	HYPH	punct	O
fibril	NN	nmod	O
expanded	VBD	conj	O
polytetrafluoroethylene	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
ePTFE	LS	appos	B-Simple_chemical
)	-RRB-	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
grafts	NNS	dobj	I-Multi-tissue_structure
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
grafts	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
implanted	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
abdominal	JJ	amod	B-Multi-tissue_structure
aortic	JJ	amod	I-Multi-tissue_structure
position	NN	nmod	O
of	IN	case	O
24	CD	nummod	O
dogs	NNS	nmod	B-Organism
autologously	RB	advmod	O
.	.	punct	O

The	DT	det	O
distribution	NN	nsubjpass	O
of	IN	case	O
basic	JJ	amod	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
bFGF	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
immunohistochemically	RB	advmod	O
in	IN	case	O
fresh	JJ	amod	O
frozen	JJ	amod	O
sections	NNS	nmod	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O
Marrow	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
survived	VBD	ROOT	O
and	CC	cc	O
continued	VBD	conj	O
exogenous	JJ	amod	O
hemopoiesis	NN	dobj	O
for	IN	prep	O
up	RB	advmod	O
to	TO	quantmod	O
six	CD	nummod	O
months	NNS	pobj	O
and	CC	cc	O
were	VBD	cop	O
immunohistochemically	RB	advmod	O
reactive	JJ	conj	O
to	TO	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
All	PDT	predet	O
the	DT	det	O
grafts	NNS	nsubj	B-Multi-tissue_structure
older	JJR	nsubj	O
than	IN	quantmod	O
three	CD	nummod	O
weeks	NNS	npadvmod	O
had	VBD	ROOT	O
complete	JJ	amod	O
endothelialization	NN	dobj	O
and	CC	cc	O
maintained	VBD	conj	O
their	PRP$	nmod:poss	O
patency	NN	dobj	O
.	.	punct	O

The	DT	det	O
graft	NN	compound	O
size	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
suspension	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
dependent	JJ	conj	O
on	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
number	NN	nmod	O
of	IN	mark	O
passages	NNS	acl	O
the	DT	det	O
cells	NNS	dobj	O
are	VBP	auxpass	O
taken	VBN	conj	O
through	IN	case	O
in	IN	case	O
culture	NN	nmod	O
prior	RB	case	O
to	TO	aux	O
grafting	VBG	advcl	O
or	CC	cc	O
on	IN	case	O
the	DT	det	O
postoperative	JJ	amod	O
survival	NN	compound	O
period	NN	conj	O
.	.	punct	O
Twenty	CD	compound	O
grafts	NNS	nsubjpass	B-Multi-tissue_structure
without	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod	I-Multi-tissue_structure
were	VBD	auxpass	O
implanted	VBN	ROOT	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Endothelialization	NN	nsubj	O
was	VBD	cop	O
present	JJ	ROOT	O
at	IN	case	O
anastomotic	JJ	amod	O
sites	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
other	JJ	amod	O
areas	NNS	nsubjpass	O
were	VBD	auxpass	O
covered	VBN	conj	O
with	IN	prep	O
fresh	JJ	amod	O
thrombi	RB	pobj	O
.	.	punct	O

The	DT	det	O
grafts	NNS	nsubjpass	O
are	VBP	auxpass	O
extensively	RB	advmod	O
vascularized	VBN	ROOT	O
with	IN	case	O
capillaries	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
nonfenestrated	JJ	amod	O
endothelium	NN	nmod	O
;	:	punct	O
intercellular	JJ	amod	O
junctions	NNS	nsubj	O
are	VBP	cop	O
evident	JJ	parataxis	O
at	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
apposition	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Four	CD	nsubj	O
out	IN	prt	O
of	IN	prep	O
seven	CD	nummod	O
control	NN	compound	O
grafts	NNS	pobj	B-Multi-tissue_structure
were	VBD	cop	O
patent	JJ	ROOT	O
with	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
lining	NN	nmod	O
at	IN	case	O
six	CD	nummod	O
months	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
three	CD	nsubjpass	O
were	VBD	auxpass	O
occluded	VBN	conj	O
and	CC	cc	O
one	CD	nsubjpass	O
of	IN	prep	O
the	DT	det	O
four	CD	nummod	O
grafts	NNS	pobj	B-Multi-tissue_structure
was	VBD	auxpass	O
still	RB	advmod	O
covered	VBN	conj	O
with	IN	prep	O
a	DT	det	O
thrombus	JJ	compound	B-Pathological_formation
layer	NN	pobj	O
.	.	punct	O

The	DT	det	O
angiogenic	JJ	amod	O
potency	NN	nsubj	O
of	IN	case	O
adipose	NN	compound	O
tissue	NN	nmod	O
was	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
its	PRP$	nmod:poss	O
localization	NN	nmod	O
(	-LRB-	punct	O
with	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
stimulation	NN	nmod	O
in	IN	case	O
60	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
SAT	NN	compound	O
samples	NNS	nmod	O
and	CC	cc	O
61	CD	nummod	O
%	NN	conj	O
of	IN	case	O
VAT	NN	compound	O
samples	NNS	nmod	O
)	-RRB-	punct	O
or	CC	cc	O
to	TO	case	O
adipocyte	NN	compound	O
size	NN	conj	O
or	CC	cc	O
inflammatory	JJ	amod	O
infiltrate	NN	conj	O
assessed	VBN	acl	O
in	IN	case	O
adipose	NN	compound	O
samples	NNS	nmod	O
before	IN	case	O
the	DT	det	O
graft	NN	nmod	O
on	IN	case	O
CAM	NN	nmod	O
.	.	punct	O
Bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubj	I-Multi-tissue_structure
with	IN	case	O
its	PRP$	nmod:poss	O
unique	JJ	amod	O
native	JJ	amod	O
properties	NNS	nmod	O
produced	VBD	ROOT	O
autocrine	JJ	amod	O
angiogenicity	NN	dobj	O
in	IN	case	O
the	DT	det	O
graft	NN	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
genetic	JJ	amod	O
instability	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
chronic	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O
Application	NN	ROOT	O
of	IN	case	O
clonal	JJ	amod	B-Organism
analysis	NN	nmod	O
.	.	punct	O

Development	NN	ROOT	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	O
model	NN	nmod	O
for	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nmod	O
with	IN	case	O
endometrial	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Differential	JJ	amod	O
diagnosis	NN	ROOT	O
for	IN	case	O
synchronous	JJ	amod	O
primary	JJ	amod	O
ovarian	JJ	amod	B-Cancer
and	CC	cc	O
endometrial	JJ	conj	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
metastatic	JJ	amod	O
cancer	NN	conj	B-Cancer
.	.	punct	O

Lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
various	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cancers	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
endometrial	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Simultaneous	JJ	amod	O
involvement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
the	DT	det	O
ovary	NN	conj	B-Organ
by	IN	case	O
carcinoma	NN	nmod	B-Cancer
is	VBZ	ROOT	O
a	DT	det	O
familiar	JJ	amod	O
problem	NN	attr	O
in	IN	prep	O
the	DT	det	O
routine	JJ	compound	O
practice	NN	pobj	O
of	IN	prep	O
surgical	JJ	amod	O
pathology	NN	pobj	O
.	.	punct	O

At	IN	prep	O
other	JJ	amod	O
times	NNS	pobj	O
,	,	punct	O
both	CC	preconj	O
the	DT	det	O
metastases	NNS	nsubj	O
and	CC	cc	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	conj	O
may	MD	aux	O
spontaneously	RB	advmod	O
regress	VB	ROOT	O
without	IN	case	O
treatment	NN	nmod	O
.	.	punct	O
Such	JJ	amod	O
cases	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
considered	VBN	ROOT	O
either	CC	det	O
examples	NNS	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
primary	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
with	IN	case	O
metastasis	NN	nmod	O
or	CC	cc	O
as	IN	case	O
synchronous	JJ	amod	B-Cancer
primary	JJ	amod	I-Cancer
neoplasms	NNS	conj	I-Cancer
.	.	punct	O

Available	JJ	amod	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
timing	NN	nsubj	O
of	IN	case	O
telomerase	NN	compound	O
activation	NN	nmod	O
may	MD	aux	O
allow	VB	ccomp	O
the	DT	det	O
distinction	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
lymphomagenetic	JJ	amod	O
models	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
an	DT	det	O
early	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
telomerase	NN	nmod	O
via	IN	case	O
exogenous	JJ	amod	O
regulators	NNS	nmod	O
of	IN	case	O
hTERT	NN	nmod	O
,	,	punct	O
along	IN	case	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
lymphocyte	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
a	DT	det	O
subsequent	JJ	amod	O
selection	NN	conj	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
increased	VBN	amod	O
transforming	VBG	amod	O
potential	NN	nmod	O
may	MD	aux	O
characterize	VB	ccomp	O
several	JJ	amod	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
lymphoid	JJ	amod	O
malignancies	NNS	dobj	O
;	:	punct	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
a	DT	det	O
progressive	JJ	amod	O
shortening	NN	nsubj	O
of	IN	case	O
telomeres	NNS	nmod	O
,	,	punct	O
leading	VBG	acl	O
to	TO	case	O
genetic	JJ	amod	O
instability	NN	nmod	O
which	WDT	nsubj	O
favors	VBZ	acl:relcl	O
a	DT	det	O
subsequent	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
telomerase	NN	nmod	O
via	IN	case	O
endogenous	JJ	amod	O
regulators	NNS	nmod	O
may	MD	aux	O
occur	VB	ccomp	O
in	IN	case	O
most	JJS	amod	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
unrelated	JJ	amod	O
lymphoid	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
distinction	NN	nsubjpass	O
between	IN	prep	O
these	DT	det	O
two	CD	nummod	O
possibilities	NNS	pobj	O
is	VBZ	auxpass	O
made	VBN	ROOT	O
based	VBN	xcomp	O
on	IN	prep	O
clinicopathologic	JJ	amod	O
observations	NNS	pobj	O
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
definitive	JJ	conj	O
.	.	punct	O

Although	IN	mark	O
implicated	VBN	advcl	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
role	NN	nsubj	O
in	IN	case	O
sporadic	JJ	amod	O
cancer	NN	nmod	O
is	VBZ	cop	O
uncertain	JJ	ROOT	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
authors	NNS	nsubj	O
used	VBD	ROOT	O
molecular	JJ	amod	O
techniques	NNS	dobj	O
to	TO	mark	O
analyze	VB	xcomp	O
the	DT	det	O
clonal	JJ	amod	O
composition	NN	dobj	O
of	IN	case	O
five	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
concurrent	JJ	amod	O
adenocarcinomas	NNS	nmod	B-Cancer
of	IN	case	O
the	DT	det	O
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
ovary	NN	conj	B-Organ
that	WDT	nsubjpass	O
were	VBD	auxpass	O
clinicopathologically	RB	advmod	O
diagnosed	VBN	acl:relcl	O
as	IN	case	O
synchronous	JJ	amod	B-Cancer
primary	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
tumors	NNS	nsubj	O
were	VBD	cop	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
fibrosarcomas	NNS	ROOT	O
.	.	punct	O
Patterns	NNS	nsubj	O
of	IN	case	O
X	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
chromosome	NN	compound	I-Cellular_component
inactivation	NN	nmod	O
,	,	punct	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
mutations	NNS	conj	O
or	CC	cc	O
allelic	JJ	amod	O
loss	NN	conj	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
,	,	punct	O
or	CC	cc	O
human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
detection	NN	conj	O
were	VBD	cop	O
identical	JJ	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
endometrial	JJ	amod	B-Pathological_formation
and	CC	cc	O
ovarian	JJ	conj	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
in	IN	case	O
three	CD	nmod	O
of	IN	case	O
the	DT	det	O
cases	NNS	nmod	O
suggesting	VBG	xcomp	O
that	IN	mark	O
those	DT	det	O
three	CD	nummod	O
cases	NNS	nsubj	O
represented	VBD	ccomp	O
single	JJ	amod	O
primary	JJ	amod	B-Cancer
tumors	NNS	dobj	I-Cancer
with	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
pigmented	VBN	acl:relcl	O
and	CC	cc	O
of	IN	case	O
epithelial	JJ	amod	O
origin	NN	conj	O
.	.	punct	O
In	IN	prep	O
both	DT	pobj	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
two	CD	nummod	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
patterns	NNS	nsubj	O
of	IN	case	O
X	NN	compound	B-Cellular_component
-	HYPH	punct	I-Cellular_component
chromosome	NN	compound	I-Cellular_component
inactivation	NN	nmod	O
clearly	RB	advmod	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
independent	JJ	amod	O
primary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
implemented	VBD	ROOT	O
a	DT	det	O
noninvasive	JJ	amod	O
molecular	JJ	amod	O
imaging	NN	compound	O
technique	NN	dobj	O
to	TO	mark	O
facilitate	VB	acl	O
the	DT	det	O
assessment	NN	dobj	O
of	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
process	NN	nmod	O
.	.	punct	O
The	DT	det	O
application	NN	nsubj	O
of	IN	case	O
molecular	JJ	amod	O
technology	NN	nmod	O
may	MD	aux	O
play	VB	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
differential	JJ	amod	O
diagnosis	NN	nmod	O
between	IN	case	O
synchronous	JJ	amod	B-Cancer
primary	JJ	amod	I-Cancer
carcinomas	NNS	nmod	I-Cancer
and	CC	cc	O
a	DT	det	O
single	JJ	amod	O
carcinoma	NN	conj	B-Cancer
with	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Angiostatin	NN	nsubj	O
and	CC	cc	O
thalidomide	NN	conj	O
inhibit	VBP	appos	O
tumor	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
angiogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
this	DT	det	O
xenograft	NN	amod	O
model	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Molecular	JJ	amod	O
biology	NN	ROOT	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
precursors	NNS	conj	B-Pathological_formation
.	.	punct	O

Paclitaxel	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
anti	JJ	npadvmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
agent	NN	appos	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
effective	JJ	xcomp	O
against	IN	case	O
several	JJ	amod	O
tumours	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
cervical	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
Cervical	JJ	amod	B-Cancer
cancer	NN	nsubj	I-Cancer
develops	VBZ	ROOT	O
from	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
defined	VBN	amod	O
precursor	NN	compound	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
referred	VBN	acl	O
to	TO	nmod	O
as	RB	case	O
either	CC	cc:preconj	O
cervical	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
neoplasia	NN	nmod	I-Pathological_formation
or	CC	cc	O
squamous	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
lesions	NNS	conj	I-Pathological_formation
.	.	punct	O

Although	IN	mark	O
several	JJ	amod	O
hypotheses	NNS	nsubjpass	O
for	IN	case	O
human	JJ	amod	O
carcinogenesis	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	advcl	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
genetic	JJ	amod	O
changes	NNS	nsubjpass	O
that	WDT	nsubj	O
cause	VBP	acl:relcl	O
normal	JJ	amod	O
cells	NNS	dobj	O
to	TO	mark	O
become	VB	advcl	O
cancer	NN	compound	O
cells	NNS	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
now	RB	advmod	O
known	VBN	ROOT	O
that	IN	mark	O
specific	JJ	amod	O
types	NNS	nsubj	O
of	IN	case	O
human	JJ	amod	B-Organism
papillomaviruses	NNS	nmod	I-Organism
(	-LRB-	punct	O
HPV	NN	appos	B-Organism
)	-RRB-	punct	O
are	VBP	cop	O
the	DT	det	O
principal	JJ	amod	O
etiologic	JJ	amod	O
agents	NNS	ccomp	O
for	IN	case	O
both	CC	cc:preconj	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
precursors	NNS	conj	B-Pathological_formation
.	.	punct	O

E1A	NN	compound	O
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	O
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	O
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
oncogenic	JJ	amod	O
-	HYPH	punct	O
risk	NN	compound	O
HPV	NNP	compound	B-Organism
types	NNS	nsubj	O
associated	VBN	acl	O
with	IN	case	O
invasive	JJ	amod	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
produce	VBP	ROOT	O
two	CD	nummod	O
oncoproteins	NNS	dobj	O
,	,	punct	O
designated	VBN	acl	O
E6	NN	xcomp	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
endogenous	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
regulatory	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
Rb	NN	conj	B-Gene_or_gene_product
.	.	punct	O

LMP1	NN	nsubj	O
of	IN	case	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	nmod	O
induces	VBZ	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	O
mouse	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	nmod	O
and	CC	cc	O
cooperatively	RB	advmod	O
transforms	VBZ	conj	O
the	DT	det	O
cells	NNS	dobj	O
with	IN	case	O
a	DT	det	O
p16	NN	nmod:npmod	O
-	HYPH	punct	O
insensitive	JJ	amod	O
CDK4	NN	compound	O
oncogene	NN	nmod	O
.	.	punct	O
The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
virally	RB	advmod	O
derived	VBN	intj	O
and	CC	cc	O
endogenous	JJ	amod	O
cellular	JJ	amod	B-Cell
proteins	NNS	nmod	O
converges	NNS	ROOT	O
in	IN	case	O
deregulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
progression	NN	nmod	O
and	CC	cc	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	cop	O
critical	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

CONTEXT	NN	ROOT	O
:	:	punct	O
Nasopharyngeal	JJ	compound	O
carcinoma	NN	nsubj	O
(	-LRB-	punct	O
NPC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
common	JJ	amod	O
in	IN	prep	O
southern	JJ	amod	O
China	NNP	pobj	O
and	CC	cc	O
North	NNP	compound	O
Africa	NNP	conj	O
,	,	punct	O
has	VBZ	dep	O
a	DT	det	O
complex	JJ	amod	O
etiology	NN	dobj	O
involving	VBG	acl	O
interplay	NN	dobj	O
between	IN	case	O
viral	JJ	amod	O
,	,	punct	O
environmental	JJ	conj	O
,	,	punct	O
and	CC	cc	O
hereditary	JJ	conj	O
factors	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
almost	RB	advmod	O
constantly	RB	advmod	O
associated	VBN	conj	O
with	IN	prep	O
the	DT	det	O
Epstein	NNP	compound	O
-	HYPH	punct	O
Barr	NN	compound	O
virus	NN	pobj	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
development	NN	nsubj	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
a	DT	det	O
multistep	NN	compound	O
process	NN	ROOT	O
that	IN	nsubjpass	O
cannot	NN	advmod	O
be	VB	auxpass	O
explained	VBN	acl:relcl	O
simply	RB	advmod	O
by	IN	case	O
infection	NN	nmod	O
with	IN	case	O
specific	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
HPV	NN	nmod	B-Organism
.	.	punct	O

The	DT	det	O
importance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
tumor	NN	compound	O
suppressor	NN	nmod	O
in	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
is	VBZ	cop	O
beyond	IN	case	O
question	NN	nsubj	O
as	IN	case	O
the	DT	det	O
inactivation	NN	nmod	O
of	IN	case	O
ARF	NN	compound	O
suppressor	NN	compound	O
activity	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
rapid	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
neoplasia	NN	nmod	O
.	.	punct	O
One	CD	nummod	O
additional	JJ	amod	O
event	NN	nsubj	O
that	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
is	VBZ	cop	O
integration	NN	ROOT	O
of	IN	case	O
HPV	NN	compound	B-Organism
DNA	NN	nmod	B-Cellular_component
into	IN	case	O
the	DT	det	O
host	NN	compound	O
genome	NN	nmod	O
.	.	punct	O

Genetic	JJ	amod	O
instability	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O
Integration	NN	nsubj	O
of	IN	case	O
HPV	NN	compound	B-Organism
DNA	NN	nmod	B-Cellular_component
frequently	RB	advmod	O
disrupts	VBZ	ROOT	O
the	DT	det	O
E2	NN	compound	B-Gene_or_gene_product
open	JJ	amod	O
reading	NN	compound	O
frames	NNS	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
the	DT	dep	O
E6	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
oncoproteins	NNS	dep	O
and	CC	cc	O
possibly	RB	advmod	O
causing	VBG	conj	O
genomic	JJ	amod	O
instability	NN	dobj	O
.	.	punct	O

The	DT	det	O
EGF	NN	compound	O
receptor	NN	compound	O
gene	NN	nsubjpass	O
is	VBZ	auxpass	O
amplified	VBN	ROOT	O
and	CC	cc	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	conj	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
increased	VBN	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nmod	O
leads	VBZ	ccomp	O
to	TO	case	O
constitutive	JJ	amod	O
activity	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
oncogene	NN	compound	O
erb	NN	compound	O
B	NN	nmod	O
.	.	punct	O
Additional	JJ	amod	O
cofactors	NNS	nsubj	O
and	CC	cc	O
mutational	JJ	amod	O
events	NNS	conj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
cervical	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
may	MD	aux	O
include	VB	conj	O
chromosomal	JJ	amod	B-Cellular_component
rearrangements	NNS	dobj	O
,	,	punct	O
loss	NN	appos	O
of	IN	case	O
constitutional	JJ	amod	O
heterozygosity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
activation	NN	conj	O
.	.	punct	O

External	JJ	amod	O
beam	NN	compound	O
radiotherapy	NN	nsubj	O
for	IN	case	O
subretinal	JJ	amod	O
neovascularization	NN	nmod	O
in	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	O
degeneration	NN	nmod	O
:	:	punct	O
is	VBZ	ROOT	O
this	DT	det	O
treatment	NN	nsubj	O
efficient	JJ	acomp	O
?	.	punct	O
The	DT	det	O
effects	NNS	ROOT	O
of	IN	case	O
radiation	NN	nmod	O
on	IN	case	O
neovascularization	NN	nmod	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

An	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
strategy	NN	nsubj	O
may	MD	aux	O
reduce	VB	ROOT	O
tissue	NN	compound	O
damage	NN	dobj	O
associated	VBN	acl	O
with	IN	case	O
radiation	NN	compound	O
vasculopathy	NN	nmod	O
and	CC	cc	O
neuropathy	NN	conj	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
that	IN	mark	O
radiation	NN	compound	O
treatment	NN	nsubj	O
inhibits	VBZ	ccomp	O
neovascularization	NN	dobj	O
of	IN	case	O
recipient	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
graft	NN	compound	B-Tissue
tissues	NNS	conj	I-Tissue
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
may	MD	aux	O
account	VB	conj	O
in	IN	case	O
part	NN	nmod	O
for	IN	case	O
abnormalities	NNS	nmod	O
in	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
radiation	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nsubjpass	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
endothelial	JJ	amod	O
cell	NN	compound	O
mitogen	NN	appos	O
and	CC	cc	O
a	DT	det	O
major	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
upregulated	VBN	ccomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
low	JJ	amod	O
heart	NN	compound	O
rate	NN	nmod	O
and	CC	cc	O
consequential	JJ	amod	O
increased	VBD	amod	O
stroke	NN	compound	O
volume	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
this	DT	det	O
hypothesis	NN	dobj	O
using	VBG	acl	O
a	DT	det	O
model	NN	dobj	O
that	WDT	nsubj	O
measures	VBZ	acl:relcl	O
the	DT	det	O
neovascularization	NN	dobj	O
of	IN	case	O
an	DT	det	O
implanted	VBN	amod	O
foreign	JJ	amod	O
material	NN	nmod	O
.	.	punct	O

First	JJ	advmod	O
clinical	JJ	amod	O
control	NN	nsubjpass	O
with	IN	case	O
second	JJ	amod	O
angiography	NN	nmod	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
6	CD	nummod	O
weeks	NNS	npadvmod	O
after	IN	case	O
irradiation	NN	dep	O
,	,	punct	O
then	RB	advmod	O
in	IN	prep	O
3	CD	nummod	O
-	HYPH	punct	O
month	NN	compound	O
intervals	NNS	pobj	O
.	.	punct	O
Expanded	VBN	amod	O
polytetrafluoroethylene	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
PTFE	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
sheets	NNS	nsubjpass	O
were	VBD	auxpass	O
implanted	VBN	ROOT	O
adjacent	JJ	xcomp	O
to	TO	case	O
both	CC	det	O
superficial	JJ	amod	O
epigastric	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
pedicles	NNS	nmod	I-Multi-tissue_structure
of	IN	case	O
63	CD	nummod	O
rats	NNS	nmod	B-Organism
distributed	VBN	acl	O
into	IN	case	O
7	CD	nummod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
7	CD	dep	O
)	-RRB-	punct	O
that	WDT	nsubj	O
differed	VBD	acl:relcl	O
with	IN	case	O
respect	NN	dep	O
to	TO	case	O
dose	NN	nmod	O
and	CC	cc	O
timing	NN	conj	O
of	IN	prep	O
irradiation	NN	pobj	O
.	.	punct	O

All	DT	det	O
patients	NNS	nsubj	O
received	VBD	ROOT	O
a	DT	det	O
total	JJ	amod	O
dose	NN	dobj	O
of	IN	case	O
16	CD	nummod	O
Gy	NN	nmod	O
in	IN	case	O
2	CD	nummod	O
-	HYPH	punct	O
Gy	NN	compound	O
daily	RB	amod	O
fractions	NNS	nmod	O
with	IN	case	O
5	CD	compound	O
-	SYM	punct	O
6	CD	nummod	O
MeV	NN	compound	O
photons	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
computerized	VBN	amod	O
treatment	NN	nmod	O
planning	NN	acl	O
in	IN	prep	O
individual	JJ	amod	O
head	NN	compound	O
mask	JJ	compound	O
fixation	NN	pobj	O
.	.	punct	O
Zero	VB	compound	O
to	IN	dep	O
10	CD	nummod	O
daily	JJ	amod	O
fractions	NNS	nsubjpass	O
of	IN	case	O
electron	NN	compound	O
-	HYPH	punct	O
beam	NN	amod	O
radiation	NN	nmod	O
(	-LRB-	punct	O
300	CD	nummod	O
cGy	NN	appos	O
each	DT	dep	O
)	-RRB-	punct	O
were	VBD	auxpass	O
delivered	VBN	ROOT	O
to	TO	prep	O
the	DT	det	O
implant	NN	pobj	O
in	IN	prep	O
the	DT	det	O
right	JJ	amod	B-Organism_subdivision
groin	NN	pobj	I-Organism_subdivision
,	,	punct	O
while	IN	mark	O
the	DT	det	O
implant	NN	nsubj	O
in	IN	prep	O
the	DT	det	O
left	JJ	amod	B-Organism_subdivision
groin	NN	pobj	I-Organism_subdivision
served	VBD	advcl	O
as	IN	prep	O
a	DT	det	O
nonirradiated	JJ	amod	O
internal	JJ	amod	O
control	NN	pobj	O
.	.	punct	O

Vascularization	NN	nsubjpass	O
of	IN	case	O
subcutaneous	JJ	amod	O
Matrigel	NNP	compound	O
implants	VBZ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	O
angiogenesis	NN	conj	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O
Unirradiated	JJ	amod	O
animals	NNS	nsubj	O
showed	VBD	ROOT	O
equal	JJ	amod	O
neovascularization	NN	dobj	O
of	IN	case	O
both	DT	det	O
implants	NNS	nmod	O
.	.	punct	O

Fractional	JJ	amod	O
tumor	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analysis	NN	nsubjpass	O
of	IN	case	O
tumors	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	conj	O
to	TO	mark	O
determine	VB	xcomp	O
degree	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
Rats	NNS	nsubj	B-Organism
that	WDT	nsubjpass	O
were	VBD	auxpass	O
irradiated	VBN	acl:relcl	O
twice	RB	advmod	O
(	-LRB-	punct	O
single	JJ	amod	O
fractions	NNS	dep	O
at	IN	case	O
0	CD	nummod	O
and	CC	cc	O
24	CD	conj	O
hours	NNS	nmod	O
after	IN	case	O
implantation	NN	nmod	O
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
show	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
the	DT	det	O
neovascularization	NN	nmod	O
of	IN	case	O
the	DT	det	O
irradiated	JJ	amod	O
implant	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
contralateral	JJ	amod	O
control	NN	compound	O
implant	NN	advcl	O
.	.	punct	O

Vascularization	NN	nsubjpass	O
of	IN	case	O
subcutaneous	JJ	amod	O
Matrigel	NNP	compound	O
implants	VBZ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	O
angiogenesis	NN	conj	O
were	VBD	auxpass	O
both	DT	cc:preconj	O
inhibited	VBN	ROOT	O
in	IN	case	O
PECAM	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
null	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
implants	NNS	nsubj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
irradiated	VBN	acl:relcl	O
three	CD	nummod	O
times	NNS	dobj	O
(	-LRB-	punct	O
single	JJ	amod	O
fractions	NNS	dep	O
at	IN	case	O
0	CD	nmod	O
,	,	punct	O
24	CD	conj	O
,	,	punct	O
and	CC	cc	O
48	CD	nummod	O
hours	NNS	conj	O
after	IN	case	O
implantation	NN	nmod	O
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
diminished	VBN	amod	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	advmod	O
25	CD	nummod	O
percent	NN	compound	O
,	,	punct	O
p	NN	appos	O
less	JJR	advmod	O
than	IN	mwe	O
0	CD	dep	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
neovascularization	NN	dobj	O
beyond	IN	case	O
day	NN	nmod	O
7	CD	nummod	O
,	,	punct	O
whereas	IN	dep	O
implants	NNS	nsubj	O
irradiated	VBN	acl	O
only	RB	advmod	O
at	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
after	IN	case	O
implantation	NN	nmod	O
did	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

sDll4	NN	nsubj	O
similarly	RB	advmod	O
induced	VBD	ROOT	O
defective	JJ	amod	O
vascular	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
implants	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
reduced	VBN	amod	O
tumor	NN	compound	O
growth	NN	nmod	O
.	.	punct	O
Interestingly	RB	advmod	O
,	,	punct	O
neovascularization	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
implants	NNS	nmod	O
irradiated	VBN	acl	O
with	IN	case	O
10	CD	nummod	O
fractions	NNS	nmod	O
(	-LRB-	punct	O
3000	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
compared	VBN	case	O
with	IN	case	O
irradiation	NN	nmod	O
with	IN	case	O
three	CD	nummod	O
fractions	NNS	nmod	O
(	-LRB-	punct	O
900	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

sDll4	NN	nsubj	O
similarly	RB	advmod	O
induced	VBD	ROOT	O
defective	JJ	amod	O
vascular	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
tumor	NN	compound	O
implants	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
reduced	VBN	amod	O
tumor	NN	compound	O
growth	NN	nmod	O
.	.	punct	O
Irradiation	NN	nsubj	O
delivered	VBN	ROOT	O
before	IN	case	O
implantation	NN	nmod	O
(	-LRB-	punct	O
900	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	conj	O
neovascularization	NN	dobj	O
significantly	RB	advmod	O
less	JJR	advmod	O
than	IN	case	O
the	DT	det	O
same	JJ	amod	O
dose	NN	nmod	O
administered	VBN	acl	O
after	IN	case	O
implantation	NN	nmod	O
.	.	punct	O

Six	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
mice	NNS	nsubjpass	O
were	VBD	auxpass	O
randomly	RB	advmod	O
divided	VBN	ROOT	O
into	IN	case	O
four	CD	nummod	O
treatment	NN	compound	O
groups	NNS	nmod	O
:	:	punct	O
untreated	JJ	amod	O
controls	NNS	dep	O
;	:	punct	O
10	CD	nummod	O
minute	NN	parataxis	O
daily	JJ	amod	O
TEMF	NN	dobj	O
;	:	punct	O
200	CD	nummod	O
cGy	NN	dep	O
of	IN	case	O
IR	NN	nmod	O
every	DT	det	O
other	JJ	amod	O
day	NN	nmod	O
(	-LRB-	punct	O
total	JJ	amod	O
800	CD	nummod	O
cGy	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
IR	NN	dep	O
plus	CC	cc	O
daily	RB	conj	O
TEMF	NN	conj	O
.	.	punct	O
The	DT	det	O
results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
subclinical	JJ	amod	O
cumulative	JJ	amod	O
dose	NN	nsubj	O
of	IN	case	O
900	CD	nummod	O
cGy	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
threshold	NN	ccomp	O
for	IN	case	O
impaired	JJ	amod	O
tissue	NN	compound	B-Tissue
revascularization	NN	nmod	O
provided	VBD	ccomp	O
that	IN	mark	O
treatment	NN	nsubjpass	O
is	VBZ	auxpass	O
delivered	VBN	ccomp	O
immediately	RB	advmod	O
after	IN	case	O
implantation	NN	nmod	O
over	IN	case	O
a	DT	det	O
48	CD	nummod	O
-	HYPH	punct	O
hour	NN	compound	O
interval	NN	nmod	O
.	.	punct	O

Targeting	VBG	ROOT	O
angiogenesis	NN	dobj	O
:	:	punct	O
progress	NN	dep	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
large	JJ	amod	O
molecules	NNS	nmod	O
.	.	punct	O
Prognostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
operable	JJ	amod	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Neovascularization	NN	nsubj	O
has	VBZ	dep	O
profound	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O
Tumour	NN	compound	B-Cancer
angiogenesis	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
factor	NN	ROOT	O
for	IN	case	O
tumour	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	JJ	pobj	O
,	,	punct	O
metronomic	JJ	amod	O
5	CD	nummod	O
-	HYPH	punct	O
FU	NNP	dep	O
+	CC	cc	O
L	NN	compound	O
-	HYPH	punct	O
OHP	NN	conj	O
+	CC	cc	O
CPT	NN	compound	O
-	:	punct	O
11	CD	nummod	O
therapy	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
microvascular	JJ	amod	O
count	NN	dobj	O
.	.	punct	O
Although	IN	mark	O
some	DT	det	O
recent	JJ	amod	O
reports	NNS	nsubj	O
suggest	VBP	advcl	O
that	IN	mark	O
microvessel	NN	compound	B-Tissue
counts	VBZ	nsubj	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
are	VBP	cop	O
related	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
poor	JJ	amod	O
disease	NN	compound	O
outcome	NN	nmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
were	VBD	cop	O
not	RB	neg	O
conclusive	JJ	ROOT	O
and	CC	cc	O
were	VBD	auxpass	O
not	RB	neg	O
compared	VBN	conj	O
with	IN	case	O
other	JJ	amod	O
molecular	JJ	amod	O
prognostic	JJ	amod	O
markers	NNS	nmod	O
.	.	punct	O

Increased	VBN	amod	O
VEGF	NN	compound	O
expression	NN	nsubjpass	O
by	IN	case	O
malignant	JJ	amod	O
tumors	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
vascularity	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
cancer	NN	compound	O
cell	NN	compound	O
growth	NN	conj	O
,	,	punct	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
.	.	punct	O
In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
107	CD	nummod	O
(	-LRB-	punct	O
T1	NN	appos	O
,	,	punct	O
2	CD	nummod	O
-	HYPH	punct	O
N0	NN	conj	O
,	,	punct	O
1	LS	appos	O
)	-RRB-	punct	O
operable	JJ	amod	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
using	VBG	advcl	O
the	DT	det	O
JC70	NN	compound	B-Gene_or_gene_product
monoclonal	JJ	amod	I-Gene_or_gene_product
antibody	NN	dobj	I-Gene_or_gene_product
to	TO	case	I-Gene_or_gene_product
CD31	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
MATERIALS	NNS	conj	O
:	:	punct	O
The	DT	det	O
prospective	JJ	amod	O
trial	NN	nsubj	O
included	VBD	ROOT	O
287	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
subfoveal	JJ	amod	O
neovascularization	NN	nmod	O
due	JJ	case	O
to	TO	case	O
AMD	NN	nmod	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
verified	VBN	acl:relcl	O
by	IN	case	O
fluorescein	NN	compound	O
angiography	NN	nmod	O
.	.	punct	O
Three	CD	nummod	O
vascular	JJ	amod	B-Multi-tissue_structure
grades	NNS	nsubjpass	O
were	VBD	auxpass	O
defined	VBN	ROOT	O
with	IN	case	O
appraisal	NN	nmod	O
by	IN	case	O
eye	NN	nmod	B-Organ
and	CC	cc	O
by	IN	case	O
Chalkley	NNP	compound	O
counting	NN	conj	O
:	:	punct	O
high	JJ	dep	O
(	-LRB-	punct	O
Chalkley	NN	compound	O
score	NN	dep	O
7	CD	nummod	O
-	SYM	punct	O
12	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
medium	NN	conj	O
(	-LRB-	punct	O
5	CD	nummod	O
-	SYM	punct	O
6	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
low	JJ	conj	O
(	-LRB-	punct	O
2	CD	nummod	O
-	SYM	punct	O
4	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	O
(	-LRB-	punct	O
14	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
regained	VBD	ROOT	O
2	CD	nummod	O
or	CC	cc	O
more	JJR	conj	O
lines	NNS	dobj	O
of	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
eye	NN	amod	B-Organ
appraisal	NN	intj	O
and	CC	cc	O
Chalkley	NN	conj	O
counting	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
0001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
clinicopathologic	JJ	amod	O
factors	NNS	nsubjpass	O
were	VBD	auxpass	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
p53	NN	nmod	O
or	CC	cc	O
VEGF	NN	conj	O
expression	NN	dep	O
.	.	punct	O
Vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
histology	NN	nmod	O
,	,	punct	O
grade	NN	conj	O
,	,	punct	O
proliferation	NN	compound	O
index	NN	conj	O
(	-LRB-	punct	O
Ki67	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
EGFR	NN	compound	B-Gene_or_gene_product
or	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
expression	NN	conj	O
.	.	punct	O

Fractional	JJ	amod	O
tumor	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analysis	NN	nsubjpass	O
of	IN	case	O
tumors	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	conj	O
to	TO	mark	O
determine	VB	xcomp	O
degree	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O
Tumours	NNS	nsubj	B-Cancer
from	IN	case	O
younger	JJR	amod	O
patients	NNS	nmod	B-Organism
had	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
grade	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
alpha	NN	compound	O
-	:	punct	O
SMA	NN	nsubjpass	O
and	CC	cc	O
lymph	NN	compound	O
node	NN	compound	O
metastasis	NN	conj	O
were	VBD	auxpass	O
identified	VBN	ccomp	O
as	IN	case	O
independent	JJ	amod	O
predictive	JJ	amod	O
factors	NNS	nmod	O
of	IN	case	O
metastasis	NN	nmod	O
.	.	punct	O
Apart	RB	advmod	O
from	IN	prep	O
the	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	pobj	O
,	,	punct	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
factors	NNS	nmod	O
examined	VBN	acl	O
was	VBD	cop	O
statistically	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
0001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
TNM	NNP	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
,	,	punct	O
grading	VBG	conj	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O
A	DT	det	O
univariate	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
survival	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
most	RBS	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	ccomp	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
0004	CD	ROOT	O
)	-RRB-	punct	O
,	,	punct	O
followed	VBN	acl	O
by	IN	case	O
N	NN	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	ROOT	O
univariate	JJ	amod	O
analysis	NN	dobj	O
,	,	punct	O
the	DT	det	O
S	NNP	compound	O
-	HYPH	punct	O
100beta	CD	compound	O
level	NN	nsubjpass	O
and	CC	cc	O
metastatic	JJ	amod	O
profile	NN	conj	O
were	VBD	auxpass	O
found	VBN	parataxis	O
to	TO	mark	O
be	VB	cop	O
statistically	RB	advmod	O
significant	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	xcomp	O
for	IN	case	O
survival	NN	nmod	O
.	.	punct	O
In	IN	case	O
a	DT	det	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
,	,	punct	O
N	NN	compound	O
-	HYPH	punct	O
stage	NN	nsubjpass	O
and	CC	cc	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	xcomp	O
,	,	punct	O
since	IN	mark	O
they	PRP	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
related	JJ	advcl	O
to	TO	case	O
each	DT	det	O
other	JJ	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
TNM	NNP	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
,	,	punct	O
grading	VBG	conj	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O
Excluding	VBG	advcl	O
N	NNP	compound	O
-	HYPH	punct	O
stage	NN	dobj	O
,	,	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nsubj	O
was	VBD	ROOT	O
the	DT	det	O
only	RB	advmod	O
independent	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	attr	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
007	CD	attr	O
)	-RRB-	punct	O
.	.	punct	O

No	DT	neg	O
difference	NN	compound	O
in	IN	prep	O
relapse	NN	compound	O
-	HYPH	punct	O
free	JJ	pobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
26	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
overall	JJ	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
63	CD	appos	O
)	-RRB-	punct	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
stratified	VBN	acl	O
by	IN	case	O
angiogenin	NN	compound	O
expression	NN	nmod	O
.	.	punct	O
Kaplan	NNP	compound	O
-	HYPH	punct	O
Meier	NNP	amod	O
survival	NN	compound	O
curves	NNS	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
worse	JJR	amod	O
prognosis	NN	dobj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
grade	NN	nmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
difference	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	conj	O
between	IN	case	O
low	JJ	amod	O
and	CC	cc	O
medium	NN	conj	O
vascular	JJ	conj	B-Multi-tissue_structure
grade	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
metastatic	JJ	amod	O
potential	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
production	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
lymphangiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
VEGF	NN	compound	O
-	:	punct	O
C	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
tumor	NN	compound	O
lymphatics	NNS	nmod	O
.	.	punct	O
These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
angiogenesis	NN	nsubj	O
in	IN	case	O
operable	JJ	amod	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	nsubj	O
for	IN	case	O
survival	NN	nmod	O
and	CC	cc	O
,	,	punct	O
among	IN	case	O
the	DT	det	O
parameters	NNS	nmod	O
tested	VBN	acl	O
,	,	punct	O
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
factor	NN	ccomp	O
related	JJ	amod	O
to	TO	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
to	TO	case	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
CECs	NNS	nsubj	O
,	,	punct	O
EPCs	NNS	conj	O
and	CC	cc	O
EMPs	NNS	conj	O
may	MD	aux	O
represent	VB	ROOT	O
potentially	RB	advmod	O
novel	JJ	amod	O
methods	NNS	dobj	O
for	IN	mark	O
evaluating	VBG	acl	O
the	DT	det	O
vascular	JJ	amod	O
status	NN	dobj	O
of	IN	case	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O
The	DT	det	O
integration	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
grading	NN	nmod	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
on	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
radiotherapy	NN	conj	O
could	MD	aux	O
substantially	RB	advmod	O
contribute	VB	ROOT	O
in	IN	mark	O
defining	VBG	advcl	O
groups	NNS	dobj	O
of	IN	case	O
operable	JJ	amod	O
patients	NNS	nmod	B-Organism
who	WP	nsubj	O
might	MD	aux	O
benefit	VB	acl:relcl	O
from	IN	case	O
cytotoxic	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
by	IN	case	O
the	DT	det	O
cancer	NN	compound	O
chemopreventive	JJ	amod	O
agent	NN	nmod	O
conjugated	VBD	ROOT	O
linoleic	JJ	amod	O
acid	NN	dobj	O
.	.	punct	O
Vitamin	NN	compound	B-Simple_chemical
E	NNP	nsubj	I-Simple_chemical
inhibits	VBZ	ROOT	O
experimental	JJ	amod	O
carcinogenesis	NN	dobj	O
and	CC	cc	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	conj	O
.	.	punct	O

In	IN	case	O
spite	NN	dep	O
of	IN	case	O
uncertainties	NNS	nmod	O
regarding	VBG	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
vitamins	NNS	appos	O
such	JJ	case	O
as	IN	mwe	O
beta	NN	compound	O
-	HYPH	punct	O
carotene	NN	nmod	O
and	CC	cc	O
vitamins	NNS	compound	O
A	NN	conj	O
,	,	punct	O
C	NN	conj	O
,	,	punct	O
and	CC	cc	O
E	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
reduce	VB	acl:relcl	O
the	DT	det	O
risk	NN	dobj	O
of	IN	case	O
cancer	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
animal	NN	dobj	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	conj	O
of	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O
In	IN	case	O
an	DT	det	O
experiment	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
vitamin	NN	nsubj	B-Simple_chemical
E	NN	dep	I-Simple_chemical
inhibited	VBD	amod	O
carcinogenesis	NN	acl:relcl	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	nsubjpass	O
and	CC	cc	O
tumour	NN	compound	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
TGF	NN	compound	B-Gene_or_gene_product
alpha	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	ccomp	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
conducted	VBN	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
insulin	NN	nmod	O
on	IN	case	O
retinal	JJ	amod	O
VEGF	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O
Forty	CD	nummod	O
male	JJ	amod	O
golden	JJ	amod	B-Organism
hamsters	NNS	nsubjpass	I-Organism
were	VBD	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
four	CD	nummod	O
equal	JJ	amod	O
groups	NNS	nmod	O
.	.	punct	O

Mice	NNS	nsubjpass	O
primed	VBN	acl	O
with	IN	prep	O
dimethyl	JJ	amod	O
-	HYPH	punct	O
benz	NN	compound	O
[	-LRB-	punct	O
a	DT	det	O
]	-RRB-	punct	O
anthracene	NN	nsubjpass	O
(	-LRB-	punct	O
DMBA	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
topically	RB	advmod	O
exposed	VBN	ROOT	O
to	IN	case	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod	O
(	-LRB-	punct	O
82	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
micromol	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
positive	JJ	amod	O
control	NN	conj	O
,	,	punct	O
12	CD	nummod	O
-	HYPH	punct	O
O	NNP	compound	O
-	HYPH	punct	O
tetradecanoylphorbol	NN	compound	O
-	:	punct	O
13	CD	nummod	O
-	HYPH	punct	O
acetate	NN	appos	O
(	-LRB-	punct	O
TPA	NN	dep	O
,	,	punct	O
17	CD	nummod	O
nmol	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
twice	RB	advmod	O
weekly	RB	advmod	O
for	IN	case	O
29	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O
Group	NN	compound	B-Organism
1	CD	nummod	I-Organism
animals	NNS	nsubj	I-Organism
had	VBD	ROOT	O
the	DT	det	O
left	JJ	amod	B-Organism_subdivision
buccal	JJ	amod	I-Organism_subdivision
pouches	NNS	nsubj	I-Organism_subdivision
painted	VBD	ccomp	O
three	CD	nummod	O
times	NNS	npadvmod	O
weekly	RB	advmod	O
with	IN	prep	O
7	CD	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
12	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
dimethylbenz	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
a	LS	det	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
anthracene	NN	pobj	I-Simple_chemical
(	-LRB-	punct	O
DMBA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
for	IN	prep	O
14	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Group	NN	compound	B-Organism
2	CD	nummod	I-Organism
animals	NNS	nsubj	I-Organism
had	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
procedure	NN	dobj	O
of	IN	case	O
DMBA	JJ	compound	B-Simple_chemical
applications	NNS	nmod	O
but	CC	cc	O
also	RB	advmod	O
received	VBD	conj	O
alpha	NN	compound	B-Simple_chemical
tocopherol	NN	dobj	I-Simple_chemical
.	.	punct	O

AMI	NN	compound	O
control	NN	compound	O
group	NN	nsubj	O
received	VBD	ROOT	O
equal	JJ	amod	O
volume	NN	compound	O
physiological	JJ	amod	O
saline	NN	dobj	O
.	.	punct	O
Groups	NNS	nsubj	B-Organism
3	CD	nummod	I-Organism
and	CC	cc	O
4	CD	conj	B-Organism
were	VBD	ROOT	O
vitamin	NN	compound	B-Simple_chemical
E	NN	attr	I-Simple_chemical
and	CC	cc	O
untreated	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

Angiogenic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
aqueous	JJ	amod	O
humor	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
by	IN	mark	O
measuring	VBG	advcl	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
with	IN	case	O
factor	NN	nmod	B-Gene_or_gene_product
8	CD	nummod	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
antigen	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	O
F8	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
RA	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
which	WDT	nsubj	O
identifies	VBZ	acl:relcl	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Subsequently	RB	advmod	O
this	DT	det	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
TGFbeta	NN	nmod	O
and	CC	cc	O
TGFalpha	NN	conj	O
an	DT	det	O
EGF	NN	compound	O
receptor	NN	compound	O
ligand	NN	dep	O
.	.	punct	O
TGF	NN	compound	B-Gene_or_gene_product
alpha	NN	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
studied	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
appropriate	JJ	amod	O
antibody	NN	nmod	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
study	NN	nsubjpass	O
with	IN	case	O
specific	JJ	amod	O
antisera	NNS	nmod	O
was	VBD	auxpass	O
done	VBN	ROOT	O
.	.	punct	O
Staining	NN	nsubjpass	O
was	VBD	auxpass	O
effected	VBN	ROOT	O
by	IN	agent	O
the	DT	det	O
standard	JJ	amod	O
avidin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
biotin	NN	compound	B-Simple_chemical
horseradish	JJ	compound	B-Organism
peroxidase	NN	compound	B-Gene_or_gene_product
system	NN	pobj	O
.	.	punct	O

Papilloma	NN	compound	O
formation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
DMBA	NNP	compound	O
-	HYPH	punct	O
TPA	NN	nmod	O
-	:	punct	O
and	CC	cc	O
DMBA	NNP	compound	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	npadvmod	O
-	HYPH	punct	O
exposed	VBN	amod	O
animals	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
skin	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	nmod:npmod	O
-	HYPH	punct	O
Cum	NNP	compound	O
-	HYPH	punct	O
OOH	NNP	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
.	.	punct	O
Mean	NNP	amod	O
tumour	NN	compound	B-Cancer
volume	NN	nsubj	O
was	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	acomp	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
vitamin	NN	compound	B-Simple_chemical
E	NN	compound	I-Simple_chemical
group	NN	nmod	O
compared	VBN	prep	O
to	TO	prep	O
the	DT	det	O
tumour	NN	compound	B-Cancer
control	NN	compound	O
group	NN	pobj	O
.	.	punct	O

Collagen	NNP	nmod:npmod	O
-	HYPH	punct	O
poly	JJ	amod	O
glycolic	JJ	amod	O
acid	NN	compound	O
hybrid	NN	compound	O
matrix	NN	nsubj	O
with	IN	case	O
basic	JJ	amod	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	nmod	O
accelerated	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
granulation	NN	compound	O
tissue	NN	compound	O
formation	NN	conj	O
in	IN	case	O
diabetic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
Angiogenesis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
DMBA	NNP	compound	B-Simple_chemical
-	HYPH	punct	O
vitamin	NN	compound	B-Simple_chemical
E	NN	compound	I-Simple_chemical
group	NN	nmod	O
and	CC	cc	O
TGF	NN	compound	B-Gene_or_gene_product
alpha	NN	compound	I-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	conj	O
.	.	punct	O

Both	DT	det	O
agents	NNS	nsubj	O
inhibited	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
induced	VBD	amod	O
apoptosis	NN	conj	O
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
tumors	NNS	nmod	O
from	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O
It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
by	IN	case	O
vitamin	NN	compound	B-Simple_chemical
E	NN	nmod	I-Simple_chemical
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
additional	JJ	amod	O
mechanism	NN	ccomp	O
for	IN	case	O
the	DT	det	O
anticancer	NN	compound	B-Cancer
action	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	B-Simple_chemical
E	NN	nmod	I-Simple_chemical
.	.	punct	O

Curcumin	NN	nsubj	O
inhibits	VBZ	ROOT	O
metastatic	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
cell	NN	nmod	O
through	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	nmod	O
by	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappa	NN	compound	O
B	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O
Curcumin	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
immortalized	VBN	amod	O
NIH	NN	compound	B-Cell
3T3	NN	nmod	I-Cell
and	CC	cc	O
malignant	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
.	.	punct	O

Organic	JJ	amod	O
peroxides	NNS	nsubj	O
,	,	punct	O
widely	RB	advmod	O
used	VBN	acl	O
in	IN	case	O
the	DT	det	O
chemical	NN	amod	O
and	CC	cc	O
pharmaceutical	JJ	conj	O
industries	NNS	nmod	O
,	,	punct	O
can	MD	aux	O
act	VB	ROOT	O
as	IN	case	O
skin	NN	compound	O
tumor	NN	compound	O
promoters	NNS	nmod	O
and	CC	cc	O
cause	VB	conj	O
epidermal	JJ	amod	O
hyperplasia	NN	dobj	O
.	.	punct	O
Curcumin	NN	nsubjpass	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	relcl	O
a	DT	det	O
widely	RB	advmod	O
used	VBN	amod	O
dietary	JJ	amod	O
pigment	NN	attr	O
and	CC	cc	O
spice	NN	conj	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
inhibitor	NN	xcomp	O
of	IN	case	O
tumor	NN	compound	B-Cancer
promotion	NN	nmod	O
in	IN	case	O
mouse	NN	compound	B-Organism
skin	NN	compound	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

Curcumin	NN	nsubj	O
inhibits	VBZ	ROOT	O
metastatic	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
cell	NN	nmod	O
through	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
urokinase	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
plasminogen	NN	compound	O
activator	NN	nmod	O
by	IN	case	O
NF	NN	compound	O
-	HYPH	punct	O
kappa	NN	compound	O
B	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
curcumin	NN	nsubj	B-Simple_chemical
induces	VBZ	ccomp	O
cell	NN	compound	B-Cell
shrinkage	NN	dobj	O
,	,	punct	O
chromatin	NN	compound	B-Cellular_component
condensation	NN	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	conj	O
,	,	punct	O
characteristics	NNS	appos	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
in	IN	case	O
immortalized	VBN	amod	O
mouse	NN	compound	B-Organism
embryo	NN	compound	B-Developing_anatomical_structure
fibroblast	NN	nmod	B-Cell
NIH	NN	compound	I-Cell
3T3	NN	compound	I-Cell
erb	NN	compound	B-Gene_or_gene_product
B2	NN	compound	I-Gene_or_gene_product
oncogene	NN	npadvmod	O
-	:	punct	O
transformed	VBN	amod	O
NIH	NN	compound	B-Cell
3T3	NN	dep	I-Cell
,	,	punct	O
mouse	NN	compound	B-Organism
sarcoma	NN	compound	B-Cell
S180	NN	conj	I-Cell
,	,	punct	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	appos	I-Cell
HT	NN	compound	I-Cell
-	HYPH	punct	I-Cell
29	CD	dep	I-Cell
,	,	punct	O
human	JJ	amod	B-Organism
kidney	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	appos	I-Cell
293	CD	nummod	I-Cell
,	,	punct	O
and	CC	cc	O
human	JJ	amod	B-Organism
hepatocellular	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
Hep	NN	compound	I-Cell
G2	NN	compound	I-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
primary	JJ	amod	B-Cell
culture	NN	conj	I-Cell
of	IN	case	O
mouse	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblast	NN	compound	I-Cell
C3H	NN	nmod	I-Cell
10T1	NN	nummod	I-Cell
/	SYM	punct	I-Cell
2	CD	nummod	I-Cell
,	,	punct	O
rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblast	NN	conj	I-Cell
,	,	punct	O
and	CC	cc	O
human	JJ	amod	B-Organism
foreskin	NN	compound	B-Cell
fibroblast	NN	compound	I-Cell
cells	NNS	conj	I-Cell
in	IN	case	O
a	DT	det	O
concentration	NN	nmod	O
-	:	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Curcumin	NN	nsubjpass	O
(	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
7	CD	nummod	O
-	HYPH	punct	O
bis	NN	dep	O
(	-LRB-	punct	O
4	CD	nummod	O
-	HYPH	punct	O
hydroxy	NN	compound	O
-	HYPH	punct	O
3	CD	nummod	O
-	HYPH	punct	O
methoxyphenyl	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
1	CD	nummod	O
,	,	punct	O
6	CD	nummod	O
-	HYPH	punct	O
heptadiene	NN	compound	O
-	,	punct	O
3	CD	conj	O
,	,	punct	O
5	CD	nummod	O
-	HYPH	punct	O
dione	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
extracted	VBN	ROOT	O
from	IN	prep	O
the	DT	det	O
plant	NN	compound	O
Curcuma	NNP	compound	O
longa	NN	pobj	O
.	.	punct	O
Many	JJ	amod	O
cellular	JJ	amod	B-Cell
and	CC	cc	O
biochemical	JJ	conj	O
effects	NNS	nsubjpass	O
of	IN	case	O
curcumin	NN	nmod	B-Simple_chemical
in	IN	case	O
mouse	NN	compound	B-Organism
fibroblast	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
inhibition	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
PKC	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
phorbol	NN	compound	B-Simple_chemical
12	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
myristate	NN	compound	I-Simple_chemical
13	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetate	NN	compound	I-Simple_chemical
treatment	NN	nmod	O
,	,	punct	O
inhibition	NN	appos	O
of	IN	case	O
tyrosine	NN	compound	B-Amino_acid
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
arachidonic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
AA	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
metabolism	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
how	WRB	advmod	O
inhibition	NN	nsubj	O
of	IN	case	O
glucose	NN	compound	O
metabolism	NN	nmod	O
could	MD	aux	O
affect	VB	ccomp	O
death	NN	nmod:npmod	O
receptor	NN	nmod:npmod	O
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
tumor	NN	compound	O
cells	NNS	nmod	O
of	IN	case	O
diverse	JJ	amod	O
origin	NN	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
of	IN	case	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
the	DT	det	O
PKC	NN	compound	B-Gene_or_gene_product
inhibitor	NN	compound	O
staurosporine	NN	nmod	B-Simple_chemical
,	,	punct	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
herbimycin	NN	compound	B-Simple_chemical
A	NN	appos	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
the	DT	det	O
AA	NN	compound	B-Simple_chemical
metabolism	NN	compound	O
inhibitor	NN	compound	O
quinacrine	NN	conj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptotic	JJ	amod	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

Transformants	NNS	nsubj	O
induced	VBN	acl	O
by	IN	agent	O
5	CD	nummod	O
-	HYPH	punct	O
azacytidine	NN	pobj	O
lost	VBD	ROOT	O
c	NN	nmod:npmod	O
-	HYPH	punct	O
myc	NN	npadvmod	O
-	HYPH	punct	O
induced	VBN	amod	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
MnSO4	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
transformants	NNS	nsubj	O
showed	VBD	parataxis	O
a	DT	det	O
higher	JJR	amod	O
degree	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
than	IN	case	O
the	DT	det	O
parental	JJ	amod	O
Rat	NN	compound	O
6	CD	nummod	O
/	:	punct	O
c	NN	compound	O
-	HYPH	punct	O
myc	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
some	DT	det	O
immortalized	VBN	amod	O
and	CC	cc	O
transformed	VBN	conj	O
cells	NNS	nmod	B-Cell
,	,	punct	O
blocking	VBG	acl	O
the	DT	det	O
cellular	JJ	amod	B-Cell
signal	NN	compound	O
transduction	NN	dobj	O
might	MD	aux	O
trigger	VB	ccomp	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
expression	NN	ROOT	O
of	IN	case	O
specific	JJ	amod	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphatases	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
neoplastically	RB	advmod	O
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
neu	NN	compound	O
oncogene	NN	nmod	O
.	.	punct	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
signaling	NN	ROOT	O
and	CC	cc	O
effects	NNS	conj	O
on	IN	case	O
receptor	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
signal	NN	compound	O
transduction	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	aux	O
try	VB	xcomp	O
to	TO	mark	O
understand	VB	xcomp	O
why	WRB	advmod	O
DU145	NN	compound	O
cells	NNS	nsubj	O
are	VBP	cop	O
resistant	JJ	ccomp	O
to	TO	case	O
CH	NN	nmod	O
-	:	punct	O
11	CD	nummod	O
and	CC	cc	O
determine	VB	conj	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	dobj	O
utilized	VBN	acl	O
by	IN	case	O
AdGFPFasL	NN	nmod	O
(	-LRB-	punct	O
TET	NN	appos	O
)	-RRB-	punct	O
to	TO	mark	O
induce	VB	advcl	O
apoptosis	NN	dobj	O
in	IN	case	O
these	DT	det	O
Fas	NN	nmod:npmod	O
-	HYPH	punct	O
resistant	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	nsubjpass	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
MCF	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
10AT	CD	amod	I-Cell
preneoplastic	JJ	amod	I-Cell
human	JJ	amod	I-Cell
breast	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
>	NN	dobj	O
2	CD	dep	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	ROOT	O
in	IN	case	O
Fas	NN	compound	O
protein	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
elevation	NN	conj	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
caspase	NN	compound	O
-	:	punct	O
8	CD	nummod	O
and	CC	cc	O
caspase	NN	conj	O
-	:	punct	O
3	CD	nmod	O
.	.	punct	O
Treatment	NN	ROOT	O
with	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
for	IN	case	O
48	CD	nummod	O
h	NN	compound	O
induced	VBD	amod	O
apoptosis	NN	nmod	O
with	IN	case	O
cells	NNS	nmod	B-Cell
exhibiting	VBG	acl	O
typical	JJ	amod	O
apoptotic	JJ	amod	O
features	NNS	dobj	O
including	VBG	case	O
loss	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
contact	NN	nmod	O
,	,	punct	O
condensation	NN	appos	O
of	IN	case	O
chromatin	NN	nmod	B-Cellular_component
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
this	DT	det	O
possibility	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
bovine	JJ	amod	O
lactoferrin	NN	nmod	O
on	IN	case	O
Fas	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	nmod	O
,	,	punct	O
activation	NN	appos	O
of	IN	case	O
caspase	NN	compound	O
-	:	punct	O
8	CD	nmod	O
and	CC	cc	O
caspase	NN	compound	O
-	:	punct	O
3	CD	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	O
fragmentation	NN	conj	O
in	IN	case	O
the	DT	det	O
colon	NN	compound	O
mucosa	NN	nmod	O
of	IN	case	O
AOM	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	O
.	.	punct	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	nsubj	O
occurred	VBD	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
anti	VB	amod	O
-	HYPH	punct	O
Fas	NN	compound	B-Gene_or_gene_product
treatment	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Neuroblastoma	NN	compound	O
cells	NNS	nsubj	O
grown	VBN	acl	O
in	IN	case	O
coculture	NN	compound	O
conditioned	JJ	amod	O
media	NNS	nmod	O
show	VBP	appos	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	nmod	O
-	SYM	punct	O
2	CD	nummod	O
and	CC	cc	O
decreased	VBN	amod	O
Fas	NN	compound	O
ligand	NN	compound	O
levels	NNS	dobj	O
.	.	punct	O
Anti	NNP	compound	O
-	HYPH	punct	O
Fas	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
decreased	VBN	amod	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
levels	NNS	nmod	O
,	,	punct	O
while	IN	mark	O
bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
and	CC	cc	O
bax	NN	compound	B-Gene_or_gene_product
protein	NN	conj	O
levels	NNS	nsubj	O
remained	VBD	advcl	O
unaffected	JJ	xcomp	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
>	NN	dobj	O
2	CD	dep	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	ROOT	O
in	IN	case	O
Fas	NN	compound	O
protein	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
elevation	NN	conj	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
both	DT	cc:preconj	O
caspase	NN	compound	O
-	:	punct	O
8	CD	nummod	O
and	CC	cc	O
caspase	NN	conj	O
-	:	punct	O
3	CD	nmod	O
.	.	punct	O
Cells	NNS	nsubj	B-Cell
treated	VBN	acl	O
with	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
exhibited	VBD	ROOT	O
increased	VBN	amod	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
c	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
met	VBN	amod	I-Gene_or_gene_product
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	compound	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod	O
.	.	punct	O

The	DT	det	O
neuroblastoma	NN	compound	O
cells	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
Fas	NN	compound	O
ligand	NN	nmod	O
.	.	punct	O
Immunoprecipitation	NN	compound	O
experiments	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
Fas	NN	nsubj	B-Gene_or_gene_product
associated	VBN	acl	O
with	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	nmod	I-Gene_or_gene_product
and	CC	cc	O
c	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
met	VBN	ccomp	I-Gene_or_gene_product
in	IN	case	O
untreated	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
neuroblastoma	NN	compound	O
cells	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
Fas	NN	compound	O
ligand	NN	nmod	O
.	.	punct	O
Treatment	NN	nsubj	O
with	IN	case	O
anti	JJ	compound	O
-	HYPH	punct	O
Fas	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
significantly	RB	advmod	O
decreased	VBD	ROOT	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
erbB2	NNP	dobj	I-Gene_or_gene_product
and	CC	cc	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
c	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
met	VBN	amod	I-Gene_or_gene_product
association	NN	conj	O
.	.	punct	O

The	DT	det	O
neuroblastoma	NN	compound	O
cells	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
Fas	NN	compound	O
ligand	NN	nmod	O
.	.	punct	O
Anti	NNP	compound	O
-	HYPH	punct	O
Fas	NN	compound	B-Gene_or_gene_product
treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	B-Cell
caused	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
p120	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
GAP	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
,	,	punct	O
ERK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
phosphorylation	NN	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
Grb2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Sosl	NNP	conj	B-Gene_or_gene_product
and	CC	cc	O
MEK	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	O
ERK	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
association	NN	conj	O
.	.	punct	O

p53	NN	compound	O
up	RB	prt	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
and	CC	cc	O
p53	NN	compound	O
-	:	punct	O
mediated	VBN	amod	O
proliferation	NN	compound	O
arrest	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
were	VBD	auxpass	O
substantiated	VBN	ROOT	O
using	VBG	xcomp	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
intrinsic	JJ	nmod	O
and	CC	cc	O
the	DT	det	O
extrinsic	JJ	amod	O
apoptotic	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Fas	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
signaling	NN	nsubj	O
exerted	VBD	ccomp	O
a	DT	det	O
suppressive	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
on	IN	case	O
downstream	JJ	amod	O
effectors	NNS	conj	O
of	IN	case	O
receptor	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
signal	NN	compound	O
transduction	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
ensuring	VBG	advcl	O
cell	NN	compound	B-Cell
death	NN	dobj	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
lung	NN	compound	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
mice	NNS	nmod	O
by	IN	case	O
adeno	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
virus	NN	nmod:npmod	O
-	HYPH	punct	O
mediated	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
vasostatin	NN	nmod	O
.	.	punct	O
Prevention	NN	ROOT	O
of	IN	case	O
hepatic	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
metastases	NNS	nmod	O
in	IN	case	O
rats	NNS	nmod	B-Organism
with	IN	case	O
herpes	NN	compound	B-Organism
viral	JJ	amod	I-Organism
vaccines	NNS	nmod	O
and	CC	cc	O
gamma	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
interferon	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Systematic	JJ	amod	O
proteomic	JJ	amod	O
studying	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
of	IN	case	O
hepatocellular	JJ	amod	O
carcinoma	NN	compound	O
(	-LRB-	punct	O
HCC	NN	appos	O
)	-RRB-	punct	O
metastasis	NN	nmod	O
remains	VBZ	ROOT	O
challenging	VBG	xcomp	O
.	.	punct	O
Previous	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
gammaIFN	JJ	nsubj	B-Gene_or_gene_product
decreases	VBZ	ccomp	O
metastatic	JJ	amod	O
hepatic	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
by	IN	mark	O
stimulating	VBG	advcl	O
Kupffer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
(	-LRB-	punct	O
KC	NN	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
murine	JJ	amod	O
models	NNS	nmod	O
,	,	punct	O
the	DT	det	O
latter	JJ	nsubj	O
produces	VBZ	ROOT	O
a	DT	det	O
hyperproliferative	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	nmod	O
,	,	punct	O
confers	VBZ	conj	O
resistance	NN	dobj	O
to	TO	case	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
enhances	VBZ	conj	O
cell	NN	compound	O
survival	NN	dobj	O
.	.	punct	O
The	DT	det	O
present	JJ	amod	O
studies	NNS	nsubj	O
examine	VBP	ROOT	O
whether	IN	mark	O
lymphocyte	NN	compound	B-Cell
stimulation	NN	nsubj	O
via	IN	case	O
cells	NNS	nmod	B-Cell
engineered	VBN	acl	O
to	TO	mark	O
secrete	VB	xcomp	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	dobj	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
decreases	VBZ	ccomp	O
hepatic	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
,	,	punct	O
and	CC	cc	O
whether	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
macrophages	NNS	nmod	B-Cell
and	CC	cc	O
lymphocytes	NNS	conj	B-Cell
is	VBZ	cop	O
more	RBR	advmod	O
effective	JJ	conj	O
than	IN	prep	O
either	CC	pobj	O
individually	RB	advmod	O
.	.	punct	O

The	DT	det	O
simian	JJ	amod	O
virus	NN	compound	O
40	CD	nummod	O
(	-LRB-	punct	O
SV40	NN	appos	O
)	-RRB-	punct	O
large	JJ	amod	O
tumor	NN	compound	O
(	-LRB-	punct	O
T	NN	compound	O
)	-RRB-	punct	O
antigen	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
transform	VB	xcomp	O
cells	NNS	dobj	O
in	IN	case	O
cultures	NNS	nmod	O
and	CC	cc	O
induce	VB	conj	O
tumors	NNS	dobj	O
in	IN	case	O
experimental	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O
Rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
immunized	VBN	ROOT	O
with	IN	case	O
irradiated	JJ	amod	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transduced	VBN	acl	O
by	IN	case	O
herpes	NN	compound	B-Organism
viral	JJ	amod	I-Organism
amplicon	NN	compound	O
vectors	NNS	nmod	O
containing	VBG	acl	O
the	DT	det	O
genes	NNS	dobj	O
for	IN	case	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	intj	I-Gene_or_gene_product
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
or	CC	cc	O
LacZ	NN	conj	B-Gene_or_gene_product
.	.	punct	O

Three	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	nsubjpass	O
from	IN	case	O
three	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
implanted	VBN	ROOT	O
into	IN	prep	O
the	DT	det	O
scar	NN	pobj	O
.	.	punct	O
On	IN	prep	O
day	NN	pobj	O
18	CD	nummod	O
,	,	punct	O
half	NN	nsubjpass	O
of	IN	prep	O
each	DT	det	O
group	NN	pobj	B-Organism
was	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
U	NNP	compound	O
gammaIFN	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
or	CC	cc	O
saline	NN	conj	B-Simple_chemical
intraperitoneally	RB	advmod	B-Immaterial_anatomical_entity
for	IN	case	O
3	CD	nummod	O
d	NN	nmod	O
.	.	punct	O

Three	CD	nummod	O
weeks	NNS	npadvmod	O
later	RB	advmod	O
,	,	punct	O
2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	nsubjpass	O
from	IN	case	O
three	CD	nummod	O
groups	NNS	nmod	O
were	VBD	auxpass	O
implanted	VBN	ROOT	O
into	IN	prep	O
the	DT	det	O
scar	NN	pobj	O
.	.	punct	O
On	IN	prep	O
day	NN	pobj	O
21	CD	nummod	O
,	,	punct	O
all	DT	det	O
rats	NNS	nsubj	B-Organism
received	VBD	ROOT	O
5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
hepatoma	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
intrasplenically	RB	advmod	B-Immaterial_anatomical_entity
.	.	punct	O

After	IN	case	O
tumor	NN	compound	O
implantation	NN	nmod	O
the	DT	det	O
animals	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
weekly	RB	advmod	O
during	IN	case	O
several	JJ	amod	O
months	NNS	nmod	O
for	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O
On	IN	case	O
day	NN	nmod	O
41	CD	nummod	O
,	,	punct	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
killed	VBN	ROOT	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
nodules	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
counted	VBN	conj	O
.	.	punct	O

Temporal	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
physiological	JJ	amod	O
spaces	NNS	nmod	O
,	,	punct	O
protein	NN	compound	O
expression	NN	conj	O
of	IN	case	O
transporters	NNS	nmod	O
and	CC	cc	O
enzymes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
enalapril	JJ	amod	O
removal	NN	conj	O
were	VBD	auxpass	O
appraised	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
liver	NN	compound	O
tumor	NN	compound	O
model	NN	nmod	O
developed	VBN	acl	O
from	IN	case	O
male	JJ	amod	O
Wag	NNP	compound	O
/	SYM	punct	O
Rij	NNP	compound	O
rats	NNS	nmod	O
after	IN	case	O
the	DT	det	O
intraportal	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
CC531	NN	compound	O
colon	NN	compound	O
adenocarcinoma	NN	compound	O
cells	NNS	nmod	O
;	:	punct	O
sham	VBN	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
preparations	NNS	nsubj	O
received	VBD	parataxis	O
PBS	NN	dobj	O
.	.	punct	O
Separate	JJ	amod	O
rats	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
splenocyte	NN	compound	B-Cell
and	CC	cc	O
KC	NN	conj	B-Cell
harvest	VBP	dobj	O
for	IN	case	O
assessment	NN	nmod	O
of	IN	case	O
lymphocyte	NN	nmod	B-Cell
-	:	punct	O
and	CC	cc	O
macrophage	NN	compound	B-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
tumor	NN	compound	B-Cell
cell	NN	conj	I-Cell
kill	NN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

While	IN	mark	O
TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
tumor	NN	compound	O
differentiation	NN	dobj	O
or	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
tumor	NN	compound	O
cell	NN	compound	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
.	.	punct	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
or	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
vaccines	NNS	conj	O
or	CC	cc	O
gammaIFN	NN	conj	B-Gene_or_gene_product
decreased	VBD	ROOT	O
tumor	NN	compound	B-Cancer
nodules	NNS	dobj	I-Cancer
significantly	RB	advmod	O
(	-LRB-	punct	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NNP	dep	I-Gene_or_gene_product
13	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
4	CD	nummod	O
,	,	punct	O
IL	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
14	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
6	CD	nummod	O
vs	CC	cc	O
.	.	punct	O
control	NN	ROOT	O
75	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
24	CD	dep	O
,	,	punct	O
P	NN	appos	O
<	-LRB-	dobj	O
0	CD	nummod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

After	IN	ROOT	O
GM	NNP	compound	O
-	HYPH	punct	O
CSF	NN	pobj	O
or	CC	cc	O
IL	NN	compound	O
-	:	punct	O
3	CD	conj	O
,	,	punct	O
a	DT	det	O
1	CD	appos	O
.	.	punct	O
2	CD	nummod	O
-	:	punct	O
to	TO	prep	O
2	CD	pobj	O
.	.	punct	O
4	CD	meta	O
-	HYPH	punct	O
fold	JJ	dep	O
increase	NN	nsubjpass	O
in	IN	case	O
S	NN	compound	O
-	HYPH	punct	O
phase	NN	compound	O
cells	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
nine	CD	nmod	O
of	IN	case	O
14	CD	nummod	O
GM	NNP	compound	O
-	HYPH	punct	O
CSF	NN	nmod	O
and	CC	cc	O
seven	CD	nummod	O
of	IN	case	O
11	CD	nummod	O
IL	NN	compound	O
-	:	punct	O
3	CD	nummod	O
cases	NNS	conj	O
.	.	punct	O
Combination	NN	compound	O
therapy	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
effective	JJ	ROOT	O
,	,	punct	O
and	CC	cc	O
completely	RB	advmod	O
eliminated	VBD	conj	O
tumor	NN	dobj	B-Cancer
in	IN	case	O
4	CD	nummod	O
of	IN	case	O
12	CD	nummod	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
GM	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
8	CD	conj	O
of	IN	case	O
11	CD	nummod	O
IFN	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
IL	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
animals	NNS	nmod	O
.	.	punct	O

Temporal	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
physiological	JJ	amod	O
spaces	NNS	nmod	O
,	,	punct	O
protein	NN	compound	O
expression	NN	conj	O
of	IN	case	O
transporters	NNS	nmod	O
and	CC	cc	O
enzymes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
enalapril	JJ	amod	O
removal	NN	conj	O
were	VBD	auxpass	O
appraised	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
liver	NN	compound	O
tumor	NN	compound	O
model	NN	nmod	O
developed	VBN	acl	O
from	IN	case	O
male	JJ	amod	O
Wag	NNP	compound	O
/	SYM	punct	O
Rij	NNP	compound	O
rats	NNS	nmod	O
after	IN	case	O
the	DT	det	O
intraportal	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
CC531	NN	compound	O
colon	NN	compound	O
adenocarcinoma	NN	compound	O
cells	NNS	nmod	O
;	:	punct	O
sham	VBN	nmod:npmod	O
-	HYPH	punct	O
operated	VBN	amod	O
preparations	NNS	nsubj	O
received	VBD	parataxis	O
PBS	NN	dobj	O
.	.	punct	O
Additional	JJ	amod	O
rats	NNS	nsubj	B-Organism
underwent	VBD	ROOT	O
partial	JJ	amod	O
hepatectomy	NN	dobj	O
,	,	punct	O
an	DT	det	O
immunosuppressive	JJ	amod	O
procedure	NN	appos	O
known	VBN	acl	O
to	TO	mark	O
accelerate	VB	xcomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
hepatic	JJ	amod	B-Cancer
tumor	NN	nmod	I-Cancer
,	,	punct	O
following	VBG	case	O
tumor	NN	compound	B-Cancer
challenge	NN	nmod	O
.	.	punct	O

Almost	RB	advmod	O
all	DT	det	O
patients	NNS	nsubj	O
respond	VBP	ROOT	O
to	TO	case	O
G	NN	compound	O
-	HYPH	punct	O
CSF	NN	nmod	O
with	IN	case	O
increased	VBN	amod	O
neutrophils	NNS	nmod	O
,	,	punct	O
reduced	VBN	amod	O
infections	NNS	conj	O
,	,	punct	O
and	CC	cc	O
improved	VBD	conj	O
survival	NN	dobj	O
.	.	punct	O
Therapy	NN	nsubj	O
was	VBD	cop	O
equally	RB	advmod	O
effective	JJ	ROOT	O
in	IN	case	O
this	DT	det	O
immunosuppressive	JJ	amod	O
setting	NN	nmod	O
.	.	punct	O

Inoculation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
in	IN	case	O
athymic	JJ	amod	O
mice	NNS	nmod	O
decreases	VBZ	ROOT	O
mouse	NN	compound	O
spleen	NN	compound	O
natural	JJ	amod	O
killer	NN	compound	O
(	-LRB-	punct	O
NK	NN	appos	O
)	-RRB-	punct	O
cell	NN	compound	O
activity	NN	dobj	O
.	.	punct	O
Vaccination	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
enhancement	NN	nmod	O
of	IN	case	O
splenocyte	NN	npadvmod	B-Cell
-	HYPH	punct	O
mediated	VBN	amod	O
tumoricidal	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
gammaIFN	NN	nmod	B-Gene_or_gene_product
is	VBZ	auxpass	O
mediated	VBN	parataxis	O
by	IN	case	O
KC	NN	nmod	B-Cell
.	.	punct	O

Liver	NN	compound	O
tissue	NN	compound	O
spaces	NNS	nsubj	O
,	,	punct	O
investigated	VBN	acl	O
with	IN	case	O
multiple	JJ	amod	O
indicator	NN	compound	O
dilution	NN	compound	O
technique	NN	nmod	O
in	IN	case	O
liver	NN	compound	O
perfusion	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
were	VBD	aux	O
unchanged	JJ	ROOT	O
at	IN	case	O
week	NN	nmod	O
3	CD	nummod	O
after	IN	case	O
tumor	NN	compound	O
induction	NN	nmod	O
.	.	punct	O
GM	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
CSF	NN	nsubj	I-Gene_or_gene_product
and	CC	cc	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
vaccine	NN	compound	O
therapy	NN	conj	O
and	CC	cc	O
pretreatment	NN	conj	O
with	IN	case	O
gammaIFN	JJ	nmod	B-Gene_or_gene_product
represent	NN	ROOT	O
effective	JJ	amod	O
strategies	NNS	dobj	O
in	IN	mark	O
reducing	VBG	advcl	O
hepatic	JJ	amod	B-Cancer
tumor	NN	dobj	I-Cancer
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
1B3	NN	nmod	O
and	CC	cc	O
DC101	NN	conj	O
in	IN	case	O
BxPC	JJ	compound	O
-	SYM	punct	O
3	CD	nummod	O
xenograft	NN	npadvmod	O
-	HYPH	punct	O
bearing	VBG	amod	O
mice	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
tumor	NN	compound	O
regression	NN	nmod	O
in	IN	case	O
58	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	O
compared	VBN	advcl	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
18	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
DC101	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O
Combination	NN	compound	O
therapy	NN	nsubj	O
targets	VBZ	ROOT	O
both	CC	cc:preconj	O
lymphocytes	NNS	dobj	B-Cell
and	CC	cc	O
macrophages	NNS	conj	B-Cell
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
more	RBR	advmod	O
effective	JJ	conj	O
in	IN	mark	O
reducing	VBG	advcl	O
tumor	NN	dobj	B-Cancer
than	IN	case	O
either	CC	det	O
therapy	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
two	CD	nummod	O
type	NN	nmod	O
II	CD	nummod	O
-	HYPH	punct	O
like	IN	case	O
tumor	NN	compound	O
hexokinase	NN	compound	O
RNA	NN	compound	O
transcripts	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
Insulin	NNP	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	acl	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	pobj	I-Gene_or_gene_product
I	NN	nsubj	I-Gene_or_gene_product
induces	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
hexokinase	NN	compound	B-Gene_or_gene_product
RNA	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Dependence	NN	nsubj	O
on	IN	case	O
glycolysis	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	appos	O
of	IN	case	O
malignant	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O
Increased	VBN	amod	O
glycolysis	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
characteristic	NN	ROOT	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cancer	NN	compound	O
cells	NNS	nsubj	O
depend	VBP	ROOT	O
mostly	RB	advmod	O
on	IN	case	O
glycolysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
aerobic	JJ	amod	O
breakdown	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
into	IN	case	O
ATP	NN	nmod	O
.	.	punct	O
Though	IN	mark	O
less	RBR	advmod	O
efficient	JJ	advcl	O
in	IN	prep	O
energy	NN	compound	O
production	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
ensures	VBZ	ROOT	O
continuous	JJ	amod	O
supply	NN	dobj	O
of	IN	prep	O
energy	NN	pobj	O
and	CC	cc	O
phosphometabolites	VBZ	conj	O
for	IN	case	O
biosynthesis	NN	nmod	O
enabling	VBG	acl	O
metastatic	JJ	amod	B-Cell
and	CC	cc	O
less	RBR	advmod	O
vascularized	JJ	conj	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
to	TO	mark	O
proliferate	VB	xcomp	O
even	RB	advmod	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
maintain	VB	ROOT	O
an	DT	det	O
elevated	JJ	amod	O
glycolytic	JJ	amod	O
rate	NN	dobj	O
,	,	punct	O
cancerous	JJ	amod	O
or	CC	cc	O
proliferating	VBG	conj	O
cells	NNS	nsubj	O
alter	VBP	parataxis	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	dobj	O
of	IN	case	O
rate	NN	compound	O
limiting	VBG	amod	O
glycolytic	JJ	amod	O
enzymes	NNS	nmod	O
.	.	punct	O
Since	IN	mark	O
hexokinase	NN	nsubj	B-Gene_or_gene_product
is	VBZ	advcl	O
the	DT	det	O
first	JJ	amod	O
rate	NN	compound	O
limiting	VBG	amod	O
enzyme	NN	attr	O
in	IN	case	O
the	DT	det	O
glycolytic	JJ	amod	O
pathway	NN	nmod	O
,	,	punct	O
elevated	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
Type	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
hexokinase	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
tumors	NNS	nmod	B-Cancer
are	VBP	cop	O
of	IN	case	O
great	JJ	amod	O
significance	NN	ROOT	O
in	IN	case	O
this	DT	det	O
context	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	compound	O
muscle	NN	compound	O
cells	NNS	nsubj	O
express	VBP	ROOT	O
only	RB	advmod	O
a	DT	det	O
approximately	RB	advmod	O
5	CD	nmod	O
.	.	punct	O
5	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
type	NN	compound	O
II	CD	nummod	O
HK	NN	compound	O
RNA	NN	compound	O
transcript	NN	dobj	O
.	.	punct	O
Under	IN	case	O
normal	JJ	amod	O
conditions	NNS	nmod	O
insulin	NN	nsubj	B-Gene_or_gene_product
regulates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
hexokinase	NN	compound	B-Gene_or_gene_product
Type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
isoenzyme	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
predominantly	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
muscle	NN	nmod	B-Organ
.	.	punct	O

Cancer	NN	compound	O
cells	NNS	nsubj	O
secrete	VBP	ROOT	O
soluble	JJ	amod	O
factors	NNS	dobj	O
which	WDT	nsubj	O
can	MD	aux	O
induce	VB	acl:relcl	O
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
capillary	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	compound	O
cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
overexpress	VBP	ROOT	O
insulin	NN	dobj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
and	CC	cc	O
their	PRP$	nmod:poss	O
receptors	NNS	conj	O
which	WDT	nsubj	O
mimic	VBP	acl:relcl	O
many	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
insulin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

RNA	NN	compound	O
encoding	NN	compound	O
glucokinase	NN	nsubjpass	O
(	-LRB-	punct	O
GK	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
high	JJ	amod	O
-	HYPH	punct	O
Km	NNP	compound	O
HK	NN	compound	O
isozyme	NN	appos	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
only	RB	advmod	O
in	IN	case	O
cancer	NN	compound	O
cells	NNS	nmod	O
originating	VBG	acl	O
from	IN	case	O
liver	NN	nmod	O
and	CC	cc	O
pancreas	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
GK	NN	dobj	O
under	IN	case	O
normal	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O
This	DT	nsubj	O
prompted	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
examine	VB	xcomp	O
a	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
insulin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factors	NNS	nmod	I-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
hexokinase	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
two	CD	nummod	O
type	NN	nmod	O
II	CD	nummod	O
-	HYPH	punct	O
like	IN	case	O
tumor	NN	compound	O
hexokinase	NN	compound	O
RNA	NN	compound	O
transcripts	NNS	nmod	O
in	IN	case	O
cancer	NN	compound	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
Our	PRP$	nmod:poss	O
experiments	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
insulin	NN	nsubj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	case	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	appos	I-Gene_or_gene_product
I	CD	nummod	I-Gene_or_gene_product
indeed	RB	advmod	O
induces	VBZ	ccomp	O
hexokinase	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
concentration	NN	nmod	O
and	CC	cc	O
time	NN	nmod:npmod	O
dependent	JJ	conj	O
manner	NN	dep	O
in	IN	case	O
two	CD	nummod	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
we	PRP	nsubj	O
studied	VBD	conj	O
.	.	punct	O

Cells	NNS	ROOT	O
transformed	VBN	acl	O
by	IN	case	O
Rous	JJ	amod	O
sarcoma	NN	compound	O
virus	NN	compound	O
release	NN	compound	O
transforming	VBG	amod	O
growth	NN	compound	O
factors	NNS	dobj	O
.	.	punct	O
Suppression	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
by	IN	case	O
the	DT	det	O
3	CD	nummod	O
'	''	punct	O
untranslated	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
mel	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	dep	I-Gene_or_gene_product
in	IN	case	O
3Y1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	dep	O
E6	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
genes	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
18	CD	nummod	I-Organism
.	.	punct	O

Previous	JJ	amod	O
work	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
LMP1	NN	compound	O
gene	NN	nsubj	O
of	IN	case	O
EBV	NN	nmod	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transform	VB	xcomp	O
certain	JJ	amod	O
established	JJ	amod	O
rodent	JJ	amod	O
fibroblast	NN	compound	O
cell	NN	compound	O
lines	NNS	dobj	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
the	DT	det	O
tumorigenicity	NN	dobj	O
of	IN	case	O
some	DT	det	O
human	JJ	amod	O
epithelial	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
.	.	punct	O
By	IN	mark	O
introducing	VBG	advcl	O
a	DT	det	O
cDNA	NN	compound	O
library	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
rat	NN	compound	B-Organism
embryonic	JJ	amod	B-Cell
fibroblast	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
several	JJ	amod	O
morphologically	RB	advmod	O
flat	JJ	amod	O
revertants	NNS	dobj	O
of	IN	case	O
rat	NN	compound	B-Organism
3Y1	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	dep	O
E6	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
genes	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
18	CD	nummod	I-Organism
(	-LRB-	punct	O
HPV18	NN	appos	B-Organism
)	-RRB-	punct	O
.	.	punct	O

Previously	RB	advmod	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
N1	NN	nsubj	O
(	-LRB-	punct	O
ic	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
N2	NN	conj	O
(	-LRB-	punct	O
ic	NN	appos	O
)	-RRB-	punct	O
could	MD	aux	O
transform	VB	ccomp	O
E1A	NN	compound	O
immortalized	JJ	amod	O
baby	NN	compound	O
rat	NN	compound	O
kidney	NN	compound	O
cells	NNS	dobj	O
(	-LRB-	punct	O
RKE	NN	appos	O
)	-RRB-	punct	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
From	IN	prep	O
one	CD	pobj	O
of	IN	prep	O
the	DT	det	O
revertants	NNS	pobj	O
,	,	punct	O
we	PRP	nsubj	O
recovered	VBD	ROOT	O
a	DT	det	O
0	CD	nummod	O
.	.	punct	O
2	CD	nummod	O
-	HYPH	punct	O
kb	NN	compound	O
cDNA	NN	dobj	O
,	,	punct	O
N56	NN	appos	B-Gene_or_gene_product
,	,	punct	O
that	WDT	nsubj	O
suppresses	VBZ	acl:relcl	O
the	DT	det	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
of	IN	case	O
the	DT	det	O
transformed	VBN	amod	B-Cell
3Y1	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
irrespective	JJ	amod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	dep	O
E6	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product
genes	NNS	dep	O
.	.	punct	O

A	DT	ROOT	O
4	CD	nummod	O
.	.	punct	O
0	CD	nummod	O
kb	NN	compound	O
mRNA	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	O
UFO	NN	compound	O
homolog	NN	nmod	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
different	JJ	amod	O
mouse	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O
The	DT	det	O
nucleotide	NN	compound	O
sequence	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cDNA	NN	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
identical	JJ	xcomp	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
3	CD	nummod	O
'	''	punct	O
untranslated	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
a	DT	det	O
putative	JJ	amod	O
mammalian	JJ	amod	B-Organism
polycomb	NN	compound	O
group	NN	compound	O
gene	NN	nmod	O
,	,	punct	O
mel	NN	xcomp	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
18	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
present	JJ	amod	O
series	NN	nsubj	O
supports	VBZ	ROOT	O
the	DT	det	O
theory	NN	dobj	O
that	IN	mark	O
opticin	NN	nsubjpass	O
is	VBZ	auxpass	O
produced	VBN	acl	O
by	IN	agent	O
the	DT	det	O
non	JJ	npadvmod	O
-	HYPH	punct	O
pigmented	VBN	amod	O
CBE	NN	pobj	O
throughout	IN	prep	O
adult	JJ	amod	O
life	NN	pobj	O
.	.	punct	O
Calretinin	NNP	ROOT	B-Gene_or_gene_product
.	.	punct	O

RAGE	NN	nsubj	O
(	-LRB-	punct	O
receptor	NN	appos	O
for	IN	case	O
AGE	NN	nmod	O
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
best	JJS	advmod	O
characterized	VBN	amod	O
signal	NN	compound	O
transduction	NN	compound	O
receptor	NN	ROOT	O
for	IN	case	O
AGEs	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
expressed	VBN	conj	O
on	IN	case	O
mesothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
A	DT	det	O
selective	JJ	amod	O
marker	NN	ROOT	O
of	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
neoplastic	JJ	conj	B-Cell
mesothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
serous	JJ	amod	B-Organism_substance
effusions	NNS	nmod	I-Organism_substance
.	.	punct	O

Immunohistochemical	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
positive	JJ	ccomp	O
for	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokeratins	NNS	nmod	O
(	-LRB-	punct	O
AE1	NN	compound	O
/	:	punct	O
AE3	NN	dep	O
,	,	punct	O
CAM5	NN	appos	O
.	.	punct	O
2	LS	ROOT	O
,	,	punct	O
epithelial	JJ	amod	O
membrane	NN	compound	O
antigen	NN	conj	O
and	CC	cc	O
cytokeratin	NN	conj	O
7	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
mesothelial	JJ	amod	O
markers	NNS	conj	O
(	-LRB-	punct	O
calretinin	NN	dep	O
,	,	punct	O
Wilms	NNP	nmod:poss	O
'	POS	case	O
tumour	NN	appos	O
1	CD	dep	O
and	CC	cc	O
D2	NN	conj	O
-	:	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
document	VB	dep	O
that	IN	mark	O
a	DT	det	O
polyclonal	JJ	amod	O
antiserum	NN	nsubj	B-Organism_substance
to	TO	case	O
calretinin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
29	CD	nummod	O
-	HYPH	punct	O
kd	NN	amod	O
calcium	NN	compound	B-Simple_chemical
-	HYPH	punct	O
binding	NN	compound	O
protein	NN	appos	O
,	,	punct	O
consistently	RB	advmod	O
decorates	VBZ	ccomp	O
normal	JJ	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cell
mesothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
in	IN	case	O
cytologic	JJ	amod	B-Tissue
preparations	NNS	nmod	I-Tissue
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	O
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
STUDY	NNP	compound	O
DESIGN	NN	nsubjpass	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
three	CD	nummod	O
archival	NN	compound	O
cytologic	JJ	amod	B-Tissue
specimens	NNS	nsubjpass	I-Tissue
from	IN	case	O
eight	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
histologically	RB	advmod	O
confirmed	VBN	amod	O
malignant	JJ	amod	B-Cancer
mesothelioma	NN	nmod	I-Cancer
and	CC	cc	O
13	CD	conj	O
from	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
metastatic	JJ	amod	O
serous	JJ	amod	B-Organism_substance
effusions	NNS	nmod	I-Organism_substance
were	VBD	auxpass	O
destained	VBN	ROOT	O
and	CC	cc	O
then	RB	advmod	O
immunostained	VBN	conj	O
with	IN	case	O
anticalretinin	NN	compound	O
antiserum	NN	nmod	B-Organism_substance
.	.	punct	O

Immunohistochemical	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
positive	JJ	ccomp	O
for	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokeratins	NNS	nmod	O
(	-LRB-	punct	O
AE1	NN	compound	O
/	:	punct	O
AE3	NN	dep	O
,	,	punct	O
CAM5	NN	appos	O
.	.	punct	O
2	LS	ROOT	O
,	,	punct	O
epithelial	JJ	amod	O
membrane	NN	compound	O
antigen	NN	conj	O
and	CC	cc	O
cytokeratin	NN	conj	O
7	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
mesothelial	JJ	amod	O
markers	NNS	conj	O
(	-LRB-	punct	O
calretinin	NN	dep	O
,	,	punct	O
Wilms	NNP	nmod:poss	O
'	POS	case	O
tumour	NN	appos	O
1	CD	dep	O
and	CC	cc	O
D2	NN	conj	O
-	:	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
For	IN	case	O
investigation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
suspensions	NNS	nmod	I-Cell
,	,	punct	O
four	CD	nummod	O
pleural	JJ	amod	B-Organism_substance
fluids	NNS	nsubjpass	I-Organism_substance
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
anticalretinin	NN	compound	O
antiserum	NN	nmod	B-Organism_substance
.	.	punct	O

Immunohistochemical	JJ	amod	O
study	NN	nsubjpass	O
with	IN	case	O
specific	JJ	amod	O
antisera	NNS	nmod	O
was	VBD	auxpass	O
done	VBN	ROOT	O
.	.	punct	O
After	IN	prep	O
cytocentrifugation	NN	pobj	O
the	DT	det	O
specimens	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
stained	VBN	ROOT	O
in	IN	case	O
accordance	NN	nmod	O
with	IN	case	O
the	DT	det	O
alkaline	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
anti	NN	compound	O
-	HYPH	punct	O
alkaline	NN	compound	B-Gene_or_gene_product
phosphatase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
APAAP	NN	appos	O
)	-RRB-	punct	O
method	NN	nmod	O
.	.	punct	O

After	IN	case	O
4	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	O
are	VBP	cop	O
harvested	VBN	ROOT	O
and	CC	cc	O
cytospins	NNS	conj	O
made	VBN	acl	O
for	IN	prep	O
immunostaining	NN	pobj	O
.	.	punct	O
For	IN	case	O
electron	NN	compound	O
microscopic	JJ	amod	O
examination	NN	nmod	O
the	DT	det	O
cell	NN	compound	B-Cell
suspensions	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
then	RB	advmod	O
incubated	VBN	ROOT	O
with	IN	case	O
gold	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
labeled	VBN	amod	O
antirabbit	NN	compound	O
antibody	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Receptor	NN	compound	O
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
visualized	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
on	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
mum	NN	compound	O
sections	NNS	nmod	O
of	IN	case	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
diagnostic	JJ	amod	O
sensitivity	NN	nsubj	O
of	IN	case	O
this	DT	det	O
new	JJ	amod	O
immunocytochemical	JJ	amod	O
approach	NN	nmod	O
reached	VBD	appos	O
100	CD	nummod	O
%	NN	dobj	O
for	IN	case	O
the	DT	det	O
eight	CD	nummod	O
malignant	JJ	amod	B-Cancer
mesotheliomas	NNS	nmod	I-Cancer
investigated	VBN	acl	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
invasive	JJ	amod	O
carcinomas	NNS	nmod	O
(	-LRB-	punct	O
0	CD	nummod	O
/	SYM	punct	O
12	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
Only	RB	advmod	O
3	CD	nsubj	O
of	IN	case	O
the	DT	det	O
13	CD	nummod	O
adenocarcinomas	NNS	nmod	B-Cancer
metastatic	JJ	amod	O
to	TO	case	O
the	DT	det	O
serous	JJ	amod	B-Organism_substance
membranes	NNS	nmod	I-Organism_substance
included	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	cop	O
weakly	RB	advmod	O
reactive	JJ	ROOT	O
,	,	punct	O
accounting	VBG	advcl	O
for	IN	prep	O
81	CD	compound	O
%	NN	compound	O
specificity	NN	pobj	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
positive	JJ	ccomp	O
for	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokeratins	NNS	nmod	O
(	-LRB-	punct	O
AE1	NN	compound	O
/	:	punct	O
AE3	NN	dep	O
,	,	punct	O
CAM5	NN	appos	O
.	.	punct	O
2	LS	ROOT	O
,	,	punct	O
epithelial	JJ	amod	O
membrane	NN	compound	O
antigen	NN	conj	O
and	CC	cc	O
cytokeratin	NN	conj	O
7	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
mesothelial	JJ	amod	O
markers	NNS	conj	O
(	-LRB-	punct	O
calretinin	NN	dep	O
,	,	punct	O
Wilms	NNP	nmod:poss	O
'	POS	case	O
tumour	NN	appos	O
1	CD	dep	O
and	CC	cc	O
D2	NN	conj	O
-	:	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
Binding	NN	nsubjpass	O
of	IN	case	O
anticalretinin	NN	compound	O
antiserum	NN	nmod	B-Organism_substance
to	TO	mark	O
living	VBG	acl	O
mesothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
was	VBD	auxpass	O
consistently	RB	advmod	O
documented	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
four	CD	nummod	O
cases	NNS	nmod	O
investigated	VBD	acl	O
.	.	punct	O

Immunohistochemical	JJ	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
epithelioid	JJ	amod	O
cells	NNS	nsubj	O
were	VBD	cop	O
strongly	RB	advmod	O
positive	JJ	ccomp	O
for	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokeratins	NNS	nmod	O
(	-LRB-	punct	O
AE1	NN	compound	O
/	:	punct	O
AE3	NN	dep	O
,	,	punct	O
CAM5	NN	appos	O
.	.	punct	O
2	LS	ROOT	O
,	,	punct	O
epithelial	JJ	amod	O
membrane	NN	compound	O
antigen	NN	conj	O
and	CC	cc	O
cytokeratin	NN	conj	O
7	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
mesothelial	JJ	amod	O
markers	NNS	conj	O
(	-LRB-	punct	O
calretinin	NN	dep	O
,	,	punct	O
Wilms	NNP	nmod:poss	O
'	POS	case	O
tumour	NN	appos	O
1	CD	dep	O
and	CC	cc	O
D2	NN	conj	O
-	:	punct	O
40	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
CONCLUSION	NN	nsubj	O
:	:	punct	O
Calretinin	NN	nsubj	B-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
very	RB	advmod	O
useful	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
positive	JJ	amod	O
identification	NN	nmod	O
of	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
tumor	NN	conj	B-Cell
mesothelial	JJ	amod	I-Cell
cells	NNS	dep	I-Cell
in	IN	case	O
serous	JJ	amod	B-Organism_substance
effusions	NNS	nmod	I-Organism_substance
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
HLA	NN	compound	O
-	HYPH	punct	O
DR	NN	compound	O
mRNA	NN	nmod	O
.	.	punct	O
Prognostic	JJ	amod	O
value	NN	ROOT	O
of	IN	case	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
dendritic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
infiltration	NN	conj	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
biological	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
of	IN	case	O
the	DT	det	O
remnant	JJ	amod	O
stomach	NN	nmod	O
(	-LRB-	punct	O
RSC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O
We	PRP	nsubj	O
attempted	VBD	ROOT	O
to	TO	mark	O
correlate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Gene_or_gene_product
leukocyte	NN	compound	I-Gene_or_gene_product
antigen	NN	compound	I-Gene_or_gene_product
DR	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
infiltration	NN	conj	O
by	IN	case	O
S	NNP	nmod:npmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
100	CD	compound	I-Gene_or_gene_product
-	HYPH	punct	O
protein	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
dendritic	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
clinicopathologic	JJ	amod	O
features	NNS	nmod	O
in	IN	case	O
165	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
HLA	NN	compound	O
-	HYPH	punct	O
DR	NN	compound	O
mRNA	NN	nmod	O
.	.	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
histologic	JJ	amod	O
type	NN	nmod	O
.	.	punct	O

CD40	NN	compound	O
expression	NN	nsubj	O
on	IN	case	O
human	JJ	amod	O
lung	NN	compound	O
cancer	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
metastatic	JJ	amod	O
spread	NN	nmod	O
.	.	punct	O
Infiltration	NN	nsubj	O
of	IN	case	O
dendritic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
correlated	VBD	ROOT	O
negatively	RB	advmod	O
with	IN	case	O
distant	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
,	,	punct	O
clinical	JJ	amod	O
stage	NN	conj	O
,	,	punct	O
and	CC	cc	O
peritoneal	JJ	amod	B-Multi-tissue_structure
invasion	NN	conj	O
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
correlates	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
HLA	NN	compound	O
-	HYPH	punct	O
DR	NN	compound	O
mRNA	NN	nmod	O
.	.	punct	O
There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
HLA	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
DR	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
infiltration	NN	conj	O
by	IN	case	O
dendritic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Low	JJ	amod	O
sVAP	NN	compound	O
-	:	punct	O
1	CD	nummod	O
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	dep	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
in	IN	case	O
gastric	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
In	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
resectable	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
grade	NN	nsubj	O
of	IN	case	O
infiltrating	VBG	amod	O
dendritic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
suitable	JJ	amod	O
predictor	NN	ROOT	O
of	IN	case	O
prognosis	NN	nmod	O
.	.	punct	O

A	DT	det	O
key	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
the	DT	det	O
integrin	NN	compound	O
alpha2beta1	NN	nmod	O
in	IN	case	O
experimental	JJ	amod	O
and	CC	cc	O
developmental	JJ	conj	O
angiogenesis	NN	nmod	O
.	.	punct	O
Integrin	NN	compound	B-Gene_or_gene_product
alphavbeta3	NN	compound	I-Gene_or_gene_product
requirement	NN	ROOT	O
for	IN	case	O
sustained	JJ	amod	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
during	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	dep	O
for	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
relies	VBZ	conj	O
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Angiogenesis	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
growth	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
vascular	JJ	amod	B-Cell
cell	NN	compound	I-Cell
adhesion	NN	compound	O
events	NNS	conj	O
.	.	punct	O

Neovascularization	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
essential	JJ	amod	O
event	NN	appos	O
for	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
.	.	punct	O
Integrins	NNS	nsubj	B-Gene_or_gene_product
and	CC	cc	O
growth	NN	compound	O
factors	NNS	conj	O
are	VBP	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
activating	VBG	advcl	O
the	DT	det	O
ras	NN	dobj	B-Gene_or_gene_product
/	:	punct	O
MAP	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
pathway	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
yet	CC	advmod	O
how	WRB	advmod	O
these	DT	det	O
signals	NNS	nsubj	O
influence	VBP	csubj	O
endothelial	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
during	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	parataxis	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
inhibits	VBZ	ROOT	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
adhesion	NN	conj	O
,	,	punct	O
tubular	JJ	amod	O
network	NN	compound	O
formation	NN	conj	O
,	,	punct	O
and	CC	cc	O
bFGF	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
neovascularization	NN	conj	O
in	IN	case	O
a	DT	det	O
chick	JJ	amod	O
chorioallantoic	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O
Upon	IN	case	O
initiation	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
with	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
chick	NN	compound	B-Organism
chorioallantoic	JJ	amod	B-Multi-tissue_structure
membrane	NN	nmod	I-Multi-tissue_structure
(	-LRB-	punct	O
CAM	NN	appos	B-Multi-tissue_structure
)	-RRB-	punct	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
MAP	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
kinase	NN	intj	I-Gene_or_gene_product
(	-LRB-	punct	O
ERK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
5	CD	nummod	O
min	NN	nmod	O
yet	RB	advmod	O
was	VBD	cop	O
sustained	JJ	conj	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
20	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Mitogen	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
protein	NN	compound	O
kinase	NN	compound	O
(	-LRB-	punct	O
MAPK	NN	appos	O
)	-RRB-	punct	O
activities	NNS	nsubjpass	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
.	.	punct	O
The	DT	det	O
initial	JJ	amod	O
wave	NN	nsubj	O
of	IN	case	O
ERK	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
(	-LRB-	punct	O
5	CD	compound	O
-	SYM	punct	O
120	CD	nummod	O
min	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
refractory	JJ	ROOT	O
to	TO	case	O
integrin	NN	compound	B-Simple_chemical
antagonists	NNS	nmod	I-Simple_chemical
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
sustained	JJ	amod	O
activity	NN	nsubj	O
(	-LRB-	punct	O
4	CD	compound	O
-	SYM	punct	O
20	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
depended	VBD	parataxis	O
on	IN	case	O
integrin	NN	nmod	B-Gene_or_gene_product
alphavbeta3	NN	nummod	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
beta1	NN	compound	B-Gene_or_gene_product
integrins	NNS	conj	I-Gene_or_gene_product
.	.	punct	O

VPF	NNP	nsubj	O
/	:	punct	O
VEGF	NN	nsubj	O
induced	VBD	ROOT	O
dermal	JJ	amod	O
microvascular	JJ	amod	O
EC	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
mRNAs	NNS	nmod	O
encoding	VBG	acl	O
the	DT	det	O
alphav	JJ	dobj	O
and	CC	cc	O
beta3	NN	compound	O
integrin	NN	compound	O
subunits	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
increased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	det	O
alphavbeta3	NN	compound	O
heterodimer	NN	nmod	O
at	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
,	,	punct	O
and	CC	cc	O
VPF	NNP	compound	O
/	:	punct	O
VEGF	NN	nsubj	O
also	RB	advmod	O
induced	VBD	conj	O
mRNA	NN	dobj	O
encoding	NN	acl	O
osteopontin	NN	dobj	O
(	-LRB-	punct	O
OPN	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
alphavbeta3	NN	compound	O
ligand	NN	appos	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
MAP	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
kinase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
MEK	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
during	IN	case	O
this	DT	det	O
sustained	JJ	amod	O
alphavbeta3	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
ERK	NN	compound	B-Gene_or_gene_product
signal	NN	nmod	O
blocked	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
while	IN	mark	O
not	RB	neg	O
influencing	VBG	advcl	O
preexisting	VBG	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	dobj	I-Multi-tissue_structure
on	IN	case	O
the	DT	det	O
CAM	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
retroviral	JJ	amod	O
gene	NN	compound	O
transfer	NN	compound	O
approach	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MEK5	NN	compound	O
/	:	punct	O
ERK5	NN	compound	O
signaling	NN	nmod	O
strongly	RB	advmod	O
inhibits	VBZ	ccomp	O
EC	NN	compound	O
migration	NN	dobj	O
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
massive	JJ	amod	O
morphological	JJ	amod	O
changes	NNS	nmod	O
.	.	punct	O
Inhibition	NN	nsubj	O
of	IN	case	O
MEK	NN	nmod	B-Gene_or_gene_product
also	RB	advmod	O
blocked	VBD	ROOT	O
growth	NN	compound	O
factor	NN	nmod:npmod	O
induced	VBD	amod	O
migration	NN	dobj	O
but	CC	cc	O
not	RB	cc	O
adhesion	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
a	DT	det	O
similar	JJ	amod	O
vascular	JJ	amod	O
phenotype	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
morpholino	NN	amod	O
-	HYPH	punct	O
mediated	VBN	amod	O
knockdown	NN	nmod	O
of	IN	case	O
the	DT	det	O
integrin	NN	compound	O
alpha2	NN	compound	O
subunit	NN	nmod	O
.	.	punct	O
Therefore	RB	advmod	O
,	,	punct	O
angiogenesis	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
sustained	JJ	amod	O
ERK	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
regulated	VBN	acl	O
by	IN	case	O
the	DT	det	O
ligation	NN	compound	O
state	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
a	DT	det	O
growth	NN	compound	O
factor	NN	compound	O
receptor	NN	nmod	O
and	CC	cc	O
integrin	NN	conj	B-Gene_or_gene_product
alphavbeta3	NN	nummod	I-Gene_or_gene_product
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
basic	JJ	amod	O
fibroblast	NN	compound	O
growth	NN	compound	O
factor	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O
Basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	ROOT	I-Gene_or_gene_product
:	:	punct	O
a	DT	det	O
missing	VBG	amod	O
link	NN	dep	O
between	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
VII	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
increased	VBN	amod	O
collagenase	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
in	IN	case	O
recessive	JJ	amod	O
dystrophic	JJ	amod	O
epidermolysis	NN	compound	O
bullosa	NN	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Head	NNP	nsubjpass	O
and	CC	cc	O
neck	NN	conj	O
squamous	JJ	amod	O
cell	NN	compound	O
carcinomas	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	dep	O
to	TO	mark	O
overexpress	VB	xcomp	O
hypoxia	NN	compound	O
-	HYPH	punct	O
inducible	JJ	amod	O
factor	NN	dep	O
(	-LRB-	punct	O
HIF	NN	compound	O
)	-RRB-	punct	O
-	:	punct	O
1alpha	NN	dobj	O
,	,	punct	O
a	DT	det	O
transcription	NN	compound	O
factor	NN	appos	O
that	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
angiogenesis	NN	compound	O
factors	NNS	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
programmed	VBN	intj	O
and	CC	cc	O
therapy	NN	conj	O
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O
BACKGROUND	NN	ROOT	O
:	:	punct	O
Patients	NNS	nsubj	B-Organism
with	IN	case	O
recessive	JJ	amod	O
dystrophic	JJ	amod	O
epidermolysis	NN	compound	O
bullosa	NN	nmod	O
(	-LRB-	punct	O
RDEB	NN	appos	O
)	-RRB-	punct	O
have	VBP	dep	O
deficiencies	NNS	dobj	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
VII	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
have	VBP	conj	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
fibroblast	NN	compound	B-Gene_or_gene_product
collagenase	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
a	DT	det	O
greatly	RB	advmod	O
increased	VBN	amod	O
risk	NN	conj	O
of	IN	case	O
cutaneous	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Proteolytic	JJ	amod	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
during	IN	case	O
wound	NN	compound	O
healing	NN	nmod	O
.	.	punct	O
Patients	NNS	nsubj	B-Organism
with	IN	case	O
other	JJ	amod	O
genetic	JJ	amod	O
blistering	NN	compound	O
disorders	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
have	VB	ROOT	O
elevated	JJ	amod	O
collagenase	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
an	DT	det	O
increased	VBN	amod	O
risk	NN	conj	O
of	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
despite	IN	case	O
chronic	JJ	amod	O
wounding	NN	nmod	O
.	.	punct	O

TSP	NN	compound	O
-	:	punct	O
2	CD	nummod	O
deficiency	NN	nsubj	O
dramatically	RB	advmod	O
enhanced	VBD	ROOT	O
susceptibility	NN	dobj	O
to	TO	case	O
skin	NN	compound	O
carcinogenesis	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
accelerated	VBN	amod	O
and	CC	cc	O
increased	VBN	conj	O
tumor	NN	compound	O
formation	NN	nmod	O
.	.	punct	O
The	DT	det	O
connection	NN	nsubjpass	O
between	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
VII	NN	compound	I-Gene_or_gene_product
deficiency	NN	nmod	O
,	,	punct	O
increased	VBN	amod	O
collagenase	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	conj	I-Cancer
is	VBZ	auxpass	O
not	RB	neg	O
understood	VBN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
function	NN	nsubj	O
of	IN	case	O
bFGF	NN	nmod	O
in	IN	case	O
parenchymal	JJ	amod	O
cells	NNS	nmod	O
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O
MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Urine	NN	appos	B-Organism_substance
from	IN	case	O
81	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RDEB	NN	nmod	O
(	-LRB-	punct	O
39	CD	nummod	O
patients	NNS	appos	B-Organism
)	-RRB-	punct	O
,	,	punct	O
junctional	JJ	amod	O
epidermolysis	NN	compound	O
bullosa	NN	conj	O
(	-LRB-	punct	O
JEB	NN	dep	O
;	:	punct	O
12	CD	nummod	O
patients	NNS	appos	B-Organism
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
epidermolysis	NN	compound	O
bullosa	NN	compound	O
simplex	NN	conj	O
(	-LRB-	punct	O
EBS	NN	dep	O
;	:	punct	O
30	CD	nummod	O
patients	NNS	appos	B-Organism
)	-RRB-	punct	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
unaffected	JJ	amod	O
family	NN	compound	O
members	NNS	conj	O
of	IN	case	O
RDEB	NN	compound	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
33	CD	nummod	O
patients	NNS	appos	B-Organism
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
basic	JJ	amod	B-Gene_or_gene_product
fibroblast	NN	compound	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
bFGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
using	VBG	acl	O
a	DT	det	O
sensitive	JJ	amod	O
radioimmunoassay	NN	dobj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
From	IN	prep	O
June	NNP	pobj	O
2004	CD	nummod	O
to	IN	prep	O
December	NNP	pobj	O
2007	CD	nummod	O
,	,	punct	O
132	CD	nummod	O
patients	NNS	nsubj	O
received	VBD	dep	O
diagnosis	NN	dobj	O
and	CC	cc	O
treatment	NN	conj	O
in	IN	case	O
our	PRP$	nmod:poss	O
hospital	NN	nmod	O
.	.	punct	O
These	DT	det	O
patients	NNS	nsubj	B-Organism
included	VBD	ROOT	O
many	JJ	dobj	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
enrolled	VBN	acl:relcl	O
in	IN	prep	O
the	DT	det	O
Epidermolysis	NNP	compound	O
Bullosa	NNP	compound	O
Registry	NNP	pobj	O
and	CC	cc	O
others	NNS	conj	O
who	WP	nsubjpass	O
were	VBD	auxpass	O
referred	VBN	relcl	O
by	IN	agent	O
their	PRP$	poss	O
physicians	NNS	pobj	O
.	.	punct	O

Immunodetection	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
bFGF	NN	compound	O
mouse	NN	compound	O
monoclonal	JJ	amod	O
antibody	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
react	VB	xcomp	O
with	IN	case	O
recombinant	JJ	amod	O
human	JJ	amod	O
bFGF	NN	nmod	O
in	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
specifically	RB	advmod	O
neutralize	VB	conj	O
the	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	O
on	IN	case	O
bovine	JJ	amod	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
RESULTS	NNS	ROOT	O
:	:	punct	O
Fifty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
RDEB	NN	nmod	O
had	VBD	appos	O
elevated	JJ	amod	O
levels	NNS	dobj	O
(	-LRB-	punct	O
greater	JJR	dep	O
than	IN	dep	O
5000	CD	nummod	O
pg	NN	compound	O
/	SYM	punct	O
g	NN	dep	O
)	-RRB-	punct	O
of	IN	case	O
urinary	JJ	amod	B-Organism_substance
bFGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	B-Organism
with	IN	case	O
JEB	NN	nmod	O
had	VBD	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
percent	NN	nsubj	O
of	IN	case	O
clinically	RB	advmod	O
unaffected	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
had	VBD	ROOT	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
13	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
EBS	NN	nmod	O
had	VBD	conj	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
The	DT	det	O
frequency	NN	nsubj	O
of	IN	case	O
elevated	JJ	amod	O
bFGF	NN	compound	B-Gene_or_gene_product
values	NNS	nmod	O
among	IN	case	O
all	DT	det	O
groups	NNS	nmod	O
was	VBD	cop	O
statistically	RB	advmod	O
significant	JJ	ROOT	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
002	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
RDEB	NN	compound	O
patients	NNS	nmod	B-Organism
were	VBD	auxpass	O
significantly	RB	advmod	O
elevated	JJ	conj	O
compared	VBN	case	O
with	IN	case	O
those	DT	nmod	O
of	IN	case	O
other	JJ	amod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
05	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Strong	JJ	amod	O
staining	NN	nsubjpass	O
for	IN	case	O
bFGF	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
cardiac	JJ	amod	O
muscle	NN	compound	O
fibers	NNS	nmod	O
,	,	punct	O
smooth	VB	amod	O
muscle	NN	compound	O
cells	NNS	appos	O
of	IN	case	O
mid	NN	compound	O
-	HYPH	punct	O
size	NN	compound	O
blood	NN	compound	O
vessels	NNS	nmod	O
,	,	punct	O
the	DT	det	O
gut	NN	appos	O
and	CC	cc	O
the	DT	det	O
myometrium	NN	conj	O
,	,	punct	O
in	IN	case	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
neurons	NNS	nmod	O
and	CC	cc	O
cerebellar	JJ	amod	O
Purkinje	NN	compound	O
cells	NNS	conj	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
epithelial	JJ	amod	O
cells	NNS	conj	O
of	IN	case	O
the	DT	det	O
bronchi	NN	nmod	O
,	,	punct	O
colon	NN	conj	O
,	,	punct	O
endometrium	NN	conj	O
,	,	punct	O
and	CC	cc	O
sweat	NN	compound	O
gland	NN	compound	O
ducts	NNS	conj	O
of	IN	prep	O
the	DT	det	O
skin	NN	pobj	O
.	.	punct	O
CONCLUSIONS	NNS	dep	O
:	:	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
patients	NNS	nsubj	B-Organism
with	IN	case	O
RDEB	NN	nmod	O
have	VBP	ccomp	O
elevated	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
increased	VBN	amod	O
fibroblast	NN	compound	B-Gene_or_gene_product
collagenase	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Immunodetection	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
bFGF	NN	compound	O
mouse	NN	compound	O
monoclonal	JJ	amod	O
antibody	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
react	VB	xcomp	O
with	IN	case	O
recombinant	JJ	amod	O
human	JJ	amod	O
bFGF	NN	nmod	O
in	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
specifically	RB	advmod	O
neutralize	VB	conj	O
the	DT	det	O
mitogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
bFGF	NN	nmod	O
on	IN	case	O
bovine	JJ	amod	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
treatment	NN	dobj	O
for	IN	case	O
RDEB	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
,	,	punct	O
angiogenesis	NN	compound	O
inhibitors	NNS	conj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
antagonize	VB	acl:relcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
bFGF	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
this	DT	det	O
disorder	NN	nmod	O
.	.	punct	O

Joint	JJ	compound	O
haemorrhage	NN	nsubj	O
and	CC	cc	O
subsequent	JJ	amod	O
haemophilic	JJ	amod	O
arthropathy	JJ	conj	O
are	VBP	cop	O
significant	JJ	amod	O
complications	NNS	ROOT	O
in	IN	case	O
haemophilia	NN	nmod	O
.	.	punct	O
There	EX	expl	O
are	VBP	ROOT	O
currently	RB	advmod	O
no	DT	det	O
other	JJ	amod	O
means	NNS	attr	O
of	IN	prep	O
treatment	NN	pobj	O
for	IN	prep	O
this	DT	det	O
disorder	NN	pobj	O
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	relcl	O
a	DT	det	O
high	JJ	amod	O
morbidity	NN	dobj	O
and	CC	cc	O
mortality	NN	compound	O
rate	NN	conj	O
.	.	punct	O

a	DT	det	O
pilot	NN	compound	O
study	NN	ROOT	O
.	.	punct	O
The	DT	det	O
myoadipose	JJ	amod	B-Multi-tissue_structure
flap	NN	ROOT	I-Multi-tissue_structure
:	:	punct	O
a	DT	det	O
new	JJ	amod	O
composite	NN	appos	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Human	JJ	amod	O
fat	NN	compound	O
tissue	NN	compound	O
fragments	NNS	nsubjpass	O
from	IN	case	O
surgery	NN	nmod	O
were	VBD	auxpass	O
placed	VBN	appos	O
in	IN	prep	O
96	CD	nummod	O
-	HYPH	punct	O
well	JJ	compound	O
plates	NNS	pobj	O
,	,	punct	O
embedded	JJ	advcl	O
in	IN	case	O
fibrin	NN	compound	O
thrombin	NN	compound	O
clot	NN	nmod	O
and	CC	cc	O
overlaid	VB	conj	O
with	IN	case	O
cell	NN	compound	O
culture	NN	compound	O
media	NNS	nmod	O
containing	VBG	acl	O
20	CD	nummod	O
%	NN	amod	O
fetal	JJ	amod	O
bovine	JJ	amod	O
serum	NN	dobj	O
.	.	punct	O
A	DT	det	O
prefabricated	JJ	amod	O
composite	JJ	amod	B-Multi-tissue_structure
fat	NN	compound	I-Multi-tissue_structure
flap	JJ	nsubjpass	I-Multi-tissue_structure
consisting	VBG	acl	O
of	IN	case	O
muscle	NN	nmod	B-Tissue
woven	VBD	acl	O
into	IN	case	O
an	DT	det	O
anatomically	RB	advmod	O
distinct	JJ	amod	O
fat	NN	compound	B-Tissue
pad	NN	nmod	I-Tissue
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
rabbit	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

Twenty	CD	nummod	O
mature	JJ	amod	O
male	JJ	amod	O
New	NNP	compound	O
Zealand	NNP	compound	O
white	JJ	amod	O
rabbits	NNS	nsubjpass	O
(	-LRB-	punct	O
3	CD	compound	O
kg	NN	compound	O
weight	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
employed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
two	CD	nummod	O
empirically	RB	advmod	O
selected	VBN	amod	O
stimulation	NN	compound	O
paradigms	NNS	nmod	O
applied	VBN	acl	O
continuously	RB	advmod	O
for	IN	case	O
7	CD	compound	O
-	SYM	punct	O
21	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
using	VBG	xcomp	O
each	DT	det	O
animal	NN	dobj	O
as	IN	prep	O
its	PRP$	poss	O
own	JJ	amod	O
control	NN	pobj	O
.	.	punct	O
In	IN	case	O
17	CD	nummod	O
rabbits	NNS	nmod	B-Organism
,	,	punct	O
a	DT	det	O
2	CD	nummod	O
-	HYPH	punct	O
cm	NN	amod	O
strip	NN	nsubjpass	B-Multi-tissue_structure
of	IN	prep	O
latissimus	JJ	compound	B-Organ
dorsi	NN	pobj	I-Organ
was	VBD	auxpass	O
woven	VBN	ROOT	O
into	IN	prep	O
the	DT	det	O
parascapular	JJ	amod	B-Tissue
fat	NN	compound	I-Tissue
pad	NN	pobj	I-Tissue
on	IN	prep	O
one	CD	nummod	O
side	NN	pobj	O
,	,	punct	O
with	IN	prep	O
the	DT	det	O
contralateral	JJ	amod	B-Tissue
fat	NN	compound	I-Tissue
pad	NN	nsubj	I-Tissue
serving	VBG	pcomp	O
as	IN	prep	O
a	DT	det	O
control	NN	pobj	O
.	.	punct	O

This	DT	det	O
assay	NN	nsubj	O
allows	VBZ	ROOT	O
exploration	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O
At	IN	prep	O
3	CD	nummod	O
weeks	NNS	pobj	O
,	,	punct	O
the	DT	det	O
endogenous	JJ	amod	O
blood	NN	compound	B-Organism_substance
supply	NN	nsubjpass	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
control	NN	nmod	O
and	CC	cc	O
the	DT	det	O
experimental	JJ	amod	O
fat	NN	compound	B-Tissue
pads	NNS	conj	I-Tissue
was	VBD	auxpass	O
isolated	VBN	ROOT	O
and	CC	cc	O
ligated	VBN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
composite	JJ	amod	B-Multi-tissue_structure
fat	NN	compound	I-Multi-tissue_structure
/	:	punct	I-Multi-tissue_structure
muscle	NN	compound	I-Multi-tissue_structure
flap	NN	nsubjpass	I-Multi-tissue_structure
was	VBD	auxpass	O
transferred	VBN	conj	O
to	TO	prep	O
the	DT	det	O
chest	JJS	compound	B-Organism_subdivision
wall	NN	pobj	I-Organism_subdivision
.	.	punct	O

All	DT	det	O
wounds	NNS	nsubj	O
were	VBD	auxpass	O
fully	RB	advmod	O
re	NN	advmod	O
-	HYPH	punct	O
epithelialized	VBN	ROOT	O
by	IN	agent	O
10	CD	nummod	O
days	NNS	compound	O
post	JJ	compound	O
-	HYPH	punct	O
injury	NN	pobj	O
.	.	punct	O
At	IN	prep	O
6	CD	nummod	O
weeks	NNS	pobj	O
,	,	punct	O
animals	NNS	nsubjpass	O
were	VBD	auxpass	O
killed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
flaps	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
analyzed	VBN	conj	O
for	IN	prep	O
length	NN	pobj	O
,	,	punct	O
width	NN	conj	O
,	,	punct	O
and	CC	cc	O
weight	NN	conj	O
;	:	punct	O
perfused	VBN	dep	O
with	IN	case	O
fluorescein	NN	nmod	B-Simple_chemical
or	CC	cc	O
lead	VB	amod	B-Simple_chemical
oxide	NN	conj	I-Simple_chemical
;	:	punct	O
and	CC	cc	O
examined	VBN	conj	O
histologically	RB	advmod	O
.	.	punct	O

Cobalt	NN	compound	O
chloride	NN	nsubj	O
,	,	punct	O
a	DT	det	O
stimulator	NN	appos	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
(	-LRB-	punct	O
VEGF	NN	appos	O
)	-RRB-	punct	O
stimulated	VBD	ROOT	O
angiogenesis	NN	compound	O
initiation	NN	dobj	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
in	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
and	CC	cc	O
the	DT	det	O
HPVAM	NNP	conj	O
,	,	punct	O
but	CC	cc	O
at	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-	SYM	punct	O
10	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
blood	NN	compound	O
vessel	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
stimulated	VBN	conj	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
fat	NN	compound	O
assay	NN	nmod	O
.	.	punct	O
Significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
control	NN	amod	O
and	CC	cc	O
experimental	JJ	conj	O
fat	JJ	compound	B-Tissue
pads	NNS	nmod	I-Tissue
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
weight	NN	nmod	O
and	CC	cc	O
length	NN	conj	O
.	.	punct	O

This	DT	det	O
assay	NN	nsubj	O
allows	VBZ	ROOT	O
exploration	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
fat	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O
Experimental	JJ	amod	O
flaps	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
perfused	VBN	xcomp	O
fully	RB	advmod	O
with	IN	case	O
fluorescein	NN	nmod	B-Simple_chemical
and	CC	cc	O
lead	VB	amod	B-Simple_chemical
oxide	NN	conj	I-Simple_chemical
;	:	punct	O
control	JJ	amod	O
fat	JJ	compound	B-Tissue
pads	NNS	nsubjpass	I-Tissue
were	VBD	auxpass	O
found	VBN	parataxis	O
not	RB	neg	O
to	TO	mark	O
be	VB	auxpass	O
perfused	VBN	xcomp	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Blood	NN	compound	O
vessels	NNS	nsubj	O
initiated	VBD	appos	O
growth	NN	dobj	O
and	CC	cc	O
elongated	VBN	conj	O
from	IN	case	O
the	DT	det	O
fat	NN	compound	O
tissue	NN	compound	O
fragments	NNS	nmod	O
over	IN	case	O
15	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O
The	DT	det	O
lead	JJ	amod	B-Simple_chemical
oxide	NN	compound	I-Simple_chemical
group	NN	nsubj	O
revealed	VBD	ROOT	O
extensive	JJ	amod	O
growth	NN	dobj	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
from	IN	case	O
the	DT	det	O
latissimus	JJ	compound	B-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
into	IN	case	O
the	DT	det	O
experimental	JJ	amod	O
fat	NN	compound	B-Tissue
pad	NN	nmod	I-Tissue
.	.	punct	O

Both	DT	det	O
levels	NNS	nsubj	O
of	IN	case	O
dietary	JJ	amod	O
CLA	NN	nmod	O
showed	VBD	ROOT	O
similar	JJ	amod	O
effects	NNS	dobj	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
RBC	NN	compound	O
-	:	punct	O
containing	VBG	amod	O
vessels	NNS	nmod	O
per	IN	case	O
20x	NN	compound	O
field	NN	nmod	O
decreased	VBD	advcl	O
to	IN	case	O
a	DT	det	O
third	NN	nmod	O
of	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
control	NN	nmod	O
.	.	punct	O
No	DT	neg	O
vessels	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
visualized	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
controls	NNS	nmod	O
.	.	punct	O

Histological	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
blood	NN	compound	O
vessels	NNS	nmod	O
throughout	IN	case	O
the	DT	det	O
soft	JJ	amod	O
connective	JJ	amod	O
tissue	NN	nmod	O
in	IN	case	O
the	DT	det	O
distraction	NN	compound	O
gap	NN	nmod	O
.	.	punct	O
Finally	RB	advmod	O
,	,	punct	O
sections	NNS	nsubjpass	B-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
control	NN	nmod	O
and	CC	cc	O
experimental	JJ	conj	O
flaps	NNS	dep	B-Multi-tissue_structure
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
histologically	RB	advmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
This	DT	det	O
angiogenesis	NN	compound	O
assay	NN	nsubj	O
based	VBN	case	O
on	IN	case	O
human	JJ	amod	O
fat	NN	compound	O
tissue	NN	nmod	O
uses	VBZ	ROOT	O
three	CD	nummod	O
-	HYPH	punct	O
dimensionally	RB	advmod	O
intact	JJ	amod	O
human	JJ	amod	O
tissue	NN	dobj	O
.	.	punct	O
A	DT	det	O
preponderance	NN	nsubjpass	O
of	IN	case	O
viable	JJ	amod	O
fat	NN	nmod	B-Tissue
,	,	punct	O
with	IN	case	O
evidence	NN	nmod	O
of	IN	case	O
neovascularization	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
experimental	JJ	amod	O
flaps	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
necrotic	JJ	amod	O
fat	NN	advcl	B-Tissue
that	WDT	nsubj	O
characterized	VBD	acl:relcl	O
the	DT	det	O
controls	NNS	dobj	O
.	.	punct	O

The	DT	det	O
graft	NN	compound	O
size	NN	nsubj	O
is	VBZ	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
density	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
suspension	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
dependent	JJ	conj	O
on	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
number	NN	nmod	O
of	IN	mark	O
passages	NNS	acl	O
the	DT	det	O
cells	NNS	dobj	O
are	VBP	auxpass	O
taken	VBN	conj	O
through	IN	case	O
in	IN	case	O
culture	NN	nmod	O
prior	RB	case	O
to	TO	aux	O
grafting	VBG	advcl	O
or	CC	cc	O
on	IN	case	O
the	DT	det	O
postoperative	JJ	amod	O
survival	NN	compound	O
period	NN	conj	O
.	.	punct	O
We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
prefabrication	NN	nsubj	O
of	IN	case	O
a	DT	det	O
fat	NN	amod	B-Multi-tissue_structure
flap	NN	nmod	I-Multi-tissue_structure
is	VBZ	cop	O
possible	JJ	ccomp	O
and	CC	cc	O
may	MD	aux	O
have	VB	conj	O
extensive	JJ	amod	O
application	NN	dobj	O
in	IN	case	O
various	JJ	amod	O
areas	NNS	nmod	O
of	IN	case	O
plastic	JJ	amod	O
surgery	NN	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
and	CC	cc	O
re	NN	compound	O
-	HYPH	punct	O
expression	NN	conj	O
of	IN	case	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
in	IN	case	O
hybrids	NNS	nmod	O
of	IN	case	O
HA	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
-	:	punct	O
1	CD	nummod	O
-	HYPH	punct	O
transformed	VBN	amod	O
rat	NN	compound	O
-	:	punct	O
1	CD	nummod	O
cells	NNS	nmod	O
and	CC	cc	O
early	JJ	amod	O
-	HYPH	punct	O
passage	NN	conj	O
rat	NN	compound	O
embryonic	JJ	amod	O
fibroblasts	NNS	conj	O
.	.	punct	O
Requirement	NN	ROOT	O
of	IN	case	O
estrogen	NN	compound	B-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
for	IN	case	O
[	-LRB-	punct	O
12Val	NN	dep	B-Amino_acid
]	-RRB-	punct	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ras	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
.	.	punct	O

A	DT	det	O
clone	NN	nsubj	O
of	IN	prep	O
NIH3T3	NN	compound	O
transformant	NN	intj	O
(	-LRB-	punct	O
H	NN	compound	O
-	:	punct	O
3	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
obtained	VBN	acl	O
by	IN	mark	O
transfecting	VBG	advcl	O
genomic	JJ	amod	O
DNA	NN	dobj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	O
colon	NN	compound	O
carcinoma	NN	compound	O
cell	NN	compound	O
line	NN	nmod	O
,	,	punct	O
contains	VBZ	ROOT	O
human	JJ	amod	O
K	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
oncogene	NN	dobj	O
and	CC	cc	O
yields	VBZ	conj	O
metastatic	JJ	amod	O
pulmonary	JJ	amod	O
nodules	NNS	dobj	O
after	IN	case	O
intravenous	JJ	amod	O
injection	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
into	IN	case	O
nude	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O
We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
biological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
estrogen	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ERs	NNS	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
by	IN	case	O
the	DT	det	O
[	-LRB-	punct	O
12Val	NN	nummod	B-Amino_acid
]	-RRB-	punct	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ras	NN	compound	I-Gene_or_gene_product
mutant	NN	nmod	O
.	.	punct	O

Such	JJ	amod	O
repression	NN	compound	O
activity	NN	nsubj	O
was	VBD	cop	O
totally	RB	advmod	O
absent	JJ	ROOT	O
with	IN	case	O
mutant	JJ	amod	O
pm490	NN	nmod	O
/	:	punct	O
1	CD	nummod	O
/	SYM	punct	O
5A	NN	appos	O
.	.	punct	O
This	DT	det	O
mutant	NN	nsubj	O
enhanced	VBD	ROOT	O
the	DT	det	O
steady	JJ	amod	O
-	HYPH	punct	O
level	NN	nmod	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
ER	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
repetitive	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
tobacco	NN	compound	O
smoke	NN	nmod	O
promotes	VBZ	ccomp	O
tumor	NN	compound	O
development	NN	dobj	O
both	CC	cc:preconj	O
in	IN	case	O
carcinogen	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	conj	O
undergoing	VBG	acl	O
sporadic	JJ	amod	O
K	NN	compound	O
-	HYPH	punct	O
ras	NN	compound	O
activation	NN	dobj	O
in	IN	case	O
lung	NN	compound	O
epithelial	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O
Coexpression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
progesterone	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
with	IN	case	O
mutant	JJ	amod	O
K	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ras	NN	nmod	I-Gene_or_gene_product
led	VBD	ROOT	O
to	TO	case	O
suppression	NN	nmod	O
of	IN	case	O
tumorigenicity	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
ER	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
RNAs	NNS	nsubj	O
were	VBD	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
reticuloendotheliosis	NN	compound	O
virus	NN	compound	O
-	HYPH	punct	O
transformed	VBN	amod	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
antisense	JJ	amod	O
oligomers	NNS	nsubj	O
complementary	JJ	amod	O
to	TO	case	O
the	DT	det	O
ER	NN	nmod	B-Gene_or_gene_product
suppressed	VBD	ROOT	O
proliferation	NN	dobj	O
and	CC	cc	O
transformed	VBN	amod	O
phenotypes	NNS	conj	O
of	IN	case	O
K12V	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Combination	NN	nsubj	O
of	IN	case	O
ATX	NN	compound	O
expression	NN	nmod	O
with	IN	case	O
ras	NN	compound	O
transformation	NN	nmod	O
produced	VBD	ROOT	O
cells	NNS	dobj	O
with	IN	case	O
greatly	RB	advmod	O
amplified	VBN	amod	O
tumorigenesis	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
potential	NN	conj	O
compared	VBN	case	O
to	TO	case	O
ras	NN	nmod:npmod	O
-	HYPH	punct	O
transformed	VBN	amod	O
controls	NNS	advcl	O
.	.	punct	O
These	DT	det	O
observations	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
ER	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
Ras	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
.	.	punct	O

Silencing	NN	nsubj	O
of	IN	case	O
monocarboxylate	JJ	amod	O
transporters	NNS	nmod	O
via	IN	case	O
small	JJ	amod	O
interfering	VBG	amod	O
ribonucleic	JJ	amod	O
acid	NN	nmod	O
inhibits	VBZ	ROOT	O
glycolysis	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
cell	NN	compound	O
death	NN	dobj	O
in	IN	case	O
malignant	JJ	amod	O
glioma	NN	nmod	O
:	:	punct	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
study	NN	dobj	O
.	.	punct	O
Gene	NN	compound	O
therapy	NN	ROOT	O
for	IN	case	O
gliomas	NNS	nmod	B-Cancer
:	:	punct	O
p53	NN	dep	B-Gene_or_gene_product
and	CC	cc	O
E2F	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
proteins	NNS	conj	O
and	CC	cc	O
the	DT	det	O
target	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Gliomas	NNS	nsubj	O
are	VBP	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
primary	JJ	amod	O
tumours	NNS	attr	O
of	IN	prep	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	pobj	O
,	,	punct	O
with	IN	prep	O
nearly	RB	advmod	O
15	CD	nummod	O
,	,	punct	O
000	CD	nsubj	O
diagnosed	VBN	pcomp	O
annually	RB	advmod	O
in	IN	prep	O
the	DT	det	O
United	NNP	compound	O
States	NNP	pobj	O
and	CC	cc	O
a	DT	det	O
lethality	NN	conj	O
approaching	VBG	acl	O
80	CD	nummod	O
%	NN	dobj	O
within	IN	case	O
the	DT	det	O
first	JJ	amod	O
year	NN	nmod	O
of	IN	case	O
glioblastoma	NN	compound	O
diagnosis	NN	nmod	O
.	.	punct	O
Current	JJ	amod	O
therapy	NN	nsubj	O
for	IN	case	O
glioma	NN	nmod	B-Cancer
is	VBZ	cop	O
suboptimal	JJ	ROOT	O
.	.	punct	O

These	DT	det	O
changes	NNS	nsubj	O
should	MD	aux	O
diminish	VB	ROOT	O
apoptosis	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O
The	DT	det	O
transfer	NN	nsubj	O
of	IN	case	O
apoptosis	NN	compound	O
genes	NNS	nmod	O
to	TO	case	O
tumors	NNS	nmod	B-Cancer
constitutes	VBZ	ROOT	O
one	CD	dobj	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
promising	JJ	amod	O
strategies	NNS	nmod	O
for	IN	case	O
cancer	NN	compound	B-Cancer
gene	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

E1A	NN	compound	O
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	O
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	O
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
massive	JJ	amod	O
apoptosis	NN	nsubj	O
occurs	VBZ	ccomp	O
when	WRB	advmod	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
p53	NN	dep	B-Gene_or_gene_product
or	CC	cc	O
E2F	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	advcl	O
in	IN	case	O
glioma	NN	nmod	B-Cancer
.	.	punct	O

E1A	NN	compound	O
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	O
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	O
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
and	CC	cc	O
the	DT	det	O
efficiency	NN	conj	O
in	IN	mark	O
inducing	VBG	acl	O
apoptosis	NN	dobj	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
proteins	NNS	nmod	O
are	VBP	cop	O
not	RB	neg	O
similar	JJ	ROOT	O
.	.	punct	O

As	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
ELISA	NN	nmod	O
and	CC	cc	O
immunoblot	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
ras	NN	compound	O
p21	NN	nsubj	O
in	IN	case	O
the	DT	det	O
serum	NN	nmod	O
increased	VBD	ROOT	O
with	IN	case	O
increased	VBN	amod	O
tumor	NN	compound	O
growth	NN	nmod	O
.	.	punct	O
Adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
transfer	NN	nsubj	O
is	VBZ	cop	O
ineffective	JJ	ROOT	O
in	IN	mark	O
causing	VBG	advcl	O
apoptosis	NN	dobj	O
in	IN	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
retain	VBP	acl:relcl	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
p53	NN	compound	B-Gene_or_gene_product
genotype	NN	dobj	O
or	CC	cc	O
overexpress	VBP	conj	O
the	DT	det	O
p21	NN	compound	B-Gene_or_gene_product
protein	NN	dobj	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
ING4	NN	nmod	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
brain	NN	compound	O
tissue	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
reduction	NN	nmod	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
from	IN	case	O
lower	JJR	nmod	O
to	IN	case	O
higher	JJR	amod	O
grades	NNS	nmod	O
of	IN	prep	O
tumours	NNS	pobj	O
.	.	punct	O
The	DT	det	O
p16	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Rb	NN	compound	B-Gene_or_gene_product
/	:	punct	O
E2F	NN	compound	B-Gene_or_gene_product
pathway	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
most	RBS	advmod	O
frequent	JJ	amod	O
target	NN	ROOT	O
of	IN	case	O
genetic	JJ	amod	O
alterations	NNS	nmod	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
therefore	RB	advmod	O
constitutes	VBZ	conj	O
a	DT	det	O
suitable	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
gene	NN	compound	O
therapy	NN	compound	O
strategies	NNS	nmod	O
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	O
cycle	NN	compound	O
inhibitors	NNS	nmod	O
,	,	punct	O
p16	NN	compound	O
(	-LRB-	punct	O
INK4A	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
p15	NN	conj	O
(	-LRB-	punct	O
INK4B	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
have	VBP	ROOT	O
tumor	NN	compound	O
suppressor	NN	compound	O
activities	NNS	dobj	O
and	CC	cc	O
are	VBP	auxpass	O
inactivated	VBN	conj	O
in	IN	case	O
human	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O
However	RB	advmod	O
,	,	punct	O
the	DT	det	O
transfer	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	dep	O
p16	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
Rb	NN	conj	B-Gene_or_gene_product
gene	NN	dep	O
to	TO	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
results	VBZ	ROOT	O
in	IN	case	O
cytostatic	JJ	amod	O
effect	NN	nmod	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
ING4	NN	nmod	O
is	VBZ	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
gliomas	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
brain	NN	compound	O
tissue	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
reduction	NN	nmod	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
from	IN	case	O
lower	JJR	nmod	O
to	IN	case	O
higher	JJR	amod	O
grades	NNS	nmod	O
of	IN	prep	O
tumours	NNS	pobj	O
.	.	punct	O
The	DT	det	O
E2F	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nsubj	O
is	VBZ	cop	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
generalized	VBN	amod	O
apoptosis	NN	dobj	O
in	IN	case	O
gliomas	NNS	nmod	B-Cancer
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
,	,	punct	O
p16	NN	conj	B-Gene_or_gene_product
or	CC	cc	O
Rb	NN	conj	B-Gene_or_gene_product
status	NN	nmod	O
.	.	punct	O

Continuous	JJ	amod	O
(	-LRB-	punct	O
24h	NN	dep	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
with	IN	case	O
5	CD	compound	O
microM	NN	amod	O
doxorubicin	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
arrest	NN	nmod	O
in	IN	case	O
G0	NN	compound	O
/	:	punct	O
G1	NN	compound	O
phase	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
neither	CC	cc:preconj	O
accompanied	VBN	acl:relcl	O
by	IN	case	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
p53	NN	nmod	O
nor	CC	cc	O
enhanced	VBD	amod	O
expression	NN	conj	O
of	IN	case	O
p21	NN	nmod	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
p21	NN	compound	B-Gene_or_gene_product
-	:	punct	O
or	CC	cc	O
p16	NN	compound	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
growth	NN	compound	O
arrest	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
protect	VB	ROOT	O
glioma	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
from	IN	case	O
E2F	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

E1A	NN	compound	O
proteins	NNS	nsubj	O
stimulate	VBP	ROOT	O
DNA	NN	compound	O
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
proliferation	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
they	PRP	nsubj	O
also	RB	advmod	O
cause	VBP	parataxis	O
rapid	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
by	IN	case	O
p53	NN	compound	O
-	:	punct	O
dependent	JJ	amod	O
and	CC	cc	O
p53	NN	nmod:npmod	O
-	:	punct	O
independent	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O
The	DT	det	O
apoptotic	JJ	amod	O
molecule	NN	compound	O
bax	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
p53	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
bax	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
not	RB	neg	O
induced	VBN	conj	O
in	IN	case	O
E2F	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	intj	I-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
glioma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

This	DT	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
strategy	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
therapeutic	JJ	dep	O
avenue	NN	ccomp	O
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
malignant	JJ	amod	O
glioma	NN	nmod	O
.	.	punct	O
Careful	JJ	amod	O
selection	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	B-Organism
may	MD	aux	O
be	VB	cop	O
necessary	JJ	ROOT	O
before	IN	mark	O
designing	VBG	advcl	O
therapeutic	JJ	amod	O
strategies	NNS	dobj	O
using	VBG	acl	O
either	CC	cc:preconj	O
p53	NN	dobj	B-Gene_or_gene_product
or	CC	cc	O
E2F	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
as	IN	case	O
a	DT	det	O
therapeutic	JJ	amod	O
tools	NNS	nmod	O
for	IN	case	O
glioma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Increased	VBN	amod	O
serum	NN	compound	O
levels	NNS	ROOT	O
of	IN	case	O
vascular	JJ	amod	O
endothelial	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
renal	JJ	amod	O
cell	NN	compound	O
carcinoma	NN	nmod	O
.	.	punct	O
Protective	JJ	amod	O
function	NN	ROOT	O
of	IN	case	O
von	NN	compound	B-Gene_or_gene_product
Hippel	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Lindau	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
against	IN	case	O
impaired	JJ	amod	O
protein	NN	compound	O
processing	NN	nmod	O
in	IN	case	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
relevance	NN	nsubjpass	O
of	IN	case	O
Brk1	NN	nmod	O
is	VBZ	auxpass	O
emphasized	VBN	ROOT	O
by	IN	case	O
correlative	JJ	amod	O
data	NNS	nmod	O
showing	VBG	acl	O
that	IN	mark	O
Von	NNP	compound	O
Hippel	NNP	compound	O
-	HYPH	punct	O
Lindau	NNP	compound	O
(	-LRB-	punct	O
VHL	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nsubjpass	O
that	WDT	nsubj	O
also	RB	advmod	O
lose	VBP	acl:relcl	O
the	DT	det	O
BRK1	NN	compound	O
gene	NN	dobj	O
are	VBP	auxpass	O
protected	VBN	ccomp	O
against	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
The	DT	det	O
absence	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
von	NN	compound	B-Gene_or_gene_product
Hippel	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Lindau	NNP	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VHL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
neoplasias	NNS	nmod	O
characteristic	JJ	amod	O
of	IN	case	O
VHL	NN	compound	B-Gene_or_gene_product
disease	NN	nmod	O
,	,	punct	O
including	VBG	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
RCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
clinical	JJ	amod	O
relevance	NN	nsubjpass	O
of	IN	case	O
Brk1	NN	nmod	O
is	VBZ	auxpass	O
emphasized	VBN	ROOT	O
by	IN	case	O
correlative	JJ	amod	O
data	NNS	nmod	O
showing	VBG	acl	O
that	IN	mark	O
Von	NNP	compound	O
Hippel	NNP	compound	O
-	HYPH	punct	O
Lindau	NNP	compound	O
(	-LRB-	punct	O
VHL	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nsubjpass	O
that	WDT	nsubj	O
also	RB	advmod	O
lose	VBP	acl:relcl	O
the	DT	det	O
BRK1	NN	compound	O
gene	NN	dobj	O
are	VBP	auxpass	O
protected	VBN	ccomp	O
against	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O
Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
RCC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
lacking	VBG	acl	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
function	NN	dobj	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
RCC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
expressing	VBG	acl	O
the	DT	det	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
(	-LRB-	punct	O
wtVHL	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
after	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
various	JJ	amod	O
stresses	NNS	nmod	O
.	.	punct	O

Changes	NNS	nsubjpass	O
in	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	compound	O
(	-LRB-	punct	O
L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cFLIPs	NN	conj	O
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
some	DT	intj	O
but	CC	cc	O
not	RB	cc	O
all	PDT	det:predet	O
the	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
studied	VBN	acl	O
following	VBG	case	O
glucose	NN	compound	O
deprivation	NN	nmod	O
.	.	punct	O
While	IN	mark	O
the	DT	det	O
response	NN	nsubjpass	O
to	TO	case	O
most	JJS	amod	O
treatments	NNS	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	advcl	O
by	IN	case	O
the	DT	det	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
status	NN	nmod	O
,	,	punct	O
glucose	NN	compound	B-Simple_chemical
deprivation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	aux	O
be	VB	cop	O
much	RB	advmod	O
more	RBR	advmod	O
cytotoxic	JJ	xcomp	O
for	IN	case	O
RCC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
lacking	VBG	acl	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
function	NN	dobj	O
than	IN	case	O
for	IN	case	O
wtVHL	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Changes	NNS	nsubjpass	O
in	IN	case	O
c	NN	compound	O
-	HYPH	punct	O
FLIP	NN	compound	O
(	-LRB-	punct	O
L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cFLIPs	NN	conj	O
levels	NNS	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
some	DT	intj	O
but	CC	cc	O
not	RB	cc	O
all	PDT	det:predet	O
the	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
studied	VBN	acl	O
following	VBG	case	O
glucose	NN	compound	O
deprivation	NN	nmod	O
.	.	punct	O
The	DT	det	O
heightened	VBN	amod	O
sensitivity	NN	nsubjpass	O
of	IN	case	O
VHL	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
cells	NNS	nmod	B-Cell
was	VBD	auxpass	O
not	RB	neg	O
attributed	VBN	ROOT	O
to	TO	case	O
dissimilar	JJ	amod	O
energy	NN	compound	O
requirements	NNS	nmod	O
or	CC	cc	O
to	TO	case	O
differences	NNS	conj	O
in	IN	case	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	nmod	O
,	,	punct	O
but	CC	cc	O
more	RBR	advmod	O
likely	RB	advmod	O
reflects	VBZ	conj	O
a	DT	det	O
lesser	JJR	amod	O
ability	NN	dobj	O
of	IN	case	O
VHL	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
cells	NNS	nmod	B-Cell
to	TO	mark	O
handle	VB	acl	O
abnormally	RB	advmod	O
processed	VBN	amod	O
proteins	NNS	dobj	O
arising	VBG	acl	O
from	IN	case	O
impaired	JJ	amod	O
glycosylation	NN	nmod	O
.	.	punct	O

With	IN	case	O
U937	NN	compound	O
cells	NNS	nmod	O
,	,	punct	O
tunicamycin	NN	compound	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
a	DT	det	O
30	CD	compound	O
-	HYPH	punct	O
40	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
staining	NN	conj	O
of	IN	case	O
a	DT	det	O
45	CD	compound	O
kDa	NN	compound	O
band	NN	nmod	O
.	.	punct	O
In	IN	case	O
support	NN	nmod	O
of	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
,	,	punct	O
other	JJ	amod	O
treatments	NNS	intj	O
which	WDT	nsubj	O
act	VBP	acl:relcl	O
through	IN	case	O
different	JJ	amod	O
mechanisms	NNS	nmod	O
to	TO	mark	O
interfere	VB	xcomp	O
with	IN	case	O
protein	NN	compound	O
processing	NN	nmod	O
(	-LRB-	punct	O
i	LS	dep	O
.	.	punct	O
e	LS	nsubjpass	O
.	.	punct	O
,	,	punct	O
tunicamycin	NN	conj	B-Simple_chemical
,	,	punct	O
brefeldin	NN	compound	B-Simple_chemical
A	NN	conj	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
azetidine	NN	conj	B-Simple_chemical
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
much	RB	advmod	O
more	RBR	advmod	O
toxic	JJ	xcomp	O
for	IN	case	O
VHL	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Glucose	NN	compound	O
deprivation	NN	nsubj	O
enhanced	VBD	ROOT	O
death	NN	compound	O
receptor	NN	npadvmod	O
-	HYPH	punct	O
triggered	VBN	amod	O
formation	NN	dobj	O
of	IN	case	O
death	NN	npadvmod	O
-	HYPH	punct	O
inducing	VBG	amod	O
signaling	NN	compound	O
complex	NN	nmod	O
and	CC	cc	O
early	JJ	amod	O
processing	NN	conj	O
of	IN	case	O
procaspase	NN	nmod	O
-	,	punct	O
8	CD	nummod	O
.	.	punct	O
Furthermore	RB	advmod	O
,	,	punct	O
ubiquitination	NN	nsubj	O
of	IN	case	O
cellular	JJ	amod	B-Cell
proteins	NNS	nmod	O
was	VBD	aux	O
elevated	JJ	ROOT	O
in	IN	case	O
VHL	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
deficient	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
particularly	RB	advmod	O
after	IN	case	O
glucose	NN	compound	B-Simple_chemical
deprivation	NN	nmod	O
,	,	punct	O
supporting	VBG	advcl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
ubiquitin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
proteolysis	NN	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
functional	JJ	amod	O
p53	NN	nsubjpass	O
was	VBD	auxpass	O
retained	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
even	RB	advmod	O
after	IN	case	O
transplantation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
explanted	VBN	amod	O
tumor	NN	compound	O
cells	NNS	nsubj	O
displayed	VBD	parataxis	O
rapid	JJ	amod	O
allele	NN	compound	O
loss	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O
Accordingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
rate	NN	nsubj	O
of	IN	case	O
elimination	NN	nmod	O
of	IN	case	O
abnormal	JJ	amod	O
proteins	NNS	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
lacking	VBG	acl	O
a	DT	det	O
functional	JJ	amod	O
VHL	NN	compound	B-Gene_or_gene_product
gene	NN	dobj	O
than	IN	case	O
in	IN	case	O
wtVHL	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
glycogen	NN	nsubjpass	O
was	VBD	auxpass	O
depleted	VBN	ccomp	O
in	IN	case	O
a	DT	det	O
low	JJ	amod	O
glucose	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
but	CC	cc	O
conserved	VBN	conj	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O
Thus	RB	advmod	O
,	,	punct	O
pVHL	NN	nsubj	B-Gene_or_gene_product
appears	VBZ	ROOT	O
to	TO	mark	O
participate	VB	xcomp	O
in	IN	case	O
the	DT	det	O
elimination	NN	nmod	O
of	IN	case	O
misprocessed	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
those	DT	nmod	O
arising	VBG	acl	O
in	IN	case	O
the	DT	det	O
cell	NN	nmod	B-Cell
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
unavailability	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
or	CC	cc	O
to	TO	case	O
other	JJ	amod	O
stresses	NNS	conj	O
.	.	punct	O
